<SEC-DOCUMENT>0001554795-24-000195.txt : 20240808
<SEC-HEADER>0001554795-24-000195.hdr.sgml : 20240808
<ACCEPTANCE-DATETIME>20240808171650
ACCESSION NUMBER:		0001554795-24-000195
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		108
CONFORMED PERIOD OF REPORT:	20240430
FILED AS OF DATE:		20240808
DATE AS OF CHANGE:		20240808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Red Cat Holdings, Inc.
		CENTRAL INDEX KEY:			0000748268
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				880490034
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40202
		FILM NUMBER:		241189657

	BUSINESS ADDRESS:	
		STREET 1:		15 AVE. MUNOZ RIVERA
		STREET 2:		STE 2200
		CITY:			SAN JUAN
		STATE:			PR
		ZIP:			00901-2510
		BUSINESS PHONE:		833-373-3228

	MAIL ADDRESS:	
		STREET 1:		15 AVE. MUNOZ RIVERA
		STREET 2:		STE 2200
		CITY:			SAN JUAN
		STATE:			PR
		ZIP:			00901-2510

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TimefireVR Inc.
		DATE OF NAME CHANGE:	20161121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EnergyTEK Corp.
		DATE OF NAME CHANGE:	20140723

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BROADLEAF CAPITAL PARTNERS INC
		DATE OF NAME CHANGE:	20040928
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>rcat0808form10k.htm
<DESCRIPTION>FORM 10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:RCAT="http://RCAT/20240430">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_RCAT_RCAT_20240430 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20230501_20240430 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0000748268 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_070_XDX_C%2D%2D\Users\zackz\Documents\XBRL accounts\RCAT\2024\10%2DK 0808\rcat0808template.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:EntityCentralIndexKey" id="ixv-13524">0000748268</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:AmendmentFlag" id="ixv-13525">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0011" name="dei:DocumentAnnualReport">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0012" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0013" name="dei:DocumentFiscalYearFocus">2024</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0014" name="dei:CurrentFiscalYearEndDate">--04-30</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0038" name="dei:EntitySmallBusiness">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0040" name="dei:IcfrAuditorAttestationFlag">true</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:Investments" contextRef="AsOf2024-04-30" id="xdx2ixbrl0058" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="AsOf2024-04-30" id="xdx2ixbrl0070" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EquityMethodInvestments" contextRef="AsOf2023-04-30" id="xdx2ixbrl0083" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent" contextRef="AsOf2023-04-30" id="xdx2ixbrl0086" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" contextRef="AsOf2024-04-30" id="xdx2ixbrl0097" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="AsOf2024-04-30" id="xdx2ixbrl0127" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2024-04-30" id="xdx2ixbrl0136" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" contextRef="AsOf2024-04-30" id="xdx2ixbrl0139" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0212" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0215" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0218" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012023-04-30_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0265" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember" id="xdx2ixbrl0266" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0268" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0269" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2022-05-012023-04-30_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0272" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0275" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0276" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012023-04-30_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0280" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0283" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0284" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-05-012023-04-30_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0288" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember" id="xdx2ixbrl0289" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0290" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0291" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-05-012023-04-30_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0295" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember" id="xdx2ixbrl0296" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0297" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0298" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0302" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember" id="xdx2ixbrl0303" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0304" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0306" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0318" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" id="xdx2ixbrl0319" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0321" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0322" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0325" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0328" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0329" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0336" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0337" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0338" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:StockIssuedDuringPeriodValueThroughATMFacility" contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0342" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:StockIssuedDuringPeriodValueThroughATMFacility" contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0345" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:StockIssuedDuringPeriodValueThroughATMFacility" contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0346" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0353" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0354" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0358" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0361" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0362" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0367" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" id="xdx2ixbrl0368" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0369" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0370" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0374" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" id="xdx2ixbrl0375" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0376" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0377" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0381" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" id="xdx2ixbrl0382" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0383" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0385" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0418" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDerivativeLiabilities" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0431" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0434" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0437" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireAssetsInvestingActivities" contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0481" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:ProceedsFromIssuanceOfCommonStockPublicOffering" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0491" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:ProceedsFromIssuanceOfCommonStockATMFacilityNet" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0505" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0508" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0520" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0521" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0523" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0524" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCash" contextRef="AsOf2024-04-30" id="xdx2ixbrl0538" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0547" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0548" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0554" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:NoncashOrPartNoncashDivestitureNoteReceivable" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0557" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:ConversionOfPreferredStockIntoCommonStock" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0563" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:FairValueOfSharesWithheldAsPaymentOfNoteReceivable" contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0565" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:TaxesRelatedToNetShareSettlementOfEquityAwards" contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0568" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DerivativeLiabilitiesCurrent" contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember" id="xdx2ixbrl0601" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities" contextRef="From2022-05-012023-04-30_custom_RestatementImpactAsRestatedMember" id="xdx2ixbrl0633" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0737" decimals="0" sign="-" unitRef="USD">21526696</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0738" decimals="0" sign="-" unitRef="USD">17687063</ix:nonFraction>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl0783" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCash" contextRef="AsOf2024-04-30" id="xdx2ixbrl0799" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" contextRef="AsOf2024-04-30" id="xdx2ixbrl0802" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" contextRef="AsOf2024-04-30" id="xdx2ixbrl0805" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" contextRef="AsOf2024-04-30" id="xdx2ixbrl0808" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="AsOf2024-04-30" id="xdx2ixbrl0811" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" contextRef="AsOf2024-04-30" id="xdx2ixbrl0814" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" contextRef="AsOf2024-04-30" id="xdx2ixbrl0817" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent" contextRef="AsOf2024-04-30" id="xdx2ixbrl0820" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" contextRef="AsOf2024-04-30" id="xdx2ixbrl0823" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" contextRef="AsOf2024-04-30" id="xdx2ixbrl0829" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" contextRef="AsOf2024-04-30" id="xdx2ixbrl0832" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" contextRef="AsOf2024-04-30" id="xdx2ixbrl0835" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent" contextRef="AsOf2024-04-30" id="xdx2ixbrl0838" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="AsOf2024-04-30" id="xdx2ixbrl0841" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent" contextRef="AsOf2024-04-30" id="xdx2ixbrl0844" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationWorkingCapital" contextRef="AsOf2024-04-30" id="xdx2ixbrl0847" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GrantsReceivableCurrent" contextRef="AsOf2023-04-30" id="xdx2ixbrl0882" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss" contextRef="AsOf2024-04-30" id="xdx2ixbrl0887" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:FiniteLivedNoncompeteAgreementsGross1" contextRef="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember" id="xdx2ixbrl0920" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:FiniteLivedCustomerRelationshipsGross1" contextRef="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember" id="xdx2ixbrl0925" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:FiniteLivedCustomerRelationshipsGross1" contextRef="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember" id="xdx2ixbrl0926" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:FiniteLivedCustomerRelationshipsGross1" contextRef="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember" id="xdx2ixbrl0927" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IndefiniteLivedTradeNames" contextRef="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember" id="xdx2ixbrl0940" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IndefiniteLivedTradeNames" contextRef="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember" id="xdx2ixbrl0943" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1" contextRef="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember" id="xdx2ixbrl0947" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1" contextRef="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember" id="xdx2ixbrl0950" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2024-04-30" id="xdx2ixbrl0970" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2024-04-30" id="xdx2ixbrl0972" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2023-04-012023-04-30" id="xdx2ixbrl0993" decimals="0" unitRef="USD">2826918</ix:nonFraction>
  <ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2024-04-012024-04-30" id="xdx2ixbrl0994" decimals="0" unitRef="USD">412999</ix:nonFraction>
  <ix:nonFraction name="RCAT:OutstandingPrincipalPaymentsDueLongTerm" contextRef="AsOf2024-04-30" id="xdx2ixbrl1119" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-04-30" id="xdx2ixbrl1130" decimals="0" sign="-" unitRef="USD">81130732</ix:nonFraction>
  <ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-04-30" id="xdx2ixbrl1131" decimals="0" sign="-" unitRef="USD">57078103</ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2022-05-012023-04-30_custom_WarrantAssumptionsUsedMember" id="xdx2ixbrl1192" unitRef="Pure" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-05-012024-04-30_custom_WarrantAssumptionsUsedMember" id="xdx2ixbrl1193" unitRef="Pure" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-05-012023-04-30_custom_WarrantAssumptionsUsedMember" id="xdx2ixbrl1194" unitRef="Pure" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2022-05-012023-04-30_custom_WarrantAssumptionsUsedMember" id="xdx2ixbrl1197" unitRef="Pure" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-05-012023-04-30_custom_WarrantsOutstanding1Member" id="xdx2ixbrl1204" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2022-05-012023-04-30_custom_WarrantsOutstanding1Member" id="xdx2ixbrl1205" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-05-012023-04-30_custom_WarrantsOutstanding1Member" id="xdx2ixbrl1206" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2022-05-012023-04-30_custom_WarrantsOutstanding1Member" id="xdx2ixbrl1207" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2023-04-30_custom_WarrantsOutstanding1Member" id="xdx2ixbrl1211" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-05-012024-04-30_custom_WarrantsOutstanding1Member" id="xdx2ixbrl1214" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2023-05-012024-04-30_custom_WarrantsOutstanding1Member" id="xdx2ixbrl1215" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-05-012024-04-30_custom_OptionsAssumptionsUsedMember" id="xdx2ixbrl1237" unitRef="Pure" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember" id="xdx2ixbrl1238" unitRef="Pure" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-05-012023-04-30_custom_Options1Member" id="xdx2ixbrl1255" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2022-05-012023-04-30_custom_Options1Member" id="xdx2ixbrl1256" unitRef="USDPShares" xs:nil="true"/>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="rcat-20240430.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-05-01to2024-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_custom_SeriesBPreferredStock1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_SeriesBPreferredStock1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_SeriesBPreferredStock1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_custom_SeriesBPreferredStock1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-012020-04-30_custom_BusinessAcquisition1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-01</xbrli:startDate>
        <xbrli:endDate>2020-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-012021-04-30_custom_BusinessAcquisition2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-01</xbrli:startDate>
        <xbrli:endDate>2021-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_BusinessAcquisition3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_BusinessAcquisition4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactOriginallyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactAsRestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_RestatementImpactChangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactChangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_RestatementImpactOriginallyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactOriginallyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_RestatementImpactAsRestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactAsRestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_RestatementImpactChangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactChangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_custom_CustomerConcentrationRisk1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_CustomerConcentrationRisk1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_custom_CustomerConcentrationRisk2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_CustomerConcentrationRisk3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_CustomerConcentrationRisk4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_CustomerConcentrationRisk5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012023-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsGrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsAccumulatedAmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsNetCarryingValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsGrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsAccumulatedAmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsNetCarryingValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012023-04-30_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012023-04-30_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012023-04-30_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-012023-04-30_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-04-30_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-012024-04-30_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-11-012022-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-11-01</xbrli:startDate>
        <xbrli:endDate>2022-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_custom_OperatingLeaseLocation1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">RCAT:OperatingLeaseLocation1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_custom_OperatingLeaseLocation3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">RCAT:OperatingLeaseLocation3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_custom_OperatingLeaseLocation4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">RCAT:OperatingLeaseLocation4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-08-31_custom_DebtObligation1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-012023-04-30_custom_DebtObligation1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-08-012023-04-30_custom_DebtObligation1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-08-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_DebtObligation2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_custom_DebtObligation2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_custom_DebtObligation2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_DebtObligation2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-31_custom_DebtObligation3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-012022-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-01</xbrli:startDate>
        <xbrli:endDate>2022-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-04-30_custom_DebtObligation6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-04-30_custom_DebtObligation6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_custom_DebtObligation6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_DebtObligation6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-012022-09-30_custom_DebtObligation8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-012023-04-30_custom_DebtObligation8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_custom_DebtObligation8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_DebtObligation8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012023-04-30_custom_DueToRelatedParty2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DueToRelatedParty2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_custom_DueToRelatedParty2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DueToRelatedParty2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-04-30_custom_DueToRelatedParty2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DueToRelatedParty2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_custom_SeriesAPreferredStock2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RCAT:SeriesAPreferredStock2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012022-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012022-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2022-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-10-012020-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-10-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_custom_WarrantAssumptionsUsedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantAssumptionsUsedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_WarrantAssumptionsUsedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantAssumptionsUsedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_custom_WarrantsOutstanding1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_WarrantsOutstanding1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_WarrantsOutstanding1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_WarrantsOutstanding1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_custom_WarrantsOutstanding1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_custom_WarrantsOutstanding1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_custom_OptionsAssumptionsUsedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_OptionsAssumptionsUsedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_custom_OptionsAssumptionsUsedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-30_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt"><b>UNITED
STATES</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt"><b>FORM
<span id="xdx_90D_edei--DocumentType_c20230501__20240430_z9u1uuzmHycd"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:DocumentType" id="ixv-14601">10-K</ix:nonNumeric></span></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">(Mark One)</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><b><span id="xdx_90F_edei--DocumentAnnualReport_dxL_c20230501__20240430_zsB4DZugrrGh" title="::XDX::true"><span style="-sec-ix-hidden: xdx2ixbrl0011">&#9745;</span></span>
</b></span><b><span style="font-size: 10pt">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt">For
the <span id="xdx_900_edei--DocumentFiscalPeriodFocus_dxL_c20230501__20240430_zPDMDX9xCSv8" title="::XDX::FY"><span style="-sec-ix-hidden: xdx2ixbrl0012">fiscal</span></span> <span id="xdx_902_edei--DocumentFiscalYearFocus_dxL_c20230501__20240430_zS9AtSL7WFZf" title="::XDX::2024"><span style="-sec-ix-hidden: xdx2ixbrl0013">year</span></span> <span id="xdx_909_edei--CurrentFiscalYearEndDate_dxL_c20230501__20240430_z6e7K4xfZfZ1" title="::XDX::--04-30"><span style="-sec-ix-hidden: xdx2ixbrl0014">ended</span></span> <span id="xdx_901_edei--DocumentPeriodEndDate_c20230501__20240430_zE3BPPNh9Qf3"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-14602">April 30, 2024</ix:nonNumeric></span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt">or</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><b><span id="xdx_904_edei--DocumentTransitionReport_c20230501__20240430_zTmOGTrSqH3l"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" format="ixt:booleanfalse" name="dei:DocumentTransitionReport" id="ixv-14603">&#9744;</ix:nonNumeric></span>
</b></span><b><span style="font-size: 10pt">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt">For
the transition period from <b>________</b> to <b>_________</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt">Commission
File Number:&#160;&#160;<span id="xdx_905_edei--EntityFileNumber_c20230501__20240430_zYko0jcGuAO6"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:EntityFileNumber" id="ixv-14604">001-40202</ix:nonNumeric></span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_905_edei--EntityRegistrantName_c20230501__20240430_zW9eWLGjbpya"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:EntityRegistrantName" id="ixv-14605">Red
Cat Holdings, Inc.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 48%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20230501__20240430_zc83hdn5y0o2"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-14606">Nevada</ix:nonNumeric></span></span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 45%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20230501__20240430_zQw4NpoqV1Z"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:EntityTaxIdentificationNumber" id="ixv-14607">88-0490034</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">(State or other jurisdiction
    of incorporation or organization)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">(I.R.S. Employer Identification
    No.)</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 48%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><span id="xdx_904_edei--EntityAddressAddressLine1_c20230501__20240430_zF5KpH5eTPib"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:EntityAddressAddressLine1" id="ixv-14608">15 Ave. Munoz Rivera</ix:nonNumeric></span>,
    <span id="xdx_90E_edei--EntityAddressAddressLine2_c20230501__20240430_z2BO9R43NRZ7"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:EntityAddressAddressLine2" id="ixv-14609">Ste 2200</ix:nonNumeric></span></span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><span id="xdx_90B_edei--EntityAddressCityOrTown_c20230501__20240430_z1VvZMqHL7T5"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:EntityAddressCityOrTown" id="ixv-14610">San Juan</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressCountry_c20230501__20240430_zQ8RMPEzXOra"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:EntityAddressCountry" id="ixv-14611">PR</ix:nonNumeric></span></span></p></td>
    <td style="vertical-align: top; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 45%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><span id="xdx_905_edei--EntityAddressPostalZipCode_c20230501__20240430_z0PCilTj1G6g"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:EntityAddressPostalZipCode" id="ixv-14612">00901</ix:nonNumeric></span></span></p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">(Address of principal executive
    offices)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Registrant&#8217;s
telephone number, including area code:&#160;<span id="xdx_906_edei--CityAreaCode_c20230501__20240430_zNrWmFekSHSd"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:CityAreaCode" id="ixv-14613">(833)</ix:nonNumeric></span> <span id="xdx_908_edei--LocalPhoneNumber_c20230501__20240430_zwNkzPGR5f7h"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:LocalPhoneNumber" id="ixv-14614">373-3228</ix:nonNumeric></span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Securities registered
pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: black 1pt solid; border-left: black 1pt solid; width: 33%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Title
    of each class</span></td>
    <td style="border-top: black 1pt solid; border-left: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-left: black 1pt solid; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt"><span id="xdx_90A_edei--Security12bTitle_c20230501__20240430_z45nciAvKpd6"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:Security12bTitle" id="ixv-14615">Common
    stock, par value $0.001</ix:nonNumeric></span></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt"><span id="xdx_903_edei--TradingSymbol_c20230501__20240430_zA9xzssKXyjf"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:TradingSymbol" id="ixv-14616">RCAT</ix:nonNumeric></span></span></td>
    <td style="border: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt"><span id="xdx_908_edei--SecurityExchangeName_c20230501__20240430_zoO1RpJ3G1oa"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-14617">Nasdaq</ix:nonNumeric></span>
    Capital Market</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Securities registered
pursuant to Section 12(g) of the Act: None.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Indicate by check mark
if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes <span style="font-family: Segoe UI Symbol,sans-serif">&#9744;
</span><span id="xdx_90B_edei--EntityWellKnownSeasonedIssuer_c20230501__20240430_z5HJbN81lJc3"><span id="xdx_90F_edei--EntityWellKnownSeasonedIssuer_c20230501__20240430_zG1lHiIyCWB2"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:EntityWellKnownSeasonedIssuer" id="ixv-14618"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:EntityWellKnownSeasonedIssuer" id="ixv-14619">No</ix:nonNumeric></ix:nonNumeric></span></span> <span style="font-family: Segoe UI Symbol,sans-serif">&#9745;</span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Indicate by check mark
if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes <span style="font-family: Segoe UI Symbol,sans-serif">&#9744;
</span><span id="xdx_90F_edei--EntityVoluntaryFilers_c20230501__20240430_zw2xB1aUJmLb"><span id="xdx_908_edei--EntityVoluntaryFilers_c20230501__20240430_zUUnB78ijR33"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:EntityVoluntaryFilers" id="ixv-14620"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:EntityVoluntaryFilers" id="ixv-14621">No</ix:nonNumeric></ix:nonNumeric></span></span> <span style="font-family: Segoe UI Symbol,sans-serif">&#9745;</span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Indicate by check mark
whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days. <span id="xdx_900_edei--EntityCurrentReportingStatus_c20230501__20240430_zEm0hxRz30lj"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:EntityCurrentReportingStatus" id="ixv-14622">Yes</ix:nonNumeric></span> <span style="font-family: Segoe UI Symbol,sans-serif">&#9745;</span> No <span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Indicate by check mark
whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T (&#167;&#8201;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required
to submit such files). <span id="xdx_902_edei--EntityInteractiveDataCurrent_c20230501__20240430_zuVqA0dMTKS2"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:EntityInteractiveDataCurrent" id="ixv-14623">Yes</ix:nonNumeric></span> <span style="font-family: Segoe UI Symbol,sans-serif">&#9745;</span> No <span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an
emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller
reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Large accelerated filer</span></td>
    <td style="width: 31%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt">&#9744;</span></td>
    <td style="width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Accelerated filer</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt">&#9744;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt"><span id="xdx_90B_edei--EntityFilerCategory_c20230501__20240430_zvaAdh7HNF9"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-14624">Non-accelerated filer</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt">&#9745;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Smaller reporting company</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><span id="xdx_903_edei--EntitySmallBusiness_dxL_c20230501__20240430_zDtMDC83rw11" title="::XDX::true"><span style="-sec-ix-hidden: xdx2ixbrl0038">&#9745;</span></span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Emerging growth company</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20230501__20240430_zofZtS3MI596"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany" id="ixv-14625">&#9744;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span></span></p>

<p style="font: 12pt Segoe UI Symbol,sans-serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Indicate by check mark
whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal
control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting
firm that prepared or issued its audit report. <span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_904_edei--IcfrAuditorAttestationFlag_dxL_c20230501__20240430_zgE377Om31gd" title="::XDX::true"><span style="-sec-ix-hidden: xdx2ixbrl0040">&#9745;</span></span></span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">If securities are registered
pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing
reflect the correction of an error to previously issued financial statements. <span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_909_edei--DocumentFinStmtErrorCorrectionFlag_c20230501__20240430_zeLf5M2TxnDa"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" format="ixt:booleanfalse" name="dei:DocumentFinStmtErrorCorrectionFlag" id="ixv-14626">&#9744;</ix:nonNumeric></span></span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Indicate by check mark
whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by
any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). <span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Indicate by check mark
whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;Yes&#160;<span style="font-family: Segoe UI Symbol,sans-serif">&#9744;
</span><span id="xdx_90C_edei--EntityShellCompany_c20230501__20240430_z8iyOVtfrFRe"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" format="ixt:booleanfalse" name="dei:EntityShellCompany" id="ixv-14627">No</ix:nonNumeric></span>&#160;<span style="font-family: Segoe UI Symbol,sans-serif">&#9745;</span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The aggregate market
value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity
was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant&#8217;s most recently
completed second fiscal quarter was $<span id="xdx_90C_edei--EntityPublicFloat_iI_c20231031_zzx5NdoBuN8g"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2023-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14628">50,844,411</ix:nonFraction></span>.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.45pt"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">As of August 5, 2024,
there were <span id="xdx_904_edei--EntityCommonStockSharesOutstanding_iI_c20240805_zKDRx3ODKyB9"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2024-08-05" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14629">74,600,737</ix:nonFraction></span> shares of the registrant&#8217;s common stock outstanding.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><b>DOCUMENTS INCORPORATED
BY REFERENCE</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; background-color: white">Portions
of the registrant&#8217;s definitive proxy statement for the 2024 Annual Meeting of Stockholders are incorporated herein by reference
in Part III of this annual report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and
Exchange Commission pursuant to Regulation 14A not later than 120 days after the close of the registrant&#8217;s fiscal year.</span><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><b>TABLE OF CONTENTS</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>Page</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 77%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>PART
    I</b></span></td>
    <td style="vertical-align: bottom; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#Business"><span style="font-size: 10pt">Item 1.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#Business"><span style="font-size: 10pt">Business</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#Business"><span style="font-size: 10pt">4</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#RiskFactors"><span style="font-size: 10pt">Item 1A.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#RiskFactors"><span style="font-size: 10pt">Risk Factors</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#RiskFactors"><span style="font-size: 10pt">10</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#UnresolvedStaffComments"><span style="font-size: 10pt">Item 1B.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#UnresolvedStaffComments"><span style="font-size: 10pt">Unresolved Staff Comments</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#UnresolvedStaffComments"><span style="font-size: 10pt">27</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#Cybersecurity"><span style="font-size: 10pt">Item 1C.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#Cybersecurity"><span style="font-size: 10pt">Cybersecurity</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#Cybersecurity"><span style="font-size: 10pt">27</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: #CCECFF">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#Properties"><span style="font-size: 10pt">Item 2.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#Properties"><span style="font-size: 10pt">Properties</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#Properties"><span style="font-size: 10pt">28</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#LegalProceedings"><span style="font-size: 10pt">Item 3.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#LegalProceedings"><span style="font-size: 10pt">Legal Proceedings</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#LegalProceedings"><span style="font-size: 10pt">29</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: #CCECFF">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#MineSafetyDisclosures"><span style="font-size: 10pt">Item 4</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#MineSafetyDisclosures"><span style="font-size: 10pt">Mine Safety Disclosures</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#MineSafetyDisclosures"><span style="font-size: 10pt">29</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>PART
    II</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#DescriptionOfSecurities"><span style="font-size: 10pt">Item 5.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#DescriptionOfSecurities"><span style="font-size: 10pt">Market for Registrant&#8217;s
    Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#DescriptionOfSecurities"><span style="font-size: 10pt">29</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#Reserved"><span style="font-size: 10pt">Item 6.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#Reserved"><span style="font-size: 10pt">Reserved</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#Reserved"><span style="font-size: 10pt">30</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#MDA"><span style="font-size: 10pt">Item 7.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#MDA"><span style="font-size: 10pt">Management&#8217;s Discussion
    and Analysis of Financial Condition and Results of Operations</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#MDA"><span style="font-size: 10pt">30</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#QualitativeDisclosures"><span style="font-size: 10pt">Item 7A.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#QualitativeDisclosures"><span style="font-size: 10pt">Quantitative and Qualitative
    Disclosures About Market Risk</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#QualitativeDisclosures"><span style="font-size: 10pt">34</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#FinancialStatements"><span style="font-size: 10pt">Item 8.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#FinancialStatements"><span style="font-size: 10pt">Financial Statements
    and Supplementary Data</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#FinancialStatements"><span style="font-size: 10pt">35</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#ChangesAndDisagreements"><span style="font-size: 10pt">Item 9.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#ChangesAndDisagreements"><span style="font-size: 10pt">Changes in and Disagreements
    with Accountants on Accounting and Financial Disclosure</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#ChangesAndDisagreements"><span style="font-size: 10pt">60</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#ControlsAndProcedures"><span style="font-size: 10pt">Item 9A.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#ControlsAndProcedures"><span style="font-size: 10pt">Controls and Procedures</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#ControlsAndProcedures"><span style="font-size: 10pt">60</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#OtherInformation"><span style="font-size: 10pt">Item 9B.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#OtherInformation"><span style="font-size: 10pt">Other Information</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#OtherInformation"><span style="font-size: 10pt">61</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#ForeignJurisdictions"><span style="font-size: 10pt">Item 9C.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#ForeignJurisdictions"><span style="font-size: 10pt">Disclosure Regarding
    Foreign Jurisdictions that Prevent Inspections</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#ForeignJurisdictions"><span style="font-size: 10pt">61</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>PART
    III</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#DirectorsAndExecutiveOfficers"><span style="font-size: 10pt">Item 10.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#DirectorsAndExecutiveOfficers"><span style="font-size: 10pt">Directors, Executive
    Officers, and Corporate Governance</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#DirectorsAndExecutiveOfficers"><span style="font-size: 10pt">61</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#ExecutiveCompensation"><span style="font-size: 10pt">Item 11.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#ExecutiveCompensation"><span style="font-size: 10pt">Executive Compensation</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#ExecutiveCompensation"><span style="font-size: 10pt">62</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#SecurityOwnership"><span style="font-size: 10pt">Item 12.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#SecurityOwnership"><span style="font-size: 10pt">Security Ownership of
    Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#SecurityOwnership"><span style="font-size: 10pt">62</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#CertainRelationships"><span style="font-size: 10pt">Item 13.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#CertainRelationships"><span style="font-size: 10pt">Certain Relationships
    and Related Transactions, and Director Independence</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#CertainRelationships"><span style="font-size: 10pt">62</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#PrincipalAccountantFeesAndServices"><span style="font-size: 10pt">Item 14.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#PrincipalAccountantFeesAndServices"><span style="font-size: 10pt">Principal Accountant
    Fees and Services</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#PrincipalAccountantFeesAndServices"><span style="font-size: 10pt">62</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>PART
    IV</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#Exhibits"><span style="font-size: 10pt">Item 15.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#Exhibits"><span style="font-size: 10pt">Exhibits and Financial
    Statement Schedules</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#Exhibits"><span style="font-size: 10pt">62</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#SummaryInformation"><span style="font-size: 10pt">Item 16.</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#SummaryInformation"><span style="font-size: 10pt">Form 10-K Summary</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#SummaryInformation"><span style="font-size: 10pt">63</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="#Signatures"><span style="font-size: 10pt">Signatures</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#Signatures"><span style="font-size: 10pt">64</span></a></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>



<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 10pt"><b>FORWARD-LOOKING
STATEMENTS</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">This Annual Report
contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities
Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Such forward-looking statements
include, among others, those statements including the words "believes", "anticipates", "expects", "intends",
"estimates", "plans" and words of similar import. Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause our actual results, performance or achievements, or industry results, to be materially
different from any future results, performance or achievements expressed or implied by such forward-looking statements.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Forward-looking statements
are based on our current expectations and assumptions regarding our business, potential target businesses, the economy, and other future
conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks
and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking
statements. Therefore, we caution you that you should not rely on any of these forward-looking statements as statements of historical
fact or as guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from
those in the forward-looking statements include (i) the market and sales success of our existing and any new products, (ii) our ability
to raise capital when needed and on acceptable terms, (iii) our ability to make acquisitions and integrate acquired businesses into our
company, (iv) our ability to attract and retain management, (v) the intensity of competition, (vi) changes in the political and regulatory
environment and in business and economic conditions in the United States and globally, (vii) geopolitical conflicts throughout the world,
including those in Ukraine and Israel. These risks and others described under the section "Risk Factors" below are not exhaustive.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Given these uncertainties,
readers of this Annual Report are cautioned not to place undue reliance on such forward-looking statements. We disclaim any obligation
to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein
to reflect future events or developments.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">All references in this
Annual Report to the "Company", "we", "us", or "our", are to Red Cat Holdings, Inc., a Nevada
corporation, including its wholly owned consolidated subsidiaries Skypersonic, Inc. (&#8220;Skypersonic&#8221;), Teal Drones, Inc. (&#8220;Teal&#8221;),
and Red Cat Propware, Inc. (&#8220;Propware&#8221;), as well as Rotor Riot LLC (&#8220;Rotor Riot&#8221;), Fat Shark Holdings, Ltd. (&#8220;Fat
Shark&#8221;), which were wholly owned subsidiaries until February 16, 2024.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>



<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;<b>PART I</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span id="Business"></span><b>ITEM 1. BUSINESS</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b>Overview </b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company was originally incorporated under the
laws of the State of Colorado in 1984 under the name Oravest International, Inc. In November 2016, we changed our name to TimefireVR,
Inc. and re-incorporated in Nevada. In May 2019, the Company completed a share exchange agreement with Propware which resulted in the
Propware shareholders acquiring an 83% ownership interest, and management control, of the Company. In connection with the share exchange
agreement, we changed our name to Red Cat Holdings, Inc. (&#8220;Red Cat&#8221; or the &#8220;Company&#8221; or &#8220;we&#8221;) and
our operating focus to the drone industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prior to the share exchange agreement, Propware was
focused on the research and development of software solutions that could provide secure cloud-based analytics, storage and services for
the drone industry. Following the share exchange agreement and its name change, Red Cat has completed a series of acquisitions and financings
which have broadened the scope of its activities in the drone industry. These acquisitions included:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><span style="font-size: 10pt">&#149;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">In January 2020, we acquired Rotor Riot, a reseller of drones and related parts, primarily to the consumer marketplace through its digital storefront located at www.rotorriot.com. The total purchase price was $2.0 million.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#149;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">In November 2020, the Company acquired Fat Shark which sells consumer electronics products to the first-person view (&#8220;FPV&#8221;) sector of the drone industry. Fat Shark&#8217;s flagship products are headsets with a built-in display (or &#8220;goggles&#8221;) that allow a pilot to see a real-time video feed from a camera typically mounted on an aerial platform or drone. The total purchase price was $8.4 million.</span></td></tr>
  </table>
<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#149;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">In May 2021, we acquired Skypersonic, a provider of drone products and software solutions that enable drone inspection flights that can be executed by pilots anywhere in the world. Skypersonic powers drones to &#8220;Fly Anywhere&#8221; and &#8220;Inspect the Impossible&#8221;. Its patented software and hardware solutions allow for inspection services in restricted spaces where GPS is denied or unavailable. The total purchase price was $2.8 million.</span></td></tr>
  </table>
<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; padding-bottom: 13pt"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 13pt; text-align: justify"><span style="font-size: 10pt">In August 2021, the Company acquired Teal, a leader in providing sophisticated and complex unmanned aerial vehicle ("UAV") technology, primarily drones, to government and commercial enterprises, most notably, the military. Teal manufactures drones approved by the U.S. Department of Defense for reconnaissance, public safety, and inspection applications. The total purchase price was $10.0 million.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Following the Teal acquisition in August 2021, we
concentrated on integrating and organizing these businesses. Effective May 1, 2022, we established the Enterprise segment and the Consumer
segment to focus on the unique opportunities in each sector. The Enterprise segment&#8217;s initial strategy was to provide UAVs to commercial
enterprises, and the military, to navigate dangerous military environments and confined industrial and commercial interior spaces. Subsequently,
the segment narrowed its near-term attention on the military and other government agencies. Skypersonic's technology has been redirected
to military applications and its operations consolidated into Teal.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The Enterprise segment&#8217;s
current business strategy is focused on providing integrated robotic hardware and software for use across a variety of applications.
Its solutions provide critical situational awareness and actionable intelligence to on-the-ground warfighters and battlefield commanders
as well as firefighters and public safety officials. Our Enterprise segment&#8217;s efforts are centered on developing and scaling an
American made family of systems. We have since completed construction of a manufacturing facility in Salt Lake City and believe that
an increased focus by the United States government and American businesses on purchasing products that are &#8220;Made in America&#8221;
provide our Enterprise segment with a competitive advantage.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">On February 16, 2024,
we closed the sale of our Consumer segment, consisting of Rotor Riot and Fat Shark, to Unusual Machines, Inc. (or &#8220;Unusual Machines&#8221;
or &#8220;UMAC&#8221;). The sale reflects our decision to focus our efforts and capital on defense where we believe there are more opportunities
to create long term shareholder value.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i></i></b></span></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Key Business
Accomplishments during Fiscal 2024 and to date include:</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-size: 10pt"><b>Scaling
Teal 2, a military-grade sUAS Designed to &#8220;Dominate the Night&#8482;&#8221;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 13pt; text-align: justify; background-color: white">Following its acquisition
by Red Cat in August 2021, Teal accelerated efforts on the development of its next generation drone for our Enterprise segment. These
efforts culminated in the launch of the Teal 2 in April 2023. The Teal 2 is the first small, unmanned aircraft system (&#8220;sUAS&#8221;)
designed to &#8220;Dominate the Night&#8221;, when most combat operations take place, through its enhanced capabilities. The Teal 2 offers
the latest intelligence, surveillance, and reconnaissance (&#8220;ISR&#8221;) technology and delivers time-critical information that enables
the warfighter to make faster and smarter decisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 13pt; text-align: justify; background-color: white">The Teal 2 is manufactured
exclusively at Teal&#8217;s purpose-built factory in Salt Lake City, Utah. Teal originally moved into the facility in October 2021. In
January 2022, Teal doubled the size of the facility, which now totals approximately 22,000 square feet, to fully scale production capacity
to meet the forecast growth in demand and to house its expanding team of software and technology engineers. We believe that maximum production
capacity for this facility can reach 5,000 or more drones per month over the next few years, provided that additional capital investments
are made and manufacturing efficiencies realized. Manufacturing in the United States, &#8220;Made in the USA,&#8221; is a critical consideration
of the U.S. government and other state and local government agencies.</p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0; background-color: white"><span style="font-size: 10pt">During
Fiscal 2024, Teal continued to scale the manufacturing facility, including dedicated teams for production and assembly, manufacturing
engineering, supply chain and logistics, warranty and returns, as well as a flight operations team that is focused on manufacturing and
quality assurance and quality control.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Designation of Teal
2 as Blue UAS received from U.S. Department of Defense</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2023, the Teal 2 received clearance from
the U.S. Department of Defense ("DoD") to be designated as a Blue UAS. The DoD defines these drones as NDAA (National Defense
Authorization Act) compliant, validated as cyber secure, and safe to fly. This designation enables Teal to fill orders from federal, state,
and local government agencies subject to oversight by the DoD, including those orders that were contingent upon receiving certification.
In addition, many governments of allied nations are more likely to purchase Blue UAS approved drones. Teal's legacy drone, the Golden
Eagle, is also on the cleared list.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">After the U.S. Army banned its forces from using
Chinese-made quadcopters due to security risks (the radio controls of the drone are unencrypted and the devices could potentially capture,
store and upload sensitive information to the Chinese government), the DoD began developing its own alternatives under a defense program
known as Blue sUAS. Blue sUAS is an initiative of the Defense Innovation Unit (&#8220;DIU&#8221;), the only DoD organization focused on accelerating
the adoption of commercial and dual use technology to solve operational challenges at a speed and scale that is faster and higher than
normal for government agencies.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Red Cat Futures Initiative</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2024, we announced the formation of the
Red Cat Futures Initiative (RFI). RFI is an independent, industry-wide consortium of robotics and autonomous systems (RAS) partners dedicated
to putting the most advanced and interoperable uncrewed aircraft systems into the hands of warfighters. Anchored by Red Cat&#8217;s Teal
Drones, the RFI unites the world&#8217;s most innovative UAS hardware and software companies focused on AI/ML, swarming, FPV, command
and control, and payloads.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Founding members include Ocean Power Technologies
(NYSE: OPTT), Sentien Robotics, Primordial Labs, Athena AI, Unusual Machines, Reach Power, Doodle Labs, and MMS Products. The shared goal
is advocacy, integrations and co-marketing that bridges considerable technology gaps through modular open architecture.</p>
<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i></i></b></span></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Government Contracts and Orders</i></b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">The Enterprise segment is focused on U.S. federal
government agencies, particularly the DoD, as its initial target market. Its longer term target customer base includes U.S.&#160;state
and local government agencies, as well as governments of foreign allies.&#160;An overview of existing government contracts and recent
developments include:</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Finalist for Short Range Reconnaissance Program
of Record</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2022, Teal was selected by the DoD&#8217;s
DIU and the U.S. Army to compete in the Short Range Reconnaissance Tranche 2 (SRR T2) Program of Record. The rigorous technical requirements
and program objectives of SRR T2 dramatically narrowed the field from 37 drone manufacturers down to two vendors. The Army has
indicated that Tranche 2 and 3 have been combined and will represent the final tranche of the SRR program.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Teal was selected to develop a next-generation
sUAS designed for intelligence, surveillance and reconnaissance (ISR) duties, with a focus on autonomous capability, for the U.S. Army.
The ultimate goal of the SRR T2 program is to provide a small, rucksack portable, fully encrypted sUAS that provides all Army infantry
platoons (consisting of 20-50 soldiers) with situational awareness beyond the next terrain.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">As of May 2024, Teal has completed all milestones
in its SRR T2 contract, whose value totaled $5.7 million. Teal expects the Army to announce vendor selection of a production award by
the fourth quarter of calendar 2024.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>U.S. Border Patrol</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>$1.8 Million Purchase Order from U.S. Border
Patrol</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">In September 2023, Teal was awarded a $1.8 million
contract from U.S. Customs and Border Protection to provide Teal 2 systems to U.S. Border Patrol. The U.S. Border Patrol is using the
Teal 2 to provide supplemental airborne reconnaissance, surveillance and tracking capability, enhancing situational awareness for U.S.
field commanders and agents.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Customs and Border Protection Contract Worth
up to $90 Million over Five Years</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2021, Teal was one of only five contractors
designated to participate in a firm, fixed price, multiple award blanket purchase agreement (BPA) by the United States Customs and Border
Protection. The BPA has an estimated value of $90 million in total over a 5-year period.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">The Department of Homeland Security agencies
can place orders through the BPA for unmanned aircraft systems (UAS). The drones will provide supplemental airborne reconnaissance, surveillance,
and tracking capability to enhance situational awareness for field commanders and agents in areas that lack nearby traditional surveillance
systems or available manned air support.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>U.S. Defense Logistics Agency</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2023, Teal received two purchase orders
totaling $5.2 million from the U.S. Defense Logistics Agency (DLA). Both orders were requested by U.S. Air Force Security Forces, whose
role is to defend Air Force bases and installations.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">The procurements were sourced&#160;by global
operations support company&#160;Noble Supply &amp; Logistics, LLC&#160;(NOBLE) as part of&#160;the&#160;DLA&#8217;s&#160;Special Operational
Equipment Tailored Logistics Support (&#8220;SOE TLS Program&#8221;). NOBLE is a&#160;DLA-designated provider&#160;for the SOE TLS Program. This 10-year
program, capped at&#160;$33&#160;billion,&#160;covers&#160;the delivery of&#160;logistics&#160;support&#160;to federal agencies, military&#160;bases&#160;and
other DLA customers worldwide,&#160;helping&#160;them meet their special operational equipment requirements.&#160;</p>
<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NATO Allied Countries</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2024, Teal received $2.5 million in
new contract awards with two NATO allied countries. As part of our expanded global sales strategy, the contract delivery featured Teal
2 drone systems, training, and accessories.</p>
<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Product
Development</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Product
development efforts in fiscal 2024 were focused on the scaling of the Teal 2 which was officially launched in April 2023 at the Army
Aviation Mission Solutions Summit. Significant resources were also expended developing the next generation system under the Army's SRR
Tranche 2 program.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Sales
and Marketing</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Since
acquiring Teal in August 2021, we have built a sales and marketing team which presently consists of 16 direct and support professionals.
Most of their efforts in fiscal 2024 were focused on developing relationships with the military agencies of the U.S. Federal Government.
While the sales cycle for government agencies can be extensive and take considerable time and effort to establish, they can often become
a long-term buyer once initial sales are closed.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">During fiscal 2024,
we continued global expansion efforts among U.S. allies. In December 2023, the team showcased the Teal 2 drone at Expodefensa 2023 in
Latin America. Expodefensa 2023 is a main hub for security and defense in Latin America, allowing international exhibitors to present
their systems and products in response to a growing regional demand. The aim of the event was to help governments and armed forces face
their operational and capability challenges while playing a role in building a safer Latin America.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">In February 2024, the
team showcased the Teal 2 drone at the World Defense Show in Saudi Arabia. The World Defense Show provided a unique platform for the
world&#8217;s defense industry to network, partner, share knowledge, and discover new innovations and capabilities across all defense
domains. The World Defense Show attracted key defense figures, government officials, decision-makers, and thought leaders across all
levels of the supply chain.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Other Teal Information</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Suppliers</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Teal purchases inventory
from over 35 suppliers. Approximately 80% of this inventory is purchased from four vendors. The most critical components are electronics
and cameras. Teal's supply chain is NDAA and Blue UAS compliant. All suppliers are approved based on Teal's strict vendor qualification
process.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Competition</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Teal's primary competitor is Shenzhen Da-Jiang Innovations
Sciences and Technologies Company Limited (&#8220;DJI&#8221;), headquartered in Shenzhen, China. Though regulation is trending toward
further restrictions against Chinese made drones, DJI remains a global industry leader and continues to serve markets on which Teal is
focused. Teal&#8217;s primary domestic competitor is Skydio Inc. This company was selected alongside Teal out of 37 companies to compete
in the Short Range Reconnaissance Tranche 2 program. Future competitors may include established defense contractors that are better capitalized
and resourced to compete in Teal's markets. Teal competes with a combination of its unique product value propositions (i.e., nighttime
capability, modular platform), and scalable, low-cost, domestic manufacturing.</p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>The Drone Industry</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The drone industry
continues to expand to become a powerful business tool and recreational activity, with growth occurring broadly and across our targeted
industries. According to Drone Industry Insights, the global drone market is expected to grow to $54.6 billion by 2030, with the commercial
market growing at a 7.7% compound annual growth rate (&#8220;CAGR&#8221;). According to Vantage Market Research, the global military
drone market is projected to reach a value of $34.9 billion by 2030 at a CAGR of 11.6%.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Government Regulation
and Federal Policy</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>The Federal Aviation
Administration</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Federal Aviation Administration (the &#8220;FAA&#8221;)
of the United States Department of Transportation is responsible for the regulation and oversight of civil aviation within the U.S. Its
primary mission is to ensure the safety of civil aviation. The FAA has adopted the name &#8220;unmanned aircraft systems&#8221; (&#8220;UAS&#8221;)
to describe aircraft systems without a flight crew on board. More common names include drone, UAV and remotely operated aircraft.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The FAA began issuing conditional approvals allowing
the operation of drones as early 2005 with their scope and frequency expanding in recent years with the significant increase in the number
of drones sold. In December 2015, the FAA announced that all drones weighing more than 250 grams, or 0.55 pounds, must be registered with
the FAA. In June 2016, the FAA released a new section under title 14 of the Code of Federal Regulations (Part 107) defining a regulatory
framework for the commercial, industrial and public safety use of drones, establishing a licensing program for drone pilots, and issuing
Remote Pilot certificates to qualified pilots. As of July 2023, the FAA reported the registration of almost 870,000 drones, of which approximately
350,000 were commercial and approximately 520,000 were recreational. In addition, more than 330,000 remote pilots were certified. This
data strongly suggests drones represent the largest share of commercial aviation in the United States by number of pilots, aircraft, and
flights.</p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">In January 2021, the
FAA finalized rules requiring that drones be identifiable remotely. These rules became effective for drone manufacturers in September
2022 and for drone pilots in September 2023. The FAA believes that remote ID technologies enhance safety and security by allowing the
FAA, law enforcement, and federal security agencies to identify drones flying in their jurisdiction. These efforts lay the foundation
for more complex operations, such as those beyond visual line of sight at low altitudes, as the FAA and the drone industry move toward
a unified air traffic management ecosystem as drone operations become a routine fixture in the National Airspace System (the &#8220;NAS&#8221;).</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">In May of 2023, the
FAA began soliciting recommendations from the industry regarding rule making supporting the implementation of Beyond Visual Line of Sight
(BVLOS) operations. This rulemaking would support standard implementation of routine flights over the horizon, and potentially multiple
miles from a drone&#8217;s control station and pilot. This rulemaking would free drone pilots and operators from restrictive and labor-intensive conditional approval petitions, and would improve the economies of scale for drones to tackle larger mission sets, such as
surveying miles of power lines or railroad tracks, or securing miles of rural border.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">In July 2023, the FAA
released a notice of proposed rulemaking for another regulation that would ease the integration of UAS into the NAS. This rule, known
as Modernization of Special Purpose Airworthiness Certificates, seeks to modernize the manner in which the FAA performs safety assessment
of the design of certain aircraft, including UAS. As a result, the testing and evaluation burden on manufacturers is greatly decreased,
and the cost of development of UAS may be dramatically reduced.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>American Security
Drone Act</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 63pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">In February 2023, two
Congressman introduced the American Security Drone Act (ASDA) which would prohibit the purchase and operation of drones from countries
identified as national security threats such as China. The basis for the legislation is that purchases from these countries (i) pose
a significant threat to national security, (ii) represent efforts to infiltrate and influence American society, and (iii) risk the theft
of personal and business data. Specifically, the American Security Drone Act:</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 96%; text-align: justify"><span style="font-size: 10pt">Prohibits federal departments and agencies from procuring
    certain foreign commercial off-the-shelf drone or covered unmanned aircraft system manufactured or assembled in countries identified
    as national security threats and provides a timeline to end current use of these drones.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 96%; text-align: justify"><span style="font-size: 10pt">Prohibits the use of federal funds awarded through certain
    contracts, grants, or cooperative agreements to state or local governments from being used to purchase foreign commercial off-the-shelf
    drones or covered unmanned aircraft systems manufactured or assembled in a country identified as a national security threat.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 96%; text-align: justify"><span style="font-size: 10pt">Requires the Comptroller General of the United States to
    submit a report to Congress detailing the amount of foreign commercial off-the-shelf drones and covered unmanned aircraft systems
    procured by federal departments and agencies from countries identified as national security threats.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin-bottom: 0pt; text-align: justify; margin-right: 0; margin-left: 0"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-bottom: 0pt; text-align: justify; margin-right: 0; margin-left: 0"><span style="font-size: 10pt">In
December 2023, the ASDA was officially passed into law as part of the National Defense Authorization Act.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font-size: 10pt"><b></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font-size: 10pt"><b>Other Corporate
Information</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0pt; text-align: justify"><span style="font-size: 10pt"><b><i>Environmental
Considerations</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0pt; text-align: justify"><span style="font-size: 10pt">While the
operations of many businesses have some form of negative impact on the environment, drones have a unique ability to provide a positive
contribution. Many of these relate to a drone&#8217;s ability to reach places in a more efficient manner, and include such activities
as:</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 5%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 2%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 93%"><span style="font-size: 10pt">Aerial mapping
    and nature monitoring</span></td></tr>
</table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 5%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 2%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 93%"><span style="font-size: 10pt">Maintenance
    of renewable energy sources and infrastructure</span></td></tr>
</table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 5%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 2%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 93%"><span style="font-size: 10pt">Disaster relief
    monitoring</span></td></tr>
</table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 5%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 2%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 93%"><span style="font-size: 10pt">Agriculture
    sustainability</span></td></tr>
</table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 5%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 2%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 93%"><span style="font-size: 10pt">Wildlife conservation</span></td></tr>
</table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Intellectual
Property</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
Company has consolidated its intellectual property (&#8220;IP&#8221;) into a subsidiary, UAVPatent Corp. The subsidiary holds 22 issued
patents and registered designs and 8 pending patents and registered designs. The IP portfolio includes design and utility patents ranging
from modular architectures to autonomous capabilities. None of the patents are currently licensed and IP is generated in the general
course of engineering design.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">UAVPatent
Corp also has the trademarks on the Teal, Skypersonic, and Red Cat brands and logos.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Employees</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">As of June 30, 2024,
the Company had 89 full-time employees.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Research and
Development</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">During the years ended
April 30, 2024 and 2023, we incurred research and development costs of $5,500,932 and $4,902,334, respectively, excluding $395,105 and
$692,947 of stock-based compensation, respectively.&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="RiskFactors"></span><span style="font-size: 10pt"><b>Item
1A. RISK FACTORS</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Risk Factor Summary</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Risks Related
to our Financial Results and Condition</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">We have incurred net losses
    since inception.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">We may need additional capital
    to fund our expanding operations until we reach profitability, and if we are not able to obtain sufficient capital, we may be forced
    to limit or curtail our operations.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Lack of long-term purchase
    orders and commitments from customers may lead to a rapid decline in sales.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our products require a continuing
    investment in research and development, and may experience technical problems or delays, which could lead the business to fail.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">The nature of our business
    involves significant risks and uncertainties that may not be covered by insurance or indemnity.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Product quality issues and
    a higher-than-expected number of warranty claims or returns could harm our business and operating results.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our products may experience
    declining unit prices and we may not be able to offset that decline with production cost decreases or higher unit sales.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our operating results may be
    adversely impacted by worldwide political, economic and public health uncertainties and specific conditions in the markets we address.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Acquisitions could divert the
    attention of key personnel, be difficult to integrate, dilute our existing shareholders and adversely impact our financial results.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our failure to effectively
    manage growth could harm our business.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our products are subject to
    lengthy development cycles.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">We expect to incur substantial
    research and development costs related to identifying and commercializing new products and services which may never result in revenues.</span></td></tr>
  </table>
<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Risks Related
to our Operations</i></b></span></p>

<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our operations may be adversely
    affected if we lose our rights under third-party technology licenses.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">If our customers are not satisfied
    with our technical support, firmware or software updates, they may choose not to purchase our products which would adversely impact
    business and operating results.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our use of open-source software
    could negatively affect our ability to sell our products and could subject us to possible litigation.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">We must recruit and retain
    highly trained and experienced employees, especially engineers, in order to succeed in our business.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our facilities and information
    systems and those of our key suppliers could be damaged as a result of disasters or unpredictable events which could have an adverse
    effect on our business operations.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">We rely on third-party suppliers,
    some of which are sole-source suppliers, to provide components for our products which may lead to supply shortages, long lead times
    for components, and supply changes, any of which could disrupt our supply chain, increase our costs, and adversely impact our operating
    results.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Several steps of our manufacturing
    processes are dependent upon certain critical machines and tools which could result in delivery interruptions and foregone revenues.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">We depend on third parties
    to provide integrated circuit chip sets and other critical components for use in our products.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font-size: 10pt"><b><i>Risks
Related to our Industry</i></b></span></p>

<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font-size: 10pt">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">We operate in an emerging and rapidly growing industry which makes it difficult
to evaluate our current business and prospects.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">We face competition from larger
    companies that have substantially greater resources which challenges our ability to establish market share, grow our business segments,
    and reach profitability.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">We may not be able to keep
    pace with technological advances in the drone industry.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Cybersecurity risks could adversely
    affect our business and disrupt our operations.</span></td></tr>
  </table>
<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Risks Related
to Our Enterprise Segment</i></b></span></p>

<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">U.S. government contracts are
    generally not fully funded at inception and may include provisions that are not favorable to us which could adversely impact our
    cash flows and results of operations.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">A decline in U.S. government
    budgets, changes in spending priorities, or delays in contract awards could adversely affect the revenues of our Teal subsidiary.</span></td></tr>
  </table>
<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our work for the U.S. government
    could expose us to security risks.</span></td></tr>
  </table>
<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">We are subject to extensive
    government regulation and our failure to comply with these regulations could subject us to penalties that may adversely impact our
    ability to operate our business.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 8pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font-size: 10pt"><b><i><br/>
<br/></i></b></span></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 8pt 0 0pt"><span style="font-size: 10pt"><b><i>Risks Related to Our Common
Stock</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 8pt 0 0"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our management has voting control
    of the Company.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our failure to maintain effective
    internal controls over financial reporting could have an adverse impact on the Company.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">We have never paid dividends
    and we do not expect to pay dividends for the foreseeable future.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">The listing of our securities
    on Nasdaq subject us to additional regulations and compliance requirements.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our Board of Directors may
    authorize and issue shares of new classes of stock that could adversely affect current holders of our common stock.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our shares will be subordinate
    to all of our debts and liabilities which increases the risk that investors could lose their entire investment.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">The market price of our shares
    of common stock is subject to fluctuation.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Future capital raises may dilute
    our existing stockholders&#8217; ownership and adversely impact the fair value of their investment.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b><i>Risks Related to Regulatory Matters</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">The drone industry is subject
    to various laws and government regulations which could complicate and delay our ability to introduce products, maintain compliance,
    and avoid violations which could negatively impact our financial condition and results of operations.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our business and products are
    subject to government regulation, and we may incur additional compliance costs or be forced to suspend or cease operations if we
    fail to comply.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our results of operations may
    suffer if we are not able to successfully manage our exposure to foreign exchange rate risks.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our international operations,
    including the use of foreign contract manufacturers, subjects us to international operational, financial, legal, political and public
    health risks which could harm our operating results.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">We could be adversely affected
    by violations of the U.S. Foreign Corrupt Practices Act or similar anti-bribery laws in other jurisdictions in which we operate.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">We are subject to governmental
    export and import controls, and economic sanctions laws that could subject us to liability and impair our ability to compete in international
    markets.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Changes in trade policy in
    the United States and other countries may have adverse impacts on our business, results of operations and financial condition.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">We may collect, store, process
    and use the personal information of our customers which subjects us to governmental regulation related to privacy, information security
    and data protection. Any cybersecurity breaches or our failure to comply with such legal obligations by us, or by our third-party
    service providers or partners, could harm our business.</span></td></tr>
  </table>
<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 8pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify"><span style="font-size: 10pt"><b><i>Risks
Related to Intellectual Property</i></b></span></p>

<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our products could infringe
    on the intellectual property rights of others.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-bottom: 8pt; text-align: justify; line-height: 106%"><span style="font-size: 10pt">Our intellectual property rights
    and proprietary rights may not adequately protect our products.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in; text-align: justify; background-color: white"></p>

<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify"></p>

<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify"><span style="font-size: 10pt"><b>Risks
Related to our Financial Results and Condition</b></span></p>

<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify"><span style="font-size: 10pt"><b><i>We
have incurred net losses since inception.&#160;</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
have never been profitable and reported an accumulated deficit of approximately $81,100,000 at April 30, 2024. These losses have had
an adverse effect on our financial condition, stockholders&#8217; equity and working capital. We will need to generate higher revenues,
improve profit margins, and control operating costs in order to attain profitability. We can provide no assurances that we will be able
to reach profitability.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>We
may need additional capital to fund our expanding operations until we reach profitability, and if we are not able to obtain sufficient
capital, we may be forced to limit or curtail our operations.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">If
additional equity and/or debt financing is not available, then we may not be able to continue to develop our business activities, and
we will have to modify our business plan. These factors could have a material adverse effect on our future operating results and our
financial condition. If we are unable to raise additional funds, we could be forced to cease our business activities and dissolve. In
such an event, we may incur additional financial obligations, including the accelerated maturity of debt obligations, lease termination
fees, employee severance payments, and other creditor and dissolution-related obligations.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Our
ability to raise financing through sales of equity and/or debt securities depends on general market conditions and the demand for our
common stock and/or debt securities. We may be unable to raise adequate capital through sales of equity and/or debt securities, and if
our stock has a low market price at the time of such sales, our existing stockholders could experience substantial dilution. If adequate
financing is not available or unavailable on acceptable terms, we may find we are unable to fund expansion, continue offering products
and services, take advantage of acquisition opportunities, develop or enhance services or products, or to respond to competitive pressures
in the industry which may jeopardize our ability to continue operations.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Lack
of long-term purchase orders and commitments from customers may lead to a rapid decline in sales.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Our
customers issue purchase orders solely at their own discretion. Customers are generally able to cancel orders (without penalty) or delay
the delivery of products on relatively short notice. In addition, current customers may decide not to purchase products for any reason.
If our customers do not continue to purchase our products, then our sales volume could decline rapidly with little or no warning.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
cannot rely on long-term purchase orders or commitments to protect us from the negative financial effects of a decline in demand for
our products. The uncertainty of product orders makes it difficult to forecast sales and allocate resources in a manner consistent with
actual sales. Moreover, expense levels and the amounts invested in capital equipment and new product development costs are based in part
on expectations of future sales and, if expectations regarding future sales are inaccurate, we may be unable to reduce costs in a timely
manner to adjust for sales shortfalls. As a result of lack of long-term purchase orders and purchase commitments, we may experience a
rapid decline in sales.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Our
products require a continuing investment in research and development, and may experience technical problems or delays, which could lead
the business to fail.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Our
research and development efforts remain subject to all the risks associated with the development of new products based on emerging and
innovative technologies. This includes, for example, unexpected technical problems or the possible insufficiency of funds for completing
development of these products. If technical problems or delays arise, further improvements in products and the introduction of future
products could be adversely impacted, and we could incur significant additional expenses, an inability to increase revenues and increasing
operating losses.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>The
nature of our business involves significant risks and uncertainties that may not be covered by insurance or indemnity.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
develop and sell products where insurance or indemnification may not be available, including (i) those using advanced and unproven technologies
and drones, and (ii) those that collect, distribute and analyze various types of information.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Failure
of certain of our products could result in loss of life or property damage. Certain products may raise questions with respect to issues
of civil liberties, intellectual property, trespass, conversion and similar concepts. Indemnification to cover potential claims or liabilities
resulting from a failure of technologies developed or deployed may be&#160;available in certain circumstances but not in others. We do
not and are not able to maintain insurance to protect against our risks and uncertainties. Substantial claims resulting from an accident,
failure of our product, or liability arising from our products in excess of any indemnity or insurance coverage (or for which indemnity
or insurance is not available or was not obtained) could harm our financial condition, cash flows, and operating results. Any accident,
even if fully covered or insured, could negatively affect our reputation among our customers and the public, and make it more difficult
for us to compete effectively.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Product
quality issues and a higher-than-expected number of warranty claims or returns could harm our business and operating results.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
products that we sell could contain defects in design or manufacture. Defects could also occur in the products or components that are
supplied to us. There can be no assurance we will be able to detect and remedy all defects in the hardware and software we sell which
could result in product recalls, product redesign efforts, loss of revenue, reputational damage and significant warranty and other remediation
expenses. If we determine that a product does not meet product quality standards or may contain a defect, the launch of such product
could be delayed until we remedy the quality issue or defect. The costs associated with any protracted delay necessary to remedy a quality
issue or defect in a new product could be substantial.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
generally provide a one-year warranty on all of our products. The occurrence of any material defects in our products could expose us
to liability for damages and warranty claims in excess of our current reserves, and we could incur significant costs to correct any defects,
warranty claims or other problems. In addition, if any of our product designs are defective or are alleged to be defective, we may be
required to participate in a recall campaign. In part due to the terms of our warranty policy, any failure rate of our products that
exceeds our expectations may result in unanticipated losses. Any negative publicity related to the perceived quality of our products
could affect our brand image and decrease retailer, distributor and consumer confidence and demand, which could adversely affect our
operating results and financial condition. Further, accidental damage coverage and extended warranties are regulated in the United States
at the state level and are treated differently within each state. Additionally, outside of the United States, regulations for extended
warranties and accidental damage vary from country to country. Changes in interpretation of the regulations concerning extended warranties
and accidental damage coverage on a federal, state, local or international level may cause us to incur costs or have additional regulatory
requirements to meet in the future in order to continue to offer our support services. Our failure to comply with past, present and future
similar laws could result in reduced sales of our products, reputational damage, penalties and other sanctions, which could harm our
business and financial condition.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Our
products may experience declining unit prices and we may not be able to offset that decline with production cost decreases or higher
unit sales.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Prices
of established enterprise electronics, displays, personal computers, and mobile products tend to decline significantly over time or as
new enhanced versions are introduced, frequently every 12 to 24 months in the markets in which we compete. In order to maintain adequate
product profit margins over the long term, we believe that we will need to continuously develop product enhancements and new technologies
that will either slow price declines of our products or reduce the cost of producing and delivering our products. While we anticipate
opportunities to reduce production costs over time, we may not be able to reduce our component costs. We expect to attempt to offset
the anticipated decrease in our average selling price by introducing new products, increasing our sales volumes, or adjusting our product
mix. If we fail to do so, our results of operations will be materially and adversely affected.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Our
operating results may be adversely impacted by worldwide political, economic and public health uncertainties and specific conditions
in the markets we address.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">A
deterioration in global economic, financial, and/or public health conditions, including global pandemics, economic recessions and political
turmoil could materially adversely affect (i) our ability to raise, or the terms of needed capital; (ii) demand for our current and future
products; and (iii) the supply of components for our products. We cannot predict the timing, strength, or duration of any economic slowdown
or subsequent economic recovery, worldwide, or in the drone industry.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Acquisitions
could divert the attention of key personnel, be difficult to integrate, dilute our existing shareholders and adversely impact our financial
results.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #222222"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Since
January 2020, we have completed four acquisitions which have significantly increased the scope of our operations and our employee headcount.
Acquisitions include a wide range of risks, any of which could hurt our business, including the following:</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#149;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">difficulties in integrating the operations of a newly acquired company
    including existing products and contracts, differences in corporate culture, operating systems and other integration issues;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#149;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">challenges supporting and transitioning the customers of acquired companies
    and the loss of any acquired customers will adversely impact our revenues and operating results;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#149;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">assumption of known and unknown operating problems and our potential
    inability to address them in a timely and efficient manner;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; width: 24px"><span style="font-size: 10pt">&#149;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">risks of entering new geographic markets where we have no prior experience
    and are required to gain an understanding of the legal, regulatory, labor and business laws of these new markets;</span></td></tr>
  </table>
<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">In
addition, there are many financial risks associated with the cost of acquisitions. If we finance the cost of an acquisition using common
stock, then our existing shareholders will be diluted and our stock price could decrease. If we finance the cost of an acquisition using
debt, such financing could include restrictive covenants that restrict our operating and financial flexibility. If the stock market perceives
that we overpaid for the acquisition, then our stock price could decrease.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Our failure
to effectively manage growth could harm our business.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
intend to expand the number and types of products we sell. We will need to replace and regularly introduce on a timely basis new products
and technologies, enhance existing products, and effectively stimulate customer demand for new products and upgraded or enhanced versions
of our existing products.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
replacement and expansion of our products places a significant strain on our management, operations and engineering resources. Specifically,
the areas that are strained most by these activities include the following:</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 90%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt"><b><span style="text-decoration: underline">New Product
    Launches:</span></b>&#160;With the changes in and growth of our product portfolio, we will experience increased complexity in coordinating
    product development, manufacturing, and shipping. As this complexity increases, it places a strain on our ability to accurately coordinate
    the commercial launch of our products with adequate supply to meet anticipated customer demand and effectively market to stimulate
    demand and market acceptance. We have experienced delays in the past. If we are unable to scale and improve our product launch coordination,
    we could frustrate our customers and lose possible retail shelf space and product sales;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 90%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Existing
    Products Impacted by New Introductions</span>:</b>&#160;The introduction of new products or product enhancements may shorten the life
    cycle of our existing products, or replace sales of some of our current products, thereby offsetting the benefit of a successful
    product introduction and may cause customers to defer purchasing our existing products in anticipation of the new products. These
    occurrences could potentially lead to challenges in managing inventory of existing products. We may also provide price protection
    to some of our retailers as a result of new product introductions and reduce the prices of existing products. If we fail to effectively
    manage new product introductions, our revenue and profitability may be harmed; and</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 90%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Forecasting,
    Planning and Supply Chain Logistics</span>:&#160;</b>With the changes in and growth of our product portfolio, we will experience increased
    complexity in forecasting customer demand, in planning for production, and in transportation and logistics management. If we are
    unable to scale and improve our forecasting, planning, production, and logistics management, we could frustrate our customers, lose
    product sales or accumulate excess inventory.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>&#160;</i></b>&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Our
products are subject to lengthy development cycles.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Our
products are subject to lengthy product development cycles. The time elapsed between initial sampling of our products, the custom design
of our products to meet specific product requirements, and the ultimate incorporation of our products into salable products is significant,
often with a duration of more than one year. If our products fail to meet our customers&#8217; cost, performance, or technical requirements
or if unexpected technical challenges arise in the integration of our products into enterprise markets, then our operating results could
be significantly and adversely affected. Long delays in achieving customer qualification and incorporation of our products also could
adversely affect our business. Many head-mounted display companies are introducing digital head-mounted displays which could create shortages
of components and provide an opportunity for companies with significantly greater resources than us to accelerate migration to digital
products in a manner or timeline which we cannot meet, which could cause us to lose market share and harm our business and prospects.
These same risks exist in our Enterprise sector where our competitors include some of the largest defense companies in the world.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>We expect
to incur substantial research and development costs related to identifying and commercializing new products and services which may never
result in revenues.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Our future growth
depends on expanding into new markets, adapting existing products to new applications, and introducing new products and services that
achieve market acceptance. We plan to incur substantial research and development costs as part of these efforts. We spent $5,896,037
million, or 33% of our revenue, in our fiscal year ended April 30, 2024, on internal research and development activities. We believe
that there are significant investment opportunities in a number of business areas. Because we account for internal research and development
as an operating expense, these expenditures will adversely affect our earnings in the future. Further, our research and development programs
may not produce successful results, and our new products and services may not achieve market acceptance, generate revenue or cash flow,
which could adversely impact our financial results and liquidity.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt/106% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Risks Related
to our Operations</b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Our
operations may be adversely affected if we lose our rights under third-party technology licenses.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Our
business relies on technology rights and software licensed from third parties. We could lose our exclusivity or other rights to use the
technology if we fail to comply with the terms and performance requirements of the licenses. In addition, certain licensors may terminate
a license upon our breach and have the right to consent to sublicense arrangements. If we were to lose our rights under any of these
licenses, or if we were unable to obtain required consents to future sublicenses, we could lose a competitive advantage in the market,
and may even lose the ability to commercialize certain products or technologies.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>If
our customers are not satisfied with our technical support, firmware or software updates, they may choose not to purchase our products
which would adversely impact business and operating results.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Our
business relies on our customers&#8217; satisfaction with the technical support, firmware, software and security updates we provide to
support our products. If we fail to provide technical support services and necessary updates that are (i) responsive, (ii) satisfy our
customers&#8217; expectations and (iii) resolve issues that they encounter with our products, then customers may choose not to purchase
additional products and we may face brand and reputational harm which could adversely affect our operating results.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Our
use of open-source software could negatively affect our ability to sell our products and could subject us to possible litigation.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
incorporate open-source software into our products. Open-source software is generally licensed by its authors or other third parties
under open-source licenses. Some of these licenses contain requirements that we make available source code for modifications or derivative
works we create based upon the open-source software, and that we license such modifications or derivative works under the terms of a
particular open-source license or other license granting third parties certain rights of further use. Additionally, if a third-party
software provider has incorporated open-source software into software that we license from such provider, we could be required to disclose
any of our source code that incorporates or is a modification of our licensed software. If an author or other third-party that distributes
open-source software that we use or license were to allege that we had not complied with the conditions of the applicable license, we
could incur significant legal expenses defending against those allegations and could be subject to significant damages, enjoined from
offering or selling our products that contained the open-source software and be required to comply with the foregoing conditions. Any
of the foregoing could disrupt and harm our business and financial condition.&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>We
must recruit and retain highly trained and experienced employees, especially engineers, in order to succeed in our business.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
will need to hire and retain highly skilled technical personnel as employees and as independent contractors in order to develop our products
and grow our business. The competition for highly skilled technical, managerial, and other personnel can be intense. Our recruiting and
retention success is substantially dependent upon our ability to offer competitive salaries and benefits to our employees. We must compete
with companies that possess greater financial and other resources than we do and that may be more attractive to potential employees and
contractors. To be competitive, we may have to increase the compensation, bonuses, stock options and other fringe benefits we offer to
employees in order to attract and retain such personnel. The costs of retaining or attracting new personnel may have a material adverse
effect on our business and operating results. If we fail to attract and retain the technical and managerial personnel required to be
successful, our business, operating results and financial condition could be materially adversely affected.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Our
facilities and information systems and those of our key suppliers could be damaged as a result of disasters or unpredictable events which
could have an adverse effect on our business operations.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Our
manufacturing facility is located in Salt Lake City, Utah. We also rely on third-party manufacturing plants in the US, Asia and other
parts of the world to provide key components for our products and services. If major disasters such as earthquakes, hurricanes, tropical
storms pandemics, fires, floods, wars, terrorist attacks, computer viruses, transportation disasters or other events occur in any of
these locations, or the effect of climate change on any of these factors or our locations, or our information systems or communications
network or those of any of our key component suppliers breaks down or operates improperly as a result of such events, our facilities
or those of our key suppliers may be seriously damaged, and we may have to stop or delay production and shipment of our products. We
may also incur expenses relating to such damages. If production or shipment of our products or components is stopped or delayed or if
we incur any increased expenses as a result of damage to our facilities, our business, operating results and financial condition could
be materially adversely affected.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>We
rely on third-party suppliers, some of which are sole-source suppliers, to provide components for our products which may lead to supply
shortages, long lead times for components, and supply changes, any of which could disrupt our supply chain, increase our costs, and adversely
impact our operating results</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Our
ability to meet customer demand depends on our ability to obtain timely and adequate delivery of components for our products. All of
the components that go into our products are sourced from third-party suppliers. Some of the key components used to manufacture our products
come from a limited or single source of supply or by a supplier that could potentially become a competitor. Our contract manufacturers
generally purchase these components on our behalf from approved suppliers. We are subject to the risk of shortages and long lead times
in the supply of these components and the risk that our suppliers discontinue or modify components used in our products. In addition,
the lead times associated with certain components are lengthy and preclude rapid changes in quantities and delivery schedules. We have
experienced component shortages and the availability of these components may be unpredictable in the future.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">If
we lose access to or experience a significant disruption in the supply of products and components from a supplier, we may be unable to
locate alternative suppliers of comparable quality at an acceptable price, or at all, and our business could be materially and adversely
affected. In addition, if we experience a significant increase in demand for our products, our suppliers might not have the capacity
or elect not to meet our needs as they allocate components to other customers. Developing suitable alternate sources of supply for these
components may be time-consuming, difficult and costly, and we may not be able to source these components on terms that are acceptable
to us, or at all, which may adversely affect our ability to fulfill our orders in a timely or cost-effective manner. Identifying a suitable
supplier is an involved process that requires us to become satisfied with the supplier&#8217;s quality control, responsiveness and service,
financial stability, labor and other ethical practices. If we seek to source materials from new suppliers, there can be no assurance
that we could do so in a manner that does not disrupt the manufacture and sale of our products.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Our
reliance on single source, or a small number of suppliers involves a number of additional risks, including risks related to supplier
capacity constraints, price increases, timely delivery, component quality, failure of a key supplier to remain in business and adjust
to market conditions, as well as natural disasters, fire, acts of terrorism or other catastrophic events, including global pandemics.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Several
steps of our manufacturing processes are dependent upon certain critical machines and tools which could result in delivery interruptions
and foregone revenues.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
currently have little equipment redundancy in manufacturing locales. If we experience any significant disruption in manufacturing or
a serious failure of a critical piece of equipment, we may be unable to supply products to our customers in a timely manner. Interruptions
in our manufacturing could be caused by equipment problems, the introduction of new equipment into the manufacturing process or delays
in the delivery of new manufacturing equipment. Lead-time for delivery, installation, testing, repair and maintenance of manufacturing
equipment can be extensive. We have experienced production interruptions in the past and no assurance can be given that we will not lose
potential sales or be able to meet production orders due to future production interruptions in our manufacturing lines.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>We
depend on third parties to provide integrated circuit chip sets and other critical components for use in our products.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
do not manufacture the integrated circuit chip sets, optics, micro-displays, backlights, projection engines, printed circuit boards or
other electronic components which are used in our products. Instead, we purchase them from third-party suppliers or rely on third-party
independent contractors for these integrated circuit chip sets and other critical components, some of which are customized, or custom
made for us. We also may use third parties to assemble all or portions of our products. Some of these third-party contractors and suppliers
are small companies with limited financial resources. If any of these third-party contractors or suppliers were unable or unwilling to
supply these components, our sales and operating results would be adversely impacted. As the availability of components decreases, the
cost of acquiring those components ordinarily increases. High growth product categories have experienced chronic shortages of components
during periods of exceptionally high demand. If we do not properly anticipate the need for or procure critical components, we may pay
higher prices for those components, our gross profits may decrease and we may be unable to meet the demands of our customers and end-users
which could reduce our competitiveness, cause a decline in our market share and have a material adverse effect on our results of operations.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 18 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Risks Related to
our Industry</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><i>We operate in an emerging
and rapidly growing industry which makes it difficult to evaluate our current business and prospects.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.7pt; background-color: white"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The drone industry is relatively
new and is growing rapidly. As a result, it is difficult to evaluate our business and prospects. We cannot accurately predict whether,
and even when, demand for our products will increase, if at all. The risks, uncertainties and challenges encountered by companies operating
in emerging and rapidly growing industries include:</p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Generating sufficient
    revenue to cover operating costs and sustain operations;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Acquiring and
    maintaining market share;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Attracting and
    retaining qualified personnel, especially engineers with the requisite technical skills;</span></td></tr>
  </table>
<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Successfully
    developing and commercially marketing new products:</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Accessing the
    capital markets to raise additional capital, on reasonable terms, if and when required to sustain operations or to grow the business.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>We
face competition from larger companies that have substantially greater resources which challenges our ability to establish market share,
grow our business segments, and reach profitability.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
drone industry is attracting a wide range of significantly larger companies which have substantially greater financial, management, research
and marketing resources than us. Competitors in the Enterprise segment include transportation companies like United Parcel Service, Federal
Express and Amazon, as well as defense companies such as Lockheed Martin Corporation, Northrop Grumman Corporation, and AeroVironment.
Our competitors may be able to provide customers with different or greater capabilities than we can provide, including technical qualifications,
pricing, and key technical support. Many of our competitors may utilize their greater resources to (i) develop competing products and
technologies, (ii) leverage their financial strength to utilize economies of scale and offer lower pricing, and (iii) hire more qualified
personnel by offering more generous compensation packages. In order to secure orders and contracts, we may have to offer comparable products
and services at lower pricing which could adversely affect our operating margins. Our inability to compete effectively against these
larger companies could have a material adverse effect on our business, financial condition, and operating results.&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>We
may not be able to keep pace with technological advances in the drone industry.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.7pt; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
drone industry continues to undergo significant changes, primarily related to technological developments. The rapid growth of technology
makes it impossible to predict the overall effect these factors could have on the drone industry. If we are not able to keep pace with
these technological advances, then our revenues, profitability and results from operations may be materially adversely affected.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Cybersecurity
risks could adversely affect our business and disrupt our operations.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
threats to network and data security are increasingly diverse and sophisticated. Despite our efforts and processes to prevent breaches,
our devices, as well as our servers, computer systems, and those of third parties that we use in our operations are vulnerable to cybersecurity
risks. These risks include cyber-attacks such as viruses and worms, phishing attacks, denial-of-service attacks, physical or electronic
break-ins, employee theft or misuse, and similar disruptions from unauthorized tampering with our servers and computer systems or those
of third parties that we use in our operations. The occurrence of any of these events could lead to interruptions, delays, loss of critical
data, unauthorized access to user data, and loss of consumer confidence. In addition, we may be the target of email scams that attempt
to acquire personal information or company assets. Despite our efforts to create security barriers to such threats, we may not be able
to entirely mitigate these risks. Any cyber-attack that attempts to obtain our data and assets, disrupt our service, or otherwise access
our systems, or those of third parties we use, if successful, could adversely affect our business, operating results, and financial condition.
A cyber attack would be expensive to remedy and could damage our reputation. In addition, any such breaches may result in negative publicity,
adversely affect our brand, decrease demand for our products and services, and adversely affect our operating results and financial condition.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Risks Related to
Our Enterprise Segment</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>U.S. government
contracts are generally not fully funded at inception and may include provisions that are not favorable to us which could adversely impact
our cash flows and results of operations.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #500050"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">US government contracts
often have long lead times for design and development and can be subject to significant changes in delivery timelines. Congress normally
appropriates funds on its fiscal year basis, and it may not fully fund a program in the same fiscal year. Depending upon the results
of political elections, the actions of Congress can change from one fiscal year to the next. As a result, we may be required to expend
funds to fulfill existing orders, but subsequently have the delivery timeline extended or the order cancelled. Such results would have
an adverse impact on our financial position and results of operations.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>A decline
in U.S. government budgets, changes in spending priorities, or delays in contract awards could adversely affect the revenues of our Teal
subsidiary.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">We presently expect
that much of our future revenue growth will be generated by our wholly owned subsidiary, Teal Drones, and that their primary customer
is likely to be the U.S. government and its agencies. As a result, our business may be adversely impacted due to changes in the political
environment, including those related to changes in the leadership of the current and or future administrations. We cannot provide assurance
that the current levels of congressional funding, for defense in general, and for drones specifically, will continue at their current
levels or decrease in the future. If annual budget appropriations are not enacted on a timely basis, we could encounter government shutdowns
which could adversely impact any existing programs including the timely payment of prior shipments, as well as the receipt of future
orders.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #222222"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Our
work for the U.S. government could expose us to security risks.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #222222"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
expect that an increasing percentage of our revenues will come from the U.S. government and its agencies. This may expose us to numerous
security threats, including cyber security attacks on our information technology infrastructure as well as threats to the physical safety
of our facilities and our employees. We utilize numerous controls and procedures to monitor and prevent these threats, however, we can
provide no assurance that they will be effective. Any improper use of our data, information technology systems or facilities could adversely
impact our operations and operating results.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>We
are subject to extensive government regulation and our failure to comply with these regulations could subject us to penalties that may
adversely impact our ability to operate our business.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">As
a vendor to the U.S. government and other state and local agencies, we are subject to and must comply with numerous government regulations
which impact how we operate our business. These regulations could adversely affect our revenues, operating costs and profit margins.
Some of the regulations to which we are subject, and the federal agencies which administer these regulations, include:</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Federal Aviation
    Administration, which regulates the use of airspace for all aircraft, including UAS such as drones</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">The Truth in
    Negotiations Act, which requires certification and disclosure of all factual pricing and cost data in contract negotiations</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">The Federal
    Acquisition Regulations, which govern the formation and administration, as well as the performance, under government contracts</span></td></tr>
  </table>
<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">The False Statements
    Act and The False Claims Act which imposes penalties on payments made on the basis of facts provided to the government</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">The Federal
    Communications Commission which regulates the wireless spectrum upon which drones depend for data transmission</span></td></tr>
  </table>
<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">It
is expensive and time consuming to comply with the regulations and requirements of these federal government agencies. The costs incurred
to maintain compliance will adversely impact our operating costs and could delay our ability to operate profitably in the future, if
at all.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Risks Related to
Our Common Stock</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Our management
has voting control of the Company</i></b>.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Jeffrey Thompson, our Chairman and Chief Executive
Officer, owns approximately 17% of our common stock, and our current officers and directors currently own approximately 21% of our common
stock. If they act together, they will be able to influence the outcome of all corporate actions requiring approval of our shareholders,
including the election of directors and approval of significant corporate transactions which may result in corporate actions that other
stockholders do not agree with. This concentration of ownership may have the effect of delaying or preventing a change in control and
may adversely affect the market price of our common stock.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Our failure to maintain effective internal
controls over financial reporting could have an adverse impact on the Company</i></b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are required to establish and maintain appropriate
internal controls over financial reporting. Failure to establish and maintain those controls could adversely impact public disclosures
regarding our business, financial condition or results of operations. In addition, management&#8217;s assessment of internal controls
over financial reporting may identify weaknesses and conditions that need to be addressed which may raise concerns for investors. Any
actual or perceived weaknesses and conditions that need to be addressed in our internal controls over financial reporting, disclosure
of management&#8217;s assessment of our internal controls, or disclosure of our public accounting firm&#8217;s attestation to our internal
controls over financial reporting may have an adverse impact on the price of our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>We have never
paid dividends and we do not expect to pay dividends for the foreseeable future.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">We have reported net
losses every year since inception. We intend to retain future earnings, if any, to finance the growth and development of our business.
If we ever become profitable, we do not expect to pay cash dividends on shares of our common stock in the foreseeable future. The payment
of future cash dividends, if any, depend upon, among other things, conditions then existing including earnings, financial condition and
capital requirements, restrictions in financing agreements, business opportunities and other factors. As a result, capital appreciation,
if any, of our common stock, will be the sole source of gain for investors for the foreseeable future.&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b>&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>The listing of&#160;our
securities on Nasdaq subjects us to additional regulations and compliance requirements.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are required to maintain compliance with the continued
listing standards of Nasdaq. These include certain financial and liquidity criteria to maintain such listing. If we fail to meet any of
Nasdaq&#8217;s listing standards, our securities may be delisted. Nasdaq requires that the trading price of its listed stocks remain above
one dollar for the stock to remain listed. If a listed stock trades below one dollar for more than 30 consecutive trading days, then it
is subject to delisting from Nasdaq.</p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">While our stock has
been trading above $1 per share, the stock price may trade below $1 per share  in the future. In addition, we must satisfy minimum
financial and other continued listing requirements and standards, including those regarding director and committee independence requirements,
minimum stockholders&#8217; equity, and certain corporate governance requirements. If we are unable to satisfy these requirements or
standards, we could be subject to delisting which would have a negative effect on the price of our common stock and would impair an investor&#8217;s
ability to sell or purchase our common stock. In the event of a delisting, we would expect to take actions to restore our compliance
with the listing requirements, but we can provide no assurance that any such action would allow our common stock to become listed again,
stabilize the market price, improve the liquidity of our common stock, or prevent future non-compliance with the listing requirements.
A delisting of our securities from Nasdaq may materially impair our stockholders&#8217; ability to buy and sell our securities and could
have an adverse effect on the market price of, and the efficiency of the trading market for, our securities.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i></i></b></span></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Our Board of
Directors may authorize and issue shares of new classes of stock that could adversely affect current holders of our common stock.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Our Board of Directors
has the power to authorize and issue shares of classes of stock, including preferred stock that have voting powers, designations, preferences,
limitations and special rights, including preferred distribution rights, conversion rights, redemption rights and liquidation rights
without further shareholder approval. These powers could adversely affect the rights of the holders of our common stock. In addition,
our board could authorize the issuance of a series of preferred stock that has greater voting power than our common stock or that is
convertible into our common stock, which could decrease the relative voting power of our common stock or result in dilution to our existing
common stockholders.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Any of these actions
could significantly adversely affect the investment made by holders of our common stock. In addition, holders of our common stock could
receive less proceeds in connection with any future sale of the Company, in liquidation or on any other basis.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Our shares will
be subordinate to all of our debts and liabilities which increases the risk that investors could lose their entire investment.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Our shares of common
stock are equity interests that will be subordinate to all of our current and future indebtedness with respect to claims on our assets.
In any liquidation, all of our debts and liabilities must be paid before any payment is made to our shareholders.&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b>&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>The market price
of our shares of common stock is subject to fluctuation.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The market prices of
our shares may fluctuate significantly in response to a wide range of factors, many of which are beyond our control, including:</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">The announcement
    and release of new products by our competitors</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Developments in our industry
    or target markets</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">General market conditions
    including factors unrelated to our operating performance</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">National or international
    economic or political events which result in a material effect on the stock market</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The stock market has,
from time to time, experienced extreme price and volume fluctuations. Continued market fluctuations could result in extreme market volatility
in the price of our shares of common stock which could cause a decline in the value of our shares.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b>&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Future capital
raises may dilute our existing stockholders&#8217; ownership and adversely impact the fair value of their investment. </i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">If we raise additional
capital by issuing equity securities, our existing stockholders&#8217; percentage ownership may decrease, and these stockholders may
experience substantial dilution. If we raise additional funds by issuing debt instruments, these debt instruments could impose significant
restrictions on our operations including liens on our assets. If we raise additional funds through collaborations and licensing arrangements,
we may be required to relinquish some rights to our technologies or products, or to grant licenses on terms that are not favorable to
us or could diminish the rights of our stockholders. Any of these developments could adversely impact our stock price.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b>Risks
Related to Regulatory Matters</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>The
drone industry is subject to various laws and government regulations which could complicate and delay our ability to introduce products,
maintain compliance, and avoid violations which could negatively impact our financial condition and results of operations.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
operate in the drone industry which is a highly regulated environment in the US and international markets. Federal, state, and local
governmental entities and foreign governments may regulate aspects of the industry, including the production or distribution of our products,
software or services. These regulations may include accounting standards, taxation requirements, product safety, trade restrictions,
environmental regulations, products directed toward children or hobbyists, and other administrative and regulatory restrictions. While
we endeavor to take all the steps necessary to comply with these laws and regulations, there can be no assurance that we can maintain
compliance on a continuing basis. Failure to comply could result in monetary liabilities and other sanctions which could increase our
costs or decrease our revenue resulting in a negative impact on our business, financial condition and results of operations.</span></p>

<!-- Field: Page; Sequence: 22 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Our
business and products are subject to government regulation, and we may incur additional compliance costs or be forced to suspend or cease
operations if we fail to comply.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
must comply with a wide variety of laws, regulations, standards and other requirements governing, among other things, electrical safety,
wireless emissions, health and safety, e-commerce, consumer protection, export and import requirements, hazardous materials usage, product-related
energy consumption, packaging, recycling and environmental matters. Compliance with these laws, regulations, standards, and other requirements
may be onerous and expensive, and they may be inconsistent from jurisdiction to jurisdiction (including from country to country), further
increasing the cost of compliance and doing business. Our products may require regulatory approvals or satisfaction of other regulatory
concerns in the various jurisdictions in which they are manufactured, sold or both. These requirements create procurement and design
challenges that require us to incur additional costs identifying suppliers and manufacturers who can obtain and produce compliant materials,
parts and products. Failure to comply with such requirements can subject us to liability, additional costs, and reputational harm and,
in extreme cases, force us to recall products or prevent us from selling our products in certain jurisdictions. If there is a new regulation,
or change to an existing regulation that significantly increases our costs of manufacturing or causes us to significantly alter the way
that we manufacture our products, this would have a material adverse effect on our business, financial condition and results of operations.
Additionally, while we have implemented policies and procedures designed to ensure compliance with applicable laws and regulations, there
can be no assurance that our employees, contractors, and agents will not violate such laws and regulations or our policies and procedures.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Our
products must comply with certain requirements of the U.S. Federal Communications Commission (&#8220;FCC&#8221;) regulating
electromagnetic radiation in order to be sold in the United States and with comparable requirements of the regulatory authorities of
the European Union (&#8220;EU&#8221;), Japan, China and other jurisdictions. Our first-person view products include wireless radios
and receivers which require additional emission testing. We are also subject to various environmental laws and governmental
regulations related to toxic, volatile, and other hazardous chemicals used in the third-party components incorporated into our
products, including the Restriction of Certain Hazardous Substances Directive (the &#8220;RoHS Directive&#8221;) and the EU Waste Electrical
and Electronic Equipment Directive (the &#8220;WEEE Directive&#8221;), as well as the implementing legislation of the EU member
states. This directive restricts the distribution of products within the EU that exceed very low maximum concentration amounts of
certain substances, including lead. Similar laws and regulations have been passed or are pending in China, Japan, and numerous
countries around the world and may be enacted in other regions, including in the United States. We are, or may in the future be,
subject to these laws and regulations.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Our
products may be subject to new domestic and international requirements. Compliance with regulations enacted in the future could substantially
increase our cost of doing business or otherwise have a material adverse effect on our results of operations and our business. Failure
to comply with regulations in the future could result in the imposition of fines or in the suspension or cessation of our operations
or sales in the applicable jurisdictions. Any such failure to comply with regulations may also result in our not being permitted, or
limit our ability, to ship our products which would adversely affect our revenue and ability to achieve or maintain profitability.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Although
we encourage our contract manufacturers and major component suppliers to comply with the supply chain transparency requirements, such
as the RoHS Directive, we cannot provide assurance that our manufacturers and suppliers consistently comply with these requirements.
In addition, if there are changes to these or other laws or if new related laws are passed in other jurisdictions, we may be required
to re-engineer our products to use components compatible with these regulations. This re-engineering and component substitution could
result in additional costs or disrupt our operations or logistics.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
WEEE Directive requires electronic goods producers to be responsible for the collection, recycling and treatment of such products. Changes
in interpretation of the directive may cause us to incur costs or have additional regulatory requirements to meet in the future in order
to comply with this directive, or with any similar laws adopted in other jurisdictions. Our failure to comply with past, present, and
future similar laws could result in reduced sales of our products, substantial product inventory write-offs, reputational damage, penalties
and other sanctions which could harm our business and financial condition. We also expect that our products will be affected by new environmental
laws and regulations on an ongoing basis. To date, our expenditures for environmental compliance have not had a material impact on our
results of operations or cash flows. Although we cannot predict the future impact of such laws or regulations, they will likely result
in additional costs and may require us to change the content of our products or how they are manufactured. These developments could have
a material adverse effect on our business and financial condition.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i></i></b></span></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Our
results of operations may suffer if we are not able to successfully manage our exposure to foreign exchange rate risks.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">A
substantial majority of our sales and cost of components are denominated in U.S. dollars. As our business grows, more of our sales and
production costs may be denominated in other currencies. Where such sales or production costs are denominated in other currencies, they
are converted to U.S. dollars for the purpose of calculating any sales or costs to us. Our sales may decrease as a result of any appreciation
of the U.S. dollar against these other currencies.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Most
of our current expenditures are incurred in U.S. dollars and many of our components come from countries that currently base their currency
against the U.S. dollar. If the exchange rates change adversely or are allowed to increase, then additional U.S. dollars will be required
to fund our purchases of these components.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Although
we do not currently enter into currency option contracts or engage in other hedging activities, we may do so in the future. There is
no assurance that we will undertake any such hedging activities or that, if we do so, they will be successful in reducing the risks associated
with our exposure to foreign currency fluctuations.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Our
international operations, including the use of foreign contract manufacturers, subjects us to international operational, financial, legal,
political and public health risks which could harm our operating results.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">A
substantial part of our operations, including manufacturing of certain components used in our products, are outside of the United States
and many of our customers and suppliers have some or all of their operations in countries other than the United States. Risks associated
with conducting business outside of the United States include:</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">compliance burdens
    and costs associated with a wide variety of foreign laws and regulations, particularly labor and environmental, that govern our operations
    in those countries;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">legal uncertainties
    regarding foreign taxes, tariffs, border taxes, quotas, and export controls,</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">export licenses,
    import controls and other trade barriers;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">economic instability
    and high levels of inflation in certain countries where our suppliers are located and</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">customers, particularly
    in the Asia-Pacific region, causing delays or reductions in orders for their products and therefore our sales;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">political or
    public health instability, including global pandemics, in the countries in which our suppliers operate;</span></td></tr>
  </table>
<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">changes or volatility
    in currency exchange rates;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">difficulties
    in collecting accounts receivable and longer accounts receivable payment cycles; and</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Any of these
    factors could harm our own, our suppliers&#8217; and our customers&#8217; international operations and businesses and impair our
    and/or their ability to continue expanding into international markets.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>We
could be adversely affected by violations of the U.S. Foreign Corrupt Practices Act or similar anti-bribery laws in other jurisdictions
in which we operate.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
global nature of our business creates various domestic and local regulatory challenges and subject us to risks associated with our international
operations. We operate in areas of the world that experience corruption by government officials to some degree and, in certain circumstances,
compliance with anti-bribery and anticorruption laws may conflict with local customs and practices. Our global operations require us
to import from several countries which geographically expands our compliance obligations. In addition, changes in such laws could result
in increased regulatory requirements and compliance costs which could adversely affect our business, financial condition, and results
of operations.&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
U.S. Foreign Corrupt Practices Act (FCPA) and similar anti-bribery and anticorruption laws in other jurisdictions prohibit U.S.-based
companies and their intermediaries from making improper payments to non-U.S. officials for the purpose of obtaining or retaining business,
directing business to another, or securing an advantage. In addition, U.S. public companies are required to maintain records that accurately
and fairly represent their transactions and have an adequate system of internal accounting controls. Under the FCPA, U.S. companies may
be held liable for the corrupt actions taken by directors, officers, employees, agents, or other strategic or local partners or representatives.
As a result, if we or our intermediaries fail to comply with the requirements of the FCPA or similar legislation, governmental authorities
in the United States and elsewhere could seek to impose substantial civil and/or criminal fines and penalties which could have a material
adverse effect on our business, reputation, operating results and financial condition.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>We
are subject to governmental export and import controls, and economic sanctions laws that could subject us to liability and impair our
ability to compete in international markets.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
U.S. and various foreign governments have imposed controls, export license requirements and restrictions on the import or export of some
technologies. Our products are subject to U.S. export controls, including the Commerce Department&#8217;s Export Administration Regulations
and various economic and trade sanction regulations established by the Treasury Department&#8217;s Office of Foreign Assets Controls.
Exports of our products must be made in compliance with these laws. Furthermore, U.S. export control laws and economic sanctions prohibit
the provision of products and services to countries, governments, and persons targeted by U.S. sanctions. Even though we take precautions
to prevent our products from being provided to targets of U.S. sanctions, our products could be provided to those targets or provided
by our customers despite such precautions. Any such provision could have negative consequences, including government investigations,
penalties, and reputational harm. Our failure to obtain required import or export approval for our products could harm our international
and domestic sales and adversely affect our revenue.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>&#160;</i></b>&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Changes
in trade policy in the United States and other countries may have adverse impacts on our business, results of operations and financial
condition.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
U.S. government has indicated its intent to alter its approach to international trade policy through the renegotiation, and potential
termination, of certain trade agreements and treaties with China, countries in EMEA and other countries. These changes could include
the imposition of additional tariffs on a wide range of products. Policy changes in the United States or other countries, such as the
tariffs already proposed, implemented, and threatened, present risks for us. Tariffs already announced and implemented are having an
adverse effect on certain of our products, tariffs announced but not yet implemented may have an adverse effect on many of our products,
and threatened tariffs could adversely affect more or all of our products. There are also risks associated with retaliatory tariffs and
resulting trade wars. We cannot predict future trade policy, the terms of any renegotiated trade agreements or treaties, or tariffs and
their impact on our business. A trade war could have a significant adverse effect on world trade and the world economy. To the extent
that trade tariffs and other restrictions imposed by the United States or other countries increase the price of, or limit the amount
of, our products or components or materials used in our products imported into the United States or other countries, or create adverse
tax consequences, the sales, cost or gross profit of our products may be adversely affected and the demand from our customers for products
and services may be diminished. Uncertainty surrounding international trade policy and disputes and protectionist measures could also
have an adverse effect on consumer confidence and spending. If we deem it necessary to alter all or a portion of our activities or operations
in response to such policies, agreements or tariffs, our capital and operating costs may increase. Our ongoing efforts to address these
risks may not be effective and may have long-term adverse effects on our operations and operating results that we may not be able to
reverse. Such efforts may also take time to implement or to have an effect, and may result in adverse quarterly financial results or
fluctuations in our quarterly financial results. As a result, changes in international trade policy, changes in trade agreements and
tariffs could adversely affect our business, results of operations and financial condition.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>We
may collect, store, process and use the personal information of our customers which subjects us to governmental regulation related to
privacy, information security and data protection. Any cybersecurity breaches or our failure to comply with such legal obligations by
us, or by our third-party service providers or partners, could harm our business.</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
may collect, store, process and use the personally identifiable information of our customers and other data in our transactions with
them. We also rely on third parties that are not directly under our control to do so as well. While we take reasonable measures to protect
the security, integrity and confidentiality of the personal information and other sensitive information we collect, store or transmit,
we cannot guarantee that inadvertent or unauthorized use or disclosure will not occur, or that third parties will not gain unauthorized
access to this information. While our privacy policies currently prohibit such activities, our third-party service providers or partners
may engage in such activity without our knowledge or consent. If we or our third- party service providers were to experience a breach,
disruption or failure of systems compromising our customers&#8217; data, or if one of our third-party service providers or partners were
to access our customers&#8217; personal data without our authorization, our brand and reputation could be adversely affected, use of
our products could decrease, and we could be exposed to a risk of loss, litigation and regulatory proceedings.&#160;</span></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Regulatory
scrutiny of privacy, data collection, use of data and data protection is intensifying globally, and the personal information and other
data we collect, store, process and use is increasingly subject to legislation and regulations in numerous jurisdictions around the world,
especially in Europe. These laws often develop in ways we cannot predict and may materially increase our cost of doing business, particularly
as we expand the nature and types of products we offer.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Data
protection legislation is becoming increasingly common in the United States at both the federal and state level. For example, in 2020,
the State of California implemented the California Consumer Privacy Act of 2018 (the "CCPA"). The CCPA requires companies that
process information on California residents to make new disclosures to consumers about their data collection, use and sharing practices,
allows consumers to opt out of certain data sharing with third parties and provides a new cause of action for data breaches. Additionally,
the Federal Trade Commission and many state attorneys general are interpreting federal and state consumer protection laws to impose standards
for the online collection, use, dissemination and security of data. The burdens of compliance imposed by the CCPA (and other similar
laws that may be enacted at the federal and state level) may require us to modify our data processing practices and policies and/or to
incur substantial expenditures.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b>Risks
Related to Intellectual Property</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Our
products could infringe on the intellectual property rights of others.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Companies
in the electronics, wireless communications, semiconductor, IT, and display industries steadfastly pursue and protect intellectual property
rights, often resulting in considerable and costly litigation to determine the validity of patents and claims by third parties of infringement
of patents or other intellectual property rights. Our products could be found to infringe on the intellectual property rights of others.
Other companies may hold or obtain patents or inventions or other proprietary rights in technology necessary for our business. Periodically,
other companies inquire about our products and technology in their attempts to assess whether we violate their intellectual property
rights. If we are forced to defend against infringement claims, we may face costly litigation, diversion of technical and management
personnel, and product shipment delays, even if the allegations of infringement are unwarranted. If there is a successful claim of infringement
against us and we are unable to develop non-infringing technology or license the infringed or similar technology on a timely basis, or
if we are required to cease using one or more of our business or product names due to a successful trademark infringement claim against
us, it could adversely affect our business.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Our
intellectual property rights and proprietary rights may not adequately protect our products.</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Our
commercial success will depend substantially on the ability to obtain patents and other intellectual property rights and maintain adequate
legal protection for products in the United States and other countries. We will be able to protect our intellectual property from unauthorized
use by third parties only to the extent that these assets are covered by valid and enforceable patents, trademarks, copyrights or other
intellectual property rights, or are effectively maintained as trade secrets. As of the date of this filing, we own 36 granted United
States and foreign patents and 16 pending United States and foreign patent applications. The U.S. patents and patent applications include
claims to, among other things, a drone, a printed circuit board, and head-mounted display technology.&#160;We apply for patents covering
our products, services, technologies, and designs as we deem appropriate. We may fail to apply for patents on important products, services,
technologies or designs in a timely fashion, or at all. We do not know whether any of our patent applications will result in the issuance
of any patents. Even if patents are issued, they may not be sufficient to protect our products, services, technologies, or designs. Our
existing and future patents may not be sufficiently broad to prevent others from developing competing products, services technologies,
or designs. Intellectual property protection and patent rights outside of the United States are even less predictable. As a result, the
validity and enforceability of patents cannot be predicted with certainty. Moreover, we cannot be certain whether:</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 97%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">we were the
    first to conceive, reduce to practice, invent, or file the inventions covered by each of our issued patents and pending patent applications;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 97%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">others will
    independently develop similar or alternative products, technologies, services or designs or duplicate any of our products, technologies,
    services or designs;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 97%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">any patents
    issued to us will provide us with any competitive advantages, or will be challenged by third parties;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 97%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">we will develop
    additional proprietary products, services, technologies or designs that are patentable; or</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="width: 97%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">the patents
    of others will have an adverse effect on our business.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="UnresolvedStaffComments"></span><span style="font-size: 10pt"><b>ITEM 1B. UNRESOLVED
STAFF COMMENTS</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Not applicable.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><span id="Cybersecurity"></span><b>ITEM 1C. CYBERSECURITY</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">We recognize the importance
of assessing, identifying, and managing material risks associated with cybersecurity threats, as such term is defined in&#160;Item 106(a)
of&#160;Regulation S-K. These risks include, among other things: operational risks, intellectual property theft, fraud, extortion, harm
to employees or customers and violation of data privacy or security laws. To mitigate the threat to our business, we take a comprehensive
approach to cybersecurity risk management. The Company&#8217;s Board of Directors as well as its Chief Technology Officer, Chief Information
Security Officer, and Chief Financial Officer are actively involved in the oversight of our risk management program, of which cybersecurity
represents an important component. We have established policies, standards, processes, and practices for assessing, identifying, managing
and mitigating material risks from cybersecurity threats.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Risk Assessment
and Management</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
rely on a multidisciplinary team, including our information security function, management, and third-party service
providers to identify, assess, remediate and manage cybersecurity threats and risks. We identify and assess risks from cybersecurity
threats by monitoring and evaluating our threat environment and our risk profile using various methods including, for example, manual
and automated tools, subscribing to reports and services that identify cybersecurity threats, analyzing reports of threats and threat
actors, conducting scans of the threat environment, utilizing internal and external audits, and conducting threat and vulnerability assessments.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #FA4030"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">At
least annually, we review our security controls and address information security vulnerabilities, conduct security testing, and assess
our external sources for their security risk (e.g., security incidents, data security, security controls, third parties, etc.). The results
of the assessment are used to drive alignment and prioritization of initiatives to enhance our security posture, improve security processes,
and to manage a broader enterprise-level risk program that is presented to the Board of Directors, the Audit Committee, and members of
management.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
Company maintains various technical, physical, and organizational measures, processes, standards, and policies designed to manage and
mitigate material risks from cybersecurity threats against our information systems and data. These include:</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">incident
                                            detection and response</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">vulnerability
                                            management</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">disaster
                                            recovery plans</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">internal
                                            controls within our accounting and financial reporting functions</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">encryption
                                            of data</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">network
                                            security controls</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">access
                                            controls</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">physical
                                            security</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">asset
                                            management</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">systems
                                            monitoring</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">vendor
                                            risk management program</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">employee
                                            training.</span></td></tr></table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Notwithstanding
the approach we take to cybersecurity, we may not be successful in preventing or mitigating a cybersecurity incident that could have
a material adverse effect on the Company. Refer to Item 1A for a discussion of cybersecurity risks.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Governance</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Our Board of Directors
is responsible for overseeing our enterprise risk management activities, and each of our Board committees assists the Board in the role
of risk oversight. The full Board receives an update on the Company&#8217;s risk management process and the risk trends related to cybersecurity
at least annually. The Audit Committee specifically assists the Board of Directors in its oversight of risks related to cybersecurity.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="Properties"></span><span style="font-size: 10pt"><b>ITEM 2. PROPERTIES</b></span></p>

<p style="font: 12pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="margin: 0; text-align: justify"><span style="font-size: 10pt">We lease all properties where our business is operated. We believe
that these properties are adequate for the purposes for which they are used. All leases are with unaffiliated third parties. We believe
that the loss of any lease would not have a material adverse effect on our operations, as we believe that we could identify and lease
comparable facilities upon approximately equivalent terms. The Company has the following operating leases for real estate locations where
it operates:</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt"><b>&#160;&#160;Location</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Monthly Rent</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Expiration</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; padding-left: 5.4pt"><span style="font-size: 10pt">South Salt Lake, Utah</span></td>
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 10pt">$</span></td>
    <td style="width: 25%; text-align: right"><span style="font-size: 10pt">22,667</span></td>
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 25%; text-align: right"><span style="font-size: 10pt">December 2030</span></td>
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">San Juan, Puerto Rico</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">5,647</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">June 2027</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Grantsville, Utah</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">1,000</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">December 2026</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/107% Times New Roman, Times, Serif; margin: 0pt"><span style="font-size: 10pt">The South Salt Lake, Utah facility
has approximately 22,000 square feet and is used for our manufacturing. The San Juan, Puerto Rico facility has approximately 3,600 square
feet and is used for administrative purposes. The Grantsville, Utah property is approximately one acre and is used for drone flight operations
and testing.</span></p>

<p style="font: 12pt/107% Times New Roman, Times, Serif; margin: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-size: 10pt">These lease agreements
have remaining terms up to 6.67 years, including options to extend certain leases for up to six years.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The weighted average
remaining lease term as of April 30, 2024 was 6.16 years. The Company used a discount rate of 12% to calculate its lease liability at
April 30, 2024. Future lease payment obligations at April 30, 2024 were as follows:</span></p>

<p style="font: 12pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td colspan="3"><span style="font-size: 10pt">Fiscal Year Ended:</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 65%"><span style="font-size: 10pt">2025</span></td>
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 4%"><span style="font-size: 10pt">$&#160;</span></td>
    <td style="width: 28%; text-align: right"><span style="font-size: 10pt">366,853</span></td>
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">2026</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">372,449</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">2027</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">372,880</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">2028</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">293,334</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">2029</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">280,080</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">Thereafter</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">443,460</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCECFF">
    <td><span style="font-size: 10pt">Total</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">2,129,056</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 12pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><span id="LegalProceedings"></span>ITEM 3. LEGAL PROCEEDINGS</b>&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On&#160;September 29, 2022, we, and our wholly owned
subsidiary Teal Drones, Inc., initiated a legal proceeding (the &#8220;Lawsuit&#8221;) against Autonodyne LLC (&#8220;Autonodyne&#8221;)
and its principal equity owner Daniel Schwinn (&#8220;Schwinn&#8221;), in Delaware Chancery Court. The case is captioned as Red Cat Holdings,
Inc., et al. v. Autonodyne LLC, et al., C.A. No. 2022-0878. The case arises from Autonodyne&#8217;s unilateral purported termination of
a software licensing agreement entered between Teal Drones and Autonodyne in May 2022. Before the defendants answered, we filed a First
Amended Complaint on&#160;December 5, 2022, which the defendants moved to dismiss. The court partially granted that motion, dismissing
the claims asserted against Autonodyne, but not against Schwinn. For jurisdictional reasons, the case subsequently was transferred to
Delaware Superior Court. The Lawsuit alleges a cause of action against Schwinn for Tortious Interference with Contractual Relations and
Prospective Contractual Relations, concerning a Software Licensing Agreement between Teal Drones and Autonodyne. No discovery or other
significant developments in the Lawsuit have occurred.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On&#160;May 9, 2024, Autonodyne
LLC filed a complaint against wholly-owned Red Cat subsidiary Teal Drones, Inc. in the Superior Court of the State of Delaware. The Complaint
alleges a single cause of action, asserting that Teal breached a Software Licensing Agreement between it and Autonodyne (the &#8220;SLA&#8221;)
by disclosing confidential information contained in the SLA. Autonodyne alleges that it rightfully terminated the SLA, and at that point
it became entitled to $8.25 million of accelerated payments, pursuant to section 14.4(e) of the SLA. Teal Drones has answered the Complaint,
but no discovery has been served yet. As any litigation is subject to many uncertainties, it is not possible to predict the ultimate outcome
of this claim or to estimate the loss, if any, which may result. Accordingly, the outcome of the claim is not yet determinable, and the
extent to which an outflow of funds may be required to settle this possible obligation cannot be reliably determined. The Company plans
to vigorously assert defenses to the complaint.</p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><span id="MineSafetyDisclosures"></span>ITEM 4. MINE SAFETY
DISCLOSURES</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Not applicable.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><b>PART II</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><span id="DescriptionOfSecurities"></span><b>ITEM 5. MARKET FOR
REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Market Information</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Our common stock has
been listed on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) since April 30, 2021 under the symbol &#8220;RCAT&#8221;.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The last reported sales
price of our common stock on August 5, 2024 was $1.98</span>.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Holders</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">As of August 5, 2024,
there were 127 stockholders of record of our common stock.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Dividends </b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The Company has never
paid dividends on its common stock and does not anticipate that it will pay dividends in the foreseeable future. It intends to use any
future earnings for the expansion of its business. Any future determination of applicable dividends will be made at the discretion of
the Board of Directors and will depend on the results of operations, financial condition, capital requirements and other factors deemed
relevant.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;<b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Recent Sales of
Unregistered Securities</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">There
were no sales of equity securities during the period covered by this Annual Report that were not registered under the Securities Act
and were not previously reported in a Quarterly Report on Form 10-Q or a Current Report on Form 8-K filed by the Company.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Purchase of Equity
Securities by the Issuer and Affiliated Purchasers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
did not repurchase any securities in the fourth quarter of the fiscal year covered by this Annual Report.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span>&#160;</p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><span id="Reserved"></span>ITEM 6. RESERVED</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="MDA"></span><span style="font-size: 10pt"><b>ITEM 7. MANAGEMENT'S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The following discussion
should be read in conjunction with our audited consolidated financial statements and related notes and other financial data included
elsewhere in this Annual Report on Form 10-K. In addition to our historical consolidated financial information, the following discussion
contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those
discussed in the forward-looking statements. For more information regarding forward-looking statements, please refer to the discussion
above under the heading &#8220;Forward-Looking Statements.&#8221;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Recent Developments</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Corporate developments
during the two years ended April 30, 2024 include:</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b><i>Capital
Transactions</i></b></span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">During
the first quarter of fiscal 2022, the Company completed two firm commitment underwritten public offerings with ThinkEquity, a division
of Fordham Financial Management. The first offering, in May 2021, generated gross and net proceeds of $16 and $14.6 million, respectively.
The second offering, in July 2021, generated gross and net proceeds of $60 and $55.5 million, respectively.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">On
December 11, 2023, the Company completed a firm commitment underwritten public offering with ThinkEquity of 18,400,000 shares of common
stock which generated gross and net proceeds of $9.2 and $8.4 million, respectively.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b>Plan of Operations</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Since April 2016, the
Company's primary business has been to provide products, services, and solutions to the drone industry which it presently does through
its four wholly owned subsidiaries. Beginning in January 2020, the Company expanded the scope of its drone products and services through
four acquisitions, including:</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">A.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">In January 2020, the Company acquired Rotor Riot, a provider of First
    Person View (FPV) drones and equipment, primarily to the consumer marketplace. The purchase price was $1,995,114.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">B.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">In November 2020, the Company acquired Fat Shark Holdings, a provider
    of FPV video goggles to the drone industry. The purchase price was $8,354,076.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">C.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">In May 2021, the Company acquired Skypersonic which provides hardware
    and software solutions that enable drones to complete inspection services in locations where GPS is not available, yet still record
    and transmit data even while being operated from thousands of miles away. The purchase price was $2,791,012.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">D.</span></td>
    <td><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">In August 2021,
    the Company acquired Teal Drones, a leader in commercial and government UAV (Unmanned Aerial Vehicles) technology. The purchase price
    was $10,011,279.</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Following the Teal
acquisition in August 2021, we concentrated on integrating and organizing these businesses. Effective May 1, 2022, we established the
Enterprise segment and the Consumer segment to focus on the unique opportunities in each sector. The Enterprise segment&#8217;s initial
strategy was to provide UAVs to commercial enterprises, and the military, to navigate dangerous military environments and confined industrial
and commercial interior spaces. Subsequently, the segment narrowed its near-term attention on the military and other government agencies.
Skypersonic's technology has been redirected to military applications and its operations consolidated into Teal.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 30; Value: 59 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The Enterprise segment&#8217;s
current business strategy is focused on providing integrated robotic hardware and software for use across a variety of applications.
Its solutions provide critical situational awareness and actionable intelligence to on-the-ground warfighters and battlefield commanders
as well as firefighters and public safety officials. Our Enterprise segment&#8217;s efforts are centered on developing and scaling an
American made family of systems. We have since completed construction of a manufacturing facility in Salt Lake City and believe that
an increased focus by the United States government and American businesses on purchasing products that are &#8220;Made in America&#8221;
provide our Enterprise segment with a competitive advantage.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">On February 16, 2024,
we closed the sale of our Consumer segment, consisting of Rotor Riot and Fat Shark, to Unusual Machines. The sale reflects our decision
to focus our efforts and capital on defense where we believe there are more opportunities to create long term shareholder value.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Results of Operations
</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
analysis of the Company's results of operations for the year ended April 30, 2024 ("Fiscal 2024") compared to the year ended
April 30, 2023 ("Fiscal 2023") includes only the Company&#8217;s Enterprise segment as our Consumer segment was divested in
February 2024. At the end of Fiscal 2023, the Company recognized an impairment loss of $2,826,918 related to Skypersonic goodwill which
was written down to zero. In addition, its operations were consolidated into Teal. Skypersonic's operating results represented 0% and
2% of consolidated revenues and operating loss for Fiscal 2024. Based on its immateriality, Skypersonic is not included in the operating
analysis set forth below.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-size: 10pt"><b>Discussion and
Analysis of Fiscal 2024 compared to Fiscal 2023</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Revenues</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Consolidated
revenues totaled $17,836,382 during the year ended April 30, 2024 (or the "2024 period") compared to $4,620,834 during the
year ended April 30, 2023 (or the "2023 period") representing an increase of $13,215,548, or 286%. The increase primarily related
to higher product revenue related to the launch of the Teal 2 in April 2023.&#160;Product revenue totaled $13,588,372 during the year
ended April 30, 2024 compared to $3,012,470 during the year ended April 30, 2023 representing&#160;an increase of $10,575,902, or&#160;351%.
The increase in revenue also partially related to increased contract revenues during the 2024 period. Contract revenues totaled $4,173,005
during the 2024 period compared to $1,312,427 during the 2023 period, representing&#160;an increase of $2,860,578, or 218%.&#160;Contract
revenues are primarily sourced through government agencies and can fluctuate from period to period based on the timing of award deliverables
and amendments.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Gross Profit</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">Consolidated
gross profit totaled $3,680,546 during the 2024 period compared to negative $834,311 during the 2023 period representing an increase
of $4,514,857, or 541%. On a percentage basis, gross profit was 21% during the 2024 period compared to negative 18% during the 2023 period.
The percentage basis increase in gross profit in the 2024 period primarily related to obsolete inventory write-offs that occurred during
the 2023 period. Additionally, lower manufacturing levels in the 2023 period resulted in higher relative overhead costs compared to the
2024 period. Our manufacturing facility is presently producing drones at a lower level than it is designed for, and these lower production
levels, combined with higher overhead costs, continue to result in lower than targeted gross profits. As production levels increase,
our fixed overhead costs, including labor, are expected to be allocated to a greater number of drones which is expected to drive our
per-drone production costs lower and increase gross profits.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Operating Expenses</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Research and development
expenses totaled $5,896,037 during the 2024 period compared to $5,595,281 during the 2023 period, representing an increase of $300,756,
or 5%. Supplies and materials expense totaled $2,017,979 in the 2024 period compared to $1,444,051 in the 2023 period.&#160;This increase
of $573,928, or 40%, primarily related to increased efforts in developing new products and represented substantially all of the total
increase in research and development costs.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Sales and marketing
costs totaled $4,568,617 during the 2024 period compared to $3,731,776 during the 2023 period, representing an increase of $836,841 or
22%. The increase was driven by higher payroll expenses to support increased sales efforts of the Teal 2.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 31; Value: 59 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">General and administrative
expenses totaled $10,679,105 during the 2024 period compared to $12,383,470 during the 2023 period, representing a decrease of $1,704,365
or 14%. The decrease primarily related to lower professional fees.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">During the 2024 period,
we incurred stock-based compensation costs of $3,609,267 compared to $3,656,724 in the 2023 period, resulting in a decrease of $47,457
or 1%.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Other Income</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Other expense totaled
$3,650,484 during the 2024 period compared to $1,004,887 during the 2023 period, representing a decrease of $2,645,597 or 263%. During
the 2024 period, the divestiture of the Consumer segment resulted in a gain of $9,642,427, impairment of $11,353,875, and an equity method
loss of $503,625.&#160;Additionally, during the 2024 period, the Company was awarded a manufacturing modernization grant from the State
of Utah for $750,000 of which $675,000 is attributable to the 2024 period.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Net Loss from Continuing
Operations</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Net loss from continuing
operations totaled $21,526,696 for the 2024 period compared to $26,376,643 for the 2023 period, resulting in a decrease of $4,849,947
or 18%. Total operating expenses totaled $21,556,758 for the 2024 period compared to $24,537,445 for the 2023 period. The decrease in
operating expenses was offset by the increase in other expense. Higher gross profit is attributable to the decrease in net loss from
continuing operations.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Results of Discontinued
Operations</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Net loss from discontinued
operations totaled $2,525,933 for the 2024 period compared to $1,730,386 for the 2023 period, representing an increase of $795,547, or
46%. Net loss for Fat Shark totaled $1,365,707 for the 2024 period, compared to $543,962 for the 2023 period, representing an increase
of $821,745 or 151%, and represents 103% of the total increase in net loss from discontinued operations. Fat Shark&#8217;s results were
adversely impacted by a charge of $1,244,920 during the 2024 period related to the write-off of excess quantities of Dominator inventory
based on sales volumes. Net loss for Rotor Riot totaled $1,160,226 for the 2024 period compared to $1,186,424 for the 2023 period, representing
a decrease of $26,198 or 2%.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>Cash Flows </b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Operating Activities</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Net cash used in operating
activities was $17,687,063 during the 2024 period compared to net cash used in operating activities of $24,313,674 during the 2023 period,
representing a decrease of $6,626,611 or 27%. The decreased use of cash primarily related to timing of accounts receivable receipts for
government customers. Net cash used in operations, net of non-cash expenses, totaled $8,512,449 during the 2024 period, compared to $7,784,364
during the 2023 period, resulting in an increase of $728,085, or 9%. Net cash used related to changes in operating assets and liabilities
totaled $4,672,816 during the 2024 period, compared to $5,721,395 during the 2023 period, representing a decrease of $1,048,579 or 18%.
Changes in operating assets and liabilities can fluctuate significantly from period to period depending upon the timing and level of
multiple factors, including inventory purchases, vendor payments, and customer collections.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Investing Activities</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net cash provided by investing activities was $13,567,078
during the 2024 period compared to net cash provided by investing activities of $29,590,235 during the 2023 period, resulting in a decrease
of $16,023,157 or 54%. Proceeds of $12,826,217 and $32,290,448 from the sale of marketable securities were used to fund operations during
the 2024 period and the 2023 period, respectively.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Financing Activities</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Net cash provided by
financing activities totaled $7,802,076 during the 2024 period compared to net cash used in financing activities of $1,215,325 during
the 2023 period. Financing activities can vary from period to period depending upon market conditions, both at a macro-level and specific
to the Company. During the fiscal 2024 period, the company received net proceeds from issuance of common stock of $8,395,600.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 32; Value: 59 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Liquidity and
Capital Resources</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">At April 30, 2024,
the Company reported current assets totaling $22,397,549, current liabilities totaling $3,651,130 and net working capital of $18,746,419.
Cash  totaled $6,067,169 at April 30, 2024.&#160;Inventory related balances, including pre-paid inventory, totaled
$8,610,125.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Going Concern</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
Company has never been profitable and has incurred net losses related to acquisitions, as well as costs incurred to pursue its long-term
growth strategy. During the year ended April 30, 2024, the Company incurred a net loss from continuing operations of </span>$21,526,696
<span style="background-color: white">and used cash in operating activities of continuing operations of </span>$17,687,063<span style="background-color: white">.
As of April 30, 2024, working capital for continuing operations totaled </span>$18,746,419<span style="background-color: white">. These
financial results and our financial position at&#160;April 30, 2024&#160;raise substantial doubt about our ability to continue as a going
concern. However, the Company has recently taken actions to strengthen its liquidity.&#160;On&#160;December 11, 2023, we completed a public
offering of 18,400,000 shares of common stock which generated net proceeds of approximately $8,400,000. Subsequent to year end, the Company
sold its equity method investment for $4,400,000. In addition, the Company&#8217;s operating plan for the next twelve months has been
updated to reflect recent operating improvements.&#160; Revenues have accelerated and are expected to continue growing. The Company&#8217;s
manufacturing facility is scaling production and gross profits are projected to increase.&#160;If necessary, the Company will seek to
obtain additional debt financing for which there can be no guarantee. Management has concluded that these recent positive developments
alleviate any substantial doubt about the Company&#8217;s ability to&#160;continue its operations, and meet its financial obligations,
for twelve months from the date these consolidated financial statements&#160;are&#160;issued.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><span style="background-color: white"></span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Critical Accounting
Policies and Estimates</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Our financial statements
and accompanying notes have been prepared in accordance with GAAP applied on a consistent basis. The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities,
the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and
expenses during the reporting periods.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">We
regularly evaluate the accounting policies and estimates that we use to prepare our financial statements. A complete summary of these
policies is included in the notes to our financial statements. In general, management's estimates are based on historical experience,
information from third party professionals, and on various other assumptions that are believed to be reasonable under the facts and circumstances.
Actual results could differ from those estimates made by management.&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Significant estimates reflected in these financial
statements include those used to (i) complete purchase price accounting for acquisitions, (ii) the evaluation of long-term assets, including
goodwill, for impairment, and (iii) the evaluation of other-than-temporary-impairment of equity method investments.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b>Goodwill
and Long-lived Assets</b> &#8211; Goodwill represents the future economic benefit arising from other assets acquired in an acquisition&#160;that
are not individually identified and separately recognized. We test goodwill for impairment in accordance with the provisions of&#160;<i>ASC
350, Intangibles &#8211; Goodwill and Other,&#160;</i>(&#8220;ASC 350&#8221;). Goodwill is tested for impairment at least annually at
the reporting unit level or whenever events or changes in circumstances indicate that goodwill might be impaired. ASC 350 provides that
an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a
determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing
the totality of events or circumstances, an entity determines it is not more likely than not that the fair value of a reporting unit
is less than its carrying amount, then additional impairment testing is not required. However, if an entity concludes otherwise, then
it is required to perform an impairment test. The impairment test involves comparing the estimated fair value of a reporting unit with
its book value, including goodwill. If the estimated fair value exceeds book value, goodwill is considered not to be impaired. If, however,
the fair value of the reporting unit is less than book value, then an impairment loss is recognized in an amount equal to the amount
that the book value of the reporting unit exceeds its fair value, not to exceed the total amount of goodwill allocated to the reporting
unit.</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 33; Value: 59 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
estimate of fair value of a reporting unit is computed using either an income approach, a market approach, or a combination of both.
Under the income approach, we utilize the discounted cash flow method to estimate the fair value of a reporting unit. Significant assumptions
inherent in estimating the fair values include the estimated future cash flows, growth assumptions for future revenues (including gross
profit, operating expenses, and capital expenditures), and a rate used to discount estimated future cash flow projections to their present
value based on estimated weighted average cost of capital (i.e., the selected discount rate). Our assumptions are based on historical
data, supplemented by current and anticipated market conditions, estimated growth rates, and management&#8217;s plans. Under the market
approach, fair value is derived from metrics of publicly traded companies or historically completed transactions of comparable businesses.
The selection of comparable businesses is based on the markets in which the reporting units operate and consider risk profiles, size,
geography, and diversity of products and services.&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt"><b>Fair
Values, Inputs and Valuation Techniques for Financial Assets and Liabilities and Related Disclosures</b> &#8211; The fair value measurements
and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that
would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants
at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities
into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and
the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair
value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has
been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment
of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific
to the asset or liability.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">The
guidance establishes three levels of the fair value hierarchy as follows:</span></p>

<p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><span style="font-size: 10pt"><i>Level
1</i>: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><span style="font-size: 10pt"><i>Level
2</i>: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices
for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated
by observable market data for substantially the full term of the related assets or liabilities; and</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-size: 10pt"><i>Level
3</i>: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported
by little or no market data.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><i>Financial Instruments
</i></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The Company's financial
instruments mainly consist of cash, receivables, current assets, accounts payable, accrued expenses and debt. The carrying amounts of
cash, receivables, current assets, accounts payable, accrued expenses and current debt approximates fair value due to the short-term
nature of these instruments.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Off-Balance Sheet
Arrangements</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">We have no off-balance
sheet arrangements.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><i>Recently Issued
Accounting Pronouncements</i></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The Company has implemented
all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements
unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued
that might have a material impact on its financial position or results of operations.&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><span id="QualitativeDisclosures"></span>ITEM 7A. QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">As a smaller reporting
company, we are not required to provide this information.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="FinancialStatements"></span><span style="font-size: 10pt"><b>ITEM 8. FINANCIAL
STATEMENTS AND SUPPLEMENTARY DATA </b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><b>RED CAT HOLDINGS,
INC.</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><b>INDEX TO CONSOLIDATED
FINANCIAL STATEMENTS</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#AuditorReport"><span style="font-size: 10pt">Report of Independent Registered Accounting Firm
    (PCAOB ID: <span id="xdx_90A_edei--AuditorFirmId_c20230501__20240430_zVzNXARcBQtg"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:AuditorFirmId" id="ixv-14630">3501</ix:nonNumeric></span>)</span></a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#AuditorReport"><span style="font-size: 10pt">F-2</span></a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#BalanceSheet"><span style="font-size: 10pt">Consolidated Balance Sheets as of April 30, 2024
    and 2023</span></a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#BalanceSheet"><span style="font-size: 10pt">F-3</span></a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#IncomeStatement"><span style="font-size: 10pt">Consolidated Statements of Operations for the
    years ended April 30, 2024 and 2023</span></a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#IncomeStatement"><span style="font-size: 10pt">F-4</span></a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#EquityStatement"><span style="font-size: 10pt">Consolidated Statements of Shareholders&#8217;
    Equity for the years ended April 30, 2024 and 2023</span></a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#EquityStatement"><span style="font-size: 10pt">F-5</span></a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#CashFlow"><span style="font-size: 10pt">Consolidated Statements of Cash Flows for the
    years ended April 30, 2024 and 2023</span></a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#CashFlow"><span style="font-size: 10pt">F-6</span></a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#Notes"><span style="font-size: 10pt">Notes to the Consolidated Financial Statements</span></a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#Notes"><span style="font-size: 10pt">F-7</span></a></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 12pt/105% Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-size: 10pt"><span id="AuditorReport"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0pt 6pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Board of Directors and<br/>
Stockholders of Red Cat Holdings, Inc.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of Red Cat Holdings, Inc. (the &#8220;Company&#8221;) as of April 30, 2024
and 2023, and the related consolidated statements of operations, stockholders&#8217; equity, and cash flows for the years then ended,
and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements
present fairly, in all material respects, the financial position of the Company as of April 30, 2024 and 2023, and the results of its
operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States
of America.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Audit Matters</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
critical audit matter communicated below is a matter arising from the current period audits of the financial statements that were communicated
or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial
statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter
does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit
matter below, providing separate opinion on the critical audit matter or on the accounts or disclosures to which they relate.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Valuation
of Goodwill and Intangibles</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in Note 8 to the financial statements, the Company acquired various businesses which resulted in the recording of significant
amounts of goodwill and intangible assets. The intangible assets management identified consisted of proprietary technology and tradenames.
Management determined the fair value of the intangible assets using a discounted cash flow model. Key assumptions used the model to determine
fair value were cash flow projections, the discount rate, long-term growth rates, effective tax rate and the estimated periods to be
benefitted of the identifiable intangible assets with definite lives.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
identified the valuation of goodwill and intangible assets for the businesses acquired as a&#160;critical&#160;audit&#160;matter&#160;because
of the significant assumptions management makes in determining the estimates. Auditing management&#8217;s assumptions involved a high
degree of auditor judgment and increased&#160;audit&#160;effort, including the use of valuation specialists, as management&#8217;s assumptions
are subjective, and changes in these assumptions could have a significant impact on the fair value of the businesses acquired.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our&#160;audit&#160;procedures
related to the Company&#8217;s valuation of goodwill and intangible assets for the businesses acquired included the following, among
others:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
evaluated the reasonableness of management&#8217;s cash flow projections by comparing management&#8217;s prior forecasts to historical
results for the Company, as well as inquiry of management of the reporting unit regarding the expected future operations, review of publicly
available industry information, and testing the completeness and accuracy of the data used in the projections.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we evaluated the reasonableness of management&#8217;s use of various rates and other assumptions by comparing them to comparable companies
and market data.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finally,
we evaluated the estimated periods to be benefitted of the identifiable intangible assets with definite lives by comparing to comparable
companies and market data, as well as recalculating the current and accumulated amortization.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
<span id="xdx_906_edei--AuditorName_c20230501__20240430_zPAaU0HKaLbe"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:AuditorName" id="ixv-14631">dbbmckennon</ix:nonNumeric></span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2024.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--AuditorLocation_c20230501__20240430_zkUSzzNF3Nif"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" name="dei:AuditorLocation" id="ixv-14632">Newport
Beach, California</ix:nonNumeric></span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
8, 2024&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 36; Options: NewSection; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;<b>RED CAT HOLDINGS, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="BalanceSheet"></span><b>Consolidated Balance Sheets</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_307_111_zlUTHSZHYsti" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_491_20240430_z9rVTk8bU4Y3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49D_20230430_zki52Y0yRiD8" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">April 30,</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">April 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2023</td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsAbstract_iB_zJcuhZ5K95re" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-indent: -10pt; padding-left: 10pt">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">(As restated)&#160;</span></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AssetsCurrentAbstract_i01B_zkUchTDRjmu1" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--Cash_i02I_maCzOyQ_zgja5uSUVKLl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; font-size: 10pt; text-indent: -10pt; padding-left: 30pt">Cash</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 15%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14633">6,067,169</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 15%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14634">3,173,649</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Investments_i02I_maCzOyQ_zujKZsVbTde9" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt">Marketable securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0058">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Investments" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14635">12,814,038</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AccountsReceivableNetCurrent_i02I_maCzOyQ_zdO3lmJE8Fjh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt">Accounts receivable, net</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14636">4,361,090</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14637">719,862</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--InventoryNet_i02I_maCzOyQ_zqiTnSiBmasa" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-indent: -10pt; padding-left: 30pt">Inventory</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14638">8,007,237</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14639">8,920,573</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OtherAssetsCurrent_i02I_maCzOyQ_zrzfQzTgpoId" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -10pt; padding-left: 30pt">Other</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14640">3,962,053</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14641">1,263,735</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_i02I_maCzOyQ_zUj6uxnunWH5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Current assets of discontinued operations</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0070">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14642">5,283,155</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AssetsCurrent_i02I_mtCzOyQ_maCzdqx_zgV7ORL1TJck" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 40pt">Total current assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14643">22,397,549</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14644">32,175,012</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Goodwill_i01I_maCzvnz_z6cYBeWOIglb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Goodwill</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14645">9,088,550</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14646">17,012,832</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_maCzvnz_z3rD6hdthsii" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Intangible assets, net</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14647">3,794,389</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14648">6,893,115</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--EquityMethodInvestments_i01I_maCzvnz_z0XLQWz0gsY1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Equity method investee</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestments" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14649">5,142,500</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0083">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LongTermAccountsNotesAndLoansReceivableNetNoncurrent_i01I_maCzvnz_znIftM1p6fe4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Note receivable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14650">4,000,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0086">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCzvnz_zl6zlXtJoJCe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Property and equipment, net</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14651">2,340,684</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14652">2,650,358</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OtherAssetsNoncurrent_i01I_maCzvnz_zl3Ml9PkYFBc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Other</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14653">293,126</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14654">303,180</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maCzvnz_zethw2pMAvG9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Operating lease right-of-use assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14655">1,480,814</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14656">1,600,434</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperation_i01I_maCzvnz_zW4Ste8iAuJ1" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Long-term assets of discontinued operations</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0097">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14657">108,397</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsNoncurrent_i01I_mtCzvnz_maCzdqx_zIFQlKLQb9ed" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 40pt">Total long-term assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14658">26,140,063</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14659">28,568,316</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--Assets_i01TI_mtCzdqx_zwPCP4fcrIz4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">TOTAL ASSETS</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14660">48,537,612</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14661">60,743,328</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_z3o6B09qZV47" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">LIABILITIES AND STOCKHOLDERS' EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesCurrentAbstract_i01B_zrvhfoJ8TR6g" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccountsPayableCurrent_i02I_maCzeV7_zfbWampQKsAc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt">Accounts payable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14662">1,580,422</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14663">1,392,550</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccruedLiabilitiesCurrent_i02I_maCzeV7_za662lIYNJW" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt">Accrued expenses</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14664">1,069,561</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14665">409,439</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ShortTermBorrowings_i02I_maCzeV7_z5sf1WU0DOv5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt">Debt obligations - short term</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14666">751,570</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14667">922,138</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityCurrent_i02I_maCzeV7_zhxdWwcVNv08" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt">Customer deposits</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14668">53,939</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14669">155,986</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maCzeV7_zBbjH1PCgNcb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt">Operating lease liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14670">195,638</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14671">159,423</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_i02I_maCzeV7_zVvYx0VVjhA2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Current liabilities of discontinued operations</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0127">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14672">1,010,501</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesCurrent_i02I_mtCzeV7_maCzV8H_zjfeRfesy0M1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 40pt">Total current liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14673">3,651,130</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14674">4,050,037</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maCzJ4l_zPRm8FqUnIgf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Operating lease liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14675">1,321,952</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14676">1,481,967</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LongTermDebtNoncurrent_i01I_maCzJ4l_zkhNf0mxw1Of" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Debt obligations - long term</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0136">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14677">401,569</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_i01I_maCzJ4l_zTtblwjMVO72" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Long-term liabilities of discontinued operations</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0139">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14678">41,814</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesNoncurrent_i01I_mtCzJ4l_maCzV8H_zhNMCRGxY4C3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 40pt">Total long-term liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14679">1,321,952</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14680">1,925,350</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CommitmentsAndContingencies_i01I_zB3rb3i39Fn" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Commitments and contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockholdersEquityAbstract_i01B_zH4TrCP69Swf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Stockholders' equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--PreferredStockValueSeriesB_i02I_maCzy6c_zfWBCUi3tGD3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt">Series B preferred stock - shares authorized <span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_c20230430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z2kO2Z7Gfml"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-04-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14681">4,300,000</ix:nonFraction></span>; issued and outstanding <span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_c20240430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zfAUJi18Bted"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-04-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14682">4,676</ix:nonFraction></span> and <span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_c20230430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zRg65aokdtfh"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-04-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14683">986,676</ix:nonFraction></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:PreferredStockValueSeriesB" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14684">47</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:PreferredStockValueSeriesB" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14685">9,867</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CommonStockValue_i02I_maCzy6c_zJFLgverDXi7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt">Common stock - shares authorized <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_c20230430_zIVh1NLzJeOe"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14686">500,000,000</ix:nonFraction></span>; issued and outstanding <span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20240430_z22BJ2A2fJj2"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14687">74,289,351</ix:nonFraction></span> and <span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20230430_zO5jIIlNAO08"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14688">54,568,065</ix:nonFraction></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14689">74,289</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14690">54,568</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AdditionalPaidInCapital_i02I_maCzy6c_zcY7ig0JEW9" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt">Additional paid-in capital</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14691">124,616,305</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14692">112,642,726</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maCzy6c_zXJC7PeV0c21" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt">Accumulated deficit</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14693">81,130,732</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14694">57,078,103</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_maCzy6c_z9vUD7K5V8dh" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Accumulated other comprehensive income (loss)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14695">4,621</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14696">861,117</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--StockholdersEquity_i02I_mtCzy6c_maCzV8H_zwvSGhaYlEP5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Total stockholders' equity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14697">43,564,530</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14698">54,767,941</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtCzV8H_zTjVZiy3Y5K9" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14699">48,537,612</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14700">60,743,328</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>See accompanying notes.&#160;</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;&#160;</p>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>RED CAT HOLDINGS, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="IncomeStatement"></span>Consolidated Statements of Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_113_zVLR3xIkW3Vc" summary="xdx: Statement - Consolidated Statements of Operations" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_495_20230501__20240430_zbiZUwmkfWlg" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49E_20220501__20230430_zoLfD7T4zJug" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>April 30,</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="3" style="font-size: 10pt; text-align: center">(As restated)</td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_maCzim7_z55NpgdZw4Pb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Revenues</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 15%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14701">17,836,382</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 15%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14702">4,620,834</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CostOfGoodsAndServicesSold_msCzim7_zMrnqGts8Lw3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Cost of goods sold</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14703">14,155,836</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14704">5,455,145</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--GrossProfit_iT_mtCzim7_maCz7t1_zVvN75QNlVCh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Gross profit (loss)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14705">3,680,546</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14706">834,311</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_ztrg67cpd3c4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Operating Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ResearchAndDevelopmentExpense_i01_maCzk5v_zJZR025ZKRu1" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Research and development</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14707">5,896,037</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14708">5,595,281</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--MarketingAndAdvertisingExpense_i01_maCzk5v_zNhEWg3qpYPj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Sales and marketing</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14709">4,568,617</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14710">3,731,776</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--GeneralAndAdministrativeExpense_i01_maCzk5v_zuCLgKOXqcF1" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">General and administrative</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14711">10,679,105</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14712">12,383,470</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_i01_maCzk5v_z1uPwR6eBUZ4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Impairment loss</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14713">412,999</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14714">2,826,918</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingExpenses_i01T_mtCzk5v_msCz7t1_z0IeFuqJo1gc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Total operating expenses</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14715">21,556,758</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14716">24,537,445</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_iT_mtCz7t1_maILFCOz6uy_z9AFGq162taj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Operating loss</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14717">17,876,212</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14718">25,371,756</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OtherNonoperatingIncomeExpenseAbstract_iB_zEui6ZjMUZU" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Other (income) expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInDerivativeAssetsAndLiabilities_i01N_di_maONIEzeNH_zJULZvS0jiC8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Gain on divestiture of consumer segment</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14719">9,642,427</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0212">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_i01_msONIEzeNH_zrlsrtdKDbt" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Impairment on equity method investment</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14720">11,353,875</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0215">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--EquityMethodInvestmentRealizedGainLossOnDisposal_i01N_di_maONIEzeNH_zSLydGVmxPAk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Equity method loss</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14721">503,625</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0218">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--InvestmentIncomeNet_i01N_di_maONIEzeNH_zg0ImEhkBWji" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Investment loss (income), net</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14722">651,943</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14723">82,798</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--InterestExpense_i01_msCzuy7_msONIEzeNH_zkckAG7cbb9b" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Interest expense</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14724">68,609</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14725">122,004</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OtherNonrecurringIncomeExpense_i01_msCzuy7_msONIEzeNH_zU3KtEphYTwb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Other, net</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherNonrecurringIncomeExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14726">714,859</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherNonrecurringIncomeExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14727">965,681</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherNonoperatingIncomeExpense_iNT_di_mtONIEzeNH_maILFCOz6uy_z4o7n8X2NqP5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Other (income) expense</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14728">3,650,484</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14729">1,004,887</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingIncomeLoss_mtILFCOz6uy_maNILz4J4_zpYOeRyKLpKc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Net loss from continuing operations</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14730">21,526,696</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14731">26,376,643</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_maNILz4J4_zU1Z33pX9nok" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Loss from discontinued
    operations</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14732">2,525,933</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14733">1,730,386</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLoss_mtNILz4J4_zB1rdOWQbgMj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -3.5pt; padding-left: 3.5pt">Net loss</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14734">24,052,629</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">)</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14735">28,107,029</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--EarningsPerShareBasicAndDilutedRCATAbstract_iB_zc3c2VPpBiYj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Loss per share - basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--EarningsPerShareBasicAndDilutedContinuingOperationsRCAT_i01_zv3KM4v6pjQ7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Continuing operations</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-14736">0.36</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-14737">0.49</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT_i01_zrgFDQ2x2Ob4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Discontinued operations</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-14738">0.04</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-14739">0.03</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_ecustom--EarningsPerShareBasicAndDilutedRCAT_i01_zSKlFTPj3Pp7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt">Loss per share - basic and diluted</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">(<ix:nonFraction name="RCAT:EarningsPerShareBasicAndDilutedRCAT" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-14740">0.40</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">)</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">(<ix:nonFraction name="RCAT:EarningsPerShareBasicAndDilutedRCAT" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-14741">0.52</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT_zob5w4IWWrzg" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Weighted average shares outstanding - basic and diluted</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><ix:nonFraction name="RCAT:WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14742">60,118,675</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><ix:nonFraction name="RCAT:WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14743">53,860,199</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>See accompanying notes.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>RED CAT HOLDINGS, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="EquityStatement"></span>Consolidated Statements of Shareholders&#8217; Equity</b></p>

<table cellspacing="0" cellpadding="0" id="xdx_30E_114_zVVGhQFeZ762" summary="xdx: Statement - Consolidated Statements of Stockholders' Equity" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 37%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 5%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_custom--SeriesBPreferredStock1Member_zAnjseKWJpEc" style="width: 4%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 5%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zLSNwomm1a0i" style="width: 5%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zYcxUtKruto" style="width: 5%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zwRJK8qA6o1d" style="width: 5%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zPOL5edi92nd" style="width: 5%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_4BE_zou1UEhAT4Vb" style="width: 5%; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="7" style="text-align: center"><span style="font-size: 8pt"><b>Series B</b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="7"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt">&#160;<b>Additional</b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt"><b>Accumulated Other</b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="7" style="text-align: center"><span style="font-size: 8pt"><b>Preferred Stock</b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="7" style="text-align: center"><span style="font-size: 8pt"><b>Common Stock</b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt"><b>Paid-in</b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt"><b>Accumulated</b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt"><b>Comprehensive</b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Shares</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Amount</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Shares</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Amount</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Capital</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Deficit</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Income (Loss)</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Equity</b></span></td></tr>
  <tr id="xdx_431_c20220501__20230430_eus-gaap--StockholdersEquity_iS_zLgGGu3C9V8a" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt"><b>Balances, April 30, 2022, as restated</b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--SharesOutstanding_iS_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPreferredStock1Member_zuvKDglyhoNf" style="text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-04-30_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14744">986,676</ix:nonFraction></b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt"><b>$</b></span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14745">9,867</ix:nonFraction></b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--SharesOutstanding_iS_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zy4n1eaUps8e" style="text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14746">53,748,735</ix:nonFraction></b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt"><b>$</b></span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14747">53,749</ix:nonFraction></b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt"><b>$</b></span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14748">109,471,010</ix:nonFraction></b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt"><b>$&#160;</b></span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14749">28,971,074</ix:nonFraction></b></span></td>
    <td><span style="font-size: 8pt"><b>)</b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt"><b>&#160;$</b></span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14750">1,470,272</ix:nonFraction></b></span></td>
    <td><span style="font-size: 8pt"><b>)</b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt"><b>$</b></span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14751">79,093,280</ix:nonFraction></b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_43B_c20220501__20230430_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_z8RdwRfeSVud" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt">Stock based compensation</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0265">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0266">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14752">3,656,724</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0268">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0269">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14753">3,656,724</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_434_c20220501__20230430_eus-gaap--RestrictedStockValueSharesIssuedNetOfTaxWithholdings_zjbjQfEdstF5" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt">Vesting of restricted stock units</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0272">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5vsIou0MPh5" style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14754">779,498</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14755">779</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14756">523,606</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">)</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0275">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0276">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14757">522,827</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_43E_c20220501__20230430_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_znAFpkHPQJa8" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt">Shares issued for services</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0280">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGKUKQxPW3d9" style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14758">39,832</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14759">40</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14760">38,598</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0283">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0284">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14761">38,638</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_439_c20220501__20230430_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_zfKcaPvwKxN1" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt">Unrealized gain on marketable securities</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0288">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0289">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0290">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0291">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14762">610,129</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14763">610,129</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_43F_c20220501__20230430_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_zqMHXBhIcRs9" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt">Currency translation adjustments</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0295">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0296">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0297">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0298">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14764">974</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">)</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14765">974</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_439_c20220501__20230430_eus-gaap--NetIncomeLoss_z8Bte8w0iQ5i" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt">Net loss</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0302">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0303">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0304">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14766">28,107,029</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">)</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0306">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14767">28,107,029</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_431_c20220501__20230430_eus-gaap--StockholdersEquity_iE_zsxwNPzU8vNl" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt"><b>Balances, April 30, 2023, as restated</b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--SharesOutstanding_iE_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPreferredStock1Member_zrKRXnKImMrh" style="border-bottom: Black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-04-30_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14768">986,676</ix:nonFraction></b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14769">9,867</ix:nonFraction></b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--SharesOutstanding_iE_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziLDZ0y124Nf" style="border-bottom: Black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14770">54,568,065</ix:nonFraction></b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14771">54,568</ix:nonFraction></b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14772">112,642,726</ix:nonFraction></b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-size: 8pt"><b>$&#160;</b></span></td>
    <td style="border-bottom: Black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14773">57,078,103</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-size: 8pt"><b>)</b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b>$ (<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14774">861,117</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-size: 8pt"><b>)</b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14775">54,767,941</ix:nonFraction></b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_431_c20230501__20240430_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zYVC2De8LcXc" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt">Stock based compensation</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0318">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0319">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14776">3,609,267</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0321">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0322">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14777">3,609,267</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_43C_c20230501__20240430_eus-gaap--RestrictedStockValueSharesIssuedNetOfTaxWithholdings_zhbeyvNFCrS" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt">Vesting of restricted stock units</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0325">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_c20230501__20240430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwjSQFysUlFc" style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14778">446,717</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14779">447</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14780">33,701</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">)</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0328">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0329">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14781">33,254</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_43B_c20230501__20240430_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zCIug5mWBWLa" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt">Conversion of preferred stock</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_iN_di_c20230501__20240430__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPreferredStock1Member_z2x5QFfNzGfk" style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14782">982,000</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">)</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14783">9,820</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">)</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_iN_di_c20230501__20240430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjIl7qFJXhzi" style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares" id="ixv-14784">818,334</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14785">818</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14786">9,002</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0336">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0337">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0338">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_43F_c20230501__20240430_ecustom--StockIssuedDuringPeriodValueThroughATMFacility_zViiIFDCZgf8" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt">Issuance of common stock through ATM facility, net</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0342">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_988_ecustom--StockSharesIssuedNetThroughATMFacility_c20230501__20240430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlmW8VkXkPV" style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="RCAT:StockSharesIssuedNetThroughATMFacility" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14787">53,235</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="RCAT:StockIssuedDuringPeriodValueThroughATMFacility" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14788">53</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="RCAT:StockIssuedDuringPeriodValueThroughATMFacility" contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14789">9,159</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0345">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0346">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="RCAT:StockIssuedDuringPeriodValueThroughATMFacility" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14790">9,212</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_435_c20230501__20240430_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zD8RrTZkG8B2" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt">Exercise of stock options</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0350">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230501__20240430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zU8rVumlYCA4" style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14791">3,000</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14792">3</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14793">2,652</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0353">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0354">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14794">2,655</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_439_c20230501__20240430_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zpW1R8oVTMa3" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt">Public offering, net of $<span id="xdx_903_eus-gaap--PaymentsOfStockIssuanceCosts_c20230501__20240430_zRmYGWPuMRM1"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14795">804,400</ix:nonFraction></span> of issuance costs</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0358">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230501__20240430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQeY7VdN8mZ" style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14796">18,400,000</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14797">18,400</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14798">8,377,200</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0361">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0362">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14799">8,395,600</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_437_c20230501__20240430_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_zrhLFyg7K2ne" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt">Unrealized gain on marketable securities</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0367">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0368">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0369">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0370">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14800">864,165</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14801">864,165</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_436_c20230501__20240430_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_zUqi6bNa5IIl" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt">Currency translation adjustments</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0374">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0375">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0376">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0377">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14802">1,573</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14803">1,573</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_43D_c20230501__20240430_eus-gaap--NetIncomeLoss_zDXmoqQxTBj8" style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 8pt">Net loss</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0381">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0382">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0383">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14804">24,052,629</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">)</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0385">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14805">24,052,629</ix:nonFraction></span></td>
    <td><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_436_c20230501__20240430_eus-gaap--StockholdersEquity_iE_zgAGWwt2Q3F2" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"><b>Balances, April 30, 2024</b></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--SharesOutstanding_iE_c20230501__20240430__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPreferredStock1Member_zoulRZ0uog59" style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-04-30_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14806">4,676</ix:nonFraction></b></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-04-30_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14807">47</ix:nonFraction></b></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--SharesOutstanding_iE_c20230501__20240430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzwiMbbmSXga" style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14808">74,289,351</ix:nonFraction></b></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14809">74,289</ix:nonFraction></b></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14810">124,616,305</ix:nonFraction></b></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font-size: 8pt"><b>&#160;$</b></span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-04-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14811">81,130,732</ix:nonFraction></b></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"><b>)</b></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14812">4,621</ix:nonFraction></b></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14813">43,564,530</ix:nonFraction></b></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>See accompanying notes.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>RED CAT HOLDINGS, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="CashFlow"></span><b>Consolidated Statements of Cash Flows</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_302_112_zwvEMFlu6aj2" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49B_20230501__20240430_zmbg2IhaCNDg" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_490_20220501__20230430_zhwVgm8eO03g" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Year ended&#160;April 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2023</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zQh5TDWrtKD2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Cash Flows from Operating Activities</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="3" style="font-size: 10pt; text-align: center">(As restated)</td></tr>
  <tr id="xdx_405_eus-gaap--NetIncomeLoss_i01_maILFCOzziB_zh5EGQLjFai3" style="vertical-align: bottom; background-color: White">
    <td style="width: 62%; font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt">Net loss</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 15%; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14814">24,052,629</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 15%; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14815">28,107,029</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_409_ecustom--IncomeLossFromDiscontinuedOperations_i01N_di_maILFCOzziB_zk57IRyWKECe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -20pt; padding-left: 30pt">Net loss from discontinued operations</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:IncomeLossFromDiscontinuedOperations" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14816">2,525,933</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:IncomeLossFromDiscontinuedOperations" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14817">1,730,386</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperations_i01_mtILFCOzziB_msNCPBUzLLg_zxpRZ0t8Znel" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt">Net loss from continuing operations</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14818">21,526,696</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14819">26,376,643</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zt9u0QYcSwp5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt">Adjustments to reconcile net loss to net cash from operations:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_i02_msNCPBUzLLg_zvNwkqGFmBsh" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt">Stock based compensation - options</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14820">2,619,501</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14821">1,617,982</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1_i02_msNCPBUzLLg_z29106e5gc2e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt">Stock based compensation - restricted units</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14822">989,766</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14823">2,038,742</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_i02_maNCPBUzLLg_z5wpMMO4WAug" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt">Common stock issued for services</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0418">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14824">38,638</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AmortizationOfIntangibleAssets_i02_maNCPBUzLLg_zxZFJtpAhi5k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt">Amortization of intangible assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14825">854,311</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14826">654,527</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--MarketableSecuritiesGainLoss_i02_msNCPBUzLLg_zfyTsCieeDI8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt">Realized loss from sale of marketable securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesGainLoss" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14827">851,986</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesGainLoss" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14828">296,012</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Depreciation_i02_maNCPBUzLLg_zDzAVVx7IwH9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -20pt; padding-left: 40pt">Depreciation</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14829">568,813</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14830">311,545</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_i02_maNCPBUzLLg_zMMRwvM9hfgi" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt">Gain on divestiture of consumer segment</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDerivativeLiabilities" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14831">9,642,427</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0431">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_i02_maNCPBUzLLg_zF1v10uXqudb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt">Impairment on equity method investment</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14832">11,353,875</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0434">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--GainLossOnDispositionOfAssets1_i02_msNCPBUzLLg_zdW8hEQ8avG7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt">Equity method loss</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14833">503,625</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0437">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_i02_maNCPBUzLLg_zGgP1XyywN8k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt">Impairment on goodwill and intangible assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14834">412,999</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14835">2,826,918</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_i01B_zn8wLjeSOe4d" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt">Changes in operating assets and liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInAccountsReceivable_i02_msNCPBUzLLg_zFCGDwDUQQdi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt">Accounts receivable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14836">3,641,228</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14837">288,986</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInInventories_i02_msNCPBUzLLg_zjs5tEdn9Dga" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-indent: -20pt; padding-left: 40pt">Inventory</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14838">913,336</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14839">5,707,525</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInOtherCurrentAssets_i02_msNCPBUzLLg_zNIAd9gu0wKf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -20pt; padding-left: 40pt">Other</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14840">2,688,264</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14841">559,660</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities_i02_msNCPBUzLLg_zFcCmR7sxzz5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt">Operating lease right-of-use assets and liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14842">4,180</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14843">25,733</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_i02_maNCPBUzLLg_zJN56kCAAvF4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt">Customer deposits</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14844">102,047</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14845">136,628</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInAccountsPayable_i02_maNCPBUzLLg_zDNuW9zzJmE5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt">Accounts payable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14846">187,872</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14847">434,803</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i02_maNCPBUzLLg_zJX5XI7naHf5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -20pt; padding-left: 40pt">Accrued expenses</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14848">661,695</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14849">608,452</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_i01_mtNCPBUzLLg_maCCERCzBEc_ziLmcnDyjfr5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt">Net cash used in operating activities of continuing operations</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14850">17,687,063</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14851">24,313,674</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -20pt; padding-left: 20pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AdditionalCashFlowElementsFinancingActivitiesAbstract_iB_zzXY4wqFja8i" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt">Cash Flows from Investing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromDivestitureOfBusinesses_i01_maCzYck_zz5lhKT2H0pi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt">Proceeds from divestiture of consumer segment</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14852">1,000,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0473">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--PaymentsToAcquireProductiveAssets_i01N_di_msCzYck_z4XWGfNOfjdc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt">Purchases of property and equipment</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14853">259,139</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14854">2,450,213</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_i01_maCzYck_zMEj9nFuf5T6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt">Proceeds from sale of marketable securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14855">12,826,217</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14856">32,290,448</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--PaymentsToAcquireAssetsInvestingActivities_i01N_di_msCzYck_zj5NGwd6w282" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -20pt; padding-left: 30pt">Investment in SAFE agreement</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0481">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireAssetsInvestingActivities" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14857">250,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_i01T_mtCzYck_maCCERCzBEc_z8mEbLsZ3yW" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt">Net cash provided by investing activities of continuing operations</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14858">13,567,078</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14859">29,590,235</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -20pt; padding-left: 20pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zTNhWaEoDmef" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt">Cash Flows from Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt">Proceeds from issuance of common stock:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--ProceedsFromIssuanceOfCommonStockPublicOffering_i01_maCzzm9_zRPH1ZyaNCdg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -7.55pt; padding-left: 30pt">Public offering, net</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:ProceedsFromIssuanceOfCommonStockPublicOffering" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14860">8,395,600</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0491">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ProceedsFromIssuanceOfCommonStockATMFacilityNet_i01_maCzzm9_zaTKu6opXnQ2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -37.45pt; padding-left: 60pt">ATM facility, net</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:ProceedsFromIssuanceOfCommonStockATMFacilityNet" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14861">9,212</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0494">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RepaymentsOfDebt_i01N_di_msCzzm9_zfAK8WBcjseh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt">Payments under debt obligations</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14862">572,137</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14863">606,897</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_ecustom--PaymentsOfTaxesRelatedToEquityTransactions_i01N_di_msCzzm9_z3s0rKcizFB7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt">Payments of taxes related to equity transactions</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:PaymentsOfTaxesRelatedToEquityTransactions" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14864">33,254</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:PaymentsOfTaxesRelatedToEquityTransactions" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14865">581,775</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--ProceedsFromStockOptionsExercised_i01_maCzzm9_zGTxVbtxciVj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -20pt; padding-left: 30pt">Exercise of stock options</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14866">2,655</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0503">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ProceedsFromRelatedPartyDebt_i01_maCzzm9_zbHYAH37r838" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt">Proceeds from related party obligations</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0505">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14867">13,404</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RepaymentsOfRelatedPartyDebt_i01N_di_msCzzm9_z9XB8ZF00jJk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -20pt; padding-left: 30pt">Payments under related party obligations</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0508">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14868">40,057</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_i01T_mtCzzm9_maCCERCzBEc_zTUbtnztdpJf" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt">Net cash provided by (used in) financing activities of continuing operations</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14869">7,802,076</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14870">1,215,325</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -20pt; padding-left: 20pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DiscontinuedOperationAdditionalDisclosuresAbstract_iB_znliHWZBmIv3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt">Discontinued operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_i01_maNCPBUzJ2A_zGFLggODjbsc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -11pt; padding-left: 20pt">Operating activities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14871">875,227</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14872">4,885,746</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_i01_maNCPBUzJ2A_zTe6SPdX4f4i" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -11pt; padding-left: 20pt">Investing activities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0520">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0521">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_i01_maNCPBUzJ2A_zTqbtS26Jd16" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -11pt; padding-left: 20pt">Financing activities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0523">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0524">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInDiscontinuedOperations_i01T_mtNCPBUzJ2A_maCCERCzBEc_zysG3Y4p1DPc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt">Net cash used in discontinued operations</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInDiscontinuedOperations" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14873">875,227</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInDiscontinuedOperations" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14874">4,885,746</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -20pt; padding-left: 20pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzBEc_zdwIunlCxASj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt">Net increase (decrease) in Cash</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14875">2,806,864</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14876">824,510</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_iS_zPvw1lJoRtI1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 1pt; text-indent: -20pt; padding-left: 20pt">Cash, beginning of period</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14877">3,260,305</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14878">4,084,815</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_iE_maNCpbuiCO_z99JBZwaSB7g" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-indent: -20pt; padding-left: 20pt">Cash, end of period</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14879">6,067,169</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14880">3,260,305</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCash_iNE_di_maNCpbuiCO_zUeicvCbCfxd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -20pt; padding-left: 20pt">Less: Cash of discontinued operations</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0538">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCash" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14881">86,656</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_mtNCpbuiCO_zxGurVcR1b2h" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -20pt; padding-left: 20pt">Cash of continuing operations, end of period</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14882">6,067,169</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14883">3,173,649</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -20pt; padding-left: 20pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--InterestPaidNet_zKrz8HSTDkIe" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt">Cash paid for interest</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14884">70,177</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14885">122,103</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeTaxesPaidNet_zT7Ex09YpPA" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt">Cash paid for income taxes</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0547">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0548">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -20pt; padding-left: 20pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_zuWrjpgp61Y4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -20pt; padding-left: 20pt">Non-cash transactions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_i01_zuBSx04m7s2c" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -20pt; padding-left: 30pt">Equity method
    investment from divestiture of consumer segment</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14886">17,000,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0554">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--NoncashOrPartNoncashDivestitureNoteReceivable_i01_zEI0xC2cNbc9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -20pt; padding-left: 30pt">Note receivable from
    divestiture of consumer segment</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:NoncashOrPartNoncashDivestitureNoteReceivable" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14887">4,000,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0557">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_i01_zHC9kvvp67E7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -20pt; padding-left: 30pt">Unrealized gain on marketable securities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14888">864,165</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14889">610,129</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--ConversionOfPreferredStockIntoCommonStock_i01_znlpwrwVeb33" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -20pt; padding-left: 30pt">Conversion of preferred stock into common stock</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:ConversionOfPreferredStockIntoCommonStock" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14890">9,820</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0563">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--FairValueOfSharesWithheldAsPaymentOfNoteReceivable_i01_zLHNnQRT4Vq4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -20pt; padding-left: 30pt">Shares withheld as payment of note receivable</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0565">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:FairValueOfSharesWithheldAsPaymentOfNoteReceivable" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14891">18,449</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--TaxesRelatedToNetShareSettlementOfEquityAwards_i01_zEJxJGwd236" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -20pt; padding-left: 30pt">Taxes related to net share settlement of equity awards</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0568">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:TaxesRelatedToNetShareSettlementOfEquityAwards" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14892">32,468</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0 0; text-align: center"><b>See accompanying notes.</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;&#160;&#160;</p>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>RED CAT HOLDINGS, INC.</b></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="Notes"></span>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;<b>April 30, 2024 and 2023&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="ixv-8401"><p id="xdx_806_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zltuPOrpHefe" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_820_zyNUDVPUESx7">Note 1 &#8211; The Business</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company was originally incorporated in February
1984. Since April 2016, the Company&#8217;s primary business has been to provide products, services, and solutions to the drone industry
which it presently does through its wholly owned operating subsidiaries. Beginning in January 2020, the Company expanded the scope
of its drone products and services through four acquisitions, including:&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">A.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">In January 2020, the Company acquired Rotor Riot, a provider of First Person View (&#8220;FPV&#8221;) drones and equipment, primarily to consumers. The purchase price was $<span id="xdx_905_eus-gaap--BusinessCombinationConsiderationTransferred1_c20190501__20200430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition1Member_zpwsbSsI3RSb"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2019-05-012020-04-30_custom_BusinessAcquisition1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14893">1,995,114</ix:nonFraction></span>.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">B.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">In November 2020, the Company acquired Fat Shark Holdings (&#8220;Fat Shark&#8221;), a provider of FPV video goggles to the&#160;drone industry. The purchase price was $<span id="xdx_902_eus-gaap--BusinessCombinationConsiderationTransferred1_c20200501__20210430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition2Member_zAFKmFlHEGj6"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2020-05-012021-04-30_custom_BusinessAcquisition2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14894">8,354,076</ix:nonFraction></span>.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;<span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">C.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">In May 2021, the Company acquired Skypersonic which provided hardware and software solutions that enable drones to complete inspection services in locations where GPS is either denied or not available, yet still record and transmit data even while being operated from thousands of miles away. The purchase price was $<span id="xdx_90B_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition3Member_zOaBBegpRDD"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2021-05-012022-04-30_custom_BusinessAcquisition3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14895">2,791,012</ix:nonFraction></span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">D.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">In August 2021, the Company acquired Teal Drones (&#8220;Teal&#8221;), a leader in commercial and government Unmanned Aerial Vehicles (&#8220;UAV&#8221;) technology.&#160;The purchase price was $<span id="xdx_90C_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition4Member_z4CsCK87WY23"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2021-05-012022-04-30_custom_BusinessAcquisition4Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14896">10,011,279</ix:nonFraction></span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Following the Teal acquisition
in August 2021, we concentrated on integrating and organizing these businesses. Effective May 1, 2022, we established the Enterprise segment
(&#8220;Enterprise&#8221;) and the Consumer segment (&#8220;Consumer&#8221;) to focus on the unique opportunities in each sector. Enterprise's
initial strategy was to provide UAVs to commercial enterprises, and the military, to navigate dangerous military environments and confined
industrial and commercial interior spaces. Subsequently, Enterprise narrowed its near-term attention on the military and other government
agencies. Skypersonic's technology has been redirected to military applications and its operations consolidated into Teal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">On December 11, 2023,
the Company completed a firm commitment underwritten public offering with ThinkEquity of <span id="xdx_909_ecustom--FirmCommitmentUnderwrittenPublicOfferingShares_c20230501__20240430_zSG6z2QSN606"><ix:nonFraction name="RCAT:FirmCommitmentUnderwrittenPublicOfferingShares" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14897">18,400,000</ix:nonFraction></span> shares of common stock which generated
gross proceeds of $<span id="xdx_909_ecustom--FirmCommitmentUnderwrittenPublicOfferingGrossProceeds_c20230501__20240430_z4eh6TKg5mMe"><ix:nonFraction name="RCAT:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14898">9,200,000</ix:nonFraction></span> and net proceeds of approximately $<span id="xdx_901_ecustom--FirmCommitmentUnderwrittenPublicOfferingNetProceeds_c20230501__20240430_zU9OJaE6rpsd"><ix:nonFraction name="RCAT:FirmCommitmentUnderwrittenPublicOfferingNetProceeds" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14899">8,400,000</ix:nonFraction></span>.</span><span style="font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">On February 16, 2024</span><span style="font-size: 8pt"></span><span style="font-size: 10pt">,
we closed the sale of our Consumer segment, consisting of Rotor Riot and Fat Shark, to Unusual Machines. The sale reflects the Company's
decision to focus its efforts and capital on defense where it believes that there are more opportunities to create long term shareholder
value. See Note 3 and Note 9.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p>

</ix:nonNumeric><p id="xdx_81C_zBORQPQPVqs9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="ixv-8461"><p id="xdx_803_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zwwPn4Q2x3yc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_828_zMckm5OJyIie">Note 2 &#8211; Summary of Significant Accounting
Policies</span></b></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="ixv-8466"><p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zcACN2x0a8Jg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86F_zWm6aVzxMiw7">Basis of Accounting</span> </b>&#8211; The financial statements
and accompanying notes are prepared in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;).
Certain prior period amounts have been restated to conform to the current year presentation.</p>

</ix:nonNumeric><p id="xdx_856_zjhcB2lVPwf6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="RCAT:RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" id="ixv-8471"><p id="xdx_84D_ecustom--RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock_zdZxPdSJcoK8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_869_zUpKgUyCkTh4">Restatement of Previously Issued Consolidated Financial Statements</span> </b>&#8211;
The Company&#8217;s Consolidated Balance Sheet as of April 30, 2023, Consolidated Statement of Operations, Stockholders&#8217; Equity
and Cash Flows for the year then ended, and its Notes to the Consolidated Financial Statements for the year ended April 30, 2023, which
were originally filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on July 27, 2023 (the &#8220;Original Form
10-K&#8221;), have been restated. The Company revised its accounting estimate of the life of an operating lease that was previously reported
in its Original Form 10-K. Upon further evaluation, the Company determined that prior year adjustments were necessary. These Consolidated
Financial Statements were restated to reflect a change in accounting estimate of the life of the operating lease under FASB ASC Topic
842 from three to nine years. Additionally, the Company revised its financial statements to&#160;remove derivative liabilities due to
erroneously reporting warrants from our convertible note financings, as described in Note 18, as having a derivative component.</p>

<ix:exclude><!-- Field: Page; Sequence: 41 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The impacts of these restatements are detailed
in the tables below:</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="RCAT:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" id="ixv-8486"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_z37Q9DXaN6uh" summary="xdx: Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49B_20230430__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zSBEY5ZMCnF2">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49A_20230430__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zJcotfhJMGR4">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_494_20230430__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zE2BMOTeUBXc">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Consolidated Balance Sheet</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of April 30, 2023</b></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Originally</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Reported</b></p></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Restated</b></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Change</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zEXj3ClQpUhe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Operating lease right-of-use assets</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14900">620,307</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14901">1,600,434</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14902">980,127</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsNoncurrent_iI_zYu0GCBj0U15" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total long-term assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14903">28,018,078</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14904">28,568,316</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14905">550,238</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--OperatingLeaseLiabilityCurrentRestatementImpact_iI_zV5Lsmzs6zX9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Operating lease liabilities, current</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:OperatingLeaseLiabilityCurrentRestatementImpact" contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14906">281,797</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:OperatingLeaseLiabilityCurrentRestatementImpact" contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14907">159,423</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:OperatingLeaseLiabilityCurrentRestatementImpact" contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14908">122,374</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--DerivativeLiabilitiesCurrent_iI_zxK5uK4Xu5t7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Warrant derivative liability</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesCurrent" contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14909">588,205</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0601">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:DerivativeLiabilitiesCurrent" contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14910">588,205</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_406_ecustom--LiabilitiesCurrentRestatementImpact_iI_zcX5gpj013m1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total current liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:LiabilitiesCurrentRestatementImpact" contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14911">4,760,616</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:LiabilitiesCurrentRestatementImpact" contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14912">4,050,037</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:LiabilitiesCurrentRestatementImpact" contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14913">710,579</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zAZyNo5AY9uj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Operating lease liabilities, long-term</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14914">379,466</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14915">1,481,967</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14916">1,102,501</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesNoncurrent_iI_zeRaeufH1G8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total long-term liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14917">822,849</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14918">1,925,350</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14919">1,102,501</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AdditionalPaidInCapital_iI_zmMRlkMLIJZj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Additional paid-in capital</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14920">109,993,100</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14921">112,642,726</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14922">2,649,626</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zz9tAYWDUSnc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Accumulated deficit</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14923">54,586,793</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14924">57,078,103</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14925">2,491,310</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--StockholdersEquityRestatement_iI_z1d3aGID1Wt2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total shareholders&#8217; equity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:StockholdersEquityRestatement" contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14926">54,609,625</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:StockholdersEquityRestatement" contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14927">54,767,941</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:StockholdersEquityRestatement" contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14928">158,316</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_z7xYP0md9CXe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total liabilities and stockholders&#8217; equity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14929">60,193,090</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14930">60,743,328</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14931">550,238</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49A_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zCkwzAt0N4Gl">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49B_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zXWdYMkcEnHd">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49C_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zmsSZnt9OMe3">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Consolidated Statement of Operations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the year ended April 30, 2023</b></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Originally</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Reported</b></p></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Restated</b></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Change</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInDerivativeAssetsAndLiabilities_zPjADrAsg60l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Change in fair value of derivative liability</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities" contextRef="From2022-05-012023-04-30_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14932">1,019,292</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0633">&#8212;</span>&#160;&#160;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities" contextRef="From2022-05-012023-04-30_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14933">1,019,292</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zNvjvy3NUWNc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Net loss</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14934">27,087,737</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30_custom_RestatementImpactAsRestatedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14935">28,107,029</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14936">1,019,292</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zjYLGJLijuGc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Amounts
presented as originally reported as of April 30, 2023 are exclusive of Discontinued Operations with the exception of (i) change in fair
value of derivative liability, (ii) net loss, and (iii) Consolidated Balance Sheet totals. The Consolidated Statement of Cash Flows is
not presented above as there was no change in net cash used in operating activities of continuing operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b></b></p>

</ix:nonNumeric><p id="xdx_857_z2bELDmieZlc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ConsolidationPolicyTextBlock" id="ixv-8766"><p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zkZvGA0mBHSh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><span id="xdx_863_zyRmJgruZNZd">Principles of Consolidation</span></b>
&#8211; <span style="background-color: white">Our consolidated financial statements include the accounts of our wholly owned subsidiaries
which include Teal and Skypersonic as well as Rotor Riot and Fat Shark which were sold on February 16, 2024. Non-majority owned investments,
including the formerly wholly owned subsidiaries Rotor Riot and Fat Shark, are accounted for using the equity method when the Company
is able to significantly influence the operating policies of the investee. Intercompany transactions and balances have been eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
Consumer segment businesses are characterized as discontinued operations in these financial statements.&#160; The operating results and
cash flows of discontinued operations are separately stated in those respective financial statements. See Note 3. </span></p>
</ix:nonNumeric><p id="xdx_851_zCQiBK40AJg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:UseOfEstimates" id="ixv-8779"><p id="xdx_842_eus-gaap--UseOfEstimates_zqrdyK4RO69i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86A_zBAJUmoHd7A7">Use of Estimates</span></b> &#8211;<span style="background-color: white">&#160;The
preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the
reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates
reflected in these financial statements include those used to (i) complete purchase price accounting for acquisitions,  (ii) the evaluation of long-term assets, including goodwill, for impairment,
and (iii) the evaluation of other-than-temporary-impairment of equity method investments.</span></p>

</ix:nonNumeric><p id="xdx_85B_z3oVXhzOnpVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="ixv-8785"><p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zSCZZ1XMQgNj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86F_zWXrT1PWaWk1">Cash and Cash Equivalents</span> </b>&#8211; At April
30, 2024, we had cash of $<span id="xdx_90D_eus-gaap--Cash_iI_c20240430_zDhCfMNsSqrd"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14937">6,067,169</ix:nonFraction></span> in multiple commercial banks and financial services companies. We have not experienced any loss on
these cash balances and believe they are not exposed to any significant credit risk.</p>

</ix:nonNumeric><p id="xdx_859_zI5S9I5ZzCok" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 42 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:MarketableSecuritiesPolicy" id="ixv-8801"><p id="xdx_843_eus-gaap--MarketableSecuritiesPolicy_zPBL5OWH1NVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span><span id="xdx_862_zEb69Umoc0T3">Marketable Securities</span></span> </b>&#8211; Our marketable
securities were classified and accounted for as available-for-sale securities. These securities were primarily invested in corporate bonds
and were readily saleable, and therefore, we have classified them as short term. Our available-for-sale securities were carried at fair
value with any unrealized gains and losses reported as a component of comprehensive income (loss). Once realized, any gains or losses
were recognized in the statement of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have elected to present accrued interest income
separately from marketable securities on our consolidated balance sheets. Accrued interest income was $<span id="xdx_90D_eus-gaap--InterestAndDividendIncomeSecuritiesOther_c20230501__20240430_z3s3egVeqBJl"><ix:nonFraction name="us-gaap:InterestAndDividendIncomeSecuritiesOther" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14938">0</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--InterestAndDividendIncomeSecuritiesOther_c20220501__20230430_zmYMfQrnKUk7"><ix:nonFraction name="us-gaap:InterestAndDividendIncomeSecuritiesOther" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14939">151,671</ix:nonFraction></span> as of April 30,
2024 and April 30, 2023, respectively, and was included in other current assets. We did not write off any accrued interest income during
the years ended April 30, 2024 and April 30, 2023.</p>

</ix:nonNumeric><p id="xdx_85B_znwQguNJh3Ze" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ReceivablesPolicyTextBlock" id="ixv-8811"><p id="xdx_84C_eus-gaap--ReceivablesPolicyTextBlock_zzUwQf7dHQS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_864_zoZnjrvVWqQ9">Accounts Receivable, net</span></b> &#8211; <span style="background-color: white">Accounts
receivable are recorded at the invoiced amount less allowances for doubtful accounts. The Company's estimate of the allowance for doubtful
accounts is based on a multitude of factors, including historical bad debt levels for its customer base, experience with a specific customer,
the economic environment, and other factors. Accounts receivable balances are written off against the allowance when it is probable that
the receivable will not be collected.</span></p>

</ix:nonNumeric><p id="xdx_851_zqj2otVRpYqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ConcentrationRiskCreditRisk" id="ixv-8817"><p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zoW6JvszIsA6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zie9xKVIAR93">Concentration
of Credit Risk</span> </b>&#8211; Financial instruments, which potentially subject the Company to concentrations of credit risk, include
trade receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company
performs ongoing credit evaluations of its customers, generally does not require collateral and considers the credit risk profile of
the customer from which the receivable is due in further evaluating collection risk. Customers that accounted for 10% or greater of
accounts receivable, net as of April&#160;30, 2024 and 2023 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="ixv-8822"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQaKUgLgYhkf" summary="xdx: Disclosure - Customer concentration risk (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">April 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left">Customer A</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zCN9cNhwol9i" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-05-012024-04-30_custom_CustomerConcentrationRisk1Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-14940">53</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zElcIGrV5OD2" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-05-012023-04-30_custom_CustomerConcentrationRisk1Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-14941">20</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zT9MUrfmoD3g" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-05-012024-04-30_custom_CustomerConcentrationRisk2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-14942">24</ix:nonFraction></td><td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer C</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk3Member_zfSzRhphaKsh" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-05-012023-04-30_custom_CustomerConcentrationRisk3Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-14943">24</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer D</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk4Member_zLX4OaDIWoh6" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-05-012023-04-30_custom_CustomerConcentrationRisk4Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-14944">14</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer E</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk5Member_zCjPkuR5tOIc" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-05-012023-04-30_custom_CustomerConcentrationRisk5Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-14945">10</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A9_zdZqixz5godd" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">* Accounts Receivable was less than 10%</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">As of April 30, 2024, three customers accounted for equal to or greater
than 10% of total revenue, totaling 28%, 23% and 10%, respectively. As of April 30, 2023, two customers accounted for equal to or greater
than 10% of total revenue, totaling 22% and 20%, respectively.</p>

</ix:nonNumeric><p id="xdx_857_z9LQfsPL8mb7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:InventoryPolicyTextBlock" id="ixv-8889"><p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zxgsdOPYKXS2" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86A_zzZlSG6nNFdj" style="font-size: 10pt"><b>Inventories</b></span><span style="font-size: 10pt">&#160;&#8211;&#160;<span style="background-color: white">Inventories,
which consist of raw materials, work-in-process, and finished goods, are stated at the lower of cost or net realizable value, and
are measured using the first-in, first-out method. Cost components include direct materials, direct labor, indirect overhead, as
well as in-bound freight. At each balance sheet date, the Company evaluates the net realizable value of its inventory using various
reference measures including current product selling prices and recent customer demand, as well as evaluating for excess quantities
and obsolescence.</span></span></p>

</ix:nonNumeric><p id="xdx_85C_zT5l4QmkQWUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="ixv-8898"><p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zkY1ypyaw2r9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><span id="xdx_866_zZii5SDJXWqk">Goodwill and Long-lived
Assets</span></b> &#8211; Goodwill represents the future economic benefit arising from other assets acquired in an acquisition&#160;that are
not individually identified and separately recognized. We test goodwill for impairment in accordance with the provisions of&#160;<i>ASC
350, Intangibles &#8211; Goodwill and Other,&#160;</i>(&#8220;ASC 350&#8221;). Goodwill is tested for impairment at least annually at
the reporting unit level or whenever events or changes in circumstances indicate that goodwill might be impaired. ASC 350 provides that
an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a
determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing
the totality of events or circumstances, an entity determines it is not more likely than not that the fair value of a reporting unit
is less than its carrying amount, then additional impairment testing is not required. However, if an entity concludes otherwise, then
it is required to perform an impairment test. The impairment test involves comparing the estimated fair value of a reporting unit with
its book value, including goodwill. If the estimated fair value exceeds book value, goodwill is considered not to be impaired. If, however,
the fair value of the reporting unit is less than book value, then an impairment loss is recognized in an amount equal to the amount
that the book value of the reporting unit exceeds its fair value, not to exceed the total amount of goodwill allocated to the reporting
unit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<ix:exclude><!-- Field: Page; Sequence: 43 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The estimate of fair value
of a reporting unit is computed using either an income approach, a market approach, or a combination of both. Under the income approach,
we utilize the discounted cash flow method to estimate the fair value of a reporting unit. Significant assumptions inherent in estimating
the fair values include the estimated future cash flows, growth assumptions for future revenues (including gross profit, operating expenses,
and capital expenditures), and a rate used to discount estimated future cash flow projections to their present value based on estimated
weighted average cost of capital (i.e., the selected discount rate). Our assumptions are based on historical data, supplemented by current
and anticipated market conditions, estimated growth rates, and management&#8217;s plans. Under the market approach, fair value is derived
from metrics of publicly traded companies or historically completed transactions of comparable businesses. The selection of comparable
businesses is based on the markets in which the reporting units operate and consider risk profiles, size, geography, and diversity of
products and services.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Goodwill for Teal is ascribed
to its existing relationship with several U.S. government agencies including its classification as an approved vendor. The Company expects
that the Goodwill recognized in each transaction will be deductible for tax purposes.&#160; The Company has reported net losses since
its inception and is presently unable to determine when and if the tax benefit of this deduction will be realized.</p>

</ix:nonNumeric><p id="xdx_85F_zg8gIXVmqzQb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="ixv-8918"><p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zlK9paOcqBP1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zCZchCcWsyZd">Property and equipment</span> &#8211; </b><span style="background-color: white">Property
and equipment is stated at cost less accumulated depreciation which is calculated using the straight-line method over the estimated useful
life of the asset. The estimated useful lives of our property and equipment are generally: (i) furniture and fixtures - seven years,
(ii) equipment and related - two to five years, and (iii) leasehold improvements &#8211; nine to fifteen years.</span></p>

</ix:nonNumeric><p id="xdx_857_z8gVcBYGcbW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:EquityMethodInvestmentsPolicy" id="ixv-8924"><p id="xdx_843_eus-gaap--EquityMethodInvestmentsPolicy_zRNYqmezB3t2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86C_z3SozqVYzUWe">Equity Method Investment</span> &#8211; </b><span style="background-color: white">The
equity method of accounting is applied to investments in which the Company has an ownership interest of between 20% and 50%. The Company
evaluates its equity method investments each reporting period for evidence of a loss in value that is other than a temporary decline.
Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount
of the investment or the inability of the investee to sustain an earnings capacity that would justify the carrying amount of the investment.
The Company performed this analysis and concluded that its investment in UMAC was other-than-temporarily impaired and recognized an impairment
charge of $<span id="xdx_906_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_c20230501__20240430_zLjRlyQIuHVk"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14946">11,353,875</ix:nonFraction></span> for the year ended April&#160;30, 2024.</span></p>

</ix:nonNumeric><p id="xdx_857_zy7AdKmGwC28" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:RevenueRecognitionLeasesOperating" id="ixv-8931"><p id="xdx_84D_eus-gaap--RevenueRecognitionLeasesOperating_zwjyPe10sMh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86C_zahzqreQGjDg">Leases</span> &#8211; </b>Accounting Standards Codification
(ASC) 842 requires the recognition of assets and liabilities associated with lease agreements. <span style="background-color: white">The
Company determines if a contract is a lease or contains a lease at inception. Operating lease liabilities are measured, on each reporting
date, based on the present value of the future minimum lease payments over the remaining lease term. The Company's leases do not provide
an implicit rate.&#160;Therefore, the Company uses an effective discount rate of 12% based on its last debt financing.&#160;Operating
lease assets are measured by adjusting the lease liability for lease incentives, initial direct costs incurred and asset impairments.
Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term with the operating lease asset reduced
by the amount of the expense. Lease terms may include options to extend or terminate a lease when they are reasonably certain to occur.</span></p>

</ix:nonNumeric><p id="xdx_856_z8yK5E1mh1Ec" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="ixv-8937"><p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zEG4RIQjII5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_860_zhrT8UDCrKS">Fair Values, Inputs and Valuation Techniques for
Financial Assets and Liabilities, and Related Disclosures</span></b> &#8211; The fair value measurements and disclosure guidance defines fair
value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset
or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. In accordance
with this guidance, the Company has categorized its recurring basis financial assets and liabilities into a three-level fair value hierarchy
based on the priority of the inputs to the valuation technique.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value hierarchy gives the highest priority
to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level
3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the
fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input
that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input
to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The guidance establishes
three levels of the fair value hierarchy as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><i>Level 1</i>:
Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><i>Level 2</i>:
Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical
or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable
market data for substantially the full term of the related assets or liabilities; and</p>

<ix:exclude><!-- Field: Page; Sequence: 44 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><i>Level 3</i>:
Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little
or no market data.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Disclosures for Non-Financial Assets Measured at
Fair Value on a Non-Recurring Basis</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's financial instruments mainly consist
of cash, receivables, current assets, accounts payable, accrued expenses and debt. The carrying amounts of these instruments approximates
fair value due to their short-term nature.</p>

</ix:nonNumeric><p id="xdx_85E_zCKWxkzpA9Ml" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="ixv-8968"><p id="xdx_843_eus-gaap--RevenueRecognitionPolicyTextBlock_zU59Ys8Odozl" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86C_zxp8L7adoPgg">Revenue Recognition</span> </b>&#8211; The Company
recognizes revenue in accordance with ASC Topic 606 - Revenue from Contracts with Customers, issued by the Financial Accounting Standards
Board (&#8220;FASB&#8221;). This standard includes a comprehensive evaluation of factors to be considered regarding revenue recognition
including (i) identifying the promised goods, (ii) evaluating performance obligations, (iii) measuring the transaction price, (iv) allocating
the transaction price to the performance obligations if there are multiple components, and (v) recognizing revenue as each obligation
is satisfied.&#160;The Company&#8217;s revenue transactions include the shipment of goods to customers as orders are fulfilled, completion
of non-recurring engineering, completion of training, and customer support services. The Company recognizes revenue upon shipment of product
or prototypes unless otherwise specified in the purchase order or contract. Customer deposits totaled $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240430_zTRmOLvQ36X4"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14947">53,939</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20230430_zUyPr8922sC6"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14948">155,986</ix:nonFraction></span> at April 30,
2024 and April 30, 2023, respectively. From time to time, non-recurring engineering contracts may involve the capitalization of engineering
prototypes, classified as contract assets. Contract assets totaled $<span id="xdx_907_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20240430_zhdr7vv0kb34"><ix:nonFraction name="us-gaap:ContractWithCustomerAssetGrossCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14949">1,477,859</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20230430_zIBr7xEVQFj3"><ix:nonFraction name="us-gaap:ContractWithCustomerAssetGrossCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14950">0</ix:nonFraction></span> at April 30, 2024 and April 30, 2023, respectively.</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the Company&#8217;s
revenue disaggregated by revenue type:</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="RCAT:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" id="ixv-8978"><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_zet5crVfizG" summary="xdx: Disclosure - Company's revenue disaggregated by revenue type (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" id="xdx_497_20230501__20240430_zMjAJJjOleO3" style="font-size: 10pt; font-weight: bold; text-align: center"/><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" id="xdx_499_20220501__20230430_zmPFbgIgRww1" style="font-size: 10pt; font-weight: bold; text-align: center"/></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Year Ended&#160;April 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">2023</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zdwJLPvW4QR9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-size: 10pt; text-align: left">Contract related</td><td style="width: 8%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14951">4,173,005</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 8%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14952">1,312,427</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomer_zm0HlgsW7Fbk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Product related</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueNotFromContractWithCustomer" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14953">13,663,377</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueNotFromContractWithCustomer" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14954">3,308,407</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Revenues_zPnw8zXZaaAd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14955">17,836,382</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14956">4,620,834</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A9_zKDDmRXWSIx6" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 5pt">&#160;</span></p>

</ix:nonNumeric><p id="xdx_854_zGLhvXkLfpFa" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 5pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="ixv-9030"><p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_z92tZr6bcLMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_zlvGi8T6cAC7">Research and Development</span> </b>&#8211; Research and
development expenses include payroll, employee benefits, and other headcount-related expenses associated with product development. Research
and development expenses also include third-party development and programming costs, materials, and a proportionate share of overhead
costs such as rent.</p>

</ix:nonNumeric><p id="xdx_854_zO2c0Kh2SYg6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies" id="ixv-9035"><p id="xdx_846_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zrulqYFkDsq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zT5ZW2pySwOe">Product
Warranty</span> - </b>The Company accrues an estimate of its exposure to warranty claims based upon both current and historical
product sales data and warranty costs incurred. Product warranty reserves are recorded in current liabilities under accrued
expenses.&#160;Warranty liability was $<span id="xdx_90D_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240430_zkpemxJKlCd5"><ix:nonFraction name="us-gaap:StandardProductWarrantyAccrualCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14957">372,000</ix:nonFraction></span>
and $<span id="xdx_90A_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20230430_zNpyM4tHDtmk"><ix:nonFraction name="us-gaap:StandardProductWarrantyAccrualCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14958">90,000</ix:nonFraction></span> as of April 30, 2024
and April 30, 2023 respectively.</p>

</ix:nonNumeric><p id="xdx_858_zaPoXhhgw6Ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock" id="ixv-9042"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zRkFoxX8Urv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_867_zhFDWVR5zHo1">Income Taxes</span></b> &#8211; Deferred taxes are provided
on the liability method whereby deferred tax assets are recognized for deductible temporary differences and deferred tax liabilities are
recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities
and their tax bases. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of
enactment.&#160;</p>

</ix:nonNumeric><p id="xdx_853_zBAPanN5HK0j" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="ixv-9047"><p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zvxhnOmm86Mb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86A_zg7JfXrxaVQj">Recent Accounting Pronouncements</span> </b>&#8211; <span style="background-color: white">Management
does not believe that recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the
accompanying consolidated financial statements.</span></p>

</ix:nonNumeric><p id="xdx_85A_zfRIZnPqn77l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="ixv-9053"><p id="xdx_841_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zKHsbsxKpxej" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_z4k4QCX9HQR">Foreign Currency</span> &#8211; </b>The functional currency
of our former international subsidiary, Skyset, was the local Italian currency. For that subsidiary, we translated assets and liabilities
to U.S. dollars using period-end exchange rates, and average monthly exchange rates for revenues, costs, and expenses. We recorded translation
gains and losses in accumulated other comprehensive income.</p>

</ix:nonNumeric><p id="xdx_857_zTFTHwMuepS6" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="ixv-9058"><p id="xdx_84F_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zeZrDIVXtY43" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86C_zWiNRp5rUhJ3">Comprehensive Loss</span> </b>&#8211; Comprehensive loss
consists of net loss and other comprehensive loss. Other comprehensive loss refers to gains and losses that are recorded as an element
of stockholders' equity but are excluded from net loss. Our other comprehensive loss is comprised of foreign currency translation adjustments
and unrealized gains or losses on available-for-sale securities. During the year ended April 30, 2024, comprehensive loss was $<span id="xdx_906_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20230501__20240430_z20MHAd0Bx09"><ix:nonFraction name="RCAT:DifferenceBetweenComprehensiveLossAndNetLoss" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14959">865,738</ix:nonFraction></span>
lower than net loss, related to unrealized gains on available-for-sale securities totaling $<span id="xdx_902_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20230501__20240430_zu9aCfjA5Wh3"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14960">864,165</ix:nonFraction></span> and foreign currency translation adjustments
of $<span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20230501__20240430_zA7NB9TbVz76"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14961">1,573</ix:nonFraction></span>. During the year ended April 30, 2023, comprehensive loss was $<span id="xdx_901_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20220501__20230430_zCjsInfVH5i4"><ix:nonFraction name="RCAT:DifferenceBetweenComprehensiveLossAndNetLoss" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14962">609,155</ix:nonFraction></span> lower than net loss, related to unrealized gains on available-for-sale
securities totaling $<span id="xdx_901_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20220501__20230430_zUYz8lZOzpvd"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14963">610,129</ix:nonFraction></span>, partially offset by foreign currency translation adjustments of $<span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20220501__20230430_zmMIZSeEG8Ma"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14964">974</ix:nonFraction></span>.&#160;</p>

</ix:nonNumeric><p id="xdx_85E_zQ3z2lCecTVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 45 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="ixv-9080"><p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zIYMkuiE3t7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_ziZAPTrXDv1a">Stock-Based Compensation</span> </b>&#8211; S<span style="background-color: white">tock
options are valued using the estimated grant-date fair value method of accounting in accordance with ASC Topic 718, Compensation &#8211;
Stock Compensation. Fair value is determined based on the Black-Scholes Model using inputs reflecting our estimates of expected volatility,
term and future dividends. We recognize forfeitures as they occur. The fair value of restricted stock is based on our stock price on the
date of grant. Compensation cost is recognized on a straight-line basis over the service period which is the vesting term.</span></p>

</ix:nonNumeric><p id="xdx_85D_z8yricEN9N3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock" id="ixv-9087"><p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zxizuRADbMh3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86E_zNqdQaJZswfb">Basic and Diluted Net Loss per Share</span></b> &#8211;
Basic and diluted net loss per share has been calculated by dividing net loss by the weighted average number of shares of common stock
outstanding during the period. Common stock equivalents were excluded from the computation of diluted net loss per share of common stock
because they were anti-dilutive. The conversion or exercise of these common stock equivalents would dilute earnings per share if we become
profitable in the future. Outstanding securities not included in the computation of diluted net loss per share because their effect would
have been anti-dilutive include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="ixv-9092"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z9tJBwS9KIPf" summary="xdx: Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_494_20230501__20240430_zqag83BE45nl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_497_20220501__20230430_zgFS9fM9BDJi" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_407_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_zgjK8cfnMyAd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Series B Preferred Stock, as converted</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 20%; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14965">3,896</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 20%; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14966">822,230</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_zhEgkUq1hHz2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Stock options</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14967">6,779,934</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14968">4,784,809</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_zOCXNCCHhdL2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14969">2,275,999</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14970">1,539,999</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_zfeTr9nC4ms5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Restricted stock</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14971">175,130</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14972">781,060</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zGwJOfxndp3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14973">9,234,959</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14974">7,928,098</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zQiqjBwavoJ5" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

</ix:nonNumeric><p id="xdx_85C_zOiYa4Rs803g" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="RCAT:RelatedPartiesPolicyTextBlock" id="ixv-9158"><p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zCXtklxqrUV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_866_zNIcK9TfCCch">Related Parties</span></b> &#8211; Parties are considered
to be related to us if they have control or significant influence, directly or indirectly, over us, including key management personnel
and members of the Board of Directors or are direct relatives of key management personnel of members of the Board of Directors. Related
Party transactions are disclosed in Note 20.</p>

</ix:nonNumeric><p id="xdx_85E_zYopETudmrMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock" id="ixv-9163"><p id="xdx_84E_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zTlQsOqnNxS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_86B_zY3r2rak3238">Liquidity
and Going Concern</span> </b>&#8211; The Company has never been profitable and has incurred net losses related to acquisitions, as well as costs
incurred to pursue its long-term growth strategy. During the year ended April 30, 2024, the Company incurred a net loss from continuing
</span>operations of $<span id="xdx_909_eus-gaap--IncomeLossFromContinuingOperations_dxL_c20230501__20240430_zSzkm1Ldsnmh" title="::XDX::-21526696"><span style="-sec-ix-hidden: xdx2ixbrl0737">21,526,696</span></span>&#160;and used cash in operating activities of continuing operations of $<span id="xdx_903_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_dxL_c20230501__20240430_zaIhyh0n4g01" title="::XDX::-17687063"><span style="-sec-ix-hidden: xdx2ixbrl0738">17,687,063</span></span>. As of April 30,
2024, working capital for continuing operations totaled $<span id="xdx_907_eus-gaap--Capital_iI_c20240430_zQPgJOzWJ7ca"><ix:nonFraction name="us-gaap:Capital" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14975">18,746,419</ix:nonFraction></span>. These financial results and our financial position <span style="background-color: white">at&#160;April
30, 2024&#160;raise substantial doubt about our ability to continue as a going concern. However, the Company has recently taken actions
to strengthen its liquidity.&#160;On&#160;December 11, 2023, we completed a public offering of 18,400,000 shares of common stock which
generated net proceeds of approximately $8,400,000 as further described in Note 1 and Note 16. In addition, the Company&#8217;s operating
plan for the next twelve months has been updated to reflect recent operating improvements.&#160; Revenues have accelerated and are expected
to continue growing. The Company&#8217;s manufacturing facility is scaling production and gross profits are projected to increase.&#160;<span style="background-color: white">If necessary, the Company will seek
to obtain additional debt financing for which there can be no guarantee.</span> Subsequent
to year end, as further described in Note 22, the Company sold its equity method investment for $4,400,000. Management has concluded
that these recent positive developments alleviate any substantial doubt about the Company&#8217;s ability to&#160;continue its operations,
and meet its financial obligations, for twelve months from the date these consolidated financial statements&#160;are&#160;issued.</span></p>

</ix:nonNumeric><p id="xdx_85D_ziynwxu1WGN5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

</ix:nonNumeric><p id="xdx_818_zPuC9sum4vnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="ixv-9179"><p id="xdx_800_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_znkVdmID5oz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_821_zmTl67wUUEn5">Note
3 &#8211; Divestiture of Consumer Segment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt; background-color: white"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt; background-color: white">On
February 16, 2024,</span><span style="font-size: 8pt">&#160;</span><span style="font-size: 10pt; background-color: white">the Company
closed the sale of Rotor Riot and Fat Shark to Unusual Machines. The sale was conducted pursuant to a Share Purchase Agreement dated November
21, 2022, as amended on April 13, 2023, July 10, 2023, and December 11, 2023 (the &#8220;SPA&#8221;). The transaction closed concurrently
with UMAC&#8217;s initial public offering and listing on the NYSE American exchange (&#8220;IPO&#8221;) under the symbol &#8220;UMAC.&#8221;
</span></p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt; background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The total consideration received
by the Company was valued at $<span id="xdx_901_eus-gaap--NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_pn6n6_c20230501__20240430_zIXV4zI4A94i"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD" id="ixv-14976">20</ix:nonFraction></span> million and consisted of i) $<span id="xdx_90D_ecustom--NoncashOrPartNoncashDivestitureCashConsiderationReceived1_pn6n6_c20230501__20240430_z1osYl9p5B02"><ix:nonFraction name="RCAT:NoncashOrPartNoncashDivestitureCashConsiderationReceived1" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD" id="ixv-14977">1</ix:nonFraction></span> million in cash, ii) $<span id="xdx_907_ecustom--NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1_pn6n6_c20230501__20240430_zCK7vEmGVK8e"><ix:nonFraction name="RCAT:NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD" id="ixv-14978">2</ix:nonFraction></span> million in a secured promissory note (&#8220;Promissory
Note&#8221;), iii) $<span id="xdx_906_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_pn6n6_c20230501__20240430_zUNYrjV0pWxc"><ix:nonFraction name="RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD" id="ixv-14979">17</ix:nonFraction></span> million in securities of Unusual Machines, and iv) a post-closing adjustment for excess working capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<ix:exclude><!-- Field: Page; Sequence: 47; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Secured Promissory Note</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Promissory Note from
Unusual Machines bears interest at a rate of 8% per year, is due 18 months from the date of issue, and requires monthly payments of interest
due in arrears on the 15th&#160;day of each month. In the event of a Qualified Financing (defined as one or more related debt or equity
financings by UMAC resulting in net proceeds of at least $5 million, other than UMAC&#8217;s completed IPO), the Company may require payment
of this Promissory Note in whole or in part upon written notice given within 10 days of the Qualified Financing. During the occurrence
and continuance of any event of default under the Note, The Company may, at its option, convert the amounts due under the Note to common
stock of UMAC in whole or in part from time to time. The conversion price will be a 10% discount to the average daily volume weighted
average price for UMAC&#8217;s common stock over the 10 days preceding the conversion price. Conversions under the Note will be limited
such that no conversion may be made to the extent that, after giving effect to the conversion, the Company, together with its affiliates,
would beneficially own in excess of 4.99% of UMAC&#8217;s common stock. This limit may be increased by the Company upon 61 days written
notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Unusual Machines Securities
</i></p>

<p style="font: 10pt/11.75pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><br/>
The $<span id="xdx_90C_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_pn6n6_c20230501__20240430_zkbm6zDCF2jj"><ix:nonFraction name="RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD" id="ixv-14980">17</ix:nonFraction></span> million worth of UMAC common stock was valued at the IPO price for UMAC&#8217;s common stock of $4.00 per share, resulting in
<span id="xdx_90E_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares_c20230501__20240430_zDwBwuAsBU63"><ix:nonFraction name="RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-14981">4,250,000</ix:nonFraction></span> shares of UMAC common stock being issued to the Company (representing approximately 49% of UMAC&#8217;s issued and outstanding
common stock after giving effect to the IPO and to the issuance of common stock to the Company upon closing of the IPO).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Working Capital</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
purchase price was adjusted for working capital as of the closing date. </span>Actual working capital excess amounts increased the
principal amount of the Promissory Note dollar for dollar. <span style="background-color: white">Working capital as of closing was
finalized at $<span id="xdx_90B_ecustom--WorkingCapitalAtClosingOfDisposalGroup_iI_pn6n6_c20240216_zbXgynZ6d6f9"><ix:nonFraction name="RCAT:WorkingCapitalAtClosingOfDisposalGroup" contextRef="AsOf2024-02-16" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD" id="ixv-14982">2</ix:nonFraction></span> million,
as further described in Note 22.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The Consumer
segment has been classified as Discontinued Operations and reported in accordance with the applicable accounting standards. Set forth
below are the results of operations for the Consumer segment for:</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="ixv-9235"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zSkyfwXJYvJf" summary="xdx: Disclosure - Discontinued Operations - results of operations (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td colspan="3" id="xdx_493_20230501__20240430_zshf715XYCU1" style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td colspan="3" id="xdx_490_20220501__20230430_zEvfNYksleKf" style="font-size: 12pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>April 30,</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2023</td></tr>
  <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_zet66lxCG3cd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-indent: -10pt; padding-left: 10pt">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14983">4,213,653</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14984">5,290,946</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_zZCp6nmbVSq1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Cost of goods sold</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14985">4,577,980</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14986">4,793,430</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_zZB2bdYGJ107" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Gross (Loss) Profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14987">364,327</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14988">497,516</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract_iB_zHCQOqo9zi16" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Operating Expenses</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_i01_zJLH4PGzI8F9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14989">118,093</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14990">346,002</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_i01_zVhUkNrCIv5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14991">1,157,448</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14992">862,384</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_i01_zVuRSUxgtgUf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">General and administrative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14993">863,361</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14994">1,044,435</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_i01_zbIlawNLqG9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14995">2,138,902</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14996">2,252,821</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_z9ivHMd3EAOj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Operating loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14997">2,503,229</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-14998">1,755,305</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_iB_zVvUU5f7lou5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Other expense (income)</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInterestExpense_i01_zpBc0jySXPA1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-14999">22,856</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0783">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherIncome_i01N_di_zKtzrAasM0nd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Other, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15000">152</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15001">24,919</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_i01_zFuBhwfCwzb3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Other expense (income)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15002">22,704</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-15003">24,919</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt; text-indent: -10pt; padding-left: 20pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_zm0JKW1Nqn7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 20pt">Net loss from discontinued operations</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-15004">2,525,933</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-15005">1,730,386</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AF_z2rczATCQB5d" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;&#160;</span>&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 48; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Assets
and liabilities for the Consumer segment included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="RCAT:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock" id="ixv-9464"><table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock_zDXki7kt0Sge" summary="xdx: Disclosure - Assets and liabilities for the Consumer Segment (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_490_20240430_znrKTTBcuGWl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_491_20230430_zsmNxUUlbZs1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_400_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_iB_z87t70LlmfEl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCash_i01I_z2NIr3x53W3d" style="vertical-align: bottom; background-color: White">
    <td style="width: 62%; font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Cash</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0799">&#8212;</span>&#160;&#160;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 15%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCash" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15006">86,656</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_i01I_zcwueUvWpSi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts receivable, net</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0802">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15007">61,107</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_i01I_z1sBCuNDbE6a" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Inventory</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0805">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15008">3,065,954</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_i01I_zb1zbFTBsK43" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Other</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0808">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15009">2,069,438</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_i01I_zBWkVUPanN5g" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Total current assets</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0811">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15010">5,283,155</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_i01I_z8Tx8utNgRlk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Intangible assets, net</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0814">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15011">20,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_i01I_zkc2jxz6q2uf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 10pt">Other</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0817">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15012">3,853</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent_iI_zSUCOiDo29Z6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Operating lease right-of-use assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0820">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15013">84,544</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_iI_zp1C8ecSpts5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Total long term assets</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0823">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15014">108,397</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_iB_z0WB0fL1ytUd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_i01I_zBxrKpDpQkq" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts payable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0829">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15015">606,872</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_i01I_zWSzKPSieU8f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Accrued expenses</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0832">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15016">109,480</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_i01I_zgpnGHr06vK5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Customer deposits</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0835">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15017">244,688</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent_i01I_zz7sEoiHkCz8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Operating lease liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0838">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15018">49,461</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_i01I_z3BPfxYaOHfb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Total current liabilities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0841">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15019">1,010,501</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent_iI_zkjV11vb9jBj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Long term liabilities - Operating lease liabilities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0844">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15020">41,814</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--DisposalGroupIncludingDiscontinuedOperationWorkingCapital_iI_zePZUDSsMGg6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Working capital</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0847">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationWorkingCapital" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15021">4,272,654</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zLsYoLAgYES6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

</ix:nonNumeric><p id="xdx_81A_zXMLtTAYP0w6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="ixv-9710"><p id="xdx_808_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_z6kDrTUWTh21" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_82C_zFwwqVWwtFx2">Note
4 &#8211; Marketable Securities</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">There
were no marketable securities at April 30, 2024.</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify">At April 30, 2023, marketable securities
consisted solely of corporate bonds and were classified at Level 2 in the Fair Value Hierarchy. Fair value, cost basis, and
unrealized losses totaled $<span id="xdx_900_ecustom--CorporateBondsAtCarryingValueFairValue_iI_c20240430_ziWNu2Vo9IE9"><ix:nonFraction name="RCAT:CorporateBondsAtCarryingValueFairValue" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15022">12,814,038</ix:nonFraction></span>,
$<span id="xdx_90F_ecustom--CorporateBondsAtCarryingValueCostBasis_iI_c20240430_zIJVJLiOC0Gc"><ix:nonFraction name="RCAT:CorporateBondsAtCarryingValueCostBasis" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15023">13,678,203</ix:nonFraction></span>, and $<span id="xdx_908_ecustom--CorporateBondsAtCarryingValueUnrealizedLosses_iNI_di_c20240430_zZoEfnZLSw7f"><ix:nonFraction name="RCAT:CorporateBondsAtCarryingValueUnrealizedLosses" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-15024">864,165</ix:nonFraction></span>
at April 30, 2023, respectively.</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

</ix:nonNumeric><p id="xdx_81F_zdS7dPGq5JQ7" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:InventoryDisclosureTextBlock" id="ixv-9725"><p id="xdx_80A_eus-gaap--InventoryDisclosureTextBlock_zLmly14NaPO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_82F_zIzyQYj4zeBg">Note
5 &#8211; Inventories</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Inventories
consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="ixv-9734"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z6BUpddFWoF9" summary="xdx: Disclosure - Inventories (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49A_20240430_znqN3pNDk0V4" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_495_20230430_zTR3DOqZWeG2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_zkyxa8aKxVd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Raw materials</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15025">5,750,324</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15026">8,132,196</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--InventoryWorkInProcess_iI_z8Vu5WAs9G9f" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">Work-in-process</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15027">1,289,997</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15028">509,381</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--InventoryFinishedGoods_iI_zCIqhYR0CO7j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Finished goods</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15029">966,916</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15030">278,996</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryNet_iI_zaJzXLheb7x5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15031">8,007,237</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15032">8,920,573</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zklwzZoeO8Ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;&#160;</span></p>

</ix:nonNumeric><p id="xdx_819_z5YKgHHjksgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;&#160;</p>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:OtherCurrentAssetsTextBlock" id="ixv-9793"><p id="xdx_808_eus-gaap--OtherCurrentAssetsTextBlock_zrXyK6Rmvhra" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_825_z1VWG65ssHXc">Note
6 &#8211; Other Current Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Other
current assets included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="ixv-9802"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zve7ktwRkWRi" summary="xdx: Disclosure - Other current assets (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_495_20240430_zngNaW3Pybsj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49F_20230430_zCwwNg2UMCl9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_40E_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_d0_zw8bDNFFohF2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Contract asset</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerAssetGrossCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15033">1,477,859</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerAssetGrossCurrent" contextRef="AsOf2023-04-30" format="ixt:zerodash" decimals="0" unitRef="USD" id="ixv-15034">&#8212;</ix:nonFraction>&#160;&#160;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--PrepaidExpenseCurrent_iI_z9jCggJwMmil" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Prepaid expenses</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15035">1,206,306</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15036">752,564</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--GrantsReceivableCurrent_iI_zqOJt7hTi7s1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Grant receivable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GrantsReceivableCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15037">675,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0882">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_zD0u2si96To6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Prepaid inventory</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15038">602,888</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15039">359,500</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss_iI_zlv58nsr7y2a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Accrued interest income</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0887">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15040">151,671</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherAssetsCurrent_iI_zwrVf7JHUR99" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15041">3,962,053</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15042">1,263,735</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zpLfa8wx07L" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

</ix:nonNumeric><p id="xdx_818_zt85XnSGBn87" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;&#160;&#160;</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="RCAT:DueFromRelatedPartyDisclosureTextBlock" id="ixv-9875"><p id="xdx_80F_ecustom--DueFromRelatedPartyDisclosureTextBlock_z6iSk9tDE2Aj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_829_zkUwNtFzveF8">Note
7 &#8211; Due From Related Party</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
January 2022, the Company determined that a senior executive had relocated in 2021 but their compensation had not been subject to the
income tax withholding required by the new jurisdiction.&#160;The amount subject to taxation included $<span id="xdx_905_ecustom--CashCompensationSubjectToTaxation_c20230101__20230430_zQxsx4gKigi8"><ix:nonFraction name="RCAT:CashCompensationSubjectToTaxation" contextRef="From2023-01-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15043">155,624</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;of
cash compensation and $<span id="xdx_90F_ecustom--IncomeAssociatedWithStockCompensationSubjectToTaxation_c20230101__20230430_zTRvDHCqurNe"><ix:nonFraction name="RCAT:IncomeAssociatedWithStockCompensationSubjectToTaxation" contextRef="From2023-01-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15044">1,413,332</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;of
income associated with the vesting of restricted stock ("Stock Compensation").&#160;In March 2022, the Company entered into a
note agreement (the "Note") with the employee in the amount of $<span id="xdx_905_ecustom--NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation_c20230301__20230430_zusjUOFElLFb"><ix:nonFraction name="RCAT:NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation" contextRef="From2023-03-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15045">510,323</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">,
representing the estimated taxes owed by the employee related to the Stock Compensation. Under the terms of the Note, <span id="xdx_904_ecustom--CommonStockWithheldByCompanyAppliedAgainstNoteShares_c20230301__20230430_zgQ8PC66lk46"><ix:nonFraction name="RCAT:CommonStockWithheldByCompanyAppliedAgainstNoteShares" contextRef="From2023-03-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15046">104,166</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">shares of common stock with a fair value
of $<span id="xdx_906_ecustom--CommonStockWithheldByCompanyAppliedAgainstNoteAmount_c20230301__20230430_zCQrzJCwEZp5"><ix:nonFraction name="RCAT:CommonStockWithheldByCompanyAppliedAgainstNoteAmount" contextRef="From2023-03-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15047">280,832</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">,
which had vested during calendar 2021, were withheld by the Company and applied against the Note.&#160;The employee agreed not to sell
or transfer <span id="xdx_90C_ecustom--SharesHeldAtTransferAgentUntilNoteReceivableRepayment_c20230301__20230430_zxjOO0m6PW6b"><ix:nonFraction name="RCAT:SharesHeldAtTransferAgentUntilNoteReceivableRepayment" contextRef="From2023-03-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15048">110,983</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;shares
of common stock held at the Company's transfer agent until the Note was repaid.&#160;In addition, the employee has <span id="xdx_90D_ecustom--RestrictedStockScheduledToVestShares_c20230301__20230430_zvevZOtcsT5j"><ix:nonFraction name="RCAT:RestrictedStockScheduledToVestShares" contextRef="From2023-03-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15049">20,833</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;shares
of restricted stock vesting monthly in calendar 2022, of which <span id="xdx_901_ecustom--RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable_c20230301__20230430_zs9qgjRKJ70l"><ix:nonFraction name="RCAT:RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable" contextRef="From2023-03-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15050">3,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">shares were withheld with&#160;the fair
value of those shares&#160;applied against the Note. Shares issued to the employee in 2022 were held at the transfer agent until the
Note was repaid.&#160;The Note matured on December 31, 2022.&#160;The Company filed amended payroll tax returns on March 16, 2022. In
March and April 2022, the Company made payments to the relevant tax authorities totaling $<span id="xdx_909_ecustom--PaymentsForTaxLiability_iN_di_c20230301__20230430_zkZI4pv5OqYk"><ix:nonFraction name="RCAT:PaymentsForTaxLiability" contextRef="From2023-03-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-15051">712,646</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;representing
$<span id="xdx_908_ecustom--NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation_c20230301__20230430_zAMluM6eRz9k"><ix:nonFraction name="RCAT:NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation" contextRef="From2023-03-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15052">510,323</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">owed by the employee, $<span id="xdx_904_ecustom--EstimatedTaxesOwedRelatedToStockCompensation_c20230301__20230430_zeXZhTxDKhRk"><ix:nonFraction name="RCAT:EstimatedTaxesOwedRelatedToStockCompensation" contextRef="From2023-03-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15053">31,604</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">owed by the Company, and $<span id="xdx_902_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20230301__20230430_zdi5GWabzaJe"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="From2023-03-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15054">170,719</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">of penalties and interest. The Note was
repaid in full in August 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

</ix:nonNumeric><p id="xdx_814_znX6Y4ca1mMg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="ixv-9909"><p id="xdx_809_eus-gaap--IntangibleAssetsDisclosureTextBlock_znmNgMdHyJ7g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_828_zUz3OvP4qMSl">Note
8 &#8211; Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Intangible
assets relate to acquisitions completed by the Company, including those described in Note 1, and were as follows:</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="ixv-9918"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zX2LoD05fw32" summary="xdx: Disclosure - Intangible assets (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"/><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_496_20240430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_z2lGxlgYlT0j" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_49E_20240430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_zQpL6rgyu3u3" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_499_20240430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zdHSJKKxRag8" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_492_20230430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_zj7diAdCNLV3" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_493_20230430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_z87k05xiuure" style="text-align: center"/><td style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_49C_20230430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zv7ORBT9jZo3" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Gross Value</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Net Value</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.85pt 0 0; text-align: center"><b>Gross</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Value</b></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Net Value</td></tr>
  <tr id="xdx_40B_ecustom--FiniteLivedProprietaryTechnologyGross_iI_z9OH8LlngRLe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt; text-align: left">Proprietary technology</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:FiniteLivedProprietaryTechnologyGross" contextRef="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15055">4,282,001</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:FiniteLivedProprietaryTechnologyGross" contextRef="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-15056">1,917,612</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:FiniteLivedProprietaryTechnologyGross" contextRef="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15057">2,364,389</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:FiniteLivedProprietaryTechnologyGross" contextRef="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15058">4,967,000</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:FiniteLivedProprietaryTechnologyGross" contextRef="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-15059">1,271,112</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:FiniteLivedProprietaryTechnologyGross" contextRef="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15060">3,695,888</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--FiniteLivedNoncompeteAgreementsGross1_iI_zZTkVcNMkU6i" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Non-compete agreements</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:FiniteLivedNoncompeteAgreementsGross1" contextRef="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15061">65,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:FiniteLivedNoncompeteAgreementsGross1" contextRef="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-15062">65,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0920">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:FiniteLivedNoncompeteAgreementsGross1" contextRef="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15063">81,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:FiniteLivedNoncompeteAgreementsGross1" contextRef="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-15064">56,667</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:FiniteLivedNoncompeteAgreementsGross1" contextRef="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15065">24,333</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--FiniteLivedCustomerRelationshipsGross1_iI_zUBASyRu0cX4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Customer relationships</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0925">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0926">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0927">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:FiniteLivedCustomerRelationshipsGross1" contextRef="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15066">39,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:FiniteLivedCustomerRelationshipsGross1" contextRef="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-15067">18,106</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:FiniteLivedCustomerRelationshipsGross1" contextRef="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15068">20,894</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--FiniteLivedIntangibleAssetsGross1_iI_zO3OZ9bu8atf" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Total finite-lived assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:FiniteLivedIntangibleAssetsGross1" contextRef="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15069">4,347,001</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:FiniteLivedIntangibleAssetsGross1" contextRef="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-15070">1,982,612</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:FiniteLivedIntangibleAssetsGross1" contextRef="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15071">2,364,389</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:FiniteLivedIntangibleAssetsGross1" contextRef="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15072">5,087,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:FiniteLivedIntangibleAssetsGross1" contextRef="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-15073">1,345,885</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:FiniteLivedIntangibleAssetsGross1" contextRef="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15074">3,741,115</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IndefiniteLivedTradeNames_iI_ztjiNZM883Fg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Brand name</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IndefiniteLivedTradeNames" contextRef="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15075">1,430,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0940">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IndefiniteLivedTradeNames" contextRef="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15076">1,430,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IndefiniteLivedTradeNames" contextRef="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15077">3,152,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0943">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IndefiniteLivedTradeNames" contextRef="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15078">3,152,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--IndefiniteLivedIntangibleAssetsExcludingGoodwill1_iI_zgHiUt7bR99j" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt">Total indefinite-lived assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1" contextRef="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15079">1,430,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0947">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1" contextRef="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15080">1,430,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1" contextRef="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15081">3,152,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0950">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1" contextRef="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15082">3,152,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IntangibleAssetsNetExcludingGoodwill1_iI_z7Gl2PfL7N0h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: 10pt">Total intangible assets, net</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:IntangibleAssetsNetExcludingGoodwill1" contextRef="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15083">5,777,001</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:IntangibleAssetsNetExcludingGoodwill1" contextRef="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-15084">1,982,612</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:IntangibleAssetsNetExcludingGoodwill1" contextRef="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15085">3,794,389</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:IntangibleAssetsNetExcludingGoodwill1" contextRef="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15086">8,239,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:IntangibleAssetsNetExcludingGoodwill1" contextRef="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-15087">1,345,885</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:IntangibleAssetsNetExcludingGoodwill1" contextRef="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15088">6,893,115</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zkZhxjEOzKul" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Proprietary
technology and non-compete agreements are being amortized over six years and three years, respectively. Customer relationships are being
amortized over seven years. Goodwill and Brand name are not amortized but evaluated for impairment on a quarterly basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<ix:exclude><!-- Field: Page; Sequence: 50; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">As
of April 30, 2024, expected amortization expense for finite-lived intangible assets for the next five years is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="ixv-10201"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zjneipPSX354" summary="xdx: Disclosure - Expected amortization expense for the unamortized finite-lived intangible assets (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-size: 10pt">&#160;</td>
    <td colspan="2" style="text-align: left; font-size: 10pt">Fiscal Year Ended:</td><td>&#160;</td>
    <td colspan="3" id="xdx_49E_20240430_zXaRMnPYpHdb">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_zexbQb0J4IVj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 65%; font-size: 10pt; text-align: left">2025</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 30%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15089">709,316</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_zuPC7NIpEPni" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">2026</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15090">709,316</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_z8fubbCcSvLk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">2027</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15091">709,316</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_zwTo7HbdELuk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">2028</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15092">236,441</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_zxuDNQg8YLt5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">2029</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0970">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_zMpmporglwSl" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_zpbixktmPMy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15093">2,364,389</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zuSgWyOZlpOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.25in">&#160;<span style="background-color: white">&#160;&#160;&#160;&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Goodwill
represents the future economic benefit arising from other assets acquired in an acquisition&#160;that are not individually identified
and separately recognized. The composition of, and changes in goodwill, consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ScheduleOfGoodwillTextBlock" id="ixv-10275"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfGoodwillTextBlock_zIm5jaFCEO12" summary="xdx: Disclosure - Composition of, and changes in goodwill (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt">Date</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Entity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_4BC_us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap--GoodwillMember_zTxPMT2MHiE9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Goodwill</td></tr>
  <tr id="xdx_43E_c20200101__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_zVBMNDR9lQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 36%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">January 2020</span></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 30%; font-size: 10pt; text-align: center; padding-left: 5.75pt">Rotor Riot</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GoodwillPeriodIncreaseDecrease" contextRef="From2020-01-012023-04-30_us-gaap_GoodwillMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15094">1,849,073</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20201101__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_z2jBZyYLS7Ti" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">November 2020</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 5.75pt">Fat Shark</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GoodwillPeriodIncreaseDecrease" contextRef="From2020-11-012023-04-30_us-gaap_GoodwillMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15095">6,168,260</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_433_c20210501__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_zyUCw4f48f31" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">May 2021</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 5.75pt">Skypersonic</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GoodwillPeriodIncreaseDecrease" contextRef="From2021-05-012023-04-30_us-gaap_GoodwillMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15096">2,826,918</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20210801__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_zJ8BOuIQznS4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">August 2021</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 5.75pt">Teal Drones</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GoodwillPeriodIncreaseDecrease" contextRef="From2021-08-012023-04-30_us-gaap_GoodwillMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15097">8,995,499</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20230401__20230430_eus-gaap--GoodwillImpairmentLoss_iN_di_zarFtKrXSuf2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">April 2023 - Impairment loss</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-bottom: 1pt; padding-left: 5.75pt">Skypersonic</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2023-04-012023-04-30_us-gaap_GoodwillMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15098">2,826,918</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_439_c20230430_eus-gaap--Goodwill_iI_z6nMnHPAnlYh" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Balance at April 30, 2023</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.75pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-04-30_us-gaap_GoodwillMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15099">17,012,832</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20240201__20240430_eus-gaap--GoodwillWrittenOffRelatedToSaleOfBusinessUnit_iN_di_zSBGoPCLIeJd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">February 2024 &#8211; Divestiture</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt; padding-left: 5.75pt">Rotor Riot, Fat Shark</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" contextRef="From2024-02-012024-04-30_us-gaap_GoodwillMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15100">7,924,282</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_434_c20240430_eus-gaap--Goodwill_iI_zba2WDzOY1E8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Balance at April 30, 2024</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt; padding-left: 5.75pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-04-30_us-gaap_GoodwillMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15101">9,088,550</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zfMXaQMEccCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;<span style="background-color: white">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Included
in the amounts presented above is goodwill related to other insignificant transactions. Following the establishment of the Enterprise
and Consumer segments, management evaluated the long-term business strategy of each segment. This resulted in the Enterprise segment narrowing
its focus on the military and other government agencies. It was determined that Skypersonic's technology would be re-focused for the near
term on military applications and consolidated into the operations of Teal. The Company completes a formal evaluation of the carrying
value of its intangible assets, including goodwill, at the end of each fiscal year. Based on (i) the operating results for Skypersonic
since its acquisition in May 2021, (ii) its consolidation into Teal, (iii) our current expectations of its future business conditions
and trends, including its projected revenues, expenses, and cash flows, the Company recognized an impairment charge of $<span id="xdx_90F_eus-gaap--GoodwillImpairmentLoss_iN_dixL_c20230401__20230430_zupUsiY7K2kd" title="::XDX::-2826918"><span style="-sec-ix-hidden: xdx2ixbrl0993">2,826,918</span></span> in April
2023. During FY2024, an impairment change of $<span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_iN_dixL_c20240401__20240430_zWxtw0o07ZAb" title="::XDX::-412999"><span style="-sec-ix-hidden: xdx2ixbrl0994">412,999</span></span> was recognized related to Skypersonic&#8217;s proprietary technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

</ix:nonNumeric><p id="xdx_819_zx7tmU0on9Ff" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="ixv-10382"><p id="xdx_80E_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_ze3r0cHA8g83" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_826_zW6Qq60QjsNk">Note
9 &#8211; Equity Method Investment</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">As
of April 30, 2024, the Company owned a 46% interest in Unusual Machines. The primary business operations include selling first-person-view
video goggles for drone pilots, drones, parts and related equipment to the consumer marketplace. UMAC&#8217;s financial statements are prepared
in accordance with GAAP.</span> See Note 3 and Note 22 for additional information.</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Financial
information for UMAC is derived from UMAC&#8217;s  Form 10-Q for the quarter ending March 31, 2024 and was as follows:</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="RCAT:EquityMethodInvestmentFinancialInformationTableTextBlock" id="ixv-10394"><table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--EquityMethodInvestmentFinancialInformationTableTextBlock_zKROqMKzMPrg" summary="xdx: Disclosure - Financial informatino for UMAC derived from their Form 10-Q (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_498_20240101__20240331__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zYeBfmK7l2wj">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AssetsCurrent_iE_zNk2JRkdgya5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 67%; font-size: 10pt; text-align: left">Current assets</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 30%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15102">6,128,890</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsNoncurrent_iE_zfYhJXWFPV3k" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Long-term assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15103">18,099,802</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesCurrent_iE_zIfxmBi54kE5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Current liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15104">691,978</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesNoncurrent_iE_zkpKr46q3Q9g" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Long-term liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15105">2,313,896</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_zEoIDgypOTUc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Revenues</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15106">618,915</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--GrossProfit_zaEArg6XVZr4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Gross profit</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15107">204,167</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_zqWGToyTOZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Net loss</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-15108">1,106,001</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zNWE9zsBjaA5" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<ix:exclude><!-- Field: Page; Sequence: 51; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
Company&#8217;s investments in UMAC have been impacted by the following:</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:EquityMethodInvestmentsTextBlock" id="ixv-10456"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--EquityMethodInvestmentsTextBlock_zLOji0k794G2" summary="xdx: Disclosure - Impacts on investments into UMAC (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr id="xdx_402_eus-gaap--EquityMethodInvestments_iS_zlF5Ab6Egy26" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 67%">Initial investment, February 16, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_494_20230501__20240430__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zVEBHNE7SSel" style="width: 30%; text-align: right">17,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromEquityMethodInvestments_iN_di_zBxykRuVOIT" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Equity method loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2023-05-012024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15109">503,625</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_iN_di_z2OIJekif81" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Impairment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" contextRef="From2023-05-012024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15110">11,353,875</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--EquityMethodInvestments_iE_zV98VQyDhPIb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Investment balance, April 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestments" contextRef="AsOf2024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15111">5,142,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_z7x9uz0RfKge" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
computation of both the initial investment as of February 16, 2024 and investment balance as of April 30, 2024, is based on the fair market
value of UMAC&#8217;s common stock. </span></p>

</ix:nonNumeric><p id="xdx_81E_zxpqGaAsclQ6" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="ixv-10492"><p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zNngJgqAgHHb" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_82E_z9dMcRlJbVge">Note
10 &#8211; Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Property
and equipment consist of assets with an estimated useful life greater than one year and are reported net of accumulated depreciation.
The reported values are periodically assessed for impairment, and were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="ixv-10501"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--PropertyPlantAndEquipmentTextBlock_z5oH0fjSeHPe" summary="xdx: Disclosure - Property and equipment (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_496_20240430_zaTMthThlrWb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_494_20230430_z1qnxPEDFgu5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentGross_iI_z2KRiK3mgwlj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Equipment and related</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15112">1,540,888</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15113">1,386,373</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LeaseholdImprovementsGross_iI_zoau8fUQKb9l" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Leasehold improvements</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15114">1,547,976</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15115">1,473,890</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--FurnitureAndFixturesGross_iI_zg3QM2Hv2a7f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Furniture and fixtures</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FurnitureAndFixturesGross" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15116">163,290</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FurnitureAndFixturesGross" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15117">132,752</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_zYuCwcne8EL1" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15118">911,470</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15119">342,657</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iI_zNnVB50SjlS7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt">Net carrying value</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15120">2,340,684</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15121">2,650,358</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Depreciation
expense totaled $<span id="xdx_906_eus-gaap--Depreciation_c20230501__20240430_zJK5OyBrgMO"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15122">568,813</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--Depreciation_c20220501__20230430_zYaiW4pDORZ7"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15123">311,545</ix:nonFraction></span> for the years ended April 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

</ix:nonNumeric></ix:nonNumeric><p id="xdx_815_zHV6TgFbc5Xb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="RCAT:OtherLongTermAssetsDisclosureTextBlock" id="ixv-10566"><p id="xdx_809_ecustom--OtherLongTermAssetsDisclosureTextBlock_zXQLH0kdO6ak" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_82B_zCTGEJagbx4f">Note
11 &#8211; Other Long-Term Assets</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Other
long-term assets included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="RCAT:ScheduleOfOtherLongTermAssetsTableTextBlock" id="ixv-10575"><table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfOtherLongTermAssetsTableTextBlock_zTbXFIaRadZd" summary="xdx: Disclosure - Other long term assets (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49A_20240430_zB94gUgtyTR3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49A_20230430_zGS0C8OOI27k" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_403_ecustom--SAFEAgreementAssets_iI_zXHoQtbOXWhi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">SAFE agreement</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:SAFEAgreementAssets" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15124">250,000</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:SAFEAgreementAssets" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15125">250,000</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--SecurityDeposit_iI_zUHiVGMrR6jb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Security deposits</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15126">43,126</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15127">53,180</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NoncurrentAssets_iI_zVI3O7DTXcjg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15128">293,126</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15129">303,180</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_ziapqAxsjAYa" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
November 2022, the Company entered into a SAFE (Simple Agreement for Future Equity) agreement with Firestorm Labs, Inc. (&#8220;Firestorm&#8221;)
under which it made a payment of $<span id="xdx_900_ecustom--PaymentForSAFEAgreement_c20221101__20221130_zSNCj7gfXCKd"><ix:nonFraction name="RCAT:PaymentForSAFEAgreement" contextRef="From2022-11-012022-11-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15130">250,000</ix:nonFraction></span> to Firestorm in exchange for the right to certain shares of Firestorm stock. The SAFE permits
the Company to participate in a future equity financing of Firestorm by converting the $<span id="xdx_90C_ecustom--PaymentForSAFEAgreement_c20221101__20221130_z1gsZASEQBQ9"><ix:nonFraction name="RCAT:PaymentForSAFEAgreement" contextRef="From2022-11-012022-11-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15131">250,000</ix:nonFraction></span> into shares of Preferred Stock of Firestorm.
If there is a change in control of Firestorm or a public offering of shares of its stock, then the Company shall have the right to receive
cash payments, or shares of stock, whichever has greater value. The Company&#8217;s investment in the SAFE agreement has been recorded
on the cost method of accounting. The Company evaluates the investment for any indications of impairment in value on a quarterly
basis. No&#160;factors indicative of impairment were identified&#160;during&#160;the&#160;year ended&#160;April&#160;30,&#160;2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

</ix:nonNumeric><p id="xdx_819_zzVHeiamrs58" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b></b></span></p>

<!-- Field: Page; Sequence: 52; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:LeasesOfLesseeDisclosureTextBlock" id="ixv-10632"><p id="xdx_80F_eus-gaap--LeasesOfLesseeDisclosureTextBlock_zw3b8dL1jBt1" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_821_zE9onxcMSbR7">Note
12 &#8211; Right of Use Assets and Liabilities</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">As
of April 30, 2024, the Company had operating type leases for real estate and no finance type leases. The Company&#8217;s leases have remaining
lease terms of up to 6.67 years, including options to extend certain leases for up to six years. Operating lease expense totaled $351,369
for the year ended April 30, 2024, including period cost for short-term, cancellable, and variable leases, not included in lease liabilities,
of $4,950 for the year ended April 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Leases
on which the Company made rent payments during the reporting period included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ScheduleOfRentExpenseTableTextBlock" id="ixv-10648"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfRentExpenseTableTextBlock_zQ1JIeepMl5k" summary="xdx: Disclosure - Operating leases (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Location</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Monthly Rent</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expiration</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 42%">South Salt Lake, Utah</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_988_eus-gaap--OperatingLeaseExpense_c20230501__20240430__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation1Member_zj3FQbQY4iSa" style="text-align: right; width: 25%"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2023-05-012024-04-30_custom_OperatingLeaseLocation1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15132">22,667</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 25%"><span style="font-size: 10pt">December 2024</span></td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">San Juan, Puerto Rico</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingLeaseExpense_c20230501__20240430__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation3Member_z08KIHOS9lxh" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2023-05-012024-04-30_custom_OperatingLeaseLocation3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15133">5,647</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">June 2027</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Grantsville, Utah</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeaseExpense_c20230501__20240430__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation4Member_zJALeoBESDX7" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2023-05-012024-04-30_custom_OperatingLeaseLocation4Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15134">1,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">December 2026</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>


</ix:nonNumeric><p id="xdx_8AC_zUjEJTYUfwP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.25in">&#160;<span style="background-color: white">&#160;&#160;&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Supplemental
information related to operating leases for the year ended April 30, 2024 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock" id="ixv-10696"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_z7efdYCP0wsl" summary="xdx: Disclosure - Supplemental information related to operating leases (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_497_20230501__20240430_zFXEY9gfNDOl" style="font-size: 12pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--OperatingCashPaidToSettleLeaseLiabilities_zOf4I3cCkeX9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt; width: 77%"><span style="font-size: 10pt">Operating cash
    paid to settle lease liabilities</span></td><td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; width: 1%"><span style="font-size: 10pt"></span></td><td style="text-align: center; width: 20%">$<span style="font-size: 10pt">$<ix:nonFraction name="RCAT:OperatingCashPaidToSettleLeaseLiabilities" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15135">350,162</ix:nonFraction></span></td><td style="text-align: center; width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0pt"><span style="font-size: 10pt">Weighted average remaining lease term (in years)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_pip0_dtY_c20240430_zbG3UQ5mByma"><ix:nonNumeric contextRef="AsOf2024-04-30" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="ixv-15136">2.16</ix:nonNumeric></span></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iE_zY85bVC2Kdmg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt"><span style="font-size: 10pt">Weighted average discount rate</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-15137">12</ix:nonFraction>%</span></td><td style="text-align: center"><span style="font-size: 10pt"></span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A1_znwjP9FnHAk2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Future
lease payments at April 30, 2024 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="ixv-10745"><table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zuRpKwgz6M9" summary="xdx: Disclosure - Future lease payment obligations (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 40%">
<tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: left; font-size: 10pt"><span style="font-size: 10pt">Fiscal Year Ended:</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_491_20240430_zvEq4KDDN9o7"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_zaYkZNg8TXwc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left; width: 65%"><span style="font-size: 10pt">2025</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%">$<span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right; width: 30%"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15138">366,853</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_zImF4TEPWzRl" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">2026</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15139">372,449</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_iI_zNHSwZ8slT03" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">2027</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15140">372,880</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_iI_zklrfpA29ay7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">2028</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15141">293,334</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix_iI_zYRWSdd79em4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">2029</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15142">280,080</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueThereafter_iI_zQQDjEuYhUv8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">Thereafter</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:LesseeOperatingLeaseLiabilityPaymentsDueThereafter" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15143">443,460</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueSubtotal_iI_zbyHydiK5Osi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"></span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:LesseeOperatingLeaseLiabilityPaymentsDueSubtotal" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15144">2,129,056</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_z1mCQdrdNofd" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">Imputed interest</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15145">611,466</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_z59T5oeilyFk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">Total liability</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15146">1,517,590</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>


</ix:nonNumeric><p id="xdx_8AB_zCkfrZTZbGWj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;<span style="background-color: white">&#160;<b>&#160;</b></span></p>

</ix:nonNumeric><p id="xdx_813_zvPILo3ZksK3" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b>&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:DebtDisclosureTextBlock" id="ixv-10874"><p id="xdx_80A_eus-gaap--DebtDisclosureTextBlock_zSZDwMmnxPZk" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_828_z6O6iZAQhi76">Note
13 &#8211; Debt Obligations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>A.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>&#160;Decathlon Capital</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">On
August 31, 2021, Teal entered into an Amended and Restated Loan and Security Agreement with Decathlon Alpha IV, L.P. (&#8220;DA4&#8221;)
in the amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20220831__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_z8el6ty3tAnj"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-08-31_custom_DebtObligation1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15147">1,670,294</ix:nonFraction></span> (the &#8220;Loan&#8221;), representing the outstanding principal amount previously due and owing by Teal to
DA4. Interest on the Loan accrues at a rate of ten (<span id="xdx_900_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220901__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_zBuPvjkJDpN3"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-09-012023-04-30_custom_DebtObligation1Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-15148">10</ix:nonFraction></span>%) percent per annum. Principal and interest is payable in monthly installments
of $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20220801__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_zjqMiZ0o4eJb"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-08-012023-04-30_custom_DebtObligation1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15149">49,275</ix:nonFraction></span> until maturity on December 31, 2024. The balance outstanding at April 30, 2024 and April 30, 2023 totaled $<span id="xdx_909_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430_zsORdDUSUolb"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15150">370,537</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--DebtInstrumentCarryingAmount_iI_c20230430_zcDSJ2x2W3bl"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15151">895,709</ix:nonFraction></span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>B.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>&#160;Pelion Note</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
May 2021, Teal entered into a note agreement totaling $<span id="xdx_900_ecustom--ConvertibleNoteAgreementAmount_c20210501__20220430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zW0nGPfn5GV"><ix:nonFraction name="RCAT:ConvertibleNoteAgreementAmount" contextRef="From2021-05-012022-04-30_custom_DebtObligation2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15152">350,000</ix:nonFraction></span>
which is payable upon demand. The Note bears interest at the applicable
Federal Rate as of the date of the Note which was <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230501__20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zBBW80i8TgBk"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2023-05-012024-04-30_custom_DebtObligation2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-15153">0.13</ix:nonFraction></span>% on the date of issuance. Accrued interest at April 30, 2024 and April 30, 2023
totaled $<span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrent_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zjzEY8KTMgU7"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-04-30_custom_DebtObligation2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15154">1,334</ix:nonFraction> </span>and $<span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrent_iI_c20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zm6eNjeuXGp"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-04-30_custom_DebtObligation2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15155">878</ix:nonFraction></span>,
respectively.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>C.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>&#160;Vendor Agreement</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
connection with the acquisition of Teal on August 31, 2021, the Company assumed an obligation with a contract manufacturing firm. The
assumed balance of $</span><span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20210831__us-gaap--DebtInstrumentAxis__custom--DebtObligation3Member_zLoCAT8gBVyh"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-08-31_custom_DebtObligation3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15156">387,500</ix:nonFraction></span>
was repaid in monthly installments of $<span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPayment_c20210801__20220731_zgiRgvbQ53l2"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2021-08-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15157">37,500</ix:nonFraction></span>
and paid in full in July 2022.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 53; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>D.</b></span></td>
    <td style="width: 97%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>&#160;Corporate Equity</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Beginning
in October 2021, and amended in January 2022, Teal financed a total of $<span id="xdx_90B_ecustom--LeaseholdImprovementAgreementFundsReceived_c20230701__20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zqkKj6PmTUS1"><ix:nonFraction name="RCAT:LeaseholdImprovementAgreementFundsReceived" contextRef="From2023-07-012024-04-30_custom_DebtObligation6Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15158">120,000</ix:nonFraction></span>
of leasehold improvements with Corporate Equity, LLC. The loan bears interest at <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20221001__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zx6kOAetsgPa"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-10-012023-04-30_custom_DebtObligation6Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-15159">8.25</ix:nonFraction></span>%
annually and requires monthly payments of $<span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPayment_c20221001__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zJavIGqWKlx3"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-10-012023-04-30_custom_DebtObligation6Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15160">3,595</ix:nonFraction></span>
through December 2024. The balance outstanding at April 30, 2024 and April 30, 2023 totaled $<span id="xdx_909_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zMXBN1sQ6NUd"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2024-04-30_custom_DebtObligation6Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15161">27,495</ix:nonFraction> </span>
and $<span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zjFvT0ZaU9ib"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2023-04-30_custom_DebtObligation6Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15162">66,586</ix:nonFraction></span>
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="width: 2%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>E.</b></span></td>
    <td style="width: 96%; padding-bottom: 8pt; padding-left: 9pt; text-align: justify; line-height: 105%; text-indent: -9pt"><span style="font-size: 10pt; line-height: 105%"><b>&#160;Ascentium Capital</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
September 2021, Teal entered into a financing agreement with Ascentium Capital to fund the purchase of a fixed asset totaling $<span id="xdx_903_ecustom--FinancingAgreementFundingOfPurchaseOfFixedAsset_c20220901__20220930__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zLiCSUUejGie"><ix:nonFraction name="RCAT:FinancingAgreementFundingOfPurchaseOfFixedAsset" contextRef="From2022-09-012022-09-30_custom_DebtObligation8Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15163">24,383</ix:nonFraction></span>.
Monthly payments of $<span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPayment_c20220901__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zlOXO7Se5X0g"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-09-012023-04-30_custom_DebtObligation8Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15164">656</ix:nonFraction></span>
are payable through October 2024. The balance outstanding at April 30, 2024 and April 30, 2023 totaled $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zOkDuHYgUIY4"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2024-04-30_custom_DebtObligation8Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15165">3,538</ix:nonFraction> </span>
and $<span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zhT0UsZNGXR3"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2023-04-30_custom_DebtObligation8Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15166">11,412</ix:nonFraction></span>
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>F.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>&#160;Summary </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; background-color: white"><span style="background-color: white">Future
annual principal payments at April 30, 2024 were as follows:</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="RCAT:ScheduleOfDebtPaymentsDueTableTextBlock" id="ixv-10987"><table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfDebtPaymentsDueTableTextBlock_z3uP9BcDMky8" summary="xdx: Disclosure - Outstanding principal payments (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-size: 10pt">&#160;</td>
    <td colspan="2" style="text-align: left; font-size: 10pt">Fiscal Year Ended:</td><td>&#160;</td>
    <td colspan="3" id="xdx_496_20240430_z2f3ASuP4Fsj">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--OutstandingPrincipalPaymentsDueYearOne_iI_zbmEsNFx6o97" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 65%; font-size: 10pt; text-align: left">2025</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 30%; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:OutstandingPrincipalPaymentsDueYearOne" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15167">751,570</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--OutstandingPrincipalPaymentsDueLongTerm_iI_zaRHrANgX5L5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">Thereafter</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1119">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--OutstandingPrincipalPaymentsDueTotal_iI_zhiLvdsDxxG5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:OutstandingPrincipalPaymentsDueTotal" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15168">751,570</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_ztdnOvdVdtyl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;<span style="background-color: white">&#160;&#160;&#160;</span></p>

</ix:nonNumeric><p id="xdx_812_z0bB4n54e6ve" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b>&#160;</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="RCAT:RelatedPartyPayablesDisclosureTextBlock" id="ixv-11026"><p id="xdx_803_ecustom--RelatedPartyPayablesDisclosureTextBlock_zFBccIINAv29" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_823_zoxdMGNj6oO8">Note
14 &#8211; Due to Related Party</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
January 2020, in connection with the acquisition of Rotor Riot, the Company assumed a line of credit obligation of the seller, BRIT, LLC,
totaling $<span id="xdx_908_ecustom--LineOfCreditObligationAssumedInConnectionWithAcquisition_c20210101__20230430__us-gaap--DebtInstrumentAxis__custom--DueToRelatedParty2Member_zgqzb5Vdps94"><ix:nonFraction name="RCAT:LineOfCreditObligationAssumedInConnectionWithAcquisition" contextRef="From2021-01-012023-04-30_custom_DueToRelatedParty2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15169">47,853</ix:nonFraction></span> which bore interest at <span id="xdx_900_ecustom--DebtInstrumentInterestRateDuringPeriod1_dp_c20210101__20230430__us-gaap--DebtInstrumentAxis__custom--DueToRelatedParty2Member_zLASTj7puVT1"><ix:nonFraction name="RCAT:DebtInstrumentInterestRateDuringPeriod1" contextRef="From2021-01-012023-04-30_custom_DueToRelatedParty2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-15170">6.67</ix:nonFraction></span>% annually. The remaining balance of $<span id="xdx_90B_ecustom--DueToOtherRelatedPartyClassifiedCurrent_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DueToRelatedParty2Member_z0oxsqoKtiua"><ix:nonFraction name="RCAT:DueToOtherRelatedPartyClassifiedCurrent" contextRef="AsOf2024-04-30_custom_DueToRelatedParty2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15171">37,196</ix:nonFraction></span> plus accrued interest totaling $<span id="xdx_904_ecustom--DebtInstrumentOutstandingAccruedInterestPayment_c20240401__20240430__us-gaap--DebtInstrumentAxis__custom--DueToRelatedParty2Member_zGH9XtXBfGmj"><ix:nonFraction name="RCAT:DebtInstrumentOutstandingAccruedInterestPayment" contextRef="From2024-04-012024-04-30_custom_DueToRelatedParty2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15172">292</ix:nonFraction></span> was paid
in October 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

</ix:nonNumeric><p id="xdx_812_zajriKcbmhfe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock" id="ixv-11040"><p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_zooMVUz7mF72" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_82D_zzTBt38pj7Eb">Note
15 &#8211; Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Our
operating subsidiary, Red Cat Propware, Inc., is incorporated and based in Puerto Rico which is a commonwealth of the United States. We
are not subject to taxation by the United States as Puerto Rico has its own taxing authority. Since inception, we have incurred net losses
in each year of operations. Our current provision for the reporting periods presented in these financial statements consisted of a tax
benefit against which we applied a full valuation allowance, resulting in no current provision for income taxes. In addition, there was
no deferred provision for any of these reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">At
April 30, 2024 and April 30, 2023, we had accumulated deficits of approximately $<span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_dxL_c20240430_zeghuUfkt2nf" title="::XDX::-81130732"><span style="-sec-ix-hidden: xdx2ixbrl1130">81,100,000 </span></span>
and $<span id="xdx_903_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_dxL_c20230430_zJwbxoKBK539" title="::XDX::-57078103"><span style="-sec-ix-hidden: xdx2ixbrl1131">54,600,000</span></span>, respectively. Deferred tax
assets related to the future benefit of these net operating losses for tax purposes totaled approximately $<span id="xdx_900_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_c20240430_zIAUdeilyCT1"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15173">15,004,000</ix:nonFraction> </span> and $<span id="xdx_903_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_c20230430_zxo5Vr9O0oLe"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15174">10,101,000</ix:nonFraction></span>,
respectively, calculated using the base Puerto Rico corporate tax rate of 18.5%.&#160;Currently, we focus on projected future taxable
income in evaluating whether it is more likely than not that these deferred assets will be realized. Based on the fact that we have not
generated an operating profit since inception, we have applied a full valuation allowance against our deferred tax assets at April 30,
2024 and April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

</ix:nonNumeric><p id="xdx_812_z4sonQr7wK7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="ixv-11070"><p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zq3Zxk9zLiH3" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_82F_z1dDSfJeyBg1">Note
16 &#8211; Common Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Our
common stock has a par value of $0.001 per share. We are authorized to issue 500,000,000 shares of common stock. Each share of common
stock is entitled to one vote.&#160;A summary of shares of common stock issued by the Company since April 30, 2022 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" id="ixv-11079"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zZwEuTZUFlwi" summary="xdx: Disclosure - Summary of shares of common stock issued (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><span style="font-size: 9pt; color: Black">Description
    of Shares</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 9pt; color: Black">&#160;</span></td>
    <td colspan="3" id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zRc8LXBmCtQ8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 9pt; color: Black">Shares
    Issued</span></td></tr>
<tr id="xdx_432_c20220501__20230430_eus-gaap--SharesOutstanding_iS_zAl3QjsXiFib" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; width: 70%"><span style="font-size: 10pt">Shares outstanding as of April 30, 2022</span></td><td style="font-size: 9pt; width: 10%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right; width: 18%"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15175">53,748,735</ix:nonFraction></span></td><td style="font-size: 9pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_439_c20220501__20230430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_zQlP30u4qsNd" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; text-indent: -9pt; padding-left: 20pt"><span style="font-size: 10pt">Vesting of restricted
    stock to employees, net of shares withheld of 273,874 to pay taxes and 9,000 to repay a Note</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15176">653,308</ix:nonFraction></span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_432_c20220501__20230430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_zS3saJZRonp9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Vesting of restricted stock to Board
    of Directors</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15177">116,507</ix:nonFraction></span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_436_c20220501__20230430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_zgHPo5WzBwvi" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Vesting of restricted stock to consultants</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15178">9,683</ix:nonFraction></span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_436_c20220501__20230430_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_zyIxJjsCexVe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-size: 10pt">Shares issued
    for services</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15179">39,832</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43B_c20220501__20230430_eus-gaap--SharesOutstanding_iE_zdcyyyjECh9c" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt"><span style="font-size: 10pt">Shares outstanding as of April 30, 2023</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15180">54,568,065</ix:nonFraction></span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43D_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_zzoEsnKJTOsg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to employees,
    net of shares withheld of 27,189 to pay taxes</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15181">192,742</ix:nonFraction></span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_433_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_zKyaDInkZ1b9" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to Board
    of Directors</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15182">252,214</ix:nonFraction></span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_434_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_zCDWbitN80yc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to consultants</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15183">1,761</ix:nonFraction></span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_432_c20230501__20240430_ecustom--StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_zm142xxnAT7c" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Conversion of preferred stock</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15184">818,334</ix:nonFraction></span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43D_c20230501__20240430_ecustom--IssuanceOfCommonStockThroughATMFacilitiesNetShares_zp6G8urM9Dkl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Issuance of common
    stock through ATM facilities</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:IssuanceOfCommonStockThroughATMFacilitiesNetShares" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15185">53,235</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43D_c20230501__20240430_ecustom--StockIssuedDuringPeriodSharesPublicOffering_zHy0mDvCPVK4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Issuance of common
    stock through public offering</span></td><td style="font-size: 9pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; text-align: right"><ix:nonFraction name="RCAT:StockIssuedDuringPeriodSharesPublicOffering" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15186">18,400,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left">&#160;</td></tr>
<tr id="xdx_43C_c20230501__20240430_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_zCG8gXSRjP4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Exercise of stock
    options</span></td><td style="font-size: 9pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15187">3,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left">&#160;</td></tr>
<tr id="xdx_435_c20230501__20240430_eus-gaap--SharesOutstanding_iE_zAq95RZPCJCh" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Shares outstanding as of April 30, 2024</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15188">74,289,351</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A7_zPE3POJNVuMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="background-color: white"><b>ATM Facility</b></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #222222">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">In August 2023,
we entered into a sales agreement (&#8220;the 2023 ATM Facility&#8221;) with ThinkEquity LLC (&#8220;ThinkEquity&#8221;), which provides
for the sale, in our sole discretion, of shares of our common stock through ThinkEquity, as our sales agent. </span><span style="letter-spacing: 0.2pt">In
accordance with the terms of the ATM Sales Agreement, the Company may offer and sell shares of our common stock, par value $0.001 per
share, having an aggregate offering price of up to $4,375,000. </span><span style="background-color: white">The issuance and sale of these
shares by us pursuant to the 2023 ATM Facility are deemed &#8220;at the market&#8221; offerings as defined in Rule 415 under the Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;), and are registered under the Securities Act. We pay a commission of up to
2.5% of gross sales proceeds of any common stock sold under the 2023 ATM Facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">During
the year ended April 30, 2024, we sold an aggregate of 53,235 shares of common stock under the 2023 ATM Facility, at an average price
of $1.07 per share, for gross proceeds of approximately $57,000 and net proceeds of approximately $55,700, after deducting commissions
and other offering expenses payable by us. Additionally, the Company incurred legal fees of approximately $46,000 establishing the 2023
ATM Facility. In December 2023, the Prospectus Supplement dated August 8, 2023 was amended to change the aggregate offering price under
the ATM facility to up to $4,375,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-size: 10pt; background-color: white">As
of April 30, 2024, approximately $4,318,000 of common stock remained available to be sold under the 2023 ATM Facility, subject to certain
conditions as specified in the sales agreement.&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b>Public
Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
December 2023, the Company entered into an underwriting agreement with ThinkEquity LLC, as representative of the underwriters, pursuant
to which the Company agreed to sell to the underwriters in a firm commitment underwritten public offering (the &#8220;Offering&#8221;)
an aggregate of 16,000,000 shares of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), at
a public offering price of $0.50 per share. The Company&#160;also granted the underwriters a 45-day option to purchase up to an additional
2,400,000 shares of Common Stock to cover over-allotments.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
Offering closed on December 11, 2023, resulting in the issuance of 18,400,000 shares of Common Stock </span>which generated gross proceeds
of $9,200,000. <span style="background-color: white">Net proceeds to the Company from the Offering, after deducting the underwriting discount,
the underwriters&#8217; fees and expenses and the Company&#8217;s estimated Offering expenses, were approximately $8,400,000.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

</ix:nonNumeric><p id="xdx_81F_zdlkKpIvESWi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b></b></span></p>

<!-- Field: Page; Sequence: 55; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:PreferredStockTextBlock" id="ixv-11276"><p id="xdx_80E_eus-gaap--PreferredStockTextBlock_zXSg6RLiGw9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_824_zpV74MIsA9n8">Note
17 &#8211; Preferred Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Our
preferred stock has a par value of $0.001 per share. Series B Preferred Stock (&#8220;Series B Stock&#8221;) is convertible into common
stock at a ratio of 0.8334 shares of common stock for each share of Series B Stock held and votes together with the common stock on an
as-if-converted basis. 982,000 shares of Series B Stock were converted into 818,334 shares of common stock in June 2023. Shares outstanding
at April 30, 2024 totaled <span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_c20240430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z0obPeoBusSi"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-04-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15189">4,676</ix:nonFraction> </span> which are convertible into <span id="xdx_90C_ecustom--StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock_c20230501__20240430__us-gaap--StatementClassOfStockAxis__custom--SeriesAPreferredStock2Member_zKwfwhaq735c"><ix:nonFraction name="RCAT:StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" contextRef="From2023-05-012024-04-30_custom_SeriesAPreferredStock2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15190">3,896</ix:nonFraction> </span>
shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

</ix:nonNumeric><p id="xdx_81F_zdx8iNgjW0a3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="RCAT:WarrantsDisclosureTextBlock" id="ixv-11288"><p id="xdx_804_ecustom--WarrantsDisclosureTextBlock_zGRAhGx4Xku5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_822_zZbqF0z2yVmd">Note
18 &#8211; Warrants</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
Company issued 5 year warrants to investors in connection with two convertible note financings. The warrants have an exercise price
of $</span><span id="xdx_90B_ecustom--WarrantsIssuedExercisePrice_c20220401__20220430_zCejfhoYEOpa"><ix:nonFraction name="RCAT:WarrantsIssuedExercisePrice" contextRef="From2022-04-012022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15191">1.50</ix:nonFraction></span>. The warrants were
valued using the multinominal lattice The value of the warrants was included in the determination of the initial accounting for each
financing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">A
summary of the warrants issued and their fair values were:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="RCAT:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock" id="ixv-11301"><table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfWarrantsIssuedAndFairValueTableTextBlock_zbYUho9Xrdlf" summary="xdx: Disclosure - Summary of warrants issued and fair values (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; text-align: center; width: 16%"/><td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; width: 3%"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; text-align: center; width: 16%"/><td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; width: 3%"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%"/><td style="font-size: 10pt; text-align: right; width: 16%"/><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; width: 3%"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; text-align: center; width: 15%"/><td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; width: 3%"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%"/><td style="font-size: 10pt; text-align: right; width: 15%"/><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Upon
    Issuance</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Outstanding at April
    30, 2024</b></span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Date
    of Transaction</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Number
    of Warrants</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Initial
    Fair Value</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Number
    of Warrants</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Fair
    Value</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">October
                                            2020&#160;</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td id="xdx_98B_ecustom--NumberOfWarrantsUponIssuance_c20201001__20201031_zrf8FE8uAXai" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black"><ix:nonFraction name="RCAT:NumberOfWarrantsUponIssuance" contextRef="From2020-10-012020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15192">399,998</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td id="xdx_988_ecustom--InitialFairValueOfWarrantsUponIssuance_c20201001__20201031_zVHJZnweFA2i" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black"><ix:nonFraction name="RCAT:InitialFairValueOfWarrantsUponIssuance" contextRef="From2020-10-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15193">267,999</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td id="xdx_988_ecustom--NumberOfWarrantsOutstanding_iI_c20240430_zcU3YTNrocc2" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black"><ix:nonFraction name="RCAT:NumberOfWarrantsOutstanding" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15194">266,666</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td id="xdx_987_ecustom--FairValueOfWarrantsOutstanding_iI_c20240430_zgGQDHf51rRg" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black"><ix:nonFraction name="RCAT:FairValueOfWarrantsOutstanding" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15195">209,938</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">January
                                            2021</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td id="xdx_98C_ecustom--NumberOfWarrantsUponIssuance_c20210401__20210430_zqoZk596H3Sa" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black"><ix:nonFraction name="RCAT:NumberOfWarrantsUponIssuance" contextRef="From2021-04-012021-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15196">675,000</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td id="xdx_981_ecustom--InitialFairValueOfWarrantsUponIssuance_c20210401__20210430_z0jnE9yWovYf" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black"><ix:nonFraction name="RCAT:InitialFairValueOfWarrantsUponIssuance" contextRef="From2021-04-012021-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15197">2,870,666</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td id="xdx_98B_ecustom--NumberOfWarrantsOutstanding2_iI_c20240430_z4fwvJPyLxcd" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black"><ix:nonFraction name="RCAT:NumberOfWarrantsOutstanding2" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15198">540,000</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td id="xdx_985_ecustom--FairValueOfWarrantsOutstanding2_iI_c20240430_z7Ph1C34RfMa" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black"><ix:nonFraction name="RCAT:FairValueOfWarrantsOutstanding2" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15199">443,242</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>


</ix:nonNumeric><p id="xdx_8AA_zeoq8hguxcca" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="background-color: white">To date,
we have received $</span><span id="xdx_905_ecustom--ProceedsReceivedFromExerciseOfWarrants_c20220301__20220430_zgA8xhD9MCKb"><ix:nonFraction name="RCAT:ProceedsReceivedFromExerciseOfWarrants" contextRef="From2022-03-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15200">301,248</ix:nonFraction>
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">related to the exercise of <span id="xdx_900_ecustom--ExerciseOfWarrantsShares_c20220301__20220430_ztGoxU2DKPN8"><ix:nonFraction name="RCAT:ExerciseOfWarrantsShares" contextRef="From2022-03-012022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15201">268,332</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
May 2021, the Company issued warrants to purchase</span>
<span id="xdx_90A_ecustom--WarrantsToPurchaseSharesIssued_c20220501__20220531_zbkVYr0YrHaa"><ix:nonFraction name="RCAT:WarrantsToPurchaseSharesIssued" contextRef="From2022-05-012022-05-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15202">200,000</ix:nonFraction></span> shares of common stock to the placement agent of its common stock offering.
The warrants have a five-year term and an exercise price of $<span id="xdx_900_ecustom--WarrantsIssuedExercisePrice_c20220501__20220531_zwWNi4oqeZb6"><ix:nonFraction name="RCAT:WarrantsIssuedExercisePrice" contextRef="From2022-05-012022-05-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15203">5.00</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
July 2021, the Company issued warrants to purchase </span><span id="xdx_90E_ecustom--WarrantsToPurchaseSharesIssued_c20230401__20230430_zmb56uvxdgwh"><ix:nonFraction name="RCAT:WarrantsToPurchaseSharesIssued" contextRef="From2023-04-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15204">533,333</ix:nonFraction>
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">shares of common stock to the placement agent of its common stock offering.
The warrants have a five-year term and an exercise price of $<span id="xdx_905_ecustom--WarrantsIssuedExercisePrice_c20230401__20230430_zACHn60xjbR9"><ix:nonFraction name="RCAT:WarrantsIssuedExercisePrice" contextRef="From2023-04-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15205">5.625</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
December 2023, the Company issued warrants to purchase 736,000</span> shares of common stock to the placement agent of its common stock
offering. The warrants have a five-year term and an exercise price of $0.625.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the range of assumptions
used to estimate the fair values of the stock warrants granted during the fiscal years ended April 30:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="ixv-11473"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_zJcU7WkxDr3g" summary="xdx: Disclosure - Assumptions used to estimate fair value of stock warrants granted (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Risk-free interest rate</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 15%; font-size: 10pt; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zQFMb5AWOQp9"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2023-05-012024-04-30_custom_WarrantAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-15206">4.25</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left">%</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 15%; font-size: 10pt; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zWd6PqRFV4fg"><span style="-sec-ix-hidden: xdx2ixbrl1192">&#8212;</span></span>&#160;&#160;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Expected dividend yield</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zqQqSW2KsB2k"><span style="-sec-ix-hidden: xdx2ixbrl1193">&#8212;</span></span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zFMXQHHtWFij"><span style="-sec-ix-hidden: xdx2ixbrl1194">&#8212;</span></span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Expected term (in years)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zu29Ss1ODlQa"><ix:nonNumeric contextRef="From2023-05-012024-04-30_custom_WarrantAssumptionsUsedMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-15207">5.00</ix:nonNumeric></span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Expected volatility</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zMwycctXaBIb"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2023-05-012024-04-30_custom_WarrantAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-15208">205.50</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_z6hX24aKQBRd"><span style="-sec-ix-hidden: xdx2ixbrl1197">&#8212;</span></span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_zwktyI1mTKO1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 56; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the changes in warrants
outstanding since April 30, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="ixv-11545"><table cellspacing="0" cellpadding="0" id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zsdFJDMohnN8" summary="xdx: Disclosure - Changes in warrants outstanding (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td colspan="3"><span style="font-size: 10pt"><b>&#160;</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Shares&#160;</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-average
    Exercise Price per Share</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;Weighted-average
                                            Remaining Contractual Term</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
    years)&#160;</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    Intrinsic Value&#160;</b></span></p></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance as of April 30, 2022</span></td>
    <td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zTW3ZBJWhzde" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-04-30_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15209">1,539,999</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td/>
    <td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zo1SLf91aMLl" style="font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="AsOf2022-04-30_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15210">3.38</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20210501__20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z7rVNAKJOWTi" style="font-size: 10pt"><ix:nonNumeric contextRef="From2021-05-012022-04-30_custom_WarrantsOutstanding1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="ixv-15211">3.89</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zH26NEBRYuvc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2022-04-30_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15212">427,533</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-left: 10pt; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; width: 12%"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_znif4T3RcJua" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1204">&#8212;</span></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right; width: 12%"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zxhPX5rdpN7e" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1205">&#8212;</span></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zPHx8GRBEyVg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1206">&#8212;</span></span></td>
    <td style="border-bottom: black 1pt solid"/>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zvwPqGg9Id1l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1207">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of April 30, 2023</span></td>
    <td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zjvR3ErN3P7i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-04-30_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15213">1,539,999</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td/>
    <td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zfRHpMCEPmwc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="AsOf2023-04-30_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15214">3.38</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zhJ9DYhfua59" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2022-05-012023-04-30_custom_WarrantsOutstanding1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="ixv-15215">2.89</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zFf9i1nIvMRc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1211">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted&#160;</span></td>
    <td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zJY4pO2gXjI9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-05-012024-04-30_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15216">736,000</ix:nonFraction></span><span style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zdiq75j8N6F7"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-05-012024-04-30_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15217">0.63</ix:nonFraction></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zangf3TGQe9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1214">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z1lfEfCZUQNl"><span style="-sec-ix-hidden: xdx2ixbrl1215">&#8212;</span></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at April 30, 2024</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zxpBA2wbZjV7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-04-30_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15218">2,275,999</ix:nonFraction></span></td>
    <td/>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$</span></td>
    <td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zLvgU96LzJdk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="AsOf2024-04-30_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15219">2.49</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z0Ddk3rPDzo6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-05-012024-04-30_custom_WarrantsOutstanding1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="ixv-15220">2.77</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zwAMcfA1BcA1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2024-04-30_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15221">666,080</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_zVB84czH59te" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

</ix:nonNumeric><p id="xdx_811_zqG4wvI5uHrg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="ixv-11846"><p id="xdx_80A_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_z10bcvI9UIt" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_828_zhfV6RI7SuAf">Note
19 &#8211; Share Based Awards</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
2019 Equity Incentive Plan (the "Plan") allows us to incentivize key employees, consultants, and directors with long term compensation
awards such as stock options, restricted stock, and restricted stock units (collectively, the "Awards"). The number of shares
issuable in connection with Awards under the Plan may not exceed <span id="xdx_90E_ecustom--NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum_c20230501__20240430_zpckOMdwMUD8"><ix:nonFraction name="RCAT:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15222">11,750,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"><b><i>A.</i></b></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Options&#160;</i></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
range of assumptions used to calculate the fair value of options granted during the year ended April 30 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="RCAT:ScheduleOfAssumptionsUsed1TableTextBlock" id="ixv-11872"><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfAssumptionsUsed1TableTextBlock_zlJsdOqFLd" summary="xdx: Disclosure - Assumptions used to calculate fair value of options granted (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; font-size: 12pt; padding-bottom: 1pt; padding-left: 5.4pt; width: 51%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%">2024</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 3%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%">2025</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Exercise Price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_znr5WCUPbCP"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2024-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15223">0.72</ix:nonFraction></span>
                                       &#8211; <span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zHbG3tmqs4L"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" contextRef="AsOf2024-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15224">1.12</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zVXfTOgwyk4c"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2023-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15225">0.89</ix:nonFraction></span> &#8211; <span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zkbYGggAn3ea"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" contextRef="AsOf2023-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15226">2.38</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Stock price on date of grant</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zjBycKek9mpk"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" contextRef="AsOf2024-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15227">0.70</ix:nonFraction></span>
                                            &#8211; <span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z0JKFik2vpkc"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" contextRef="AsOf2024-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15228">1.12</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zGtDkv14j5p4"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" contextRef="AsOf2023-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15229">0.89</ix:nonFraction></span> &#8211; <span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zvfA2hkLNG6l"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" contextRef="AsOf2023-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15230">2.38</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"> <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zmXWPdFCN85i"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2023-05-012024-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-15231">3.46</ix:nonFraction></span></span>
                                            &#8211; <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zN2NFFOAl9n6"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2023-05-012024-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-15232">4.41</ix:nonFraction></span>%</td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zul8iVPo6PW7"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-15233">3.34</ix:nonFraction></span> &#8211; <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zBNgmE0Chh0c"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-15234">4.18</ix:nonFraction></span>%</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zjAMVTqHJoDh"><span style="-sec-ix-hidden: xdx2ixbrl1237">&#8212;</span></span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zM3kr2EDyfcb"><span style="-sec-ix-hidden: xdx2ixbrl1238">&#8212;</span></span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zWRksUn4u3Zh"><ix:nonNumeric contextRef="From2023-05-012024-04-30_custom_OptionsAssumptionsUsedMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-15235">5.28</ix:nonNumeric></span>
                                            &#8211; <span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dtY_c20230501__20240430_zNHiDYXCl967"><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" format="ixt-sec:duryear" name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" id="ixv-15236">8.25</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pip0_dtY_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zruNJFgz5wdf"><ix:nonNumeric contextRef="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-15237">6.25</ix:nonNumeric></span> &#8211;<span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_pip0_dtY_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zpwSLuFgA2m5"> <ix:nonNumeric contextRef="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember" format="ixt-sec:duryear" name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" id="ixv-15238">8.25</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zuT1upOL7n9l" style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2023-05-012024-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-15239">206.99</ix:nonFraction></span>
                                            &#8211; <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zvsJVhzHcbQk"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2023-05-012024-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-15240">262.07</ix:nonFraction></span>%</td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zmHcQktbERCa"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-15241">245.57</ix:nonFraction></span> &#8211; <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zhZz3gVuuXPj"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-15242">260.06</ix:nonFraction></span>%</span></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_z3DArA8jR2xd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;&#160;<span style="background-color: white">&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">A
summary of options activity under the Plan since April 30, 2022 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="ixv-11982"><table cellspacing="0" cellpadding="0" id="xdx_894_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_z5BxiEb8u2p4" summary="xdx: Disclosure - Summary of activity under the Plan (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"/>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-Average
    Exercise Price</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-Average
    Remaining Contractual Term</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    Intrinsic Value</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
    as of April 30, 2022</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z9JddxlLgW45" style="text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15243">3,694,142</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zDfQygnCPCS3" style="text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="AsOf2022-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15244">2.17</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; width: 10%"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20210501__20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zGwlEPulhxN" style="font-size: 10pt"><ix:nonNumeric contextRef="From2021-05-012022-04-30_custom_Options1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-15245">8.56</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zbymHYYhCbFf" style="text-align: right; width: 10%"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2022-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15246">1,407,545</ix:nonFraction><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zHVGkEKKMFai" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-05-012023-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15247">1,503,500</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zOWUkHLe1st9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2022-05-012023-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15248">1.40</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zOyBMZy95HX6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1255">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zsBav4TEliq9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1256">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or expired</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zrW8u4ZZ9JLf" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2022-05-012023-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15249">412,833</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zhdPZhIPzwUj" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2022-05-012023-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15250">2.67</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of April
    30, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zRSYnvSeXz3k" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15251">4,784,809</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td/>
    <td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zgq68MUr38H1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="AsOf2023-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15252">1.88</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zB5q62szJRI3" style="font-size: 10pt"><ix:nonNumeric contextRef="From2022-05-012023-04-30_custom_Options1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-15253">8.72</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zvgCYYRYVGSk" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2023-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15254">74,586</ix:nonFraction><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zUlbR3r75jh7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-05-012024-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15255">2,903,542</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zTryk9fE3Q2g" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-05-012024-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15256">1.02</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zpGkhHfXKiOh" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-05-012024-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15257">3,000</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_ziMGzb74CkBa" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2023-05-012024-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15258">0.89</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or expired</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z17Tq6RDB5e7" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2023-05-012024-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15259">905,417</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zt4VdGNJkAPh" style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2023-05-012024-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15260">2.27</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of April
    30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zV9ZP6gH2lVf" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15261">6,779,934</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"/>
    <td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zhOok9YBrO74" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="AsOf2024-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15262">1.46</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zebS582N3eX5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-05-012024-04-30_custom_Options1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-15263">8.02</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"/>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zDC90se1bOvk" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2024-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15264">2,762,242</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable as of April
    30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zgjZ1UjN8Pci" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15265">3,578,756</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zyXxS8pebzn5" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2024-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15266">1.78</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_pip0_dtY_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zgQszYc0IZ06" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-05-012024-04-30_custom_Options1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="ixv-15267">6.77</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zIFtUMZ7G9P5" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" contextRef="AsOf2024-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15268">1,246,497</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A8_zGRmYjvNuSY8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;<span style="background-color: white">&#160;&#160;&#160;&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 57; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
aggregate intrinsic value of outstanding options represents the excess of the stock price at the indicated date over the exercise price
of each option. As of April 30, 2024 and April 30, 2023, there was $<span id="xdx_902_ecustom--UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions_c20230501__20240430_zZoeAsxhxJOd"><ix:nonFraction name="RCAT:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15269">943,648</ix:nonFraction> </span> and $<span id="xdx_903_ecustom--UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions_c20220501__20230430_zcRltzszwp71"><ix:nonFraction name="RCAT:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15270">2,940,239</ix:nonFraction> </span> of unrecognized stock-based compensation expense
related to unvested stock options which is expected to be recognized over the weighted average periods of 1.95 and 1.94 years, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"><b><i>B.</i></b></span></td>
    <td><span style="font-size: 10pt"><b><i>Restricted Stock</i></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">A
summary of restricted stock activity under the Plan since April 30, 2022 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="ixv-12398"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z84tdguiL5Rl" summary="xdx: Disclosure - Summary of restricted stock activity under the Plan (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
<tr style="vertical-align: bottom">
    <td style="padding-left: -10pt; text-align: center"/><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Weighted Average Grant-Date Fair Value Per Share</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt; width: 52%">Unvested and outstanding as of April 30, 2022</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zV8dAXgikZgj" style="text-align: right; width: 20%"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" contextRef="AsOf2021-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15271">1,083,675</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_98B_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zhXB56LbIqZ3" style="text-align: right; width: 20%"><ix:nonFraction name="RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15272">2.59</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z4jVvh0rQXr3" style="text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" contextRef="From2022-05-012023-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15273">780,884</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zHv6OUJbVmt9" style="text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2022-05-012023-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15274">2.14</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zQ8MxyxITMWa" style="text-align: right">(<ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" contextRef="From2022-05-012023-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15275">1,062,372</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zOb6h99Xb7M9" style="text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="From2022-05-012023-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15276">2.42</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zq6ViujPLwkf" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" contextRef="From2022-05-012023-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares" id="ixv-15277">21,127</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zMEAvNtQfW98" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2022-05-012023-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15278">2.13</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Unvested and outstanding as of April 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zf0VHQ1spJak" style="text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" contextRef="AsOf2023-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15279">781,060</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zf5lBVZ5H87k" style="text-align: right"><ix:nonFraction name="RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15280">2.44</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzWnvNEyDM8h" style="text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" contextRef="From2023-05-012024-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15281">298,643</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zc1G6x12U2B4" style="text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-05-012024-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15282">1.06</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zgBw5Arl4w0c" style="text-align: right">(<ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" contextRef="From2023-05-012024-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15283">485,024</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zXvowxgTscu6" style="text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-05-012024-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15284">1.92</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzmxbe74ulea" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" contextRef="From2023-05-012024-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15285">419,549</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zCcY2OlxCoEi" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2023-05-012024-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15286">2.09</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Unvested and outstanding as of April 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 3pt double; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zRbhP7FOc4Rf" style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" contextRef="AsOf2024-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-15287">175,130</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 3pt double; text-align: left">$</td><td id="xdx_98D_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zCQ8YUGgjMm3" style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-15288">2.09</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A5_z49cwLUvr352" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;<span style="background-color: white">&#160;&#160;&#160;&#160;&#160;&#160;</span>&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"><b><i>C.</i></b></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Stock Compensation</i></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Stock
compensation expense by functional operating expense was:</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" id="ixv-12516"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_zthfBHLiJRfg" summary="xdx: Disclosure - Stock compensation expense by functional category (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49A_20230501__20240430_zcIPDrqmhWY1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_492_20220501__20230430_zzGJzJJOam09" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2023</td></tr>
  <tr id="xdx_407_ecustom--ResearchAndDevelopmentStockCompensationExpense_zeYrjtkC57Ki" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Research and development</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:ResearchAndDevelopmentStockCompensationExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15289">395,105</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:ResearchAndDevelopmentStockCompensationExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15290">692,947</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--SalesAndMarketingStockCompensationExpense_zbYC6Vzdfuc4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Sales and marketing</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:SalesAndMarketingStockCompensationExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15291">562,110</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:SalesAndMarketingStockCompensationExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15292">566,153</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--GeneralAndAdministrativeStockCompensationExpense_zXISc5acHtK5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">General and administrative</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:GeneralAndAdministrativeStockCompensationExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15293">2,652,052</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:GeneralAndAdministrativeStockCompensationExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15294">2,397,624</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--TotalStockCompensationExpense_zGbdAjOOIZx2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:TotalStockCompensationExpense" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15295">3,609,267</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:TotalStockCompensationExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15296">3,656,724</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock compensation expense pertaining to options totaled
$<span id="xdx_906_ecustom--StockCompensationExpensePertainingToOptions_c20230501__20240430_z8umk4xuPXQ4"><ix:nonFraction name="RCAT:StockCompensationExpensePertainingToOptions" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15297">2,619,501</ix:nonFraction> </span> and
$<span id="xdx_90F_ecustom--StockCompensationExpensePertainingToOptions_c20220501__20230430_zjbpv0lroDOg"><ix:nonFraction name="RCAT:StockCompensationExpensePertainingToOptions" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15298">1,617,982</ix:nonFraction> </span> for the year ended April 30, 2024 and 2023, respectively. Stock compensation expense pertaining to restricted
stock totaled $<span id="xdx_90E_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20230501__20240430_zYVyrNIfyO0l"><ix:nonFraction name="RCAT:StockCompensationExpensePertainingToRestrictedStockUnits" contextRef="From2023-05-01to2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15299">989,766</ix:nonFraction></span> and $<span id="xdx_901_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20220501__20230430_zA1TpSTKGV4j"><ix:nonFraction name="RCAT:StockCompensationExpensePertainingToRestrictedStockUnits" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-15300">2,038,742</ix:nonFraction> </span>  for the year ended April 30, 2024 and 2023, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric></ix:nonNumeric><p id="xdx_81A_zQcereuLtnm4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="ixv-12573"><p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zCeuTJOA1JFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_822_zmrto8EkK6Q7">Note
20 - Related-Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
January 2022, the Company entered into a note agreement with an employee in the principal amount of $510,323, as further described in
Note 7.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
February 2024, the Company sold Rotor Riot and Fat Shark to Unusual Machines, as further described in Note 3 and Note 9. UMAC&#8217;s
Chief Executive Officer is a direct relative of a member of the Company&#8217;s management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Additional
related party transactions are disclosed in Note 14.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

</ix:nonNumeric><p id="xdx_819_z4wAb4ldJnjc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b></b></span></p>

<!-- Field: Page; Sequence: 58; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="ixv-12603"><p id="xdx_80B_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zjcUp5DmeAv3" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt; background-color: white"><b><span id="xdx_82D_zb3uvmSSls8d">Note
21 &#8211; Commitments and Contingencies</span>&#160;</b></span><span style="font-size: 8pt; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt/11.75pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="background-color: white">In
the ordinary course of business, we may be involved, at times, in various legal proceedings involving a variety of matters. We do not
believe there are any pending legal proceedings that will have a material adverse effect on our business, consolidated financial position,
results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant
uncertainties. We have not recorded any litigation reserves as of&#160;April 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">One pending
legal matter is an action filed against Teal and the Company in a U.S. District Court in California.&#160;The complaint asserts claims
for breach of contract, and the unlawful conversion and sale of shares of common stock that plaintiff alleges to have purchased in Teal
prior to its acquisition by the Company. The complaint also alleges breach of fiduciary duty and seeks in excess of $1 million in damages.
The Company plans to vigorously assert defenses to the complaint.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Another pending legal matter is an action filed against
Teal in a U.S. District Court in Delaware. The complaint asserts claims for breach of contract which management denies. We are asserting
vigorous defenses to the complaint. Additionally, the Company has filed a lawsuit against the complainant for Tortious Interference with
Contractual Relations and Prospective Contractual Relations. No discovery or other significant developments in the Lawsuit have occurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="background-color: yellow"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

</ix:nonNumeric><p id="xdx_81C_zod0efAKpOj3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2024-04-30" escape="true" name="us-gaap:SubsequentEventsTextBlock" id="ixv-12626"><p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zYDkfI5lm2B4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_82A_zTmqKKtFM0dg">Note
22 &#8211; Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Subsequent events have been evaluated
through the date of this filing and there are no subsequent events which require disclosure, except as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">As described in Note 3, the SPA pertaining
to the divestiture of the Consumer segment provided that the purchase price was to be increased on a dollar-for-dollar basis by the amount
by which the working capital exceeded the agreed working capital (the &#8220;Working Capital Adjustment&#8221;). After negotiations between
the parties, it was determined in July 2024 that UMAC owed the Company $2,000,000 as a Working Capital Adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">As a result, UMAC issued the Company
$4,000,000 of its 8% Promissory Notes due November 30, 2025 (the &#8220;New Notes&#8221;) reflecting (i) satisfaction and settlement of
working capital adjustments and (ii) a maturity date extension to November 30, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">On July 22, 2024, the Company sold
all of its securities in UMAC to two unaffiliated third-party purchasers (the &#8220;Purchasers&#8221;). As part of the transaction,
on July 22, 2024, the Company entered into an Exchange Agreement (the &#8220;Exchange Agreement&#8221;) with UMAC pursuant to which the
Company exchanged 4,250,000 shares of UMAC&#8217;s common stock, par value $0.001 per share, for 4,250 shares of UMAC&#8217;s newly designated
Series A Convertible Preferred Stock (the &#8220;Series A&#8221;). The Company sold the Series A and the New Notes to the Purchasers
for $4.4 million in cash pursuant to a Purchase Agreement in a transaction that closed on July 22, 2024.</span></p>

</ix:nonNumeric><p id="xdx_810_z9gyYFyODz1a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 59; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-variant: small-caps"><b><span id="ChangesAndDisagreements"></span>ITEM 9.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There were no changes in or disagreements with accountants
on accounting and financial disclosure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="ControlsAndProcedures"></span><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-variant: small-caps"><b>ITEM 9A.
CONTROLS AND PROCEDURES</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-variant: small-caps"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Disclosure Controls and Procedures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our management, with the participation of our CEO
(principal executive officer) and CFO (principal financial officer), has evaluated the effectiveness of the Company&#8217;s disclosure
controls and procedures, as defined in Rule 13a-15(e) and 15d-15(e) of the Exchange Act, as of April 30, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The term &#8220;disclosure controls and procedures&#8221;
as defined in Rules 13a-15(e) and 15d-15(e) means controls and other procedures of the Company that are designed to ensure that information
required to be disclosed by the Company in reports, such as this report, that it files or submits under the Exchange Act is recorded,
processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures
include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the
reports that it files or submits under the Exchange Act is accumulated and communicated to the Company&#8217;s management, including its
principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions
regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide
only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit
relationship of possible controls and procedures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Based on that evaluation,
our CEO and CFO concluded that our disclosure controls and procedures were effective as of April 30, 2024. </span><span style="font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Management's annual report on internal control
over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our management is responsible for establishing and
maintaining adequate internal control over financial reporting. Our internal control over financial reporting is designed to provide reasonable
assurances regarding the reliability of financial reporting and the preparation of our consolidated financial statements in accordance
with GAAP. Our accounting policies and internal controls over financial reporting, established and maintained by management, are under
the general oversight of the Board&#8217;s audit committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our internal control over financial reporting includes
those policies and procedures that:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures are being made only in accordance with authorizations of our management and directors; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#149;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the financial statements.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Because of its inherent limitations, internal control
over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods
are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree or compliance with the
policies or procedures may deteriorate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management assessed our internal control over financial
reporting as of April 30, 2024. The standard measures adopted by management in making its evaluation are the measures in the Internal-Control
Integrated Framework published by the Committee of Sponsoring Organizations (&#8220;COSO&#8221;) of the Treadway Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 60; Options: NewSection; Value: 60 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Based on management&#8217;s assessment using the
COSO criteria, our CEO and CFO concluded that our internal control over financial reporting was not effective, specifically
pertaining to the year ended April 30, 2023 for which we restated items related to right of use assets and liabilities as well as
the removal of the derivative liabilities. The Company is currently in the process of formalizing narratives and processes which are
expected to mitigate these weaknesses, and has hired additional personnel to strengthen the internal control environment.&#160;</p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Attestation Report of the Registered Public Accounting
Firm.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Because the Company is a non-accelerated filer, this
annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial
reporting. Management&#8217;s report was not subject to attestation by our registered public accounting firm pursuant to rules of the
SEC where registrants that are non-accelerated filers are not required to provide the auditor attestation report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Changes In Controls Over Financial Reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">There were no changes
in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during the year ended
April 30, 2024, that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.</span><span style="font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-variant: small-caps"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-variant: small-caps"><b><span id="OtherInformation"></span>ITEM 9B.
OTHER INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">During the fiscal
quarter ended April 30, 2024, none of our directors or executive officers&#160;adopted&#160;or&#160;terminated&#160;any contract, instruction
or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule
10b5-1(c) or any "non-Rule 10b5-1 trading arrangement."</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-variant: small-caps"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="ForeignJurisdictions"></span>ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS
THAT PREVENT INSPECTIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">Not applicable</span>.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PART III</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-variant: small-caps"><b><span id="DirectorsAndExecutiveOfficers"></span>ITEM 10.
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The information required
by this Item 10 will be included under the captions &#8220;Board of Directors and Corporate Governance,&#8221; &#8220;Executive Officers,&#8221;
and &#8220;Delinquent Section 16(a) Reports&#8221; in our definitive Proxy Statement for the 2024 Annual Meeting of Stockholders to be
filed with the SEC within 120 days after the end of our fiscal year (the &#8220;Proxy Statement&#8221;) and is incorporated herein by
reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15.75pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">We have adopted a Corporate
Code of Conduct and Ethics applicable to our directors, officers and employees which is designed to deter wrongdoing and to promote:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">honest and ethical conduct;</span></td></tr></table>

<p style="font: 13.5pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">full, fair, accurate, timely and understandable disclosure in reports and
documents that we file with the SEC and in our other public communications;</span></td></tr></table>

<p style="font: 13.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">compliance with applicable laws, rules and regulations, including insider
trading compliance; and</span></td></tr></table>

<p style="font: 13.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-size: 10pt">accountability for adherence to the code and prompt internal reporting of
violations of the code, including illegal or unethical behavior regarding accounting or auditing practices.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">You may obtain a copy of
our Corporate Code of Conduct and Ethics on our website at&#160;<i>www.redcat.red</i>&#160;under Company &#8212;&#160;Investor Relations&#160;&#8212;&#160;Governance
&#8212;&#160;Governance Documents. The Compliance Committee, which is composed of our Chief Executive Officer and Chief Financial Officer,
is responsible for reviewing the Corporate Code of Conduct and Ethics and amending as necessary. Any amendments will be disclosed on our
website.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/110% Times New Roman, Times, Serif; margin: 0 5.25pt 0 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 61; Value: 59 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt/110% Times New Roman, Times, Serif; margin: 0 5.25pt 0 0; text-align: justify"><span id="ExecutiveCompensation"></span><b>ITEM 11. EXECUTIVE COMPENSATION<span style="font-variant: small-caps">&#160;</span></b></p>

<p style="font: 10pt/110% Times New Roman, Times, Serif; margin: 0 5.25pt 0 2.5pt; text-align: justify; text-indent: -0.25pt"><span style="font-variant: small-caps"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The information required
by this Item 11 will be included under the captions &#8220;Director Compensation Table,&#8221; &#8220;Non-Employee Director Compensation
Arrangements,&#8221; and "Executive Compensation" in the Proxy Statement and is incorporated herein by reference.</p>

<p style="font: 10pt/110% Times New Roman, Times, Serif; margin: 0 5.25pt 0 2.5pt; text-align: justify; text-indent: -0.25pt"><span style="font-variant: small-caps"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="SecurityOwnership"></span>ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The information
required by this Item 12 will be included under the captions &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221;
and &#8220;2019 Equity Incentive Plan&#8221; in the Proxy Statement and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="CertainRelationships"></span>ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS,
AND DIRECTOR INDEPENDENCE </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The information
required by this Item 13 will be included under the captions &#8220;Certain Relationships and Related Transactions, and Director Independence,&#8221;
</span>&#8220;Director Compensation Table,&#8221; &#8220;Non-Employee Director Compensation Arrangements,&#8221; and &#8220;Executive
Compensation&#8221; <span style="background-color: white">in the Proxy Statement and is incorporated herein by reference.</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="PrincipalAccountantFeesAndServices"></span><b>ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white">The information required by this
Item 14 will be included under the caption &#8220;Fees Paid to Auditors&#8221; in the Proxy Statement and is incorporated herein by reference.</span>&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;<span style="font-variant: small-caps"><b>PART
IV</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span id="Exhibits"></span><b>ITEM 15</b></span><span style="font-size: 8pt">&#160;&#160;</span><span style="font-size: 10pt"><b>.
EXHIBITS, FINANCIAL STATEMENTS SCHEDULES.</b></span><span style="font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Exhibit
    No.</b></span></td>
    <td style="vertical-align: bottom; width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 86%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Description</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479519000202/tfvr0702def14c.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.1</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479519000202/tfvr0702def14c.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Amended
    and Restated Articles of Incorporation, dated July 17, 2019 (incorporated by reference to Exhibit B to the Company&#8217;s Schedule
    14C Information Statement filed with the SEC on July 2, 2019)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479517000052/tfvr0207forms1exh3_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.2</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479517000052/tfvr0207forms1exh3_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Bylaws
    (incorporated by reference to Exhibit 3.2 to the Company&#8217;s Registration Statement on Form S-1 filed with the SEC on February
    8, 2017)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479518000371/tfvr1212form8kexh3_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.3</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479518000371/tfvr1212form8kexh3_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Certification
    of Designation of Series A Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form
    8-K filed with the SEC on December 12, 2018)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479518000371/tfvr1212form8kexh3_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.4</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479518000371/tfvr1212form8kexh3_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Certification
    of Designation of Series E Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report
    on Form 8-K filed with the SEC on December 12, 2018)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479518000371/tfvr1212form8kexh3_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.5</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479518000371/tfvr1212form8kexh3_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Amendment
    No. 1 to Certification of Designation of Series E Convertible Preferred Stock (incorporated by reference to Exhibit 3.2 to the Company&#8217;s
    Current Report on Form 8-K filed with the SEC on December 12, 2018)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479519000143/tfvr0515form8kexh3_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.6</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479519000143/tfvr0515form8kexh3_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Certificate
    of Withdrawal, dated May 13, 2019 of Certification of Designation of the Series A Preferred Stock, dated December 6, 2018, Series
    E Convertible Preferred Stock, dated January 3, 2018 and the Amendment to the Certification of Designation of the Series E Convertible
    Preferred Stock, dated January 3, 2018 (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K
    filed with the SEC on May 16, 2019)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479519000143/tfvr0515form8kexh3_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.7</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479519000143/tfvr0515form8kexh3_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Certification
    of Designation of Series A Preferred Stock, dated May 10, 2019 (incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current
    Report on Form 8-K filed with the SEC on May 16, 2019)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479519000143/tfvr0515form8kexh3_3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.8</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479519000143/tfvr0515form8kexh3_3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Certification
    of Designation of Series B Preferred Stock, dated May 10, 2019 (incorporated by reference to Exhibit 3.3 to the Company&#8217;s Current
    Report on Form 8-K filed with the SEC on May 16, 2019)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479520000206/rcat0811form10kexh4_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4.1</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479520000206/rcat0811form10kexh4_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Description
    of Capital Stock (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on
    August 13, 2020)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="rcat0808form10kexh4_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4.2#*</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="rcat0808form10kexh4_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Form
    of Stock Option Agreement</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="rcat0808form10kexh4_3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4.3#*</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="rcat0808form10kexh4_3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Form
    of Restricted Share Unit Award Agreement</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="rcat0808form10kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.1#*</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="rcat0808form10kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2019
Equity Incentive Plan</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000181/rcat0518form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.2#</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000181/rcat0518form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">First
    Amendment to Executive Employment Agreement with Jeffrey Thompson (incorporated by reference to Exhibit 10.1 to the Company&#8217;s
    Current Report on Form 8-K filed with the SEC on May 22, 2023).</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000181/rcat0518form8kexh10_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.3#</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000181/rcat0518form8kexh10_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">First
    Amendment to Executive Employment Agreement with Allan Evans (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current
    Report on Form 8-K filed with the SEC on May 22, 2023).</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000213/rcat0712form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.4</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000213/rcat0712form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Amendment
    No. 2 to Share Purchase Agreement Amendment dated March 31, 2023 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s
    Current Report on Form 8-K filed with the SEC on July 14, 2023).</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000213/rcat0712form8kexh10_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.5</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000213/rcat0712form8kexh10_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Form
    of Registration Rights Agreement (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed
    with the SEC on July 14, 2023).</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"/></tr></table>

<!-- Field: Page; Sequence: 62; Value: 59 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; width: 12%"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000251/rcat0807form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.6</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 86%"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000251/rcat0807form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">ATM
    Sales Agreement with ThinkEquity LLC (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K
    filed with the SEC on August 8, 2023).</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000366/rcat1207form8kexh1_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.7</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000366/rcat1207form8kexh1_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Underwriting
    Agreement (incorporated by reference to Exhibit 1.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December
    8, 2023).</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000369/rcat1215form10qexh10_3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.8</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000369/rcat1215form10qexh10_3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Amendment
    No. 3 to Share Purchase Agreement dated September 18, 2023 (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Quarterly
    Report on Form 10-Q filed with the SEC on December 15, 2023)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000371/rcat1215form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.9</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000371/rcat1215form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Amendment
    No. 4 to Share Purchase Agreement with Unusual Machines, Inc. (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current
    Report on Form 8-K filed with the SEC on December 15, 2023)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000371/rcat1215form8kexh10_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.10</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000371/rcat1215form8kexh10_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Form
    of 8% Promissory Note from Unusual Machines, Inc. (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report
    on Form 8-K filed with the SEC on December 15, 2023)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000020/rcat0220form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.11</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000020/rcat0220form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">8%
Promissory Note from Unusual Machines, Inc. (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form
8-K filed with the SEC on February 22, 2024)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000371/rcat1215form8kexh10_3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.12</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000371/rcat1215form8kexh10_3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Form
    of Registration Rights Agreement with Unusual Machines, Inc. (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current
    Report on Form 8-K filed with the SEC on December 15, 2023)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000020/rcat0220form8kexh10_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.13</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000020/rcat0220form8kexh10_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Registration
    Rights Agreement with Unusual Machines, Inc. (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on
    Form 8-K filed with the SEC on February 22, 2024)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000020/rcat0220form8kexh10_3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.14</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000020/rcat0220form8kexh10_3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Non-Competition
    Agreement with Unusual Machines, Inc., Rotor Riot, LLC, and Fat Shark Holdings, Ltd. (incorporated by reference to Exhibit 10.3 to
    the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 22, 2024)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000020/rcat0220form8kexh10_4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.15</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000020/rcat0220form8kexh10_4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Non-Compete
    agreement with Allan Evans (incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed with
    the SEC on February 22, 2024)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"/></tr></table>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; width: 12%"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000063/rcat0318form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.16#</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 86%"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000063/rcat0318form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Addendum
    to Executive Employment Agreement with Joseph Hernon &#160;(incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly
    Report on Form 10-Q filed with the SEC on March 18, 2024)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000063/rcat0318form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.17#</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000063/rcat0318form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Addendum
    #2 to&#160;Executive Employment&#160;Agreement, between Joseph Hernon and the Company, dated March 15, 2024 (incorporated by reference
    to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 18, 2024)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000063/rcat0318form8kexh10_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.18#</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000063/rcat0318form8kexh10_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Consulting
Services Agreement, between Joseph Hernon and the Company, dated March 15, 2024 (incorporated by reference to Exhibit 10.2 to the Company&#8217;s
Current Report on Form 8-K filed with the SEC on March 18, 2024)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="rcat0808form10kexh21_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">21.1*</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="rcat0808form10kexh21_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">List
    of Subsidiaries</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000251/rcat0807form8kexh5_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">23.1</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479523000251/rcat0807form8kexh5_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Consent
    of The Crone Law Group, P.C. (incorporated by reference to Exhibit 23.1 to the Company&#8217;s Current Report on Form 8-K filed with
    the SEC on August 8, 2023)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">23.2*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Consent
    of dbbmckennon</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="rcat0808form10kexh31_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">31.1*</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="rcat0808form10kexh31_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Certification
    of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the
    Sarbanes-Oxley Act of 2002</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="rcat0808form10kexh31_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">31.2*</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="rcat0808form10kexh31_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Certification
    of Principal Financial and Accounting Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section
    302 of the Sarbanes-Oxley Act of 2002</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="rcat0808form10kexh32_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">32.1**</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="rcat0808form10kexh32_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Certification
    of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="rcat0808form10kexh32_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">32.2**</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="rcat0808form10kexh32_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Certification
    of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="rcat0808form10kexh97_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">97.1*</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="rcat0808form10kexh97_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Clawback
Policy</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">101.INS*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Inline
    XBRL Instance Document</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">101.SCH*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Inline
    XBRL Schema Document</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">101.CAL*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Inline
    XBRL Calculation Linkbase Document</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">101.LAB*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Inline
    XBRL Label Linkbase Document</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">101.PRE*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Inline
    XBRL Presentation Linkbase Document</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">101.DEF*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Inline
    XBRL Definition Linkbase Document</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">104*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cover
    Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr>
  </table>
<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0">* &#160;&#160;&#160;&#160;&#160;Filed herewith.</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0"><span style="background-color: white">**&#160;&#160;&#160;&#160;Furnished
herewith.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white">#&#160;&#160;&#160;&#160;&#160;&#160;Indicates
management contract or compensatory plan.</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><span id="SummaryInformation"></span><b>ITEM 16. FORM 10-K SUMMARY</b></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">Not applicable.</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;&#160;</p>

<!-- Field: Page; Sequence: 63; Value: 74 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="Signatures"></span><b>SIGNATURES</b></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-indent: 3in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of Section 13 or 15(d)
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunder
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Red Cat Holdings, Inc.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 54%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Dated: August 8, 2024</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt"><b>/</b>s/ Jeffrey Thompson</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Jeffrey Thompson</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Chief Executive Officer and President</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(Principal Executive Officer)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities Exchange
Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates
indicated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>Name</b></span></td>
    <td style="vertical-align: top; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>Title</b></span></td>
    <td style="vertical-align: top; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">/s/ Jeffrey M. Thompson</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Chief Executive Officer, President and Director</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">August 8, 2024</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Jeffrey M. Thompson</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">(Principal Executive Officer)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">/s/ Leah Lunger</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Chief Financial Officer, Treasurer and Secretary</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">August 8, 2024</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Leah Lunger</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">(Principal Financial and Accounting Officer)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">/s/ Nicholas Liuzza, Jr.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Director </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">August 8, 2024</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Nicolas Liuzza, Jr.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">/s/ Christopher Moe</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Director</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">August 8, 2024</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;Christopher Moe</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">/s/ Joseph Freedman</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Director</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">August 8, 2024</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Joseph Freedman</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">/s/ Paul Edward Funk II</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Director</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">August 8, 2024</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 10pt">Paul Edward Funk II</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">64</p>



</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>rcat0808form10kexh4_2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.2</B></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">RED CAT HOLDINGS, INC.<BR>
STOCK OPTION GRANT NOTICE AND OPTION AGREEMENT<BR>
(2019 Equity Incentive Plan)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As a key leader in our
business, you are in a position to have significant influence on the performance and success of Red Cat Holdings, Inc. (the &ldquo;<B>Company</B>&rdquo;).
I am pleased to inform you that, in recognition of the role you play in our collective success, you have been granted an option to purchase
shares of the Company&rsquo;s Common Stock. This award is subject to the terms and conditions of the Red Cat Holdings, Inc. 2019 Equity
Incentive Plan, this Grant Notice, and the following Stock Option Agreement. The details of this award are indicated below.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif">Optionee:</TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif">Date of Grant:</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif">Number of Shares subject to the Option:</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif">Exercise Price Per Share:</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">$___________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif">Type of Option:</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 12pt/115% Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: MS Gothic, Helvetica, Sans-Serif">&#9744;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">ISO</FONT></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: MS Gothic, Helvetica, Sans-Serif">&#9744;</FONT>Nonqualified
    Stock Option</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif">Expiration Date:</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">The tenth (10<SUP>th</SUP>) anniversary of the Date of Grant</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif">Vesting:</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-variant: small-caps">Red Cat Holdings, Inc.</FONT>, a
Nevada corporation</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">By:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Its:</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">RED CAT HOLDINGS, INC</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">2019 EQUITY INCENTIVE PLAN</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">STOCK OPTION AGREEMENT</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">THIS STOCK OPTION AGREEMENT
(together with the above grant notice (the &ldquo;<B>Grant Notice</B>&rdquo;), the &ldquo;<B>Agreement</B>&rdquo;) is made and entered
into as of the date set forth on the Grant Notice by and between Red Cat Holdings, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;),
and the individual (the &ldquo;<B>Optionee</B>&rdquo;) set forth on the Grant Notice.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">A.&#9;Pursuant to the Red
Cat Holdings Inc. 2019 Equity Incentive Plan (the &ldquo;<B>Plan</B>&rdquo;), the Administrator has determined that it is to the advantage
and best interest of the Company to grant to the Optionee an option to purchase the number of Shares (the &ldquo;<B>Shares</B>&rdquo;)
set forth on the Grant Notice, at the exercise price per Share set forth on the Grant Notice, and in all respects subject to the terms,
definitions and provisions of the Plan, which is incorporated herein by reference, and this Agreement (the &ldquo;<B>Option</B>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">B.&#9;Unless otherwise
defined herein, capitalized terms used in this Agreement shall have the meanings set forth in the Plan. For purposes of this Agreement,
the following definitions shall apply:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(i) &quot;<B>Disability</B>&rdquo;
shall mean the inability of the Optionee to perform services to the Company due to injury or illness.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(ii) &ldquo;<B>Termination</B>&rdquo;
shall mean the termination of the employment or service of the Optionee with the Company and all Affiliates thereof (including because
of the Optionee&rsquo;s employer ceasing to be an affiliate of the Company). For purposes of this Agreement, Termination will not occur
when Optionee goes on a military leave, a sick leave, or another bona fide leave of absence that was approved by the Company in writing,
<I>provided that</I> unless reemployment upon the expiration of such leave is guaranteed by contract or law, such leave is for a period
of not more than 3 months; and <I>provided that</I> continued service crediting may be suspended during such leave, unless otherwise required
by Applicable Laws. However, Termination will occur when approved leave described in this section ends, unless Grantee immediately returns
to active work. Notwithstanding the foregoing, in no event shall an Option be exercised after the Expiration Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(iii) &ldquo;<B>Termination
Date</B>&rdquo; shall mean the date of the Optionee&rsquo;s Termination of Service.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the mutual agreements contained herein, the Optionee and the Company hereby agree as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Acceptance of Agreement</U>. Optionee has reviewed all of the provisions of the Plan and this Agreement. Optionee hereby agrees
to accept as binding, conclusive and final all decisions or interpretations of the Administrator on questions relating to the Plan and
this Agreement, and, solely as they relate to this Option, the applicable provisions (if any) contained in a written service agreement
(or other agreement) between the Company or an Affiliate and the Optionee. The Optionee&rsquo;s electronic signature of this Agreement
shall have the same validity and effect as a signature affixed by hand.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Grant and Terms of Stock Option</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">2.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Grant of Option</U>. Pursuant to this Agreement, the Company has granted to the Optionee the right and option to purchase, subject
to the terms and conditions set forth in the Plan and this Agreement, all or any part of the number of Shares set forth on the Grant Notice
at a purchase price per Share equal to the exercise price per Share set forth on the Grant Notice. An Option granted pursuant to the Grant
Notice and this Agreement shall be [an ISO/a Nonqualified Stock Option].</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">2.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Vesting and Term of Option</U>. This Section 2.2 is subject to the provisions of the Plan and the other provisions of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">2.2.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>This Option shall vest and become exercisable as described in the Grant Notice.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">2.2.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The &ldquo;<B>Term</B>&rdquo; of this Option shall begin on the Date of Grant set forth in the Grant Notice and end on the Expiration
Date specified in the Grant Notice. No portion of this Option may be exercised after the expiration of the Term.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">2.2.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as otherwise provided in the Grant Notice, in the event of Optionee&rsquo;s Termination for any reason other than death,
Disability, or Cause:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">2.2.3.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;
</FONT>the portion of this Option that is not vested and exercisable as of the Termination Date shall not continue to vest and shall be
immediately cancelled and terminated; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">2.2.3.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;
</FONT>the portion of this Option that is vested and exercisable as of the Termination Date shall terminate and be cancelled on the earlier
of:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the expiration of the Term and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>ninety (90) days after such Termination Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">2.2.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as otherwise provided in the Grant Notice, in the event of Termination due to death or Disability:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">2.2.4.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;
</FONT>the portion of this Option that is not vested and exercisable as of the Termination Date shall not continue to vest and shall be
immediately cancelled and terminated; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1.5in">2.2.4.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;
</FONT>the portion of this Option that is vested and exercisable as of the Termination Date shall terminate and be cancelled on the earlier
of (a) the expiration of the Term and (b) the date that is twelve (12) months after the Termination Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">2.2.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event of Optionee&rsquo;s Termination for Cause, or if, after the Termination, the Administrator determines that Cause existed
before such Termination, this entire Option shall not continue to vest, shall be cancelled and terminated as of the Termination Date,
and shall no longer be exercisable as to any Shares, whether or not previously vested.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Method of Exercise</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">3.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Method of Exercise</U>. Each election to exercise the Option shall be subject to the terms and conditions of the Plan and shall
be in writing, signed by the Optionee or by his or her executor, administrator, or permitted transferee (subject to any restrictions provided
under the Plan), made pursuant to and in accordance with the terms and conditions set forth in the Plan and received by the Company at
its principal offices, accompanied by payment in full as provided in the Plan or in this Agreement. Notwithstanding any of the foregoing,
the Administrator shall have the right to specify all conditions of the manner of exercise. Upon the Company&rsquo;s determination that
the Option has been validly exercised as to any of the Shares, the Company may issue certificates in the Optionee&rsquo;s name for such
Shares. However, the Company shall not be liable to the Optionee for damages relating to any reasonable delays in issuing the certificates
to the Optionee, any loss of the certificates, or any mistakes or errors in the issuance of the certificates or in the certificates themselves
which it promptly undertakes to correct.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">3.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Restrictions on Exercise</U>. No Shares will be issued pursuant to the exercise of this Option unless and until there shall
have been full compliance with all applicable requirements of the Securities Act of 1933 (&ldquo;<B>Securities Act</B>&rdquo;), as amended
(whether by registration or satisfaction of exemption conditions), all applicable listing requirements of any national securities exchange
or other market system on which the Common Stock is then listed and all applicable requirements of any Applicable Laws and of any regulatory
bodies having jurisdiction over such issuance. As a condition to the exercise of this Option, the Company may require the Optionee to
make any representation and warranty to the Company as may be necessary or appropriate, in the judgment of the Administrator, to comply
with any Applicable Law. In addition, Optionee shall not sell any Shares acquired upon exercise of this Option at a time when Applicable
Laws, regulations or Company&rsquo;s or underwriter trading policies prohibit such sale. Any other provision of this Agreement notwithstanding,
the Company shall have the right to designate one or more periods of time, each of which shall not exceed 180 days in length, during which
this Option shall not be exercisable if the Administrator determines (in its sole discretion) that such limitation on exercise could in
any way facilitate a lessening of any restriction on transfer pursuant to the Securities Act or any state securities laws with respect
to any issuance of securities by the Company, facilitate the registration or qualification of any securities by the Company under the
Securities Act or any state securities laws, or facilitate the perfection of any exemption from the registration or qualification requirements
of the Securities Act or any applicable state securities laws for the issuance or transfer of any securities. Such limitation on exercise
shall not alter the vesting schedule set forth in this Agreement other than to limit the periods during which this Option shall be exercisable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">3.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Method of Payment</U>. Payment of the exercise price shall be made in full at the time of exercise (a) by the delivery of cash
or check acceptable to the Administrator, including an amount to cover the withholding taxes (as provided in Section 7.12) with respect
to such exercise, or (b) any other method, if any, approved by the Administrator, including (i)&nbsp;by means of consideration received
under any cashless exercise procedure, if any, approved by the Administrator (including the withholding of Shares otherwise issuable upon
exercise) or (ii)&nbsp;any other form of consideration approved by the Administrator and permitted by Applicable Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">3.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Rights as a Shareholder</U>. Until the Shares are issued to the Optionee (as evidenced by the appropriate entry on the books
of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a
shareholder will exist with respect to the Shares, notwithstanding the exercise of the Option.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Non-Transferability of Option</U>. Except as provided below, this Option may not be sold, assigned or transferred in any manner,
pledged or otherwise encumbered other than by will or by the laws of descent or distribution or to a beneficiary designated pursuant to
the Plan, and may be exercised during the lifetime of Optionee only by Optionee or the Optionee&rsquo;s guardian or legal representative.
Subject to all of the other terms and conditions of this Agreement, following the death of Optionee, this Option may, to the extent it
is vested and exercisable by Optionee in accordance with its terms on the Termination Date, be exercised by Optionee&rsquo;s executor
or administrator, or the person or persons to whom the Optionee&rsquo;s rights under this Agreement shall pass by will or by the laws
of descent and distribution as the case may be. Any heir or legatee of the Optionee shall take rights herein granted subject to the terms
and conditions hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Restrictions; Restrictive Legends</U>. Ownership and transfer of Shares issued pursuant to the exercise of this Option will
be subject to the provisions of, including ownership and transfer restrictions contained in, the Company&rsquo;s Certificate of Incorporation
or Bylaws, as amended from time to time, restrictions imposed by Applicable Laws and restrictions set forth or referenced in legends imprinted
on certificates representing such Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Dissolution or Liquidation</U>. In the event of the proposed dissolution or liquidation of the Company, to the extent that this
Option had not been previously exercised, it will terminate immediately prior to the consummation of such proposed dissolution or liquidation.
In such instance, the Administrator may, in the exercise of its sole discretion, declare that this Option will terminate as of a date
fixed by the Administrator and give the Optionee the right to exercise this Option prior to such date as to all or any part of the optioned
stock, including Shares as to which this Option would not otherwise be exercisable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>General</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governing Law</U>. This Agreement shall be governed by and construed under the laws of the State of Nevada applicable to agreements
made and to be performed entirely in Nevada, without regard to the conflicts of law provisions of Nevada or any other jurisdiction.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Community Property</U>. Without prejudice to the actual rights of the spouses as between each other, for all purposes of this
Agreement, the Optionee shall be treated as agent and attorney-in-fact for that interest held or claimed by his or her spouse with respect
to this Option and the parties hereto shall act in all matters as if the Optionee was the sole owner of this Option. This appointment
is coupled with an interest and is irrevocable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Employment Rights</U>. Nothing herein contained shall be construed as an agreement by the Company or any of its Subsidiaries,
express or implied, to employ the Optionee or contract for the Optionee&rsquo;s services, to restrict the Company&rsquo;s or such Subsidiary&rsquo;s
right to discharge the Optionee or cease contracting for the Optionee&rsquo;s services or to modify, extend or otherwise affect in any
manner whatsoever the terms of any service agreement (or other agreement) or contract for services which may exist between the Optionee
and the Company or any Affiliate.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Application to Other Stock</U>. In the event any capital stock of the Company or any other corporation shall be distributed
on, with respect to, or in exchange for Shares as a stock dividend, stock split, reclassification or recapitalization in connection with
any merger or reorganization or otherwise, all restrictions, rights and obligations set forth in this Agreement shall apply with respect
to such other capital stock to the same extent as they are, or would have been applicable, to the Shares on or with respect to which such
other capital stock was distributed, and references to &ldquo;Company&rdquo; in respect of such distributed stock shall be deemed to refer
to the company to which such distributed stock relates.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Third-Party Benefits</U>. Except as otherwise expressly provided in this Agreement, none of the provisions of this Agreement
shall be for the benefit of, or enforceable by, any third-party beneficiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Successors and Assigns</U>. Except as provided herein to the contrary, this Agreement shall be binding upon and inure to the
benefit of the parties, their respective successors and permitted assigns.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Assignment</U>. Except as otherwise provided in this Agreement, the Optionee may not assign any of his or her rights under
this Agreement without the prior written consent of the Company, which consent may be withheld in its sole discretion. The Company shall
be permitted to assign its rights or obligations under this Agreement so long as such assignee agrees to perform all of the Company&rsquo;s
obligations hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Severability</U>. The validity, legality or enforceability of the remainder of this Agreement shall not be affected even if
one or more of the provisions of this Agreement shall be held to be invalid, illegal or unenforceable in any respect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Equitable Relief</U>. The Optionee acknowledges that, in the event of a threatened or actual breach of any of the provisions
of this Agreement, damages alone will be an inadequate remedy, and such breach will cause the Company great, immediate and irreparable
injury and damage. Accordingly, the Optionee agrees that the Company shall be entitled to injunctive and other equitable relief, and that
such relief shall be in addition to, and not in lieu of, any remedies it may have at law or under this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Jurisdiction</U>. Any suit, action or proceeding with respect to this Agreement, or any judgment entered by any court in respect
of any thereof, shall be brought in any court of competent jurisdiction in the State of Nevada, and the Company and the Optionee hereby
submit to the exclusive jurisdiction of such courts for the purpose of any such suit, action, proceeding or judgment. The Optionee and
the Company hereby irrevocably waive (i) any objections which it may now or hereafter have to the laying of the venue of any suit, action
or proceeding arising out of or relating to this Agreement brought in any court of competent jurisdiction in the State of Nevada, (ii)
any claim that any such suit, action or proceeding brought in any such court has been brought in any inconvenient forum and (iii) any
right to a jury trial.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notice</U>. Any notice to the Company provided for in this Agreement shall be addressed to the Company in care of its Secretary
at its principal executive offices or at such other address as to which the Company shall have notified Optionee in writing, and any notice
to the Optionee shall be addressed to such Optionee at the current address shown on the payroll of the Company or its respective Affiliate,
or to such other address as the Optionee may designate to the Company. Any notice shall be delivered by hand or by a recognized courier
service such as FedEx or UPS, sent by telecopy, or enclosed in a properly sealed envelope addressed as stated above, registered and deposited,
postage prepaid, in a post office regularly maintained by the United States Postal Service.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Taxes</U>. By agreeing to this Agreement, the Optionee acknowledges and agrees that the Company has not made any warranties
or representations to the Optionee with respect to the tax consequences of the grant of the Option hereunder, and the Optionee is in no
manner relying on the Company or its representatives for an assessment of such tax consequences. The Optionee is advised to consult with
his or her own tax advisor with respect to such tax consequences of the grant. The Company shall be entitled to require a cash payment
by or on behalf of the Optionee and/or to deduct from the Shares or cash otherwise issuable hereunder or other compensation payable to
the Optionee the minimum amount of any sums required by federal, state or local tax law to be withheld (or other such sums that will not
cause adverse accounting consequences for the Company and is permitted under applicable withholding rules promulgated by the Internal
Revenue Service or another applicable governmental entity) in respect of the Option, its exercise or any payment or transfer under or
with respect to the Option.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.13<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Headings</U>. The section headings in this Agreement are inserted only as a matter of convenience, and in no way define, limit,
extend or interpret the scope of this Agreement or of any particular section.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.14<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Number and Gender</U>. Throughout this Agreement, as the context may require, (a) the masculine gender includes the feminine
and the neuter gender includes the masculine and the feminine; (b) the singular tense and number includes the plural, and the plural tense
and number includes the singular; (c) the past tense includes the present, and the present tense includes the past; (d) references to
parties, sections, paragraphs and exhibits mean the parties, sections, paragraphs and exhibits of and to this Agreement; and (e) periods
of days, weeks or months mean calendar days, weeks or months.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.15<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Acknowledgments of Optionee</U>. Optionee has reviewed the Plan and this Agreement in their entirety, has had an opportunity
to obtain the advice of counsel prior to executing this Agreement, fully understands all provisions of the Plan and this Agreement and,
by accepting the Notice of Grant, acknowledges and agrees to all of the provisions of the Grant Notice, the Plan and this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.16<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Complete Agreement</U>. The Grant Notice, this Stock Option Agreement, the Plan, and the applicable provisions (if any) contained
in a written service agreement (or other agreement) between the Company or an Affiliate and the Optionee constitute the parties&rsquo;
entire agreement with respect to the subject matter hereof and supersede all agreements, representations, warranties, statements, promises
and understandings, whether oral or written, with respect to the subject matter hereof. In the event of any inconsistency between the
Plan and this Agreement, the terms of the Plan shall control.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.17<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Waiver</U>. The Optionee acknowledges that a waiver by the Company of a breach of any provision of this Agreement shall not
operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by the Optionee.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.18<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Signature in Counterparts</U>. This Agreement may be signed in counterparts, each of which shall be an original, with the same
effect as if the signatures thereto and hereto were upon the same instrument.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.19<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendments and Termination</U>. To the extent permitted by the Plan, this Agreement may be wholly or partially amended, altered
or terminated at any time or from time to time by the Administrator or the Board, but (unless otherwise permitted in the Plan) no amendment,
alteration or termination shall be made that would materially impair the rights of an Optionee under the Option without such Optionee&rsquo;s
consent.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.20<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Waiver of Jury Trial</U>. TO THE EXTENT EITHER PARTY INITIATES LITIGATION INVOLVING THIS AGREEMENT OR ANY ASPECT OF THE RELATIONSHIP
BETWEEN US (EVEN IF OTHER PARTIES OR OTHER CLAIMS ARE INCLUDED IN SUCH LITIGATION), ALL OF THE PARTIES WAIVE THEIR RIGHT TO A TRIAL BY
JURY. THIS WAIVER WILL APPLY TO ALL CAUSES OF ACTION THAT ARE OR MIGHT BE INCLUDED IN SUCH ACTION, INCLUDING CLAIMS RELATED TO THE ENFORCEMENT
OR INTERPRETATION OF THIS AGREEMENT, ALLEGATIONS OF STATE OR FEDERAL STATUTORY VIOLATIONS, FRAUD, MISREPRESENTATION, OR SIMILAR CAUSES
OF ACTION, AND IN CONNECTION WITH ANY LEGAL ACTION INITIATED FOR THE RECOVERY OF DAMAGES BETWEEN OR AMONG US OR BETWEEN OR AMONG ANY OF
OUR OWNERS, AFFILIATES, OFFICERS, EMPLOYEES OR AGENTS.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.21<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Electronic Delivery and Disclosure</U>. The Company may, in its sole discretion, decide to deliver or disclose, as applicable,
any documents related to this Option granted under the Plan, future awards that may be granted under the Plan, the prospectus related
to the Plan, the Company&rsquo;s annual reports or proxy statements by electronic means or to request Optionee&rsquo;s consent to participate
in the Plan by electronic means, including, but not limited to, the Securities and Exchange Commission&rsquo;s Electronic Data Gathering,
Analysis, and Retrieval system or any successor system (&ldquo;<B>EDGAR</B>&rdquo;). Optionee hereby consents to receive such documents
delivered electronically or to retrieve such documents furnished electronically (including on EDGAR), as applicable, and agrees to participate
in the Plan through any online or electronic system established and maintained by the Company or another third party designated by the
Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.22<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Data Privacy</U>. Optionee agrees that all of Optionee&rsquo;s information that is described or referenced in this Agreement
and the Plan may be used by the Company, its affiliates and the designated broker and its affiliates to administer and manage Optionee&rsquo;s
participation in the Plan.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.23<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Section 409A</U>. The parties intend for the Option to be exempt from Section 409A of the Code or, if not so exempt, to be treated
in a manner which complies with the requirements of such section, and intend that this Agreement be construed and administered in accordance
with such intention. In the event that the parties determine that the terms of this Agreement or the Option needs to be modified in order
to comply with Section 409A of the Code, the parties shall cooperate reasonably to do so in a manner intended to best preserve the economic
benefits of this Agreement. Any payments that qualify for the &ldquo;short-term deferral&rdquo; exception or another exception under Section
409A of the Code shall be paid under the applicable exception. For purposes of the limitations on nonqualified deferred compensation under
Section 409A of the Code, each payment of compensation under this Agreement shall be treated as a separate payment of compensation. Notwithstanding
anything contained herein to the contrary, to the extent required in order to avoid accelerated taxation and/or tax penalties under Section
409A of the Code, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to this Agreement during
the six-month period immediately following the Optionee&rsquo;s separation from service shall instead be paid on the first business day
after the date that is six months following the Optionee&rsquo;s termination date (or death, if earlier).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.24<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Section 280G</U>. In the event that the benefits provided for in this Agreement or otherwise payable hereunder (a) constitute
&ldquo;parachute payments&rdquo; within the meaning of Section 280G of the Code; and (b) would be subject to the excise tax imposed by
Section 4999 of the Code (the &ldquo;<B>Excise Tax</B>&rdquo;), then the parties hereto will cooperate to ensure that the benefits hereunder
will be either (i) delivered in full; or (ii) delivered as to such lesser extent which would result in no portion of such benefits being
subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes
and the Excise Tax, results in the Optionee&rsquo;s receipt on an after-tax basis of the greatest amount of benefits, notwithstanding
that all or some portion of such benefits may be taxable under Section 4999 of the Code. Unless mutually agreed in writing, any determination
required under this section shall be made at no expense to Optionee in writing by the Company&rsquo;s independent public accountants,
whose determination shall be conclusive and binding</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">7.25<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Clawback of Incentive Compensation</U>. Executives shall be subject to the Company&rsquo;s Policy on Recovery of Erroneously
Awarded Compensation, as filed as filed as Exhibit 97 to Company&rsquo;s Form 10-K for the last Company fiscal year as such policy may
be amended or replaced by the Company from time to time (the &ldquo;<B>Clawback Policy</B>&rdquo;).</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>3
<FILENAME>rcat0808form10kexh4_3.htm
<DESCRIPTION>EXHIBIT 4.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.3</B></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">RED CAT HOLDINGS, INC.<BR>
RESTRICTED SHARE UNIT AWARD GRANT NOTICE<BR>
(2019 Equity Incentive Plan)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As a key leader in our
business, you are in a position to have significant influence on the performance and success of Red Cat Holdings, Inc. (the &ldquo;<B>Company</B>&rdquo;).
I am pleased to inform you that, in recognition of the role you play in our collective success, you have been granted a RSU award (the
&ldquo;<B>Restricted Share Unit Award</B>&rdquo;). This award is subject to the terms and conditions of the Red Cat Holdings, Inc. 2019
Equity Incentive Plan, this Grant Notice, and the following Restricted Share Unit Award Agreement. The details of this award are indicated
below.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 46%; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Grantee:</TD>
    <TD STYLE="width: 54%; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Date of Grant:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Number of Restricted Share Units <FONT STYLE="text-decoration: underline double">(RSUs):</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Vesting Commencement Date:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Vesting:</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Delivery Dates:</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-variant: small-caps">Red Cat Holdings, Inc.</FONT>, a
Nevada corporation</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">By:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Its:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Acknowledged and Agreed as of this _____ day of __________, 20[__].</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Name: ______________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">RED CAT HOLDINGS, INC</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">2019 EQUITY INCENTIVE PLAN</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">RESTRICTED SHARE UNIT AWARD AGREEMENT</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">THIS RESTRICTED SHARE UNIT
AWARD AGREEMENT (together with the above grant notice (the &ldquo;<B>Grant Notice</B>&rdquo;), this &ldquo;<B>Agreement</B>&rdquo;) is
made and entered into as of the date set forth on the Grant Notice by and between the Company and the individual (the &ldquo;<B>Grantee</B>&rdquo;)
set forth on the Grant Notice.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">WHEREAS, pursuant to the
Plan, the Company has determined that it is to the advantage and best interest of the Company to grant to the Grantee this award of restricted
share units (the &ldquo;<B>RSUs</B>&rdquo; or &ldquo;<B>Restricted Share Units</B>&rdquo;) as set forth in the Grant Notice and subject
to the terms and provisions of the Plan, which is incorporated herein by reference, and this Agreement (the &ldquo;<B>Award</B>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">WHEREAS, unless otherwise
defined herein, capitalized terms used in this Agreement shall have the meanings set forth in the Plan. For purposes of this Agreement,
the following definitions shall apply:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(i)&#9;&ldquo;<B>Termination</B>&rdquo;
shall mean the termination of the employment or service of the Grantee with the Company and all Affiliates thereof (including because
of the Grantee&rsquo;s employer ceasing to be an affiliate of the Company). For purposes of this Agreement, Termination will not occur
when Grantee goes on a military leave, a sick leave, or another bona fide leave of absence that was approved by the Company in writing,
<I>provided that</I> unless reemployment upon the expiration of such leave is guaranteed by contract or law, such leave is for a period
of not more than 3 months; and <I>provided that</I> continued service crediting may be suspended during such leave, unless otherwise required
by Applicable Laws. However, Termination will occur when approved leave described in this section ends, unless Grantee immediately returns
to active work.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&#9;&ldquo;<B>Termination
Date</B>&rdquo; shall mean the date of the Grantee&rsquo;s Termination of Service.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0in">NOW, THEREFORE, in
consideration of the mutual agreements contained herein, the Grantee and the Company hereby agree as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Acceptance of Agreement</U></B>. Grantee has reviewed all of the provisions of the Plan, the Grant Notice and this Restricted
Share Unit Award Agreement. By accepting this Award, Grantee agrees that this Award is granted under and governed by the terms and conditions
of the Plan, the Grant Notice and this Restricted Share Unit Award Agreement, and the applicable provisions contained in a written service
agreement (if any) between the Company or an affiliate and the Grantee. Grantee hereby agrees to accept as binding, conclusive and final
all decisions or interpretations of the Committee on questions relating to the Plan, the Grant Notice, this Agreement and, solely in so
far as they relate to this Award, the applicable provisions contained in a written service agreement (if any) between the Company or an
affiliate and the Grantee. If Grantee signs this Agreement and Grant Notice electronically, Grantee&rsquo;s electronic signature of this
Agreement shall have the same validity and effect as a signature affixed by hand.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Grant of Award</U></B>. Pursuant to this Agreement, the Company has granted to the Grantee the Restricted Share Units, subject
to the terms and conditions set forth in the Plan and this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Vesting</U></B>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>3.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Subject to the provisions of the Plan and Section 3.2 of this Agreement, and except as otherwise provided in a written service
agreement (or other agreement) between the Company or an affiliate and the Grantee (if any), the Restricted Share Units shall vest in
installments as described in the Grant Notice, subject to the Grantee not experiencing a Termination prior to each applicable <B>Vesting
Date </B>(as such term is defined in the Grant Notice).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>3.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except as otherwise provided in the Plan or in a written service agreement (or other agreement) between the Company and the
Grantee (if any), if the Grantee experiences a Termination for any reason prior to an applicable Vesting Date, as of the Termination Date,
the Grantee shall forfeit any unvested Restricted Share Units.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>3.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Transfer and Settlement of Restricted Share Units</U>. The Restricted Share Units issued under this Agreement may not be
sold, transferred or otherwise disposed of and may not be pledged or otherwise hypothecated (each, a &ldquo;<B>Transfer</B>&rdquo;). In
addition, Grantee shall not sell any Shares received with respect to Restricted Share Units (even following settlement of Restricted Share
Units) at a time when applicable laws, regulations or Company&rsquo;s or underwriter trading policies prohibit such sale. The applicable
portion of this Award (to the extent vested) shall be settled by the Company by the issuance and delivery of Shares as soon as reasonably
practical after (but no later than [60<FONT STYLE="font-size: 8pt">&nbsp;</FONT>] days after) the Delivery Dates, as indicated in the
Grant Notice, to the Grantee (or if applicable, the beneficiaries of the Grantee). Any issuance of Shares shall be made only in whole
Shares, and any fractional shares shall be distributed in an equivalent cash amount.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 27pt"><B>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Dividends.</U></B>
Subject to the terms and conditions of the Plan and this Agreement, as well as any procedures established by the Administrator, prior
to the expiration of the applicable vesting period of an RSU, the Administrator may determine to pay dividend equivalent rights with respect
to RSUs, in which case, the Company shall establish an account for the Grantee and reflect in that account any securities, cash or other
property comprising any dividend or property distribution with respect to the shares of Common Stock underlying each Restricted Share
Unit. Each amount or other property credited to any such account shall be subject to the same vesting conditions as the Restricted Share
Unit to which it relates. The Grantee shall have the right to be paid the amounts or other property credited to such account upon vesting
of the subject Restricted Share Unit.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>General</U></B>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governing Law</U></B>. This Agreement shall be governed by and construed under the laws of the State of Nevada applicable to
agreements made and to be performed entirely in Nevada, without regard to the conflicts of law provisions of Nevada or any other jurisdiction.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Community Property</U></B>. Without prejudice to the actual rights of the spouses as between each other, for all purposes of
this Agreement, the Grantee shall be treated as agent and attorney-in-fact for that interest held or claimed by his or her spouse with
respect to this Award and the parties hereto shall act in all matters as if the Grantee was the sole owner of this Award. This appointment
is coupled with an interest and is irrevocable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Employment Rights</U></B>. Nothing contained herein shall be construed as an agreement by the Company or any of its subsidiaries,
express or implied, to employ the Grantee or contract for the Grantee&rsquo;s services, to restrict the Company&rsquo;s or such subsidiary&rsquo;s
right to discharge the Grantee or cease contracting for the Grantee&rsquo;s services or to modify, extend or otherwise affect in any manner
whatsoever the terms of any service agreement (or other agreement) or contract for services which may exist between the Grantee and the
Company or any affiliate.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Application to Other Stock</U></B>. In the event any capital stock of the Company or any other corporation shall be distributed
on, with respect to or in exchange for Shares underlying Restricted Share Units as a stock dividend, stock split, reclassification, recapitalization
or similar transaction in connection with any merger or reorganization or otherwise, all restrictions, rights and obligations set forth
in this Agreement shall apply with respect to such other capital stock to the same extent as they are, or would have been applicable,
to the Shares underlying Restricted Share Units on or with respect to which such other capital stock was distributed, and references to
&ldquo;Company&rdquo; in respect of such distributed stock shall be deemed to refer to the company to which such distributed stock relates.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Third-Party Benefits</U></B>. Except as otherwise expressly provided in this Agreement, none of the provisions of this Agreement
shall be for the benefit of, or enforceable by, any third-party beneficiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Successors and Assigns</U></B>. Except as provided herein to the contrary, this Agreement shall be binding upon and inure to
the benefit of the parties, their respective successors and permitted assigns.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Assignment</U></B>. Except as otherwise provided in this Agreement, the Grantee may not assign any of his or her rights under
this Agreement without the prior written consent of the Company, which consent may be withheld in its sole discretion. The Company shall
be permitted to assign its rights or obligations under this Agreement so long as such assignee agrees to perform all of the Company&rsquo;s
obligations hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Severability</U></B>. The validity, legality or enforceability of the remainder of this Agreement shall not be affected even
if one or more of the provisions of this Agreement shall be held to be invalid, illegal or unenforceable in any respect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Equitable Relief</U></B>. The Grantee acknowledges that, in the event of a threatened or actual breach of any of the provisions
of this Agreement, damages alone will be an inadequate remedy, and such breach will cause the Company great, immediate and irreparable
injury and damage. Accordingly, the Grantee agrees that the Company shall be entitled to injunctive and other equitable relief, and that
such relief shall be in addition to, and not in lieu of, any remedies it may have at law or under this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Jurisdiction</U></B>. Any suit, action or proceeding with respect to this Agreement, or any judgment entered by any court in
respect of any thereof, shall be brought in any court of competent jurisdiction in the State of Nevada, and the Company and the Grantee
hereby submit to the exclusive jurisdiction of such courts for the purpose of any such suit, action, proceeding or judgment. The Grantee
and the Company hereby irrevocably waive (i) any objections which it may now or hereafter have to the laying of the venue of any suit,
action or proceeding arising out of or relating to this Agreement brought in any court of competent jurisdiction in the State of Nevada
and (ii) any claim that any such suit, action or proceeding brought in any such court has been brought in any inconvenient forum.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notice</U></B>. Any notice to the Company provided for in this Agreement shall be addressed to the Company in care of its Secretary
at its principal executive offices or at such other address as to which the Company shall have notified Grantee in writing, and any notice
to the Grantee shall be addressed to such Grantee at the current address shown on the payroll of the Company or its respective Affiliate,
or to such other address as the Grantee may designate to the Company. Any notice shall be delivered by hand or by a recognized courier
service such as FedEx or UPS, sent by telecopy, or enclosed in a properly sealed envelope addressed as stated above, registered and deposited,
postage prepaid, in a post office regularly maintained by the United States Postal Service.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Taxes</U></B>. By agreeing to this Agreement, the Grantee acknowledges and agrees that the Company has not made any warranties
or representations to the Grantee with respect to the tax consequences of the grant of the Restricted Share Units hereunder, and the Grantee
is in no manner relying on the Company or its representatives for an assessment of such tax consequences. The Grantee is advised to consult
with his or her own tax advisor with respect to such tax consequences of the grant. The Company shall be entitled to require a cash payment
by or on behalf of the Grantee and/or to deduct from the Shares or cash issuable hereunder or from other compensation payable to the Grantee
the minimum amount of any sums required by federal, state or local tax law to be withheld (or other such sums that that will not cause
adverse accounting consequences for the Company and is permitted under applicable withholding rules promulgated by the Internal Revenue
Service or another applicable governmental entity) with respect to the Restricted Share Unit Award.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.13<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Headings</U></B>. The section headings in this Agreement are inserted only as a matter of convenience, and in no way define,
limit, extend or interpret the scope of this Agreement or of any particular section.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.14<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Number and Gender</U></B>. Throughout this Agreement, as the context may require, (a) the masculine gender includes the feminine
and the neuter gender includes the masculine and the feminine; (b) the singular tense and number includes the plural, and the plural tense
and number includes the singular; (c) the past tense includes the present, and the present tense includes the past; (d) references to
parties, sections, paragraphs and exhibits mean the parties, sections, paragraphs and exhibits of and to this Agreement; and (e) periods
of days, weeks or months mean calendar days, weeks or months.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.15<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Acknowledgments of Grantee</U></B>. Grantee has reviewed the Plan and this Agreement in their entirety, has had an opportunity
to obtain the advice of counsel prior to executing this Agreement, fully understands all provisions of the Plan and this Agreement and,
by accepting the Grant Notice, acknowledges and agrees to all of the provisions of the Plan and this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.16<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Complete Agreement</U></B>. The Grant Notice, this Agreement, the Plan and applicable provisions (if any) contained in a written
service agreement (or other agreement) between the Company or an affiliate and the Grantee constitute the parties&rsquo; entire agreement
with respect to the subject matter hereof and supersede all agreements, representations, warranties, statements, promises and understandings,
whether oral or written, with respect to the subject matter hereof. Notwithstanding the forgoing and for avoidance of doubt, in the event
that any of the terms of this Agreement conflicts with the Plan, then the terms of the Plan shall govern. In the event that any of the
terms of this Agreement or the Plan conflicts with an applicable employment agreement for the Grantee, then the terms of the applicable
employee agreement of the Grantee shall govern.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.17<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Waiver</U></B>. The Grantee acknowledges that a waiver by the Company of a breach of any provision of this Agreement shall not
operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by the Grantee.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.18<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Signature in Counterparts</U></B>. This Agreement may be signed in counterparts, each of which shall be an original, with the
same effect as if the signatures thereto and hereto were upon the same instrument.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.19<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendments and Termination</U></B>. To the extent permitted by the Plan, this Agreement may be wholly or partially amended,
altered or terminated at any time or from time to time by the Committee or the Board, but (unless otherwise permitted in the Plan) no
amendment, alteration or termination shall be made that would materially impair the rights of a Grantee under this Restricted Share Unit
Award Agreement without such Grantee&rsquo;s consent.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.20<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Waiver of Jury Trial</U></B>. TO THE EXTENT EITHER PARTY INITIATES LITIGATION INVOLVING THIS AGREEMENT OR ANY ASPECT OF THE
RELATIONSHIP BETWEEN US (EVEN IF OTHER PARTIES OR OTHER CLAIMS ARE INCLUDED IN SUCH LITIGATION), ALL OF THE PARTIES WAIVE THEIR RIGHT
TO A TRIAL BY JURY. THIS WAIVER WILL APPLY TO ALL CAUSES OF ACTION THAT ARE OR MIGHT BE INCLUDED IN SUCH ACTION, INCLUDING CLAIMS RELATED
TO THE ENFORCEMENT OR INTERPRETATION OF THIS AGREEMENT, ALLEGATIONS OF STATE OR FEDERAL STATUTORY VIOLATIONS, FRAUD, MISREPRESENTATION,
OR SIMILAR CAUSES OF ACTION, AND IN CONNECTION WITH ANY LEGAL ACTION INITIATED FOR THE RECOVERY OF DAMAGES BETWEEN OR AMONG US OR BETWEEN
OR AMONG ANY OF OUR OWNERS, AFFILIATES, OFFICERS, EMPLOYEES OR AGENTS.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.21<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Electronic Delivery and Disclosure</U></B>. The Company may, in its sole discretion, decide to deliver or disclose, as applicable,
any documents related to this Award granted under the Plan, future awards that may be granted under the Plan, the prospectus related to
the Plan, the Company&rsquo;s annual reports or proxy statements by electronic means or to request Grantee&rsquo;s consent to participate
in the Plan by electronic means, including, but not limited to, the Securities and Exchange Commission&rsquo;s Electronic Data Gathering,
Analysis, and Retrieval system or any successor system (&ldquo;<B>EDGAR</B>&rdquo;). Grantee hereby consents to receive such documents
delivered electronically or to retrieve such documents furnished electronically (including on EDGAR), as applicable, and agrees to participate
in the Plan through any online or electronic system established and maintained by the Company or another third party designated by the
Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.22<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Data Privacy</U></B>. Grantee agrees that all of Grantee&rsquo;s information that is described or referenced in this Agreement
and the Plan may be used by the Company, its affiliates and the designated broker and its affiliates to administer and manage Grantee&rsquo;s
participation in the Plan.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.23<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Section 409A Compliance</U></B>. The parties intend for the Award to be exempt from Section 409A of the Code or, if not so exempt,
to be treated in a manner which complies with the requirements of such section, and intend that this Agreement be construed and administered
in accordance with such intention. In the event that the parties determine that the terms of this Agreement or the Award needs to be modified
in order to comply with Section 409A of the Code, the parties shall cooperate reasonably to do so in a manner intended to best preserve
the economic benefits of this Agreement. Any payments that qualify for the &ldquo;short-term deferral&rdquo; exception or another exception
under Section 409A of the Code shall be paid under the applicable exception. For purposes of the limitations on nonqualified deferred
compensation under Section 409A of the Code, each payment of compensation under this Agreement shall be treated as a separate payment
of compensation. Notwithstanding anything contained herein to the contrary, to the extent required in order to avoid accelerated taxation
and/or tax penalties under Section 409A of the Code, amounts that would otherwise be payable and benefits that would otherwise be provided
pursuant to this Agreement during the six-month period immediately following the Grantee&rsquo;s separation from service shall instead
be paid on the first business day after the date that is six months following the Grantee&rsquo;s termination date (or death, if earlier).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.24<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Section 280G</U></B>. In the event that the benefits provided for in this Agreement or otherwise payable hereunder (a) constitute
&ldquo;parachute payments&rdquo; within the meaning of Section 280G of the Code; and (b) would be subject to the excise tax imposed by
Section 4999 of the Code (the &ldquo;<B>Excise Tax</B>&rdquo;), then the parties hereto will cooperate to ensure that the benefits hereunder
will be either (i) delivered in full; or (ii) delivered as to such lesser extent which would result in no portion of such benefits being
subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes
and the Excise Tax, results in the Grantee&rsquo;s receipt on an after-tax basis of the greatest amount of benefits, notwithstanding that
all or some portion of such benefits may be taxable under Section 4999 of the Code. Unless mutually agreed in writing, any determination
required under this section shall be made at no expense to Grantee in writing by the Company&rsquo;s independent public accountants, whose
determination shall be conclusive and binding.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><B>5.25<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Clawback of Incentive Compensation</U></B>. Executives shall be subject to the Company&rsquo;s Policy on Recovery of Erroneously
Awarded Compensation, as filed as Exhibit 97 to Company&rsquo;s Form 10-K for the last Company fiscal year as such policy may be amended
or replaced by the Company from time to time (the &ldquo;<B>Clawback Policy</B>&rdquo;).</P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>rcat0808form10kexh10_1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0 0pt; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">RED CAT HOLDINGS, INC.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2019 EQUITY INCENTIVE PLAN</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">INCENTIVE STOCK OPTION AGREEMENT</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">This INCENTIVE STOCK OPTION AGREEMENT
(the &ldquo;Option Agreement&rdquo;), dated as of the <B><U>29th day of April, 2023</U></B> (the &ldquo;Grant Date&rdquo;), is between
Red Cat Holdings, Inc., a Nevada corporation (the &ldquo;Company&rdquo;), and <B>_____________ </B>(the &ldquo;Optionee&rdquo;), an Eligible
Person as defined in the Red Cat Holdings, Inc. 2019 Equity Incentive Plan (the &ldquo;Plan&rdquo;).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">WHEREAS, the Company desires to
give the Optionee the opportunity to purchase shares of common stock of the Company, par value $0.001 (&ldquo;Common Shares&rdquo;) in
accordance with the provisions of the Plan, a copy of which is attached hereto;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">NOW THEREFORE, in consideration
of the mutual covenants hereinafter set forth and for other good and valuable consideration, the parties hereto, intending to be legally
bound hereby, agree as follows:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant
of Option</U>. The Company hereby grants to the Optionee the right and option (the &ldquo;Option&rdquo;) to purchase all or any part of
an aggregate of <B>______</B> Common Shares. The Option is in all respects limited and conditioned as hereinafter provided, and is subject
in all respects to the terms and conditions of the Plan now in effect and as it may be amended from time to time (but only to the extent
that such amendments apply to outstanding options). Such terms and conditions are incorporated herein by reference, made a part hereof,
and shall control in the event of any conflict with any other terms of this Option Agreement. The Option granted hereunder shall constitute
and be treated at all times by you and the Company as an incentive stock option (&ldquo;ISO&rdquo;) as defined under Section 422(b) of
the Internal Revenue Code of 1986, as amended.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">Any part of the Option which does not qualify to be
an &ldquo;incentive stock option&rdquo; due to the annual vesting limitation of $100,000 shall be classified as a non-qualified stock
option (&ldquo;NQSO&rdquo;) and <U>not</U> an ISO.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise
Price</U>. The exercise price of the Common Shares covered by this Option shall be <B>$____</B> per share, which shall not be less than
100% of the fair market value of one share of Common Stock on the Grant Date. If the Optionee is the holder of ten percent (10%) or more
of the Company&rsquo;s voting stock, the exercise price is not less than 110% of the fair market value of one share of Common Stock on
the Grant Date.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Term</U>.
Unless earlier terminated pursuant to any provision of the Plan or of this Option Agreement, this Option shall expire on the date which
is ten years from the Grant Date (the &ldquo;Expiration Date&rdquo;). If the Optionee is the holder of ten percent (10%) or more of the
Company&rsquo;s voting stock, this Option shall expire on the date which is 5 years from the Grant Date. In the event that the Optionee
has terminated service prior to the Expiration Date, then the Expiration Date shall be adjusted to that date which is three months from
the date of the termination of service.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise
of Option</U>. The Optionee shall have the right to purchase from the Company, on and after the following dates, the following number
of Common Shares, provided the Optionee has not terminated his or her service as of the applicable vesting date:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border: black 1pt solid; width: 59%; padding-right: 2pt; padding-left: 2pt; text-align: justify">Date Installment Becomes Exercisable</TD>
    <TD STYLE="border-top: black 1pt solid; width: 41%; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 2pt; padding-left: 2pt; text-align: justify">Number of Common Shares</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 2pt; padding-left: 2pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 2pt; padding-left: 2pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 2pt; padding-left: 2pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 2pt; padding-left: 2pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 2pt; padding-left: 2pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 2pt; padding-left: 2pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 2pt; padding-left: 2pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 2pt; padding-left: 2pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">The Board of Directors of the Company, or its Compensation
Committee, if any, may accelerate any exercise date of the Option, in its discretion, if it deems such acceleration to be desirable. Once
the Option becomes exercisable, it will remain exercisable until it is exercised or until it terminates.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify"><B>The exercise of this option will affect your personal
income taxes. You should consult with a tax advisor or otherwise educate yourself regarding how the exercise of any of these stock options
will impact your personal income taxes. </B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Method
of Exercising Option</U>. Subject to the terms and conditions of this Option Agreement and the Plan, the Option may be exercised by written
notice to the Company at its principal office, which is presently located at 15 Ave. Munoz Rivera, STE 2200, Puerto Rico 00901. The form
of such notice is attached hereto and shall state the election to exercise the Option and the number of whole shares with respect to which
it is being exercised; shall be signed by the person or persons so exercising the Option; and shall be accompanied by payment of the full
exercise price of such shares. Only full shares will be issued.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">The exercise price shall be paid to the Company
&ndash;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in cash, or by certified check, bank draft, or postal or express money order;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>through the delivery of Common Shares previously acquired by the Optionee;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by delivering a properly executed notice of exercise of the Option to the Company and a broker, with irrevocable instructions to
the broker promptly to deliver to the Company the amount necessary to pay the exercise price of the Option;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in Common Shares newly acquired by the Optionee upon exercise of the Option. Under this method, the Optionee may provide payment
by having the Company withhold that number of shares associated with this exercise with a fair value equal to the required payment. &nbsp;(For
example, an exercise of 1,000 options with an exercise price of $2.00 would require a payment of $2,000.&nbsp; If the Company&rsquo;s
stock price is $4.00 at this time, then $2,000 / $4.00 = 500 which is the number of shares that will be withheld by the Company to provide
payment for the exercise.&nbsp; This results in the net issuance of 1,000 - 500 = 500 shares of common stock);</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in any combination of (a), (b), (c), or (d) above.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">Upon receipt of notice of exercise
and payment, the Company shall deliver a certificate or certificates representing the Common Shares with respect to which the Option is
so exercised. The Optionee shall obtain the rights of a stockholder upon receipt of a certificate(s) representing such Common Shares.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">Such certificate(s) shall be registered
in the name of the person so exercising the Option (or, if the Option is exercised by the Optionee and if the Optionee so requests in
the notice exercising the Option, shall be registered in the name of the Optionee and the Optionee&rsquo;s spouse, jointly, with right
of survivorship), and shall be delivered as provided above to, or upon the written order of, the person exercising the Option. In the
event the Option is exercised by any person after the death or disability (as determined in accordance with Section 22(e)(3) of the Code)
of the Optionee, the notice shall be accompanied by appropriate proof of the right of such person to exercise the Option. All Common Shares
that are purchased upon exercise of the Option as provided herein shall be fully paid and non-assessable.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery
of Shares Upon Exercise</U>. An Incentive Stock Option (&quot;ISO&quot;) has distinct tax advantages when exercised compared to a non-qualified
stock option (&quot;NON-Q&quot;). Most importantly, the exercise of an ISO will normally not result in the immediate recognition of taxable
income whereas the exercise of a NON-Q always results in the immediate recognition of taxable income. In addition, the shares received
upon exercise of an ISO will qualify for long term capital gains treatment if held for more than one year following the date of exercise.
In order for an ISO to preserve its tax advantages, the shares received upon the exercise of an ISO must be held for both (i) two years
from the date of grant and (ii) one year from the date of exercise. The Company is subject to federal and tax withholding obligations
if the holding period requirements of an ISO are not met. Therefore, as a material condition to this Option Agreement, the Optionee agrees
to hold the shares in book entry form with the Company's transfer agent until the holding period requirements are met. An Optionee may
sell the shares held in book entry form at any time, however, a sale of the shares prior to the holding period being met will result in
the sale being treated as ordinary income and not eligible for capital gains treatment.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-Transferability
of Option</U>. This Option is not assignable or transferable, in whole or in part, by the Optionee other than by will or by the laws of
descent and distribution or to the extent permitted by the Plan. During the lifetime of the Optionee, the Option shall be exercisable
only by the Optionee or, in the event of his or her disability, by his or her guardian or legal representative or to the extent permitted
by the Plan.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination
of Service</U>. If the Optionee&rsquo;s employment with the Company and all subsidiaries is terminated for any reason prior to the Expiration
Date, this Option may be exercised, to the extent permitted by the Plan and any other applicable agreement, no later than <B>three (3)
months</B> after termination of employment, or no later than twelve (12) months after termination of employment if such termination is
the result of the Optionee&rsquo;s death or disability). However, if employment is terminated for &ldquo;cause&rdquo;, all options, both
vested and unvested, are forfeited upon termination.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify"><B>&quot;Cause&quot; </B>shall mean: (i) conviction
of a felony or a crime involving fraud or moral turpitude; or (i i) theft, material act of dishonesty or fraud, intentional falsification
of any employment or Company records, or commission of any criminal act which impairs participant's ability to perform appropriate employment
duties for the Corporation; or (iii) intentional or reckless conduct or gross negligence materially harmful to the Company or the successor
to the Corporation after a Change in Control, including violation of a non-competition or confidentiality agreement; or (iv) willful failure
to follow lawful instructions of the person or body to which participant reports; or (v) gross negligence or willful misconduct in the
performance of participant's assigned duties. Cause shall not include mere unsatisfactory performance in the achievement of participant's
job objectives.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Taxes;
Disqualifying Disposition of Shares</U>. The obligation of the Company to deliver Common Shares upon the exercise of this Option shall
be subject to applicable federal, state and local tax withholding requirements. The Optionee acknowledges and agrees that, in the event
he shall dispose (whether by sale, exchange, gift or any like transfer) of any shares of common stock of the Company (to the extent such
shares are deemed to have been purchased pursuant to this incentive stock option) acquired by him pursuant hereto <B>within two years
of the Grant Date</B> of this Option <B><U>or </U>within one year after the acquisition of such shares</B> pursuant hereto (a &ldquo;Disqualifying
Disposition&rdquo;):</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1.5in">(a) he will notify the Chief Financial
Officer of the Company no later than 15 days from the date of such disposition of such date or dates and the number of shares disposed
of by him and the consideration received, if any, and, upon notification from the Company, promptly forward to the Chief Financial Officer
of the Company any amount requested by the Company for the purpose of satisfying its liability, if any, to withhold federal, state or
local income or earnings tax or any other applicable tax or assessment (plus interest or penalties thereon, if any, caused by any delay
in making such payment) incurred by reason of such disposition; and</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1.5in">(b) he may be subject to additional
personal income taxes. The Optionee is advised and encouraged to seek the advice of a tax professional in this regard.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law</U>. This Option Agreement shall be governed by the applicable Code provisions to the maximum extent possible. Otherwise, the laws
of the State of Nevada (without reference to the principles of conflict of laws) shall govern the operation of, and the rights of the
Optionee under, the Plan and Options granted thereunder.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Stock Option Agreement to be duly executed by its authorized officer, and the Optionee has hereunto set his or her hand
and seal.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 3in">Red Cat Holdings, Inc.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 220pt; text-align: justify"><IMG SRC="image_001.gif" ALT="A signature on a white background&#10;&#10;Description automatically generated" STYLE="height: 56px; width: 178px"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 3in">______________________________</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 3in">By: Leah Lunger, CFO</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 396.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 3in">________________________________</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 3in">_________________, Optionee</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="text-align: justify; margin-right: 0pt; margin-bottom: 6pt; margin-left: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: justify; margin-right: 0pt; break-before: page; margin-top: 6pt; margin-left: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">RED CAT HOLDINGS, INC.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2019 EQUITY INCENTIVE PLAN</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Notice of Exercise of Incentive Stock Option</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">I hereby exercise the
incentive stock option granted to me pursuant to the Option Agreement dated as of _________ __, 20___, by Red Cat Holdings, Inc. (the
&ldquo;Company&rdquo;), with respect to the following number of shares of the Company&rsquo;s common stock (&ldquo;Shares&rdquo;), par
value $0.001 per Share, covered by said option:</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 40pt">&#9;Number of Shares to be purchased:&#9; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;_______</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 40pt">&#9;Purchase price per Share:&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$_______</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 40pt">&#9;Total purchase price:&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$_______</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in">___</TD><TD STYLE="text-align: justify; width: 0.5in">A.</TD><TD STYLE="text-align: justify; padding-right: 43.5pt">Enclosed is cash or my certified check, bank draft, or postal or express money
order in the amount of $________ in full/partial <B>[circle one]</B> payment for such Shares;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 3in">and/or</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in">___</TD><TD STYLE="text-align: justify; width: 0.5in">B.</TD><TD STYLE="text-align: justify; padding-right: 43.5pt">Enclosed is/are Share(s) with a total fair market value of $ on the date hereof
in full/partial <B>[circle one]</B> payment for such Shares;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 3in">and/or</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in">___</TD><TD STYLE="text-align: justify; width: 0.5in">C.</TD><TD STYLE="text-align: justify; padding-right: 43.5pt">I have provided notice to <B>[insert name of broker]</B>, a broker, who will render
full/partial <B>[circle one]</B> payment for such Shares. <B>[Optionee should attach to the notice of exercise provided to such broker
a copy of this Notice of Exercise and irrevocable instructions to pay to the Company the full/partial (as elected above) exercise price.]</B></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: -1in"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 3in">and/or</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in">___</TD><TD STYLE="text-align: justify; width: 0.5in">D.</TD><TD STYLE="text-align: justify; padding-right: 43.5pt">I  elect to
satisfy the payment for Shares purchased hereunder by having the Company withhold that number of shares associated with this exercise
with a fair value equal to the required payment. &nbsp;(For example, an exercise of 1,000 options with an exercise price of $2.00 would
require a payment of $2,000.&nbsp; If the Company&rsquo;s stock price is $4.00 at this time, then $2,000 / $4.00 = 500 which is the number
of shares that will be withheld by the Company to provide payment for the exercise.&nbsp; This results in the net issuance of 1,000 -
500 = 500 shares of common stock)</TD></TR>
</TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Please have the certificate
or certificates representing the purchased Shares registered in the following name or names<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><SUP>[1]</SUP></FONT>*:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;;</U>
and sent to <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>.</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0pt">DATED: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
___, 20__&#9;&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;______________________</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 2.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Optionee&rsquo;s Signature</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 3.95pt 0pt 0"><FONT STYLE="letter-spacing: -0.1pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 9.5pt Times New Roman, Times, Serif; text-align: justify; margin: 3.95pt 0pt 0"><FONT STYLE="letter-spacing: -0.1pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt"><FONT STYLE="letter-spacing: -0.1pt"></FONT></P>


<HR ALIGN="LEFT" SIZE="1" STYLE="width: 33%">

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt 12pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><SUP>[1]</SUP></FONT><FONT STYLE="font-family: Open Sans,sans-serif; font-size: 10pt">*</FONT><FONT STYLE="font-size: 10pt">&#9;Certificates
may be registered in the name of the Optionee alone or in the joint names (with right of survivorship) of the Optionee and his or her
spouse.</FONT></P>

<P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin: 3.95pt 0pt 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="text-align: justify; margin: 6pt 0pt"></DIV>
    <DIV STYLE="text-align: justify; margin: 6pt 0pt; break-before: page"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 3.95pt; margin-bottom: 0; text-align: center"><FONT STYLE="letter-spacing: -0.1pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 3.95pt; margin-bottom: 0; text-align: center"><FONT STYLE="letter-spacing: -0.1pt"><B></B></FONT></P>

<P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 3.95pt; margin-bottom: 0; text-align: center"><FONT STYLE="letter-spacing: -0.1pt"><B>APPENDIX
A</B></FONT></P>

<P STYLE="font: 9.5pt Times New Roman, Times, Serif; text-align: center; margin-top: 1.55pt; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>RED CAT HOLDINGS, <FONT STYLE="letter-spacing: -0.2pt">INC.</FONT></B></P>

<P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 1pt; margin-bottom: 0; text-align: center"><B>2019 EQUITY INCENTIVE <FONT STYLE="letter-spacing: -0.2pt">PLAN</FONT></B></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.95pt 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 13.5pt"></TD><TD STYLE="text-align: justify; width: 11.35pt"><FONT STYLE="font-size: 9.5pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt"><B>PURPOSE OF <FONT STYLE="letter-spacing: -0.2pt">PLAN</FONT></B></FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 2.3pt 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 45pt"><B>1.1</B> The purpose of this 2019
Equity Incentive Plan (this <B>&quot;Plan&quot;) </B>of Red Cat Holdings, Inc., a Nevada corporation (the <B>&quot;Corporation&quot;),
</B>is to promote the success of the Corporation and to increase stockholder value by providing an additional means through the grant
of awards to attract, motivate, retain and reward selected employees and other eligible persons.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.7pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 16.4pt"></TD><TD STYLE="text-align: justify; width: 18pt"><FONT STYLE="font-size: 9.5pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt; letter-spacing: -0.1pt"><B>ELIGIBILITY</B></FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.55pt 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt/110% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-size: 9.5pt"><B>2.1</B>
The Administrator (as such tennis defined in Section 3.1) may grant awards under this Plan only to those persons that the Administrator
determines to be Eligible Persons. An</FONT> <FONT STYLE="font-size: 10.5pt"><B>&quot;Eligible Person&quot;</B></FONT> <FONT STYLE="font-size: 9.5pt">is
any person who is either: (a) an officer (whether or not a director) or employee of the Corporation or one of its Subsidiaries; (b) a
director of the Corporation or one of its Subsidiaries; or (c) a consultant who renders bona fide services (other than services in connection
with the offering or sale of securities of the Corporation or one of its Subsidiaries in a capital-raising transaction or as a market
maker or promoter of securities of the Corporation or one of its Subsidiaries) to the Corporation or one of its Subsidiaries and who is
selected to participate in this Plan by the Administrator; <I>provided, however,</I> that a person who is otherwise an Eligible Person
under clause (c) above may participate in this Plan only if s1.1ch participation would not adversely affect either the Corporation's eligibility
to use Form S-8 to register under the Securities Act of 1933, as amended (the <B>&quot;Securities Act&quot;),</B> the offering and sale
of shares issuable under this Plan by the Corporation, or the Corporation's compliance with any other applicable laws. An Eligible Person
who has been granted an award (a <B>&quot;participant&quot;) </B>may, if otherwise eligible, be granted additional awards if the Administrator
shall so determine. As used herein, <B>&quot;Subsidiary&quot;</B> means any corporation or other entity a majority of whose outstanding
voting stock or voting power is beneficially owned directly or indirectly by the Corporation; and <B>&quot;Board&quot; </B>means the Board
of Directors of the Corporation.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.7pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 5.9pt"></TD><TD STYLE="text-align: justify; width: 27.7pt"><FONT STYLE="font-size: 9.5pt"><B>3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt"><B>PLAN <FONT STYLE="letter-spacing: -0.1pt">ADMINISTRATION</FONT></B></FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.4pt 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt/110% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-size: 10pt"><B>3.1
<I>The Administrator. </I></B></FONT><FONT STYLE="font-size: 9.5pt">This Plan shall be administered by and all awards under this Plan
shall be authorized by the Administrator. The <B>&quot;Administrator&quot; </B>means the Board or one or more committees appointed by
the Board or another committee (within its delegated authority) to administer all or certain aspects of this Plan. Any such committee
shall be comprised solely of one or more directors or such number of directors as may be required under applicable law. A committee may
delegate some or all of its authority to another committee so constituted. The Board or a committee comprised solely of directors may
also delegate, to the extent permitted by NRS 78.125 or any applicable law, to one or more officers of the Corporation, its powers under
this Plan (a) to designate Eligible Persons who will receive grants of awards under this Plan, and (b) to detem1ine the number of shares
subject to, and the other terms and conditions of, such awards. The Board may delegate different levels of authority to different committees
with administrative and grant authority under this Plan. Unless otherwise provided in the bylaws of the Corporation or the applicable
charter of any Administrator: (a) a majority of the members of the acting Administrator shall constitute a quorum, and (b) the affim1ative
vote of a majority of the members present assuming the presence of a quorum or the unanimous written consent of the members of the Administrator
shall constitute due authorization of an action by the acting Administrator.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.2pt 0pt 0; text-indent: 40pt">&nbsp;</P>

<P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin: 1.2pt 0pt 0; text-align: justify; text-indent: 40pt">With respect to awards intended to satisfy the requirements
for performance-based compensation under Section l 62(m) of the Internal Revenue Code of 1986, as amended (the <B>&quot;Code&quot;) </B>,
this Plan shall be administered by a committee consisting solely of two or more outside directors (as this requirement is applied under
Section I62(m) of the Code); <I>provided, however; </I>that the failure to satisfy such requirement shall not affect the validity of
the action of any committee otherwise duly authorized and acting in the matter. Award grants, and transactions in or involving awards,
intended to be exempt under Rule l 6b-3 under the Securities Exchange Act of 1934, as amended (the <B>&quot;Exchange Act&quot;) </B>,
must be duly and timely authorized by the Board or a committee consisting solely of two or more non-employee directors (as this requirement
is applied under Rule I6b-3 promulgated under the Exchange Act). To the extent required by any applicable stock exchange, this Plan shall
be administered by a committee composed entirely of independent directors (within the meaning of the applicable stock exchange). Awards
granted to non-employee directors shall not be subject to the discretion of any officer or employee of the Corporation and shall be administered
exclusively by a committee consisting solely of independent <FONT STYLE="letter-spacing: -0.1pt">directors.</FONT></P>

<P STYLE="font: 11pt/110% Times New Roman, Times, Serif; margin: 10.55pt 0pt 10pt; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-size: 10pt"><B>3.2
<I>Powers of the Administrator. </I></B></FONT><FONT STYLE="font-size: 9.5pt">Subject to the express provisions of this Plan, the Administrator
is authorized and empowered to do all things necessary or desirable in connection with the authorization of awards and the administration
of this Plan (in the case of a committee or delegation to one or more officers, within the authority delegated to that committee or person(s)),
including, without limitation, the authority to:</FONT></P>

<P STYLE="font: 11pt/110% Times New Roman, Times, Serif; margin: 3.4pt 0pt 0pt; text-align: justify; text-indent: 39.7pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 10pt">determine eligibility and, from among those persons determined to be eligible, the particular Eligible
Persons who will receive awards under this Plan;</FONT></P>

<P STYLE="font: 11pt/105% Times New Roman, Times, Serif; margin: 11.15pt 0pt 0pt; text-align: justify; text-indent: 39.75pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 10pt">grant awards to Eligible Persons, determine the price at which securities will be offered or awarded
and the number of securities to be offered or awarded to any of such persons, determine the other specific terms and conditions of such
awards consistent with the express limits of this Plan, establish the installments (if any) in which such awards shall become exercisable
or shall vest (which may include, without limitation, performance and/or time-based schedules), or determine that no delayed exercisability
or vesting is required, establish any applicable performance targets, and establish the events of termination or reversion of such awards;</FONT></P>

<P STYLE="font: 11pt/105% Times New Roman, Times, Serif; margin: 11.15pt 0pt 0pt; text-align: justify; text-indent: 39.75pt"><FONT STYLE="font-size: 10pt">(c)
approve the forms of award agreements (which need not be identical either as to type of award or among participants); </FONT><P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 11pt/106% Times New Roman, Times, Serif; margin: 0 0pt 0pt; text-align: justify; text-indent: 40.25pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">construe and interpret this Plan and any agreements defining the rights and obligations of the Corporation,
its Subsidiaries, and participants under this Plan, further define the terms used in this Plan, and prescribe, amend and rescind rules
and regulations relating to the administration of this Plan or the awards granted under this Plan;</FONT></P>

<P STYLE="font: 11pt/110% Times New Roman, Times, Serif; margin: 11.45pt 0pt 0pt; text-align: justify; text-indent: 39.95pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 10pt">cancel, modify, or waive the Corporation's rights with respect to, or modify, discontinue, suspend,
or terminate any or all outstanding awards, subject to any required consent under Section 8.6.5;</FONT></P>

<P STYLE="font: 11pt/105% Times New Roman, Times, Serif; margin: 10.75pt 0pt 0pt; text-align: justify; text-indent: 39.95pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 10pt">accelerate or extend the vesting or exercisability or extend the term of any or all such outstanding
awards (in the case of options or stock appreciation rights, within the maximum ten-year term of such awards) in such circumstances as
the Administrator may deem appropriate (including, without limitation, in connection with a termination of employment or services or other
events of a personal nature) subject to any required consent under Section 8.6.5;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt/105% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0pt; text-align: justify; text-indent: 40.25pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 10pt">adjust the number of shares of Common Stock subject to any award, adjust the price of any or all
outstanding awards or otherwise change previously imposed terms and conditions, in such circumstances as the Administrator may deem appropriate,
in each case subject to compliance with applicable stock exchange requirements, Sections 4 and 8.6 and the applicable requirements of
Code Section 162(m) and treasury regulations thereunder with respect to awards that are intended to satisfy the requirements for performance-based
compensation under Section 162(m), and provided that in no case (except due to an adjustment contemplated by Section 7 or any repricing
that may be approved by stockholders) shall such an adjustment constitute a repricing (by amendment, cancellation and regrant, exchange
or other means) of the per share exercise or base price of any stock option or stock appreciation right or other award granted under this
Plan, and further provided that any adjustment or change in terms made pursuant to this Section 3.2(g) shall be made in a manner that,
in the good faith determination of the Administrator will not likely result in the imposition of additional taxes or interest under Section
409A of the Code;</FONT></P>

<P STYLE="font: 11pt/107% Times New Roman, Times, Serif; margin: 11.25pt 0pt 0pt; text-align: justify; text-indent: 39.7pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">determine the date of grant of an award, which may be a designated date after but not before the
date of the Administrator's action (unless otherwise designated by the Administrator, the date of grant of an award shall be the date
upon which the Administrator took the action granting an award);</FONT></P>

<P STYLE="font: 11pt/107% Times New Roman, Times, Serif; margin: 11.05pt 0pt 0pt; text-align: justify; text-indent: 39.9pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">determine whether, and the extent to which, adjustments are required pursuant to Section 7 hereof
and authorize the termination, conversion, substitution, acceleration or succession of awards upon the occurrence of an event of the type
described in Section 7;</FONT></P>

<P STYLE="font: 11pt/112% Times New Roman, Times, Serif; margin: 10.35pt 0pt 0pt; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">acquire or settle (subject to Sections 7 and 8.6) rights under awards in cash, stock of equivalent
value, or other consideration; and</FONT></P>

<P STYLE="font: 11pt/110% Times New Roman, Times, Serif; margin: 10.1pt 0pt 0pt; text-align: justify; text-indent: 39.7pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 10pt">determine the Fair Market Value (as defined in Section 5.6) of the Common Stock or awards under this
Plan from time to time and/or the manner in which such value will be determined.</FONT></P>

<P STYLE="font: 11pt/105% Times New Roman, Times, Serif; text-align: justify; margin: 10.4pt 0pt 0; text-indent: 45pt"><FONT STYLE="font-size: 9.5pt"><B>3.3
<I>Binding Determinations. </I></B></FONT><FONT STYLE="font-size: 10pt">Any action taken by, or inaction of, the Corporation, any Subsidiary,
or the Administrator relating or pursuant to this Plan and within its authority hereunder or under applicable law shall be within the
absolute discretion of that entity or body and shall be conclusive and binding upon all persons. Neither the Board, the Administrator,
nor any Board committee, nor any member thereof or person acting at the direction thereof, shall be liable for any act, omission, interpretation,
construction or determination made in good faith in connection with this Plan (or any award made under this Plan), and all such persons
shall be entitled to indemnification and reimbursement by the Corporation in respect of any claim, loss, damage or expense (including,
without limitation, legal fees) arising or resulting therefrom to the fullest extent permitted by law and/or under any directors and officers
liability insurance coverage that may be in effect from time to time.</FONT></P>

<P STYLE="font: 11pt/105% Times New Roman, Times, Serif; text-align: justify; margin: 11.25pt 0pt 0; text-indent: 45pt"><FONT STYLE="font-size: 9.5pt"><B>3.4
<I>Reliance on Experts. </I></B></FONT><FONT STYLE="font-size: 10pt">In making any determination or in taking or not taking any action
under this Plan, the Administrator may obtain and may rely upon the advice of experts, including professional advisors to the Corporation.
The Administrator shall not be liable for any such action or determination taken or made or omitted in good faith based upon such advice.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 3.25pt 0pt 0; text-indent: 45pt"><B>&nbsp;</B></P>

<P STYLE="font: 9.5pt/110% Times New Roman, Times, Serif; text-align: justify; margin: 3.25pt 0pt 0; text-indent: 45pt"><B>3.5 <I>Delegation of Non-Discretionary
Functions. </I></B>In addition to the ability to delegate certain grant authority to officers of the Corporation as set forth in Section
3.1, the Administrator may also delegate ministerial, non-discretionary functions to individuals who are officers or employees of the
Corporation or any of its Subsidiaries or to third parties.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.75pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 8.15pt"></TD><TD STYLE="text-align: justify; width: 27.55pt">4.</TD><TD STYLE="text-align: justify">SHARES OF COMMON STOCK SUBJECT TO THE PLAN; SHARE <FONT STYLE="letter-spacing: -0.1pt">LIMIT</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 11pt/107% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><FONT STYLE="font-size: 9.5pt"><B>4.1
<I>Shares Available. </I></B>Subject to the provisions of Section 7.1</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">,</FONT>
<FONT STYLE="font-size: 9.5pt">the capital stock available for issuance under this Plan shall be shares of the Corporation's authorized
but unissued Common Stock. For purposes of this Plan, </FONT><FONT STYLE="font-size: 10pt"><B>&quot;Common Stock&quot; </B></FONT><FONT STYLE="font-size: 9.5pt">shall
mean the common stock of the Corporation and such other securities or property as may become the subject of awards under this Plan, or
may become subject to such awards, pursuant to an adjustment made under Section 7.1.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.85pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt/110% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-indent: 45pt"><FONT STYLE="font-size: 10pt"><B>4.2
<I>Share Limit.</I></B></FONT> <FONT STYLE="font-size: 9.5pt">The maximum number of shares of Common Stock that may be delivered pursuant
to awards granted to Eligible Persons under this Plan may not exceed 10,500,000,000 shares (the &quot;Share Limit&quot;) The foregoing
Share Limit is subject to adjustment as contemplated by Section 4.3, Section 7.1, and Section 8.10.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.05pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><FONT STYLE="font-size: 10pt"><B>4.3
<I>Awards Settled ill Cash, Reissue of Awards a11d Shares</I></B><I>.</I></FONT> <FONT STYLE="font-size: 9.5pt">The Administrator may
adopt reasonable counting procedures to ensure appropriate counting, avoid double counting (as, for example, in the case of tandem or
substitute awards) and make adjustments in accordance with this Section 4.3. Shares shall be counted against those reserved to the extent
such shares have been delivered and are no longer subject to a substantial risk of forfeiture. Accordingly, (i) to the extent that an
award under the Plan, in whole or in part, is canceled, expired, forfeited, settled in cash, settled by delivery of fewer shares than
the number of shares underlying the award, or otherwise terminated without delivery of shares to the participant, the shares retained
by or returned to the Corporation will not be deemed to have been delivered under the Plan and will be deemed to remain or to become available
under this Plan; and (ii) shares that are withheld from such an award or separately surrendered by the participant in payment of the exercise
price or taxes relating to such an award shall be deemed to constitute shares not delivered and will be deemed to remain or to become
available under the Plan. The foregoing adjustments to the Share Limit of this Plan are subject to any applicable limitations under Section
162(m) of the Code with respect to awards intended as performance-based compensation thereunder.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.5pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt/108% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-indent: 45pt"><FONT STYLE="font-size: 10pt"><B>4.4
<I>Reservation of Shares; No Fractional Shares</I></B><I>.</I></FONT> <FONT STYLE="font-size: 9.5pt">The Corporation shall at all times
reserve a number of shares of Common Stock sufficient to cover the Corporation's obligations and contingent obligations to deliver shares
with respect to awards then outstanding under this Plan (exclusive of any dividend equivalent obligations to the extent the Corporation
has the right to settle such rights in cash). No fractional shares shall be delivered under this Plan. The Administrator may pay cash
in lieu of any fractional shares in settlements of awards under this Plan.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.65pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 6.65pt"></TD><TD STYLE="text-align: justify; width: 28.4pt">5.</TD><TD STYLE="text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">AWARDS</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 11pt/107% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><FONT STYLE="font-size: 10pt"><B>5.1
<I>Type and Form of Awards</I></B><I>. </I></FONT><FONT STYLE="font-size: 9.5pt">The Administrator shall determine the type or types of
award(s) to be made to each selected Eligible Person. Awards may be granted singly, in combination or in tandem. Awards also may be made
in combination or in tandem with, in replacement of, as alternatives to, or as the payment form for grants or rights under any other employee
or compensation plan of the Corporation or one of its Subsidiaries. The types of awards that may be granted under this Plan are:</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.75pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt/110% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-indent: 45pt"><FONT STYLE="font-size: 9.5pt"><B>5.1.1
<I>Stock Options.</I></B> A stock option is the grant of a right to purchase a specified number of shares of Common Stock during a specified
period as determined by the Administrator. An option may be intended as an incentive stock option within the meaning of Section 422 of
the Code (an </FONT><FONT STYLE="font-size: 10pt"><B>&quot;ISO&quot;) </B></FONT><FONT STYLE="font-size: 9.5pt">or a nonqualified stock
option (an option not intended to be an ISO). The award agreement for an option will indicate if the option is intended as an ISO; otherwise
it will be deemed to be a nonqualified stock option. The maximum term of each option (ISO or nonqualified) shall be ten (10) years. The
per share exercise price for each ISO shall be not less than I 00% of the Fair Market Value of a share of Common Stock on the date of
grant of the option. When an option is exercised, the exercise price for the shares to be purchased shall be paid in full in cash or such
other method permitted by the Administrator consistent with Section 5.5.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.2pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt/107% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 49.5pt"><FONT STYLE="font-size: 10pt"><B>5.1.2
<I>Additional Rules Applicable to ISOs</I></B><I>. </I></FONT><FONT STYLE="font-size: 9.5pt">To the extent that the aggregate Fair Market
Value (determined at the time of grant of the applicable option) of stock with respect to which ISOs first become exercisable by a participant
in any calendar year exceeds $100,000, taking into account both Common Stock subject to ISOs under this Plan and stock subject to ISOs
under all other plans of the Corporation or one of its Subsidiaries (or any parent or predecessor corporation to the extent required by
and within the meaning of Section 422 of the Code and the regulations promulgated thereunder), such options shall be treated as nonqualified
stock options. In reducing the number of options treated as ISOs to meet the $100,000 limit, the most recently granted options shall be
reduced first. To the extent a reduction of simultaneously granted options is neces<FONT STYLE="letter-spacing: 1.3pt">s</FONT>ary to
meet the $100,000 limit, the Administrator may, in the manner and to the extent permitted by law, designate which shares of Common Stock
are to be treated as shares acquired pursuant to the exercise of an ISO. ISOs may only be granted to employees of the Corporation or one
of its subsidiaries (for this purpose, the term &quot;subsidiary&quot; is used as defined in Section 424(f) of the Code, which generally
requires an unbroken chain of ownership of at least 50% of the total combined voting power of all classes of stock of each subsidiary
in the chain beginning with the </FONT><FONT STYLE="font-size: 10pt">Corporation and ending with the subsidiary in question). There shall
be imposed in any award agreement relating to ISOs such other terms and conditions as from time to time are required in order that the
option be an &quot;incentive stock option&quot; as that term is defined in Section 422 of the Code. No ISO may be granted to any person
who, at the time the option is granted, owns (or is deemed to own under Section 424(d) of the Code) shares of outstanding Common Stock
possessing more than 10% of the total combined voting power of all classes of stock of the Corporation, unless the exercise price of such
option is at least 110% of the Fair Market Value of the stock subject to the option and such option by its terms is not exercisable after
the expiration of five years from the date such option is <FONT STYLE="letter-spacing: -0.1pt">granted.</FONT></FONT></P>

<P STYLE="text-align: justify; font: 11pt/106% Times New Roman, Times, Serif; margin: 10.95pt 0pt 0; text-indent: 45pt"><FONT STYLE="font-size: 9.5pt"><B>5.1.3
<I>Stock Appreciation Rights. </I></B></FONT><FONT STYLE="font-size: 10pt">A stock appreciation right or</FONT> <FONT STYLE="font-size: 9.5pt"><B>&quot;SAR&quot;
</B></FONT><FONT STYLE="font-size: 10pt">is a right to receive a payment, in cash and/or Common Stock, equal to the number of shares of
Common Stock being exercised multiplied by the excess of (i) the Fair Market Value of a share of Common Stock on the date the SAR is exercised,
over (ii) the Fair Market Value of a share of Common Stock on the date the SAR was granted as specified in the applicable award agreement
(the &quot;base price&quot;). The maximum term of a SAR shall be ten (10) <FONT STYLE="letter-spacing: -0.1pt">years.</FONT></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 1.05pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><B>5.1.4 <I>Restricted <FONT STYLE="letter-spacing: -0.1pt">Shares.</FONT></I></B></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.1pt 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt/105% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 80.15pt"><FONT STYLE="color: #333333; letter-spacing: -0.05pt">(a)</FONT>
<I>Restrictions.</I> Restricted shares are shares of Common Stock subject to such restrictions on transferability, risk of forfeiture
and other restrictions, if any, as the Administrator may impose, which restrictions may lapse separately or in combination at such times,
under such circumstances (including based on achievement of perfom1ance goals and/or future service requirements), in such installments
or otherwise, as the Administrator may determine at the date of grant or thereafter. Except to the extent restricted under the terms of
this Plan and the applicable award agreement relating to the restricted stock, a participant granted restricted stock shall have all of
the rights of a shareholder, including the right to vote the restricted stock and the right to receive dividends thereon (subject to any
mandatory reinvestment or other requirement imposed by the Administrator).</P>

<P STYLE="font: 11pt/105% Times New Roman, Times, Serif; margin: 11.45pt 0pt 0; text-align: justify; text-indent: 80.05pt"><FONT STYLE="font-size: 10pt; color: #333333; letter-spacing: -0.05pt">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: #333333; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><I>Certificates for Shares. </I>Restricted shares granted under this Plan may be evidenced in such
manner as the Administrator shall determine. If certificates representing restricted stock are registered in the name of the participant,
the Administrator may require that such certificates bear an appropriate legend referring to the terms, conditions and restrictions applicable
to such restricted stock, that the Corporation retain physical possession of the certificates, and that the participant deliver a stock
power to the Corporation, endorsed in blank, relating to the restricted stock. The Administrator may require that restricted shares are
held in escrow until all restrictions lapse.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt/105% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 80.15pt"><FONT STYLE="color: #333333; letter-spacing: -0.05pt">(c)</FONT>
<I>Dividends and Splits. </I>As a condition to the grant of an award of restricted stock, subject to applicable law, the Administrator
may require or permit a participant to elect that any cash dividends paid on a share of restricted stock be automatically reinvested in
additional shares of restricted stock or applied to the purchase of additional awards under this Plan. Unless otherwise determined by
the Administrator, stock distributed in connection with a stock split or stock dividend, and other property distributed as a dividend,
shall be subject to restrictions and a risk of forfeiture to the same extent as the restricted stock with respect to which such stock
or other property has been distributed.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0.25pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><B>5.1.5 <I>Restricted Share <FONT STYLE="letter-spacing: -0.1pt">Units.</FONT></I></B></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.45pt 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 11pt/105% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-indent: 85.5pt"><FONT STYLE="font-size: 10pt">(a)
<I>Grant of Restricted Share Units. </I>A restricted share unit, or </FONT><FONT STYLE="font-size: 9.5pt"><B>&quot;RSU&quot;, </B></FONT><FONT STYLE="font-size: 10pt">represents
the right to receive from the Corporation on the respective scheduled vesting or payment date for such RSU, one Common Share. An award
of RSUs may be subject to the attainment of specified performance goals or targets, forfeitability provisions and such other tem1s and
conditions as the Administrator may determine, subject to the provisions of this Plan. At the time an award of RSUs is made, the Administrator
shall establish a period of time during which the restricted share units shall vest and the timing for settlement of the RSU.</FONT></P>

<P STYLE="text-align: justify; font: 10pt/105% Times New Roman, Times, Serif; margin: 11.4pt 0pt 0; text-indent: 85.5pt">(b) <I>Dividend Equivalent Accounts.
</I>Subject to the terms and conditions of the Plan and the applicable award agreement, as well as any procedures established by the Administrator,
prior to the expiration of the applicable vesting period of an RSU, the Administrator may determine to pay dividend equivalent rights
with respect to RSUs, in which case, the Corporation shall establish an account for the participant and reflect in that account any securities,
cash or other property comprising any dividend or property distribution with respect to the shares of Common Stock underlying each RSU.
Each amount or other property credited to any such account shall be subject to the same vesting conditions as the RSU to which it relates.
The participant shall have the right to be paid the amounts or other property credited to such account upon vesting of the subject RSU.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0.25pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt/102% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 85.5pt">(c) <I>Rights as a Shareholder.</I>
Subject to the restrictions imposed under the terms and conditions of this Plan and the applicable award agreement, each participant receiving
RSUs shall have no rights as a shareholder with respect to such RSUs until such time as shares of Common Stock are issued to the participant.
No shares of Common Stock shall be issued at the time a RSU is granted, and the Company will not be required to set aside a fund for the
payment of any such award. Except as otherwise provided in the applicable award agreement, shares of Common Stock issuable under an RSU
shall be treated as issued on the first date that the holder of the RSU is no longer subject to a substantial risk of forfeiture as determined
for purposes of Section 409A of the Code, and the holder shall be the owner of such shares of Common Stock on such date. An award agreement
may provide that issuance of shares of Common Stock under an RSU may be deferred beyond the first date that the RSU is no longer subject
to a substantial risk of forfeiture, provided that such deferral is structured in a manner that is intended to comply with the requirements
of Section 409A of the <FONT STYLE="letter-spacing: -0.1pt">Code.</FONT></P>

<P STYLE="text-align: justify; font: 11pt/107% Times New Roman, Times, Serif; margin: 11.05pt 0pt 0; text-indent: 45pt"><FONT STYLE="font-size: 9.5pt"><B>5.1.6
<I>Cash Awards.</I></B></FONT> <FONT STYLE="font-size: 10pt">The Administrator may, from time to time, subject to the provisions of the
Plan and such other terms and conditions as it may determine, grant cash bonuses (including without limitation, discretionary awards,
awards based on objective or subjective perforn1ance criteria, awards subject to other vesting criteria or awards granted consistent with
Section 5.2 below). Cash awards shall be awarded in such amount and at such times during the term of the Plan as the Administrator shall
determine.</FONT></P>

<P STYLE="text-align: justify; font: 11pt/106% Times New Roman, Times, Serif; margin: 11.3pt 0pt 0; text-indent: 45pt"><FONT STYLE="font-size: 9.5pt"><B>5.1.7
<I>Other Awards. </I></B></FONT><FONT STYLE="font-size: 10pt">The other types of awards that may be granted under this Plan include: (a)
stock bonuses, performance stock, performance units, dividend equivalents, or similar rights to purchase or acquire shares, whether at
a fixed or variable price or ratio related to the Common Stock (subject to the requirements of Section 5.1.1 and in compliance with applicable
laws), upon the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions,
or any combination thereof; or (b) any similar securities with a value derived from the value of or related to the Common Stock and/or
returns <FONT STYLE="letter-spacing: -0.1pt">thereon.</FONT></FONT></P>

<P STYLE="text-align: justify; font: 11pt/105% Times New Roman, Times, Serif; margin: 10.55pt 0pt 0; text-indent: 49.5pt"><FONT STYLE="font-size: 9.5pt"><B>5.2
<I>Section 162(m) Performance-Based Awards. </I></B></FONT><FONT STYLE="font-size: 10pt">Without limiting the generality of the foregoing,
any of the types of awards listed in Sections 5.1.4 through 5.1.7 above may be, and options and SARs granted with an exercise or base
price not less than the Fair Market Value of a share of Common Stock at the date of grant </FONT><FONT STYLE="font-size: 9.5pt"><B>(&quot;Qualifying
Options&quot; </B></FONT><FONT STYLE="font-size: 10pt">and</FONT> <FONT STYLE="font-size: 9.5pt"><B>&quot;Qualifying SARs </B>,&quot;</FONT>
<FONT STYLE="font-size: 10pt">respectively) typically will be, granted as awards intended to satisfy the requirements for &quot;performance-based
compensation&quot; within the meaning of Section 162(m) of the Code</FONT> <FONT STYLE="font-size: 9.5pt"><B>(&quot;Performance-Based
Awards&quot;)</B> .</FONT> <FONT STYLE="font-size: 10pt">The grant, vesting, exercisability or payment of Performance-Based Awards may
depend (or, in the case of Qualifying Options or Qualifying SARs, may also depend) on the degree of achievement of one or more performance
goals relative to a pre-established targeted level or levels using the Business Criteria provided for below for the Corporation on a consolidated
basis or for one or more of the Corporation's subsidiaries, segments, divisions or business units, or any <FONT STYLE="letter-spacing: -0.1pt">combination
of the foregoing. Such criteria may be evaluated on an absolute basis or relative to prior periods, industry peers, or stock market indices.
Any Qualifying Option or Qualifying SAR shall be subject to the requirements of Section 5.2.1 and 5.2.3 in order for </FONT>such award
to satisfy the requirements for &quot;perfon11ance-based compensation&quot; under Section 162(m) of the Code. Any other Perforn1ance-Based
Award shall be subject to all of the following provisions of this Section 5.2.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0.1pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt/105% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-indent: 49.5pt"><FONT STYLE="font-size: 9.5pt"><B>5.2.1
<I>Class; Administrator. </I></B></FONT><FONT STYLE="font-size: 10pt">The eligible class of persons for Performance-Based Awards under
this Section 5.2 shall be officers and employees of the Corporation or one of its Subsidiaries. The Administrator approving Performance-Based
Awards or making any certification required pursuant to Section 5.2.4 must be constituted as provided in Section 3.1 for awards that are
intended as performance-based compensation under Section 162(m) of the Code.</FONT></P>

<P STYLE="text-align: justify; font: 11pt/105% Times New Roman, Times, Serif; margin: 11.1pt 0pt 0; text-indent: 49.5pt"><FONT STYLE="font-size: 10pt"><B>5.2.2
<I>Performance Goals</I></B><I>. </I>The specific performance goals for Performance-Based Awards (other than Qualifying Options and Qualifying
SARs) shall be, on an absolute or relative basis, established based on such business criteria as selected by the Administrator in its
sole discretion </FONT><FONT STYLE="font-size: 9.5pt"><B>(&quot;Business Criteria&quot;), </B></FONT><FONT STYLE="font-size: 10pt">including
the following: (1) earnings per share, (2) cash flow (which means cash and cash equivalents derived from either (i) net cash flow from
operations or (ii) net cash flow from operations, financing and investing activities), (3) total stockholder return, (4) price per share
of Common Stock, (5) gross revenue, (6) revenue growth, (7) operating income (before or after taxes), (8) net earnings (before or after
interest, taxes, depreciation and/or amortization), (9) return on equity, (10) capital employed, or on assets or on net investment, (11)
cost containment or reduction, (12) cash cost per ounce of production, (13) operating margin, (14) debt reduction, (15) resource amounts,
(16) production or production growth, (17) resource replacement or resource growth, (18) successful completion of financings, or (19)
any combination of the foregoing. To qualify awards as performance-based under Section 162(m), the applicable Business Criterion (or Business
Criteria, as the case may be) and specific performance goal or goals </FONT><FONT STYLE="font-size: 9.5pt"><B>(&quot;targets&quot;) </B></FONT><FONT STYLE="font-size: 10pt">must
be established and approved by the Administrator during the first 90 days of the performance period (and, in the case of performance periods
of less than one year, in no event after 25% or more of the performance period has elapsed) and while performance relating to such target(s)
remains substantially uncertain within the meaning of Section l62(m) of the Code. Performance targets shall be adjusted to mitigate the
unbudgeted impact of material, unusual or nonrecurring gains and losses, accounting changes or other extraordinary events not foreseen
at the time the targets were set unless the Administrator provides otherwise at the time of establishing the targets; provided that the
Administrator may not make any adjustment to the extent it would adversely affect the qualification of any compensation payable under
such performance targets as &quot;performance-based compensation&quot; under Section 162(m) of Code. The applicable performance measurement
period may not be less than 3 months nor more than 10 years.</FONT></P>

<P STYLE="text-align: justify; font: 10pt/112% Times New Roman, Times, Serif; margin: 0.15in 0pt 0; text-indent: 45pt"><B>5.2.3 <I>Form of Payment</I></B><I>.</I>
Grants or awards intended to qualify under this Section 5.2 may be paid in cash or shares of Common Stock or any combination thereof.</P>

<P STYLE="text-align: justify; font: 10pt/106% Times New Roman, Times, Serif; margin: 9.35pt 0pt 0; text-indent: 45pt"><B>5.2.4 <I>Certification of Payment</I></B><I>.
</I>Before any Perfom1ru1ce-Based Award under this Section 5.2 (other than Qualifying Options and Qualifying SARs) is paid and to the
extent required to qualify the award as performance-based compensation within the meaning of Section l62(m) of the Code, the Administrator
must certify in writing that the perfom1ance target(s) and any other material terms of the Performance-Based Award were in fact timely
satisfied.</P>

<P STYLE="text-align: justify; font: 11pt/112% Times New Roman, Times, Serif; margin: 3.8pt 0pt 0; text-indent: 45pt"><FONT STYLE="font-size: 10pt"><B>5.2.5
<I>Reservation of Discretion</I></B><I>.</I></FONT> <FONT STYLE="font-size: 9.5pt">The Administrator will have the discretion to determine
the restrictions or other limitations of the individual awards granted under this Section 5.2 including the authority to reduce awards,
payouts or vesting or to pay no awards, in its sole discretion, if the Administrator preserves such authority at the time of grant by
language to this effect in its authorizing resolutions or otherwise.</FONT></P>

<P STYLE="text-align: justify; font: 11pt/111% Times New Roman, Times, Serif; margin: 10.9pt 0pt 0; text-indent: 45pt"><FONT STYLE="font-size: 9.5pt"><B>5.2.6
<I>Expiration </I></B></FONT><I><FONT STYLE="font-size: 10pt">of </FONT><FONT STYLE="font-size: 9.5pt"><B>Grant Authority. </B></FONT></I><FONT STYLE="font-size: 9.5pt">As
required pursuant to Section 162(m) of the Code and the regulations promulgated thereunder, the Administrator's authority to grant new
awards that are intended to qualify as performance-based compensation within the meaning of Section 162(m) of the Code (other than Qualifying
Options and Qualifying SARs) shall terminate upon the first meeting of the Corporation's stockholders that occurs in the fifth year following
the year in which the Corporation's stockholders first approve this Plan (the <B>&quot;162(m) Term&quot;) </B>.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt/111% Times New Roman, Times, Serif; margin: 0.15in 0pt 0; text-indent: 45pt"><B>5.2.7 <I>Compensation Limitations.
</I></B>The maximum aggregate number of shares of Common Stock that may be issued to any Eligible Person during the term of this Plan
pursuant to Qualifying Options and Qualifying SARs may not exceed the Share Limit. The maximum aggregate number of shares of Common Stock
that may be issued to any Eligible Person pursuant to Performance-Based Awards granted during the 162(m) Term (other than cash awards
granted pursuant to Section 5.1.6 and Qualifying Options or Qualifying SARs) may not exceed the Share Limit. The maximum amount that may
be paid to any Eligible Person pursuant to Performance-Based Awards granted pursuant to Sections 5.1.6 (ca<FONT STYLE="letter-spacing: 1.9pt">s</FONT>h
awards) during the 162(m) Term may not exceed $1,000,000.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.4pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><B>5.3 <I>Award Agreements. </I></B>Each
award shall be evidenced by a written or electronic award agreement in the form approved by the Administrator and, if required by the
Administrator, executed by the recipient of the award. The Administrator may authorize any officer of the Corporation (other than the
particular award recipient) to execute any or all award agreements on behalf of the Corporation (electronically or otherwise). The award
agreement shall set forth the material terms and conditions of the award as established by the Administrator consistent with the express
limitations of this Plan.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.55pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-indent: 45pt"><B>5.4 <I>Deferrals and Settlements.
</I></B>Payment of awards may be in the form of cash, Common Stock, other awards or combinations thereof as the Administrator shall determine,
and with such restrictions as it may impose. The Administrator may also require or permit participants to elect to defer the issuance
of shares of Common Stock or the settlement of awards in cash under such rules and procedures as it may establish under this Plan. The
Administrator may also provide that deferred settlements include the payment or crediting of interest or other earnings on the deferral
amounts, or the payment or crediting of dividend equivalents where the deferred amounts are denominated in shares. All mandatory or elective
deferrals of the issuance of shares of Common Stock or the settlement of cash awards shall be structured in a manner that is intended
to comply with the requirements of Section 409A of the <FONT STYLE="letter-spacing: -0.1pt">Code.</FONT></P>

<P STYLE="text-align: justify; font: 11pt/112% Times New Roman, Times, Serif; margin: 10.35pt 0pt 0; text-indent: 45pt"><FONT STYLE="font-size: 10pt"><B>5.5
<I>Consideration for Common Stock or Awards</I></B><I>.</I></FONT> <FONT STYLE="font-size: 9.5pt">The purchase price for any award granted
under this Plan or the Common Stock to be delivered pursuant to an award, as applicable, may be paid by means of any lawful consideration
as determined by the Administrator and subject to compliance with applicable laws, including, without limitation, one or a combination
of the following <FONT STYLE="letter-spacing: -0.1pt">methods:</FONT></FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.1pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 33.4pt"></TD><TD STYLE="text-align: justify; width: 6.1pt"><FONT STYLE="font-size: 9.5pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">services rendered by the recipient of such <FONT STYLE="letter-spacing: -0.1pt">award;</FONT></FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 3.4pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 33.4pt"></TD><TD STYLE="text-align: justify; width: 6.65pt"><FONT STYLE="font-size: 9.5pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">cash, check payable to the order of the Corporation, or electronic funds <FONT STYLE="letter-spacing: -0.1pt">transfer;</FONT></FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 3.75pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 33.4pt"></TD><TD STYLE="text-align: justify; width: 6.65pt"><FONT STYLE="font-size: 9.5pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">notice and third party payment in such manner as may
be authorized by the <FONT STYLE="letter-spacing: -0.1pt">Administrator;</FONT></FONT></TD></TR>
</TABLE>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt">&nbsp;</P>

<P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 33.4pt"></TD><TD STYLE="text-align: justify; width: 6.65pt"><FONT STYLE="font-size: 9.5pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">the delivery of previously owned shares of Common Stock
that are fully vested and <FONT STYLE="letter-spacing: -0.1pt">unencumbered;</FONT></FONT></TD></TR>
</TABLE>
<P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify"></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 3.75pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 34.15pt"></TD><TD STYLE="text-align: justify; width: 5.9pt"><FONT STYLE="font-size: 9.5pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">by a reduction in the number of shares otherwise deliverable pursuant to the
award; <FONT STYLE="letter-spacing: -0.25pt">or</FONT></FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 3.35pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/105% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 34.1pt"></TD><TD STYLE="text-align: justify; width: 6.7pt"><FONT STYLE="font-size: 9.5pt">&bull;</FONT></TD><TD STYLE="text-align: justify; padding-right: 9.25pt"><FONT STYLE="font-size: 9.5pt">subject to such procedures as the Administrator may
adopt, pursuant to a &quot;cashless exercise&quot; with a third party who provides financing for the purposes of (or who otherwise facilitates)
the purchase or exercise of awards.</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.2pt 0pt 0">&nbsp;</P>

<P STYLE="font: 9.5pt/107% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0.2pt">In the event that the
Administrator allows a participant to exercise an award by delivering shares of Common Stock previously owned by such participant and
unless otherwise expressly provided by the Administrator, any shares delivered which were initially acquired by the participant from
the Corporation (upon exercise of a stock option or otherwise) must have been owned by the participant at least six months as of the
date of delivery (or such other period as may be required by the Administrator in order to avoid adverse accounting treatment). Shares
of Common Stock used to satisfy the exercise price of an option shall be valued at their Fair Market Value on the date of exercise. The
Corporation will not be obligated to deliver any shares unless and until it receives full payment of the exercise or purchase price therefor
and any related withholding obligations under Section 8.5 and any other conditions to exercise or purchase, as established from time
to time by the Administrator, have been satisfied. Unless otherwise expressly provided in the applicable award agreement, the Administrator
may at any time eliminate or limit a participant's ability to pay the purchase or exercise price of any award by any method other than
cash payment to the Corporation.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.65pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-indent: 45pt"><B>5.6 <I>Definition of Fair Market
Value.</I></B> For purposes of this Plan &quot;Fair Market Value&quot; shall mean, unless otherwise determined or provided by the Administrator
in the circumstances, the closing price for a share of Common Stock on the trading day immediately before the grant date, as furnished
by the NASDAQ Stock Market or other principal stock exchange on which the Common Stock is then listed for the date in question, or if
the Common Stock is no longer listed on a principal stock exchange, then by the Over-the-Counter Bulletin Board or OTC Markets. If the
Common Stock is no longer listed on the NASDAQ Capital Market or listed on a principal stock exchange or is no longer actively traded
on the Over-the-Counter Bulletin Board or OTC Markets as of the applicable date, the Fair Market Value of the Common Stock shall be the
value as reasonably determined by the Administrator for purposes of the award in the circumstances.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.9pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><B>5.7 <I>Transfer <FONT STYLE="letter-spacing: -0.1pt">Restrictions.</FONT></I></B></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.95pt 0pt 0"><I>&nbsp;</I></P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><B>5.7.1 <I>Limitations on Exercise
and Transfer.</I></B> Unless otherwise expressly provided in (or pursuant to) this Section 5.7, by applicable law and by the award agreement,
as the same may be amended, (a) all awards are non-transferable and shall not be subject in any manner to sale, transfer, anticipation,
alienation, assignment, pledge, encumbrance or charge; (b) awards shall be exercised only by the participant; and (c) amounts payable
or shares issuable pursuant to any award shall be delivered only to (or for the account of) the participant.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.15pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><B>5.7.2 <I>Exceptions. </I></B>The
Administrator may permit awards to be exercised by and paid to, or otherwise transferred to, other persons or entities pursuant to such
conditions and procedures, including limitations on subsequent transfers, as the Administrator may, in its sole discretion, establish
in writing (provided that any such transfers of ISOs shall be limited to the extent permitted under the federal tax laws governing ISOs).
Any permitted transfer shall be subject to compliance with applicable federal and state securities <FONT STYLE="letter-spacing: -0.2pt">laws.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.5pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-indent: 45pt"><B>5.7.3 <I>Further Exceptions to Limits on
Transfer</I></B><I>.</I> The exercise and transfer restrictions in Section 5.7.1 shall not apply <FONT STYLE="letter-spacing: -0.25pt">to:</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.95pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 45.7pt"></TD><TD STYLE="text-align: justify; width: 14.3pt"><FONT STYLE="font-size: 9.5pt; letter-spacing: -0.05pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">transfers to the <FONT STYLE="letter-spacing: -0.1pt">Corporation,</FONT></FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.95pt 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 39.95pt"><FONT STYLE="font-size: 9.5pt; letter-spacing: -0.05pt">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 9.5pt">the designation of a beneficiary to receive benefits in the event of the participant's death or,
if the participant has died, transfers to or exercise by the participant's beneficiary, or, in the absence of a validly designated beneficiary,
transfers by will or the laws of descent and distribution,</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.7pt 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt/111% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 41.05pt"><FONT STYLE="font-size: 9.5pt; letter-spacing: -0.05pt">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 9.5pt">subject to any applicable limitations on ISOs, transfers to a family member (or former family member)
pursuant to a domestic relations order if approved or ratified by the Administrator,</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.7pt 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt/111% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 39.95pt"><FONT STYLE="font-size: 9.5pt; letter-spacing: -0.05pt">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 9.5pt">subject to any applicable limitations on ISOs, if the participant has suffered a disability, permitted
transfers or exercises on behalf of the participant by his or her legal representative, or</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.65pt 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt/110% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-align: justify; text-indent: 39.7pt"><FONT STYLE="font-size: 9.5pt; letter-spacing: -0.05pt">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 9.5pt">the authorization by the Administrator of &ldquo;cashless exercise&quot; procedures with third parties
who provide financing for the purpose of (or who otherwise facilitate) the exercise of awards consistent with applicable laws and the
express authorization of the <FONT STYLE="letter-spacing: -0.1pt">Administrator.</FONT></FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.65pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><B>5.8 <I>International Awards</I></B><I>.</I>
One or more awards may be granted to Eligible Persons who provide services to the Corporation or one of its Subsidiaries outside of the
United States. Any awards granted to such persons may, if deemed necessary or advisable by the Administrator, be granted pursuant to the
terms and conditions of any applicable sub-plans, if any, appended to this Plan and approved by the Administrator.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.85pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><B>5.9 <I>Vesting. </I></B>Subject to
Sections 5.1.2 and 5.10 hereof, awards shall vest at such time or times and subject to such terms and conditions as shall be determined
by the Administrator at the time of grant; <I>provided, however </I>, that in the absence of any award vesting periods designated by the
Administrator at the time of grant in the applicable award agreement, awards shall vest as to one third of the total number of shares
subject to the award on each of the first, second and third anniversaries of the date of grant.</P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: -0.75pt"><B>6. EEFFECT OF TERMINATION
OF SERVICE</B></P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 35.25pt"><B>6.1 <I>Termination of Employment.</I></B></P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 35.25pt"><I>&nbsp;</I></P>

<P STYLE="text-align: justify; font: 11pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 35.25pt"><FONT STYLE="font-size: 9.5pt; line-height: 110%"><B>6.1.1
</B>The administrator shall establish the effect of a termination of employment of service on the rights and benefits under each award
under this Plan and in so doing may make distinctions based upon, inter alia, the cause of termination and type of award. If the participant
is not an employee of the Corporation or one of its Subsidiaries and provides other services to the Corporation or one of </FONT>its <FONT STYLE="font-size: 9.5pt; line-height: 110%">Subsidiaries,
the Administrator shall be the sole judge for purposes of this Plan (unless a contract or the award agreement otherwise provides) of whether
the participant continues to render services to the Corporation or one of its Subsidiaries and the date, if any, upon which such services
shall be deemed to have terminated.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.4pt 0pt 0">&nbsp;</P>

<P STYLE="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 54.5pt"><B>6.1.2</B>
For awards of stock options or SARs, unless the award agreement provides otherwise, the exercise period of such options or SARs shall
expire: (1) three months after the last day that the participant is employed by or provides services to the Corporation or a Subsidiary
(provided; however, that in the event of the participant's death during this period, those persons entitled to exercise the option or
SAR pursuant to the laws of descent and distribution shall have one year following the date of death within which to exercise such option
or SAR); (2) in the case of a participant whose termination of employment is due to death or disability (as defined in the applicable
award agreement), 12 months after the last day that the participant is employed by or provides services to the Corporation or a Subsidiary;
and (3) immediately upon a participant's termination for &quot;cause&quot;. The Administrator will, in its absolute discretion, determine
the effect of all matters and questions relating to a termination of employment, including, but not by way of limitation, the question
of whether a leave of absence constitutes a termination of employment and whether a participant's termination is for &quot;cause.&quot;</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.65pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.05pt 0pt 0">If not defined in the applicable award
agreement, <B>&quot;Cause&quot;</B> shall <FONT STYLE="letter-spacing: -0.1pt">mean:</FONT></P>

<P STYLE="font: 9.5pt Times New Roman, Times, Serif; text-align: justify; margin: 0.05pt 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt/108% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 80.05pt"><FONT STYLE="font-size: 9.5pt; letter-spacing: -0.05pt">(i)
conviction of a felony or a crime involving fraud or moral turpitude; <FONT STYLE="letter-spacing: -0.25pt">or</FONT></FONT></P>

<P STYLE="font: 11pt/108% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 80.05pt"><FONT STYLE="font-size: 9.5pt; letter-spacing: -0.05pt"><FONT STYLE="letter-spacing: -0.25pt">&nbsp;</FONT></FONT></P>

<P STYLE="font: 11pt/108% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 80.05pt"><FONT STYLE="font-size: 9.5pt; letter-spacing: -0.05pt"><FONT STYLE="letter-spacing: -0.25pt">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 9.5pt">theft, material act of dishonesty or fraud, intentional falsification of any employment or Company
records, or commission of any criminal act which impairs participant's ability to perform appropriate employment duties for the Corporation;
or</FONT></FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.35pt 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt/108% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 79.7pt"><FONT STYLE="font-size: 9.5pt; letter-spacing: -0.05pt">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 9.5pt">intentional or reckless conduct or gross negligence materially harmful to the Company or the successor
to the Corporation after a Change in Control, including violation of a non-competition or confidentiality agreement; or</FONT></P>

<P STYLE="font: 11pt/108% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 79.7pt"><FONT STYLE="font-size: 9.5pt">(iv)
&nbsp;willful failure to follow lawful instructions of the person or body to which participant reports; <FONT STYLE="letter-spacing: -0.25pt">or</FONT></FONT></P>

<P STYLE="font: 11pt/108% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 79.7pt"><FONT STYLE="font-size: 9.5pt"><FONT STYLE="letter-spacing: -0.25pt">&nbsp;</FONT></FONT></P>

<P STYLE="font: 11pt/108% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 80pt"><FONT STYLE="font-size: 9.5pt; letter-spacing: -0.05pt">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 9.5pt">gross negligence or willful misconduct in the performance of participant's assigned duties. Cause
shall <U>not</U> include mere unsatisfactory performance in the achievement of participant's job objectives.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.95pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-indent: 45pt"><B>6.1.3 </B>For awards of restricted
shares, unless the award agreement provides otherwise, restricted shares that are subject to restrictions at the time that a participant
whose employment or service is terminated shall be forfeited and reacquired by the Corporation; <I>provided that, </I>the Administrator
may provide, by rule or regulation or in any award agreement, or may determine in any individual case, that restrictions or forfeiture
conditions relating to restricted shares shall be waived in whole or in part in the event of terminations resulting from specified causes,
and the Administrator may in other cases waive in whole or in part the forfeiture of restricted shares. Similar rules shall apply in respect
of RSUs.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.65pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><B>6.2 <I>Events Not Deemed Terminations
of Service</I></B><I>.</I> Unless the express policy of the Corporation or one of its Subsidiaries, or the Administrator, otherwise provides,
the employment relationship shall not be considered terminated in the case of (a) sick leave, (b) military leave, or (c) any other leave
of absence authorized by the Corporation or one of its Subsidiaries, or the Administrator; provided that unless reemployment upon the
expiration of such leave is guaranteed by contract or law, such leave is for a period of not more than 3 mouths. In the case of any employee
of the Corporation or one of its Subsidiaries on an approved leave of absence, continued vesting of the award while on leave from the
employ of the Corporation or one of its Subsidiaries may be suspended until the employee returns to service, unless the Administrator
otherwise provides or applicable law otherwise requires. In no event shall an award be exercised after the expiration of the term set
forth in the award agreement.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.7pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><B>6.3 <I>Effect of Change of Subsidiary
Status</I></B><I>.</I> For purposes of this Plan and any award, if an entity ceases to be a Subsidiary of the Corporation, a termination
of employment or service shall be deemed to have occurred with respect to each Eligible Person in respect of such Subsidiary who does
not continue as an Eligible Person in respect of another entity within the Corporation or another Subsidiary that continues as such after
giving effect to the transaction or other event giving rise to the change in status.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.25pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt"><B>7. ADJUSTMENTS; <FONT STYLE="letter-spacing: -0.1pt">ACCELERATION</FONT></B></P>

<P STYLE="text-align: justify; font: 9.5pt/108% Times New Roman, Times, Serif; margin: 9.65pt 0pt 0; text-indent: 40.5pt"><B>7.1 <I>Adjustments.</I></B>
Upon or in contemplation of any of the following events described in this Section 7.1,: any reclassification, recapitalization, stock
split (including a stock split in the form of a stock dividend) or reverse stock split <B>(&quot;stock split&quot;) </B>; any merger,
arrangement, combination, consolidation, or other reorganization; any spin-off, split-up, or similar extraordinary dividend distribution
in respect of the Common Stock (whether in the form of securities or property); any exchange of Common Stock or other securities of the
Corporation, or any similar, unusual or extraordinary corporate transaction in respect of the Common Stock; then the Administrator shall
in such manner, to such extent and at such time as it deems appropriate and equitable in the circumstances (but subject to compliance
with applicable laws and stock exchange requirements) proportionately adjust any or all of (1) the number and type of shares of Common
Stock (or other securities) that thereafter may be made the subject of awards (including the number of shares provided for in this Plan),
(2) the number, amount and type of shares of Common Stock (or other securities or property) subject to any or all outstanding awards,
(3) the grant, purchase, or exercise price (which term includes the base price of any SAR or similar right) of any or all outstanding
awards, (4) the securities, cash or other property deliverable upon exercise or payment of any outstanding awards, and (5) the 162(m)
compensation limitations set forth in Section 5.2.7 and (subject to Section 8.8.3(a)) the performance standards applicable to any outstanding
awards (provided that no adjustment shall be allowed to the extent inconsistent with the requirements of Code section l 62(m)). Any adjustment
made pursuant to this Section 7. I shall be made in a manner that, in the good faith determination of the Administrator, will not likely
result in the imposition of additional taxes or interest under Section 409A of the Code. With respect to any award of an ISO, the Administrator
may make such an adjustment that causes the option to cease to qualify as an ISO without the consent of the affected participant.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.8pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 40.5pt"><FONT STYLE="font-size: 10.5pt"><B>7.2
<I>Change in Control.</I></B></FONT> <FONT STYLE="font-size: 9.5pt">Upon a Change in Control, each then-outstanding option and SAR shall
automatically become fully vested, all restricted shares then outstanding shall automatically fully vest free of restrictions, and each
other award granted under this Plan that is then outstanding shall automatically become vested and payable to the holder of such award
<B><U>unless</U></B> the Administrator has made appropriate provision for the substitution, assumption, exchange or other continuation
of the award pursuant to the Change in Control. Notwithstanding the foregoing, the Administrator, in its sole and absolute discretion,
may choose (in an award agreement or otherwise) to provide for full or partial accelerated vesting of any award upon a Change In Control
(or upon any other event or other circumstance related to the Change in Control, such as an involuntary termination of employment occurring
after such Change in Control, as the Administrator may determine), irrespective of whether such any such award bas been substituted, assumed,
exchanged or otherwise continued pursuant to the Change in Control.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.4pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt">For purposes of this Plan, <B>&quot;Change in Control&quot;</B>
shall be deemed to have occurred <FONT STYLE="letter-spacing: -0.25pt">if:</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.95pt 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt/108% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0.05pt"><FONT STYLE="font-size: 9.5pt; letter-spacing: -0.05pt">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 9.5pt">a tender offer (or series of related offers) shall be made and consummated for the ownership of
50% or more of the outstanding voting securities of the Corporation, unless as a result of such tender offer more than 50% of the outstanding
voting securities of the surviving or resulting corporation shall be owned in the aggregate by the stockholders of the Corporation (as
of the time immediately prior to the commencement of such offer), any employee benefit plan of the Corporation or its Subsidiaries, and
their affiliates;</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.3pt 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt/110% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-align: justify; text-indent: 0.05pt"><FONT STYLE="font-size: 9.5pt; letter-spacing: -0.05pt">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 9.5pt">the Corporation shall be merged or consolidated with another entity, unless as a result of such
merger or consolidation more than 50% of the outstanding voting securities of the surviving or resulting entity shall be owned in the
aggregate by the stockholders of the Corporation (as of the time immediately prior to such transaction), any employee benefit plan of
the Corporation or its Subsidiaries, and their affiliates;</FONT></P>

<P STYLE="font: 11pt/110% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-align: justify; text-indent: 0.05pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt/110% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-align: justify; text-indent: 0.05pt"><FONT STYLE="font-size: 9.5pt">(iii)
the Corporation shall sell substantially all of
its assets to another entity that is not wholly owned by the Corporation, unless as a result of such sale more than 50% of such assets
shall be owned in the aggregate by the stockholders of the Corporation (as of the time immediately prior to such transaction), any employee
benefit plan of the Corporation or its Subsidiaries and their affiliates; or&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.2pt 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0.4pt"><FONT STYLE="font-size: 9.5pt; letter-spacing: -0.05pt">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 9.5pt">a Person (as defined below) shall acquire 50% or more of the outstanding voting securities of the
Corporation (whether directly, indirectly, beneficially or of record), unless as a result of such acquisition more than 50% of the outstanding
voting securities of the surviving or resulting corporation shall be owned in the aggregate by the stockholders of the Corporation (as
of the time immediately prior to the first acquisition of such securities by such Person), any employee benefit plan of the Corporation
or its Subsidiaries, and their affiliates.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.15pt 0pt 0">&nbsp;</P>

<P STYLE="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 40.35pt">For purposes
of this Section 5(c), ownership of voting securities shall take into account and shall include ownership as determined by applying the
provisions of Rule 13d-3(d)(I)(i) (as in effect on the date hereof) under the Exchange Act. In addition, for such purposes, &quot;Person&quot;
shall have the meaning given in Section 3(a)(9) of the Exchange Act, as modified and used in Sections 13(d) and 14(d) thereof; <U>12rovided</U>
, <U>however</U> , that a Person shall not include (A) the Company or any of its Subsidiaries; (B) a trustee or other fiduciary holding
securities under an employee benefit plan of the Company or any of its Subsidiaries; (C) an underwriter temporarily holding securities
pursuant to an offering of such securities; or (D) a corporation owned, directly or indirectly, by the stockholders of the Company in
substantially the same proportion as their ownership of stock of the Company.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.85pt 0pt 0">&nbsp;</P>

<P STYLE="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-align: justify; text-indent: 40.5pt">Notwithstanding
the foregoing, (1) the Administrator may waive the requirement described in paragraph (iv) above that a Person must acquire more than
50% of the outstanding voting securities of the Corporation for a Change in Control to have occurred if the Administrator determines that
the percentage acquired by a person is significant (as determined by the Administrator in its discretion) and that waiving such condition
is appropriate in light of all facts and circumstances, and (2) no compensation that has been deferred for purposes of Section 409A of
the Code shall be payable as a result of a Change in Control unless the Change in Control qualifies as a change in ownership or effective
control of the Corporation within the meaning of Section 409A of the Code.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.15pt 0pt 0">&nbsp;</P>

<P STYLE="font: 9.5pt/106% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 39.7pt"><B>7.3
<FONT STYLE="font-size: 10pt; line-height: 106%"><I>Early Termination of Awards.</I></FONT></B> Any award that has been accelerated as
required or permitted by Section 7.2 upon a Change in Control (or would have been so accelerated but for Section 7.4 or 7.5) shall terminate
upon such event, subject to any provision that has been expressly made by the Administrator, through a plan of reorganization or otherwise,
for the survival, substitution, assumption, exchange or other continuation of such award and provided that, in the case of options and
SARs that will not survive, be substituted for, assumed, exchanged, or otherwise continued in the transaction, the holder of such award
shall be given reasonable advance notice of the impending termination and a reasonable opportunity to exercise his or her outstanding
options and SARs in accordance with their terms before the termination of such awards (except that in no case shall more than ten days'
notice of accelerated vesting and the impending termination be required and any acceleration may be made contingent upon the actual occurrence
of the event).</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.45pt 0pt 0">&nbsp;</P>

<P STYLE="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 39.85pt">The Administrator
may make provision for payment in cash or property (or both) in respect of awards terminated pursuant to this section as a result of the
Change in Control and may adopt such valuation methodologies for outstanding awards as it deems reasonable and, in the case of options,
SARs or similar rights, and without limiting other methodologies, may base such settlement solely upon the excess if any of the per share
amount payable upon or in respect of such event over the exercise or base price of the <FONT STYLE="letter-spacing: -0.1pt">award.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.65pt 0pt 0">&nbsp;</P>

<P STYLE="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-align: justify; text-indent: 40.15pt"><B>7.4
<FONT STYLE="font-size: 10pt; line-height: 110%"><I>Other Acceleration Rules</I></FONT></B><FONT STYLE="font-size: 10pt; line-height: 110%"><I>.</I></FONT>
Any acceleration of awards pursuant to this Section 7 shall comply with applicable legal and stock exchange requirements and, if necessary
to accomplish the purposes of the acceleration or if the circumstances require, may be deemed by the Administrator to occur a limited
period of time not greater than 30 days before the event. Without limiting the generality of the foregoing, the Administrator may deem
an acceleration to occur immediately prior to the applicable event and/or reinstate the original terms of an award if an event giving
rise to the acceleration does not occur. Notwithstanding any other provision of the Plan to the contrary, the Administrator may override
the provisions of Section 7.2, 7.3, and/or 7.5 by express provision in the award agreement or otherwise. The portion of any ISO accelerated
pursuant to Section 7.2 or any other action permitted hereunder shall remain exercisable as an ISO only to the extent the applicable $100,000
limitation on ISOs is not exceeded. To the extent exceeded, the accelerated portion of the option shall be exercisable as a nonqualified
stock option under the Code.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.45pt 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 9.5pt/107% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 39.65pt"><B>7.5 <FONT STYLE="font-size: 10pt; line-height: 107%"><I>Possible
Rescission of Acceleration.</I></FONT></B> If the vesting of an award has been accelerated expressly in anticipation of an event and the
Administrator later determines that the event will not occur, the Administrator may rescind the effect of the acceleration as to any then
outstanding and unexercised or otherwise unvested awards; <FONT STYLE="font-size: 10pt; line-height: 107%"><I>provided, that </I>, </FONT>in
the case of any compensation that has been deferred for purposes of Section 409A of the Code, the Administrator determines that such rescission
will not likely result in the imposition of additional tax or interest under Code Section 409A.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.6pt 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0.05pt 0pt 0; text-indent: 0pt">8. OTHER <FONT STYLE="letter-spacing: -0.1pt">PROVISIONS</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 11pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><FONT STYLE="font-size: 10pt"><B>8.1
<I>Compliance with Laws.</I></B></FONT> <FONT STYLE="font-size: 9.5pt">This Plan, the granting and vesting of awards under this Plan,
the offer, issuance and delivery of shares of Common Stock, the acceptance of promissory notes and/or the payment of money under this
Plan or under awards are subject to compliance with all applicable federal and state laws, rules and regulations (including but not limited
to state and federal securities law, federal margin requirements) and to such approvals by any applicable stock exchange listing, regulatory
or governmental authority as may, in the opinion of counsel for the Corporation, be necessary or advisable in connection therewith. The
person acquiring any securities under this Plan will, if requested by the Corporation or one of its Subsidiaries, provide such assurances
and representations to the Corporation or one of its Subsidiaries as the Administrator may deem necessary or desirable to assure compliance
with all applicable legal and accounting requirements.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.5pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><B>8.2 <I>Future Awards/Other Rights.
</I></B>No person shall have any claim or rights to be granted an award (or additional awards, as the case may be) under this Plan, subject
to any express contractual rights (set forth in a document other than this Plan) to the contrary.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.65pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt/108% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><FONT STYLE="font-size: 10pt"><B>8.3
<I>No Employment/Service Contract. </I></B></FONT><FONT STYLE="font-size: 9.5pt">Nothing contained in this Plan (or in any other documents
under this Plan or in any award) shall confer upon any Eligible Person or other participant any right to continue in the employ or other
service of the Corporation or one of its Subsidiaries, constitute any contract or agreement of employment or other service or affect an
employee's status as an employee at will, nor shall interfere in any way with the right of the Corporation or one of its Subsidiaries
to change a person's compensation or other benefits, or to terminate his or her employment or other service, with or without cause. Nothing
in this Section 8.3, however, is intended to adversely affect any express independent right of such person under a separate employment
or service contract other than an award agreement.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.1pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-indent: 45pt"><B>8.4 <I>Plan Not Funded. </I></B>Awards
payable under this Plan shall be payable in shares or from the general assets of the Corporation, and no special or separate reserve,
fund or deposit shall be made to assure payment of such awards. No participant, beneficiary or other person shall have any right, title
or interest in any fund or in any specific asset (including shares of Common Stock, except as expressly otherwise provided) of the Corporation
or one of its Subsidiaries by reason of any award hereunder. Neither the provisions of this Plan (or of any related documents), nor the
creation or adoption of this Plan, nor any action taken pursuant to the provisions of this Plan shall create, or be construed to create,
a trust of any kind or a fiduciary relationship between the Corporation or one of its Subsidiaries and any participant, beneficiary or
other person. To the extent that a participant, beneficiary or other person acquires a right to receive payment pursuant to any award
hereunder, such right shall be no greater than the right of any unsecured general creditor of the Corporation.</P>

<P STYLE="text-align: justify; font: 10pt/100% Times New Roman, Times, Serif; margin: 3.35pt 0pt 0; text-indent: 45pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 11pt/100% Times New Roman, Times, Serif; margin: 3.35pt 0pt 0; text-indent: 45pt"><FONT STYLE="font-size: 10pt"><B>8.5
<I>Tax Withholding</I></B><I>. </I></FONT><FONT STYLE="font-size: 9.5pt">Upon any exercise, vesting, or payment of any award, the Corporation
or one of its Subsidiaries shall have the right at its option to:</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 3.3pt 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt/108% Times New Roman, Times, Serif; margin: 0.05pt 0pt 0; text-align: justify; text-indent: 39.7pt"><FONT STYLE="font-size: 9.5pt; color: #4D4D4D; letter-spacing: -0.05pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: #4D4D4D; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 9.5pt">require the participant (or the participant's personal representative or beneficiary, as the case
may be) to pay or provide for payment of at least the minimum amount of any taxes which the Corporation or one of its Subsidiaries may
be required to withhold with respect to such award event or payment; or</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.65pt 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt/108% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 40.1pt"><FONT STYLE="font-size: 9.5pt; color: #4D4D4D; letter-spacing: -0.05pt">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: #4D4D4D; letter-spacing: -0.05pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 9.5pt">deduct from any amount otherwise payable in cash to the participant (or the participant's personal
representative or beneficiary, as the case may be) the minimum amount of any taxes which the Corporation or one of its Subsidiaries may
be required to withhold with respect to such cash payment.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 1.7pt 0pt 0">&nbsp;</P>

<P STYLE="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 40.6pt">In any case
where a tax is required to be withheld in connection with the delivery of shares of Common Stock under this Plan, the Administrator may
in its sole discretion (subject to Section 8.1) grant (either at the time of the award or thereafter) to the participant the right to
elect, pursuant to such rules and subject to such conditions as the Administrator may establish, to have the Corporation reduce the number
of shares to be delivered by (or otherwise reacquire) the appropriate number of shares, valued in a consistent manner at their Fair Market
Value or at the sales price in accordance with authorized procedures for cashless exercises, necessary to satisfy the minimum applicable
withholding obligation on exercise, vesting or payment. In no event shall the shares withheld exceed the minimum whole number of shares
required for tax withholding under applicable law.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.75pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: italic 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><FONT STYLE="font-style: normal"><B>8.6</B></FONT><B>
Effective Date, Termination and Suspension, <FONT STYLE="letter-spacing: -0.1pt">Amendments.</FONT></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0.8pt 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 9.5pt/108% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 37.7pt"><B>8.6.1
<FONT STYLE="font-size: 10pt; line-height: 108%"><I>Effective Date and Termination</I></FONT></B><FONT STYLE="font-size: 10pt; line-height: 108%"><I>.</I></FONT>
This Plan was approved by the Board and became effective on August 3, 2016. Unless earlier terminated by the Board, this Plan shall terminate
at the close of business on August 3, 2026. After the termination of this Plan either upon such stated expiration date or its earlier
termination by the Board, no additional awards may be granted under this Plan, but previously granted awards (and the authority of the
Administrator with respect thereto, including the authority to amend such awards) shall remain outstanding in accordance with their applicable
terms and conditions and the terms and conditions of this Plan.</P>

<P STYLE="text-align: justify; font: 9.5pt/111% Times New Roman, Times, Serif; margin: 0.15pt 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 9.5pt/111% Times New Roman, Times, Serif; margin: 0.15pt 0pt 0; text-indent: 45pt"><B>8.6.2 <I>Board Authorization.</I></B>
The Board may, at any time, terminate or, from time to time, amend, modify or suspend this Plan, in whole or in part. No awards may be
granted during any period that the Board suspends this Plan.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.2pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><FONT STYLE="font-size: 10pt"><B>8.6.3
<I>Stockholder Approval</I></B><I>. </I></FONT><FONT STYLE="font-size: 9.5pt">To the extent then required by applicable law or any applicable
stock exchange or required under Sections 162, 422 or 424 of the Code to preserve the intended tax consequences of this Plan, or deemed
necessary or advisable by the Board, this Plan and any amendment to this Plan shall be subject to stockholder approval.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><FONT STYLE="font-size: 10pt"><B>8.6.4
<I>Amendments to Awards</I></B><I>.</I></FONT> <FONT STYLE="font-size: 9.5pt">Without limiting any other express authority of the Administrator
under (but subject to) the express limits of this Plan, the Administrator by agreement or resolution may waive conditions of or limitations
on awards to participants that the Administrator in the prior exercise of its discretion has imposed, without the consent of a participant,
and (subject to the requirements of Sections 3.2 and 8.6.5) may make other changes to the terms and conditions of awards. Any amendment
or other action that would constitute a repricing of an award is subject to the limitations set forth in Section 3.2(g).</FONT></P>

<P STYLE="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><B>8.6.5 <I>Limitations on Amendments
to Plan and Awards. </I></B>No amendment, suspension or termination of this Plan or change of or affecting any outstanding award shall,
without written consent of the participant, affect in any manner materially adverse to the participant any rights or benefits of the participant
or obligations of the Corporation under any award granted under this Plan prior to the effective date of such change. Changes, settlements
and other actions contemplated by Section 7 shall not be deemed to constitute changes or amendments for purposes of this Section 8.6.</P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.1pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 11pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><FONT STYLE="font-size: 10pt"><B>8.7
<I>Privileges of Stock Ownership.</I></B></FONT> <FONT STYLE="font-size: 9.5pt">Except as otherwise expressly authorized by the Administrator
or this Plan, a participant shall not be entitled to any privilege of stock ownership as to any shares of Common Stock not actually delivered
to and held of record by the participant. No adjustment will be made for dividends or other rights as a stockholder for which a record
date is prior to such date of delivery.</FONT></P>

<P STYLE="text-align: justify; font: 9.5pt Times New Roman, Times, Serif; margin: 0.25pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: italic 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 45pt"><FONT STYLE="font-style: normal"><B>8.8</B></FONT><B>
Governing Law; Construction; <FONT STYLE="letter-spacing: -0.1pt">Severability.</FONT></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0.8pt 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 40pt"><B>8.8.1 <FONT STYLE="font-size: 10pt; line-height: 110%"><I>Choice
of Law.</I></FONT></B> This Plan, the awards, all documents evidencing awards and all other related documents shall be governed by, and
construed in accordance with the laws of the State of Nevada.</P>

<P STYLE="font: 9.5pt/113% Times New Roman, Times, Serif; margin: 0.15in 0pt 0; text-align: justify; text-indent: 39.7pt"><B>8.8.2
<FONT STYLE="font-size: 10pt; line-height: 113%"><I>Severability.</I></FONT></B> If a court of competent jurisdiction holds any provision
invalid and unenforceable, the remaining provisions of this Plan shall continue in effect.</P>

<P STYLE="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 10.9pt 0pt 0"><FONT STYLE="font-size: 9.5pt"><B>8.8.3 </B></FONT><B><FONT STYLE="font-size: 10pt"><I>Plan
<FONT STYLE="letter-spacing: -0.1pt">Construction.</FONT></I></FONT></B></P>

<P STYLE="font: 11pt/107% Times New Roman, Times, Serif; margin: 3.25pt 0pt 0; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><I>Rule 16b-3. </I>It is the intent of the Corporation that the awards and transactions permitted
by awards be interpreted in a manner that, in the case of participants who are or may be subject to Section 16 of the Exchange Act, qualify,
to the maximum extent compatible with the express tem1s of the award, for exemption from matching liability under Rule l 6b-3 promulgated
under the Exchange Act. Notwithstanding the foregoing, the Corporation shall have no liability to any participant for Section 16 consequences
of awards or events under awards if an award or event does not so qualify.</FONT></P>

<P STYLE="font: 10pt/105% Times New Roman, Times, Serif; margin: 10.75pt 0pt 0; text-align: justify; text-indent: 39.9pt"><FONT STYLE="letter-spacing: -0.05pt">(b)</FONT>
<I>Section 162(m). </I>Awards under Sections 5.1.4 through 5.1.7 to persons described in Section 5.2 that are either granted or become
vested, exercisable or payable based on attainment of one or more performance goals related to the Business Criteria, as well as Qualifying
Options and Qualifying SARs granted to persons described in Section 5.2, that are approved by a committee composed solely of two or more
outside directors (as this requirement is applied under Section 162(m) of the Code) shall be deemed to be intended as performance-based
compensation within the meaning of Section l 62(m) of the Code unless such committee provides otherwise at the time of grant of the award.
It is the further intent of the Corporation that (to the extent the Corporation or one of its Subsidiaries or awards under this Plan may
be or become subject to limitations on deductibility under Section 162(m) of the Code) any such awards and any other Performance-Based
Awards under Section 5.2 that are granted to or held by a person subject to Section l 62(m) will qualify as performance-based compensation
or otherwise be exempt from deductibility limitations under Section l 62(m).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 1pt 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt/105% Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 44.35pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><I>Code Section 409A Compliance.</I> The Board intends that, except as may be otherwise determined
by the Administrator, any awards under the Plan are either exempt from or satisfy the requirements of Section 409A of the Code and related
regulations and Treasury pronouncements </FONT><FONT STYLE="font-size: 9.5pt"><B>(&quot;Section 409A&quot;) </B></FONT><FONT STYLE="font-size: 10pt">to
avoid the imposition of any taxes, including additional income or penalty taxes, thereunder. If the Administrator determines that an award,
award agreement, acceleration, adjustment to the terms of an award, payment, distribution, deferral election, transaction or any other
action or arrangement contemplated by the provisions of the Plan would, if undertaken, cause a participant's award to become subject to
Section 409A, unless the Administrator expressly determines otherwise, such award, award agreement, payment, acceleration, adjustment,
distrib11tion, deferral election, transaction or other action or arrangement shall not be undertaken and the related provisions of the
Plan and/or award agreement will be deemed modified or, if necessary, rescinded in order to comply with the requirements of Section 409A
to the extent determined by the Administrator without the content or notice to the participant. Notwithstanding the foregoing, neither
the Company nor the Administrator shall have any obligation to take any action to prevent the assessment of any excise tax or penalty
on any participant under Section 409A and neither the Company nor the Administrator will have any liability to any participant for such
tax or penalty.</FONT></P>

<P STYLE="font: 11pt/106% Times New Roman, Times, Serif; margin: 11.3pt 0pt 0; text-align: justify; text-indent: 39.9pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><I>No Guarantee of Favorable Tax Treatment. </I>Although the Company intends that awards under the
Plan will be exempt from, or will comply with, the requirements of Section 409A of the Code, the Company does not warrant that any award
under the Plan will qualify for favorable tax treatment under Section 409A of the Code or any other provision of federal, state, local
or foreign law. The Company shall not be liable to any participant for any tax, interest or penalties the participant might owe as a result
of the grant, holding, vesting, exercise or payment of any award under the Plan</FONT></P>

<P STYLE="text-align: justify; font: 10pt/112% Times New Roman, Times, Serif; margin: 10.25pt 0pt 0; text-indent: 49.5pt"><B>8.9 <I>Captions</I></B><I>.
</I>Captions and headings are given to the sections and subsections of this Plan solely as a convenience to facilitate reference. Such
headings shall not be deemed in any way material or relevant to the construction or interpretation of this Plan or any provision thereof.</P>

<P STYLE="text-align: justify; font: 10pt/103% Times New Roman, Times, Serif; margin: 9.35pt 0pt 0; text-indent: 49.5pt"><B>8.10 <I>Stock-Based Awards
in Substitution for Stock Options or Awards Granted by Other Corporation</I></B><I>.</I> Awards may be granted to Eligible Persons in
substitution for or in connection with an assumption of employee stock options, SARs, restricted stock or other stock-based awards granted
by other entities to persons who are or who will become Eligible Persons in respect of the Corporation or one of its Subsidiaries, in
connection with a distribution, arrangement, business combination, merger or other reorganization by or with the granting entity or an
affiliated entity, or the acquisition by the Corporation or one of its Subsidiaries, directly or indirectly, of all or a substantial part
of the stock or assets of the employing entity. The awards so granted need not comply with other specific tem1s of this Plan, provided
the awards reflect only adjustments giving effect to the assumption or substitution consistent with the conversion applicable to the Common
Stock in the transaction and any change in the issuer of the security. Any shares that are delivered and any awards that are granted by,
or become obligations of, the Corporation, as a result of the assumption by the Corporation of, or in substitution for, outstanding awards
previously granted by an acquired company (or previously granted by a predecessor employer (or direct or indirect parent thereof) in the
case of persons that become employed by the Corporation or one of its Subsidiaries in connection with a business or asset acquisition
or similar transaction) shall not be counted against the Share Limit or other limits on the number of shares available for issuance under
this Plan, except as may otherwise be provided by the Administrator at the time of such assumption or substitution or as may be required
to comply with the requirements of any applicable stock exchange.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0.65pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 49.5pt"><B>8.11 <I>Non-Exclusivity of Plan</I></B><I>.
</I>Nothing in this Plan shall limit or be deemed to limit the authority of the Board or the Administrator to grant awards or authorize
any other compensation, with or without reference to the Common Stock, under any other plan or authority.</P>

<P STYLE="text-align: justify; font: 10pt/103% Times New Roman, Times, Serif; margin: 7.6pt 0pt 0; text-indent: 49.5pt"><B>8.12 <I>No Corporate Action
Restriction. </I></B>The existence of this Plan, the award agreements and the awards granted hereunder shall not limit, affect or restrict
in any way the right or power of the Board or the stockholders of the Corporation to make or <FONT STYLE="letter-spacing: -0.1pt">authorize:</FONT>(a)
any adjustment, recapitalization, reorganization or other change in the capital structure or business of the Corporation or <FONT STYLE="letter-spacing: -0.25pt">any</FONT></P>

<P STYLE="font: 10pt/105% Times New Roman, Times, Serif; margin: 3.25pt 0pt 0; text-align: justify">Subsidiary, (b) any merger,
arrangement, business combination, amalgamation, consolidation or change in the ownership of the Corporation or any Subsidiary, (c) any
issue of bonds, debentures, capital, preferred or prior preference stock ahead of or affecting the capital stock (or the rights thereof)
of the Corporation or any Subsidiary, (d) any dissolution or liquidation of the Corporation or any Subsidiary, (e) any sale or transfer
of all or any part of the assets or business of the Corporation or any Subsidiary, or (f) any other corporate act or proceeding by the
Corporation or any Subsidiary. No participant, beneficiary or any other person shall have any claim under any award or award agreement
against any member of the Board or the Administrator, or the Corporation or any employees, officers or agents of the Corporation or any
Subsidiary, as a result of any such action.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0.25pt 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt/105% Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 49.5pt"><B>8.13 <I>Other Corporation Benefit
and Compensation Programs.</I></B> Payments and other benefits received by a participant under an award made pursuant to this Plan shall
not be deemed a part of a participant's compensation for purposes of the determination of benefits under any other employee welfare or
benefit plans or arrangements, if any, provided by the Corporation or any Subsidiary, except where the Administrator expressly otherwise
provides or authorizes in writing or except as otherwise specifically set forth in the terms and conditions of such other employee welfare
or benefit plan or arrangement. Awards under this Plan may be made in addition to, in combination with, as alternatives to or in payment
of grants, awards or commitments under any other plans or arrangements of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 1.85pt 0pt 0; text-align: justify">the Corporation or its <FONT STYLE="letter-spacing: -0.1pt">Subsidiaries.</FONT></P>

<P STYLE="text-align: justify; font: 10pt/106% Times New Roman, Times, Serif; margin: 10.9pt 0pt 0; text-indent: 49.5pt"><B>8.14 <I>Prohibition on Repricing.</I></B>
Subject to Section 4, the Administrator shall not, without the approval of the stockholders of the Corporation (i) reduce the exercise
price, or cancel and reissue options so as to in effect reduce the exercise price or (ii) change the manner of determining the exercise
price so that the exercise price is less than the fair market value per share of Common Stock.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0.25pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt">As adopted by the Board of Directors of Red Cat
Holdings, Inc. on May_, <FONT STYLE="letter-spacing: -0.1pt">2019.</FONT></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>5
<FILENAME>rcat0808form10kexh21_1.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit 21.1</B></FONT></P>

<P STYLE="font: 12pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>List
of Subsidiaries of Red Cat Holdings, Inc.</B></FONT></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B>&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: black 1.5pt solid; padding-bottom: 8pt; padding-left: 10pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Name
    of Subsidiaries</B></FONT></TD>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; padding-bottom: 8pt; padding-left: 10pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Jurisdiction</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 8pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-bottom: 8pt; padding-left: 10pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Red
    Cat Propware, Inc.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; padding-left: 10pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nevada</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 8pt; padding-left: 10pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Skypersonic,
    Inc.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; padding-left: 10pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indirect
    Subsidiary (Michigan)</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCECFF">
    <TD STYLE="padding-bottom: 8pt; padding-left: 10pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Red
    Cat Skypersonic, Inc.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; padding-left: 10pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Subsidiary
    (Nevada)</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 8pt; padding-left: 10pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Teal
    Drones, Inc.&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; padding-left: 10pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Subsidiary
    (Delaware)</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>rcat0808form10kexh31_1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATION OF CHIEF EXECUTIVE OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT
AND RULE 13A-14(A)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OR 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF
1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">I, Jeffrey Thompson, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt">1. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this Annual Report on Form 10-K of Red Cat Holdings, Inc., a Nevada corporation, for the year ended April 30, 2024;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">2. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">3. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">4. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 48px">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt">(a) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">(b) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">(c) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">(d) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt">5. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 48px">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt">(a) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">(b) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 53%"><FONT STYLE="font-size: 10pt">Date: August 8, 2024</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 46%; border-bottom: black 1.5pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Jeffrey Thompson</I></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Jeffrey Thompson</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Executive Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Principal Executive Officer)</P></TD></TR>
  </TABLE>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>rcat0808form10kexh31_2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">I, Leah Lunger, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt">1. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this Annual Report on Form 10-K of Red Cat Holdings, Inc., a Nevada corporation, for the year ended April 30, 2024;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">2. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">3. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">4. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 48px">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt">(a) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">(b) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">(c) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">(d) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt">5. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 48px">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt">(a) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">(b) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 53%"><FONT STYLE="font-size: 10pt">Date: August 8, 2024</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD STYLE="width: 46%; border-bottom: black 1.5pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Leah Lunger</I></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Leah Lunger</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(Principal Financial and Accounting Officer)</FONT></TD></TR>
  </TABLE>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>rcat0808form10kexh32_1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">In connection with the Annual
Report on Form 10-K of Red Cat Holdings, Inc., a Nevada corporation (the &ldquo;Company&rdquo;), for the year ended April 30, 2024, as
filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Jeffrey Thompson, Chief Executive
Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 48px">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt">(1) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">(2) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Date: August 8, 2024</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: black 1.5pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Jeffrey Thompson</I></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jeffrey Thompson</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer </FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(Principal Executive Officer)</FONT></TD></TR>
  </TABLE>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>rcat0808form10kexh32_2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">In connection with the Annual
Report on Form 10-K of Red Cat Holdings, Inc., a Nevada corporation (the &ldquo;Company&rdquo;), for the year ended April 30, 2024, as
filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Leah Lunger, Chief Financial Officer
of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 48px">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt">(1) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">(2) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Date: August 8, 2024</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: black 1.5pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Leah Lunger</I></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Leah Lunger</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(Principal Financial and Accounting Officer)</FONT></TD></TR>
  </TABLE>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>10
<FILENAME>rcat0808form10kexh97_1.htm
<DESCRIPTION>EXHIBIT 97.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 97.1</B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>RED CAT HOLDINGS, INC. </B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>POLICY ON RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION</B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>November 28, 2023</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><B>1.</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><U>Overview</U></FONT></B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify">The Board believes that it is in the best interests
of the Company and its stockholders to adopt this Policy to provide for the recovery of certain Incentive-Based Compensation in the event
of an Accounting Restatement. This Policy is designed to comply with, and shall be interpreted to be consistent with, Section 10D of the
Exchange Act, the regulations and rules promulgated by the SEC thereunder, including, without limitation, Rule 10D-1 promulgated under
the Exchange Act (&ldquo;<U>Rule 10D-1</U>&rdquo;), and the applicable rules, regulations and listing standards of the Exchange (collectively,
and as the same may be in effect from time to time, the &ldquo;<U>Applicable Rules</U>&rdquo;). Unless otherwise defined in this Policy,
capitalized terms used in this Policy have the meanings given to them in Section 2.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><B>2.</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><U>Definitions</U></FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Accounting Restatement</U>&rdquo; means an
accounting restatement of the Company&rsquo;s financial statements due to the Company&rsquo;s material noncompliance with any financial
reporting requirement under U.S. securities laws, including any required accounting restatement to correct an error in previously issued
financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if
the error were corrected in the current period or left uncorrected in the current period. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Board</U>&rdquo; means the Board of Directors
of the Company, as constituted from time to time.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Clawback Eligible Incentive-Based Compensation</U>&rdquo;
means, in connection with an Accounting Restatement and with respect to each individual who served as a Senior Executive at any time during
the applicable performance period for any Incentive-Based Compensation (whether or not such Senior Executive is serving at the time the
Erroneously Awarded Compensation is required to be recouped by the Company), all Incentive-Based Compensation Received by such Senior
Executive (i) on or after the Effective Date, (ii) after beginning service as a Senior Executive, (iii) while the Company has a class
of securities listed on a national securities exchange, and (iv) during the applicable Look-Back Period.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Committee</U>&rdquo; means the Compensation
Committee of the Board or such other committee or subcommittee of the Board, if any, duly appointed to administer this Policy and having
such powers in each instance as shall be specified by the Board and as specified in Section 3 of this Policy. The Board may also serve
as the Committee.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Company</U>&rdquo; means Red Cat Holdings,
Inc. a Nevada corporation.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Effective Date</U>&rdquo; means October 2,
2023.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Erroneously Awarded Compensation</U>&rdquo;
means, with respect to each Senior Executive in connection with an Accounting Restatement, the amount of the Clawback Eligible Incentive-Based
Compensation that exceeds the amount of the Incentive-Based Compensation that would have been Received had the amount of such Incentive-Based
Compensation been calculated based on the restated amounts, as determined by the Committee, calculated by the Committee without regard
to any taxes paid. With respect to Incentive-Based Compensation based on (or derived from) TSR or stock price, where the amount of Erroneously
Awarded Compensation is not subject to mathematical recalculation directly from the information in the applicable Accounting Restatement,
the Committee shall determine the amount of Erroneously Awarded Compensation based on a reasonable estimate of the effect of the Accounting
Restatement on the TSR or stock price upon which the Incentive-Based Compensation was Received.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Exchange</U>&rdquo; means The Nasdaq Stock
Market.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Exchange Act</U>&rdquo; means the Securities
Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Financial Reporting Measure</U>&rdquo; means
any measure that is determined and presented in accordance with the accounting principles used in preparing the Company&rsquo;s financial
statements, and any measure that is derived wholly or in part from such measure, including but not limited to, &ldquo;non-GAAP financial
measures&rdquo; for purposes of Exchange Act Regulation G and Item 10 of Regulation S-K, as well as other measures, metrics and ratios
that are not non-GAAP measures, like same store sales. Financial Reporting Measures include but are not limited to the following (and
any measures derived from the following): stock price; TSR; revenues; net income; operating income; profitability of one or more reportable
segments; financial ratios (e.g., accounts receivable turnover and inventory turnover rates); earnings before interest, taxes, depreciation
and amortization; funds from operations and adjusted funds from operations; liquidity measures (e.g., working capital, operating cash
flow); return measures (e.g., return on invested capital, return on assets); earnings measures (e.g., earnings per share); sales per square
foot or same store sales, where sales is subject to an Accounting Restatement; revenue per user, or average revenue per user, where revenue
is subject to an Accounting Restatement; cost per employee, where cost is subject to an Accounting Restatement; any of such financial
reporting measures relative to a peer group, where the Company&rsquo;s financial reporting measure is subject to an Accounting Restatement;
and tax basis income. A Financial Reporting Measure need not be presented within the Company&rsquo;s financial statements or included
in a report or other document filed with the SEC.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Incentive-Based Compensation</U>&rdquo; means
any compensation granted, earned or vested based wholly or in part upon the attainment of a Financial Reporting Measure, measured on a
pre-tax basis. Incentive-Based Compensation includes, without limitation: any non-equity incentive plan awards that are earned based wholly
or in part on satisfying a Financial Reporting Measure performance goal; bonuses paid from a &ldquo;bonus pool,&rdquo; the size of which
is determined based wholly or in part on satisfying a Financial Reporting Measure performance goal; other cash awards based on satisfaction
of a Financial Reporting Measure performance goal; restricted stock, restricted stock units, performance share units, stock options, and
stock appreciation rights that are granted or become vested based wholly or in part on satisfying a Financial Reporting Measure Performance
Goal; and proceeds received upon the sale of shares acquired through an incentive plan that were granted or vested based wholly or in
part on satisfying a Financial Reporting Measure performance goal. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Look-Back Period</U>&rdquo; means, with respect
to an Accounting Restatement, the three completed fiscal years of the Company immediately preceding the Restatement Date and any transition
period (that results from a change in the Company&rsquo;s fiscal year) within or immediately following those three completed fiscal years
(except that a transition period that comprises a period of at least nine months shall count as a completed fiscal year).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Policy</U>&rdquo; means this Policy on Recovery
of Erroneously Awarded Compensation as the same may be amended, modified, supplemented, and/or restated from time to time.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(n)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Received</U>&rdquo; means, with respect to
Incentive-Based Compensation, actual or deemed receipt, and Incentive-Based Compensation shall be deemed &ldquo;Received&rdquo; in the
Company&rsquo;s fiscal period during which the applicable Financial Reporting Measure specified in the Incentive-Based Compensation award
is attained, even if the payment or grant of such Incentive-Based Compensation occurs after the end of that period. If an equity award
vests only upon satisfaction of a Financial Reporting Measure performance condition, the award shall be deemed Received in the fiscal
period when it vests. Ministerial acts or other conditions necessary to effect issuance or payment, such as calculating the amount earned
or obtaining Board approval of payment, do not affect the determination of the date Received. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(o)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Restatement Date</U>&rdquo; means the earlier
to occur of (i) the date the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action
if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting
Restatement or (ii) the date a court, regulator or other legally authorized body directs the Company to prepare an Accounting Restatement,
in each case regardless of if or when the restated financial statements are filed.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(p)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>SEC</U>&rdquo; means the U.S. Securities and
Exchange Commission.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(q)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>Senior Executives</U>&rdquo; means any person
who was the Company&rsquo;s president, principal financial officer, principal accounting officer (or if there is no such accounting officer,
the controller), any vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration,
or finance), any other officer who performed a policy-making function, or any other person who performed similar policy-making functions
for the Company and any other &ldquo;key employees&rdquo; who were designated as &ldquo;Senior Executives&rdquo; by the Committee. Executive
officers of the Company&rsquo;s parents or subsidiaries may be deemed Senior Executives if they perform policy-making functions for the
Company. For purposes of this definition, policy-making function is not intended to include policy-making functions that are not significant.
All executive officers of the Company identified by the Board pursuant to Item 401(b) of Regulation S-K shall be deemed Senior Executives.
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(r)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">&ldquo;<U>TSR</U>&rdquo; means total stockholder return.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><B>3.</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><U>Administration of Policy</U></FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">The Policy shall be administrated by the Committee.
All questions of interpretation or application of this Policy shall be determined by the Committee. All Committee decisions shall be final
and binding upon all persons and shall be afforded the maximum deference permitted under applicable law. The Committee is authorized to
make all determinations necessary, appropriate or advisable for the administration of this Policy and to use any of the Company&rsquo;s
resources it deems appropriate to recoup Erroneously Awarded Compensation.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">Determinations of financial and/or accounting irregularities
for purposes of this Policy shall be made by the Committee independently of, and the Committee shall not be bound by, determinations by
management or by any other committee of the Board.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">In the administration of this Policy, the Committee
is authorized and directed to consult with the full Board or such other committees of the Board as may be necessary or appropriate as
to matters within the scope of such other committee&rsquo;s responsibility and authority. Subject to any limitation under applicable law,
the Committee may authorize and empower any officer or employee of the Company to take any and all actions necessary or appropriate to
carry out the purpose and intent of this Policy (other than with respect to any recovery under this Policy involving such officer or employee).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><B>4.</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><U>Accounting Restatements; Recoupment</U></FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">If the Company is required to prepare an Accounting
Restatement, the Company shall determine, in accordance with this Policy and the Applicable Rules, the amount of any Erroneously Awarded
Compensation for each Senior Executive in connection with such Accounting Restatement, irrespective of any fault, misconduct or responsibility
of any Senior Executive for the Accounting Restatement, and thereafter the Company shall reasonably promptly recover such amount of Erroneously
Awarded Compensation. In connection with the foregoing, the Committee, which may act in conjunction with the Company&rsquo;s Audit Committee,
shall take all such actions required by this Policy and the Applicable Rules. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">If there was Erroneously Awarded Compensation, the Committee
shall determine, in its sole discretion, the timing and method(s) for promptly recouping the same, which methods may include, without
limitation, one or more of the following: (i) requiring reimbursement of any Erroneously Awarded Compensation; (ii) requiring reimbursement
of any equity based compensation awarded; (iii) cancelling outstanding cash or equity-based awards, whether vested or unvested or paid
or unpaid; (iv) cancelling or offsetting against any compensation otherwise owed by the Company to the Senior Executive, including any
future cash or equity-based awards; (v) requiring the forfeiture of deferred compensation, subject to compliance with Section 409A of
the Internal Revenue Code and the regulations promulgated thereunder; (vi) seeking recovery of any gain realized on the vesting, exercise,
settlement, sale, transfer, or other disposition of any equity-based awards; and (viii) pursuing any other reasonable remedies. Subject
to compliance with applicable law, the Committee may effect recoupment under this Policy from any amount otherwise payable to a Senior
Executive, including amounts payable to such individual under any otherwise applicable Company plan or program, including base salary,
bonuses or commissions and compensation previously deferred by the Senior Executive.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">To the extent that the Committee determines to recoup
Erroneously Awarded Compensation from a Senior Executive by requiring the repayment of such Erroneously Awarded Compensation to the Company,
and such Senior Executive fails to repay all Erroneously Awarded Compensation to the Company when due, the Company may take all actions
reasonable and appropriate to recover such Erroneously Awarded Compensation from the applicable Senior Executive. The applicable Senior
Executive shall be required to reimburse the Company for any and all expenses reasonably incurred (including legal fees) by the Company
in recovering such Erroneously Awarded Compensation in accordance with the immediately preceding sentence.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">In the event of an Accounting Restatement, except to
the extent permitted by the Applicable Rules, the Committee will generally treat all Senior Executives (including former employees) the
same with respect to any actions seeking to recoup Erroneously Awarded Compensation. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><B>5.</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><U>Impracticability</U></FONT></B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Notwithstanding anything
to the contrary herein, the Company shall not be required to recoup Erroneously Awarded Compensation under this Policy if the Compensation
Committee of the Board, or in the absence of such a committee, a majority of the independent directors serving on the Board, has determined
that recovery would be impracticable in accordance with the Applicable Rules and subject to the procedural and disclosure requirements
in the Applicable Rules.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><B>6.</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><U>Other Recoupment Rights</U></FONT></B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">The Board intends that
this Policy shall be applied to the fullest extent of the law. Any right of recoupment under this Policy is in addition to, and not in
lieu of, any other remedies or rights of recoupment that may be available to the Company under applicable law (including, without limitation,
Section 304 of the U.S. Sarbanes-Oxley Act of 2002, as amended, or Section 954 of the U.S. Dodd-Frank Wall Street Reform and Consumer
Protection Act of 2010, as amended), pursuant to the terms of any other policy of the Company, pursuant to the terms of any employment
agreement, equity award agreement, severance or other agreement, and any other legal remedies available to the Company. Nothing herein,
and no recoupment or recovery as contemplated by this Policy, shall (i) limit any claims, damages or other legal remedies the Company
or any of its affiliates may have against a Senior Executive arising out of or resulting from any actions or omissions by the Senior Executive
or (ii) limit the Company&rsquo;s ability to seek recovery, in appropriate circumstances (including circumstances beyond the scope of
this Policy) as permitted by applicable law, of any amounts from any employee, whether or not the employee is a Senior Executive.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><B>7.</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><U>No Indemnification or Company-Paid Insurance</U></FONT></B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Notwithstanding the terms
of any indemnification or insurance policy or any contractual arrangement with any Senior Executive that may be interpreted to the contrary:
(a) the Company shall not indemnify any Senior Executive against (i) the loss of any Erroneously Awarded Compensation that is recouped,
repaid, returned or recovered pursuant to the terms of this Policy; or (ii) any claims relating to the Company&rsquo;s enforcement of
its rights under this Policy; and (b) the Company is prohibited from paying or reimbursing a Senior Executive for the cost of or premiums
of any third-party insurance purchased to fund any potential obligations of a Senior Executive under this Policy. Further, the Company
shall not enter into any agreement that exempts any Incentive-Based Compensation from the application of this Policy or that waives the
Company&rsquo;s right to recoup any Erroneously Awarded Compensation, and this Policy shall supersede any such agreement (whether entered
into before, on or after the Effective Date).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><B>8.</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><U>Committee Indemnification </U></FONT></B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">No members of the Committee,
nor any other members of the Board who assist in the administration of this Policy, nor any officer of employee of the Company authorized
and empowered by the Committee who assists in the administration of this Policy shall be personally liable for any action, determination
or interpretation made with respect to this Policy, and each of the foregoing shall be fully indemnified by the Company to the fullest
extent under applicable law and Company policy with respect to any such action, determination or interpretation. The foregoing sentence
shall not limit any other rights to indemnification of the members of the Board or any officer of employee of the Company under applicable
law, Company policy or contractual arrangement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><B>9.</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><U>Retroactive Application</U></FONT></B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">This Policy applies to
any Incentive-Based Compensation that is Received by a Senior Executive on or after the Effective Date, even if such Incentive-Based Compensation
was approved, awarded, granted or paid to such Senior Executive prior to the Effective Date. Without limiting the generality of Section
4, and subject to applicable law, the Committee may recoup Erroneously Awarded Compensation under this Policy from any amount of compensation
approved, awarded, granted, payable or paid to the Senior Executive prior to, on or after the Effective Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><B>10.</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><U>Notice to Senior Executives</U></FONT></B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">The Company shall provide
notice and seek written agreement to this Policy from each Senior Executive in form attached hereto; provided, that the failure to obtain
such agreement shall have no impact on the applicability or enforceability of this Policy.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><B>11.</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt"><U>Amendment and Termination; Interpretation; Successors</U></FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">The Board may amend, modify, supplement, restate, rescind,
terminate or replace all or any portion of this Policy at any time and from time to time in its sole discretion, including, without limitation,
as the Board deems necessary to reflect and comply with applicable law or any of the Applicable Rules. To the extent of any inconsistency
between this Policy and any of the Applicable Rules, the Applicable Rules shall control and this Policy shall be deemed amended to incorporate
such Applicable Rules unless the Committee shall expressly determine otherwise. Notwithstanding anything to the contrary herein, no amendment,
modification, supplement, restatement, rescission, termination or replacement of this Policy shall be effective if such amendment, modification,
supplement, restatement, rescission, termination or replacement would (after taking into account any actions taken by the Company contemporaneously
with such amendment, modification, supplement, restatement, rescission, termination or replacement) cause the Company to violate any of
the Applicable Rules or other applicable law.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">This Policy shall be binding and enforceable against
all Senior Executives and their beneficiaries, heirs, executors, administrators or other legal representatives, to the fullest extent
of the law. </FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><B>RED CAT HOLDINGS, INC.<BR>
Agreement to the Policy on Recovery of Erroneously Awarded Compensation</B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">This agreement is made
as of _____________, by and between Red Cat Holdings, Inc., a Nevada corporation (the &ldquo;Company&rdquo;), and _____________ (the &ldquo;Senior
Executive&rdquo;). Capitalized terms used in this agreement not defined in this agreement shall have the meaning set forth in the Policy
(as defined below).</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">In exchange for any compensation
received by (or to be paid) or awarded (or to be awarded) to the Senior Executive under any Company plan, policy or arrangement or on
a discretionary basis whether or not pursuant to any plan, which includes without limitation any Incentive-Based Compensation (the &ldquo;Compensation&rdquo;),
the parties hereby agree as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">1.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">The Senior Executive agrees to be bound fully by the
terms of the Company&rsquo;s Policy on Recovery of Erroneously Awarded Compensation (as the same may be amended, modified, supplemented,
and/or restated from time to time, the &ldquo;Policy&rdquo;), a copy of the present form of which has been provided to, and read and understood
by, the Senior Executive. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">2.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">The Senior Executive agrees to abide by the terms of
the Policy, and in the event it is determined by the Committee that any amounts granted, awarded, earned or paid to the Senior Executive
must be recouped or recovered by, or repaid, forfeited or reimbursed to, the Company in accordance with the Policy, the Senior Executive
will promptly take any action necessary to effectuate the same.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">3.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">The Policy applies to the Compensation notwithstanding
any terms of the plan, policy or agreement under which it is granted or the terms of any employment agreement to which the Senior Executive
is a party. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">4.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">Any amendments, modifications, supplements, or restatements
to or of the Policy, including without limitation any amendments to comply with applicable law, will be applicable to the Senior Executive.
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">5.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">The laws of the State of Nevada, without regard to its
conflict of law provisions, shall govern the interpretation and validity of the provisions of this agreement and all questions relating
to this agreement. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">6.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">This agreement shall be binding on the Senior Executive
and his/her heirs, successors and legal representatives, and on the Company and its successors. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">7.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">If the terms of the Policy and this agreement conflict,
the terms of the Policy shall prevail. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">8.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">In the event that any provision of this agreement, or
the application thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder
of this agreement shall continue in full force and effect and shall be interpreted so as reasonably to effect the intent of the parties
hereto. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">9.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">Any Compensation may be subject to reimbursement, clawback
and/or forfeiture pursuant to applicable law, under circumstances that are different from those applicable under the Policy, and the Senior
Executive consents to application of any such reimbursement, clawback or forfeiture.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">This agreement, together
with the Policy, which incorporated by reference herein, sets forth the entire understanding of the parties and supersedes all prior agreements,
arrangements, and other communications, whether oral or written, pertaining to the subject matter hereof; and this agreement shall not
be modified or amended except by written agreement of the Company and the Senior Executive.</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the
Company and the Senior Executive have executed this agreement effective as of the day and year first above written.</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-right: 0; margin-left: 3in">____________________________<BR>
[Name of Senior Executive]</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-right: 0; margin-left: 3in">&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-right: 0; margin-left: 3in">Red Cat Holdings, Inc.</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-right: 0; margin-left: 3in">&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-right: 0; margin-left: 3in">____________________________<BR>
By:<BR>
Its:</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>rcat-20240430.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9Ks5s7xRiXgOn8uEZ3NcOaaCuaOdwZ93yekhvGt6fXmqfykoPGRJ7iabiceWQRoI -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:RCAT="http://RCAT/20240430" elementFormDefault="qualified" targetNamespace="http://RCAT/20240430">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://RCAT/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/StatementsOfOperations" id="StatementsOfOperations">
          <link:definition>00000004 - Statement - Consolidated Statements of Operations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/StatementsOfStockholdersEquity" id="StatementsOfStockholdersEquity">
          <link:definition>00000005 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/StatementsOfStockholdersEquityParenthetical" id="StatementsOfStockholdersEquityParenthetical">
          <link:definition>00000006 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000007 - Statement - Consolidated Statements of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note1Business" id="Note1Business">
          <link:definition>00000008 - Disclosure - Note 1 &#8211; The Business</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies" id="Note2SummaryOfSignificantAccountingPolicies">
          <link:definition>00000009 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegment" id="Note3DivestitureOfConsumerSegment">
          <link:definition>00000010 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note4MarketableSecurities" id="Note4MarketableSecurities">
          <link:definition>00000011 - Disclosure - Note 4 &#8211; Marketable Securities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note5Inventories" id="Note5Inventories">
          <link:definition>00000012 - Disclosure - Note 5 &#8211; Inventories</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note6OtherCurrentAssets" id="Note6OtherCurrentAssets">
          <link:definition>00000013 - Disclosure - Note 6 &#8211; Other Current Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note7DueFromRelatedParty" id="Note7DueFromRelatedParty">
          <link:definition>00000014 - Disclosure - Note 7 &#8211; Due From Related Party</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note8IntangibleAssets" id="Note8IntangibleAssets">
          <link:definition>00000015 - Disclosure - Note 8 &#8211; Intangible Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note9EquityMethodInvestment" id="Note9EquityMethodInvestment">
          <link:definition>00000016 - Disclosure - Note 9 &#8211; Equity Method Investment</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note10PropertyAndEquipment" id="Note10PropertyAndEquipment">
          <link:definition>00000017 - Disclosure - Note 10 &#8211; Property and Equipment</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note11OtherLong-termAssets" id="Note11OtherLong-termAssets">
          <link:definition>00000018 - Disclosure - Note 11 &#8211; Other Long-Term Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note12RightOfUseAssetsAndLiabilities" id="Note12RightOfUseAssetsAndLiabilities">
          <link:definition>00000019 - Disclosure - Note 12 &#8211; Right of Use Assets and Liabilities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note13DebtObligations" id="Note13DebtObligations">
          <link:definition>00000020 - Disclosure - Note 13 &#8211; Debt Obligations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note14DueToRelatedParty" id="Note14DueToRelatedParty">
          <link:definition>00000021 - Disclosure - Note 14 &#8211; Due to Related Party</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note15IncomeTaxes" id="Note15IncomeTaxes">
          <link:definition>00000022 - Disclosure - Note 15 &#8211; Income Taxes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note16CommonStock" id="Note16CommonStock">
          <link:definition>00000023 - Disclosure - Note 16 &#8211; Common Stock</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note17PreferredStock" id="Note17PreferredStock">
          <link:definition>00000024 - Disclosure - Note 17 &#8211; Preferred Stock</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note18Warrants" id="Note18Warrants">
          <link:definition>00000025 - Disclosure - Note 18 &#8211; Warrants</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note19ShareBasedAwards" id="Note19ShareBasedAwards">
          <link:definition>00000026 - Disclosure - Note 19 &#8211; Share Based Awards</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note20-Related-partyTransactions" id="Note20-Related-partyTransactions">
          <link:definition>00000027 - Disclosure - Note 20 - Related-Party Transactions</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note21CommitmentsAndContingencies" id="Note21CommitmentsAndContingencies">
          <link:definition>00000028 - Disclosure - Note 21 &#8211; Commitments and Contingencies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note22SubsequentEvents" id="Note22SubsequentEvents">
          <link:definition>00000029 - Disclosure - Note 22 &#8211; Subsequent Events</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies" id="Note2SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>00000030 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables" id="Note2SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>00000031 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentTables" id="Note3DivestitureOfConsumerSegmentTables">
          <link:definition>00000032 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note5InventoriesTables" id="Note5InventoriesTables">
          <link:definition>00000033 - Disclosure - Note 5 &#8211; Inventories (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note6OtherCurrentAssetsTables" id="Note6OtherCurrentAssetsTables">
          <link:definition>00000034 - Disclosure - Note 6 &#8211; Other Current Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note8IntangibleAssetsTables" id="Note8IntangibleAssetsTables">
          <link:definition>00000035 - Disclosure - Note 8 &#8211; Intangible Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note9EquityMethodInvestmentTables" id="Note9EquityMethodInvestmentTables">
          <link:definition>00000036 - Disclosure - Note 9 &#8211; Equity Method Investment (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note10PropertyAndEquipmentTables" id="Note10PropertyAndEquipmentTables">
          <link:definition>00000037 - Disclosure - Note 10 &#8211; Property and Equipment (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note11OtherLong-termAssetsTables" id="Note11OtherLong-termAssetsTables">
          <link:definition>00000038 - Disclosure - Note 11 &#8211; Other Long-Term Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note12RightOfUseAssetsAndLiabilitiesTables" id="Note12RightOfUseAssetsAndLiabilitiesTables">
          <link:definition>00000039 - Disclosure - Note 12 &#8211; Right of Use Assets and Liabilities (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note13DebtObligationsTables" id="Note13DebtObligationsTables">
          <link:definition>00000040 - Disclosure - Note 13 &#8211; Debt Obligations (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note16CommonStockTables" id="Note16CommonStockTables">
          <link:definition>00000041 - Disclosure - Note 16 &#8211; Common Stock (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note18WarrantsTables" id="Note18WarrantsTables">
          <link:definition>00000042 - Disclosure - Note 18 &#8211; Warrants (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note19ShareBasedAwardsTables" id="Note19ShareBasedAwardsTables">
          <link:definition>00000043 - Disclosure - Note 19 &#8211; Share Based Awards (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" id="ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails">
          <link:definition>00000044 - Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note1BusinessDetailsNarrative" id="Note1BusinessDetailsNarrative">
          <link:definition>00000045 - Disclosure - Note 1 &#8211; The Business (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/CustomerConcentrationRiskDetails" id="CustomerConcentrationRiskDetails">
          <link:definition>00000046 - Disclosure - Customer concentration risk (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails" id="CompanysRevenueDisaggregatedByRevenueTypeDetails">
          <link:definition>00000047 - Disclosure - Company's revenue disaggregated by revenue type (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" id="AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails">
          <link:definition>00000048 - Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000049 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails" id="DiscontinuedOperations-ResultsOfOperationsDetails">
          <link:definition>00000050 - Disclosure - Discontinued Operations - results of operations (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails" id="AssetsAndLiabilitiesForConsumerSegmentDetails">
          <link:definition>00000051 - Disclosure - Assets and liabilities for the Consumer Segment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative" id="Note3DivestitureOfConsumerSegmentDetailsNarrative">
          <link:definition>00000052 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note4MarketableSecuritiesDetailsNarrative" id="Note4MarketableSecuritiesDetailsNarrative">
          <link:definition>00000053 - Disclosure - Note 4 &#8211; Marketable Securities (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/InventoriesDetails" id="InventoriesDetails">
          <link:definition>00000054 - Disclosure - Inventories (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/OtherCurrentAssetsDetails" id="OtherCurrentAssetsDetails">
          <link:definition>00000055 - Disclosure - Other current assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative" id="Note7DueFromRelatedPartyDetailsNarrative">
          <link:definition>00000056 - Disclosure - Note 7 &#8211; Due From Related Party (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/IntangibleAssetsDetails" id="IntangibleAssetsDetails">
          <link:definition>00000057 - Disclosure - Intangible assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails" id="ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails">
          <link:definition>00000058 - Disclosure - Expected amortization expense for the unamortized finite-lived intangible assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/CompositionOfAndChangesInGoodwillDetails" id="CompositionOfAndChangesInGoodwillDetails">
          <link:definition>00000059 - Disclosure - Composition of, and changes in goodwill (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note8IntangibleAssetsDetailsNarrative" id="Note8IntangibleAssetsDetailsNarrative">
          <link:definition>00000060 - Disclosure - Note 8 &#8211; Intangible Assets (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails" id="FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails">
          <link:definition>00000061 - Disclosure - Financial informatino for UMAC derived from their Form 10-Q (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails" id="ImpactsOnInvestmentsIntoUmacDetails">
          <link:definition>00000062 - Disclosure - Impacts on investments into UMAC (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/PropertyAndEquipmentDetails" id="PropertyAndEquipmentDetails">
          <link:definition>00000063 - Disclosure - Property and equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note10PropertyAndEquipmentDetailsNarrative" id="Note10PropertyAndEquipmentDetailsNarrative">
          <link:definition>00000064 - Disclosure - Note 10 &#8211; Property and Equipment (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/OtherLongTermAssetsDetails" id="OtherLongTermAssetsDetails">
          <link:definition>00000065 - Disclosure - Other long term assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note11OtherLong-termAssetsDetailsNarrative" id="Note11OtherLong-termAssetsDetailsNarrative">
          <link:definition>00000066 - Disclosure - Note 11 &#8211; Other Long-Term Assets (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/OperatingLeasesDetails" id="OperatingLeasesDetails">
          <link:definition>00000067 - Disclosure - Operating leases (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails" id="SupplementalInformationRelatedToOperatingLeasesDetails">
          <link:definition>00000068 - Disclosure - Supplemental information related to operating leases (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/FutureLeasePaymentObligationsDetails" id="FutureLeasePaymentObligationsDetails">
          <link:definition>00000069 - Disclosure - Future lease payment obligations (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/OutstandingPrincipalPaymentsDetails" id="OutstandingPrincipalPaymentsDetails">
          <link:definition>00000070 - Disclosure - Outstanding principal payments (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note13DebtObligationsDetailsNarrative" id="Note13DebtObligationsDetailsNarrative">
          <link:definition>00000071 - Disclosure - Note 13 &#8211; Debt Obligations (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative" id="Note14DueToRelatedPartyDetailsNarrative">
          <link:definition>00000072 - Disclosure - Note 14 &#8211; Due to Related Party (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note15IncomeTaxesDetailsNarrative" id="Note15IncomeTaxesDetailsNarrative">
          <link:definition>00000073 - Disclosure - Note 15 &#8211; Income Taxes (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails" id="SummaryOfSharesOfCommonStockIssuedDetails">
          <link:definition>00000074 - Disclosure - Summary of shares of common stock issued (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note17PreferredStockDetailsNarrative" id="Note17PreferredStockDetailsNarrative">
          <link:definition>00000075 - Disclosure - Note 17 &#8211; Preferred Stock (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails" id="SummaryOfWarrantsIssuedAndFairValuesDetails">
          <link:definition>00000076 - Disclosure - Summary of warrants issued and fair values (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails" id="AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails">
          <link:definition>00000077 - Disclosure - Assumptions used to estimate fair value of stock warrants granted (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/ChangesInWarrantsOutstandingDetails" id="ChangesInWarrantsOutstandingDetails">
          <link:definition>00000078 - Disclosure - Changes in warrants outstanding (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note18WarrantsDetailsNarrative" id="Note18WarrantsDetailsNarrative">
          <link:definition>00000079 - Disclosure - Note 18 &#8211; Warrants (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" id="AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails">
          <link:definition>00000080 - Disclosure - Assumptions used to calculate fair value of options granted (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/SummaryOfActivityUnderPlanDetails" id="SummaryOfActivityUnderPlanDetails">
          <link:definition>00000081 - Disclosure - Summary of activity under the Plan (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails" id="SummaryOfRestrictedStockActivityUnderPlanDetails">
          <link:definition>00000082 - Disclosure - Summary of restricted stock activity under the Plan (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails" id="StockCompensationExpenseByFunctionalCategoryDetails">
          <link:definition>00000083 - Disclosure - Stock compensation expense by functional category (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note19ShareBasedAwardsDetailsNarrative" id="Note19ShareBasedAwardsDetailsNarrative">
          <link:definition>00000084 - Disclosure - Note 19 &#8211; Share Based Awards (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="rcat-20240430_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rcat-20240430_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rcat-20240430_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rcat-20240430_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="RCAT_SeriesBPreferredStock1Member" name="SeriesBPreferredStock1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_BusinessAcquisition1Member" name="BusinessAcquisition1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_BusinessAcquisition2Member" name="BusinessAcquisition2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_BusinessAcquisition3Member" name="BusinessAcquisition3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_BusinessAcquisition4Member" name="BusinessAcquisition4Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RestatementImpactOriginallyReportedMember" name="RestatementImpactOriginallyReportedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RestatementImpactAsRestatedMember" name="RestatementImpactAsRestatedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RestatementImpactChangeMember" name="RestatementImpactChangeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_CustomerConcentrationRisk1Member" name="CustomerConcentrationRisk1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_CustomerConcentrationRisk2Member" name="CustomerConcentrationRisk2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_CustomerConcentrationRisk3Member" name="CustomerConcentrationRisk3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_CustomerConcentrationRisk4Member" name="CustomerConcentrationRisk4Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_CustomerConcentrationRisk5Member" name="CustomerConcentrationRisk5Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IntangibleAssetsGrossCarryingAmountMember" name="IntangibleAssetsGrossCarryingAmountMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IntangibleAssetsAccumulatedAmortizationMember" name="IntangibleAssetsAccumulatedAmortizationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IntangibleAssetsNetCarryingValueMember" name="IntangibleAssetsNetCarryingValueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OperatingLeaseLocation1Member" name="OperatingLeaseLocation1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OperatingLeaseLocation3Member" name="OperatingLeaseLocation3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OperatingLeaseLocation4Member" name="OperatingLeaseLocation4Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DebtObligation1Member" name="DebtObligation1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DebtObligation2Member" name="DebtObligation2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DebtObligation3Member" name="DebtObligation3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DebtObligation6Member" name="DebtObligation6Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DebtObligation8Member" name="DebtObligation8Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DueToRelatedParty2Member" name="DueToRelatedParty2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SeriesAPreferredStock2Member" name="SeriesAPreferredStock2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_WarrantAssumptionsUsedMember" name="WarrantAssumptionsUsedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_WarrantsOutstanding1Member" name="WarrantsOutstanding1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OptionsAssumptionsUsedMember" name="OptionsAssumptionsUsedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_Options1Member" name="Options1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_PreferredStockValueSeriesB" name="PreferredStockValueSeriesB" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_EarningsPerShareBasicAndDilutedRCATAbstract" name="EarningsPerShareBasicAndDilutedRCATAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" name="EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" name="EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_EarningsPerShareBasicAndDilutedRCAT" name="EarningsPerShareBasicAndDilutedRCAT" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" name="WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockIssuedDuringPeriodValueThroughATMFacility" name="StockIssuedDuringPeriodValueThroughATMFacility" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockSharesIssuedNetThroughATMFacility" name="StockSharesIssuedNetThroughATMFacility" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IncomeLossFromDiscontinuedOperations" name="IncomeLossFromDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ProceedsFromIssuanceOfCommonStockPublicOffering" name="ProceedsFromIssuanceOfCommonStockPublicOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ProceedsFromIssuanceOfCommonStockATMFacilityNet" name="ProceedsFromIssuanceOfCommonStockATMFacilityNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_PaymentsOfTaxesRelatedToEquityTransactions" name="PaymentsOfTaxesRelatedToEquityTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" name="NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NoncashOrPartNoncashDivestitureNoteReceivable" name="NoncashOrPartNoncashDivestitureNoteReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ConversionOfPreferredStockIntoCommonStock" name="ConversionOfPreferredStockIntoCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FairValueOfSharesWithheldAsPaymentOfNoteReceivable" name="FairValueOfSharesWithheldAsPaymentOfNoteReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_TaxesRelatedToNetShareSettlementOfEquityAwards" name="TaxesRelatedToNetShareSettlementOfEquityAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisclosureNote7DueFromRelatedPartyAbstract" name="DisclosureNote7DueFromRelatedPartyAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DueFromRelatedPartyDisclosureTextBlock" name="DueFromRelatedPartyDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisclosureNote11OtherLongtermAssetsAbstract" name="DisclosureNote11OtherLongtermAssetsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OtherLongTermAssetsDisclosureTextBlock" name="OtherLongTermAssetsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisclosureNote14DueToRelatedPartyAbstract" name="DisclosureNote14DueToRelatedPartyAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RelatedPartyPayablesDisclosureTextBlock" name="RelatedPartyPayablesDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisclosureNote18WarrantsAbstract" name="DisclosureNote18WarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_WarrantsDisclosureTextBlock" name="WarrantsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" name="RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RelatedPartiesPolicyTextBlock" name="RelatedPartiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" name="RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" name="RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock" name="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock" name="EquityMethodInvestmentFinancialInformationTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock" name="ScheduleOfOtherLongTermAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ScheduleOfDebtPaymentsDueTableTextBlock" name="ScheduleOfDebtPaymentsDueTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock" name="ScheduleOfWarrantsIssuedAndFairValueTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ScheduleOfAssumptionsUsed1TableTextBlock" name="ScheduleOfAssumptionsUsed1TableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RestatementImpactAxis" name="RestatementImpactAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="RCAT_RestatementImpactDomain" name="RestatementImpactDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OperatingLeaseLiabilityCurrentRestatementImpact" name="OperatingLeaseLiabilityCurrentRestatementImpact" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_LiabilitiesCurrentRestatementImpact" name="LiabilitiesCurrentRestatementImpact" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockholdersEquityRestatement" name="StockholdersEquityRestatement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FirmCommitmentUnderwrittenPublicOfferingShares" name="FirmCommitmentUnderwrittenPublicOfferingShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" name="FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds" name="FirmCommitmentUnderwrittenPublicOfferingNetProceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" name="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" name="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" name="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" name="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DifferenceBetweenComprehensiveLossAndNetLoss" name="DifferenceBetweenComprehensiveLossAndNetLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" name="DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" name="DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" name="DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" name="DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" name="DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent" name="DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent" name="DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisposalGroupIncludingDiscontinuedOperationWorkingCapital" name="DisposalGroupIncludingDiscontinuedOperationWorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1" name="NoncashOrPartNoncashDivestitureCashConsiderationReceived1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" name="NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" name="NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_WorkingCapitalAtClosingOfDisposalGroup" name="WorkingCapitalAtClosingOfDisposalGroup" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_CorporateBondsAtCarryingValueFairValue" name="CorporateBondsAtCarryingValueFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_CorporateBondsAtCarryingValueCostBasis" name="CorporateBondsAtCarryingValueCostBasis" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_CorporateBondsAtCarryingValueUnrealizedLosses" name="CorporateBondsAtCarryingValueUnrealizedLosses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_CashCompensationSubjectToTaxation" name="CashCompensationSubjectToTaxation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IncomeAssociatedWithStockCompensationSubjectToTaxation" name="IncomeAssociatedWithStockCompensationSubjectToTaxation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation" name="NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteShares" name="CommonStockWithheldByCompanyAppliedAgainstNoteShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteAmount" name="CommonStockWithheldByCompanyAppliedAgainstNoteAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharesHeldAtTransferAgentUntilNoteReceivableRepayment" name="SharesHeldAtTransferAgentUntilNoteReceivableRepayment" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RestrictedStockScheduledToVestShares" name="RestrictedStockScheduledToVestShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable" name="RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_PaymentsForTaxLiability" name="PaymentsForTaxLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_EstimatedTaxesOwedRelatedToStockCompensation" name="EstimatedTaxesOwedRelatedToStockCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FiniteLivedProprietaryTechnologyGross" name="FiniteLivedProprietaryTechnologyGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FiniteLivedNoncompeteAgreementsGross1" name="FiniteLivedNoncompeteAgreementsGross1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FiniteLivedCustomerRelationshipsGross1" name="FiniteLivedCustomerRelationshipsGross1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FiniteLivedIntangibleAssetsGross1" name="FiniteLivedIntangibleAssetsGross1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1" name="IndefiniteLivedIntangibleAssetsExcludingGoodwill1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IntangibleAssetsNetExcludingGoodwill1" name="IntangibleAssetsNetExcludingGoodwill1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SAFEAgreementAssets" name="SAFEAgreementAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_PaymentForSAFEAgreement" name="PaymentForSAFEAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OperatingCashPaidToSettleLeaseLiabilities" name="OperatingCashPaidToSettleLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix" name="LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueThereafter" name="LesseeOperatingLeaseLiabilityPaymentsDueThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueSubtotal" name="LesseeOperatingLeaseLiabilityPaymentsDueSubtotal" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OutstandingPrincipalPaymentsDueYearOne" name="OutstandingPrincipalPaymentsDueYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OutstandingPrincipalPaymentsDueLongTerm" name="OutstandingPrincipalPaymentsDueLongTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OutstandingPrincipalPaymentsDueTotal" name="OutstandingPrincipalPaymentsDueTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ConvertibleNoteAgreementAmount" name="ConvertibleNoteAgreementAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_LeaseholdImprovementAgreementFundsReceived" name="LeaseholdImprovementAgreementFundsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset" name="FinancingAgreementFundingOfPurchaseOfFixedAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_LineOfCreditObligationAssumedInConnectionWithAcquisition" name="LineOfCreditObligationAssumedInConnectionWithAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DebtInstrumentInterestRateDuringPeriod1" name="DebtInstrumentInterestRateDuringPeriod1" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DueToOtherRelatedPartyClassifiedCurrent" name="DueToOtherRelatedPartyClassifiedCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DebtInstrumentOutstandingAccruedInterestPayment" name="DebtInstrumentOutstandingAccruedInterestPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" name="StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares" name="IssuanceOfCommonStockThroughATMFacilitiesNetShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockIssuedDuringPeriodSharesPublicOffering" name="StockIssuedDuringPeriodSharesPublicOffering" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" name="StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NumberOfWarrantsUponIssuance" name="NumberOfWarrantsUponIssuance" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_InitialFairValueOfWarrantsUponIssuance" name="InitialFairValueOfWarrantsUponIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NumberOfWarrantsOutstanding" name="NumberOfWarrantsOutstanding" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FairValueOfWarrantsOutstanding" name="FairValueOfWarrantsOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NumberOfWarrantsOutstanding2" name="NumberOfWarrantsOutstanding2" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FairValueOfWarrantsOutstanding2" name="FairValueOfWarrantsOutstanding2" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_WarrantsIssuedExercisePrice" name="WarrantsIssuedExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ProceedsReceivedFromExerciseOfWarrants" name="ProceedsReceivedFromExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ExerciseOfWarrantsShares" name="ExerciseOfWarrantsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_WarrantsToPurchaseSharesIssued" name="WarrantsToPurchaseSharesIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FairValueOfOptionsAxis" name="FairValueOfOptionsAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="RCAT_FairValueOfOptionsDomain" name="FairValueOfOptionsDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" name="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationSharesRestrictedStockAxis" name="ShareBasedCompensationSharesRestrictedStockAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="RCAT_ShareBasedCompensationSharesRestrictedStockDomain" name="ShareBasedCompensationSharesRestrictedStockDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" name="SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" name="SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" name="SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ResearchAndDevelopmentStockCompensationExpense" name="ResearchAndDevelopmentStockCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SalesAndMarketingStockCompensationExpense" name="SalesAndMarketingStockCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_GeneralAndAdministrativeStockCompensationExpense" name="GeneralAndAdministrativeStockCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_TotalStockCompensationExpense" name="TotalStockCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" name="NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" name="UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockCompensationExpensePertainingToOptions" name="StockCompensationExpensePertainingToOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockCompensationExpensePertainingToRestrictedStockUnits" name="StockCompensationExpensePertainingToRestrictedStockUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>rcat-20240430_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://RCAT/role/Cover" xlink:href="rcat-20240430.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/BalanceSheets" xlink:href="rcat-20240430.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/BalanceSheetsParenthetical" xlink:href="rcat-20240430.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfOperations" xlink:href="rcat-20240430.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfStockholdersEquity" xlink:href="rcat-20240430.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfStockholdersEquityParenthetical" xlink:href="rcat-20240430.xsd#StatementsOfStockholdersEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfCashFlows" xlink:href="rcat-20240430.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note1Business" xlink:href="rcat-20240430.xsd#Note1Business" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies" xlink:href="rcat-20240430.xsd#Note2SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegment" xlink:href="rcat-20240430.xsd#Note3DivestitureOfConsumerSegment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note4MarketableSecurities" xlink:href="rcat-20240430.xsd#Note4MarketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note5Inventories" xlink:href="rcat-20240430.xsd#Note5Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note6OtherCurrentAssets" xlink:href="rcat-20240430.xsd#Note6OtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note7DueFromRelatedParty" xlink:href="rcat-20240430.xsd#Note7DueFromRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8IntangibleAssets" xlink:href="rcat-20240430.xsd#Note8IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note9EquityMethodInvestment" xlink:href="rcat-20240430.xsd#Note9EquityMethodInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10PropertyAndEquipment" xlink:href="rcat-20240430.xsd#Note10PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11OtherLong-termAssets" xlink:href="rcat-20240430.xsd#Note11OtherLong-termAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note12RightOfUseAssetsAndLiabilities" xlink:href="rcat-20240430.xsd#Note12RightOfUseAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note13DebtObligations" xlink:href="rcat-20240430.xsd#Note13DebtObligations" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note14DueToRelatedParty" xlink:href="rcat-20240430.xsd#Note14DueToRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note15IncomeTaxes" xlink:href="rcat-20240430.xsd#Note15IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note16CommonStock" xlink:href="rcat-20240430.xsd#Note16CommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note17PreferredStock" xlink:href="rcat-20240430.xsd#Note17PreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note18Warrants" xlink:href="rcat-20240430.xsd#Note18Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note19ShareBasedAwards" xlink:href="rcat-20240430.xsd#Note19ShareBasedAwards" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note20-Related-partyTransactions" xlink:href="rcat-20240430.xsd#Note20-Related-partyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note21CommitmentsAndContingencies" xlink:href="rcat-20240430.xsd#Note21CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note22SubsequentEvents" xlink:href="rcat-20240430.xsd#Note22SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="rcat-20240430.xsd#Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables" xlink:href="rcat-20240430.xsd#Note2SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentTables" xlink:href="rcat-20240430.xsd#Note3DivestitureOfConsumerSegmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note5InventoriesTables" xlink:href="rcat-20240430.xsd#Note5InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note6OtherCurrentAssetsTables" xlink:href="rcat-20240430.xsd#Note6OtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8IntangibleAssetsTables" xlink:href="rcat-20240430.xsd#Note8IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note9EquityMethodInvestmentTables" xlink:href="rcat-20240430.xsd#Note9EquityMethodInvestmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10PropertyAndEquipmentTables" xlink:href="rcat-20240430.xsd#Note10PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11OtherLong-termAssetsTables" xlink:href="rcat-20240430.xsd#Note11OtherLong-termAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note12RightOfUseAssetsAndLiabilitiesTables" xlink:href="rcat-20240430.xsd#Note12RightOfUseAssetsAndLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note13DebtObligationsTables" xlink:href="rcat-20240430.xsd#Note13DebtObligationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note16CommonStockTables" xlink:href="rcat-20240430.xsd#Note16CommonStockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note18WarrantsTables" xlink:href="rcat-20240430.xsd#Note18WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note19ShareBasedAwardsTables" xlink:href="rcat-20240430.xsd#Note19ShareBasedAwardsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:href="rcat-20240430.xsd#ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note1BusinessDetailsNarrative" xlink:href="rcat-20240430.xsd#Note1BusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/CustomerConcentrationRiskDetails" xlink:href="rcat-20240430.xsd#CustomerConcentrationRiskDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:href="rcat-20240430.xsd#CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:href="rcat-20240430.xsd#AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="rcat-20240430.xsd#Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails" xlink:href="rcat-20240430.xsd#DiscontinuedOperations-ResultsOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails" xlink:href="rcat-20240430.xsd#AssetsAndLiabilitiesForConsumerSegmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:href="rcat-20240430.xsd#Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note4MarketableSecuritiesDetailsNarrative" xlink:href="rcat-20240430.xsd#Note4MarketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/InventoriesDetails" xlink:href="rcat-20240430.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OtherCurrentAssetsDetails" xlink:href="rcat-20240430.xsd#OtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative" xlink:href="rcat-20240430.xsd#Note7DueFromRelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/IntangibleAssetsDetails" xlink:href="rcat-20240430.xsd#IntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails" xlink:href="rcat-20240430.xsd#ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/CompositionOfAndChangesInGoodwillDetails" xlink:href="rcat-20240430.xsd#CompositionOfAndChangesInGoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8IntangibleAssetsDetailsNarrative" xlink:href="rcat-20240430.xsd#Note8IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails" xlink:href="rcat-20240430.xsd#FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails" xlink:href="rcat-20240430.xsd#ImpactsOnInvestmentsIntoUmacDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/PropertyAndEquipmentDetails" xlink:href="rcat-20240430.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10PropertyAndEquipmentDetailsNarrative" xlink:href="rcat-20240430.xsd#Note10PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OtherLongTermAssetsDetails" xlink:href="rcat-20240430.xsd#OtherLongTermAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11OtherLong-termAssetsDetailsNarrative" xlink:href="rcat-20240430.xsd#Note11OtherLong-termAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OperatingLeasesDetails" xlink:href="rcat-20240430.xsd#OperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails" xlink:href="rcat-20240430.xsd#SupplementalInformationRelatedToOperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/FutureLeasePaymentObligationsDetails" xlink:href="rcat-20240430.xsd#FutureLeasePaymentObligationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OutstandingPrincipalPaymentsDetails" xlink:href="rcat-20240430.xsd#OutstandingPrincipalPaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note13DebtObligationsDetailsNarrative" xlink:href="rcat-20240430.xsd#Note13DebtObligationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative" xlink:href="rcat-20240430.xsd#Note14DueToRelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note15IncomeTaxesDetailsNarrative" xlink:href="rcat-20240430.xsd#Note15IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails" xlink:href="rcat-20240430.xsd#SummaryOfSharesOfCommonStockIssuedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note17PreferredStockDetailsNarrative" xlink:href="rcat-20240430.xsd#Note17PreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:href="rcat-20240430.xsd#SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails" xlink:href="rcat-20240430.xsd#AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ChangesInWarrantsOutstandingDetails" xlink:href="rcat-20240430.xsd#ChangesInWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note18WarrantsDetailsNarrative" xlink:href="rcat-20240430.xsd#Note18WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:href="rcat-20240430.xsd#AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfActivityUnderPlanDetails" xlink:href="rcat-20240430.xsd#SummaryOfActivityUnderPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:href="rcat-20240430.xsd#SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails" xlink:href="rcat-20240430.xsd#StockCompensationExpenseByFunctionalCategoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note19ShareBasedAwardsDetailsNarrative" xlink:href="rcat-20240430.xsd#Note19ShareBasedAwardsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:label="loc_us-gaapLongTermAccountsNotesAndLoansReceivableNetNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapLongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:label="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperation" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_PreferredStockValueSeriesB" xlink:label="loc_RCATPreferredStockValueSeriesB" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_RCATPreferredStockValueSeriesB" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInDerivativeAssetsAndLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapIncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense" xlink:label="loc_us-gaapOtherNonrecurringIncomeExpense" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonrecurringIncomeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfStockholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Stockholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfStockholdersEquityParenthetical" xlink:title="00000006 - Statement - Consolidated Statements of Stockholders&apos; Equity (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IncomeLossFromDiscontinuedOperations" xlink:label="loc_RCATIncomeLossFromDiscontinuedOperations" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_RCATIncomeLossFromDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesGainLoss" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapMarketableSecuritiesGainLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInDerivativeLiabilities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInDerivativeLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:label="loc_RCATIncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_RCATIncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaapProceedsFromDivestitureOfBusinesses" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromDivestitureOfBusinesses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAssetsInvestingActivities" xlink:label="loc_us-gaapPaymentsToAcquireAssetsInvestingActivities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsToAcquireAssetsInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ProceedsFromIssuanceOfCommonStockPublicOffering" xlink:label="loc_RCATProceedsFromIssuanceOfCommonStockPublicOffering" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_RCATProceedsFromIssuanceOfCommonStockPublicOffering" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ProceedsFromIssuanceOfCommonStockATMFacilityNet" xlink:label="loc_RCATProceedsFromIssuanceOfCommonStockATMFacilityNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_RCATProceedsFromIssuanceOfCommonStockATMFacilityNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_PaymentsOfTaxesRelatedToEquityTransactions" xlink:label="loc_RCATPaymentsOfTaxesRelatedToEquityTransactions" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_RCATPaymentsOfTaxesRelatedToEquityTransactions" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInDiscontinuedOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInDiscontinuedOperations" xlink:to="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInDiscontinuedOperations" xlink:to="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInDiscontinuedOperations" xlink:to="loc_us-gaapCashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCash" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCash" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note1Business" xlink:title="00000008 - Disclosure - Note 1 &#8211; The Business" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegment" xlink:title="00000010 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note4MarketableSecurities" xlink:title="00000011 - Disclosure - Note 4 &#8211; Marketable Securities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note5Inventories" xlink:title="00000012 - Disclosure - Note 5 &#8211; Inventories" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note6OtherCurrentAssets" xlink:title="00000013 - Disclosure - Note 6 &#8211; Other Current Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note7DueFromRelatedParty" xlink:title="00000014 - Disclosure - Note 7 &#8211; Due From Related Party" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note8IntangibleAssets" xlink:title="00000015 - Disclosure - Note 8 &#8211; Intangible Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note9EquityMethodInvestment" xlink:title="00000016 - Disclosure - Note 9 &#8211; Equity Method Investment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note10PropertyAndEquipment" xlink:title="00000017 - Disclosure - Note 10 &#8211; Property and Equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note11OtherLong-termAssets" xlink:title="00000018 - Disclosure - Note 11 &#8211; Other Long-Term Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note12RightOfUseAssetsAndLiabilities" xlink:title="00000019 - Disclosure - Note 12 &#8211; Right of Use Assets and Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note13DebtObligations" xlink:title="00000020 - Disclosure - Note 13 &#8211; Debt Obligations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note14DueToRelatedParty" xlink:title="00000021 - Disclosure - Note 14 &#8211; Due to Related Party" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note15IncomeTaxes" xlink:title="00000022 - Disclosure - Note 15 &#8211; Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note16CommonStock" xlink:title="00000023 - Disclosure - Note 16 &#8211; Common Stock" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note17PreferredStock" xlink:title="00000024 - Disclosure - Note 17 &#8211; Preferred Stock" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note18Warrants" xlink:title="00000025 - Disclosure - Note 18 &#8211; Warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note19ShareBasedAwards" xlink:title="00000026 - Disclosure - Note 19 &#8211; Share Based Awards" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note20-Related-partyTransactions" xlink:title="00000027 - Disclosure - Note 20 - Related-Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note21CommitmentsAndContingencies" xlink:title="00000028 - Disclosure - Note 21 &#8211; Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note22SubsequentEvents" xlink:title="00000029 - Disclosure - Note 22 &#8211; Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000030 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000031 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegmentTables" xlink:title="00000032 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note5InventoriesTables" xlink:title="00000033 - Disclosure - Note 5 &#8211; Inventories (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note6OtherCurrentAssetsTables" xlink:title="00000034 - Disclosure - Note 6 &#8211; Other Current Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note8IntangibleAssetsTables" xlink:title="00000035 - Disclosure - Note 8 &#8211; Intangible Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note9EquityMethodInvestmentTables" xlink:title="00000036 - Disclosure - Note 9 &#8211; Equity Method Investment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note10PropertyAndEquipmentTables" xlink:title="00000037 - Disclosure - Note 10 &#8211; Property and Equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note11OtherLong-termAssetsTables" xlink:title="00000038 - Disclosure - Note 11 &#8211; Other Long-Term Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note12RightOfUseAssetsAndLiabilitiesTables" xlink:title="00000039 - Disclosure - Note 12 &#8211; Right of Use Assets and Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note13DebtObligationsTables" xlink:title="00000040 - Disclosure - Note 13 &#8211; Debt Obligations (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note16CommonStockTables" xlink:title="00000041 - Disclosure - Note 16 &#8211; Common Stock (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note18WarrantsTables" xlink:title="00000042 - Disclosure - Note 18 &#8211; Warrants (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note19ShareBasedAwardsTables" xlink:title="00000043 - Disclosure - Note 19 &#8211; Share Based Awards (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:title="00000044 - Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note1BusinessDetailsNarrative" xlink:title="00000045 - Disclosure - Note 1 &#8211; The Business (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/CustomerConcentrationRiskDetails" xlink:title="00000046 - Disclosure - Customer concentration risk (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:title="00000047 - Disclosure - Company&apos;s revenue disaggregated by revenue type (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:title="00000048 - Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000049 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails" xlink:title="00000050 - Disclosure - Discontinued Operations - results of operations (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails" xlink:title="00000051 - Disclosure - Assets and liabilities for the Consumer Segment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:title="00000052 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note4MarketableSecuritiesDetailsNarrative" xlink:title="00000053 - Disclosure - Note 4 &#8211; Marketable Securities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/InventoriesDetails" xlink:title="00000054 - Disclosure - Inventories (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/OtherCurrentAssetsDetails" xlink:title="00000055 - Disclosure - Other current assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative" xlink:title="00000056 - Disclosure - Note 7 &#8211; Due From Related Party (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/IntangibleAssetsDetails" xlink:title="00000057 - Disclosure - Intangible assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails" xlink:title="00000058 - Disclosure - Expected amortization expense for the unamortized finite-lived intangible assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/CompositionOfAndChangesInGoodwillDetails" xlink:title="00000059 - Disclosure - Composition of, and changes in goodwill (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note8IntangibleAssetsDetailsNarrative" xlink:title="00000060 - Disclosure - Note 8 &#8211; Intangible Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails" xlink:title="00000061 - Disclosure - Financial informatino for UMAC derived from their Form 10-Q (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails" xlink:title="00000062 - Disclosure - Impacts on investments into UMAC (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/PropertyAndEquipmentDetails" xlink:title="00000063 - Disclosure - Property and equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note10PropertyAndEquipmentDetailsNarrative" xlink:title="00000064 - Disclosure - Note 10 &#8211; Property and Equipment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/OtherLongTermAssetsDetails" xlink:title="00000065 - Disclosure - Other long term assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note11OtherLong-termAssetsDetailsNarrative" xlink:title="00000066 - Disclosure - Note 11 &#8211; Other Long-Term Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/OperatingLeasesDetails" xlink:title="00000067 - Disclosure - Operating leases (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails" xlink:title="00000068 - Disclosure - Supplemental information related to operating leases (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/FutureLeasePaymentObligationsDetails" xlink:title="00000069 - Disclosure - Future lease payment obligations (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/OutstandingPrincipalPaymentsDetails" xlink:title="00000070 - Disclosure - Outstanding principal payments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note13DebtObligationsDetailsNarrative" xlink:title="00000071 - Disclosure - Note 13 &#8211; Debt Obligations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative" xlink:title="00000072 - Disclosure - Note 14 &#8211; Due to Related Party (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note15IncomeTaxesDetailsNarrative" xlink:title="00000073 - Disclosure - Note 15 &#8211; Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails" xlink:title="00000074 - Disclosure - Summary of shares of common stock issued (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note17PreferredStockDetailsNarrative" xlink:title="00000075 - Disclosure - Note 17 &#8211; Preferred Stock (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:title="00000076 - Disclosure - Summary of warrants issued and fair values (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails" xlink:title="00000077 - Disclosure - Assumptions used to estimate fair value of stock warrants granted (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/ChangesInWarrantsOutstandingDetails" xlink:title="00000078 - Disclosure - Changes in warrants outstanding (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note18WarrantsDetailsNarrative" xlink:title="00000079 - Disclosure - Note 18 &#8211; Warrants (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:title="00000080 - Disclosure - Assumptions used to calculate fair value of options granted (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfActivityUnderPlanDetails" xlink:title="00000081 - Disclosure - Summary of activity under the Plan (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:title="00000082 - Disclosure - Summary of restricted stock activity under the Plan (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails" xlink:title="00000083 - Disclosure - Stock compensation expense by functional category (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note19ShareBasedAwardsDetailsNarrative" xlink:title="00000084 - Disclosure - Note 19 &#8211; Share Based Awards (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>rcat-20240430_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://RCAT/role/Cover" xlink:href="rcat-20240430.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/BalanceSheets" xlink:href="rcat-20240430.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/BalanceSheetsParenthetical" xlink:href="rcat-20240430.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfOperations" xlink:href="rcat-20240430.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfStockholdersEquity" xlink:href="rcat-20240430.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfStockholdersEquityParenthetical" xlink:href="rcat-20240430.xsd#StatementsOfStockholdersEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfCashFlows" xlink:href="rcat-20240430.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note1Business" xlink:href="rcat-20240430.xsd#Note1Business" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies" xlink:href="rcat-20240430.xsd#Note2SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegment" xlink:href="rcat-20240430.xsd#Note3DivestitureOfConsumerSegment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note4MarketableSecurities" xlink:href="rcat-20240430.xsd#Note4MarketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note5Inventories" xlink:href="rcat-20240430.xsd#Note5Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note6OtherCurrentAssets" xlink:href="rcat-20240430.xsd#Note6OtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note7DueFromRelatedParty" xlink:href="rcat-20240430.xsd#Note7DueFromRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8IntangibleAssets" xlink:href="rcat-20240430.xsd#Note8IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note9EquityMethodInvestment" xlink:href="rcat-20240430.xsd#Note9EquityMethodInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10PropertyAndEquipment" xlink:href="rcat-20240430.xsd#Note10PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11OtherLong-termAssets" xlink:href="rcat-20240430.xsd#Note11OtherLong-termAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note12RightOfUseAssetsAndLiabilities" xlink:href="rcat-20240430.xsd#Note12RightOfUseAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note13DebtObligations" xlink:href="rcat-20240430.xsd#Note13DebtObligations" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note14DueToRelatedParty" xlink:href="rcat-20240430.xsd#Note14DueToRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note15IncomeTaxes" xlink:href="rcat-20240430.xsd#Note15IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note16CommonStock" xlink:href="rcat-20240430.xsd#Note16CommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note17PreferredStock" xlink:href="rcat-20240430.xsd#Note17PreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note18Warrants" xlink:href="rcat-20240430.xsd#Note18Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note19ShareBasedAwards" xlink:href="rcat-20240430.xsd#Note19ShareBasedAwards" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note20-Related-partyTransactions" xlink:href="rcat-20240430.xsd#Note20-Related-partyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note21CommitmentsAndContingencies" xlink:href="rcat-20240430.xsd#Note21CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note22SubsequentEvents" xlink:href="rcat-20240430.xsd#Note22SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="rcat-20240430.xsd#Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables" xlink:href="rcat-20240430.xsd#Note2SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentTables" xlink:href="rcat-20240430.xsd#Note3DivestitureOfConsumerSegmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note5InventoriesTables" xlink:href="rcat-20240430.xsd#Note5InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note6OtherCurrentAssetsTables" xlink:href="rcat-20240430.xsd#Note6OtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8IntangibleAssetsTables" xlink:href="rcat-20240430.xsd#Note8IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note9EquityMethodInvestmentTables" xlink:href="rcat-20240430.xsd#Note9EquityMethodInvestmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10PropertyAndEquipmentTables" xlink:href="rcat-20240430.xsd#Note10PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11OtherLong-termAssetsTables" xlink:href="rcat-20240430.xsd#Note11OtherLong-termAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note12RightOfUseAssetsAndLiabilitiesTables" xlink:href="rcat-20240430.xsd#Note12RightOfUseAssetsAndLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note13DebtObligationsTables" xlink:href="rcat-20240430.xsd#Note13DebtObligationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note16CommonStockTables" xlink:href="rcat-20240430.xsd#Note16CommonStockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note18WarrantsTables" xlink:href="rcat-20240430.xsd#Note18WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note19ShareBasedAwardsTables" xlink:href="rcat-20240430.xsd#Note19ShareBasedAwardsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:href="rcat-20240430.xsd#ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note1BusinessDetailsNarrative" xlink:href="rcat-20240430.xsd#Note1BusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/CustomerConcentrationRiskDetails" xlink:href="rcat-20240430.xsd#CustomerConcentrationRiskDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:href="rcat-20240430.xsd#CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:href="rcat-20240430.xsd#AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="rcat-20240430.xsd#Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails" xlink:href="rcat-20240430.xsd#DiscontinuedOperations-ResultsOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails" xlink:href="rcat-20240430.xsd#AssetsAndLiabilitiesForConsumerSegmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:href="rcat-20240430.xsd#Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note4MarketableSecuritiesDetailsNarrative" xlink:href="rcat-20240430.xsd#Note4MarketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/InventoriesDetails" xlink:href="rcat-20240430.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OtherCurrentAssetsDetails" xlink:href="rcat-20240430.xsd#OtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative" xlink:href="rcat-20240430.xsd#Note7DueFromRelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/IntangibleAssetsDetails" xlink:href="rcat-20240430.xsd#IntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails" xlink:href="rcat-20240430.xsd#ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/CompositionOfAndChangesInGoodwillDetails" xlink:href="rcat-20240430.xsd#CompositionOfAndChangesInGoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8IntangibleAssetsDetailsNarrative" xlink:href="rcat-20240430.xsd#Note8IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails" xlink:href="rcat-20240430.xsd#FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails" xlink:href="rcat-20240430.xsd#ImpactsOnInvestmentsIntoUmacDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/PropertyAndEquipmentDetails" xlink:href="rcat-20240430.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10PropertyAndEquipmentDetailsNarrative" xlink:href="rcat-20240430.xsd#Note10PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OtherLongTermAssetsDetails" xlink:href="rcat-20240430.xsd#OtherLongTermAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11OtherLong-termAssetsDetailsNarrative" xlink:href="rcat-20240430.xsd#Note11OtherLong-termAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OperatingLeasesDetails" xlink:href="rcat-20240430.xsd#OperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails" xlink:href="rcat-20240430.xsd#SupplementalInformationRelatedToOperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/FutureLeasePaymentObligationsDetails" xlink:href="rcat-20240430.xsd#FutureLeasePaymentObligationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OutstandingPrincipalPaymentsDetails" xlink:href="rcat-20240430.xsd#OutstandingPrincipalPaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note13DebtObligationsDetailsNarrative" xlink:href="rcat-20240430.xsd#Note13DebtObligationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative" xlink:href="rcat-20240430.xsd#Note14DueToRelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note15IncomeTaxesDetailsNarrative" xlink:href="rcat-20240430.xsd#Note15IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails" xlink:href="rcat-20240430.xsd#SummaryOfSharesOfCommonStockIssuedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note17PreferredStockDetailsNarrative" xlink:href="rcat-20240430.xsd#Note17PreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:href="rcat-20240430.xsd#SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails" xlink:href="rcat-20240430.xsd#AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ChangesInWarrantsOutstandingDetails" xlink:href="rcat-20240430.xsd#ChangesInWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note18WarrantsDetailsNarrative" xlink:href="rcat-20240430.xsd#Note18WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:href="rcat-20240430.xsd#AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfActivityUnderPlanDetails" xlink:href="rcat-20240430.xsd#SummaryOfActivityUnderPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:href="rcat-20240430.xsd#SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails" xlink:href="rcat-20240430.xsd#StockCompensationExpenseByFunctionalCategoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note19ShareBasedAwardsDetailsNarrative" xlink:href="rcat-20240430.xsd#Note19ShareBasedAwardsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfStockholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SeriesBPreferredStock1Member" xlink:label="loc_RCATSeriesBPreferredStock1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_RCATSeriesBPreferredStock1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:label="loc_us-gaapRestrictedStockValueSharesIssuedNetOfTaxWithholdings_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRestrictedStockValueSharesIssuedNetOfTaxWithholdings_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:label="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockIssuedDuringPeriodValueThroughATMFacility" xlink:label="loc_RCATStockIssuedDuringPeriodValueThroughATMFacility_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodValueThroughATMFacility_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockSharesIssuedNetThroughATMFacility" xlink:label="loc_RCATStockSharesIssuedNetThroughATMFacility_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATStockSharesIssuedNetThroughATMFacility_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" xlink:type="arc" order="18" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfStockholdersEquityParenthetical" xlink:title="00000006 - Statement - Consolidated Statements of Stockholders&apos; Equity (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note1Business" xlink:title="00000008 - Disclosure - Note 1 &#8211; The Business" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegment" xlink:title="00000010 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note4MarketableSecurities" xlink:title="00000011 - Disclosure - Note 4 &#8211; Marketable Securities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note5Inventories" xlink:title="00000012 - Disclosure - Note 5 &#8211; Inventories" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note6OtherCurrentAssets" xlink:title="00000013 - Disclosure - Note 6 &#8211; Other Current Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note7DueFromRelatedParty" xlink:title="00000014 - Disclosure - Note 7 &#8211; Due From Related Party" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note8IntangibleAssets" xlink:title="00000015 - Disclosure - Note 8 &#8211; Intangible Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note9EquityMethodInvestment" xlink:title="00000016 - Disclosure - Note 9 &#8211; Equity Method Investment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note10PropertyAndEquipment" xlink:title="00000017 - Disclosure - Note 10 &#8211; Property and Equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note11OtherLong-termAssets" xlink:title="00000018 - Disclosure - Note 11 &#8211; Other Long-Term Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note12RightOfUseAssetsAndLiabilities" xlink:title="00000019 - Disclosure - Note 12 &#8211; Right of Use Assets and Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note13DebtObligations" xlink:title="00000020 - Disclosure - Note 13 &#8211; Debt Obligations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note14DueToRelatedParty" xlink:title="00000021 - Disclosure - Note 14 &#8211; Due to Related Party" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note15IncomeTaxes" xlink:title="00000022 - Disclosure - Note 15 &#8211; Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note16CommonStock" xlink:title="00000023 - Disclosure - Note 16 &#8211; Common Stock" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note17PreferredStock" xlink:title="00000024 - Disclosure - Note 17 &#8211; Preferred Stock" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note18Warrants" xlink:title="00000025 - Disclosure - Note 18 &#8211; Warrants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note19ShareBasedAwards" xlink:title="00000026 - Disclosure - Note 19 &#8211; Share Based Awards" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note20-Related-partyTransactions" xlink:title="00000027 - Disclosure - Note 20 - Related-Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note21CommitmentsAndContingencies" xlink:title="00000028 - Disclosure - Note 21 &#8211; Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note22SubsequentEvents" xlink:title="00000029 - Disclosure - Note 22 &#8211; Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000030 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000031 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegmentTables" xlink:title="00000032 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note5InventoriesTables" xlink:title="00000033 - Disclosure - Note 5 &#8211; Inventories (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note6OtherCurrentAssetsTables" xlink:title="00000034 - Disclosure - Note 6 &#8211; Other Current Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note8IntangibleAssetsTables" xlink:title="00000035 - Disclosure - Note 8 &#8211; Intangible Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note9EquityMethodInvestmentTables" xlink:title="00000036 - Disclosure - Note 9 &#8211; Equity Method Investment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note10PropertyAndEquipmentTables" xlink:title="00000037 - Disclosure - Note 10 &#8211; Property and Equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note11OtherLong-termAssetsTables" xlink:title="00000038 - Disclosure - Note 11 &#8211; Other Long-Term Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note12RightOfUseAssetsAndLiabilitiesTables" xlink:title="00000039 - Disclosure - Note 12 &#8211; Right of Use Assets and Liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note13DebtObligationsTables" xlink:title="00000040 - Disclosure - Note 13 &#8211; Debt Obligations (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note16CommonStockTables" xlink:title="00000041 - Disclosure - Note 16 &#8211; Common Stock (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note18WarrantsTables" xlink:title="00000042 - Disclosure - Note 18 &#8211; Warrants (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note19ShareBasedAwardsTables" xlink:title="00000043 - Disclosure - Note 19 &#8211; Share Based Awards (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:title="00000044 - Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementImpactAxis" xlink:label="loc_RCATRestatementImpactAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATRestatementImpactAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementImpactDomain" xlink:label="loc_RCATRestatementImpactDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_RCATRestatementImpactAxis" xlink:to="loc_RCATRestatementImpactDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementImpactDomain" xlink:label="loc_RCATRestatementImpactDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_RCATRestatementImpactAxis" xlink:to="loc_RCATRestatementImpactDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementImpactOriginallyReportedMember" xlink:label="loc_RCATRestatementImpactOriginallyReportedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATRestatementImpactDomain" xlink:to="loc_RCATRestatementImpactOriginallyReportedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementImpactAsRestatedMember" xlink:label="loc_RCATRestatementImpactAsRestatedMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATRestatementImpactDomain" xlink:to="loc_RCATRestatementImpactAsRestatedMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementImpactChangeMember" xlink:label="loc_RCATRestatementImpactChangeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATRestatementImpactDomain" xlink:to="loc_RCATRestatementImpactChangeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsNoncurrent_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OperatingLeaseLiabilityCurrentRestatementImpact" xlink:label="loc_RCATOperatingLeaseLiabilityCurrentRestatementImpact_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATOperatingLeaseLiabilityCurrentRestatementImpact_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_LiabilitiesCurrentRestatementImpact" xlink:label="loc_RCATLiabilitiesCurrentRestatementImpact_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATLiabilitiesCurrentRestatementImpact_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrent_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockholdersEquityRestatement" xlink:label="loc_RCATStockholdersEquityRestatement_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATStockholdersEquityRestatement_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInDerivativeAssetsAndLiabilities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInDerivativeAssetsAndLiabilities_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note1BusinessDetailsNarrative" xlink:title="00000045 - Disclosure - Note 1 &#8211; The Business (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_BusinessAcquisition1Member" xlink:label="loc_RCATBusinessAcquisition1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_BusinessAcquisition2Member" xlink:label="loc_RCATBusinessAcquisition2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition2Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_BusinessAcquisition3Member" xlink:label="loc_RCATBusinessAcquisition3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition3Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_BusinessAcquisition4Member" xlink:label="loc_RCATBusinessAcquisition4Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition4Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingShares" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingShares_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingGrossProceeds_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingGrossProceeds_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingNetProceeds_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingNetProceeds_60" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/CustomerConcentrationRiskDetails" xlink:title="00000046 - Disclosure - Customer concentration risk (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CustomerConcentrationRisk1Member" xlink:label="loc_RCATCustomerConcentrationRisk1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RCATCustomerConcentrationRisk1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CustomerConcentrationRisk2Member" xlink:label="loc_RCATCustomerConcentrationRisk2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RCATCustomerConcentrationRisk2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CustomerConcentrationRisk3Member" xlink:label="loc_RCATCustomerConcentrationRisk3Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RCATCustomerConcentrationRisk3Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CustomerConcentrationRisk4Member" xlink:label="loc_RCATCustomerConcentrationRisk4Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RCATCustomerConcentrationRisk4Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CustomerConcentrationRisk5Member" xlink:label="loc_RCATCustomerConcentrationRisk5Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RCATCustomerConcentrationRisk5Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:title="00000047 - Disclosure - Company&apos;s revenue disaggregated by revenue type (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:title="00000048 - Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000049 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails" xlink:title="00000050 - Disclosure - Discontinued Operations - results of operations (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails" xlink:title="00000051 - Disclosure - Assets and liabilities for the Consumer Segment (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:title="00000052 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note4MarketableSecuritiesDetailsNarrative" xlink:title="00000053 - Disclosure - Note 4 &#8211; Marketable Securities (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/InventoriesDetails" xlink:title="00000054 - Disclosure - Inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/OtherCurrentAssetsDetails" xlink:title="00000055 - Disclosure - Other current assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative" xlink:title="00000056 - Disclosure - Note 7 &#8211; Due From Related Party (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/IntangibleAssetsDetails" xlink:title="00000057 - Disclosure - Intangible assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:label="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:label="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IntangibleAssetsGrossCarryingAmountMember" xlink:label="loc_RCATIntangibleAssetsGrossCarryingAmountMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:to="loc_RCATIntangibleAssetsGrossCarryingAmountMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IntangibleAssetsAccumulatedAmortizationMember" xlink:label="loc_RCATIntangibleAssetsAccumulatedAmortizationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:to="loc_RCATIntangibleAssetsAccumulatedAmortizationMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IntangibleAssetsNetCarryingValueMember" xlink:label="loc_RCATIntangibleAssetsNetCarryingValueMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:to="loc_RCATIntangibleAssetsNetCarryingValueMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedProprietaryTechnologyGross" xlink:label="loc_RCATFiniteLivedProprietaryTechnologyGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATFiniteLivedProprietaryTechnologyGross_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedNoncompeteAgreementsGross1" xlink:label="loc_RCATFiniteLivedNoncompeteAgreementsGross1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATFiniteLivedNoncompeteAgreementsGross1_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedCustomerRelationshipsGross1" xlink:label="loc_RCATFiniteLivedCustomerRelationshipsGross1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATFiniteLivedCustomerRelationshipsGross1_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedIntangibleAssetsGross1" xlink:label="loc_RCATFiniteLivedIntangibleAssetsGross1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATFiniteLivedIntangibleAssetsGross1_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaapIndefiniteLivedTradeNames_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIndefiniteLivedTradeNames_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1" xlink:label="loc_RCATIndefiniteLivedIntangibleAssetsExcludingGoodwill1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATIndefiniteLivedIntangibleAssetsExcludingGoodwill1_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IntangibleAssetsNetExcludingGoodwill1" xlink:label="loc_RCATIntangibleAssetsNetExcludingGoodwill1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATIntangibleAssetsNetExcludingGoodwill1_70" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails" xlink:title="00000058 - Disclosure - Expected amortization expense for the unamortized finite-lived intangible assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/CompositionOfAndChangesInGoodwillDetails" xlink:title="00000059 - Disclosure - Composition of, and changes in goodwill (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillMember" xlink:label="loc_us-gaapGoodwillMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapGoodwillMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="loc_us-gaapGoodwillPeriodIncreaseDecrease_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapGoodwillPeriodIncreaseDecrease_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapGoodwill_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="loc_us-gaapGoodwillWrittenOffRelatedToSaleOfBusinessUnit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapGoodwillWrittenOffRelatedToSaleOfBusinessUnit_90" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note8IntangibleAssetsDetailsNarrative" xlink:title="00000060 - Disclosure - Note 8 &#8211; Intangible Assets (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails" xlink:title="00000061 - Disclosure - Financial informatino for UMAC derived from their Form 10-Q (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapAssetsCurrent_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapAssetsNoncurrent_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrent_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapRevenues_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapGrossProfit_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapNetIncomeLoss_30" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails" xlink:title="00000062 - Disclosure - Impacts on investments into UMAC (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapEquityMethodInvestments_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/PropertyAndEquipmentDetails" xlink:title="00000063 - Disclosure - Property and equipment (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note10PropertyAndEquipmentDetailsNarrative" xlink:title="00000064 - Disclosure - Note 10 &#8211; Property and Equipment (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/OtherLongTermAssetsDetails" xlink:title="00000065 - Disclosure - Other long term assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note11OtherLong-termAssetsDetailsNarrative" xlink:title="00000066 - Disclosure - Note 11 &#8211; Other Long-Term Assets (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/OperatingLeasesDetails" xlink:title="00000067 - Disclosure - Operating leases (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OperatingLeaseLocation1Member" xlink:label="loc_RCATOperatingLeaseLocation1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_RCATOperatingLeaseLocation1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OperatingLeaseLocation3Member" xlink:label="loc_RCATOperatingLeaseLocation3Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_RCATOperatingLeaseLocation3Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OperatingLeaseLocation4Member" xlink:label="loc_RCATOperatingLeaseLocation4Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_RCATOperatingLeaseLocation4Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails" xlink:title="00000068 - Disclosure - Supplemental information related to operating leases (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/FutureLeasePaymentObligationsDetails" xlink:title="00000069 - Disclosure - Future lease payment obligations (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/OutstandingPrincipalPaymentsDetails" xlink:title="00000070 - Disclosure - Outstanding principal payments (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note13DebtObligationsDetailsNarrative" xlink:title="00000071 - Disclosure - Note 13 &#8211; Debt Obligations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtObligation1Member" xlink:label="loc_RCATDebtObligation1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtObligation2Member" xlink:label="loc_RCATDebtObligation2Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation2Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtObligation3Member" xlink:label="loc_RCATDebtObligation3Member_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation3Member_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtObligation6Member" xlink:label="loc_RCATDebtObligation6Member_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation6Member_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtObligation8Member" xlink:label="loc_RCATDebtObligation8Member_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation8Member_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_200" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_200" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_200" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount_200" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ConvertibleNoteAgreementAmount" xlink:label="loc_RCATConvertibleNoteAgreementAmount_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATConvertibleNoteAgreementAmount_200" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_200" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_LeaseholdImprovementAgreementFundsReceived" xlink:label="loc_RCATLeaseholdImprovementAgreementFundsReceived_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATLeaseholdImprovementAgreementFundsReceived_200" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset" xlink:label="loc_RCATFinancingAgreementFundingOfPurchaseOfFixedAsset_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATFinancingAgreementFundingOfPurchaseOfFixedAsset_200" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative" xlink:title="00000072 - Disclosure - Note 14 &#8211; Due to Related Party (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DueToRelatedParty2Member" xlink:label="loc_RCATDueToRelatedParty2Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDueToRelatedParty2Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_LineOfCreditObligationAssumedInConnectionWithAcquisition" xlink:label="loc_RCATLineOfCreditObligationAssumedInConnectionWithAcquisition_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATLineOfCreditObligationAssumedInConnectionWithAcquisition_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtInstrumentInterestRateDuringPeriod1" xlink:label="loc_RCATDebtInstrumentInterestRateDuringPeriod1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATDebtInstrumentInterestRateDuringPeriod1_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DueToOtherRelatedPartyClassifiedCurrent" xlink:label="loc_RCATDueToOtherRelatedPartyClassifiedCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATDueToOtherRelatedPartyClassifiedCurrent_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtInstrumentOutstandingAccruedInterestPayment" xlink:label="loc_RCATDebtInstrumentOutstandingAccruedInterestPayment_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATDebtInstrumentOutstandingAccruedInterestPayment_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note15IncomeTaxesDetailsNarrative" xlink:title="00000073 - Disclosure - Note 15 &#8211; Income Taxes (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails" xlink:title="00000074 - Disclosure - Summary of shares of common stock issued (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" xlink:label="loc_RCATStockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares" xlink:label="loc_RCATIssuanceOfCommonStockThroughATMFacilitiesNetShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATIssuanceOfCommonStockThroughATMFacilitiesNetShares_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockIssuedDuringPeriodSharesPublicOffering" xlink:label="loc_RCATStockIssuedDuringPeriodSharesPublicOffering_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodSharesPublicOffering_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note17PreferredStockDetailsNarrative" xlink:title="00000075 - Disclosure - Note 17 &#8211; Preferred Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SeriesAPreferredStock2Member" xlink:label="loc_RCATSeriesAPreferredStock2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RCATSeriesAPreferredStock2Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" xlink:label="loc_RCATStockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:title="00000076 - Disclosure - Summary of warrants issued and fair values (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails" xlink:title="00000077 - Disclosure - Assumptions used to estimate fair value of stock warrants granted (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WarrantAssumptionsUsedMember" xlink:label="loc_RCATWarrantAssumptionsUsedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_RCATWarrantAssumptionsUsedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_30" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/ChangesInWarrantsOutstandingDetails" xlink:title="00000078 - Disclosure - Changes in warrants outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WarrantsOutstanding1Member" xlink:label="loc_RCATWarrantsOutstanding1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_RCATWarrantsOutstanding1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_70" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note18WarrantsDetailsNarrative" xlink:title="00000079 - Disclosure - Note 18 &#8211; Warrants (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:title="00000080 - Disclosure - Assumptions used to calculate fair value of options granted (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FairValueOfOptionsAxis" xlink:label="loc_RCATFairValueOfOptionsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATFairValueOfOptionsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FairValueOfOptionsDomain" xlink:label="loc_RCATFairValueOfOptionsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_RCATFairValueOfOptionsAxis" xlink:to="loc_RCATFairValueOfOptionsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FairValueOfOptionsDomain" xlink:label="loc_RCATFairValueOfOptionsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_RCATFairValueOfOptionsAxis" xlink:to="loc_RCATFairValueOfOptionsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OptionsAssumptionsUsedMember" xlink:label="loc_RCATOptionsAssumptionsUsedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATFairValueOfOptionsDomain" xlink:to="loc_RCATOptionsAssumptionsUsedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_60" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfActivityUnderPlanDetails" xlink:title="00000081 - Disclosure - Summary of activity under the Plan (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_Options1Member" xlink:label="loc_RCATOptions1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_RCATOptions1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_70" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:title="00000082 - Disclosure - Summary of restricted stock activity under the Plan (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationSharesRestrictedStockAxis" xlink:label="loc_RCATShareBasedCompensationSharesRestrictedStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATShareBasedCompensationSharesRestrictedStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationSharesRestrictedStockDomain" xlink:label="loc_RCATShareBasedCompensationSharesRestrictedStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_RCATShareBasedCompensationSharesRestrictedStockAxis" xlink:to="loc_RCATShareBasedCompensationSharesRestrictedStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationSharesRestrictedStockDomain" xlink:label="loc_RCATShareBasedCompensationSharesRestrictedStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_RCATShareBasedCompensationSharesRestrictedStockAxis" xlink:to="loc_RCATShareBasedCompensationSharesRestrictedStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATShareBasedCompensationSharesRestrictedStockDomain" xlink:to="loc_us-gaapRestrictedStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" xlink:label="loc_RCATSharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_60" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails" xlink:title="00000083 - Disclosure - Stock compensation expense by functional category (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note19ShareBasedAwardsDetailsNarrative" xlink:title="00000084 - Disclosure - Note 19 &#8211; Share Based Awards (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>rcat-20240430_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SeriesBPreferredStock1Member" xlink:label="RCAT_SeriesBPreferredStock1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SeriesBPreferredStock1Member" xlink:to="RCAT_SeriesBPreferredStock1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SeriesBPreferredStock1Member_lbl" xml:lang="en-US">Series B Preferred Stock 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_BusinessAcquisition1Member" xlink:label="RCAT_BusinessAcquisition1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_BusinessAcquisition1Member" xlink:to="RCAT_BusinessAcquisition1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_BusinessAcquisition1Member_lbl" xml:lang="en-US">Business Acquisition 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_BusinessAcquisition2Member" xlink:label="RCAT_BusinessAcquisition2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_BusinessAcquisition2Member" xlink:to="RCAT_BusinessAcquisition2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_BusinessAcquisition2Member_lbl" xml:lang="en-US">Business Acquisition 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_BusinessAcquisition3Member" xlink:label="RCAT_BusinessAcquisition3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_BusinessAcquisition3Member" xlink:to="RCAT_BusinessAcquisition3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_BusinessAcquisition3Member_lbl" xml:lang="en-US">Business Acquisition 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_BusinessAcquisition4Member" xlink:label="RCAT_BusinessAcquisition4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_BusinessAcquisition4Member" xlink:to="RCAT_BusinessAcquisition4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_BusinessAcquisition4Member_lbl" xml:lang="en-US">Business Acquisition 4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementImpactAxis" xlink:label="RCAT_RestatementImpactAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestatementImpactAxis" xlink:to="RCAT_RestatementImpactAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RestatementImpactAxis_lbl" xml:lang="en-US">Restatement Impact [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementImpactOriginallyReportedMember" xlink:label="RCAT_RestatementImpactOriginallyReportedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestatementImpactOriginallyReportedMember" xlink:to="RCAT_RestatementImpactOriginallyReportedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RestatementImpactOriginallyReportedMember_lbl" xml:lang="en-US">Restatement Impact Originally Reported [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementImpactAsRestatedMember" xlink:label="RCAT_RestatementImpactAsRestatedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestatementImpactAsRestatedMember" xlink:to="RCAT_RestatementImpactAsRestatedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RestatementImpactAsRestatedMember_lbl" xml:lang="en-US">Restatement Impact As Restated [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementImpactChangeMember" xlink:label="RCAT_RestatementImpactChangeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestatementImpactChangeMember" xlink:to="RCAT_RestatementImpactChangeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RestatementImpactChangeMember_lbl" xml:lang="en-US">Restatement Impact Change [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CustomerConcentrationRisk1Member" xlink:label="RCAT_CustomerConcentrationRisk1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_CustomerConcentrationRisk1Member" xlink:to="RCAT_CustomerConcentrationRisk1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_CustomerConcentrationRisk1Member_lbl" xml:lang="en-US">Customer Concentration Risk 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CustomerConcentrationRisk2Member" xlink:label="RCAT_CustomerConcentrationRisk2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_CustomerConcentrationRisk2Member" xlink:to="RCAT_CustomerConcentrationRisk2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_CustomerConcentrationRisk2Member_lbl" xml:lang="en-US">Customer Concentration Risk 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CustomerConcentrationRisk3Member" xlink:label="RCAT_CustomerConcentrationRisk3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_CustomerConcentrationRisk3Member" xlink:to="RCAT_CustomerConcentrationRisk3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_CustomerConcentrationRisk3Member_lbl" xml:lang="en-US">Customer Concentration Risk 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CustomerConcentrationRisk4Member" xlink:label="RCAT_CustomerConcentrationRisk4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_CustomerConcentrationRisk4Member" xlink:to="RCAT_CustomerConcentrationRisk4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_CustomerConcentrationRisk4Member_lbl" xml:lang="en-US">Customer Concentration Risk 4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CustomerConcentrationRisk5Member" xlink:label="RCAT_CustomerConcentrationRisk5Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_CustomerConcentrationRisk5Member" xlink:to="RCAT_CustomerConcentrationRisk5Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_CustomerConcentrationRisk5Member_lbl" xml:lang="en-US">Customer Concentration Risk 5 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite Lived And Indefinite Lived Intangible Assets By Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IntangibleAssetsGrossCarryingAmountMember" xlink:label="RCAT_IntangibleAssetsGrossCarryingAmountMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IntangibleAssetsGrossCarryingAmountMember" xlink:to="RCAT_IntangibleAssetsGrossCarryingAmountMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IntangibleAssetsGrossCarryingAmountMember_lbl" xml:lang="en-US">Intangible Assets Gross Carrying Amount [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IntangibleAssetsAccumulatedAmortizationMember" xlink:label="RCAT_IntangibleAssetsAccumulatedAmortizationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IntangibleAssetsAccumulatedAmortizationMember" xlink:to="RCAT_IntangibleAssetsAccumulatedAmortizationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IntangibleAssetsAccumulatedAmortizationMember_lbl" xml:lang="en-US">Intangible Assets Accumulated Amortization [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IntangibleAssetsNetCarryingValueMember" xlink:label="RCAT_IntangibleAssetsNetCarryingValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IntangibleAssetsNetCarryingValueMember" xlink:to="RCAT_IntangibleAssetsNetCarryingValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IntangibleAssetsNetCarryingValueMember_lbl" xml:lang="en-US">Intangible Assets Net Carrying Value [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillMember" xlink:label="us-gaap_GoodwillMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillMember" xlink:to="us-gaap_GoodwillMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillMember_lbl" xml:lang="en-US">Goodwill [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_lbl" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_lbl" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee, Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OperatingLeaseLocation1Member" xlink:label="RCAT_OperatingLeaseLocation1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OperatingLeaseLocation1Member" xlink:to="RCAT_OperatingLeaseLocation1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OperatingLeaseLocation1Member_lbl" xml:lang="en-US">Operating Lease Location 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OperatingLeaseLocation3Member" xlink:label="RCAT_OperatingLeaseLocation3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OperatingLeaseLocation3Member" xlink:to="RCAT_OperatingLeaseLocation3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OperatingLeaseLocation3Member_lbl" xml:lang="en-US">Operating Lease Location 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OperatingLeaseLocation4Member" xlink:label="RCAT_OperatingLeaseLocation4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OperatingLeaseLocation4Member" xlink:to="RCAT_OperatingLeaseLocation4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OperatingLeaseLocation4Member_lbl" xml:lang="en-US">Operating Lease Location 4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtObligation1Member" xlink:label="RCAT_DebtObligation1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DebtObligation1Member" xlink:to="RCAT_DebtObligation1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DebtObligation1Member_lbl" xml:lang="en-US">Debt Obligation 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtObligation2Member" xlink:label="RCAT_DebtObligation2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DebtObligation2Member" xlink:to="RCAT_DebtObligation2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DebtObligation2Member_lbl" xml:lang="en-US">Debt Obligation 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtObligation3Member" xlink:label="RCAT_DebtObligation3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DebtObligation3Member" xlink:to="RCAT_DebtObligation3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DebtObligation3Member_lbl" xml:lang="en-US">Debt Obligation 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtObligation6Member" xlink:label="RCAT_DebtObligation6Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DebtObligation6Member" xlink:to="RCAT_DebtObligation6Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DebtObligation6Member_lbl" xml:lang="en-US">Debt Obligation 6 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtObligation8Member" xlink:label="RCAT_DebtObligation8Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DebtObligation8Member" xlink:to="RCAT_DebtObligation8Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DebtObligation8Member_lbl" xml:lang="en-US">Debt Obligation 8 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DueToRelatedParty2Member" xlink:label="RCAT_DueToRelatedParty2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DueToRelatedParty2Member" xlink:to="RCAT_DueToRelatedParty2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DueToRelatedParty2Member_lbl" xml:lang="en-US">Due To Related Party 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SeriesAPreferredStock2Member" xlink:label="RCAT_SeriesAPreferredStock2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SeriesAPreferredStock2Member" xlink:to="RCAT_SeriesAPreferredStock2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SeriesAPreferredStock2Member_lbl" xml:lang="en-US">Series A Preferred Stock 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WarrantAssumptionsUsedMember" xlink:label="RCAT_WarrantAssumptionsUsedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_WarrantAssumptionsUsedMember" xlink:to="RCAT_WarrantAssumptionsUsedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_WarrantAssumptionsUsedMember_lbl" xml:lang="en-US">Warrant Assumptions Used [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WarrantsOutstanding1Member" xlink:label="RCAT_WarrantsOutstanding1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_WarrantsOutstanding1Member" xlink:to="RCAT_WarrantsOutstanding1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_WarrantsOutstanding1Member_lbl" xml:lang="en-US">Warrants Outstanding 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FairValueOfOptionsAxis" xlink:label="RCAT_FairValueOfOptionsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FairValueOfOptionsAxis" xlink:to="RCAT_FairValueOfOptionsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FairValueOfOptionsAxis_lbl" xml:lang="en-US">Fair Value Of Options [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OptionsAssumptionsUsedMember" xlink:label="RCAT_OptionsAssumptionsUsedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OptionsAssumptionsUsedMember" xlink:to="RCAT_OptionsAssumptionsUsedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OptionsAssumptionsUsedMember_lbl" xml:lang="en-US">Options Assumptions Used [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_Options1Member" xlink:label="RCAT_Options1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_Options1Member" xlink:to="RCAT_Options1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_Options1Member_lbl" xml:lang="en-US">Options 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationSharesRestrictedStockAxis" xlink:label="RCAT_ShareBasedCompensationSharesRestrictedStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationSharesRestrictedStockAxis" xlink:to="RCAT_ShareBasedCompensationSharesRestrictedStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationSharesRestrictedStockAxis_lbl" xml:lang="en-US">Share Based Compensation Shares Restricted Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Investments_lbl" xml:lang="en-US">Marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xml:lang="en-US">Current assets of discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestments_lbl" xml:lang="en-US">Equity method investee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:to="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent_lbl" xml:lang="en-US">Note receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_lbl" xml:lang="en-US">Long-term assets of discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total long-term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings" xlink:label="us-gaap_ShortTermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Debt obligations - short term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xml:lang="en-US">Current liabilities of discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Debt obligations - long term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_lbl" xml:lang="en-US">Long-term liabilities of discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_PreferredStockValueSeriesB" xlink:label="RCAT_PreferredStockValueSeriesB" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_PreferredStockValueSeriesB" xlink:to="RCAT_PreferredStockValueSeriesB_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_PreferredStockValueSeriesB_lbl" xml:lang="en-US">Series B preferred stock - shares authorized 4,300,000; issued and outstanding 4,676 and 986,676</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock - shares authorized 500,000,000; issued and outstanding 74,289,351 and 54,568,065</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of goods sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="us-gaap_MarketingAndAdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingAndAdvertisingExpense" xlink:to="us-gaap_MarketingAndAdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingAndAdvertisingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US">Impairment loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other (income) expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:label="us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:to="us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities_lbl" xml:lang="en-US">Gain on divestiture of consumer segment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl" xml:lang="en-US">Impairment on equity method investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xml:lang="en-US">Equity method loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment loss (income), net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense" xlink:label="us-gaap_OtherNonrecurringIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonrecurringIncomeExpense" xlink:to="us-gaap_OtherNonrecurringIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonrecurringIncomeExpense_lbl" xml:lang="en-US">Other, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other (income) expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Net loss from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xml:lang="en-US">Loss from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_EarningsPerShareBasicAndDilutedRCATAbstract" xlink:label="RCAT_EarningsPerShareBasicAndDilutedRCATAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_EarningsPerShareBasicAndDilutedRCATAbstract" xlink:to="RCAT_EarningsPerShareBasicAndDilutedRCATAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_EarningsPerShareBasicAndDilutedRCATAbstract_lbl" xml:lang="en-US">Loss per share - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" xlink:label="RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" xlink:to="RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT_lbl" xml:lang="en-US">Continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" xlink:label="RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" xlink:to="RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT_lbl" xml:lang="en-US">Discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_EarningsPerShareBasicAndDilutedRCAT" xlink:label="RCAT_EarningsPerShareBasicAndDilutedRCAT" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_EarningsPerShareBasicAndDilutedRCAT" xlink:to="RCAT_EarningsPerShareBasicAndDilutedRCAT_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_EarningsPerShareBasicAndDilutedRCAT_lbl" xml:lang="en-US">Loss per share - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" xlink:label="RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" xlink:to="RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT_lbl" xml:lang="en-US">Weighted average shares outstanding - basic and diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balances, April 30, 2022, as restated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Shares, Outstanding, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Stock based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:label="us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:to="us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_lbl" xml:lang="en-US">Vesting of restricted stock units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:label="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:to="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_lbl" xml:lang="en-US">Restricted Stock, Shares Issued Net of Shares for Tax Withholdings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Shares issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xml:lang="en-US">Unrealized gain on marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Currency translation adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockIssuedDuringPeriodValueThroughATMFacility" xlink:label="RCAT_StockIssuedDuringPeriodValueThroughATMFacility" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockIssuedDuringPeriodValueThroughATMFacility" xlink:to="RCAT_StockIssuedDuringPeriodValueThroughATMFacility_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockIssuedDuringPeriodValueThroughATMFacility_lbl" xml:lang="en-US">Issuance of common stock through ATM facility, net</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockSharesIssuedNetThroughATMFacility" xlink:label="RCAT_StockSharesIssuedNetThroughATMFacility" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockSharesIssuedNetThroughATMFacility" xlink:to="RCAT_StockSharesIssuedNetThroughATMFacility_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockSharesIssuedNetThroughATMFacility_lbl" xml:lang="en-US">[custom:StockSharesIssuedNetThroughATMFacility]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Public offering, net of $804,400 of issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Shares, Outstanding, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IncomeLossFromDiscontinuedOperations" xlink:label="RCAT_IncomeLossFromDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IncomeLossFromDiscontinuedOperations" xlink:to="RCAT_IncomeLossFromDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RCAT_IncomeLossFromDiscontinuedOperations_lbl" xml:lang="en-US">Net loss from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">Net loss from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash from operations:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Stock based compensation - options</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Stock based compensation - restricted units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Common stock issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:label="us-gaap_MarketableSecuritiesGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesGainLoss" xlink:to="us-gaap_MarketableSecuritiesGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesGainLoss_lbl" xml:lang="en-US">Realized loss from sale of marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="us-gaap_IncreaseDecreaseInDerivativeLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:to="us-gaap_IncreaseDecreaseInDerivativeLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDerivativeLiabilities_lbl" xml:lang="en-US">Gain on divestiture of consumer segment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xml:lang="en-US">Equity method loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_2_lbl" xml:lang="en-US">Impairment on goodwill and intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:label="RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:to="RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities_lbl" xml:lang="en-US">Operating lease right-of-use assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash used in operating activities of continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:label="us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:to="us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Investing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinesses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xml:lang="en-US">Proceeds from divestiture of consumer segment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xml:lang="en-US">Proceeds from sale of marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAssetsInvestingActivities" xlink:label="us-gaap_PaymentsToAcquireAssetsInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAssetsInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireAssetsInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireAssetsInvestingActivities_lbl" xml:lang="en-US">Investment in SAFE agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash provided by investing activities of continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ProceedsFromIssuanceOfCommonStockPublicOffering" xlink:label="RCAT_ProceedsFromIssuanceOfCommonStockPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ProceedsFromIssuanceOfCommonStockPublicOffering" xlink:to="RCAT_ProceedsFromIssuanceOfCommonStockPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ProceedsFromIssuanceOfCommonStockPublicOffering_lbl" xml:lang="en-US">Public offering, net</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ProceedsFromIssuanceOfCommonStockATMFacilityNet" xlink:label="RCAT_ProceedsFromIssuanceOfCommonStockATMFacilityNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ProceedsFromIssuanceOfCommonStockATMFacilityNet" xlink:to="RCAT_ProceedsFromIssuanceOfCommonStockATMFacilityNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ProceedsFromIssuanceOfCommonStockATMFacilityNet_lbl" xml:lang="en-US">ATM facility, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Payments under debt obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_PaymentsOfTaxesRelatedToEquityTransactions" xlink:label="RCAT_PaymentsOfTaxesRelatedToEquityTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_PaymentsOfTaxesRelatedToEquityTransactions" xlink:to="RCAT_PaymentsOfTaxesRelatedToEquityTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RCAT_PaymentsOfTaxesRelatedToEquityTransactions_lbl" xml:lang="en-US">Payments of taxes related to equity transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Proceeds from related party obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Payments under related party obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash provided by (used in) financing activities of continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract" xlink:label="us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract" xlink:to="us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_lbl" xml:lang="en-US">Discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_lbl" xml:lang="en-US">Operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:to="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_lbl" xml:lang="en-US">Investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:to="us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_lbl" xml:lang="en-US">Financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:label="us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:to="us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_lbl" xml:lang="en-US">Net cash used in discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase (decrease) in Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_lbl" xml:lang="en-US">Cash, beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_lbl" xml:lang="en-US">Less: Cash of discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash of continuing operations, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Cash paid for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non-cash transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" xlink:label="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" xlink:to="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_lbl" xml:lang="en-US">Equity method investment from divestiture of consumer segment</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NoncashOrPartNoncashDivestitureNoteReceivable" xlink:label="RCAT_NoncashOrPartNoncashDivestitureNoteReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NoncashOrPartNoncashDivestitureNoteReceivable" xlink:to="RCAT_NoncashOrPartNoncashDivestitureNoteReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NoncashOrPartNoncashDivestitureNoteReceivable_lbl" xml:lang="en-US">Note receivable from divestiture of consumer segment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_lbl" xml:lang="en-US">Unrealized gain on marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ConversionOfPreferredStockIntoCommonStock" xlink:label="RCAT_ConversionOfPreferredStockIntoCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ConversionOfPreferredStockIntoCommonStock" xlink:to="RCAT_ConversionOfPreferredStockIntoCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ConversionOfPreferredStockIntoCommonStock_lbl" xml:lang="en-US">Conversion of preferred stock into common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FairValueOfSharesWithheldAsPaymentOfNoteReceivable" xlink:label="RCAT_FairValueOfSharesWithheldAsPaymentOfNoteReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FairValueOfSharesWithheldAsPaymentOfNoteReceivable" xlink:to="RCAT_FairValueOfSharesWithheldAsPaymentOfNoteReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FairValueOfSharesWithheldAsPaymentOfNoteReceivable_lbl" xml:lang="en-US">Shares withheld as payment of note receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_TaxesRelatedToNetShareSettlementOfEquityAwards" xlink:label="RCAT_TaxesRelatedToNetShareSettlementOfEquityAwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_TaxesRelatedToNetShareSettlementOfEquityAwards" xlink:to="RCAT_TaxesRelatedToNetShareSettlementOfEquityAwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_TaxesRelatedToNetShareSettlementOfEquityAwards_lbl" xml:lang="en-US">Taxes related to net share settlement of equity awards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">Note 1 &#8211; The Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Note 2 &#8211; Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xml:lang="en-US">Note 3 &#8211; Divestiture of Consumer Segment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Note 4 &#8211; Marketable Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Note 5 &#8211; Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="us-gaap_OtherCurrentAssetsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentAssetsTextBlock_lbl" xml:lang="en-US">Note 6 &#8211; Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote7DueFromRelatedPartyAbstract" xlink:label="RCAT_DisclosureNote7DueFromRelatedPartyAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisclosureNote7DueFromRelatedPartyAbstract" xlink:to="RCAT_DisclosureNote7DueFromRelatedPartyAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisclosureNote7DueFromRelatedPartyAbstract_lbl" xml:lang="en-US">Note 7 Due From Related Party</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DueFromRelatedPartyDisclosureTextBlock" xlink:label="RCAT_DueFromRelatedPartyDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DueFromRelatedPartyDisclosureTextBlock" xlink:to="RCAT_DueFromRelatedPartyDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DueFromRelatedPartyDisclosureTextBlock_lbl" xml:lang="en-US">Note 7 &#8211; Due From Related Party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Note 8 &#8211; Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xml:lang="en-US">Note 9 &#8211; Equity Method Investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Note 10 &#8211; Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote11OtherLongtermAssetsAbstract" xlink:label="RCAT_DisclosureNote11OtherLongtermAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisclosureNote11OtherLongtermAssetsAbstract" xlink:to="RCAT_DisclosureNote11OtherLongtermAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisclosureNote11OtherLongtermAssetsAbstract_lbl" xml:lang="en-US">Note 11 Other Long-term Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OtherLongTermAssetsDisclosureTextBlock" xlink:label="RCAT_OtherLongTermAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OtherLongTermAssetsDisclosureTextBlock" xlink:to="RCAT_OtherLongTermAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OtherLongTermAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Note 11 &#8211; Other Long-Term Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Leases [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:label="us-gaap_LeasesOfLesseeDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:to="us-gaap_LeasesOfLesseeDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesOfLesseeDisclosureTextBlock_lbl" xml:lang="en-US">Note 12 &#8211; Right of Use Assets and Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Note 13 &#8211; Debt Obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote14DueToRelatedPartyAbstract" xlink:label="RCAT_DisclosureNote14DueToRelatedPartyAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisclosureNote14DueToRelatedPartyAbstract" xlink:to="RCAT_DisclosureNote14DueToRelatedPartyAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisclosureNote14DueToRelatedPartyAbstract_lbl" xml:lang="en-US">Note 14 Due To Related Party</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RelatedPartyPayablesDisclosureTextBlock" xlink:label="RCAT_RelatedPartyPayablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RelatedPartyPayablesDisclosureTextBlock" xlink:to="RCAT_RelatedPartyPayablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RelatedPartyPayablesDisclosureTextBlock_lbl" xml:lang="en-US">Note 14 &#8211; Due to Related Party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Note 15 &#8211; Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Note 16 &#8211; Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockTextBlock" xlink:label="us-gaap_PreferredStockTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xml:lang="en-US">Note 17 &#8211; Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote18WarrantsAbstract" xlink:label="RCAT_DisclosureNote18WarrantsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisclosureNote18WarrantsAbstract" xlink:to="RCAT_DisclosureNote18WarrantsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisclosureNote18WarrantsAbstract_lbl" xml:lang="en-US">Note 18 Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WarrantsDisclosureTextBlock" xlink:label="RCAT_WarrantsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_WarrantsDisclosureTextBlock" xlink:to="RCAT_WarrantsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_WarrantsDisclosureTextBlock_lbl" xml:lang="en-US">Note 18 &#8211; Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Note 19 &#8211; Share Based Awards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Note 20 - Related-Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Note 21 &#8211; Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Note 22 &#8211; Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Accounting</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" xlink:label="RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" xlink:to="RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock_lbl" xml:lang="en-US">Restatement of Previously Issued Consolidated Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xml:lang="en-US">Marketable Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xml:lang="en-US">Accounts Receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xml:lang="en-US">Goodwill and Long-lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="us-gaap_EquityMethodInvestmentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsPolicy" xlink:to="us-gaap_EquityMethodInvestmentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_lbl" xml:lang="en-US">Equity Method Investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionLeasesOperating" xlink:label="us-gaap_RevenueRecognitionLeasesOperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionLeasesOperating" xlink:to="us-gaap_RevenueRecognitionLeasesOperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionLeasesOperating_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:label="us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:to="us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_lbl" xml:lang="en-US">Product Warranty</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-US">Comprehensive Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and Diluted Net Loss per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RelatedPartiesPolicyTextBlock" xlink:label="RCAT_RelatedPartiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RelatedPartiesPolicyTextBlock" xlink:to="RCAT_RelatedPartiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RelatedPartiesPolicyTextBlock_lbl" xml:lang="en-US">Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">Liquidity and Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" xlink:label="RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" xlink:to="RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_lbl" xml:lang="en-US">[custom:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" xlink:label="RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" xlink:to="RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_lbl" xml:lang="en-US">[custom:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock" xlink:label="RCAT_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock" xlink:to="RCAT_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock_lbl" xml:lang="en-US">[custom:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock" xlink:label="RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock" xlink:to="RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock_lbl" xml:lang="en-US">[custom:EquityMethodInvestmentFinancialInformationTableTextBlock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="us-gaap_EquityMethodInvestmentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock_lbl" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock" xlink:label="RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock" xlink:to="RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock_lbl" xml:lang="en-US">[custom:ScheduleOfOtherLongTermAssetsTableTextBlock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRentExpenseTableTextBlock" xlink:label="us-gaap_ScheduleOfRentExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRentExpenseTableTextBlock" xlink:to="us-gaap_ScheduleOfRentExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRentExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of Rent Expense [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl" xml:lang="en-US">Lessee, Operating Lease, Disclosure [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ScheduleOfDebtPaymentsDueTableTextBlock" xlink:label="RCAT_ScheduleOfDebtPaymentsDueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ScheduleOfDebtPaymentsDueTableTextBlock" xlink:to="RCAT_ScheduleOfDebtPaymentsDueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ScheduleOfDebtPaymentsDueTableTextBlock_lbl" xml:lang="en-US">[custom:ScheduleOfDebtPaymentsDueTableTextBlock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_lbl" xml:lang="en-US">Schedule of Common Stock Outstanding Roll Forward [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock" xlink:label="RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock" xlink:to="RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock_lbl" xml:lang="en-US">[custom:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:label="us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_lbl" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ScheduleOfAssumptionsUsed1TableTextBlock" xlink:label="RCAT_ScheduleOfAssumptionsUsed1TableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ScheduleOfAssumptionsUsed1TableTextBlock" xlink:to="RCAT_ScheduleOfAssumptionsUsed1TableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ScheduleOfAssumptionsUsed1TableTextBlock_lbl" xml:lang="en-US">[custom:ScheduleOfAssumptionsUsed1TableTextBlock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Share-Based Payments [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestatementImpactAxis" xlink:to="RCAT_RestatementImpactAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_RestatementImpactAxis_2_lbl" xml:lang="en-US">RestatementImpactAxis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OperatingLeaseLiabilityCurrentRestatementImpact" xlink:label="RCAT_OperatingLeaseLiabilityCurrentRestatementImpact" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OperatingLeaseLiabilityCurrentRestatementImpact" xlink:to="RCAT_OperatingLeaseLiabilityCurrentRestatementImpact_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OperatingLeaseLiabilityCurrentRestatementImpact_lbl" xml:lang="en-US">Operating lease liabilities, current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="us-gaap_DerivativeLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesCurrent" xlink:to="us-gaap_DerivativeLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesCurrent_lbl" xml:lang="en-US">Warrant derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_LiabilitiesCurrentRestatementImpact" xlink:label="RCAT_LiabilitiesCurrentRestatementImpact" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_LiabilitiesCurrentRestatementImpact" xlink:to="RCAT_LiabilitiesCurrentRestatementImpact_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_LiabilitiesCurrentRestatementImpact_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Operating lease liabilities, long-term</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockholdersEquityRestatement" xlink:label="RCAT_StockholdersEquityRestatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockholdersEquityRestatement" xlink:to="RCAT_StockholdersEquityRestatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockholdersEquityRestatement_lbl" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:to="us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities_2_lbl" xml:lang="en-US">Change in fair value of derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingShares" xlink:label="RCAT_FirmCommitmentUnderwrittenPublicOfferingShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FirmCommitmentUnderwrittenPublicOfferingShares" xlink:to="RCAT_FirmCommitmentUnderwrittenPublicOfferingShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FirmCommitmentUnderwrittenPublicOfferingShares_lbl" xml:lang="en-US">[custom:FirmCommitmentUnderwrittenPublicOfferingShares]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" xlink:label="RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" xlink:to="RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds_lbl" xml:lang="en-US">[custom:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds" xlink:label="RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds" xlink:to="RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds_lbl" xml:lang="en-US">[custom:FirmCommitmentUnderwrittenPublicOfferingNetProceeds]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration Risk, Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Contract related</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer" xlink:label="us-gaap_RevenueNotFromContractWithCustomer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueNotFromContractWithCustomer" xlink:to="us-gaap_RevenueNotFromContractWithCustomer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueNotFromContractWithCustomer_lbl" xml:lang="en-US">Product related</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" xlink:to="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_lbl" xml:lang="en-US">Series B Preferred Stock, as converted</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" xlink:to="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_lbl" xml:lang="en-US">Stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" xlink:to="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" xlink:to="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_lbl" xml:lang="en-US">Restricted stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndDividendIncomeSecuritiesOther" xlink:label="us-gaap_InterestAndDividendIncomeSecuritiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndDividendIncomeSecuritiesOther" xlink:to="us-gaap_InterestAndDividendIncomeSecuritiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndDividendIncomeSecuritiesOther_lbl" xml:lang="en-US">Interest and Dividend Income, Securities, Operating, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_2_lbl" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_2_lbl" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:label="us-gaap_ContractWithCustomerAssetGrossCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:to="us-gaap_ContractWithCustomerAssetGrossCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerAssetGrossCurrent_lbl" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss, Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrualCurrent" xlink:label="us-gaap_StandardProductWarrantyAccrualCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyAccrualCurrent" xlink:to="us-gaap_StandardProductWarrantyAccrualCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StandardProductWarrantyAccrualCurrent_lbl" xml:lang="en-US">Standard Product Warranty Accrual, Current</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DifferenceBetweenComprehensiveLossAndNetLoss" xlink:label="RCAT_DifferenceBetweenComprehensiveLossAndNetLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DifferenceBetweenComprehensiveLossAndNetLoss" xlink:to="RCAT_DifferenceBetweenComprehensiveLossAndNetLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DifferenceBetweenComprehensiveLossAndNetLoss_lbl" xml:lang="en-US">[custom:DifferenceBetweenComprehensiveLossAndNetLoss]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_lbl" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Gain (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Capital" xlink:label="us-gaap_Capital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Capital" xlink:to="us-gaap_Capital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Capital_lbl" xml:lang="en-US">Banking Regulation, Total Capital, Actual</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_lbl" xml:lang="en-US">Cost of goods sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_lbl" xml:lang="en-US">Gross (Loss) Profit</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_lbl" xml:lang="en-US">Other expense (income)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_lbl" xml:lang="en-US">Other, net</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_lbl" xml:lang="en-US">Other expense (income)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2_lbl" xml:lang="en-US">Net loss from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_2_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_2_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent_lbl" xml:lang="en-US">Operating lease right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_lbl" xml:lang="en-US">Total long term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_2_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent_lbl" xml:lang="en-US">Long term liabilities - Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationWorkingCapital" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationWorkingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationWorkingCapital" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationWorkingCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationWorkingCapital_lbl" xml:lang="en-US">Working capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl" xml:lang="en-US">Noncash or Part Noncash Divestiture, Amount of Consideration Received</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1" xlink:label="RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1" xlink:to="RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1_lbl" xml:lang="en-US">[custom:NoncashOrPartNoncashDivestitureCashConsiderationReceived1]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" xlink:label="RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" xlink:to="RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1_lbl" xml:lang="en-US">[custom:NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" xlink:to="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_2_lbl" xml:lang="en-US">[custom:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" xlink:label="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" xlink:to="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares_lbl" xml:lang="en-US">[custom:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WorkingCapitalAtClosingOfDisposalGroup" xlink:label="RCAT_WorkingCapitalAtClosingOfDisposalGroup" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_WorkingCapitalAtClosingOfDisposalGroup" xlink:to="RCAT_WorkingCapitalAtClosingOfDisposalGroup_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_WorkingCapitalAtClosingOfDisposalGroup_lbl" xml:lang="en-US">[custom:WorkingCapitalAtClosingOfDisposalGroup-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CorporateBondsAtCarryingValueFairValue" xlink:label="RCAT_CorporateBondsAtCarryingValueFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_CorporateBondsAtCarryingValueFairValue" xlink:to="RCAT_CorporateBondsAtCarryingValueFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_CorporateBondsAtCarryingValueFairValue_lbl" xml:lang="en-US">[custom:CorporateBondsAtCarryingValueFairValue-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CorporateBondsAtCarryingValueCostBasis" xlink:label="RCAT_CorporateBondsAtCarryingValueCostBasis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_CorporateBondsAtCarryingValueCostBasis" xlink:to="RCAT_CorporateBondsAtCarryingValueCostBasis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_CorporateBondsAtCarryingValueCostBasis_lbl" xml:lang="en-US">[custom:CorporateBondsAtCarryingValueCostBasis-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CorporateBondsAtCarryingValueUnrealizedLosses" xlink:label="RCAT_CorporateBondsAtCarryingValueUnrealizedLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_CorporateBondsAtCarryingValueUnrealizedLosses" xlink:to="RCAT_CorporateBondsAtCarryingValueUnrealizedLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RCAT_CorporateBondsAtCarryingValueUnrealizedLosses_lbl" xml:lang="en-US">[custom:CorporateBondsAtCarryingValueUnrealizedLosses-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-process</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:to="us-gaap_ContractWithCustomerAssetGrossCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ContractWithCustomerAssetGrossCurrent_2_lbl" xml:lang="en-US">Contract asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivableCurrent" xlink:label="us-gaap_GrantsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivableCurrent" xlink:to="us-gaap_GrantsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrantsReceivableCurrent_lbl" xml:lang="en-US">Grant receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss_lbl" xml:lang="en-US">Accrued interest income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherAssetsCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CashCompensationSubjectToTaxation" xlink:label="RCAT_CashCompensationSubjectToTaxation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_CashCompensationSubjectToTaxation" xlink:to="RCAT_CashCompensationSubjectToTaxation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_CashCompensationSubjectToTaxation_lbl" xml:lang="en-US">[custom:CashCompensationSubjectToTaxation]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IncomeAssociatedWithStockCompensationSubjectToTaxation" xlink:label="RCAT_IncomeAssociatedWithStockCompensationSubjectToTaxation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IncomeAssociatedWithStockCompensationSubjectToTaxation" xlink:to="RCAT_IncomeAssociatedWithStockCompensationSubjectToTaxation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IncomeAssociatedWithStockCompensationSubjectToTaxation_lbl" xml:lang="en-US">[custom:IncomeAssociatedWithStockCompensationSubjectToTaxation]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation" xlink:label="RCAT_NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation" xlink:to="RCAT_NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation_lbl" xml:lang="en-US">[custom:NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteShares" xlink:label="RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteShares" xlink:to="RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteShares_lbl" xml:lang="en-US">[custom:CommonStockWithheldByCompanyAppliedAgainstNoteShares]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteAmount" xlink:label="RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteAmount" xlink:to="RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteAmount_lbl" xml:lang="en-US">[custom:CommonStockWithheldByCompanyAppliedAgainstNoteAmount]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharesHeldAtTransferAgentUntilNoteReceivableRepayment" xlink:label="RCAT_SharesHeldAtTransferAgentUntilNoteReceivableRepayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharesHeldAtTransferAgentUntilNoteReceivableRepayment" xlink:to="RCAT_SharesHeldAtTransferAgentUntilNoteReceivableRepayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharesHeldAtTransferAgentUntilNoteReceivableRepayment_lbl" xml:lang="en-US">[custom:SharesHeldAtTransferAgentUntilNoteReceivableRepayment]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestrictedStockScheduledToVestShares" xlink:label="RCAT_RestrictedStockScheduledToVestShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestrictedStockScheduledToVestShares" xlink:to="RCAT_RestrictedStockScheduledToVestShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RestrictedStockScheduledToVestShares_lbl" xml:lang="en-US">[custom:RestrictedStockScheduledToVestShares]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable" xlink:label="RCAT_RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable" xlink:to="RCAT_RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable_lbl" xml:lang="en-US">[custom:RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_PaymentsForTaxLiability" xlink:label="RCAT_PaymentsForTaxLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_PaymentsForTaxLiability" xlink:to="RCAT_PaymentsForTaxLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RCAT_PaymentsForTaxLiability_lbl" xml:lang="en-US">[custom:PaymentsForTaxLiability]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_EstimatedTaxesOwedRelatedToStockCompensation" xlink:label="RCAT_EstimatedTaxesOwedRelatedToStockCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_EstimatedTaxesOwedRelatedToStockCompensation" xlink:to="RCAT_EstimatedTaxesOwedRelatedToStockCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_EstimatedTaxesOwedRelatedToStockCompensation_lbl" xml:lang="en-US">[custom:EstimatedTaxesOwedRelatedToStockCompensation]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis_2_lbl" xml:lang="en-US">FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedProprietaryTechnologyGross" xlink:label="RCAT_FiniteLivedProprietaryTechnologyGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FiniteLivedProprietaryTechnologyGross" xlink:to="RCAT_FiniteLivedProprietaryTechnologyGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FiniteLivedProprietaryTechnologyGross_lbl" xml:lang="en-US">Proprietary technology</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedNoncompeteAgreementsGross1" xlink:label="RCAT_FiniteLivedNoncompeteAgreementsGross1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FiniteLivedNoncompeteAgreementsGross1" xlink:to="RCAT_FiniteLivedNoncompeteAgreementsGross1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FiniteLivedNoncompeteAgreementsGross1_lbl" xml:lang="en-US">Non-compete agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedCustomerRelationshipsGross1" xlink:label="RCAT_FiniteLivedCustomerRelationshipsGross1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FiniteLivedCustomerRelationshipsGross1" xlink:to="RCAT_FiniteLivedCustomerRelationshipsGross1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FiniteLivedCustomerRelationshipsGross1_lbl" xml:lang="en-US">Customer relationships</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedIntangibleAssetsGross1" xlink:label="RCAT_FiniteLivedIntangibleAssetsGross1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FiniteLivedIntangibleAssetsGross1" xlink:to="RCAT_FiniteLivedIntangibleAssetsGross1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FiniteLivedIntangibleAssetsGross1_lbl" xml:lang="en-US">Total finite-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="us-gaap_IndefiniteLivedTradeNames" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedTradeNames" xlink:to="us-gaap_IndefiniteLivedTradeNames_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedTradeNames_lbl" xml:lang="en-US">Brand name</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1" xlink:label="RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1" xlink:to="RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1_lbl" xml:lang="en-US">Total indefinite-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IntangibleAssetsNetExcludingGoodwill1" xlink:label="RCAT_IntangibleAssetsNetExcludingGoodwill1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IntangibleAssetsNetExcludingGoodwill1" xlink:to="RCAT_IntangibleAssetsNetExcludingGoodwill1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IntangibleAssetsNetExcludingGoodwill1_lbl" xml:lang="en-US">Total intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_lbl" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US">&#160;</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Goodwill_2_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl" xml:lang="en-US">&#160;</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_GoodwillImpairmentLoss_2_lbl" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Long-term assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Long-term liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_EquityMethodInvestments_2_lbl" xml:lang="en-US">Initial investment, February 16, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Equity method loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_3_lbl" xml:lang="en-US">Impairment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_EquityMethodInvestments_3_lbl" xml:lang="en-US">Investment balance, April 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Equipment and related</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="us-gaap_LeaseholdImprovementsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl" xml:lang="en-US">Leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="us-gaap_FurnitureAndFixturesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesGross" xlink:to="us-gaap_FurnitureAndFixturesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl" xml:lang="en-US">Furniture and fixtures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Net carrying value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisclosureNote11OtherLongtermAssetsAbstract" xlink:to="RCAT_DisclosureNote11OtherLongtermAssetsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_DisclosureNote11OtherLongtermAssetsAbstract_2_lbl" xml:lang="en-US">Other Long Term Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SAFEAgreementAssets" xlink:label="RCAT_SAFEAgreementAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SAFEAgreementAssets" xlink:to="RCAT_SAFEAgreementAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SAFEAgreementAssets_lbl" xml:lang="en-US">SAFE agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets" xlink:label="us-gaap_NoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncurrentAssets" xlink:to="us-gaap_NoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NoncurrentAssets_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_PaymentForSAFEAgreement" xlink:label="RCAT_PaymentForSAFEAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_PaymentForSAFEAgreement" xlink:to="RCAT_PaymentForSAFEAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_PaymentForSAFEAgreement_lbl" xml:lang="en-US">[custom:PaymentForSAFEAgreement]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Operating Lease, Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OperatingCashPaidToSettleLeaseLiabilities" xlink:label="RCAT_OperatingCashPaidToSettleLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OperatingCashPaidToSettleLeaseLiabilities" xlink:to="RCAT_OperatingCashPaidToSettleLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OperatingCashPaidToSettleLeaseLiabilities_lbl" xml:lang="en-US">Operating cash paid to settle lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix" xlink:label="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix" xlink:to="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_LesseeOperatingLeaseLiabilityPaymentsDueThereafter" xlink:label="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueThereafter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueThereafter" xlink:to="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueThereafter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueThereafter_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_LesseeOperatingLeaseLiabilityPaymentsDueSubtotal" xlink:label="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueSubtotal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueSubtotal" xlink:to="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueSubtotal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueSubtotal_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OutstandingPrincipalPaymentsDueYearOne" xlink:label="RCAT_OutstandingPrincipalPaymentsDueYearOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OutstandingPrincipalPaymentsDueYearOne" xlink:to="RCAT_OutstandingPrincipalPaymentsDueYearOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_OutstandingPrincipalPaymentsDueYearOne_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OutstandingPrincipalPaymentsDueLongTerm" xlink:label="RCAT_OutstandingPrincipalPaymentsDueLongTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OutstandingPrincipalPaymentsDueLongTerm" xlink:to="RCAT_OutstandingPrincipalPaymentsDueLongTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_OutstandingPrincipalPaymentsDueLongTerm_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OutstandingPrincipalPaymentsDueTotal" xlink:label="RCAT_OutstandingPrincipalPaymentsDueTotal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OutstandingPrincipalPaymentsDueTotal" xlink:to="RCAT_OutstandingPrincipalPaymentsDueTotal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_OutstandingPrincipalPaymentsDueTotal_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US">Long-Term Debt, Gross</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ConvertibleNoteAgreementAmount" xlink:label="RCAT_ConvertibleNoteAgreementAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ConvertibleNoteAgreementAmount" xlink:to="RCAT_ConvertibleNoteAgreementAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ConvertibleNoteAgreementAmount_lbl" xml:lang="en-US">[custom:ConvertibleNoteAgreementAmount]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Accrued Liabilities, Current</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_LeaseholdImprovementAgreementFundsReceived" xlink:label="RCAT_LeaseholdImprovementAgreementFundsReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_LeaseholdImprovementAgreementFundsReceived" xlink:to="RCAT_LeaseholdImprovementAgreementFundsReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_LeaseholdImprovementAgreementFundsReceived_lbl" xml:lang="en-US">[custom:LeaseholdImprovementAgreementFundsReceived]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset" xlink:label="RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset" xlink:to="RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset_lbl" xml:lang="en-US">[custom:FinancingAgreementFundingOfPurchaseOfFixedAsset]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_LineOfCreditObligationAssumedInConnectionWithAcquisition" xlink:label="RCAT_LineOfCreditObligationAssumedInConnectionWithAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_LineOfCreditObligationAssumedInConnectionWithAcquisition" xlink:to="RCAT_LineOfCreditObligationAssumedInConnectionWithAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_LineOfCreditObligationAssumedInConnectionWithAcquisition_lbl" xml:lang="en-US">[custom:LineOfCreditObligationAssumedInConnectionWithAcquisition]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtInstrumentInterestRateDuringPeriod1" xlink:label="RCAT_DebtInstrumentInterestRateDuringPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DebtInstrumentInterestRateDuringPeriod1" xlink:to="RCAT_DebtInstrumentInterestRateDuringPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DebtInstrumentInterestRateDuringPeriod1_lbl" xml:lang="en-US">[custom:DebtInstrumentInterestRateDuringPeriod1]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DueToOtherRelatedPartyClassifiedCurrent" xlink:label="RCAT_DueToOtherRelatedPartyClassifiedCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DueToOtherRelatedPartyClassifiedCurrent" xlink:to="RCAT_DueToOtherRelatedPartyClassifiedCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DueToOtherRelatedPartyClassifiedCurrent_lbl" xml:lang="en-US">[custom:DueToOtherRelatedPartyClassifiedCurrent-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtInstrumentOutstandingAccruedInterestPayment" xlink:label="RCAT_DebtInstrumentOutstandingAccruedInterestPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DebtInstrumentOutstandingAccruedInterestPayment" xlink:to="RCAT_DebtInstrumentOutstandingAccruedInterestPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DebtInstrumentOutstandingAccruedInterestPayment_lbl" xml:lang="en-US">[custom:DebtInstrumentOutstandingAccruedInterestPayment]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_lbl" xml:lang="en-US">Vesting of restricted stock to employees, net of shares withheld of 27,189 to pay taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_lbl" xml:lang="en-US">Vesting of restricted stock to Board of Directors</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_lbl" xml:lang="en-US">Vesting of restricted stock to consultants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Shares issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" xlink:label="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" xlink:to="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares" xlink:label="RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares" xlink:to="RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares_lbl" xml:lang="en-US">Issuance of common stock through ATM facilities</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockIssuedDuringPeriodSharesPublicOffering" xlink:label="RCAT_StockIssuedDuringPeriodSharesPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockIssuedDuringPeriodSharesPublicOffering" xlink:to="RCAT_StockIssuedDuringPeriodSharesPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockIssuedDuringPeriodSharesPublicOffering_lbl" xml:lang="en-US">Issuance of common stock through public offering</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" xlink:label="RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" xlink:to="RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock_lbl" xml:lang="en-US">[custom:StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisclosureNote18WarrantsAbstract" xlink:to="RCAT_DisclosureNote18WarrantsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_DisclosureNote18WarrantsAbstract_2_lbl" xml:lang="en-US">Summary Of Warrants Issued And Fair Values</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NumberOfWarrantsUponIssuance" xlink:label="RCAT_NumberOfWarrantsUponIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NumberOfWarrantsUponIssuance" xlink:to="RCAT_NumberOfWarrantsUponIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NumberOfWarrantsUponIssuance_lbl" xml:lang="en-US">[custom:NumberOfWarrantsUponIssuance]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_InitialFairValueOfWarrantsUponIssuance" xlink:label="RCAT_InitialFairValueOfWarrantsUponIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_InitialFairValueOfWarrantsUponIssuance" xlink:to="RCAT_InitialFairValueOfWarrantsUponIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_InitialFairValueOfWarrantsUponIssuance_lbl" xml:lang="en-US">[custom:InitialFairValueOfWarrantsUponIssuance]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NumberOfWarrantsOutstanding" xlink:label="RCAT_NumberOfWarrantsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NumberOfWarrantsOutstanding" xlink:to="RCAT_NumberOfWarrantsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NumberOfWarrantsOutstanding_lbl" xml:lang="en-US">[custom:NumberOfWarrantsOutstanding-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FairValueOfWarrantsOutstanding" xlink:label="RCAT_FairValueOfWarrantsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FairValueOfWarrantsOutstanding" xlink:to="RCAT_FairValueOfWarrantsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FairValueOfWarrantsOutstanding_lbl" xml:lang="en-US">[custom:FairValueOfWarrantsOutstanding-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NumberOfWarrantsOutstanding2" xlink:label="RCAT_NumberOfWarrantsOutstanding2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NumberOfWarrantsOutstanding2" xlink:to="RCAT_NumberOfWarrantsOutstanding2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NumberOfWarrantsOutstanding2_lbl" xml:lang="en-US">[custom:NumberOfWarrantsOutstanding2-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FairValueOfWarrantsOutstanding2" xlink:label="RCAT_FairValueOfWarrantsOutstanding2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FairValueOfWarrantsOutstanding2" xlink:to="RCAT_FairValueOfWarrantsOutstanding2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FairValueOfWarrantsOutstanding2_lbl" xml:lang="en-US">[custom:FairValueOfWarrantsOutstanding2-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WarrantsIssuedExercisePrice" xlink:label="RCAT_WarrantsIssuedExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_WarrantsIssuedExercisePrice" xlink:to="RCAT_WarrantsIssuedExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_WarrantsIssuedExercisePrice_lbl" xml:lang="en-US">[custom:WarrantsIssuedExercisePrice]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ProceedsReceivedFromExerciseOfWarrants" xlink:label="RCAT_ProceedsReceivedFromExerciseOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ProceedsReceivedFromExerciseOfWarrants" xlink:to="RCAT_ProceedsReceivedFromExerciseOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ProceedsReceivedFromExerciseOfWarrants_lbl" xml:lang="en-US">[custom:ProceedsReceivedFromExerciseOfWarrants]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ExerciseOfWarrantsShares" xlink:label="RCAT_ExerciseOfWarrantsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ExerciseOfWarrantsShares" xlink:to="RCAT_ExerciseOfWarrantsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ExerciseOfWarrantsShares_lbl" xml:lang="en-US">[custom:ExerciseOfWarrantsShares]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WarrantsToPurchaseSharesIssued" xlink:label="RCAT_WarrantsToPurchaseSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_WarrantsToPurchaseSharesIssued" xlink:to="RCAT_WarrantsToPurchaseSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_WarrantsToPurchaseSharesIssued_lbl" xml:lang="en-US">[custom:WarrantsToPurchaseSharesIssued]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FairValueOfOptionsAxis" xlink:to="RCAT_FairValueOfOptionsAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_FairValueOfOptionsAxis_2_lbl" xml:lang="en-US">FairValueOfOptionsAxis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_lbl" xml:lang="en-US">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationSharesRestrictedStockAxis" xlink:to="RCAT_ShareBasedCompensationSharesRestrictedStockAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_ShareBasedCompensationSharesRestrictedStockAxis_2_lbl" xml:lang="en-US">ShareBasedCompensationSharesRestrictedStockAxis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" xlink:label="RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" xlink:to="RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">[custom:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_lbl" xml:lang="en-US">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_2_lbl" xml:lang="en-US">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ResearchAndDevelopmentStockCompensationExpense" xlink:label="RCAT_ResearchAndDevelopmentStockCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ResearchAndDevelopmentStockCompensationExpense" xlink:to="RCAT_ResearchAndDevelopmentStockCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_ResearchAndDevelopmentStockCompensationExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SalesAndMarketingStockCompensationExpense" xlink:label="RCAT_SalesAndMarketingStockCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SalesAndMarketingStockCompensationExpense" xlink:to="RCAT_SalesAndMarketingStockCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_SalesAndMarketingStockCompensationExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_GeneralAndAdministrativeStockCompensationExpense" xlink:label="RCAT_GeneralAndAdministrativeStockCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_GeneralAndAdministrativeStockCompensationExpense" xlink:to="RCAT_GeneralAndAdministrativeStockCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_GeneralAndAdministrativeStockCompensationExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_TotalStockCompensationExpense" xlink:label="RCAT_TotalStockCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_TotalStockCompensationExpense" xlink:to="RCAT_TotalStockCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_TotalStockCompensationExpense_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" xlink:label="RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" xlink:to="RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum_lbl" xml:lang="en-US">[custom:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" xlink:label="RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" xlink:to="RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions_lbl" xml:lang="en-US">[custom:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockCompensationExpensePertainingToOptions" xlink:label="RCAT_StockCompensationExpensePertainingToOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockCompensationExpensePertainingToOptions" xlink:to="RCAT_StockCompensationExpensePertainingToOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockCompensationExpensePertainingToOptions_lbl" xml:lang="en-US">[custom:StockCompensationExpensePertainingToOptions]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockCompensationExpensePertainingToRestrictedStockUnits" xlink:label="RCAT_StockCompensationExpensePertainingToRestrictedStockUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockCompensationExpensePertainingToRestrictedStockUnits" xlink:to="RCAT_StockCompensationExpensePertainingToRestrictedStockUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockCompensationExpensePertainingToRestrictedStockUnits_lbl" xml:lang="en-US">[custom:StockCompensationExpensePertainingToRestrictedStockUnits]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_2_lbl" xml:lang="en-US">Other Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_2_lbl" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_2_lbl" xml:lang="en-US">Investment Income, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_EarningsPerShareBasicAndDilutedRCAT" xlink:to="RCAT_EarningsPerShareBasicAndDilutedRCAT_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_EarningsPerShareBasicAndDilutedRCAT_2_lbl" xml:lang="en-US">EarningsPerShareBasicAndDilutedRCAT</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IncomeLossFromDiscontinuedOperations" xlink:to="RCAT_IncomeLossFromDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IncomeLossFromDiscontinuedOperations_2_lbl" xml:lang="en-US">IncomeLossFromDiscontinuedOperations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_2_lbl" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAssetsInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireAssetsInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireAssetsInvestingActivities_2_lbl" xml:lang="en-US">Payments to Acquire Assets, Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_2_lbl" xml:lang="en-US">Repayments of Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_PaymentsOfTaxesRelatedToEquityTransactions" xlink:to="RCAT_PaymentsOfTaxesRelatedToEquityTransactions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_PaymentsOfTaxesRelatedToEquityTransactions_2_lbl" xml:lang="en-US">PaymentsOfTaxesRelatedToEquityTransactions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_2_lbl" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xml:lang="en-US">Repayments of Related Party Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:to="us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_3_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, before Tax, Portion Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_LiabilitiesCurrentRestatementImpact" xlink:to="RCAT_LiabilitiesCurrentRestatementImpact_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_LiabilitiesCurrentRestatementImpact_2_lbl" xml:lang="en-US">LiabilitiesCurrentRestatementImpact</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Costs of Goods Sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_2_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_2_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, General and Administrative Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_2_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Capital Leased Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent_2_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_CorporateBondsAtCarryingValueUnrealizedLosses" xlink:to="RCAT_CorporateBondsAtCarryingValueUnrealizedLosses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_CorporateBondsAtCarryingValueUnrealizedLosses_2_lbl" xml:lang="en-US">CorporateBondsAtCarryingValueUnrealizedLosses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_PaymentsForTaxLiability" xlink:to="RCAT_PaymentsForTaxLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_PaymentsForTaxLiability_2_lbl" xml:lang="en-US">PaymentsForTaxLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillImpairmentLoss_3_lbl" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_2_lbl" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncurrentAssets" xlink:to="us-gaap_NoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncurrentAssets_2_lbl" xml:lang="en-US">Long-Lived Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2_lbl" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Rolling Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Rolling Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Rolling Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Rolling Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix" xlink:to="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix_2_lbl" xml:lang="en-US">LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueThereafter" xlink:to="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueThereafter_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueThereafter_2_lbl" xml:lang="en-US">LesseeOperatingLeaseLiabilityPaymentsDueThereafter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueSubtotal" xlink:to="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueSubtotal_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_LesseeOperatingLeaseLiabilityPaymentsDueSubtotal_2_lbl" xml:lang="en-US">LesseeOperatingLeaseLiabilityPaymentsDueSubtotal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OutstandingPrincipalPaymentsDueYearOne" xlink:to="RCAT_OutstandingPrincipalPaymentsDueYearOne_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OutstandingPrincipalPaymentsDueYearOne_2_lbl" xml:lang="en-US">OutstandingPrincipalPaymentsDueYearOne</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OutstandingPrincipalPaymentsDueLongTerm" xlink:to="RCAT_OutstandingPrincipalPaymentsDueLongTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OutstandingPrincipalPaymentsDueLongTerm_2_lbl" xml:lang="en-US">OutstandingPrincipalPaymentsDueLongTerm</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OutstandingPrincipalPaymentsDueTotal" xlink:to="RCAT_OutstandingPrincipalPaymentsDueTotal_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OutstandingPrincipalPaymentsDueTotal_2_lbl" xml:lang="en-US">OutstandingPrincipalPaymentsDueTotal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" xlink:to="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_2_lbl" xml:lang="en-US">StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_2_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ResearchAndDevelopmentStockCompensationExpense" xlink:to="RCAT_ResearchAndDevelopmentStockCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ResearchAndDevelopmentStockCompensationExpense_2_lbl" xml:lang="en-US">ResearchAndDevelopmentStockCompensationExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SalesAndMarketingStockCompensationExpense" xlink:to="RCAT_SalesAndMarketingStockCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SalesAndMarketingStockCompensationExpense_2_lbl" xml:lang="en-US">SalesAndMarketingStockCompensationExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_GeneralAndAdministrativeStockCompensationExpense" xlink:to="RCAT_GeneralAndAdministrativeStockCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_GeneralAndAdministrativeStockCompensationExpense_2_lbl" xml:lang="en-US">GeneralAndAdministrativeStockCompensationExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_TotalStockCompensationExpense" xlink:to="RCAT_TotalStockCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_TotalStockCompensationExpense_2_lbl" xml:lang="en-US">TotalStockCompensationExpense</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>rcat-20240430_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://RCAT/role/Cover" xlink:href="rcat-20240430.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/BalanceSheets" xlink:href="rcat-20240430.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/BalanceSheetsParenthetical" xlink:href="rcat-20240430.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfOperations" xlink:href="rcat-20240430.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfStockholdersEquity" xlink:href="rcat-20240430.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfStockholdersEquityParenthetical" xlink:href="rcat-20240430.xsd#StatementsOfStockholdersEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfCashFlows" xlink:href="rcat-20240430.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note1Business" xlink:href="rcat-20240430.xsd#Note1Business" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies" xlink:href="rcat-20240430.xsd#Note2SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegment" xlink:href="rcat-20240430.xsd#Note3DivestitureOfConsumerSegment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note4MarketableSecurities" xlink:href="rcat-20240430.xsd#Note4MarketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note5Inventories" xlink:href="rcat-20240430.xsd#Note5Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note6OtherCurrentAssets" xlink:href="rcat-20240430.xsd#Note6OtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note7DueFromRelatedParty" xlink:href="rcat-20240430.xsd#Note7DueFromRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8IntangibleAssets" xlink:href="rcat-20240430.xsd#Note8IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note9EquityMethodInvestment" xlink:href="rcat-20240430.xsd#Note9EquityMethodInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10PropertyAndEquipment" xlink:href="rcat-20240430.xsd#Note10PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11OtherLong-termAssets" xlink:href="rcat-20240430.xsd#Note11OtherLong-termAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note12RightOfUseAssetsAndLiabilities" xlink:href="rcat-20240430.xsd#Note12RightOfUseAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note13DebtObligations" xlink:href="rcat-20240430.xsd#Note13DebtObligations" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note14DueToRelatedParty" xlink:href="rcat-20240430.xsd#Note14DueToRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note15IncomeTaxes" xlink:href="rcat-20240430.xsd#Note15IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note16CommonStock" xlink:href="rcat-20240430.xsd#Note16CommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note17PreferredStock" xlink:href="rcat-20240430.xsd#Note17PreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note18Warrants" xlink:href="rcat-20240430.xsd#Note18Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note19ShareBasedAwards" xlink:href="rcat-20240430.xsd#Note19ShareBasedAwards" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note20-Related-partyTransactions" xlink:href="rcat-20240430.xsd#Note20-Related-partyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note21CommitmentsAndContingencies" xlink:href="rcat-20240430.xsd#Note21CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note22SubsequentEvents" xlink:href="rcat-20240430.xsd#Note22SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="rcat-20240430.xsd#Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables" xlink:href="rcat-20240430.xsd#Note2SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentTables" xlink:href="rcat-20240430.xsd#Note3DivestitureOfConsumerSegmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note5InventoriesTables" xlink:href="rcat-20240430.xsd#Note5InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note6OtherCurrentAssetsTables" xlink:href="rcat-20240430.xsd#Note6OtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8IntangibleAssetsTables" xlink:href="rcat-20240430.xsd#Note8IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note9EquityMethodInvestmentTables" xlink:href="rcat-20240430.xsd#Note9EquityMethodInvestmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10PropertyAndEquipmentTables" xlink:href="rcat-20240430.xsd#Note10PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11OtherLong-termAssetsTables" xlink:href="rcat-20240430.xsd#Note11OtherLong-termAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note12RightOfUseAssetsAndLiabilitiesTables" xlink:href="rcat-20240430.xsd#Note12RightOfUseAssetsAndLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note13DebtObligationsTables" xlink:href="rcat-20240430.xsd#Note13DebtObligationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note16CommonStockTables" xlink:href="rcat-20240430.xsd#Note16CommonStockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note18WarrantsTables" xlink:href="rcat-20240430.xsd#Note18WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note19ShareBasedAwardsTables" xlink:href="rcat-20240430.xsd#Note19ShareBasedAwardsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:href="rcat-20240430.xsd#ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note1BusinessDetailsNarrative" xlink:href="rcat-20240430.xsd#Note1BusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/CustomerConcentrationRiskDetails" xlink:href="rcat-20240430.xsd#CustomerConcentrationRiskDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:href="rcat-20240430.xsd#CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:href="rcat-20240430.xsd#AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="rcat-20240430.xsd#Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails" xlink:href="rcat-20240430.xsd#DiscontinuedOperations-ResultsOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails" xlink:href="rcat-20240430.xsd#AssetsAndLiabilitiesForConsumerSegmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:href="rcat-20240430.xsd#Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note4MarketableSecuritiesDetailsNarrative" xlink:href="rcat-20240430.xsd#Note4MarketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/InventoriesDetails" xlink:href="rcat-20240430.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OtherCurrentAssetsDetails" xlink:href="rcat-20240430.xsd#OtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative" xlink:href="rcat-20240430.xsd#Note7DueFromRelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/IntangibleAssetsDetails" xlink:href="rcat-20240430.xsd#IntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails" xlink:href="rcat-20240430.xsd#ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/CompositionOfAndChangesInGoodwillDetails" xlink:href="rcat-20240430.xsd#CompositionOfAndChangesInGoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8IntangibleAssetsDetailsNarrative" xlink:href="rcat-20240430.xsd#Note8IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails" xlink:href="rcat-20240430.xsd#FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails" xlink:href="rcat-20240430.xsd#ImpactsOnInvestmentsIntoUmacDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/PropertyAndEquipmentDetails" xlink:href="rcat-20240430.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10PropertyAndEquipmentDetailsNarrative" xlink:href="rcat-20240430.xsd#Note10PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OtherLongTermAssetsDetails" xlink:href="rcat-20240430.xsd#OtherLongTermAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11OtherLong-termAssetsDetailsNarrative" xlink:href="rcat-20240430.xsd#Note11OtherLong-termAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OperatingLeasesDetails" xlink:href="rcat-20240430.xsd#OperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails" xlink:href="rcat-20240430.xsd#SupplementalInformationRelatedToOperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/FutureLeasePaymentObligationsDetails" xlink:href="rcat-20240430.xsd#FutureLeasePaymentObligationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OutstandingPrincipalPaymentsDetails" xlink:href="rcat-20240430.xsd#OutstandingPrincipalPaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note13DebtObligationsDetailsNarrative" xlink:href="rcat-20240430.xsd#Note13DebtObligationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative" xlink:href="rcat-20240430.xsd#Note14DueToRelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note15IncomeTaxesDetailsNarrative" xlink:href="rcat-20240430.xsd#Note15IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails" xlink:href="rcat-20240430.xsd#SummaryOfSharesOfCommonStockIssuedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note17PreferredStockDetailsNarrative" xlink:href="rcat-20240430.xsd#Note17PreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:href="rcat-20240430.xsd#SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails" xlink:href="rcat-20240430.xsd#AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ChangesInWarrantsOutstandingDetails" xlink:href="rcat-20240430.xsd#ChangesInWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note18WarrantsDetailsNarrative" xlink:href="rcat-20240430.xsd#Note18WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:href="rcat-20240430.xsd#AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfActivityUnderPlanDetails" xlink:href="rcat-20240430.xsd#SummaryOfActivityUnderPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:href="rcat-20240430.xsd#SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails" xlink:href="rcat-20240430.xsd#StockCompensationExpenseByFunctionalCategoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note19ShareBasedAwardsDetailsNarrative" xlink:href="rcat-20240430.xsd#Note19ShareBasedAwardsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:label="loc_us-gaapLongTermAccountsNotesAndLoansReceivableNetNoncurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapLongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:label="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperation" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_PreferredStockValueSeriesB" xlink:label="loc_RCATPreferredStockValueSeriesB" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_RCATPreferredStockValueSeriesB" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInDerivativeAssetsAndLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense" xlink:label="loc_us-gaapOtherNonrecurringIncomeExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonrecurringIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_EarningsPerShareBasicAndDilutedRCATAbstract" xlink:label="loc_RCATEarningsPerShareBasicAndDilutedRCATAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_RCATEarningsPerShareBasicAndDilutedRCATAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" xlink:label="loc_RCATEarningsPerShareBasicAndDilutedContinuingOperationsRCAT" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATEarningsPerShareBasicAndDilutedRCATAbstract" xlink:to="loc_RCATEarningsPerShareBasicAndDilutedContinuingOperationsRCAT" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" xlink:label="loc_RCATEarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATEarningsPerShareBasicAndDilutedRCATAbstract" xlink:to="loc_RCATEarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_EarningsPerShareBasicAndDilutedRCAT" xlink:label="loc_RCATEarningsPerShareBasicAndDilutedRCAT" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATEarningsPerShareBasicAndDilutedRCATAbstract" xlink:to="loc_RCATEarningsPerShareBasicAndDilutedRCAT" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" xlink:label="loc_RCATWeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_RCATWeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfStockholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SeriesBPreferredStock1Member" xlink:label="loc_RCATSeriesBPreferredStock1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_RCATSeriesBPreferredStock1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:label="loc_us-gaapRestrictedStockValueSharesIssuedNetOfTaxWithholdings" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:label="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockIssuedDuringPeriodValueThroughATMFacility" xlink:label="loc_RCATStockIssuedDuringPeriodValueThroughATMFacility" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodValueThroughATMFacility" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockSharesIssuedNetThroughATMFacility" xlink:label="loc_RCATStockSharesIssuedNetThroughATMFacility" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATStockSharesIssuedNetThroughATMFacility" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfStockholdersEquityParenthetical" xlink:title="00000006 - Statement - Consolidated Statements of Stockholders&apos; Equity (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IncomeLossFromDiscontinuedOperations" xlink:label="loc_RCATIncomeLossFromDiscontinuedOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_RCATIncomeLossFromDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesGainLoss" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInDerivativeLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDerivativeLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:label="loc_RCATIncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_RCATIncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:label="loc_us-gaapAdditionalCashFlowElementsFinancingActivitiesAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaapProceedsFromDivestitureOfBusinesses" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromDivestitureOfBusinesses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAssetsInvestingActivities" xlink:label="loc_us-gaapPaymentsToAcquireAssetsInvestingActivities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireAssetsInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ProceedsFromIssuanceOfCommonStockPublicOffering" xlink:label="loc_RCATProceedsFromIssuanceOfCommonStockPublicOffering" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_RCATProceedsFromIssuanceOfCommonStockPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ProceedsFromIssuanceOfCommonStockATMFacilityNet" xlink:label="loc_RCATProceedsFromIssuanceOfCommonStockATMFacilityNet" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_RCATProceedsFromIssuanceOfCommonStockATMFacilityNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_PaymentsOfTaxesRelatedToEquityTransactions" xlink:label="loc_RCATPaymentsOfTaxesRelatedToEquityTransactions" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_RCATPaymentsOfTaxesRelatedToEquityTransactions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract" xlink:label="loc_us-gaapDiscontinuedOperationAdditionalDisclosuresAbstract" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapDiscontinuedOperationAdditionalDisclosuresAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapCashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInDiscontinuedOperations" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_2" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCash" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" xlink:label="loc_RCATNoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_RCATNoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NoncashOrPartNoncashDivestitureNoteReceivable" xlink:label="loc_RCATNoncashOrPartNoncashDivestitureNoteReceivable" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_RCATNoncashOrPartNoncashDivestitureNoteReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ConversionOfPreferredStockIntoCommonStock" xlink:label="loc_RCATConversionOfPreferredStockIntoCommonStock" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_RCATConversionOfPreferredStockIntoCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FairValueOfSharesWithheldAsPaymentOfNoteReceivable" xlink:label="loc_RCATFairValueOfSharesWithheldAsPaymentOfNoteReceivable" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_RCATFairValueOfSharesWithheldAsPaymentOfNoteReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_TaxesRelatedToNetShareSettlementOfEquityAwards" xlink:label="loc_RCATTaxesRelatedToNetShareSettlementOfEquityAwards" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_RCATTaxesRelatedToNetShareSettlementOfEquityAwards" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note1Business" xlink:title="00000008 - Disclosure - Note 1 &#8211; The Business">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegment" xlink:title="00000010 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note4MarketableSecurities" xlink:title="00000011 - Disclosure - Note 4 &#8211; Marketable Securities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note5Inventories" xlink:title="00000012 - Disclosure - Note 5 &#8211; Inventories">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note6OtherCurrentAssets" xlink:title="00000013 - Disclosure - Note 6 &#8211; Other Current Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="loc_us-gaapOtherCurrentAssetsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherCurrentAssetsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note7DueFromRelatedParty" xlink:title="00000014 - Disclosure - Note 7 &#8211; Due From Related Party">
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote7DueFromRelatedPartyAbstract" xlink:label="loc_RCATDisclosureNote7DueFromRelatedPartyAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DueFromRelatedPartyDisclosureTextBlock" xlink:label="loc_RCATDueFromRelatedPartyDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote7DueFromRelatedPartyAbstract" xlink:to="loc_RCATDueFromRelatedPartyDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note8IntangibleAssets" xlink:title="00000015 - Disclosure - Note 8 &#8211; Intangible Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note9EquityMethodInvestment" xlink:title="00000016 - Disclosure - Note 9 &#8211; Equity Method Investment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="loc_us-gaapEquityMethodInvestmentsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note10PropertyAndEquipment" xlink:title="00000017 - Disclosure - Note 10 &#8211; Property and Equipment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note11OtherLong-termAssets" xlink:title="00000018 - Disclosure - Note 11 &#8211; Other Long-Term Assets">
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote11OtherLongtermAssetsAbstract" xlink:label="loc_RCATDisclosureNote11OtherLongtermAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OtherLongTermAssetsDisclosureTextBlock" xlink:label="loc_RCATOtherLongTermAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote11OtherLongtermAssetsAbstract" xlink:to="loc_RCATOtherLongTermAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note12RightOfUseAssetsAndLiabilities" xlink:title="00000019 - Disclosure - Note 12 &#8211; Right of Use Assets and Liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaapLeasesOfLesseeDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLeasesOfLesseeDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note13DebtObligations" xlink:title="00000020 - Disclosure - Note 13 &#8211; Debt Obligations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note14DueToRelatedParty" xlink:title="00000021 - Disclosure - Note 14 &#8211; Due to Related Party">
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote14DueToRelatedPartyAbstract" xlink:label="loc_RCATDisclosureNote14DueToRelatedPartyAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RelatedPartyPayablesDisclosureTextBlock" xlink:label="loc_RCATRelatedPartyPayablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote14DueToRelatedPartyAbstract" xlink:to="loc_RCATRelatedPartyPayablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note15IncomeTaxes" xlink:title="00000022 - Disclosure - Note 15 &#8211; Income Taxes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note16CommonStock" xlink:title="00000023 - Disclosure - Note 16 &#8211; Common Stock">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note17PreferredStock" xlink:title="00000024 - Disclosure - Note 17 &#8211; Preferred Stock">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockTextBlock" xlink:label="loc_us-gaapPreferredStockTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapPreferredStockTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note18Warrants" xlink:title="00000025 - Disclosure - Note 18 &#8211; Warrants">
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote18WarrantsAbstract" xlink:label="loc_RCATDisclosureNote18WarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WarrantsDisclosureTextBlock" xlink:label="loc_RCATWarrantsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_RCATWarrantsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note19ShareBasedAwards" xlink:title="00000026 - Disclosure - Note 19 &#8211; Share Based Awards">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note20-Related-partyTransactions" xlink:title="00000027 - Disclosure - Note 20 - Related-Party Transactions">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note21CommitmentsAndContingencies" xlink:title="00000028 - Disclosure - Note 21 &#8211; Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note22SubsequentEvents" xlink:title="00000029 - Disclosure - Note 22 &#8211; Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000030 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" xlink:label="loc_RCATRestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATRestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaapMarketableSecuritiesPolicy" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaapReceivablesPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapReceivablesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="loc_us-gaapEquityMethodInvestmentsPolicy" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionLeasesOperating" xlink:label="loc_us-gaapRevenueRecognitionLeasesOperating" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionLeasesOperating" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:label="loc_us-gaapGuaranteesIndemnificationsAndWarrantiesPolicies" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGuaranteesIndemnificationsAndWarrantiesPolicies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RelatedPartiesPolicyTextBlock" xlink:label="loc_RCATRelatedPartiesPolicyTextBlock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATRelatedPartiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000031 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" xlink:label="loc_RCATRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" xlink:label="loc_RCATRevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATRevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegmentTables" xlink:title="00000032 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="loc_us-gaapScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock" xlink:label="loc_RCATScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note5InventoriesTables" xlink:title="00000033 - Disclosure - Note 5 &#8211; Inventories (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note6OtherCurrentAssetsTables" xlink:title="00000034 - Disclosure - Note 6 &#8211; Other Current Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherCurrentAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note8IntangibleAssetsTables" xlink:title="00000035 - Disclosure - Note 8 &#8211; Intangible Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaapScheduleOfGoodwillTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfGoodwillTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note9EquityMethodInvestmentTables" xlink:title="00000036 - Disclosure - Note 9 &#8211; Equity Method Investment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock" xlink:label="loc_RCATEquityMethodInvestmentFinancialInformationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_RCATEquityMethodInvestmentFinancialInformationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsTextBlock" xlink:label="loc_us-gaapEquityMethodInvestmentsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note10PropertyAndEquipmentTables" xlink:title="00000037 - Disclosure - Note 10 &#8211; Property and Equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note11OtherLong-termAssetsTables" xlink:title="00000038 - Disclosure - Note 11 &#8211; Other Long-Term Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote11OtherLongtermAssetsAbstract" xlink:label="loc_RCATDisclosureNote11OtherLongtermAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock" xlink:label="loc_RCATScheduleOfOtherLongTermAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote11OtherLongtermAssetsAbstract" xlink:to="loc_RCATScheduleOfOtherLongTermAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note12RightOfUseAssetsAndLiabilitiesTables" xlink:title="00000039 - Disclosure - Note 12 &#8211; Right of Use Assets and Liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRentExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleOfRentExpenseTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapScheduleOfRentExpenseTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaapOperatingLeasesOfLesseeDisclosureTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeasesOfLesseeDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note13DebtObligationsTables" xlink:title="00000040 - Disclosure - Note 13 &#8211; Debt Obligations (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ScheduleOfDebtPaymentsDueTableTextBlock" xlink:label="loc_RCATScheduleOfDebtPaymentsDueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_RCATScheduleOfDebtPaymentsDueTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note16CommonStockTables" xlink:title="00000041 - Disclosure - Note 16 &#8211; Common Stock (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:label="loc_us-gaapScheduleOfCommonStockOutstandingRollForwardTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note18WarrantsTables" xlink:title="00000042 - Disclosure - Note 18 &#8211; Warrants (Tables)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote18WarrantsAbstract" xlink:label="loc_RCATDisclosureNote18WarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock" xlink:label="loc_RCATScheduleOfWarrantsIssuedAndFairValueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_RCATScheduleOfWarrantsIssuedAndFairValueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:label="loc_us-gaapScheduleOfAssumptionsUsedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_us-gaapScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note19ShareBasedAwardsTables" xlink:title="00000043 - Disclosure - Note 19 &#8211; Share Based Awards (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ScheduleOfAssumptionsUsed1TableTextBlock" xlink:label="loc_RCATScheduleOfAssumptionsUsed1TableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATScheduleOfAssumptionsUsed1TableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="loc_us-gaapDisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:title="00000044 - Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementImpactAxis" xlink:label="loc_RCATRestatementImpactAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATRestatementImpactAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementImpactDomain" xlink:label="loc_RCATRestatementImpactDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATRestatementImpactAxis" xlink:to="loc_RCATRestatementImpactDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementImpactOriginallyReportedMember" xlink:label="loc_RCATRestatementImpactOriginallyReportedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATRestatementImpactDomain" xlink:to="loc_RCATRestatementImpactOriginallyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementImpactAsRestatedMember" xlink:label="loc_RCATRestatementImpactAsRestatedMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATRestatementImpactDomain" xlink:to="loc_RCATRestatementImpactAsRestatedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestatementImpactChangeMember" xlink:label="loc_RCATRestatementImpactChangeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATRestatementImpactDomain" xlink:to="loc_RCATRestatementImpactChangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OperatingLeaseLiabilityCurrentRestatementImpact" xlink:label="loc_RCATOperatingLeaseLiabilityCurrentRestatementImpact" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATOperatingLeaseLiabilityCurrentRestatementImpact" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_LiabilitiesCurrentRestatementImpact" xlink:label="loc_RCATLiabilitiesCurrentRestatementImpact" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATLiabilitiesCurrentRestatementImpact" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockholdersEquityRestatement" xlink:label="loc_RCATStockholdersEquityRestatement" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATStockholdersEquityRestatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInDerivativeAssetsAndLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note1BusinessDetailsNarrative" xlink:title="00000045 - Disclosure - Note 1 &#8211; The Business (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_BusinessAcquisition1Member" xlink:label="loc_RCATBusinessAcquisition1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_BusinessAcquisition2Member" xlink:label="loc_RCATBusinessAcquisition2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_BusinessAcquisition3Member" xlink:label="loc_RCATBusinessAcquisition3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_BusinessAcquisition4Member" xlink:label="loc_RCATBusinessAcquisition4Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingShares" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingGrossProceeds" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingGrossProceeds" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingNetProceeds" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingNetProceeds" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/CustomerConcentrationRiskDetails" xlink:title="00000046 - Disclosure - Customer concentration risk (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CustomerConcentrationRisk1Member" xlink:label="loc_RCATCustomerConcentrationRisk1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RCATCustomerConcentrationRisk1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CustomerConcentrationRisk2Member" xlink:label="loc_RCATCustomerConcentrationRisk2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RCATCustomerConcentrationRisk2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CustomerConcentrationRisk3Member" xlink:label="loc_RCATCustomerConcentrationRisk3Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RCATCustomerConcentrationRisk3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CustomerConcentrationRisk4Member" xlink:label="loc_RCATCustomerConcentrationRisk4Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RCATCustomerConcentrationRisk4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CustomerConcentrationRisk5Member" xlink:label="loc_RCATCustomerConcentrationRisk5Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RCATCustomerConcentrationRisk5Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:title="00000047 - Disclosure - Company&apos;s revenue disaggregated by revenue type (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer" xlink:label="loc_us-gaapRevenueNotFromContractWithCustomer" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueNotFromContractWithCustomer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:title="00000048 - Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" xlink:label="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" xlink:label="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" xlink:label="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" xlink:label="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000049 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndDividendIncomeSecuritiesOther" xlink:label="loc_us-gaapInterestAndDividendIncomeSecuritiesOther" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInterestAndDividendIncomeSecuritiesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:label="loc_us-gaapContractWithCustomerAssetGrossCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapContractWithCustomerAssetGrossCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrualCurrent" xlink:label="loc_us-gaapStandardProductWarrantyAccrualCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStandardProductWarrantyAccrualCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DifferenceBetweenComprehensiveLossAndNetLoss" xlink:label="loc_RCATDifferenceBetweenComprehensiveLossAndNetLoss" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATDifferenceBetweenComprehensiveLossAndNetLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:label="loc_us-gaapDebtSecuritiesAvailableForSaleUnrealizedGainLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Capital" xlink:label="loc_us-gaapCapital" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCapital" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails" xlink:title="00000050 - Disclosure - Discontinued Operations - results of operations (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:label="loc_RCATDisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATDisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:label="loc_RCATDisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:to="loc_RCATDisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" xlink:label="loc_RCATDisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:to="loc_RCATDisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:label="loc_RCATDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInterestExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherIncome" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:label="loc_RCATDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:to="loc_RCATDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails" xlink:title="00000051 - Disclosure - Assets and liabilities for the Consumer Segment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:label="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCash" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInventoryCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherLiabilities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent" xlink:label="loc_RCATDisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="loc_RCATDisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent" xlink:label="loc_RCATDisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATDisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationWorkingCapital" xlink:label="loc_RCATDisposalGroupIncludingDiscontinuedOperationWorkingCapital" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATDisposalGroupIncludingDiscontinuedOperationWorkingCapital" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:title="00000052 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:label="loc_us-gaapNoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapNoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1" xlink:label="loc_RCATNoncashOrPartNoncashDivestitureCashConsiderationReceived1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATNoncashOrPartNoncashDivestitureCashConsiderationReceived1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" xlink:label="loc_RCATNoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATNoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" xlink:label="loc_RCATNoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATNoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" xlink:label="loc_RCATNoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATNoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WorkingCapitalAtClosingOfDisposalGroup" xlink:label="loc_RCATWorkingCapitalAtClosingOfDisposalGroup" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATWorkingCapitalAtClosingOfDisposalGroup" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note4MarketableSecuritiesDetailsNarrative" xlink:title="00000053 - Disclosure - Note 4 &#8211; Marketable Securities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CorporateBondsAtCarryingValueFairValue" xlink:label="loc_RCATCorporateBondsAtCarryingValueFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_RCATCorporateBondsAtCarryingValueFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CorporateBondsAtCarryingValueCostBasis" xlink:label="loc_RCATCorporateBondsAtCarryingValueCostBasis" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_RCATCorporateBondsAtCarryingValueCostBasis" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CorporateBondsAtCarryingValueUnrealizedLosses" xlink:label="loc_RCATCorporateBondsAtCarryingValueUnrealizedLosses" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_RCATCorporateBondsAtCarryingValueUnrealizedLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/InventoriesDetails" xlink:title="00000054 - Disclosure - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/OtherCurrentAssetsDetails" xlink:title="00000055 - Disclosure - Other current assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:label="loc_us-gaapContractWithCustomerAssetGrossCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapContractWithCustomerAssetGrossCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivableCurrent" xlink:label="loc_us-gaapGrantsReceivableCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapGrantsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative" xlink:title="00000056 - Disclosure - Note 7 &#8211; Due From Related Party (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote7DueFromRelatedPartyAbstract" xlink:label="loc_RCATDisclosureNote7DueFromRelatedPartyAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CashCompensationSubjectToTaxation" xlink:label="loc_RCATCashCompensationSubjectToTaxation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote7DueFromRelatedPartyAbstract" xlink:to="loc_RCATCashCompensationSubjectToTaxation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IncomeAssociatedWithStockCompensationSubjectToTaxation" xlink:label="loc_RCATIncomeAssociatedWithStockCompensationSubjectToTaxation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote7DueFromRelatedPartyAbstract" xlink:to="loc_RCATIncomeAssociatedWithStockCompensationSubjectToTaxation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation" xlink:label="loc_RCATNoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote7DueFromRelatedPartyAbstract" xlink:to="loc_RCATNoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteShares" xlink:label="loc_RCATCommonStockWithheldByCompanyAppliedAgainstNoteShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote7DueFromRelatedPartyAbstract" xlink:to="loc_RCATCommonStockWithheldByCompanyAppliedAgainstNoteShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteAmount" xlink:label="loc_RCATCommonStockWithheldByCompanyAppliedAgainstNoteAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote7DueFromRelatedPartyAbstract" xlink:to="loc_RCATCommonStockWithheldByCompanyAppliedAgainstNoteAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharesHeldAtTransferAgentUntilNoteReceivableRepayment" xlink:label="loc_RCATSharesHeldAtTransferAgentUntilNoteReceivableRepayment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote7DueFromRelatedPartyAbstract" xlink:to="loc_RCATSharesHeldAtTransferAgentUntilNoteReceivableRepayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestrictedStockScheduledToVestShares" xlink:label="loc_RCATRestrictedStockScheduledToVestShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote7DueFromRelatedPartyAbstract" xlink:to="loc_RCATRestrictedStockScheduledToVestShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable" xlink:label="loc_RCATRestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote7DueFromRelatedPartyAbstract" xlink:to="loc_RCATRestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_PaymentsForTaxLiability" xlink:label="loc_RCATPaymentsForTaxLiability" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote7DueFromRelatedPartyAbstract" xlink:to="loc_RCATPaymentsForTaxLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_EstimatedTaxesOwedRelatedToStockCompensation" xlink:label="loc_RCATEstimatedTaxesOwedRelatedToStockCompensation" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote7DueFromRelatedPartyAbstract" xlink:to="loc_RCATEstimatedTaxesOwedRelatedToStockCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote7DueFromRelatedPartyAbstract" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/IntangibleAssetsDetails" xlink:title="00000057 - Disclosure - Intangible assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:label="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IntangibleAssetsGrossCarryingAmountMember" xlink:label="loc_RCATIntangibleAssetsGrossCarryingAmountMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:to="loc_RCATIntangibleAssetsGrossCarryingAmountMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IntangibleAssetsAccumulatedAmortizationMember" xlink:label="loc_RCATIntangibleAssetsAccumulatedAmortizationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:to="loc_RCATIntangibleAssetsAccumulatedAmortizationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IntangibleAssetsNetCarryingValueMember" xlink:label="loc_RCATIntangibleAssetsNetCarryingValueMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:to="loc_RCATIntangibleAssetsNetCarryingValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedProprietaryTechnologyGross" xlink:label="loc_RCATFiniteLivedProprietaryTechnologyGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATFiniteLivedProprietaryTechnologyGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedNoncompeteAgreementsGross1" xlink:label="loc_RCATFiniteLivedNoncompeteAgreementsGross1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATFiniteLivedNoncompeteAgreementsGross1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedCustomerRelationshipsGross1" xlink:label="loc_RCATFiniteLivedCustomerRelationshipsGross1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATFiniteLivedCustomerRelationshipsGross1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FiniteLivedIntangibleAssetsGross1" xlink:label="loc_RCATFiniteLivedIntangibleAssetsGross1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATFiniteLivedIntangibleAssetsGross1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaapIndefiniteLivedTradeNames" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIndefiniteLivedTradeNames" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1" xlink:label="loc_RCATIndefiniteLivedIntangibleAssetsExcludingGoodwill1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATIndefiniteLivedIntangibleAssetsExcludingGoodwill1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IntangibleAssetsNetExcludingGoodwill1" xlink:label="loc_RCATIntangibleAssetsNetExcludingGoodwill1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATIntangibleAssetsNetExcludingGoodwill1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails" xlink:title="00000058 - Disclosure - Expected amortization expense for the unamortized finite-lived intangible assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/CompositionOfAndChangesInGoodwillDetails" xlink:title="00000059 - Disclosure - Composition of, and changes in goodwill (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillMember" xlink:label="loc_us-gaapGoodwillMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapGoodwillMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="loc_us-gaapGoodwillPeriodIncreaseDecrease" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapGoodwillPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="loc_us-gaapGoodwillWrittenOffRelatedToSaleOfBusinessUnit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapGoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note8IntangibleAssetsDetailsNarrative" xlink:title="00000060 - Disclosure - Note 8 &#8211; Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails" xlink:title="00000061 - Disclosure - Financial informatino for UMAC derived from their Form 10-Q (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails" xlink:title="00000062 - Disclosure - Impacts on investments into UMAC (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapEquityMethodInvestments_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/PropertyAndEquipmentDetails" xlink:title="00000063 - Disclosure - Property and equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="loc_us-gaapLeaseholdImprovementsGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapLeaseholdImprovementsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="loc_us-gaapFurnitureAndFixturesGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapFurnitureAndFixturesGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note10PropertyAndEquipmentDetailsNarrative" xlink:title="00000064 - Disclosure - Note 10 &#8211; Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/OtherLongTermAssetsDetails" xlink:title="00000065 - Disclosure - Other long term assets (Details)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote11OtherLongtermAssetsAbstract" xlink:label="loc_RCATDisclosureNote11OtherLongtermAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SAFEAgreementAssets" xlink:label="loc_RCATSAFEAgreementAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote11OtherLongtermAssetsAbstract" xlink:to="loc_RCATSAFEAgreementAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote11OtherLongtermAssetsAbstract" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaapNoncurrentAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote11OtherLongtermAssetsAbstract" xlink:to="loc_us-gaapNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note11OtherLong-termAssetsDetailsNarrative" xlink:title="00000066 - Disclosure - Note 11 &#8211; Other Long-Term Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote11OtherLongtermAssetsAbstract" xlink:label="loc_RCATDisclosureNote11OtherLongtermAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_PaymentForSAFEAgreement" xlink:label="loc_RCATPaymentForSAFEAgreement" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote11OtherLongtermAssetsAbstract" xlink:to="loc_RCATPaymentForSAFEAgreement" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/OperatingLeasesDetails" xlink:title="00000067 - Disclosure - Operating leases (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OperatingLeaseLocation1Member" xlink:label="loc_RCATOperatingLeaseLocation1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_RCATOperatingLeaseLocation1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OperatingLeaseLocation3Member" xlink:label="loc_RCATOperatingLeaseLocation3Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_RCATOperatingLeaseLocation3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OperatingLeaseLocation4Member" xlink:label="loc_RCATOperatingLeaseLocation4Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_RCATOperatingLeaseLocation4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails" xlink:title="00000068 - Disclosure - Supplemental information related to operating leases (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OperatingCashPaidToSettleLeaseLiabilities" xlink:label="loc_RCATOperatingCashPaidToSettleLeaseLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_RCATOperatingCashPaidToSettleLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/FutureLeasePaymentObligationsDetails" xlink:title="00000069 - Disclosure - Future lease payment obligations (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix" xlink:label="loc_RCATLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_RCATLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_LesseeOperatingLeaseLiabilityPaymentsDueThereafter" xlink:label="loc_RCATLesseeOperatingLeaseLiabilityPaymentsDueThereafter" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_RCATLesseeOperatingLeaseLiabilityPaymentsDueThereafter" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_LesseeOperatingLeaseLiabilityPaymentsDueSubtotal" xlink:label="loc_RCATLesseeOperatingLeaseLiabilityPaymentsDueSubtotal" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_RCATLesseeOperatingLeaseLiabilityPaymentsDueSubtotal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/OutstandingPrincipalPaymentsDetails" xlink:title="00000070 - Disclosure - Outstanding principal payments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OutstandingPrincipalPaymentsDueYearOne" xlink:label="loc_RCATOutstandingPrincipalPaymentsDueYearOne" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_RCATOutstandingPrincipalPaymentsDueYearOne" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OutstandingPrincipalPaymentsDueLongTerm" xlink:label="loc_RCATOutstandingPrincipalPaymentsDueLongTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_RCATOutstandingPrincipalPaymentsDueLongTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OutstandingPrincipalPaymentsDueTotal" xlink:label="loc_RCATOutstandingPrincipalPaymentsDueTotal" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_RCATOutstandingPrincipalPaymentsDueTotal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note13DebtObligationsDetailsNarrative" xlink:title="00000071 - Disclosure - Note 13 &#8211; Debt Obligations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtObligation1Member" xlink:label="loc_RCATDebtObligation1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtObligation2Member" xlink:label="loc_RCATDebtObligation2Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtObligation3Member" xlink:label="loc_RCATDebtObligation3Member" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtObligation6Member" xlink:label="loc_RCATDebtObligation6Member" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation6Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtObligation8Member" xlink:label="loc_RCATDebtObligation8Member" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation8Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ConvertibleNoteAgreementAmount" xlink:label="loc_RCATConvertibleNoteAgreementAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATConvertibleNoteAgreementAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_LeaseholdImprovementAgreementFundsReceived" xlink:label="loc_RCATLeaseholdImprovementAgreementFundsReceived" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATLeaseholdImprovementAgreementFundsReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset" xlink:label="loc_RCATFinancingAgreementFundingOfPurchaseOfFixedAsset" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATFinancingAgreementFundingOfPurchaseOfFixedAsset" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative" xlink:title="00000072 - Disclosure - Note 14 &#8211; Due to Related Party (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote14DueToRelatedPartyAbstract" xlink:label="loc_RCATDisclosureNote14DueToRelatedPartyAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote14DueToRelatedPartyAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DueToRelatedParty2Member" xlink:label="loc_RCATDueToRelatedParty2Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDueToRelatedParty2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_LineOfCreditObligationAssumedInConnectionWithAcquisition" xlink:label="loc_RCATLineOfCreditObligationAssumedInConnectionWithAcquisition" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATLineOfCreditObligationAssumedInConnectionWithAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtInstrumentInterestRateDuringPeriod1" xlink:label="loc_RCATDebtInstrumentInterestRateDuringPeriod1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATDebtInstrumentInterestRateDuringPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DueToOtherRelatedPartyClassifiedCurrent" xlink:label="loc_RCATDueToOtherRelatedPartyClassifiedCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATDueToOtherRelatedPartyClassifiedCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DebtInstrumentOutstandingAccruedInterestPayment" xlink:label="loc_RCATDebtInstrumentOutstandingAccruedInterestPayment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATDebtInstrumentOutstandingAccruedInterestPayment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note15IncomeTaxesDetailsNarrative" xlink:title="00000073 - Disclosure - Note 15 &#8211; Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails" xlink:title="00000074 - Disclosure - Summary of shares of common stock issued (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" xlink:label="loc_RCATStockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares" xlink:label="loc_RCATIssuanceOfCommonStockThroughATMFacilitiesNetShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATIssuanceOfCommonStockThroughATMFacilitiesNetShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockIssuedDuringPeriodSharesPublicOffering" xlink:label="loc_RCATStockIssuedDuringPeriodSharesPublicOffering" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodSharesPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note17PreferredStockDetailsNarrative" xlink:title="00000075 - Disclosure - Note 17 &#8211; Preferred Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SeriesAPreferredStock2Member" xlink:label="loc_RCATSeriesAPreferredStock2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RCATSeriesAPreferredStock2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" xlink:label="loc_RCATStockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:title="00000076 - Disclosure - Summary of warrants issued and fair values (Details)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote18WarrantsAbstract" xlink:label="loc_RCATDisclosureNote18WarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NumberOfWarrantsUponIssuance" xlink:label="loc_RCATNumberOfWarrantsUponIssuance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_RCATNumberOfWarrantsUponIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_InitialFairValueOfWarrantsUponIssuance" xlink:label="loc_RCATInitialFairValueOfWarrantsUponIssuance" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_RCATInitialFairValueOfWarrantsUponIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NumberOfWarrantsOutstanding" xlink:label="loc_RCATNumberOfWarrantsOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_RCATNumberOfWarrantsOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FairValueOfWarrantsOutstanding" xlink:label="loc_RCATFairValueOfWarrantsOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_RCATFairValueOfWarrantsOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NumberOfWarrantsOutstanding2" xlink:label="loc_RCATNumberOfWarrantsOutstanding2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_RCATNumberOfWarrantsOutstanding2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FairValueOfWarrantsOutstanding2" xlink:label="loc_RCATFairValueOfWarrantsOutstanding2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_RCATFairValueOfWarrantsOutstanding2" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails" xlink:title="00000077 - Disclosure - Assumptions used to estimate fair value of stock warrants granted (Details)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote18WarrantsAbstract" xlink:label="loc_RCATDisclosureNote18WarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WarrantAssumptionsUsedMember" xlink:label="loc_RCATWarrantAssumptionsUsedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_RCATWarrantAssumptionsUsedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/ChangesInWarrantsOutstandingDetails" xlink:title="00000078 - Disclosure - Changes in warrants outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote18WarrantsAbstract" xlink:label="loc_RCATDisclosureNote18WarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WarrantsOutstanding1Member" xlink:label="loc_RCATWarrantsOutstanding1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_RCATWarrantsOutstanding1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note18WarrantsDetailsNarrative" xlink:title="00000079 - Disclosure - Note 18 &#8211; Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_DisclosureNote18WarrantsAbstract" xlink:label="loc_RCATDisclosureNote18WarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WarrantsIssuedExercisePrice" xlink:label="loc_RCATWarrantsIssuedExercisePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_RCATWarrantsIssuedExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ProceedsReceivedFromExerciseOfWarrants" xlink:label="loc_RCATProceedsReceivedFromExerciseOfWarrants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_RCATProceedsReceivedFromExerciseOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ExerciseOfWarrantsShares" xlink:label="loc_RCATExerciseOfWarrantsShares" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_RCATExerciseOfWarrantsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_WarrantsToPurchaseSharesIssued" xlink:label="loc_RCATWarrantsToPurchaseSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote18WarrantsAbstract" xlink:to="loc_RCATWarrantsToPurchaseSharesIssued" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:title="00000080 - Disclosure - Assumptions used to calculate fair value of options granted (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FairValueOfOptionsAxis" xlink:label="loc_RCATFairValueOfOptionsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATFairValueOfOptionsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_FairValueOfOptionsDomain" xlink:label="loc_RCATFairValueOfOptionsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATFairValueOfOptionsAxis" xlink:to="loc_RCATFairValueOfOptionsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_OptionsAssumptionsUsedMember" xlink:label="loc_RCATOptionsAssumptionsUsedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATFairValueOfOptionsDomain" xlink:to="loc_RCATOptionsAssumptionsUsedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfActivityUnderPlanDetails" xlink:title="00000081 - Disclosure - Summary of activity under the Plan (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_Options1Member" xlink:label="loc_RCATOptions1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_RCATOptions1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:title="00000082 - Disclosure - Summary of restricted stock activity under the Plan (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationSharesRestrictedStockAxis" xlink:label="loc_RCATShareBasedCompensationSharesRestrictedStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATShareBasedCompensationSharesRestrictedStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationSharesRestrictedStockDomain" xlink:label="loc_RCATShareBasedCompensationSharesRestrictedStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATShareBasedCompensationSharesRestrictedStockAxis" xlink:to="loc_RCATShareBasedCompensationSharesRestrictedStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATShareBasedCompensationSharesRestrictedStockDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" xlink:label="loc_RCATSharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails" xlink:title="00000083 - Disclosure - Stock compensation expense by functional category (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_ResearchAndDevelopmentStockCompensationExpense" xlink:label="loc_RCATResearchAndDevelopmentStockCompensationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATResearchAndDevelopmentStockCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_SalesAndMarketingStockCompensationExpense" xlink:label="loc_RCATSalesAndMarketingStockCompensationExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATSalesAndMarketingStockCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_GeneralAndAdministrativeStockCompensationExpense" xlink:label="loc_RCATGeneralAndAdministrativeStockCompensationExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATGeneralAndAdministrativeStockCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_TotalStockCompensationExpense" xlink:label="loc_RCATTotalStockCompensationExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATTotalStockCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note19ShareBasedAwardsDetailsNarrative" xlink:title="00000084 - Disclosure - Note 19 &#8211; Share Based Awards (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" xlink:label="loc_RCATNumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATNumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" xlink:label="loc_RCATUnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATUnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockCompensationExpensePertainingToOptions" xlink:label="loc_RCATStockCompensationExpensePertainingToOptions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATStockCompensationExpensePertainingToOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240430.xsd#RCAT_StockCompensationExpensePertainingToRestrictedStockUnits" xlink:label="loc_RCATStockCompensationExpensePertainingToRestrictedStockUnits" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATStockCompensationExpensePertainingToRestrictedStockUnits" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.gif
M1TE&.#=AWP!& '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
M    WP!& (<V-C8R,C(]/3TN+BXS,S,Z.CH[.SLX.#A965E>7EY.3DY?7U]3
M4U-65E9:6EI;6UM75U=,3$Q45%1<7%Q=75U/3T]$1$186%A5555(2$A04%!%
M145+2TM.3$U"0D)&1D9+2$E-34U?7EY)24E145%*2DI!04%C6UYZ>GIQ<7%\
M?'QD9&1J:FI[>WMK:VMH:&A^?GY_?W]P<'!M;6UT='1B8F)R<G)]?7UL;&QC
M8V-W=W=A86%N;FYO;V]G9V=V=G9S<W-X>'AU=75@8&!I:6EE965F9F9Y>7EW
M=G=P;F]D8F-V='9W<7)K8V9X<'-U;G%]=GAY=WB">WV0D)"?GY^3DY.1D9&$
MA(24E)2<G)R&AH:.CHZ,C(R>GIZ)B8F9F9F=G9V5E962DI*-C8V;FYN @("7
MEY>#@X.:FIJ"@H*6EI:*BHJ(B(B/CX^%A868F)B+BXN'AX>!@8&#@8*7E9:0
MCY"4DI.,AHB%AH:WM[>@H*"YN;FOKZ^\O+RCHZ.XN+BEI:6NKJZQL;&JJJJT
MM+2BHJ*GIZ>]O;VHJ*BKJZNMK:VUM;6DI*2LK*RAH:&IJ:FFIJ:PL+"^OKZ[
MN[NVMK:RLK*_O[^ZNKJSL[.FIZ:^O;VVM;:_OK[1T='"PL+9V=G8V-C$Q,3%
MQ<7=W=W)R<G-S<W5U=73T]/+R\O4U-36UM;;V]O(R,C.SL[7U]? P,#>WM[#
MP\/?W]_<W-S!P<'&QL;/S\_2TM+:VMK*RLK,S,S0T-#'Q\?,R\S3TM/<W=W=
MW-S!PL+^_O[\_/SM[>WGY^?Y^?GS\_/Z^OKJZNKAX>'X^/CQ\?'BXN+]_?W[
M^_OKZ^OEY>7HZ.CT]/3N[N[FYN;R\O+P\/#DY.3V]O;O[^_@X.#W]_?CX^/U
M]?7L[.SIZ>GR\?'S\O/W]O;]_/W___\! @,! @,! @,! @,! @,! @,! @,!
M @,! @,! @,! @,! @,! @,! @,! @,! @,! @,! @,! @,! @,! @,! @,!
M @,! @,! @,! @,(_P#+"1Q(L*#!@P@3*ES(L*'#AQ C2IQ(L:+%BQ@S:MS(
ML:/'CR!#BAQ)LJ3)DRA3JER)4)A%ERQC3H0I4R7-FCASZMS)LZ?/GT"#"AU*
MM*C1D#>/*M4IS.6PI5"C7LPSA9C4JU@5NNR$(H6GK ]A?@(%]F<Q%:'TB"K;
M4-BP/2M8C&++DP\58U5":1QV#%E2GJ00]+'BAZ[.9%>4+<-22N.?%L5^NF0&
MJ$^Y+($,UW0I2(NP9%N:932%P$4RH,8&G2KGS HJS36?<>E4+AD6JQ>+O:AB
M!1I00H-<1N,B#79'9KX=EH)AK%RJ+LLN/BOD156,R#Y!32E>KA25O\8K&O_;
M0NKA%S "_Q#"N,K0LU17IOET%N;/P%*LP(+?2$U&*X?,S/"5,(:X<M$R7^CU
MBAA/[>12*#0<(] PAS2&E3,-@D3-&+ X%$L-U93CBA?67(2*&!(.@HA/R-A0
MR$#7](%-5DV)),L-(3;$Q1;E#,-%(A==@X,B I%QB$^=Y#"C2[.0%=Y&M,B0
M34/%)-!8*CJ<9A$8,IR6#1>?^+2%%0,1L\B,3VK$1QD.C3%#<V:0:9$V.RPB
MD"HM,',2,L4PLY] S:SPFD",A(%,FAIE<49#VBC02#G;\"#+18(LH.4?6* T
MBR.J.*-0(CUP(Q J/H2):$9C:-&0* P0\\P6CUS_E,T*:)335!B0G#0,&9%,
MF= Q/_ A$#8IY(&488RD\.= 9:113AXW^(I0A@F)TD WMEKC0BT.">.I1<Z<
M8<A"M3C@FS<HJ/&M1\,L"U4L#TC84CG10&"++#9TF- SV3QC:U(8EE.&"LXT
M-PH0W-'4U$W>/L-PC?,.Y!)U OWEUAICE'/-&2J4"!+$$H%,D+L'D?S0+1$8
MJ) @0.#RP[A_\G6H,^NR]HPST$@@23E31E*&7\\TV!0RT=DZC#-NW?1,<S#1
M[(Q?Y3PSS<W/+.,,*0M\A;1+3WN*RP2K2)-&$-?8&G'))@M$<T0B2[QPVFMG
MQ(T086AU!1LX@$%MR=QX_WKT0,XX7 XB"UCC##//M!&)T?XB [0WC3O\C*AF
M"W.S6WYC>$QSRTPSS##/3#[-(PV\,B%KR/@;B J*_."(GD@?%#!XEM_TMT'&
M')--T1*K_5?<_[(-^+II)\1* J(9Q.0#+P!IMD+M_EMCX#P/P4C4QWS#Q9*U
M#X.,,\<P8\PSQW#M[]]NV6J,IUL;PXTPQCQEC#<]RM>%!(. 4U R%%00PZ +
M@TC3E+8WUG #&<-@!OT&TJ[ _>5S@%M&AKQED+4]PR\-6EM3:%8\Y6GA"D])
MBC%X8(%)5(PAWPL8:VAVJ%SD0!G_ZD0;BN:,;'BJ*9,+&N58XY(>"DUB3S.&
M,/^F03]O4,,MT_!4(QAP@2D$@A* L (+'* +KGTN:!6+7=M&UC8,B3 ;GV,&
M,6!"P=OU#G@]$EH-FT.0"Y;#<;=;V+= 9Y%B[& +;!R(*LX  &,YQ(L%8Q_2
M'.:&-1"$$)#XUM/("+$0ILY6-_27\B#H#5%-#G4P(48>KO "(@0!#3L85^^F
MUT/6-&AO35->4I;FC&5<@QE(B]T*"[(UAGV+:X<BB/?*L0QDN$^(-X,@)"\"
M"Q=@0 ^GJ$4EW%"#"NB@9@M1F,+*@8T%Y$<@XS%=!8]F.PD.TUL]A,DSO)%!
M3TW.6TQ;'POIUXD+A F'0>LA M=6,%M!K2D0I" X>4C_D-C-<QK9L-RZ5$A*
M.C*P9A0$HL.^]\8DKH\U%;N<19A!A1RL@ ()L,(D'E">1+% /@))QA=R)$"&
MR!)P/X0DM6)0!N)Y,:)0V^7S B=+,C;P)@P]QC%"9\X;JBV63G&+7_#I,&\=
M#8NRZR'2QA>UT%VP@PD9!C$\UH@@Y/% #W@#06@1"&BV!22PV($MPB*1T(VL
M8B"SF+=\*DT&'@V-_1PF/RV'P(\80P;&@BI"; $!?0F$$'K1*TC&D :O<N2E
M%1'L9EP2B1I\8R-7: %!O@&)XBAV(RZ!!1'&>BJ;E(,9$GB11HJ! 4H0Q!*F
MW8D8>-19EF!A!O(Z83EV(89*_UR5(7GPP0*%X8T_D/1C)'/)*2A@"JVT%B2I
MP,!8DP**"6R!#;AXB#-BH%68=.(5AE5>14ZJD&/P(%,MB=YQ.^(,%7CA(*^P
M@22*807N-*0:*\B%V9(Q!95I#&H',6/)# L_VA4$$"XHF]L&(HU)+!!PK.G$
M8\TV#0&7C)8(408J L&(*D+S@9*4;4Y$4008%B04$C#=)-Z0W8/X@0=3<LDE
MK)!+5U!@#Q(3;QHG5#,,U5.V 9S0'_3048+ 8@B\H*53RC$)->P0=;,=PG\$
M\@H@Y$ 0"LE&'PJ1"G&N"QM$@ ,<KF"#PE3P&[L0!"/6D(86E$$/BO!P3J!!
M 3T81/\6#S"M-]R@%X$\XQ26 *GR9@#><BCC!ZH02#%@4(076,5R$IR@6Z[(
M/F,@\%#"0&"D-SB9,V# "!;0Q4"6QH8K*-56P5Q&-EKP*'OZ\FIL0, NRO&-
M1+#!$IB@ &W,Z1)C[ (2:WA!!JK PYM%K1QJ ()+CD&#. R$&\5@A2-2P (B
MR. &84@$)M[ @@!D3"=J<(&T!+(,%:@A/5Z FC',((0;!/H@Q4" -I=Q!4!P
M6PR1  <"=O8YITUPCD]YI.5,V11R/@\11Y#&,L"P@$G9"A :P$7\'"@,;A15
M%T.@3=2,T1Q=!"$/0UBU',J@I\M<8"Z?Z\8CY/"#-X1"%E7_<$7@O(<T45GA
M#,QXQ NN4 QB7$(--X !"K! B5)L@W?2>$01H$NR@N&W1MXX<&++@0L(K*5W
MDK!!B::!@J=SHPI8F$08J(&04&P@&@)1A!"T\=E"?*&&#QA$CX)6;[/=KIYQ
MC-H-&>H2;," -MSHAA!H(*IN-& 0R+C&%07B<%MQX0?R&<;[RK&*($R"&"_8
MPA2.X!O#<2,(.: &,<9@A#4L0G_#T,,DD"$?85AM(%@0  9\H 8YL. %-GC#
M(6816SOKH@HO2(,E#J7?@I@/=$/S%#>B<]D)E8$-@AO(,H)E*]Y\"Q)R&(46
MOH*03$Q /K%@ 6V>088JT&\80*CN_P#=+K3SU2R?*?07'] CC&P@0QHK>,,Q
MTN 99+QO&:+B[:'::05SELT;,# %^&<%&4 $V( AUG HUX "#, !&" *@5,,
MJ' %4\ -P\ [QY +A. %,V $/L &<% %?[ +6N)K&D,*71 ':; %MB!)0214
MH=,NX)106R,XHM8MOW80K$ !R7-"N> #CQ4);M!QI' #L" &5= @X( )1X8$
M<U .FI #058.I] #]C4&-/ YX\-0_10X+N@4S>%&D88A$L0(L8 ,V2 -)=(*
M$U #*1 9QI!$W)!B :4-6  #9C S4Y(+;3 CSD (#5!<UO ,UA =S! '.R #
M-* ",  #*O\@!XQ@#0+%:H)P RZ@ UF #8I'#0<V/D_S1I*  P@ !YT@+0U$
M<4_##=Q028[C%RID$)WS/ ;!"RD8!ST0!#R@ U1P";CP+=)0 X[@>^5P!F:P
M#&8  V!7#MSP [5 "C @(2Y!"37 =0.1!'2P"4G0"P*1#5O@"/[B$J)0 ;>P
M0B;(1614,4]!4&[Q#,D0!K P#=8P50+Q" .0 F1G-NYS0E4@!H^A)RYA#930
M"9=#"S!P#4\S3LL@"RR0 MUP#)V0!Y<0"WV@!C)07'YF!BQ0!I-0#=N&5J9G
M8\D  PJP!;-0#MZ@#;DT$!0',6_C0Q/"->SC,+PS$,@ "1+@ F?_@ : 8 A_
M\ 8H4 0/< .&0 LN( 099C;+P *&  -C (WET I7L UE0!LN00UK  ,$$0Y*
MT %+X MJ@PA;X(\"@0Q < ,^I1&_\ C$MXKTP@-LT (3  G?\!>48 2R  H+
M$%WE8 Q9T @IUDJ"ET7.0 4\H'35  E < 8SD!^'X(:UX#?+P# 5,U3+< 1#
ML!H"$3XWM$'E*#O?8E:J2#1+91"(0 &8:1#/  J+T 8>0  Q8' $$0H?P *0
MD$N< 09DX&Y<4PMZ( ,EX@RS4 <@8 ?B8#:C, :I8!"=$ );4$ 680I[,$>U
M(029D@V/4 ,K< :!  O)4 RO  <,L#/6_X #F7$-<F #R:$VP3,0:" #W[ ,
MS' *CH "-T *V( "EO %,4 +MKE%O<,:*,!: _:?QG5&EI-2 Y$,*1!8"L$(
M*Q +5J !7O *I. )BG #&4 !)5D0?" #,6 5-S,+M' -08 #7< #,L %(@ ,
M$,4,8= 'X$$+%X "W> IS  *A_ */1@1=\ $XV VS- #9;!#VI +@) "1+
M-; #;C". B$(&" &*X "O[5"2=$-:4 !%& #*/ &G^ IA>  02!_%%$*.T #
MB( +2C<2?'!>">$2?S "3Q<*,G !.]  +] %*- &!Z$'/K *!!8&V-(,<: "
MD- -V+ #P2 0VO\0 UZPIL^#"S[0  _@  _  F)P"MH@6"?0!))D##'@ ER7
M%-ZP#:VP"]C!0(4P XU /^[B$M. "I;@"M  $]GP B$ H[)(5I]@!3G0 #U
M!;&P"JI0#$S%+E<0":J +0C1=,)"$,C #/+B!USPG]T0!,[B*=G0!;3PB@(1
M#45 "^70"4-0!GKF>RYQ#:%P"8'@"<R:4!'A!$] #B:I!31PCR/Q.^40"P7@
M//YI4MMH"J(0"&IP!E=P!3O2!;F KQF1#6<@"K:0J@6Q##)@2 I!""]0,Z3
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M"/"A."B+_UJ@XT40G[ (?8 #^L,3R* -Q"!AK' )D# (NB")'W8 W#(0?_
MZK*K\OL2\WM"U+ 'HP #J6447@4.*5 ) F$*:[ #F* 9W.43PD *I4 )+N Q
M6.$)*X #+G !9:"V65%OR?LQMK +KA $03;#,2$,I] (BF"1A@&O0 $.:' *
M;; B#/S 2MP1MG #-! &Y[K$4MP1D<  :O"T4YS%&C$+L7"46OS%8!S&8CS&
'9*P2 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979626548848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Aug. 05, 2024</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--04-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Red
Cat Holdings, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000748268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-0490034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">15 Ave. Munoz Rivera<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Ste 2200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Juan<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">PR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">00901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(833)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">373-3228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    stock, par value $0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RCAT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,844,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,600,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">3501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">dbbmckennon<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Newport
Beach, California<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979625389600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 6,067,169<span></span>
</td>
<td class="nump">$ 3,173,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">12,814,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">4,361,090<span></span>
</td>
<td class="nump">719,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">8,007,237<span></span>
</td>
<td class="nump">8,920,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other</a></td>
<td class="nump">3,962,053<span></span>
</td>
<td class="nump">1,263,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current assets of discontinued operations</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,283,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">22,397,549<span></span>
</td>
<td class="nump">32,175,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,088,550<span></span>
</td>
<td class="nump">17,012,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">3,794,389<span></span>
</td>
<td class="nump">6,893,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investee</a></td>
<td class="nump">5,142,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent', window );">Note receivable</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">2,340,684<span></span>
</td>
<td class="nump">2,650,358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other</a></td>
<td class="nump">293,126<span></span>
</td>
<td class="nump">303,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,480,814<span></span>
</td>
<td class="nump">1,600,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Long-term assets of discontinued operations</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">108,397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total long-term assets</a></td>
<td class="nump">26,140,063<span></span>
</td>
<td class="nump">28,568,316<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">48,537,612<span></span>
</td>
<td class="nump">60,743,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,580,422<span></span>
</td>
<td class="nump">1,392,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">1,069,561<span></span>
</td>
<td class="nump">409,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Debt obligations - short term</a></td>
<td class="nump">751,570<span></span>
</td>
<td class="nump">922,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Customer deposits</a></td>
<td class="nump">53,939<span></span>
</td>
<td class="nump">155,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">195,638<span></span>
</td>
<td class="nump">159,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current liabilities of discontinued operations</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,010,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,651,130<span></span>
</td>
<td class="nump">4,050,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">1,321,952<span></span>
</td>
<td class="nump">1,481,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Debt obligations - long term</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">401,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities', window );">Long-term liabilities of discontinued operations</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">41,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">1,321,952<span></span>
</td>
<td class="nump">1,925,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_PreferredStockValueSeriesB', window );">Series B preferred stock - shares authorized 4,300,000; issued and outstanding 4,676 and 986,676</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">9,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock - shares authorized 500,000,000; issued and outstanding 74,289,351 and 54,568,065</a></td>
<td class="nump">74,289<span></span>
</td>
<td class="nump">54,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">124,616,305<span></span>
</td>
<td class="nump">112,642,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(81,130,732)<span></span>
</td>
<td class="num">(57,078,103)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">4,621<span></span>
</td>
<td class="num">(861,117)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">43,564,530<span></span>
</td>
<td class="nump">54,767,941<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 48,537,612<span></span>
</td>
<td class="nump">$ 60,743,328<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_PreferredStockValueSeriesB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_PreferredStockValueSeriesB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as noncurrent. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619269264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - shares<br></strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">74,289,351<span></span>
</td>
<td class="nump">54,568,065<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">4,676<span></span>
</td>
<td class="nump">986,676<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979625083536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 17,836,382<span></span>
</td>
<td class="nump">$ 4,620,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">14,155,836<span></span>
</td>
<td class="nump">5,455,145<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit (loss)</a></td>
<td class="nump">3,680,546<span></span>
</td>
<td class="num">(834,311)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">5,896,037<span></span>
</td>
<td class="nump">5,595,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Sales and marketing</a></td>
<td class="nump">4,568,617<span></span>
</td>
<td class="nump">3,731,776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">10,679,105<span></span>
</td>
<td class="nump">12,383,470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment loss</a></td>
<td class="nump">412,999<span></span>
</td>
<td class="nump">2,826,918<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">21,556,758<span></span>
</td>
<td class="nump">24,537,445<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Operating loss</a></td>
<td class="num">(17,876,212)<span></span>
</td>
<td class="num">(25,371,756)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other (income) expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities', window );">Gain on divestiture of consumer segment</a></td>
<td class="num">(9,642,427)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment on equity method investment</a></td>
<td class="nump">11,353,875<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Equity method loss</a></td>
<td class="nump">503,625<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment loss (income), net</a></td>
<td class="nump">651,943<span></span>
</td>
<td class="num">(82,798)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">68,609<span></span>
</td>
<td class="nump">122,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonrecurringIncomeExpense', window );">Other, net</a></td>
<td class="nump">714,859<span></span>
</td>
<td class="nump">965,681<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense</a></td>
<td class="nump">3,650,484<span></span>
</td>
<td class="nump">1,004,887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Net loss from continuing operations</a></td>
<td class="num">(21,526,696)<span></span>
</td>
<td class="num">(26,376,643)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="num">(2,525,933)<span></span>
</td>
<td class="num">(1,730,386)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (24,052,629)<span></span>
</td>
<td class="num">$ (28,107,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_EarningsPerShareBasicAndDilutedRCATAbstract', window );"><strong>Loss per share - basic and diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT', window );">Continuing operations</a></td>
<td class="num">$ (0.36)<span></span>
</td>
<td class="num">$ (0.49)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT', window );">Discontinued operations</a></td>
<td class="num">(0.04)<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_EarningsPerShareBasicAndDilutedRCAT', window );">Loss per share - basic and diluted</a></td>
<td class="num">$ (0.40)<span></span>
</td>
<td class="num">$ (0.52)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT', window );">Weighted average shares outstanding - basic and diluted</a></td>
<td class="nump">60,118,675<span></span>
</td>
<td class="nump">53,860,199<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_EarningsPerShareBasicAndDilutedRCAT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_EarningsPerShareBasicAndDilutedRCAT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_EarningsPerShareBasicAndDilutedRCATAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_EarningsPerShareBasicAndDilutedRCATAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482551/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the net carrying value of derivative instruments reported as assets and liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonrecurringIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) that is infrequent in occurrence or unusual in nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483613/220-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonrecurringIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979625403696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Series B Preferred Stock 1 [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances, April 30, 2022, as restated at Apr. 30, 2022</a></td>
<td class="nump">$ 9,867<span></span>
</td>
<td class="nump">$ 53,749<span></span>
</td>
<td class="nump">$ 109,471,010<span></span>
</td>
<td class="num">$ (28,971,074)<span></span>
</td>
<td class="num">$ (1,470,272)<span></span>
</td>
<td class="nump">$ 79,093,280<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding, Beginning Balance at Apr. 30, 2022</a></td>
<td class="nump">986,676<span></span>
</td>
<td class="nump">53,748,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,656,724<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,656,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 779<span></span>
</td>
<td class="num">(523,606)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(522,827)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Restricted Stock, Shares Issued Net of Shares for Tax Withholdings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">779,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Shares issued for services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">38,598<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">38,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gain on marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">610,129<span></span>
</td>
<td class="nump">610,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Currency translation adjustments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(974)<span></span>
</td>
<td class="num">(974)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(28,107,029)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(28,107,029)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Apr. 30, 2023</a></td>
<td class="nump">$ 9,867<span></span>
</td>
<td class="nump">$ 54,568<span></span>
</td>
<td class="nump">112,642,726<span></span>
</td>
<td class="num">(57,078,103)<span></span>
</td>
<td class="num">(861,117)<span></span>
</td>
<td class="nump">54,767,941<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding, Ending Balance at Apr. 30, 2023</a></td>
<td class="nump">986,676<span></span>
</td>
<td class="nump">54,568,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,609,267<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,609,267<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 447<span></span>
</td>
<td class="num">(33,701)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(33,254)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Restricted Stock, Shares Issued Net of Shares for Tax Withholdings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gain on marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">864,165<span></span>
</td>
<td class="nump">864,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Currency translation adjustments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,573<span></span>
</td>
<td class="nump">1,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(24,052,629)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(24,052,629)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock</a></td>
<td class="num">$ (9,820)<span></span>
</td>
<td class="nump">$ 818<span></span>
</td>
<td class="nump">9,002<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock Issued During Period, Shares, Conversion of Convertible Securities</a></td>
<td class="num">(982,000)<span></span>
</td>
<td class="nump">818,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockIssuedDuringPeriodValueThroughATMFacility', window );">Issuance of common stock through ATM facility, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">9,159<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockSharesIssuedNetThroughATMFacility', window );">[custom:StockSharesIssuedNetThroughATMFacility]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">2,652<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Public offering, net of $804,400 of issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 18,400<span></span>
</td>
<td class="nump">8,377,200<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,395,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Apr. 30, 2024</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 74,289<span></span>
</td>
<td class="nump">$ 124,616,305<span></span>
</td>
<td class="num">$ (81,130,732)<span></span>
</td>
<td class="nump">$ 4,621<span></span>
</td>
<td class="nump">$ 43,564,530<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding, Ending Balance at Apr. 30, 2024</a></td>
<td class="nump">4,676<span></span>
</td>
<td class="nump">74,289,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockIssuedDuringPeriodValueThroughATMFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockIssuedDuringPeriodValueThroughATMFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockSharesIssuedNetThroughATMFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockSharesIssuedNetThroughATMFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627432784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Parenthetical)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of Stock Issuance Costs</a></td>
<td class="nump">$ 804,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979622737552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (24,052,629)<span></span>
</td>
<td class="num">$ (28,107,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IncomeLossFromDiscontinuedOperations', window );">Net loss from discontinued operations</a></td>
<td class="num">(2,525,933)<span></span>
</td>
<td class="num">(1,730,386)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net loss from continuing operations</a></td>
<td class="num">(21,526,696)<span></span>
</td>
<td class="num">(26,376,643)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash from operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Stock based compensation - options</a></td>
<td class="nump">2,619,501<span></span>
</td>
<td class="nump">1,617,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1', window );">Stock based compensation - restricted units</a></td>
<td class="nump">989,766<span></span>
</td>
<td class="nump">2,038,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Common stock issued for services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">38,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">854,311<span></span>
</td>
<td class="nump">654,527<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesGainLoss', window );">Realized loss from sale of marketable securities</a></td>
<td class="nump">851,986<span></span>
</td>
<td class="nump">296,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">568,813<span></span>
</td>
<td class="nump">311,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDerivativeLiabilities', window );">Gain on divestiture of consumer segment</a></td>
<td class="num">(9,642,427)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment on equity method investment</a></td>
<td class="nump">11,353,875<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Equity method loss</a></td>
<td class="nump">503,625<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment on goodwill and intangible assets</a></td>
<td class="nump">412,999<span></span>
</td>
<td class="nump">2,826,918<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in operating assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(3,641,228)<span></span>
</td>
<td class="num">(288,986)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">913,336<span></span>
</td>
<td class="num">(5,707,525)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other</a></td>
<td class="num">(2,688,264)<span></span>
</td>
<td class="nump">559,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities', window );">Operating lease right-of-use assets and liabilities</a></td>
<td class="num">(4,180)<span></span>
</td>
<td class="nump">25,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Customer deposits</a></td>
<td class="num">(102,047)<span></span>
</td>
<td class="num">(136,628)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">187,872<span></span>
</td>
<td class="nump">434,803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">661,695<span></span>
</td>
<td class="num">(608,452)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operating activities of continuing operations</a></td>
<td class="num">(17,687,063)<span></span>
</td>
<td class="num">(24,313,674)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of consumer segment</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchases of property and equipment</a></td>
<td class="num">(259,139)<span></span>
</td>
<td class="num">(2,450,213)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sale of marketable securities</a></td>
<td class="nump">12,826,217<span></span>
</td>
<td class="nump">32,290,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAssetsInvestingActivities', window );">Investment in SAFE agreement</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(250,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash provided by investing activities of continuing operations</a></td>
<td class="nump">13,567,078<span></span>
</td>
<td class="nump">29,590,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ProceedsFromIssuanceOfCommonStockPublicOffering', window );">Public offering, net</a></td>
<td class="nump">8,395,600<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ProceedsFromIssuanceOfCommonStockATMFacilityNet', window );">ATM facility, net</a></td>
<td class="nump">9,212<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payments under debt obligations</a></td>
<td class="num">(572,137)<span></span>
</td>
<td class="num">(606,897)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_PaymentsOfTaxesRelatedToEquityTransactions', window );">Payments of taxes related to equity transactions</a></td>
<td class="num">(33,254)<span></span>
</td>
<td class="num">(581,775)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">2,655<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party obligations</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">13,404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments under related party obligations</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(40,057)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net cash provided by (used in) financing activities of continuing operations</a></td>
<td class="nump">7,802,076<span></span>
</td>
<td class="num">(1,215,325)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract', window );"><strong>Discontinued operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Operating activities</a></td>
<td class="num">(875,227)<span></span>
</td>
<td class="num">(4,885,746)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations', window );">Investing activities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations', window );">Financing activities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations', window );">Net cash used in discontinued operations</a></td>
<td class="num">(875,227)<span></span>
</td>
<td class="num">(4,885,746)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in Cash</a></td>
<td class="nump">2,806,864<span></span>
</td>
<td class="num">(824,510)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations', window );">Cash, beginning of period</a></td>
<td class="nump">3,260,305<span></span>
</td>
<td class="nump">4,084,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations', window );">Cash, end of period</a></td>
<td class="nump">6,067,169<span></span>
</td>
<td class="nump">3,260,305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash', window );">Less: Cash of discontinued operations</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(86,656)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash of continuing operations, end of period</a></td>
<td class="nump">6,067,169<span></span>
</td>
<td class="nump">3,173,649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">70,177<span></span>
</td>
<td class="nump">122,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1', window );">Equity method investment from divestiture of consumer segment</a></td>
<td class="nump">17,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NoncashOrPartNoncashDivestitureNoteReceivable', window );">Note receivable from divestiture of consumer segment</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent', window );">Unrealized gain on marketable securities</a></td>
<td class="nump">864,165<span></span>
</td>
<td class="nump">610,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ConversionOfPreferredStockIntoCommonStock', window );">Conversion of preferred stock into common stock</a></td>
<td class="nump">9,820<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FairValueOfSharesWithheldAsPaymentOfNoteReceivable', window );">Shares withheld as payment of note receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">18,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_TaxesRelatedToNetShareSettlementOfEquityAwards', window );">Taxes related to net share settlement of equity awards</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 32,468<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ConversionOfPreferredStockIntoCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ConversionOfPreferredStockIntoCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FairValueOfSharesWithheldAsPaymentOfNoteReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FairValueOfSharesWithheldAsPaymentOfNoteReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_IncomeLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_IncomeLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NoncashOrPartNoncashDivestitureNoteReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NoncashOrPartNoncashDivestitureNoteReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_PaymentsOfTaxesRelatedToEquityTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_PaymentsOfTaxesRelatedToEquityTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ProceedsFromIssuanceOfCommonStockATMFacilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ProceedsFromIssuanceOfCommonStockATMFacilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ProceedsFromIssuanceOfCommonStockPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ProceedsFromIssuanceOfCommonStockPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_TaxesRelatedToNetShareSettlementOfEquityAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_TaxesRelatedToNetShareSettlementOfEquityAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the entity and the disposal group, cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand, demand deposits with banks or financial institutions, and other kinds of accounts that have the general characteristics of demand deposits, held by a disposal group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-18<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in cash associated with the entity's discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAssetsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash payments for a combination of transactions that are classified as investing activities in which assets, which may include securities, other types of investments, or productive assets, are purchased from third-party sellers. This element can be used by entities to aggregate payments for all asset purchases that are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAssetsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979725829056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 &#8211; The Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Note 1 &#8211; The Business</a></td>
<td class="text"><p id="xdx_806_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zltuPOrpHefe" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_820_zyNUDVPUESx7">Note 1 &#8211; The Business</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company was originally incorporated in February
1984. Since April 2016, the Company&#8217;s primary business has been to provide products, services, and solutions to the drone industry
which it presently does through its wholly owned operating subsidiaries. Beginning in January 2020, the Company expanded the scope
of its drone products and services through four acquisitions, including:&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">A.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">In January 2020, the Company acquired Rotor Riot, a provider of First Person View (&#8220;FPV&#8221;) drones and equipment, primarily to consumers. The purchase price was $<span id="xdx_905_eus-gaap--BusinessCombinationConsiderationTransferred1_c20190501__20200430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition1Member_zpwsbSsI3RSb">1,995,114</span>.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">B.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">In November 2020, the Company acquired Fat Shark Holdings (&#8220;Fat Shark&#8221;), a provider of FPV video goggles to the&#160;drone industry. The purchase price was $<span id="xdx_902_eus-gaap--BusinessCombinationConsiderationTransferred1_c20200501__20210430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition2Member_zAFKmFlHEGj6">8,354,076</span>.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;<span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">C.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">In May 2021, the Company acquired Skypersonic which provided hardware and software solutions that enable drones to complete inspection services in locations where GPS is either denied or not available, yet still record and transmit data even while being operated from thousands of miles away. The purchase price was $<span id="xdx_90B_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition3Member_zOaBBegpRDD">2,791,012</span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">D.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">In August 2021, the Company acquired Teal Drones (&#8220;Teal&#8221;), a leader in commercial and government Unmanned Aerial Vehicles (&#8220;UAV&#8221;) technology.&#160;The purchase price was $<span id="xdx_90C_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition4Member_z4CsCK87WY23">10,011,279</span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Following the Teal acquisition
in August 2021, we concentrated on integrating and organizing these businesses. Effective May 1, 2022, we established the Enterprise segment
(&#8220;Enterprise&#8221;) and the Consumer segment (&#8220;Consumer&#8221;) to focus on the unique opportunities in each sector. Enterprise's
initial strategy was to provide UAVs to commercial enterprises, and the military, to navigate dangerous military environments and confined
industrial and commercial interior spaces. Subsequently, Enterprise narrowed its near-term attention on the military and other government
agencies. Skypersonic's technology has been redirected to military applications and its operations consolidated into Teal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">On December 11, 2023,
the Company completed a firm commitment underwritten public offering with ThinkEquity of <span id="xdx_909_ecustom--FirmCommitmentUnderwrittenPublicOfferingShares_c20230501__20240430_zSG6z2QSN606">18,400,000</span> shares of common stock which generated
gross proceeds of $<span id="xdx_909_ecustom--FirmCommitmentUnderwrittenPublicOfferingGrossProceeds_c20230501__20240430_z4eh6TKg5mMe">9,200,000</span> and net proceeds of approximately $<span id="xdx_901_ecustom--FirmCommitmentUnderwrittenPublicOfferingNetProceeds_c20230501__20240430_zU9OJaE6rpsd">8,400,000</span>.</span><span style="font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">On February 16, 2024</span><span style="font-size: 8pt"></span><span style="font-size: 10pt">,
we closed the sale of our Consumer segment, consisting of Rotor Riot and Fat Shark, to Unusual Machines. The sale reflects the Company's
decision to focus its efforts and capital on defense where it believes that there are more opportunities to create long term shareholder
value. See Note 3 and Note 9.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627360320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 &#8211; Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Note 2 &#8211; Summary of Significant Accounting Policies</a></td>
<td class="text"><p id="xdx_803_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zwwPn4Q2x3yc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_828_zMckm5OJyIie">Note 2 &#8211; Summary of Significant Accounting
Policies</span></b></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zcACN2x0a8Jg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86F_zWm6aVzxMiw7">Basis of Accounting</span> </b>&#8211; The financial statements
and accompanying notes are prepared in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;).
Certain prior period amounts have been restated to conform to the current year presentation.</p>

<p id="xdx_856_zjhcB2lVPwf6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84D_ecustom--RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock_zdZxPdSJcoK8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_869_zUpKgUyCkTh4">Restatement of Previously Issued Consolidated Financial Statements</span> </b>&#8211;
The Company&#8217;s Consolidated Balance Sheet as of April 30, 2023, Consolidated Statement of Operations, Stockholders&#8217; Equity
and Cash Flows for the year then ended, and its Notes to the Consolidated Financial Statements for the year ended April 30, 2023, which
were originally filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on July 27, 2023 (the &#8220;Original Form
10-K&#8221;), have been restated. The Company revised its accounting estimate of the life of an operating lease that was previously reported
in its Original Form 10-K. Upon further evaluation, the Company determined that prior year adjustments were necessary. These Consolidated
Financial Statements were restated to reflect a change in accounting estimate of the life of the operating lease under FASB ASC Topic
842 from three to nine years. Additionally, the Company revised its financial statements to&#160;remove derivative liabilities due to
erroneously reporting warrants from our convertible note financings, as described in Note 18, as having a derivative component.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The impacts of these restatements are detailed
in the tables below:</p>

<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_z37Q9DXaN6uh" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49B_20230430__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zSBEY5ZMCnF2">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49A_20230430__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zJcotfhJMGR4">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_494_20230430__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zE2BMOTeUBXc">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Consolidated Balance Sheet</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of April 30, 2023</b></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Originally</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Reported</b></p></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Restated</b></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Change</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zEXj3ClQpUhe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Operating lease right-of-use assets</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">620,307</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">1,600,434</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">980,127</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsNoncurrent_iI_zYu0GCBj0U15" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total long-term assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">28,018,078</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">28,568,316</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">550,238</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--OperatingLeaseLiabilityCurrentRestatementImpact_iI_zV5Lsmzs6zX9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Operating lease liabilities, current</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">281,797</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">159,423</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(122,374</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--DerivativeLiabilitiesCurrent_iI_zxK5uK4Xu5t7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Warrant derivative liability</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">588,205</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0601">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(588,205</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_406_ecustom--LiabilitiesCurrentRestatementImpact_iI_zcX5gpj013m1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total current liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,760,616</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,050,037</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(710,579</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zAZyNo5AY9uj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Operating lease liabilities, long-term</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">379,466</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,481,967</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,102,501</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesNoncurrent_iI_zeRaeufH1G8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total long-term liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">822,849</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,925,350</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,102,501</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AdditionalPaidInCapital_iI_zmMRlkMLIJZj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Additional paid-in capital</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">109,993,100</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">112,642,726</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,649,626</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zz9tAYWDUSnc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Accumulated deficit</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(54,586,793</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(57,078,103</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(2,491,310</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--StockholdersEquityRestatement_iI_z1d3aGID1Wt2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total shareholders&#8217; equity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">54,609,625</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">54,767,941</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">158,316</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_z7xYP0md9CXe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total liabilities and stockholders&#8217; equity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">60,193,090</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">60,743,328</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">550,238</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49A_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zCkwzAt0N4Gl">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49B_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zXWdYMkcEnHd">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49C_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zmsSZnt9OMe3">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Consolidated Statement of Operations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the year ended April 30, 2023</b></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Originally</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Reported</b></p></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Restated</b></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Change</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInDerivativeAssetsAndLiabilities_zPjADrAsg60l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Change in fair value of derivative liability</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">(1,019,292</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0633">&#8212;</span>&#160;&#160;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">1,019,292</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zNvjvy3NUWNc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Net loss</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(27,087,737</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(28,107,029</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(1,019,292</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A0_zjYLGJLijuGc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Amounts
presented as originally reported as of April 30, 2023 are exclusive of Discontinued Operations with the exception of (i) change in fair
value of derivative liability, (ii) net loss, and (iii) Consolidated Balance Sheet totals. The Consolidated Statement of Cash Flows is
not presented above as there was no change in net cash used in operating activities of continuing operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b></b></p>

<p id="xdx_857_z2bELDmieZlc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zkZvGA0mBHSh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><span id="xdx_863_zyRmJgruZNZd">Principles of Consolidation</span></b>
&#8211; <span style="background-color: white">Our consolidated financial statements include the accounts of our wholly owned subsidiaries
which include Teal and Skypersonic as well as Rotor Riot and Fat Shark which were sold on February 16, 2024. Non-majority owned investments,
including the formerly wholly owned subsidiaries Rotor Riot and Fat Shark, are accounted for using the equity method when the Company
is able to significantly influence the operating policies of the investee. Intercompany transactions and balances have been eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
Consumer segment businesses are characterized as discontinued operations in these financial statements.&#160; The operating results and
cash flows of discontinued operations are separately stated in those respective financial statements. See Note 3. </span></p>
<p id="xdx_851_zCQiBK40AJg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_842_eus-gaap--UseOfEstimates_zqrdyK4RO69i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86A_zBAJUmoHd7A7">Use of Estimates</span></b> &#8211;<span style="background-color: white">&#160;The
preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the
reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates
reflected in these financial statements include those used to (i) complete purchase price accounting for acquisitions,  (ii) the evaluation of long-term assets, including goodwill, for impairment,
and (iii) the evaluation of other-than-temporary-impairment of equity method investments.</span></p>

<p id="xdx_85B_z3oVXhzOnpVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zSCZZ1XMQgNj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86F_zWXrT1PWaWk1">Cash and Cash Equivalents</span> </b>&#8211; At April
30, 2024, we had cash of $<span id="xdx_90D_eus-gaap--Cash_iI_c20240430_zDhCfMNsSqrd">6,067,169</span> in multiple commercial banks and financial services companies. We have not experienced any loss on
these cash balances and believe they are not exposed to any significant credit risk.</p>

<p id="xdx_859_zI5S9I5ZzCok" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



<p id="xdx_843_eus-gaap--MarketableSecuritiesPolicy_zPBL5OWH1NVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span><span id="xdx_862_zEb69Umoc0T3">Marketable Securities</span></span> </b>&#8211; Our marketable
securities were classified and accounted for as available-for-sale securities. These securities were primarily invested in corporate bonds
and were readily saleable, and therefore, we have classified them as short term. Our available-for-sale securities were carried at fair
value with any unrealized gains and losses reported as a component of comprehensive income (loss). Once realized, any gains or losses
were recognized in the statement of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have elected to present accrued interest income
separately from marketable securities on our consolidated balance sheets. Accrued interest income was $<span id="xdx_90D_eus-gaap--InterestAndDividendIncomeSecuritiesOther_c20230501__20240430_z3s3egVeqBJl">0</span> and $<span id="xdx_908_eus-gaap--InterestAndDividendIncomeSecuritiesOther_c20220501__20230430_zmYMfQrnKUk7">151,671</span> as of April 30,
2024 and April 30, 2023, respectively, and was included in other current assets. We did not write off any accrued interest income during
the years ended April 30, 2024 and April 30, 2023.</p>

<p id="xdx_85B_znwQguNJh3Ze" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84C_eus-gaap--ReceivablesPolicyTextBlock_zzUwQf7dHQS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_864_zoZnjrvVWqQ9">Accounts Receivable, net</span></b> &#8211; <span style="background-color: white">Accounts
receivable are recorded at the invoiced amount less allowances for doubtful accounts. The Company's estimate of the allowance for doubtful
accounts is based on a multitude of factors, including historical bad debt levels for its customer base, experience with a specific customer,
the economic environment, and other factors. Accounts receivable balances are written off against the allowance when it is probable that
the receivable will not be collected.</span></p>

<p id="xdx_851_zqj2otVRpYqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zoW6JvszIsA6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zie9xKVIAR93">Concentration
of Credit Risk</span> </b>&#8211; Financial instruments, which potentially subject the Company to concentrations of credit risk, include
trade receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company
performs ongoing credit evaluations of its customers, generally does not require collateral and considers the credit risk profile of
the customer from which the receivable is due in further evaluating collection risk. Customers that accounted for 10% or greater of
accounts receivable, net as of April&#160;30, 2024 and 2023 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQaKUgLgYhkf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Customer concentration risk (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">April 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left">Customer A</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zCN9cNhwol9i" style="width: 12%; text-align: right">53</td><td style="width: 1%; text-align: left">%</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zElcIGrV5OD2" style="width: 12%; text-align: right">20</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zT9MUrfmoD3g" style="text-align: right">24</td><td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer C</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk3Member_zfSzRhphaKsh" style="text-align: right">24</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer D</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk4Member_zLX4OaDIWoh6" style="text-align: right">14</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer E</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk5Member_zCjPkuR5tOIc" style="text-align: right">10</td><td style="text-align: left">%</td></tr>
  </table>


<p id="xdx_8A9_zdZqixz5godd" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">* Accounts Receivable was less than 10%</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">As of April 30, 2024, three customers accounted for equal to or greater
than 10% of total revenue, totaling 28%, 23% and 10%, respectively. As of April 30, 2023, two customers accounted for equal to or greater
than 10% of total revenue, totaling 22% and 20%, respectively.</p>

<p id="xdx_857_z9LQfsPL8mb7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zxgsdOPYKXS2" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86A_zzZlSG6nNFdj" style="font-size: 10pt"><b>Inventories</b></span><span style="font-size: 10pt">&#160;&#8211;&#160;<span style="background-color: white">Inventories,
which consist of raw materials, work-in-process, and finished goods, are stated at the lower of cost or net realizable value, and
are measured using the first-in, first-out method. Cost components include direct materials, direct labor, indirect overhead, as
well as in-bound freight. At each balance sheet date, the Company evaluates the net realizable value of its inventory using various
reference measures including current product selling prices and recent customer demand, as well as evaluating for excess quantities
and obsolescence.</span></span></p>

<p id="xdx_85C_zT5l4QmkQWUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zkY1ypyaw2r9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><span id="xdx_866_zZii5SDJXWqk">Goodwill and Long-lived
Assets</span></b> &#8211; Goodwill represents the future economic benefit arising from other assets acquired in an acquisition&#160;that are
not individually identified and separately recognized. We test goodwill for impairment in accordance with the provisions of&#160;<i>ASC
350, Intangibles &#8211; Goodwill and Other,&#160;</i>(&#8220;ASC 350&#8221;). Goodwill is tested for impairment at least annually at
the reporting unit level or whenever events or changes in circumstances indicate that goodwill might be impaired. ASC 350 provides that
an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a
determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing
the totality of events or circumstances, an entity determines it is not more likely than not that the fair value of a reporting unit
is less than its carrying amount, then additional impairment testing is not required. However, if an entity concludes otherwise, then
it is required to perform an impairment test. The impairment test involves comparing the estimated fair value of a reporting unit with
its book value, including goodwill. If the estimated fair value exceeds book value, goodwill is considered not to be impaired. If, however,
the fair value of the reporting unit is less than book value, then an impairment loss is recognized in an amount equal to the amount
that the book value of the reporting unit exceeds its fair value, not to exceed the total amount of goodwill allocated to the reporting
unit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The estimate of fair value
of a reporting unit is computed using either an income approach, a market approach, or a combination of both. Under the income approach,
we utilize the discounted cash flow method to estimate the fair value of a reporting unit. Significant assumptions inherent in estimating
the fair values include the estimated future cash flows, growth assumptions for future revenues (including gross profit, operating expenses,
and capital expenditures), and a rate used to discount estimated future cash flow projections to their present value based on estimated
weighted average cost of capital (i.e., the selected discount rate). Our assumptions are based on historical data, supplemented by current
and anticipated market conditions, estimated growth rates, and management&#8217;s plans. Under the market approach, fair value is derived
from metrics of publicly traded companies or historically completed transactions of comparable businesses. The selection of comparable
businesses is based on the markets in which the reporting units operate and consider risk profiles, size, geography, and diversity of
products and services.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Goodwill for Teal is ascribed
to its existing relationship with several U.S. government agencies including its classification as an approved vendor. The Company expects
that the Goodwill recognized in each transaction will be deductible for tax purposes.&#160; The Company has reported net losses since
its inception and is presently unable to determine when and if the tax benefit of this deduction will be realized.</p>

<p id="xdx_85F_zg8gIXVmqzQb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zlK9paOcqBP1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zCZchCcWsyZd">Property and equipment</span> &#8211; </b><span style="background-color: white">Property
and equipment is stated at cost less accumulated depreciation which is calculated using the straight-line method over the estimated useful
life of the asset. The estimated useful lives of our property and equipment are generally: (i) furniture and fixtures - seven years,
(ii) equipment and related - two to five years, and (iii) leasehold improvements &#8211; nine to fifteen years.</span></p>

<p id="xdx_857_z8gVcBYGcbW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_843_eus-gaap--EquityMethodInvestmentsPolicy_zRNYqmezB3t2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86C_z3SozqVYzUWe">Equity Method Investment</span> &#8211; </b><span style="background-color: white">The
equity method of accounting is applied to investments in which the Company has an ownership interest of between 20% and 50%. The Company
evaluates its equity method investments each reporting period for evidence of a loss in value that is other than a temporary decline.
Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount
of the investment or the inability of the investee to sustain an earnings capacity that would justify the carrying amount of the investment.
The Company performed this analysis and concluded that its investment in UMAC was other-than-temporarily impaired and recognized an impairment
charge of $<span id="xdx_906_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_c20230501__20240430_zLjRlyQIuHVk">11,353,875</span> for the year ended April&#160;30, 2024.</span></p>

<p id="xdx_857_zy7AdKmGwC28" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84D_eus-gaap--RevenueRecognitionLeasesOperating_zwjyPe10sMh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86C_zahzqreQGjDg">Leases</span> &#8211; </b>Accounting Standards Codification
(ASC) 842 requires the recognition of assets and liabilities associated with lease agreements. <span style="background-color: white">The
Company determines if a contract is a lease or contains a lease at inception. Operating lease liabilities are measured, on each reporting
date, based on the present value of the future minimum lease payments over the remaining lease term. The Company's leases do not provide
an implicit rate.&#160;Therefore, the Company uses an effective discount rate of 12% based on its last debt financing.&#160;Operating
lease assets are measured by adjusting the lease liability for lease incentives, initial direct costs incurred and asset impairments.
Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term with the operating lease asset reduced
by the amount of the expense. Lease terms may include options to extend or terminate a lease when they are reasonably certain to occur.</span></p>

<p id="xdx_856_z8yK5E1mh1Ec" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zEG4RIQjII5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_860_zhrT8UDCrKS">Fair Values, Inputs and Valuation Techniques for
Financial Assets and Liabilities, and Related Disclosures</span></b> &#8211; The fair value measurements and disclosure guidance defines fair
value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset
or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. In accordance
with this guidance, the Company has categorized its recurring basis financial assets and liabilities into a three-level fair value hierarchy
based on the priority of the inputs to the valuation technique.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value hierarchy gives the highest priority
to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level
3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the
fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input
that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input
to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The guidance establishes
three levels of the fair value hierarchy as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><i>Level 1</i>:
Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><i>Level 2</i>:
Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical
or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable
market data for substantially the full term of the related assets or liabilities; and</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><i>Level 3</i>:
Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little
or no market data.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Disclosures for Non-Financial Assets Measured at
Fair Value on a Non-Recurring Basis</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's financial instruments mainly consist
of cash, receivables, current assets, accounts payable, accrued expenses and debt. The carrying amounts of these instruments approximates
fair value due to their short-term nature.</p>

<p id="xdx_85E_zCKWxkzpA9Ml" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p id="xdx_843_eus-gaap--RevenueRecognitionPolicyTextBlock_zU59Ys8Odozl" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86C_zxp8L7adoPgg">Revenue Recognition</span> </b>&#8211; The Company
recognizes revenue in accordance with ASC Topic 606 - Revenue from Contracts with Customers, issued by the Financial Accounting Standards
Board (&#8220;FASB&#8221;). This standard includes a comprehensive evaluation of factors to be considered regarding revenue recognition
including (i) identifying the promised goods, (ii) evaluating performance obligations, (iii) measuring the transaction price, (iv) allocating
the transaction price to the performance obligations if there are multiple components, and (v) recognizing revenue as each obligation
is satisfied.&#160;The Company&#8217;s revenue transactions include the shipment of goods to customers as orders are fulfilled, completion
of non-recurring engineering, completion of training, and customer support services. The Company recognizes revenue upon shipment of product
or prototypes unless otherwise specified in the purchase order or contract. Customer deposits totaled $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240430_zTRmOLvQ36X4">53,939</span> and $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20230430_zUyPr8922sC6">155,986</span> at April 30,
2024 and April 30, 2023, respectively. From time to time, non-recurring engineering contracts may involve the capitalization of engineering
prototypes, classified as contract assets. Contract assets totaled $<span id="xdx_907_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20240430_zhdr7vv0kb34">1,477,859</span> and $<span id="xdx_907_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20230430_zIBr7xEVQFj3">0</span> at April 30, 2024 and April 30, 2023, respectively.</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the Company&#8217;s
revenue disaggregated by revenue type:</p>

<table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_zet5crVfizG" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Company's revenue disaggregated by revenue type (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" id="xdx_497_20230501__20240430_zMjAJJjOleO3" style="font-size: 10pt; font-weight: bold; text-align: center"></td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" id="xdx_499_20220501__20230430_zmPFbgIgRww1" style="font-size: 10pt; font-weight: bold; text-align: center"></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Year Ended&#160;April 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">2023</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zdwJLPvW4QR9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-size: 10pt; text-align: left">Contract related</td><td style="width: 8%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">4,173,005</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 8%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">1,312,427</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomer_zm0HlgsW7Fbk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Product related</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">13,663,377</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,308,407</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Revenues_zPnw8zXZaaAd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">17,836,382</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,620,834</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A9_zKDDmRXWSIx6" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 5pt">&#160;</span></p>

<p id="xdx_854_zGLhvXkLfpFa" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 5pt">&#160;</span></p>

<p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_z92tZr6bcLMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_zlvGi8T6cAC7">Research and Development</span> </b>&#8211; Research and
development expenses include payroll, employee benefits, and other headcount-related expenses associated with product development. Research
and development expenses also include third-party development and programming costs, materials, and a proportionate share of overhead
costs such as rent.</p>

<p id="xdx_854_zO2c0Kh2SYg6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_846_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zrulqYFkDsq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zT5ZW2pySwOe">Product
Warranty</span> - </b>The Company accrues an estimate of its exposure to warranty claims based upon both current and historical
product sales data and warranty costs incurred. Product warranty reserves are recorded in current liabilities under accrued
expenses.&#160;Warranty liability was $<span id="xdx_90D_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240430_zkpemxJKlCd5">372,000</span>
and $<span id="xdx_90A_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20230430_zNpyM4tHDtmk">90,000</span> as of April 30, 2024
and April 30, 2023 respectively.</p>

<p id="xdx_858_zaPoXhhgw6Ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zRkFoxX8Urv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_867_zhFDWVR5zHo1">Income Taxes</span></b> &#8211; Deferred taxes are provided
on the liability method whereby deferred tax assets are recognized for deductible temporary differences and deferred tax liabilities are
recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities
and their tax bases. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of
enactment.&#160;</p>

<p id="xdx_853_zBAPanN5HK0j" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zvxhnOmm86Mb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86A_zg7JfXrxaVQj">Recent Accounting Pronouncements</span> </b>&#8211; <span style="background-color: white">Management
does not believe that recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the
accompanying consolidated financial statements.</span></p>

<p id="xdx_85A_zfRIZnPqn77l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_841_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zKHsbsxKpxej" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_z4k4QCX9HQR">Foreign Currency</span> &#8211; </b>The functional currency
of our former international subsidiary, Skyset, was the local Italian currency. For that subsidiary, we translated assets and liabilities
to U.S. dollars using period-end exchange rates, and average monthly exchange rates for revenues, costs, and expenses. We recorded translation
gains and losses in accumulated other comprehensive income.</p>

<p id="xdx_857_zTFTHwMuepS6" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;&#160;</p>

<p id="xdx_84F_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zeZrDIVXtY43" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86C_zWiNRp5rUhJ3">Comprehensive Loss</span> </b>&#8211; Comprehensive loss
consists of net loss and other comprehensive loss. Other comprehensive loss refers to gains and losses that are recorded as an element
of stockholders' equity but are excluded from net loss. Our other comprehensive loss is comprised of foreign currency translation adjustments
and unrealized gains or losses on available-for-sale securities. During the year ended April 30, 2024, comprehensive loss was $<span id="xdx_906_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20230501__20240430_z20MHAd0Bx09">865,738</span>
lower than net loss, related to unrealized gains on available-for-sale securities totaling $<span id="xdx_902_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20230501__20240430_zu9aCfjA5Wh3">864,165</span> and foreign currency translation adjustments
of $<span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20230501__20240430_zA7NB9TbVz76">1,573</span>. During the year ended April 30, 2023, comprehensive loss was $<span id="xdx_901_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20220501__20230430_zCjsInfVH5i4">609,155</span> lower than net loss, related to unrealized gains on available-for-sale
securities totaling $<span id="xdx_901_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20220501__20230430_zUYz8lZOzpvd">610,129</span>, partially offset by foreign currency translation adjustments of $<span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20220501__20230430_zmMIZSeEG8Ma">974</span>.&#160;</p>

<p id="xdx_85E_zQ3z2lCecTVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zIYMkuiE3t7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_ziZAPTrXDv1a">Stock-Based Compensation</span> </b>&#8211; S<span style="background-color: white">tock
options are valued using the estimated grant-date fair value method of accounting in accordance with ASC Topic 718, Compensation &#8211;
Stock Compensation. Fair value is determined based on the Black-Scholes Model using inputs reflecting our estimates of expected volatility,
term and future dividends. We recognize forfeitures as they occur. The fair value of restricted stock is based on our stock price on the
date of grant. Compensation cost is recognized on a straight-line basis over the service period which is the vesting term.</span></p>

<p id="xdx_85D_z8yricEN9N3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zxizuRADbMh3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86E_zNqdQaJZswfb">Basic and Diluted Net Loss per Share</span></b> &#8211;
Basic and diluted net loss per share has been calculated by dividing net loss by the weighted average number of shares of common stock
outstanding during the period. Common stock equivalents were excluded from the computation of diluted net loss per share of common stock
because they were anti-dilutive. The conversion or exercise of these common stock equivalents would dilute earnings per share if we become
profitable in the future. Outstanding securities not included in the computation of diluted net loss per share because their effect would
have been anti-dilutive include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z9tJBwS9KIPf" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_494_20230501__20240430_zqag83BE45nl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_497_20220501__20230430_zgFS9fM9BDJi" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_407_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_zgjK8cfnMyAd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Series B Preferred Stock, as converted</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 20%; font-size: 10pt; text-align: right">3,896</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 20%; font-size: 10pt; text-align: right">822,230</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_zhEgkUq1hHz2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Stock options</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">6,779,934</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,784,809</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_zOCXNCCHhdL2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,275,999</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,539,999</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_zfeTr9nC4ms5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Restricted stock</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">175,130</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">781,060</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zGwJOfxndp3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">9,234,959</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">7,928,098</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zQiqjBwavoJ5" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p id="xdx_85C_zOiYa4Rs803g" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zCXtklxqrUV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_866_zNIcK9TfCCch">Related Parties</span></b> &#8211; Parties are considered
to be related to us if they have control or significant influence, directly or indirectly, over us, including key management personnel
and members of the Board of Directors or are direct relatives of key management personnel of members of the Board of Directors. Related
Party transactions are disclosed in Note 20.</p>

<p id="xdx_85E_zYopETudmrMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84E_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zTlQsOqnNxS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_86B_zY3r2rak3238">Liquidity
and Going Concern</span> </b>&#8211; The Company has never been profitable and has incurred net losses related to acquisitions, as well as costs
incurred to pursue its long-term growth strategy. During the year ended April 30, 2024, the Company incurred a net loss from continuing
</span>operations of $<span id="xdx_909_eus-gaap--IncomeLossFromContinuingOperations_dxL_c20230501__20240430_zSzkm1Ldsnmh" title="::XDX::-21526696"><span style="-sec-ix-hidden: xdx2ixbrl0737">21,526,696</span></span>&#160;and used cash in operating activities of continuing operations of $<span id="xdx_903_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_dxL_c20230501__20240430_zaIhyh0n4g01" title="::XDX::-17687063"><span style="-sec-ix-hidden: xdx2ixbrl0738">17,687,063</span></span>. As of April 30,
2024, working capital for continuing operations totaled $<span id="xdx_907_eus-gaap--Capital_iI_c20240430_zQPgJOzWJ7ca">18,746,419</span>. These financial results and our financial position <span style="background-color: white">at&#160;April
30, 2024&#160;raise substantial doubt about our ability to continue as a going concern. However, the Company has recently taken actions
to strengthen its liquidity.&#160;On&#160;December 11, 2023, we completed a public offering of 18,400,000 shares of common stock which
generated net proceeds of approximately $8,400,000 as further described in Note 1 and Note 16. In addition, the Company&#8217;s operating
plan for the next twelve months has been updated to reflect recent operating improvements.&#160; Revenues have accelerated and are expected
to continue growing. The Company&#8217;s manufacturing facility is scaling production and gross profits are projected to increase.&#160;<span style="background-color: white">If necessary, the Company will seek
to obtain additional debt financing for which there can be no guarantee.</span> Subsequent
to year end, as further described in Note 22, the Company sold its equity method investment for $4,400,000. Management has concluded
that these recent positive developments alleviate any substantial doubt about the Company&#8217;s ability to&#160;continue its operations,
and meet its financial obligations, for twelve months from the date these consolidated financial statements&#160;are&#160;issued.</span></p>

<p id="xdx_85D_ziynwxu1WGN5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619376496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 &#8211; Divestiture of Consumer Segment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Note 3 &#8211; Divestiture of Consumer Segment</a></td>
<td class="text"><p id="xdx_800_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_znkVdmID5oz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_821_zmTl67wUUEn5">Note
3 &#8211; Divestiture of Consumer Segment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt; background-color: white"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt; background-color: white">On
February 16, 2024,</span><span style="font-size: 8pt">&#160;</span><span style="font-size: 10pt; background-color: white">the Company
closed the sale of Rotor Riot and Fat Shark to Unusual Machines. The sale was conducted pursuant to a Share Purchase Agreement dated November
21, 2022, as amended on April 13, 2023, July 10, 2023, and December 11, 2023 (the &#8220;SPA&#8221;). The transaction closed concurrently
with UMAC&#8217;s initial public offering and listing on the NYSE American exchange (&#8220;IPO&#8221;) under the symbol &#8220;UMAC.&#8221;
</span></p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt; background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The total consideration received
by the Company was valued at $<span id="xdx_901_eus-gaap--NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_pn6n6_c20230501__20240430_zIXV4zI4A94i">20</span> million and consisted of i) $<span id="xdx_90D_ecustom--NoncashOrPartNoncashDivestitureCashConsiderationReceived1_pn6n6_c20230501__20240430_z1osYl9p5B02">1</span> million in cash, ii) $<span id="xdx_907_ecustom--NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1_pn6n6_c20230501__20240430_zCK7vEmGVK8e">2</span> million in a secured promissory note (&#8220;Promissory
Note&#8221;), iii) $<span id="xdx_906_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_pn6n6_c20230501__20240430_zUNYrjV0pWxc">17</span> million in securities of Unusual Machines, and iv) a post-closing adjustment for excess working capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Secured Promissory Note</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Promissory Note from
Unusual Machines bears interest at a rate of 8% per year, is due 18 months from the date of issue, and requires monthly payments of interest
due in arrears on the 15th&#160;day of each month. In the event of a Qualified Financing (defined as one or more related debt or equity
financings by UMAC resulting in net proceeds of at least $5 million, other than UMAC&#8217;s completed IPO), the Company may require payment
of this Promissory Note in whole or in part upon written notice given within 10 days of the Qualified Financing. During the occurrence
and continuance of any event of default under the Note, The Company may, at its option, convert the amounts due under the Note to common
stock of UMAC in whole or in part from time to time. The conversion price will be a 10% discount to the average daily volume weighted
average price for UMAC&#8217;s common stock over the 10 days preceding the conversion price. Conversions under the Note will be limited
such that no conversion may be made to the extent that, after giving effect to the conversion, the Company, together with its affiliates,
would beneficially own in excess of 4.99% of UMAC&#8217;s common stock. This limit may be increased by the Company upon 61 days written
notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Unusual Machines Securities
</i></p>

<p style="font: 10pt/11.75pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><br/>
The $<span id="xdx_90C_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_pn6n6_c20230501__20240430_zkbm6zDCF2jj">17</span> million worth of UMAC common stock was valued at the IPO price for UMAC&#8217;s common stock of $4.00 per share, resulting in
<span id="xdx_90E_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares_c20230501__20240430_zDwBwuAsBU63">4,250,000</span> shares of UMAC common stock being issued to the Company (representing approximately 49% of UMAC&#8217;s issued and outstanding
common stock after giving effect to the IPO and to the issuance of common stock to the Company upon closing of the IPO).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Working Capital</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
purchase price was adjusted for working capital as of the closing date. </span>Actual working capital excess amounts increased the
principal amount of the Promissory Note dollar for dollar. <span style="background-color: white">Working capital as of closing was
finalized at $<span id="xdx_90B_ecustom--WorkingCapitalAtClosingOfDisposalGroup_iI_pn6n6_c20240216_zbXgynZ6d6f9">2</span> million,
as further described in Note 22.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The Consumer
segment has been classified as Discontinued Operations and reported in accordance with the applicable accounting standards. Set forth
below are the results of operations for the Consumer segment for:</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zSkyfwXJYvJf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Discontinued Operations - results of operations (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td colspan="3" id="xdx_493_20230501__20240430_zshf715XYCU1" style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td colspan="3" id="xdx_490_20220501__20230430_zEvfNYksleKf" style="font-size: 12pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>April 30,</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2023</td></tr>
  <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_zet66lxCG3cd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-indent: -10pt; padding-left: 10pt">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">4,213,653</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">5,290,946</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_zZCp6nmbVSq1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Cost of goods sold</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,577,980</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,793,430</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_zZB2bdYGJ107" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Gross (Loss) Profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(364,327</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">497,516</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract_iB_zHCQOqo9zi16" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Operating Expenses</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_i01_zJLH4PGzI8F9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118,093</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">346,002</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_i01_zVhUkNrCIv5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,157,448</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">862,384</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_i01_zVuRSUxgtgUf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">General and administrative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">863,361</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,044,435</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_i01_zbIlawNLqG9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,138,902</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,252,821</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_z9ivHMd3EAOj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Operating loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,503,229</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,755,305</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_iB_zVvUU5f7lou5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Other expense (income)</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInterestExpense_i01_zpBc0jySXPA1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,856</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0783">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherIncome_i01N_di_zKtzrAasM0nd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Other, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(152</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(24,919</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_i01_zFuBhwfCwzb3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Other expense (income)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,704</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(24,919</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt; text-indent: -10pt; padding-left: 20pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_zm0JKW1Nqn7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 20pt">Net loss from discontinued operations</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(2,525,933</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(1,730,386</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>


<p id="xdx_8AF_z2rczATCQB5d" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;&#160;</span>&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Assets
and liabilities for the Consumer segment included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock_zDXki7kt0Sge" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Assets and liabilities for the Consumer Segment (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_490_20240430_znrKTTBcuGWl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_491_20230430_zsmNxUUlbZs1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_400_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_iB_z87t70LlmfEl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCash_i01I_z2NIr3x53W3d" style="vertical-align: bottom; background-color: White">
    <td style="width: 62%; font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Cash</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0799">&#8212;</span>&#160;&#160;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 15%; font-size: 10pt; text-align: right">86,656</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_i01I_zcwueUvWpSi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts receivable, net</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0802">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">61,107</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_i01I_z1sBCuNDbE6a" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Inventory</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0805">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,065,954</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_i01I_zb1zbFTBsK43" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Other</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0808">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,069,438</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_i01I_zBWkVUPanN5g" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Total current assets</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0811">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">5,283,155</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_i01I_z8Tx8utNgRlk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Intangible assets, net</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0814">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">20,000</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_i01I_zkc2jxz6q2uf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 10pt">Other</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0817">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,853</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent_iI_zSUCOiDo29Z6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Operating lease right-of-use assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0820">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">84,544</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_iI_zp1C8ecSpts5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Total long term assets</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0823">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">108,397</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_iB_z0WB0fL1ytUd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_i01I_zBxrKpDpQkq" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts payable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0829">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">606,872</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_i01I_zWSzKPSieU8f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Accrued expenses</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0832">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">109,480</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_i01I_zgpnGHr06vK5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Customer deposits</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0835">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">244,688</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent_i01I_zz7sEoiHkCz8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Operating lease liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0838">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">49,461</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_i01I_z3BPfxYaOHfb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Total current liabilities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0841">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,010,501</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent_iI_zkjV11vb9jBj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Long term liabilities - Operating lease liabilities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0844">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">41,814</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--DisposalGroupIncludingDiscontinuedOperationWorkingCapital_iI_zePZUDSsMGg6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Working capital</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0847">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,272,654</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_zLsYoLAgYES6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205-20/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619830432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4 &#8211; Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Note 4 &#8211; Marketable Securities</a></td>
<td class="text"><p id="xdx_808_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_z6kDrTUWTh21" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_82C_zFwwqVWwtFx2">Note
4 &#8211; Marketable Securities</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">There
were no marketable securities at April 30, 2024.</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify">At April 30, 2023, marketable securities
consisted solely of corporate bonds and were classified at Level 2 in the Fair Value Hierarchy. Fair value, cost basis, and
unrealized losses totaled $<span id="xdx_900_ecustom--CorporateBondsAtCarryingValueFairValue_iI_c20240430_ziWNu2Vo9IE9">12,814,038</span>,
$<span id="xdx_90F_ecustom--CorporateBondsAtCarryingValueCostBasis_iI_c20240430_zIJVJLiOC0Gc">13,678,203</span>, and $<span id="xdx_908_ecustom--CorporateBondsAtCarryingValueUnrealizedLosses_iNI_di_c20240430_zZoEfnZLSw7f">864,165</span>
at April 30, 2023, respectively.</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br> -Publisher SEC<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//946-320/tableOfContent<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 940<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//940-320/tableOfContent<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//942-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619373440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 &#8211; Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Note 5 &#8211; Inventories</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--InventoryDisclosureTextBlock_zLmly14NaPO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_82F_zIzyQYj4zeBg">Note
5 &#8211; Inventories</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Inventories
consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z6BUpddFWoF9" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Inventories (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49A_20240430_znqN3pNDk0V4" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_495_20230430_zTR3DOqZWeG2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_zkyxa8aKxVd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Raw materials</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">5,750,324</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">8,132,196</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--InventoryWorkInProcess_iI_z8Vu5WAs9G9f" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">Work-in-process</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,289,997</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">509,381</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--InventoryFinishedGoods_iI_zCIqhYR0CO7j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Finished goods</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">966,916</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">278,996</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryNet_iI_zaJzXLheb7x5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8,007,237</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8,920,573</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zklwzZoeO8Ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979719883008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 &#8211; Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">Note 6 &#8211; Other Current Assets</a></td>
<td class="text"><p id="xdx_808_eus-gaap--OtherCurrentAssetsTextBlock_zrXyK6Rmvhra" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_825_z1VWG65ssHXc">Note
6 &#8211; Other Current Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Other
current assets included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zve7ktwRkWRi" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Other current assets (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_495_20240430_zngNaW3Pybsj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49F_20230430_zCwwNg2UMCl9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_40E_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_d0_zw8bDNFFohF2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Contract asset</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">1,477,859</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">&#8212;&#160;&#160;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--PrepaidExpenseCurrent_iI_z9jCggJwMmil" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Prepaid expenses</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,206,306</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">752,564</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--GrantsReceivableCurrent_iI_zqOJt7hTi7s1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Grant receivable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">675,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0882">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_zD0u2si96To6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Prepaid inventory</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">602,888</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">359,500</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss_iI_zlv58nsr7y2a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Accrued interest income</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0887">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">151,671</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherAssetsCurrent_iI_zwrVf7JHUR99" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,962,053</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,263,735</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zpLfa8wx07L" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619334144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 &#8211; Due From Related Party<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote7DueFromRelatedPartyAbstract', window );"><strong>Note 7 Due From Related Party</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DueFromRelatedPartyDisclosureTextBlock', window );">Note 7 &#8211; Due From Related Party</a></td>
<td class="text"><p id="xdx_80F_ecustom--DueFromRelatedPartyDisclosureTextBlock_z6iSk9tDE2Aj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_829_zkUwNtFzveF8">Note
7 &#8211; Due From Related Party</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
January 2022, the Company determined that a senior executive had relocated in 2021 but their compensation had not been subject to the
income tax withholding required by the new jurisdiction.&#160;The amount subject to taxation included $<span id="xdx_905_ecustom--CashCompensationSubjectToTaxation_c20230101__20230430_zQxsx4gKigi8">155,624</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;of
cash compensation and $<span id="xdx_90F_ecustom--IncomeAssociatedWithStockCompensationSubjectToTaxation_c20230101__20230430_zTRvDHCqurNe">1,413,332</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;of
income associated with the vesting of restricted stock ("Stock Compensation").&#160;In March 2022, the Company entered into a
note agreement (the "Note") with the employee in the amount of $<span id="xdx_905_ecustom--NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation_c20230301__20230430_zusjUOFElLFb">510,323</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">,
representing the estimated taxes owed by the employee related to the Stock Compensation. Under the terms of the Note, <span id="xdx_904_ecustom--CommonStockWithheldByCompanyAppliedAgainstNoteShares_c20230301__20230430_zgQ8PC66lk46">104,166
</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">shares of common stock with a fair value
of $<span id="xdx_906_ecustom--CommonStockWithheldByCompanyAppliedAgainstNoteAmount_c20230301__20230430_zCQrzJCwEZp5">280,832</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">,
which had vested during calendar 2021, were withheld by the Company and applied against the Note.&#160;The employee agreed not to sell
or transfer <span id="xdx_90C_ecustom--SharesHeldAtTransferAgentUntilNoteReceivableRepayment_c20230301__20230430_zxjOO0m6PW6b">110,983</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;shares
of common stock held at the Company's transfer agent until the Note was repaid.&#160;In addition, the employee has <span id="xdx_90D_ecustom--RestrictedStockScheduledToVestShares_c20230301__20230430_zvevZOtcsT5j">20,833</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;shares
of restricted stock vesting monthly in calendar 2022, of which <span id="xdx_901_ecustom--RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable_c20230301__20230430_zs9qgjRKJ70l">3,000
</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">shares were withheld with&#160;the fair
value of those shares&#160;applied against the Note. Shares issued to the employee in 2022 were held at the transfer agent until the
Note was repaid.&#160;The Note matured on December 31, 2022.&#160;The Company filed amended payroll tax returns on March 16, 2022. In
March and April 2022, the Company made payments to the relevant tax authorities totaling $<span id="xdx_909_ecustom--PaymentsForTaxLiability_iN_di_c20230301__20230430_zkZI4pv5OqYk">712,646</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;representing
$<span id="xdx_908_ecustom--NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation_c20230301__20230430_zAMluM6eRz9k">510,323
</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">owed by the employee, $<span id="xdx_904_ecustom--EstimatedTaxesOwedRelatedToStockCompensation_c20230301__20230430_zeXZhTxDKhRk">31,604
</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">owed by the Company, and $<span id="xdx_902_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20230301__20230430_zdi5GWabzaJe">170,719
</span></span><span style="font-family: Times New Roman, Times, Serif; background-color: white">of penalties and interest. The Note was
repaid in full in August 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote7DueFromRelatedPartyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote7DueFromRelatedPartyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DueFromRelatedPartyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DueFromRelatedPartyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627286784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 &#8211; Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Note 8 &#8211; Intangible Assets</a></td>
<td class="text"><p id="xdx_809_eus-gaap--IntangibleAssetsDisclosureTextBlock_znmNgMdHyJ7g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_828_zUz3OvP4qMSl">Note
8 &#8211; Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Intangible
assets relate to acquisitions completed by the Company, including those described in Note 1, and were as follows:</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zX2LoD05fw32" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_496_20240430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_z2lGxlgYlT0j" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_49E_20240430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_zQpL6rgyu3u3" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_499_20240430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zdHSJKKxRag8" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_492_20230430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_zj7diAdCNLV3" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_493_20230430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_z87k05xiuure" style="text-align: center"></td><td style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_49C_20230430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zv7ORBT9jZo3" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Gross Value</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Net Value</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.85pt 0 0; text-align: center"><b>Gross</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Value</b></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Net Value</td></tr>
  <tr id="xdx_40B_ecustom--FiniteLivedProprietaryTechnologyGross_iI_z9OH8LlngRLe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt; text-align: left">Proprietary technology</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right">4,282,001</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right">(1,917,612</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right">2,364,389</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right">4,967,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right">(1,271,112</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right">3,695,888</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--FiniteLivedNoncompeteAgreementsGross1_iI_zZTkVcNMkU6i" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Non-compete agreements</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">65,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(65,000</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0920">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">81,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(56,667</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">24,333</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--FiniteLivedCustomerRelationshipsGross1_iI_zUBASyRu0cX4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Customer relationships</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0925">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0926">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0927">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">39,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(18,106</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">20,894</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--FiniteLivedIntangibleAssetsGross1_iI_zO3OZ9bu8atf" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Total finite-lived assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,347,001</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(1,982,612</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,364,389</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">5,087,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(1,345,885</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,741,115</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IndefiniteLivedTradeNames_iI_ztjiNZM883Fg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Brand name</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,430,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0940">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,430,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,152,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0943">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,152,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--IndefiniteLivedIntangibleAssetsExcludingGoodwill1_iI_zgHiUt7bR99j" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt">Total indefinite-lived assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,430,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0947">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,430,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,152,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0950">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,152,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IntangibleAssetsNetExcludingGoodwill1_iI_z7Gl2PfL7N0h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: 10pt">Total intangible assets, net</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">5,777,001</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(1,982,612</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,794,389</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8,239,000</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(1,345,885</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">6,893,115</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A7_zkZhxjEOzKul" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Proprietary
technology and non-compete agreements are being amortized over six years and three years, respectively. Customer relationships are being
amortized over seven years. Goodwill and Brand name are not amortized but evaluated for impairment on a quarterly basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">As
of April 30, 2024, expected amortization expense for finite-lived intangible assets for the next five years is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zjneipPSX354" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Expected amortization expense for the unamortized finite-lived intangible assets (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-size: 10pt">&#160;</td>
    <td colspan="2" style="text-align: left; font-size: 10pt">Fiscal Year Ended:</td><td>&#160;</td>
    <td colspan="3" id="xdx_49E_20240430_zXaRMnPYpHdb">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_zexbQb0J4IVj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 65%; font-size: 10pt; text-align: left">2025</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 30%; font-size: 10pt; text-align: right">709,316</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_zuPC7NIpEPni" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">2026</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">709,316</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_z8fubbCcSvLk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">2027</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">709,316</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_zwTo7HbdELuk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">2028</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">236,441</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_zxuDNQg8YLt5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">2029</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0970">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_zMpmporglwSl" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_zpbixktmPMy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,364,389</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zuSgWyOZlpOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.25in">&#160;<span style="background-color: white">&#160;&#160;&#160;&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Goodwill
represents the future economic benefit arising from other assets acquired in an acquisition&#160;that are not individually identified
and separately recognized. The composition of, and changes in goodwill, consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfGoodwillTextBlock_zIm5jaFCEO12" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Composition of, and changes in goodwill (Details)">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt">Date</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Entity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_4BC_us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap--GoodwillMember_zTxPMT2MHiE9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Goodwill</td></tr>
  <tr id="xdx_43E_c20200101__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_zVBMNDR9lQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 36%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">January 2020</span></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 30%; font-size: 10pt; text-align: center; padding-left: 5.75pt">Rotor Riot</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">1,849,073</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20201101__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_z2jBZyYLS7Ti" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">November 2020</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 5.75pt">Fat Shark</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">6,168,260</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_433_c20210501__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_zyUCw4f48f31" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">May 2021</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 5.75pt">Skypersonic</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,826,918</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20210801__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_zJ8BOuIQznS4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">August 2021</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 5.75pt">Teal Drones</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">8,995,499</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20230401__20230430_eus-gaap--GoodwillImpairmentLoss_iN_di_zarFtKrXSuf2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">April 2023 - Impairment loss</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-bottom: 1pt; padding-left: 5.75pt">Skypersonic</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(2,826,918</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_439_c20230430_eus-gaap--Goodwill_iI_z6nMnHPAnlYh" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Balance at April 30, 2023</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.75pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">17,012,832</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20240201__20240430_eus-gaap--GoodwillWrittenOffRelatedToSaleOfBusinessUnit_iN_di_zSBGoPCLIeJd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">February 2024 &#8211; Divestiture</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt; padding-left: 5.75pt">Rotor Riot, Fat Shark</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(7,924,282</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_434_c20240430_eus-gaap--Goodwill_iI_zba2WDzOY1E8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Balance at April 30, 2024</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt; padding-left: 5.75pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">9,088,550</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_zfMXaQMEccCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;<span style="background-color: white">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Included
in the amounts presented above is goodwill related to other insignificant transactions. Following the establishment of the Enterprise
and Consumer segments, management evaluated the long-term business strategy of each segment. This resulted in the Enterprise segment narrowing
its focus on the military and other government agencies. It was determined that Skypersonic's technology would be re-focused for the near
term on military applications and consolidated into the operations of Teal. The Company completes a formal evaluation of the carrying
value of its intangible assets, including goodwill, at the end of each fiscal year. Based on (i) the operating results for Skypersonic
since its acquisition in May 2021, (ii) its consolidation into Teal, (iii) our current expectations of its future business conditions
and trends, including its projected revenues, expenses, and cash flows, the Company recognized an impairment charge of $<span id="xdx_90F_eus-gaap--GoodwillImpairmentLoss_iN_dixL_c20230401__20230430_zupUsiY7K2kd" title="::XDX::-2826918"><span style="-sec-ix-hidden: xdx2ixbrl0993">2,826,918</span></span> in April
2023. During FY2024, an impairment change of $<span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_iN_dixL_c20240401__20240430_zWxtw0o07ZAb" title="::XDX::-412999"><span style="-sec-ix-hidden: xdx2ixbrl0994">412,999</span></span> was recognized related to Skypersonic&#8217;s proprietary technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619757392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 &#8211; Equity Method Investment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Note 9 &#8211; Equity Method Investment</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_ze3r0cHA8g83" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_826_zW6Qq60QjsNk">Note
9 &#8211; Equity Method Investment</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">As
of April 30, 2024, the Company owned a 46% interest in Unusual Machines. The primary business operations include selling first-person-view
video goggles for drone pilots, drones, parts and related equipment to the consumer marketplace. UMAC&#8217;s financial statements are prepared
in accordance with GAAP.</span> See Note 3 and Note 22 for additional information.</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Financial
information for UMAC is derived from UMAC&#8217;s  Form 10-Q for the quarter ending March 31, 2024 and was as follows:</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--EquityMethodInvestmentFinancialInformationTableTextBlock_zKROqMKzMPrg" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Financial informatino for UMAC derived from their Form 10-Q (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_498_20240101__20240331__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zYeBfmK7l2wj">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AssetsCurrent_iE_zNk2JRkdgya5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 67%; font-size: 10pt; text-align: left">Current assets</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 30%; font-size: 10pt; text-align: right">6,128,890</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsNoncurrent_iE_zfYhJXWFPV3k" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Long-term assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">18,099,802</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesCurrent_iE_zIfxmBi54kE5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Current liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">691,978</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesNoncurrent_iE_zkpKr46q3Q9g" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Long-term liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,313,896</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_zEoIDgypOTUc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Revenues</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">618,915</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--GrossProfit_zaEArg6XVZr4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Gross profit</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">204,167</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_zqWGToyTOZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Net loss</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(1,106,001</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A0_zNWE9zsBjaA5" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>



<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
Company&#8217;s investments in UMAC have been impacted by the following:</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--EquityMethodInvestmentsTextBlock_zLOji0k794G2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Impacts on investments into UMAC (Details)">
  <tr id="xdx_402_eus-gaap--EquityMethodInvestments_iS_zlF5Ab6Egy26" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 67%">Initial investment, February 16, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_494_20230501__20240430__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zVEBHNE7SSel" style="width: 30%; text-align: right">17,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromEquityMethodInvestments_iN_di_zBxykRuVOIT" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Equity method loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(503,625</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_iN_di_z2OIJekif81" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Impairment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(11,353,875</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--EquityMethodInvestments_iE_zV98VQyDhPIb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Investment balance, April 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,142,500</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_z7x9uz0RfKge" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
computation of both the initial investment as of February 16, 2024 and investment balance as of April 30, 2024, is based on the fair market
value of UMAC&#8217;s common stock. </span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 323<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481543/323-740-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 323<br> -Publisher FASB<br> -URI https://asc.fasb.org//323/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619765536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 &#8211; Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Note 10 &#8211; Property and Equipment</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zNngJgqAgHHb" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_82E_z9dMcRlJbVge">Note
10 &#8211; Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Property
and equipment consist of assets with an estimated useful life greater than one year and are reported net of accumulated depreciation.
The reported values are periodically assessed for impairment, and were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--PropertyPlantAndEquipmentTextBlock_z5oH0fjSeHPe" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Property and equipment (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_496_20240430_zaTMthThlrWb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_494_20230430_z1qnxPEDFgu5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentGross_iI_z2KRiK3mgwlj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Equipment and related</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">1,540,888</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">1,386,373</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LeaseholdImprovementsGross_iI_zoau8fUQKb9l" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Leasehold improvements</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,547,976</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,473,890</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--FurnitureAndFixturesGross_iI_zg3QM2Hv2a7f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Furniture and fixtures</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">163,290</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">132,752</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_zYuCwcne8EL1" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(911,470</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(342,657</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iI_zNnVB50SjlS7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt">Net carrying value</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,340,684</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,650,358</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Depreciation
expense totaled $<span id="xdx_906_eus-gaap--Depreciation_c20230501__20240430_zJK5OyBrgMO">568,813</span> and $<span id="xdx_905_eus-gaap--Depreciation_c20220501__20230430_zYaiW4pDORZ7">311,545</span> for the years ended April 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627457280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 11 &#8211; Other Long-Term Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote11OtherLongtermAssetsAbstract', window );"><strong>Note 11 Other Long-term Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_OtherLongTermAssetsDisclosureTextBlock', window );">Note 11 &#8211; Other Long-Term Assets</a></td>
<td class="text"><p id="xdx_809_ecustom--OtherLongTermAssetsDisclosureTextBlock_zXQLH0kdO6ak" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_82B_zCTGEJagbx4f">Note
11 &#8211; Other Long-Term Assets</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Other
long-term assets included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfOtherLongTermAssetsTableTextBlock_zTbXFIaRadZd" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Other long term assets (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49A_20240430_zB94gUgtyTR3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49A_20230430_zGS0C8OOI27k" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_403_ecustom--SAFEAgreementAssets_iI_zXHoQtbOXWhi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">SAFE agreement</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">250,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">250,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--SecurityDeposit_iI_zUHiVGMrR6jb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Security deposits</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">43,126</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">53,180</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NoncurrentAssets_iI_zVI3O7DTXcjg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">293,126</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">303,180</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A3_ziapqAxsjAYa" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
November 2022, the Company entered into a SAFE (Simple Agreement for Future Equity) agreement with Firestorm Labs, Inc. (&#8220;Firestorm&#8221;)
under which it made a payment of $<span id="xdx_900_ecustom--PaymentForSAFEAgreement_c20221101__20221130_zSNCj7gfXCKd">250,000</span> to Firestorm in exchange for the right to certain shares of Firestorm stock. The SAFE permits
the Company to participate in a future equity financing of Firestorm by converting the $<span id="xdx_90C_ecustom--PaymentForSAFEAgreement_c20221101__20221130_z1gsZASEQBQ9">250,000</span> into shares of Preferred Stock of Firestorm.
If there is a change in control of Firestorm or a public offering of shares of its stock, then the Company shall have the right to receive
cash payments, or shares of stock, whichever has greater value. The Company&#8217;s investment in the SAFE agreement has been recorded
on the cost method of accounting. The Company evaluates the investment for any indications of impairment in value on a quarterly
basis. No&#160;factors indicative of impairment were identified&#160;during&#160;the&#160;year ended&#160;April&#160;30,&#160;2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote11OtherLongtermAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote11OtherLongtermAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_OtherLongTermAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_OtherLongTermAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979715438800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 &#8211; Right of Use Assets and Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOfLesseeDisclosureTextBlock', window );">Note 12 &#8211; Right of Use Assets and Liabilities</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--LeasesOfLesseeDisclosureTextBlock_zw3b8dL1jBt1" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_821_zE9onxcMSbR7">Note
12 &#8211; Right of Use Assets and Liabilities</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">As
of April 30, 2024, the Company had operating type leases for real estate and no finance type leases. The Company&#8217;s leases have remaining
lease terms of up to 6.67 years, including options to extend certain leases for up to six years. Operating lease expense totaled $351,369
for the year ended April 30, 2024, including period cost for short-term, cancellable, and variable leases, not included in lease liabilities,
of $4,950 for the year ended April 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Leases
on which the Company made rent payments during the reporting period included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfRentExpenseTableTextBlock_zQ1JIeepMl5k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Operating leases (Details)">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Location</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Monthly Rent</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expiration</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 42%">South Salt Lake, Utah</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_988_eus-gaap--OperatingLeaseExpense_c20230501__20240430__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation1Member_zj3FQbQY4iSa" style="text-align: right; width: 25%">22,667</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 25%"><span style="font-size: 10pt">December 2024</span></td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">San Juan, Puerto Rico</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingLeaseExpense_c20230501__20240430__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation3Member_z08KIHOS9lxh" style="text-align: right">5,647</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">June 2027</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Grantsville, Utah</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeaseExpense_c20230501__20240430__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation4Member_zJALeoBESDX7" style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">December 2026</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>


<p id="xdx_8AC_zUjEJTYUfwP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.25in">&#160;<span style="background-color: white">&#160;&#160;&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Supplemental
information related to operating leases for the year ended April 30, 2024 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_z7efdYCP0wsl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Supplemental information related to operating leases (Details)">
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_497_20230501__20240430_zFXEY9gfNDOl" style="font-size: 12pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--OperatingCashPaidToSettleLeaseLiabilities_zOf4I3cCkeX9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt; width: 77%"><span style="font-size: 10pt">Operating cash
    paid to settle lease liabilities</span></td><td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; width: 1%"><span style="font-size: 10pt"></span></td><td style="text-align: center; width: 20%">$<span style="font-size: 10pt">$350,162</span></td><td style="text-align: center; width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0pt"><span style="font-size: 10pt">Weighted average remaining lease term (in years)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_pip0_dtY_c20240430_zbG3UQ5mByma">2.16</span></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iE_zY85bVC2Kdmg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt"><span style="font-size: 10pt">Weighted average discount rate</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">12%</span></td><td style="text-align: center"><span style="font-size: 10pt"></span></td></tr>
</table>

<p id="xdx_8A1_znwjP9FnHAk2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Future
lease payments at April 30, 2024 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zuRpKwgz6M9" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 40%" summary="xdx: Disclosure - Future lease payment obligations (Details)">
<tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: left; font-size: 10pt"><span style="font-size: 10pt">Fiscal Year Ended:</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_491_20240430_zvEq4KDDN9o7"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_zaYkZNg8TXwc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left; width: 65%"><span style="font-size: 10pt">2025</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%">$<span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right; width: 30%"><span style="font-size: 10pt">366,853</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_zImF4TEPWzRl" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">2026</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">372,449</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_iI_zNHSwZ8slT03" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">2027</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">372,880</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_iI_zklrfpA29ay7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">2028</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">293,334</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix_iI_zYRWSdd79em4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">2029</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">280,080</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueThereafter_iI_zQQDjEuYhUv8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">Thereafter</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">443,460</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueSubtotal_iI_zbyHydiK5Osi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"></span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,129,056</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_z1mCQdrdNofd" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">Imputed interest</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(611,466</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_z59T5oeilyFk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">Total liability</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,517,590</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>


<p id="xdx_8AB_zCkfrZTZbGWj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;<span style="background-color: white">&#160;<b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//840/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627427136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 13 &#8211; Debt Obligations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Note 13 &#8211; Debt Obligations</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--DebtDisclosureTextBlock_zSZDwMmnxPZk" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_828_z6O6iZAQhi76">Note
13 &#8211; Debt Obligations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>A.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>&#160;Decathlon Capital</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">On
August 31, 2021, Teal entered into an Amended and Restated Loan and Security Agreement with Decathlon Alpha IV, L.P. (&#8220;DA4&#8221;)
in the amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20220831__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_z8el6ty3tAnj">1,670,294</span> (the &#8220;Loan&#8221;), representing the outstanding principal amount previously due and owing by Teal to
DA4. Interest on the Loan accrues at a rate of ten (<span id="xdx_900_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220901__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_zBuPvjkJDpN3">10</span>%) percent per annum. Principal and interest is payable in monthly installments
of $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20220801__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_zjqMiZ0o4eJb">49,275</span> until maturity on December 31, 2024. The balance outstanding at April 30, 2024 and April 30, 2023 totaled $<span id="xdx_909_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430_zsORdDUSUolb">370,537</span> and $<span id="xdx_903_eus-gaap--DebtInstrumentCarryingAmount_iI_c20230430_zcDSJ2x2W3bl">895,709</span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>B.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>&#160;Pelion Note</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
May 2021, Teal entered into a note agreement totaling $<span id="xdx_900_ecustom--ConvertibleNoteAgreementAmount_c20210501__20220430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zW0nGPfn5GV">350,000</span>
which is payable upon demand. The Note bears interest at the applicable
Federal Rate as of the date of the Note which was <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230501__20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zBBW80i8TgBk">0.13</span>% on the date of issuance. Accrued interest at April 30, 2024 and April 30, 2023
totaled $<span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrent_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zjzEY8KTMgU7">1,334 </span>and $<span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrent_iI_c20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zm6eNjeuXGp">878</span>,
respectively.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>C.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>&#160;Vendor Agreement</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
connection with the acquisition of Teal on August 31, 2021, the Company assumed an obligation with a contract manufacturing firm. The
assumed balance of $</span><span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20210831__us-gaap--DebtInstrumentAxis__custom--DebtObligation3Member_zLoCAT8gBVyh">387,500</span>
was repaid in monthly installments of $<span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPayment_c20210801__20220731_zgiRgvbQ53l2">37,500</span>
and paid in full in July 2022.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>D.</b></span></td>
    <td style="width: 97%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>&#160;Corporate Equity</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Beginning
in October 2021, and amended in January 2022, Teal financed a total of $<span id="xdx_90B_ecustom--LeaseholdImprovementAgreementFundsReceived_c20230701__20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zqkKj6PmTUS1">120,000</span>
of leasehold improvements with Corporate Equity, LLC. The loan bears interest at <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20221001__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zx6kOAetsgPa">8.25</span>%
annually and requires monthly payments of $<span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPayment_c20221001__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zJavIGqWKlx3">3,595</span>
through December 2024. The balance outstanding at April 30, 2024 and April 30, 2023 totaled $<span id="xdx_909_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zMXBN1sQ6NUd">27,495 </span>
and $<span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zjFvT0ZaU9ib">66,586</span>
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="width: 2%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>E.</b></span></td>
    <td style="width: 96%; padding-bottom: 8pt; padding-left: 9pt; text-align: justify; line-height: 105%; text-indent: -9pt"><span style="font-size: 10pt; line-height: 105%"><b>&#160;Ascentium Capital</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
September 2021, Teal entered into a financing agreement with Ascentium Capital to fund the purchase of a fixed asset totaling $<span id="xdx_903_ecustom--FinancingAgreementFundingOfPurchaseOfFixedAsset_c20220901__20220930__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zLiCSUUejGie">24,383</span>.
Monthly payments of $<span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPayment_c20220901__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zlOXO7Se5X0g">656</span>
are payable through October 2024. The balance outstanding at April 30, 2024 and April 30, 2023 totaled $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zOkDuHYgUIY4">3,538 </span>
and $<span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zhT0UsZNGXR3">11,412</span>
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>F.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-size: 10pt; line-height: 105%"><b>&#160;Summary </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; background-color: white"><span style="background-color: white">Future
annual principal payments at April 30, 2024 were as follows:</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfDebtPaymentsDueTableTextBlock_z3uP9BcDMky8" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Outstanding principal payments (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-size: 10pt">&#160;</td>
    <td colspan="2" style="text-align: left; font-size: 10pt">Fiscal Year Ended:</td><td>&#160;</td>
    <td colspan="3" id="xdx_496_20240430_z2f3ASuP4Fsj">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--OutstandingPrincipalPaymentsDueYearOne_iI_zbmEsNFx6o97" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 65%; font-size: 10pt; text-align: left">2025</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 30%; font-size: 10pt; text-align: right">751,570</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--OutstandingPrincipalPaymentsDueLongTerm_iI_zaRHrANgX5L5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">Thereafter</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1119">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--OutstandingPrincipalPaymentsDueTotal_iI_zhiLvdsDxxG5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">751,570</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AD_ztdnOvdVdtyl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;<span style="background-color: white">&#160;&#160;&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627445520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 14 &#8211; Due to Related Party<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote14DueToRelatedPartyAbstract', window );"><strong>Note 14 Due To Related Party</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RelatedPartyPayablesDisclosureTextBlock', window );">Note 14 &#8211; Due to Related Party</a></td>
<td class="text"><p id="xdx_803_ecustom--RelatedPartyPayablesDisclosureTextBlock_zFBccIINAv29" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_823_zoxdMGNj6oO8">Note
14 &#8211; Due to Related Party</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
January 2020, in connection with the acquisition of Rotor Riot, the Company assumed a line of credit obligation of the seller, BRIT, LLC,
totaling $<span id="xdx_908_ecustom--LineOfCreditObligationAssumedInConnectionWithAcquisition_c20210101__20230430__us-gaap--DebtInstrumentAxis__custom--DueToRelatedParty2Member_zgqzb5Vdps94">47,853</span> which bore interest at <span id="xdx_900_ecustom--DebtInstrumentInterestRateDuringPeriod1_dp_c20210101__20230430__us-gaap--DebtInstrumentAxis__custom--DueToRelatedParty2Member_zLASTj7puVT1">6.67</span>% annually. The remaining balance of $<span id="xdx_90B_ecustom--DueToOtherRelatedPartyClassifiedCurrent_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DueToRelatedParty2Member_z0oxsqoKtiua">37,196</span> plus accrued interest totaling $<span id="xdx_904_ecustom--DebtInstrumentOutstandingAccruedInterestPayment_c20240401__20240430__us-gaap--DebtInstrumentAxis__custom--DueToRelatedParty2Member_zGH9XtXBfGmj">292</span> was paid
in October 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote14DueToRelatedPartyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote14DueToRelatedPartyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RelatedPartyPayablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RelatedPartyPayablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627360320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 15 &#8211; Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Note 15 &#8211; Income Taxes</a></td>
<td class="text"><p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_zooMVUz7mF72" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_82D_zzTBt38pj7Eb">Note
15 &#8211; Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Our
operating subsidiary, Red Cat Propware, Inc., is incorporated and based in Puerto Rico which is a commonwealth of the United States. We
are not subject to taxation by the United States as Puerto Rico has its own taxing authority. Since inception, we have incurred net losses
in each year of operations. Our current provision for the reporting periods presented in these financial statements consisted of a tax
benefit against which we applied a full valuation allowance, resulting in no current provision for income taxes. In addition, there was
no deferred provision for any of these reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">At
April 30, 2024 and April 30, 2023, we had accumulated deficits of approximately $<span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_dxL_c20240430_zeghuUfkt2nf" title="::XDX::-81130732"><span style="-sec-ix-hidden: xdx2ixbrl1130">81,100,000 </span></span>
and $<span id="xdx_903_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_dxL_c20230430_zJwbxoKBK539" title="::XDX::-57078103"><span style="-sec-ix-hidden: xdx2ixbrl1131">54,600,000</span></span>, respectively. Deferred tax
assets related to the future benefit of these net operating losses for tax purposes totaled approximately $<span id="xdx_900_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_c20240430_zIAUdeilyCT1">15,004,000 </span> and $<span id="xdx_903_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_c20230430_zxo5Vr9O0oLe">10,101,000</span>,
respectively, calculated using the base Puerto Rico corporate tax rate of 18.5%.&#160;Currently, we focus on projected future taxable
income in evaluating whether it is more likely than not that these deferred assets will be realized. Based on the fact that we have not
generated an operating profit since inception, we have applied a full valuation allowance against our deferred tax assets at April 30,
2024 and April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627445520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 16 &#8211; Common Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Note 16 &#8211; Common Stock</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zq3Zxk9zLiH3" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_82F_z1dDSfJeyBg1">Note
16 &#8211; Common Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Our
common stock has a par value of $0.001 per share. We are authorized to issue 500,000,000 shares of common stock. Each share of common
stock is entitled to one vote.&#160;A summary of shares of common stock issued by the Company since April 30, 2022 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zZwEuTZUFlwi" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of shares of common stock issued (Details)">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><span style="font-size: 9pt; color: Black">Description
    of Shares</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 9pt; color: Black">&#160;</span></td>
    <td colspan="3" id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zRc8LXBmCtQ8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 9pt; color: Black">Shares
    Issued</span></td></tr>
<tr id="xdx_432_c20220501__20230430_eus-gaap--SharesOutstanding_iS_zAl3QjsXiFib" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; width: 70%"><span style="font-size: 10pt">Shares outstanding as of April 30, 2022</span></td><td style="font-size: 9pt; width: 10%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right; width: 18%"><span style="font-size: 10pt">53,748,735</span></td><td style="font-size: 9pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_439_c20220501__20230430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_zQlP30u4qsNd" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; text-indent: -9pt; padding-left: 20pt"><span style="font-size: 10pt">Vesting of restricted
    stock to employees, net of shares withheld of 273,874 to pay taxes and 9,000 to repay a Note</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">653,308</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_432_c20220501__20230430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_zS3saJZRonp9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Vesting of restricted stock to Board
    of Directors</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">116,507</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_436_c20220501__20230430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_zgHPo5WzBwvi" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Vesting of restricted stock to consultants</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">9,683</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_436_c20220501__20230430_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_zyIxJjsCexVe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-size: 10pt">Shares issued
    for services</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"><span style="font-size: 10pt">39,832</span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43B_c20220501__20230430_eus-gaap--SharesOutstanding_iE_zdcyyyjECh9c" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt"><span style="font-size: 10pt">Shares outstanding as of April 30, 2023</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">54,568,065</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43D_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_zzoEsnKJTOsg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to employees,
    net of shares withheld of 27,189 to pay taxes</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">192,742</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_433_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_zKyaDInkZ1b9" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to Board
    of Directors</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">252,214</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_434_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_zCDWbitN80yc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to consultants</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">1,761</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_432_c20230501__20240430_ecustom--StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_zm142xxnAT7c" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Conversion of preferred stock</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">818,334</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43D_c20230501__20240430_ecustom--IssuanceOfCommonStockThroughATMFacilitiesNetShares_zp6G8urM9Dkl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Issuance of common
    stock through ATM facilities</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">53,235</span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43D_c20230501__20240430_ecustom--StockIssuedDuringPeriodSharesPublicOffering_zHy0mDvCPVK4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Issuance of common
    stock through public offering</span></td><td style="font-size: 9pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; text-align: right">18,400,000</td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left">&#160;</td></tr>
<tr id="xdx_43C_c20230501__20240430_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_zCG8gXSRjP4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Exercise of stock
    options</span></td><td style="font-size: 9pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right">3,000</td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left">&#160;</td></tr>
<tr id="xdx_435_c20230501__20240430_eus-gaap--SharesOutstanding_iE_zAq95RZPCJCh" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Shares outstanding as of April 30, 2024</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"><span style="font-size: 10pt">74,289,351</span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<p id="xdx_8A7_zPE3POJNVuMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="background-color: white"><b>ATM Facility</b></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #222222">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">In August 2023,
we entered into a sales agreement (&#8220;the 2023 ATM Facility&#8221;) with ThinkEquity LLC (&#8220;ThinkEquity&#8221;), which provides
for the sale, in our sole discretion, of shares of our common stock through ThinkEquity, as our sales agent. </span><span style="letter-spacing: 0.2pt">In
accordance with the terms of the ATM Sales Agreement, the Company may offer and sell shares of our common stock, par value $0.001 per
share, having an aggregate offering price of up to $4,375,000. </span><span style="background-color: white">The issuance and sale of these
shares by us pursuant to the 2023 ATM Facility are deemed &#8220;at the market&#8221; offerings as defined in Rule 415 under the Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;), and are registered under the Securities Act. We pay a commission of up to
2.5% of gross sales proceeds of any common stock sold under the 2023 ATM Facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">During
the year ended April 30, 2024, we sold an aggregate of 53,235 shares of common stock under the 2023 ATM Facility, at an average price
of $1.07 per share, for gross proceeds of approximately $57,000 and net proceeds of approximately $55,700, after deducting commissions
and other offering expenses payable by us. Additionally, the Company incurred legal fees of approximately $46,000 establishing the 2023
ATM Facility. In December 2023, the Prospectus Supplement dated August 8, 2023 was amended to change the aggregate offering price under
the ATM facility to up to $4,375,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-size: 10pt; background-color: white">As
of April 30, 2024, approximately $4,318,000 of common stock remained available to be sold under the 2023 ATM Facility, subject to certain
conditions as specified in the sales agreement.&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b>Public
Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
December 2023, the Company entered into an underwriting agreement with ThinkEquity LLC, as representative of the underwriters, pursuant
to which the Company agreed to sell to the underwriters in a firm commitment underwritten public offering (the &#8220;Offering&#8221;)
an aggregate of 16,000,000 shares of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), at
a public offering price of $0.50 per share. The Company&#160;also granted the underwriters a 45-day option to purchase up to an additional
2,400,000 shares of Common Stock to cover over-allotments.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
Offering closed on December 11, 2023, resulting in the issuance of 18,400,000 shares of Common Stock </span>which generated gross proceeds
of $9,200,000. <span style="background-color: white">Net proceeds to the Company from the Offering, after deducting the underwriting discount,
the underwriters&#8217; fees and expenses and the Company&#8217;s estimated Offering expenses, were approximately $8,400,000.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979624930336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 17 &#8211; Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Note 17 &#8211; Preferred Stock</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--PreferredStockTextBlock_zXSg6RLiGw9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_824_zpV74MIsA9n8">Note
17 &#8211; Preferred Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Our
preferred stock has a par value of $0.001 per share. Series B Preferred Stock (&#8220;Series B Stock&#8221;) is convertible into common
stock at a ratio of 0.8334 shares of common stock for each share of Series B Stock held and votes together with the common stock on an
as-if-converted basis. 982,000 shares of Series B Stock were converted into 818,334 shares of common stock in June 2023. Shares outstanding
at April 30, 2024 totaled <span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_c20240430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z0obPeoBusSi">4,676 </span> which are convertible into <span id="xdx_90C_ecustom--StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock_c20230501__20240430__us-gaap--StatementClassOfStockAxis__custom--SeriesAPreferredStock2Member_zKwfwhaq735c">3,896 </span>
shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979621206544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 18 &#8211; Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote18WarrantsAbstract', window );"><strong>Note 18 Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_WarrantsDisclosureTextBlock', window );">Note 18 &#8211; Warrants</a></td>
<td class="text"><p id="xdx_804_ecustom--WarrantsDisclosureTextBlock_zGRAhGx4Xku5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_822_zZbqF0z2yVmd">Note
18 &#8211; Warrants</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
Company issued 5 year warrants to investors in connection with two convertible note financings. The warrants have an exercise price
of $</span><span id="xdx_90B_ecustom--WarrantsIssuedExercisePrice_c20220401__20220430_zCejfhoYEOpa">1.50</span>. The warrants were
valued using the multinominal lattice The value of the warrants was included in the determination of the initial accounting for each
financing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">A
summary of the warrants issued and their fair values were:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfWarrantsIssuedAndFairValueTableTextBlock_zbYUho9Xrdlf" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of warrants issued and fair values (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; text-align: center; width: 16%"></td><td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; width: 3%"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; text-align: center; width: 16%"></td><td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; width: 3%"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%"></td><td style="font-size: 10pt; text-align: right; width: 16%"></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; width: 3%"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; text-align: center; width: 15%"></td><td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; width: 3%"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%"></td><td style="font-size: 10pt; text-align: right; width: 15%"></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Upon
    Issuance</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Outstanding at April
    30, 2024</b></span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Date
    of Transaction</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Number
    of Warrants</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Initial
    Fair Value</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Number
    of Warrants</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Fair
    Value</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">October
                                            2020&#160;</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td id="xdx_98B_ecustom--NumberOfWarrantsUponIssuance_c20201001__20201031_zrf8FE8uAXai" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">399,998</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td id="xdx_988_ecustom--InitialFairValueOfWarrantsUponIssuance_c20201001__20201031_zVHJZnweFA2i" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">267,999</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td id="xdx_988_ecustom--NumberOfWarrantsOutstanding_iI_c20240430_zcU3YTNrocc2" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">266,666</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td id="xdx_987_ecustom--FairValueOfWarrantsOutstanding_iI_c20240430_zgGQDHf51rRg" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">209,938</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">January
                                            2021</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td id="xdx_98C_ecustom--NumberOfWarrantsUponIssuance_c20210401__20210430_zqoZk596H3Sa" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">675,000</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td id="xdx_981_ecustom--InitialFairValueOfWarrantsUponIssuance_c20210401__20210430_z0jnE9yWovYf" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">2,870,666</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td id="xdx_98B_ecustom--NumberOfWarrantsOutstanding2_iI_c20240430_z4fwvJPyLxcd" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">540,000</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td id="xdx_985_ecustom--FairValueOfWarrantsOutstanding2_iI_c20240430_z7Ph1C34RfMa" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">443,242</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>


<p id="xdx_8AA_zeoq8hguxcca" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="background-color: white">To date,
we have received $</span><span id="xdx_905_ecustom--ProceedsReceivedFromExerciseOfWarrants_c20220301__20220430_zgA8xhD9MCKb">301,248
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">related to the exercise of <span id="xdx_900_ecustom--ExerciseOfWarrantsShares_c20220301__20220430_ztGoxU2DKPN8">268,332
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
May 2021, the Company issued warrants to purchase</span>
<span id="xdx_90A_ecustom--WarrantsToPurchaseSharesIssued_c20220501__20220531_zbkVYr0YrHaa">200,000</span> shares of common stock to the placement agent of its common stock offering.
The warrants have a five-year term and an exercise price of $<span id="xdx_900_ecustom--WarrantsIssuedExercisePrice_c20220501__20220531_zwWNi4oqeZb6">5.00</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
July 2021, the Company issued warrants to purchase </span><span id="xdx_90E_ecustom--WarrantsToPurchaseSharesIssued_c20230401__20230430_zmb56uvxdgwh">533,333
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">shares of common stock to the placement agent of its common stock offering.
The warrants have a five-year term and an exercise price of $<span id="xdx_905_ecustom--WarrantsIssuedExercisePrice_c20230401__20230430_zACHn60xjbR9">5.625</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
December 2023, the Company issued warrants to purchase 736,000</span> shares of common stock to the placement agent of its common stock
offering. The warrants have a five-year term and an exercise price of $0.625.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the range of assumptions
used to estimate the fair values of the stock warrants granted during the fiscal years ended April 30:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_zJcU7WkxDr3g" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%" summary="xdx: Disclosure - Assumptions used to estimate fair value of stock warrants granted (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Risk-free interest rate</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 15%; font-size: 10pt; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zQFMb5AWOQp9">4.25</span></td><td style="width: 1%; font-size: 10pt; text-align: left">%</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 15%; font-size: 10pt; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zWd6PqRFV4fg"><span style="-sec-ix-hidden: xdx2ixbrl1192">&#8212;</span></span>&#160;&#160;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Expected dividend yield</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zqQqSW2KsB2k"><span style="-sec-ix-hidden: xdx2ixbrl1193">&#8212;</span></span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zFMXQHHtWFij"><span style="-sec-ix-hidden: xdx2ixbrl1194">&#8212;</span></span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Expected term (in years)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zu29Ss1ODlQa">5.00</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Expected volatility</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zMwycctXaBIb">205.50</span></td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_z6hX24aKQBRd"><span style="-sec-ix-hidden: xdx2ixbrl1197">&#8212;</span></span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AA_zwktyI1mTKO1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the changes in warrants
outstanding since April 30, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zsdFJDMohnN8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Changes in warrants outstanding (Details)">
<tr style="vertical-align: bottom">
    <td colspan="3"><span style="font-size: 10pt"><b>&#160;</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Shares&#160;</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-average
    Exercise Price per Share</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;Weighted-average
                                            Remaining Contractual Term</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
    years)&#160;</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    Intrinsic Value&#160;</b></span></p></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance as of April 30, 2022</span></td>
    <td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zTW3ZBJWhzde" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,539,999</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td></td>
    <td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zo1SLf91aMLl" style="font-size: 10pt">3.38</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20210501__20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z7rVNAKJOWTi" style="font-size: 10pt">3.89</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zH26NEBRYuvc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">427,533</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-left: 10pt; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; width: 12%"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_znif4T3RcJua" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1204">&#8212;</span></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right; width: 12%"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zxhPX5rdpN7e" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1205">&#8212;</span></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zPHx8GRBEyVg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1206">&#8212;</span></span></td>
    <td style="border-bottom: black 1pt solid"></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zvwPqGg9Id1l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1207">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of April 30, 2023</span></td>
    <td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zjvR3ErN3P7i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,539,999</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td></td>
    <td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zfRHpMCEPmwc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.38</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zhJ9DYhfua59" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.89</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zFf9i1nIvMRc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1211">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted&#160;</span></td>
    <td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zJY4pO2gXjI9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">736,000</span><span style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zdiq75j8N6F7">0.63</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zangf3TGQe9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1214">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z1lfEfCZUQNl"><span style="-sec-ix-hidden: xdx2ixbrl1215">&#8212;</span></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at April 30, 2024</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zxpBA2wbZjV7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,275,999</span></td>
    <td></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$</span></td>
    <td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zLvgU96LzJdk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.49</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z0Ddk3rPDzo6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.77</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zwAMcfA1BcA1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">666,080</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p id="xdx_8AA_zVB84czH59te" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote18WarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote18WarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_WarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_WarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627441552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 19 &#8211; Share Based Awards<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Note 19 &#8211; Share Based Awards</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_z10bcvI9UIt" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_828_zhfV6RI7SuAf">Note
19 &#8211; Share Based Awards</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
2019 Equity Incentive Plan (the "Plan") allows us to incentivize key employees, consultants, and directors with long term compensation
awards such as stock options, restricted stock, and restricted stock units (collectively, the "Awards"). The number of shares
issuable in connection with Awards under the Plan may not exceed <span id="xdx_90E_ecustom--NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum_c20230501__20240430_zpckOMdwMUD8">11,750,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"><b><i>A.</i></b></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Options&#160;</i></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
range of assumptions used to calculate the fair value of options granted during the year ended April 30 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfAssumptionsUsed1TableTextBlock_zlJsdOqFLd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Assumptions used to calculate fair value of options granted (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; font-size: 12pt; padding-bottom: 1pt; padding-left: 5.4pt; width: 51%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%">2024</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 3%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%">2025</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Exercise Price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_znr5WCUPbCP">0.72</span>
                                       &#8211; <span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zHbG3tmqs4L">1.12</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zVXfTOgwyk4c">0.89</span> &#8211; <span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zkbYGggAn3ea">2.38</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Stock price on date of grant</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zjBycKek9mpk">0.70</span>
                                            &#8211; <span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z0JKFik2vpkc">1.12</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zGtDkv14j5p4">0.89</span> &#8211; <span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zvfA2hkLNG6l">2.38</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"> <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zmXWPdFCN85i">3.46</span></span>
                                            &#8211; <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zN2NFFOAl9n6">4.41</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zul8iVPo6PW7">3.34</span> &#8211; <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zBNgmE0Chh0c">4.18</span>%</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zjAMVTqHJoDh"><span style="-sec-ix-hidden: xdx2ixbrl1237">&#8212;</span></span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zM3kr2EDyfcb"><span style="-sec-ix-hidden: xdx2ixbrl1238">&#8212;</span></span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zWRksUn4u3Zh">5.28</span>
                                            &#8211; <span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dtY_c20230501__20240430_zNHiDYXCl967">8.25</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pip0_dtY_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zruNJFgz5wdf">6.25</span> &#8211;<span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_pip0_dtY_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zpwSLuFgA2m5"> 8.25</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zuT1upOL7n9l" style="font-size: 10pt">206.99</span>
                                            &#8211; <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zvsJVhzHcbQk">262.07</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zmHcQktbERCa">245.57</span> &#8211; <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zhZz3gVuuXPj">260.06</span>%</span></td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A9_z3DArA8jR2xd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;&#160;<span style="background-color: white">&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">A
summary of options activity under the Plan since April 30, 2022 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_z5BxiEb8u2p4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of activity under the Plan (Details)">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-Average
    Exercise Price</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-Average
    Remaining Contractual Term</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    Intrinsic Value</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
    as of April 30, 2022</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z9JddxlLgW45" style="text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,694,142</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zDfQygnCPCS3" style="text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.17</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; width: 10%"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20210501__20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zGwlEPulhxN" style="font-size: 10pt">8.56</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zbymHYYhCbFf" style="text-align: right; width: 10%"><span style="font-size: 10pt">1,407,545<span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zHVGkEKKMFai" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,503,500</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zOWUkHLe1st9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.40</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zOyBMZy95HX6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1255">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zsBav4TEliq9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1256">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or expired</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zrW8u4ZZ9JLf" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(412,833</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zhdPZhIPzwUj" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.67</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of April
    30, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zRSYnvSeXz3k" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,784,809</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td></td>
    <td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zgq68MUr38H1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.88</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zB5q62szJRI3" style="font-size: 10pt">8.72</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zvgCYYRYVGSk" style="text-align: right"><span style="font-size: 10pt">74,586<span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zUlbR3r75jh7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,903,542</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zTryk9fE3Q2g" style="text-align: right"><span style="font-size: 10pt">1.02</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zpGkhHfXKiOh" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_ziMGzb74CkBa" style="text-align: right"><span style="font-size: 10pt">0.89</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or expired</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z17Tq6RDB5e7" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(905,417</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zt4VdGNJkAPh" style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">2.27</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of April
    30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zV9ZP6gH2lVf" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,779,934</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"></td>
    <td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zhOok9YBrO74" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.46</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zebS582N3eX5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.02</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zDC90se1bOvk" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,762,242</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable as of April
    30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zgjZ1UjN8Pci" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,578,756</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zyXxS8pebzn5" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.78</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_pip0_dtY_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zgQszYc0IZ06" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.77</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zIFtUMZ7G9P5" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,246,497</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p id="xdx_8A8_zGRmYjvNuSY8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;<span style="background-color: white">&#160;&#160;&#160;&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
aggregate intrinsic value of outstanding options represents the excess of the stock price at the indicated date over the exercise price
of each option. As of April 30, 2024 and April 30, 2023, there was $<span id="xdx_902_ecustom--UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions_c20230501__20240430_zZoeAsxhxJOd">943,648 </span> and $<span id="xdx_903_ecustom--UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions_c20220501__20230430_zcRltzszwp71">2,940,239 </span> of unrecognized stock-based compensation expense
related to unvested stock options which is expected to be recognized over the weighted average periods of 1.95 and 1.94 years, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"><b><i>B.</i></b></span></td>
    <td><span style="font-size: 10pt"><b><i>Restricted Stock</i></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">A
summary of restricted stock activity under the Plan since April 30, 2022 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z84tdguiL5Rl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Summary of restricted stock activity under the Plan (Details)">
<tr style="vertical-align: bottom">
    <td style="padding-left: -10pt; text-align: center"></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Weighted Average Grant-Date Fair Value Per Share</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt; width: 52%">Unvested and outstanding as of April 30, 2022</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zV8dAXgikZgj" style="text-align: right; width: 20%">1,083,675</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_98B_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zhXB56LbIqZ3" style="text-align: right; width: 20%">2.59</td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z4jVvh0rQXr3" style="text-align: right">780,884</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zHv6OUJbVmt9" style="text-align: right">2.14</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zQ8MxyxITMWa" style="text-align: right">(1,062,372</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zOb6h99Xb7M9" style="text-align: right">2.42</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zq6ViujPLwkf" style="border-bottom: Black 1pt solid; text-align: right">(21,127</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zMEAvNtQfW98" style="border-bottom: Black 1pt solid; text-align: right">2.13</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Unvested and outstanding as of April 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zf0VHQ1spJak" style="text-align: right">781,060</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zf5lBVZ5H87k" style="text-align: right">2.44</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzWnvNEyDM8h" style="text-align: right">298,643</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zc1G6x12U2B4" style="text-align: right">1.06</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zgBw5Arl4w0c" style="text-align: right">(485,024</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zXvowxgTscu6" style="text-align: right">1.92</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzmxbe74ulea" style="border-bottom: Black 1pt solid; text-align: right">(419,549</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zCcY2OlxCoEi" style="border-bottom: Black 1pt solid; text-align: right">2.09</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Unvested and outstanding as of April 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 3pt double; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zRbhP7FOc4Rf" style="border-bottom: Black 3pt double; text-align: right">175,130</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 3pt double; text-align: left">$</td><td id="xdx_98D_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zCQ8YUGgjMm3" style="border-bottom: Black 3pt double; text-align: right">2.09</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A5_z49cwLUvr352" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;<span style="background-color: white">&#160;&#160;&#160;&#160;&#160;&#160;</span>&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"><b><i>C.</i></b></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b><i>Stock Compensation</i></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Stock
compensation expense by functional operating expense was:</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_zthfBHLiJRfg" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Stock compensation expense by functional category (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49A_20230501__20240430_zcIPDrqmhWY1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_492_20220501__20230430_zzGJzJJOam09" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2023</td></tr>
  <tr id="xdx_407_ecustom--ResearchAndDevelopmentStockCompensationExpense_zeYrjtkC57Ki" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Research and development</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">395,105</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">692,947</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--SalesAndMarketingStockCompensationExpense_zbYC6Vzdfuc4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Sales and marketing</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">562,110</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">566,153</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--GeneralAndAdministrativeStockCompensationExpense_zXISc5acHtK5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">General and administrative</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,652,052</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,397,624</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--TotalStockCompensationExpense_zGbdAjOOIZx2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,609,267</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,656,724</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock compensation expense pertaining to options totaled
$<span id="xdx_906_ecustom--StockCompensationExpensePertainingToOptions_c20230501__20240430_z8umk4xuPXQ4">2,619,501 </span> and
$<span id="xdx_90F_ecustom--StockCompensationExpensePertainingToOptions_c20220501__20230430_zjbpv0lroDOg">1,617,982 </span> for the year ended April 30, 2024 and 2023, respectively. Stock compensation expense pertaining to restricted
stock totaled $<span id="xdx_90E_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20230501__20240430_zYVyrNIfyO0l">989,766</span> and $<span id="xdx_901_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20220501__20230430_zA1TpSTKGV4j">2,038,742 </span>  for the year ended April 30, 2024 and 2023, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619359648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 20 - Related-Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Note 20 - Related-Party Transactions</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zCeuTJOA1JFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_822_zmrto8EkK6Q7">Note
20 - Related-Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
January 2022, the Company entered into a note agreement with an employee in the principal amount of $510,323, as further described in
Note 7.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
February 2024, the Company sold Rotor Riot and Fat Shark to Unusual Machines, as further described in Note 3 and Note 9. UMAC&#8217;s
Chief Executive Officer is a direct relative of a member of the Company&#8217;s management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Additional
related party transactions are disclosed in Note 14.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619363168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 21 &#8211; Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Note 21 &#8211; Commitments and Contingencies</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zjcUp5DmeAv3" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt; background-color: white"><b><span id="xdx_82D_zb3uvmSSls8d">Note
21 &#8211; Commitments and Contingencies</span>&#160;</b></span><span style="font-size: 8pt; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt/11.75pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="background-color: white">In
the ordinary course of business, we may be involved, at times, in various legal proceedings involving a variety of matters. We do not
believe there are any pending legal proceedings that will have a material adverse effect on our business, consolidated financial position,
results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant
uncertainties. We have not recorded any litigation reserves as of&#160;April 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">One pending
legal matter is an action filed against Teal and the Company in a U.S. District Court in California.&#160;The complaint asserts claims
for breach of contract, and the unlawful conversion and sale of shares of common stock that plaintiff alleges to have purchased in Teal
prior to its acquisition by the Company. The complaint also alleges breach of fiduciary duty and seeks in excess of $1 million in damages.
The Company plans to vigorously assert defenses to the complaint.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Another pending legal matter is an action filed against
Teal in a U.S. District Court in Delaware. The complaint asserts claims for breach of contract which management denies. We are asserting
vigorous defenses to the complaint. Additionally, the Company has filed a lawsuit against the complainant for Tortious Interference with
Contractual Relations and Prospective Contractual Relations. No discovery or other significant developments in the Lawsuit have occurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="background-color: yellow"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619373440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 22 &#8211; Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Note 22 &#8211; Subsequent Events</a></td>
<td class="text"><p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zYDkfI5lm2B4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_82A_zTmqKKtFM0dg">Note
22 &#8211; Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Subsequent events have been evaluated
through the date of this filing and there are no subsequent events which require disclosure, except as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">As described in Note 3, the SPA pertaining
to the divestiture of the Consumer segment provided that the purchase price was to be increased on a dollar-for-dollar basis by the amount
by which the working capital exceeded the agreed working capital (the &#8220;Working Capital Adjustment&#8221;). After negotiations between
the parties, it was determined in July 2024 that UMAC owed the Company $2,000,000 as a Working Capital Adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">As a result, UMAC issued the Company
$4,000,000 of its 8% Promissory Notes due November 30, 2025 (the &#8220;New Notes&#8221;) reflecting (i) satisfaction and settlement of
working capital adjustments and (ii) a maturity date extension to November 30, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">On July 22, 2024, the Company sold
all of its securities in UMAC to two unaffiliated third-party purchasers (the &#8220;Purchasers&#8221;). As part of the transaction,
on July 22, 2024, the Company entered into an Exchange Agreement (the &#8220;Exchange Agreement&#8221;) with UMAC pursuant to which the
Company exchanged 4,250,000 shares of UMAC&#8217;s common stock, par value $0.001 per share, for 4,250 shares of UMAC&#8217;s newly designated
Series A Convertible Preferred Stock (the &#8220;Series A&#8221;). The Company sold the Series A and the New Notes to the Purchasers
for $4.4 million in cash pursuant to a Purchase Agreement in a transaction that closed on July 22, 2024.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979626530160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 &#8211; Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zcACN2x0a8Jg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86F_zWm6aVzxMiw7">Basis of Accounting</span> </b>&#8211; The financial statements
and accompanying notes are prepared in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;).
Certain prior period amounts have been restated to conform to the current year presentation.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock', window );">Restatement of Previously Issued Consolidated Financial Statements</a></td>
<td class="text"><p id="xdx_84D_ecustom--RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock_zdZxPdSJcoK8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_869_zUpKgUyCkTh4">Restatement of Previously Issued Consolidated Financial Statements</span> </b>&#8211;
The Company&#8217;s Consolidated Balance Sheet as of April 30, 2023, Consolidated Statement of Operations, Stockholders&#8217; Equity
and Cash Flows for the year then ended, and its Notes to the Consolidated Financial Statements for the year ended April 30, 2023, which
were originally filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on July 27, 2023 (the &#8220;Original Form
10-K&#8221;), have been restated. The Company revised its accounting estimate of the life of an operating lease that was previously reported
in its Original Form 10-K. Upon further evaluation, the Company determined that prior year adjustments were necessary. These Consolidated
Financial Statements were restated to reflect a change in accounting estimate of the life of the operating lease under FASB ASC Topic
842 from three to nine years. Additionally, the Company revised its financial statements to&#160;remove derivative liabilities due to
erroneously reporting warrants from our convertible note financings, as described in Note 18, as having a derivative component.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The impacts of these restatements are detailed
in the tables below:</p>

<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_z37Q9DXaN6uh" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49B_20230430__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zSBEY5ZMCnF2">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49A_20230430__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zJcotfhJMGR4">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_494_20230430__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zE2BMOTeUBXc">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Consolidated Balance Sheet</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of April 30, 2023</b></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Originally</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Reported</b></p></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Restated</b></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Change</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zEXj3ClQpUhe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Operating lease right-of-use assets</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">620,307</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">1,600,434</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">980,127</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsNoncurrent_iI_zYu0GCBj0U15" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total long-term assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">28,018,078</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">28,568,316</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">550,238</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--OperatingLeaseLiabilityCurrentRestatementImpact_iI_zV5Lsmzs6zX9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Operating lease liabilities, current</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">281,797</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">159,423</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(122,374</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--DerivativeLiabilitiesCurrent_iI_zxK5uK4Xu5t7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Warrant derivative liability</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">588,205</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0601">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(588,205</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_406_ecustom--LiabilitiesCurrentRestatementImpact_iI_zcX5gpj013m1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total current liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,760,616</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,050,037</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(710,579</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zAZyNo5AY9uj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Operating lease liabilities, long-term</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">379,466</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,481,967</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,102,501</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesNoncurrent_iI_zeRaeufH1G8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total long-term liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">822,849</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,925,350</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,102,501</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AdditionalPaidInCapital_iI_zmMRlkMLIJZj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Additional paid-in capital</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">109,993,100</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">112,642,726</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,649,626</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zz9tAYWDUSnc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Accumulated deficit</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(54,586,793</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(57,078,103</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(2,491,310</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--StockholdersEquityRestatement_iI_z1d3aGID1Wt2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total shareholders&#8217; equity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">54,609,625</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">54,767,941</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">158,316</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_z7xYP0md9CXe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total liabilities and stockholders&#8217; equity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">60,193,090</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">60,743,328</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">550,238</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49A_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zCkwzAt0N4Gl">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49B_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zXWdYMkcEnHd">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49C_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zmsSZnt9OMe3">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Consolidated Statement of Operations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the year ended April 30, 2023</b></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Originally</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Reported</b></p></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Restated</b></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Change</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInDerivativeAssetsAndLiabilities_zPjADrAsg60l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Change in fair value of derivative liability</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">(1,019,292</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0633">&#8212;</span>&#160;&#160;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">1,019,292</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zNvjvy3NUWNc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Net loss</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(27,087,737</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(28,107,029</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(1,019,292</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A0_zjYLGJLijuGc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Amounts
presented as originally reported as of April 30, 2023 are exclusive of Discontinued Operations with the exception of (i) change in fair
value of derivative liability, (ii) net loss, and (iii) Consolidated Balance Sheet totals. The Consolidated Statement of Cash Flows is
not presented above as there was no change in net cash used in operating activities of continuing operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b></b></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zkZvGA0mBHSh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><span id="xdx_863_zyRmJgruZNZd">Principles of Consolidation</span></b>
&#8211; <span style="background-color: white">Our consolidated financial statements include the accounts of our wholly owned subsidiaries
which include Teal and Skypersonic as well as Rotor Riot and Fat Shark which were sold on February 16, 2024. Non-majority owned investments,
including the formerly wholly owned subsidiaries Rotor Riot and Fat Shark, are accounted for using the equity method when the Company
is able to significantly influence the operating policies of the investee. Intercompany transactions and balances have been eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">The
Consumer segment businesses are characterized as discontinued operations in these financial statements.&#160; The operating results and
cash flows of discontinued operations are separately stated in those respective financial statements. See Note 3. </span></p>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_842_eus-gaap--UseOfEstimates_zqrdyK4RO69i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86A_zBAJUmoHd7A7">Use of Estimates</span></b> &#8211;<span style="background-color: white">&#160;The
preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the
reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates
reflected in these financial statements include those used to (i) complete purchase price accounting for acquisitions,  (ii) the evaluation of long-term assets, including goodwill, for impairment,
and (iii) the evaluation of other-than-temporary-impairment of equity method investments.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zSCZZ1XMQgNj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86F_zWXrT1PWaWk1">Cash and Cash Equivalents</span> </b>&#8211; At April
30, 2024, we had cash of $<span id="xdx_90D_eus-gaap--Cash_iI_c20240430_zDhCfMNsSqrd">6,067,169</span> in multiple commercial banks and financial services companies. We have not experienced any loss on
these cash balances and believe they are not exposed to any significant credit risk.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><p id="xdx_843_eus-gaap--MarketableSecuritiesPolicy_zPBL5OWH1NVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span><span id="xdx_862_zEb69Umoc0T3">Marketable Securities</span></span> </b>&#8211; Our marketable
securities were classified and accounted for as available-for-sale securities. These securities were primarily invested in corporate bonds
and were readily saleable, and therefore, we have classified them as short term. Our available-for-sale securities were carried at fair
value with any unrealized gains and losses reported as a component of comprehensive income (loss). Once realized, any gains or losses
were recognized in the statement of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have elected to present accrued interest income
separately from marketable securities on our consolidated balance sheets. Accrued interest income was $<span id="xdx_90D_eus-gaap--InterestAndDividendIncomeSecuritiesOther_c20230501__20240430_z3s3egVeqBJl">0</span> and $<span id="xdx_908_eus-gaap--InterestAndDividendIncomeSecuritiesOther_c20220501__20230430_zmYMfQrnKUk7">151,671</span> as of April 30,
2024 and April 30, 2023, respectively, and was included in other current assets. We did not write off any accrued interest income during
the years ended April 30, 2024 and April 30, 2023.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable, net</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--ReceivablesPolicyTextBlock_zzUwQf7dHQS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_864_zoZnjrvVWqQ9">Accounts Receivable, net</span></b> &#8211; <span style="background-color: white">Accounts
receivable are recorded at the invoiced amount less allowances for doubtful accounts. The Company's estimate of the allowance for doubtful
accounts is based on a multitude of factors, including historical bad debt levels for its customer base, experience with a specific customer,
the economic environment, and other factors. Accounts receivable balances are written off against the allowance when it is probable that
the receivable will not be collected.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zoW6JvszIsA6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zie9xKVIAR93">Concentration
of Credit Risk</span> </b>&#8211; Financial instruments, which potentially subject the Company to concentrations of credit risk, include
trade receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company
performs ongoing credit evaluations of its customers, generally does not require collateral and considers the credit risk profile of
the customer from which the receivable is due in further evaluating collection risk. Customers that accounted for 10% or greater of
accounts receivable, net as of April&#160;30, 2024 and 2023 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQaKUgLgYhkf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Customer concentration risk (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">April 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left">Customer A</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zCN9cNhwol9i" style="width: 12%; text-align: right">53</td><td style="width: 1%; text-align: left">%</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zElcIGrV5OD2" style="width: 12%; text-align: right">20</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zT9MUrfmoD3g" style="text-align: right">24</td><td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer C</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk3Member_zfSzRhphaKsh" style="text-align: right">24</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer D</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk4Member_zLX4OaDIWoh6" style="text-align: right">14</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer E</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk5Member_zCjPkuR5tOIc" style="text-align: right">10</td><td style="text-align: left">%</td></tr>
  </table>


<p id="xdx_8A9_zdZqixz5godd" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">* Accounts Receivable was less than 10%</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">As of April 30, 2024, three customers accounted for equal to or greater
than 10% of total revenue, totaling 28%, 23% and 10%, respectively. As of April 30, 2023, two customers accounted for equal to or greater
than 10% of total revenue, totaling 22% and 20%, respectively.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zxgsdOPYKXS2" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86A_zzZlSG6nNFdj" style="font-size: 10pt"><b>Inventories</b></span><span style="font-size: 10pt">&#160;&#8211;&#160;<span style="background-color: white">Inventories,
which consist of raw materials, work-in-process, and finished goods, are stated at the lower of cost or net realizable value, and
are measured using the first-in, first-out method. Cost components include direct materials, direct labor, indirect overhead, as
well as in-bound freight. At each balance sheet date, the Company evaluates the net realizable value of its inventory using various
reference measures including current product selling prices and recent customer demand, as well as evaluating for excess quantities
and obsolescence.</span></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill and Long-lived Assets</a></td>
<td class="text"><p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zkY1ypyaw2r9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><span id="xdx_866_zZii5SDJXWqk">Goodwill and Long-lived
Assets</span></b> &#8211; Goodwill represents the future economic benefit arising from other assets acquired in an acquisition&#160;that are
not individually identified and separately recognized. We test goodwill for impairment in accordance with the provisions of&#160;<i>ASC
350, Intangibles &#8211; Goodwill and Other,&#160;</i>(&#8220;ASC 350&#8221;). Goodwill is tested for impairment at least annually at
the reporting unit level or whenever events or changes in circumstances indicate that goodwill might be impaired. ASC 350 provides that
an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a
determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing
the totality of events or circumstances, an entity determines it is not more likely than not that the fair value of a reporting unit
is less than its carrying amount, then additional impairment testing is not required. However, if an entity concludes otherwise, then
it is required to perform an impairment test. The impairment test involves comparing the estimated fair value of a reporting unit with
its book value, including goodwill. If the estimated fair value exceeds book value, goodwill is considered not to be impaired. If, however,
the fair value of the reporting unit is less than book value, then an impairment loss is recognized in an amount equal to the amount
that the book value of the reporting unit exceeds its fair value, not to exceed the total amount of goodwill allocated to the reporting
unit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The estimate of fair value
of a reporting unit is computed using either an income approach, a market approach, or a combination of both. Under the income approach,
we utilize the discounted cash flow method to estimate the fair value of a reporting unit. Significant assumptions inherent in estimating
the fair values include the estimated future cash flows, growth assumptions for future revenues (including gross profit, operating expenses,
and capital expenditures), and a rate used to discount estimated future cash flow projections to their present value based on estimated
weighted average cost of capital (i.e., the selected discount rate). Our assumptions are based on historical data, supplemented by current
and anticipated market conditions, estimated growth rates, and management&#8217;s plans. Under the market approach, fair value is derived
from metrics of publicly traded companies or historically completed transactions of comparable businesses. The selection of comparable
businesses is based on the markets in which the reporting units operate and consider risk profiles, size, geography, and diversity of
products and services.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Goodwill for Teal is ascribed
to its existing relationship with several U.S. government agencies including its classification as an approved vendor. The Company expects
that the Goodwill recognized in each transaction will be deductible for tax purposes.&#160; The Company has reported net losses since
its inception and is presently unable to determine when and if the tax benefit of this deduction will be realized.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text"><p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zlK9paOcqBP1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zCZchCcWsyZd">Property and equipment</span> &#8211; </b><span style="background-color: white">Property
and equipment is stated at cost less accumulated depreciation which is calculated using the straight-line method over the estimated useful
life of the asset. The estimated useful lives of our property and equipment are generally: (i) furniture and fixtures - seven years,
(ii) equipment and related - two to five years, and (iii) leasehold improvements &#8211; nine to fifteen years.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investment</a></td>
<td class="text"><p id="xdx_843_eus-gaap--EquityMethodInvestmentsPolicy_zRNYqmezB3t2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86C_z3SozqVYzUWe">Equity Method Investment</span> &#8211; </b><span style="background-color: white">The
equity method of accounting is applied to investments in which the Company has an ownership interest of between 20% and 50%. The Company
evaluates its equity method investments each reporting period for evidence of a loss in value that is other than a temporary decline.
Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount
of the investment or the inability of the investee to sustain an earnings capacity that would justify the carrying amount of the investment.
The Company performed this analysis and concluded that its investment in UMAC was other-than-temporarily impaired and recognized an impairment
charge of $<span id="xdx_906_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_c20230501__20240430_zLjRlyQIuHVk">11,353,875</span> for the year ended April&#160;30, 2024.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionLeasesOperating', window );">Leases</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--RevenueRecognitionLeasesOperating_zwjyPe10sMh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86C_zahzqreQGjDg">Leases</span> &#8211; </b>Accounting Standards Codification
(ASC) 842 requires the recognition of assets and liabilities associated with lease agreements. <span style="background-color: white">The
Company determines if a contract is a lease or contains a lease at inception. Operating lease liabilities are measured, on each reporting
date, based on the present value of the future minimum lease payments over the remaining lease term. The Company's leases do not provide
an implicit rate.&#160;Therefore, the Company uses an effective discount rate of 12% based on its last debt financing.&#160;Operating
lease assets are measured by adjusting the lease liability for lease incentives, initial direct costs incurred and asset impairments.
Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term with the operating lease asset reduced
by the amount of the expense. Lease terms may include options to extend or terminate a lease when they are reasonably certain to occur.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures</a></td>
<td class="text"><p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zEG4RIQjII5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_860_zhrT8UDCrKS">Fair Values, Inputs and Valuation Techniques for
Financial Assets and Liabilities, and Related Disclosures</span></b> &#8211; The fair value measurements and disclosure guidance defines fair
value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset
or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. In accordance
with this guidance, the Company has categorized its recurring basis financial assets and liabilities into a three-level fair value hierarchy
based on the priority of the inputs to the valuation technique.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value hierarchy gives the highest priority
to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level
3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the
fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input
that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input
to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The guidance establishes
three levels of the fair value hierarchy as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><i>Level 1</i>:
Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><i>Level 2</i>:
Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical
or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable
market data for substantially the full term of the related assets or liabilities; and</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><i>Level 3</i>:
Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little
or no market data.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Disclosures for Non-Financial Assets Measured at
Fair Value on a Non-Recurring Basis</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's financial instruments mainly consist
of cash, receivables, current assets, accounts payable, accrued expenses and debt. The carrying amounts of these instruments approximates
fair value due to their short-term nature.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_843_eus-gaap--RevenueRecognitionPolicyTextBlock_zU59Ys8Odozl" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86C_zxp8L7adoPgg">Revenue Recognition</span> </b>&#8211; The Company
recognizes revenue in accordance with ASC Topic 606 - Revenue from Contracts with Customers, issued by the Financial Accounting Standards
Board (&#8220;FASB&#8221;). This standard includes a comprehensive evaluation of factors to be considered regarding revenue recognition
including (i) identifying the promised goods, (ii) evaluating performance obligations, (iii) measuring the transaction price, (iv) allocating
the transaction price to the performance obligations if there are multiple components, and (v) recognizing revenue as each obligation
is satisfied.&#160;The Company&#8217;s revenue transactions include the shipment of goods to customers as orders are fulfilled, completion
of non-recurring engineering, completion of training, and customer support services. The Company recognizes revenue upon shipment of product
or prototypes unless otherwise specified in the purchase order or contract. Customer deposits totaled $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240430_zTRmOLvQ36X4">53,939</span> and $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20230430_zUyPr8922sC6">155,986</span> at April 30,
2024 and April 30, 2023, respectively. From time to time, non-recurring engineering contracts may involve the capitalization of engineering
prototypes, classified as contract assets. Contract assets totaled $<span id="xdx_907_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20240430_zhdr7vv0kb34">1,477,859</span> and $<span id="xdx_907_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20230430_zIBr7xEVQFj3">0</span> at April 30, 2024 and April 30, 2023, respectively.</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the Company&#8217;s
revenue disaggregated by revenue type:</p>

<table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_zet5crVfizG" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Company's revenue disaggregated by revenue type (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" id="xdx_497_20230501__20240430_zMjAJJjOleO3" style="font-size: 10pt; font-weight: bold; text-align: center"></td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" id="xdx_499_20220501__20230430_zmPFbgIgRww1" style="font-size: 10pt; font-weight: bold; text-align: center"></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Year Ended&#160;April 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">2023</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zdwJLPvW4QR9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-size: 10pt; text-align: left">Contract related</td><td style="width: 8%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">4,173,005</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 8%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">1,312,427</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomer_zm0HlgsW7Fbk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Product related</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">13,663,377</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,308,407</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Revenues_zPnw8zXZaaAd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">17,836,382</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,620,834</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A9_zKDDmRXWSIx6" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 5pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_z92tZr6bcLMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_zlvGi8T6cAC7">Research and Development</span> </b>&#8211; Research and
development expenses include payroll, employee benefits, and other headcount-related expenses associated with product development. Research
and development expenses also include third-party development and programming costs, materials, and a proportionate share of overhead
costs such as rent.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies', window );">Product Warranty</a></td>
<td class="text"><p id="xdx_846_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zrulqYFkDsq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zT5ZW2pySwOe">Product
Warranty</span> - </b>The Company accrues an estimate of its exposure to warranty claims based upon both current and historical
product sales data and warranty costs incurred. Product warranty reserves are recorded in current liabilities under accrued
expenses.&#160;Warranty liability was $<span id="xdx_90D_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240430_zkpemxJKlCd5">372,000</span>
and $<span id="xdx_90A_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20230430_zNpyM4tHDtmk">90,000</span> as of April 30, 2024
and April 30, 2023 respectively.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zRkFoxX8Urv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_867_zhFDWVR5zHo1">Income Taxes</span></b> &#8211; Deferred taxes are provided
on the liability method whereby deferred tax assets are recognized for deductible temporary differences and deferred tax liabilities are
recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities
and their tax bases. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of
enactment.&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zvxhnOmm86Mb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86A_zg7JfXrxaVQj">Recent Accounting Pronouncements</span> </b>&#8211; <span style="background-color: white">Management
does not believe that recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the
accompanying consolidated financial statements.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text"><p id="xdx_841_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zKHsbsxKpxej" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_z4k4QCX9HQR">Foreign Currency</span> &#8211; </b>The functional currency
of our former international subsidiary, Skyset, was the local Italian currency. For that subsidiary, we translated assets and liabilities
to U.S. dollars using period-end exchange rates, and average monthly exchange rates for revenues, costs, and expenses. We recorded translation
gains and losses in accumulated other comprehensive income.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zeZrDIVXtY43" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86C_zWiNRp5rUhJ3">Comprehensive Loss</span> </b>&#8211; Comprehensive loss
consists of net loss and other comprehensive loss. Other comprehensive loss refers to gains and losses that are recorded as an element
of stockholders' equity but are excluded from net loss. Our other comprehensive loss is comprised of foreign currency translation adjustments
and unrealized gains or losses on available-for-sale securities. During the year ended April 30, 2024, comprehensive loss was $<span id="xdx_906_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20230501__20240430_z20MHAd0Bx09">865,738</span>
lower than net loss, related to unrealized gains on available-for-sale securities totaling $<span id="xdx_902_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20230501__20240430_zu9aCfjA5Wh3">864,165</span> and foreign currency translation adjustments
of $<span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20230501__20240430_zA7NB9TbVz76">1,573</span>. During the year ended April 30, 2023, comprehensive loss was $<span id="xdx_901_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20220501__20230430_zCjsInfVH5i4">609,155</span> lower than net loss, related to unrealized gains on available-for-sale
securities totaling $<span id="xdx_901_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20220501__20230430_zUYz8lZOzpvd">610,129</span>, partially offset by foreign currency translation adjustments of $<span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20220501__20230430_zmMIZSeEG8Ma">974</span>.&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zIYMkuiE3t7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_ziZAPTrXDv1a">Stock-Based Compensation</span> </b>&#8211; S<span style="background-color: white">tock
options are valued using the estimated grant-date fair value method of accounting in accordance with ASC Topic 718, Compensation &#8211;
Stock Compensation. Fair value is determined based on the Black-Scholes Model using inputs reflecting our estimates of expected volatility,
term and future dividends. We recognize forfeitures as they occur. The fair value of restricted stock is based on our stock price on the
date of grant. Compensation cost is recognized on a straight-line basis over the service period which is the vesting term.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Net Loss per Share</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zxizuRADbMh3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86E_zNqdQaJZswfb">Basic and Diluted Net Loss per Share</span></b> &#8211;
Basic and diluted net loss per share has been calculated by dividing net loss by the weighted average number of shares of common stock
outstanding during the period. Common stock equivalents were excluded from the computation of diluted net loss per share of common stock
because they were anti-dilutive. The conversion or exercise of these common stock equivalents would dilute earnings per share if we become
profitable in the future. Outstanding securities not included in the computation of diluted net loss per share because their effect would
have been anti-dilutive include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z9tJBwS9KIPf" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_494_20230501__20240430_zqag83BE45nl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_497_20220501__20230430_zgFS9fM9BDJi" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_407_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_zgjK8cfnMyAd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Series B Preferred Stock, as converted</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 20%; font-size: 10pt; text-align: right">3,896</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 20%; font-size: 10pt; text-align: right">822,230</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_zhEgkUq1hHz2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Stock options</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">6,779,934</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,784,809</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_zOCXNCCHhdL2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,275,999</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,539,999</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_zfeTr9nC4ms5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Restricted stock</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">175,130</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">781,060</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zGwJOfxndp3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">9,234,959</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">7,928,098</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zQiqjBwavoJ5" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RelatedPartiesPolicyTextBlock', window );">Related Parties</a></td>
<td class="text"><p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zCXtklxqrUV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_866_zNIcK9TfCCch">Related Parties</span></b> &#8211; Parties are considered
to be related to us if they have control or significant influence, directly or indirectly, over us, including key management personnel
and members of the Board of Directors or are direct relatives of key management personnel of members of the Board of Directors. Related
Party transactions are disclosed in Note 20.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">Liquidity and Going Concern</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zTlQsOqnNxS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_86B_zY3r2rak3238">Liquidity
and Going Concern</span> </b>&#8211; The Company has never been profitable and has incurred net losses related to acquisitions, as well as costs
incurred to pursue its long-term growth strategy. During the year ended April 30, 2024, the Company incurred a net loss from continuing
</span>operations of $<span id="xdx_909_eus-gaap--IncomeLossFromContinuingOperations_dxL_c20230501__20240430_zSzkm1Ldsnmh" title="::XDX::-21526696"><span style="-sec-ix-hidden: xdx2ixbrl0737">21,526,696</span></span>&#160;and used cash in operating activities of continuing operations of $<span id="xdx_903_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_dxL_c20230501__20240430_zaIhyh0n4g01" title="::XDX::-17687063"><span style="-sec-ix-hidden: xdx2ixbrl0738">17,687,063</span></span>. As of April 30,
2024, working capital for continuing operations totaled $<span id="xdx_907_eus-gaap--Capital_iI_c20240430_zQPgJOzWJ7ca">18,746,419</span>. These financial results and our financial position <span style="background-color: white">at&#160;April
30, 2024&#160;raise substantial doubt about our ability to continue as a going concern. However, the Company has recently taken actions
to strengthen its liquidity.&#160;On&#160;December 11, 2023, we completed a public offering of 18,400,000 shares of common stock which
generated net proceeds of approximately $8,400,000 as further described in Note 1 and Note 16. In addition, the Company&#8217;s operating
plan for the next twelve months has been updated to reflect recent operating improvements.&#160; Revenues have accelerated and are expected
to continue growing. The Company&#8217;s manufacturing facility is scaling production and gross profits are projected to increase.&#160;<span style="background-color: white">If necessary, the Company will seek
to obtain additional debt financing for which there can be no guarantee.</span> Subsequent
to year end, as further described in Note 22, the Company sold its equity method investment for $4,400,000. Management has concluded
that these recent positive developments alleviate any substantial doubt about the Company&#8217;s ability to&#160;continue its operations,
and meet its financial obligations, for twelve months from the date these consolidated financial statements&#160;are&#160;issued.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RelatedPartiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RelatedPartiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21D<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-21D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//460/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionLeasesOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition for operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481178/840-20-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionLeasesOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619357328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 &#8211; Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock', window );">[custom:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_z37Q9DXaN6uh" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49B_20230430__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zSBEY5ZMCnF2">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49A_20230430__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zJcotfhJMGR4">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_494_20230430__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zE2BMOTeUBXc">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Consolidated Balance Sheet</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of April 30, 2023</b></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Originally</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Reported</b></p></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Restated</b></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Change</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zEXj3ClQpUhe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Operating lease right-of-use assets</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">620,307</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">1,600,434</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">980,127</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsNoncurrent_iI_zYu0GCBj0U15" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total long-term assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">28,018,078</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">28,568,316</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">550,238</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--OperatingLeaseLiabilityCurrentRestatementImpact_iI_zV5Lsmzs6zX9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Operating lease liabilities, current</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">281,797</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">159,423</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(122,374</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--DerivativeLiabilitiesCurrent_iI_zxK5uK4Xu5t7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Warrant derivative liability</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">588,205</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0601">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(588,205</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_406_ecustom--LiabilitiesCurrentRestatementImpact_iI_zcX5gpj013m1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total current liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,760,616</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,050,037</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(710,579</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zAZyNo5AY9uj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Operating lease liabilities, long-term</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">379,466</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,481,967</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,102,501</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesNoncurrent_iI_zeRaeufH1G8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total long-term liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">822,849</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,925,350</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,102,501</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AdditionalPaidInCapital_iI_zmMRlkMLIJZj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Additional paid-in capital</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">109,993,100</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">112,642,726</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,649,626</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zz9tAYWDUSnc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Accumulated deficit</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(54,586,793</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(57,078,103</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(2,491,310</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--StockholdersEquityRestatement_iI_z1d3aGID1Wt2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total shareholders&#8217; equity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">54,609,625</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">54,767,941</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">158,316</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_z7xYP0md9CXe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total liabilities and stockholders&#8217; equity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">60,193,090</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">60,743,328</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">550,238</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49A_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zCkwzAt0N4Gl">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49B_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zXWdYMkcEnHd">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49C_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zmsSZnt9OMe3">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Consolidated Statement of Operations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the year ended April 30, 2023</b></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Originally</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Reported</b></p></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Restated</b></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Change</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInDerivativeAssetsAndLiabilities_zPjADrAsg60l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Change in fair value of derivative liability</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">(1,019,292</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0633">&#8212;</span>&#160;&#160;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">1,019,292</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zNvjvy3NUWNc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Net loss</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(27,087,737</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(28,107,029</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(1,019,292</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQaKUgLgYhkf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Customer concentration risk (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">April 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-align: left">Customer A</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zCN9cNhwol9i" style="width: 12%; text-align: right">53</td><td style="width: 1%; text-align: left">%</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zElcIGrV5OD2" style="width: 12%; text-align: right">20</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zT9MUrfmoD3g" style="text-align: right">24</td><td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer C</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk3Member_zfSzRhphaKsh" style="text-align: right">24</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer D</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk4Member_zLX4OaDIWoh6" style="text-align: right">14</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer E</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk5Member_zCjPkuR5tOIc" style="text-align: right">10</td><td style="text-align: left">%</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock', window );">[custom:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_zet5crVfizG" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Company's revenue disaggregated by revenue type (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" id="xdx_497_20230501__20240430_zMjAJJjOleO3" style="font-size: 10pt; font-weight: bold; text-align: center"></td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" id="xdx_499_20220501__20230430_zmPFbgIgRww1" style="font-size: 10pt; font-weight: bold; text-align: center"></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Year Ended&#160;April 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">2023</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zdwJLPvW4QR9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-size: 10pt; text-align: left">Contract related</td><td style="width: 8%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">4,173,005</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 8%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">1,312,427</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomer_zm0HlgsW7Fbk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Product related</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">13,663,377</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,308,407</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Revenues_zPnw8zXZaaAd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">17,836,382</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,620,834</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z9tJBwS9KIPf" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_494_20230501__20240430_zqag83BE45nl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_497_20220501__20230430_zgFS9fM9BDJi" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_407_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_zgjK8cfnMyAd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Series B Preferred Stock, as converted</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 20%; font-size: 10pt; text-align: right">3,896</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 20%; font-size: 10pt; text-align: right">822,230</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_zhEgkUq1hHz2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Stock options</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">6,779,934</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,784,809</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_zOCXNCCHhdL2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,275,999</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,539,999</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_zfeTr9nC4ms5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Restricted stock</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">175,130</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">781,060</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zGwJOfxndp3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">9,234,959</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">7,928,098</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-16<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627248992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 &#8211; Divestiture of Consumer Segment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zSkyfwXJYvJf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Discontinued Operations - results of operations (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td colspan="3" id="xdx_493_20230501__20240430_zshf715XYCU1" style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td colspan="3" id="xdx_490_20220501__20230430_zEvfNYksleKf" style="font-size: 12pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>April 30,</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2023</td></tr>
  <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_zet66lxCG3cd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-indent: -10pt; padding-left: 10pt">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">4,213,653</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">5,290,946</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_zZCp6nmbVSq1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Cost of goods sold</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,577,980</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,793,430</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_zZB2bdYGJ107" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Gross (Loss) Profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(364,327</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">497,516</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract_iB_zHCQOqo9zi16" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Operating Expenses</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_i01_zJLH4PGzI8F9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118,093</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">346,002</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_i01_zVhUkNrCIv5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,157,448</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">862,384</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_i01_zVuRSUxgtgUf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">General and administrative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">863,361</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,044,435</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_i01_zbIlawNLqG9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,138,902</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,252,821</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_z9ivHMd3EAOj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Operating loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,503,229</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,755,305</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_iB_zVvUU5f7lou5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Other expense (income)</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInterestExpense_i01_zpBc0jySXPA1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,856</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0783">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherIncome_i01N_di_zKtzrAasM0nd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Other, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(152</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(24,919</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_i01_zFuBhwfCwzb3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Other expense (income)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,704</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(24,919</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt; text-indent: -10pt; padding-left: 20pt">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt; text-align: left">&#160;</td><td style="font-size: 12pt; text-align: right">&#160;</td><td style="font-size: 12pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_zm0JKW1Nqn7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 20pt">Net loss from discontinued operations</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(2,525,933</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(1,730,386</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock', window );">[custom:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock_zDXki7kt0Sge" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Assets and liabilities for the Consumer Segment (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_490_20240430_znrKTTBcuGWl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_491_20230430_zsmNxUUlbZs1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_400_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_iB_z87t70LlmfEl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCash_i01I_z2NIr3x53W3d" style="vertical-align: bottom; background-color: White">
    <td style="width: 62%; font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Cash</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0799">&#8212;</span>&#160;&#160;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 15%; font-size: 10pt; text-align: right">86,656</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_i01I_zcwueUvWpSi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts receivable, net</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0802">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">61,107</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_i01I_z1sBCuNDbE6a" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Inventory</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0805">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,065,954</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_i01I_zb1zbFTBsK43" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Other</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0808">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,069,438</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_i01I_zBWkVUPanN5g" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Total current assets</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0811">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">5,283,155</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_i01I_z8Tx8utNgRlk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Intangible assets, net</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0814">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">20,000</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_i01I_zkc2jxz6q2uf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 10pt">Other</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0817">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,853</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent_iI_zSUCOiDo29Z6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Operating lease right-of-use assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0820">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">84,544</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_iI_zp1C8ecSpts5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Total long term assets</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0823">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">108,397</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_iB_z0WB0fL1ytUd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_i01I_zBxrKpDpQkq" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts payable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0829">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">606,872</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_i01I_zWSzKPSieU8f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Accrued expenses</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0832">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">109,480</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_i01I_zgpnGHr06vK5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Customer deposits</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0835">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">244,688</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent_i01I_zz7sEoiHkCz8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Operating lease liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0838">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">49,461</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_i01I_z3BPfxYaOHfb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Total current liabilities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0841">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,010,501</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent_iI_zkjV11vb9jBj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Long term liabilities - Operating lease liabilities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0844">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">41,814</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--DisposalGroupIncludingDiscontinuedOperationWorkingCapital_iI_zePZUDSsMGg6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Working capital</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0847">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,272,654</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5D<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3A<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627425248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 &#8211; Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z6BUpddFWoF9" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Inventories (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49A_20240430_znqN3pNDk0V4" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_495_20230430_zTR3DOqZWeG2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_zkyxa8aKxVd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Raw materials</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">5,750,324</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">8,132,196</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--InventoryWorkInProcess_iI_z8Vu5WAs9G9f" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">Work-in-process</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,289,997</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">509,381</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--InventoryFinishedGoods_iI_zCIqhYR0CO7j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Finished goods</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">966,916</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">278,996</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryNet_iI_zaJzXLheb7x5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8,007,237</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8,920,573</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619431824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 &#8211; Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zve7ktwRkWRi" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Other current assets (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_495_20240430_zngNaW3Pybsj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49F_20230430_zCwwNg2UMCl9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_40E_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_d0_zw8bDNFFohF2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Contract asset</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">1,477,859</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">&#8212;&#160;&#160;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--PrepaidExpenseCurrent_iI_z9jCggJwMmil" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Prepaid expenses</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,206,306</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">752,564</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--GrantsReceivableCurrent_iI_zqOJt7hTi7s1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Grant receivable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">675,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0882">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_zD0u2si96To6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Prepaid inventory</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">602,888</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">359,500</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss_iI_zlv58nsr7y2a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Accrued interest income</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0887">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">151,671</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherAssetsCurrent_iI_zwrVf7JHUR99" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,962,053</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,263,735</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627327872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 &#8211; Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zX2LoD05fw32" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_496_20240430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_z2lGxlgYlT0j" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_49E_20240430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_zQpL6rgyu3u3" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_499_20240430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zdHSJKKxRag8" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_492_20230430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_zj7diAdCNLV3" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_493_20230430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_z87k05xiuure" style="text-align: center"></td><td style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_49C_20230430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zv7ORBT9jZo3" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Gross Value</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Net Value</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.85pt 0 0; text-align: center"><b>Gross</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Value</b></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Net Value</td></tr>
  <tr id="xdx_40B_ecustom--FiniteLivedProprietaryTechnologyGross_iI_z9OH8LlngRLe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt; text-align: left">Proprietary technology</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right">4,282,001</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right">(1,917,612</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right">2,364,389</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right">4,967,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right">(1,271,112</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 6%; font-size: 10pt; text-align: right">3,695,888</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--FiniteLivedNoncompeteAgreementsGross1_iI_zZTkVcNMkU6i" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Non-compete agreements</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">65,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(65,000</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0920">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">81,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(56,667</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">24,333</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--FiniteLivedCustomerRelationshipsGross1_iI_zUBASyRu0cX4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Customer relationships</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0925">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0926">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0927">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">39,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(18,106</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">20,894</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--FiniteLivedIntangibleAssetsGross1_iI_zO3OZ9bu8atf" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Total finite-lived assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,347,001</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(1,982,612</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,364,389</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">5,087,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(1,345,885</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,741,115</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IndefiniteLivedTradeNames_iI_ztjiNZM883Fg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Brand name</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,430,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0940">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,430,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,152,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0943">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,152,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--IndefiniteLivedIntangibleAssetsExcludingGoodwill1_iI_zgHiUt7bR99j" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt">Total indefinite-lived assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,430,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0947">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,430,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,152,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0950">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,152,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IntangibleAssetsNetExcludingGoodwill1_iI_z7Gl2PfL7N0h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: 10pt">Total intangible assets, net</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">5,777,001</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(1,982,612</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,794,389</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8,239,000</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(1,345,885</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">6,893,115</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zjneipPSX354" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Expected amortization expense for the unamortized finite-lived intangible assets (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-size: 10pt">&#160;</td>
    <td colspan="2" style="text-align: left; font-size: 10pt">Fiscal Year Ended:</td><td>&#160;</td>
    <td colspan="3" id="xdx_49E_20240430_zXaRMnPYpHdb">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_zexbQb0J4IVj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 65%; font-size: 10pt; text-align: left">2025</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 30%; font-size: 10pt; text-align: right">709,316</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_zuPC7NIpEPni" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">2026</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">709,316</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_z8fubbCcSvLk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">2027</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">709,316</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_zwTo7HbdELuk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">2028</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">236,441</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_zxuDNQg8YLt5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">2029</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0970">&#8212;</span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_zMpmporglwSl" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_zpbixktmPMy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,364,389</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfGoodwillTextBlock_zIm5jaFCEO12" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Composition of, and changes in goodwill (Details)">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt">Date</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Entity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_4BC_us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap--GoodwillMember_zTxPMT2MHiE9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Goodwill</td></tr>
  <tr id="xdx_43E_c20200101__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_zVBMNDR9lQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 36%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">January 2020</span></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 30%; font-size: 10pt; text-align: center; padding-left: 5.75pt">Rotor Riot</td><td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">1,849,073</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20201101__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_z2jBZyYLS7Ti" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">November 2020</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 5.75pt">Fat Shark</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">6,168,260</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_433_c20210501__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_zyUCw4f48f31" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">May 2021</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 5.75pt">Skypersonic</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,826,918</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20210801__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_zJ8BOuIQznS4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">August 2021</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-left: 5.75pt">Teal Drones</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">8,995,499</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20230401__20230430_eus-gaap--GoodwillImpairmentLoss_iN_di_zarFtKrXSuf2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">April 2023 - Impairment loss</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-bottom: 1pt; padding-left: 5.75pt">Skypersonic</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(2,826,918</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_439_c20230430_eus-gaap--Goodwill_iI_z6nMnHPAnlYh" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Balance at April 30, 2023</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.75pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">17,012,832</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20240201__20240430_eus-gaap--GoodwillWrittenOffRelatedToSaleOfBusinessUnit_iN_di_zSBGoPCLIeJd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">February 2024 &#8211; Divestiture</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt; padding-left: 5.75pt">Rotor Riot, Fat Shark</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(7,924,282</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_434_c20240430_eus-gaap--Goodwill_iI_zba2WDzOY1E8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Balance at April 30, 2024</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt; padding-left: 5.75pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">9,088,550</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627401344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 &#8211; Equity Method Investment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock', window );">[custom:EquityMethodInvestmentFinancialInformationTableTextBlock]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--EquityMethodInvestmentFinancialInformationTableTextBlock_zKROqMKzMPrg" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Financial informatino for UMAC derived from their Form 10-Q (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_498_20240101__20240331__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zYeBfmK7l2wj">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AssetsCurrent_iE_zNk2JRkdgya5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 67%; font-size: 10pt; text-align: left">Current assets</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 30%; font-size: 10pt; text-align: right">6,128,890</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsNoncurrent_iE_zfYhJXWFPV3k" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Long-term assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">18,099,802</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesCurrent_iE_zIfxmBi54kE5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Current liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">691,978</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesNoncurrent_iE_zkpKr46q3Q9g" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Long-term liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,313,896</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Revenues_zEoIDgypOTUc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Revenues</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">618,915</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--GrossProfit_zaEArg6XVZr4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Gross profit</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">204,167</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_zqWGToyTOZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Net loss</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(1,106,001</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--EquityMethodInvestmentsTextBlock_zLOji0k794G2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Impacts on investments into UMAC (Details)">
  <tr id="xdx_402_eus-gaap--EquityMethodInvestments_iS_zlF5Ab6Egy26" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 67%">Initial investment, February 16, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_494_20230501__20240430__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zVEBHNE7SSel" style="width: 30%; text-align: right">17,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromEquityMethodInvestments_iN_di_zBxykRuVOIT" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Equity method loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(503,625</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_iN_di_z2OIJekif81" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Impairment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(11,353,875</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--EquityMethodInvestments_iE_zV98VQyDhPIb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Investment balance, April 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,142,500</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627427136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 &#8211; Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--PropertyPlantAndEquipmentTextBlock_z5oH0fjSeHPe" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Property and equipment (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_496_20240430_zaTMthThlrWb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_494_20230430_z1qnxPEDFgu5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentGross_iI_z2KRiK3mgwlj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Equipment and related</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">1,540,888</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">1,386,373</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LeaseholdImprovementsGross_iI_zoau8fUQKb9l" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Leasehold improvements</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,547,976</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,473,890</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--FurnitureAndFixturesGross_iI_zg3QM2Hv2a7f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Furniture and fixtures</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">163,290</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">132,752</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_zYuCwcne8EL1" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(911,470</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(342,657</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iI_zNnVB50SjlS7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt">Net carrying value</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,340,684</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,650,358</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">Depreciation
expense totaled $<span id="xdx_906_eus-gaap--Depreciation_c20230501__20240430_zJK5OyBrgMO">568,813</span> and $<span id="xdx_905_eus-gaap--Depreciation_c20220501__20230430_zYaiW4pDORZ7">311,545</span> for the years ended April 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627327344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 11 &#8211; Other Long-Term Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote11OtherLongtermAssetsAbstract', window );"><strong>Note 11 Other Long-term Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock', window );">[custom:ScheduleOfOtherLongTermAssetsTableTextBlock]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfOtherLongTermAssetsTableTextBlock_zTbXFIaRadZd" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Other long term assets (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49A_20240430_zB94gUgtyTR3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49A_20230430_zGS0C8OOI27k" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2023</td></tr>
  <tr id="xdx_403_ecustom--SAFEAgreementAssets_iI_zXHoQtbOXWhi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">SAFE agreement</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">250,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">250,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--SecurityDeposit_iI_zUHiVGMrR6jb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Security deposits</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">43,126</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">53,180</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NoncurrentAssets_iI_zVI3O7DTXcjg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">293,126</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">303,180</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote11OtherLongtermAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote11OtherLongtermAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619426624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 &#8211; Right of Use Assets and Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRentExpenseTableTextBlock', window );">Schedule of Rent Expense [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfRentExpenseTableTextBlock_zQ1JIeepMl5k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Operating leases (Details)">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Location</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Monthly Rent</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expiration</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 42%">South Salt Lake, Utah</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_988_eus-gaap--OperatingLeaseExpense_c20230501__20240430__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation1Member_zj3FQbQY4iSa" style="text-align: right; width: 25%">22,667</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 25%"><span style="font-size: 10pt">December 2024</span></td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">San Juan, Puerto Rico</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingLeaseExpense_c20230501__20240430__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation3Member_z08KIHOS9lxh" style="text-align: right">5,647</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">June 2027</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Grantsville, Utah</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeaseExpense_c20230501__20240430__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation4Member_zJALeoBESDX7" style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">December 2026</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock', window );">Lessee, Operating Lease, Disclosure [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_z7efdYCP0wsl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Supplemental information related to operating leases (Details)">
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_497_20230501__20240430_zFXEY9gfNDOl" style="font-size: 12pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--OperatingCashPaidToSettleLeaseLiabilities_zOf4I3cCkeX9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt; width: 77%"><span style="font-size: 10pt">Operating cash
    paid to settle lease liabilities</span></td><td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; width: 1%"><span style="font-size: 10pt"></span></td><td style="text-align: center; width: 20%">$<span style="font-size: 10pt">$350,162</span></td><td style="text-align: center; width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0pt"><span style="font-size: 10pt">Weighted average remaining lease term (in years)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_pip0_dtY_c20240430_zbG3UQ5mByma">2.16</span></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iE_zY85bVC2Kdmg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt"><span style="font-size: 10pt">Weighted average discount rate</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">12%</span></td><td style="text-align: center"><span style="font-size: 10pt"></span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zuRpKwgz6M9" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 40%" summary="xdx: Disclosure - Future lease payment obligations (Details)">
<tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: left; font-size: 10pt"><span style="font-size: 10pt">Fiscal Year Ended:</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_491_20240430_zvEq4KDDN9o7"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_zaYkZNg8TXwc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left; width: 65%"><span style="font-size: 10pt">2025</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%">$<span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right; width: 30%"><span style="font-size: 10pt">366,853</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_zImF4TEPWzRl" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">2026</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">372,449</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_iI_zNHSwZ8slT03" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">2027</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">372,880</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_iI_zklrfpA29ay7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">2028</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">293,334</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix_iI_zYRWSdd79em4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">2029</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">280,080</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueThereafter_iI_zQQDjEuYhUv8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">Thereafter</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">443,460</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueSubtotal_iI_zbyHydiK5Osi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"></span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,129,056</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_z1mCQdrdNofd" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">Imputed interest</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(611,466</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_z59T5oeilyFk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">Total liability</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,517,590</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481440/840-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481418/840-10-55-40<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481501/840-20-50-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481501/840-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRentExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of rental expense from operating leases for each period for which an income statement is presented with separate amounts for minimum rentals, contingent rentals, and sublease rentals. Rental payments under leases with terms of a month or less that were not renewed need not be included.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481501/840-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRentExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627450592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 13 &#8211; Debt Obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ScheduleOfDebtPaymentsDueTableTextBlock', window );">[custom:ScheduleOfDebtPaymentsDueTableTextBlock]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfDebtPaymentsDueTableTextBlock_z3uP9BcDMky8" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Outstanding principal payments (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-size: 10pt">&#160;</td>
    <td colspan="2" style="text-align: left; font-size: 10pt">Fiscal Year Ended:</td><td>&#160;</td>
    <td colspan="3" id="xdx_496_20240430_z2f3ASuP4Fsj">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--OutstandingPrincipalPaymentsDueYearOne_iI_zbmEsNFx6o97" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 65%; font-size: 10pt; text-align: left">2025</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 30%; font-size: 10pt; text-align: right">751,570</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--OutstandingPrincipalPaymentsDueLongTerm_iI_zaRHrANgX5L5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">Thereafter</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1119">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--OutstandingPrincipalPaymentsDueTotal_iI_zhiLvdsDxxG5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">751,570</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ScheduleOfDebtPaymentsDueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ScheduleOfDebtPaymentsDueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627393808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 16 &#8211; Common Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock', window );">Schedule of Common Stock Outstanding Roll Forward [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zZwEuTZUFlwi" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of shares of common stock issued (Details)">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><span style="font-size: 9pt; color: Black">Description
    of Shares</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 9pt; color: Black">&#160;</span></td>
    <td colspan="3" id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zRc8LXBmCtQ8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 9pt; color: Black">Shares
    Issued</span></td></tr>
<tr id="xdx_432_c20220501__20230430_eus-gaap--SharesOutstanding_iS_zAl3QjsXiFib" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; width: 70%"><span style="font-size: 10pt">Shares outstanding as of April 30, 2022</span></td><td style="font-size: 9pt; width: 10%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right; width: 18%"><span style="font-size: 10pt">53,748,735</span></td><td style="font-size: 9pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_439_c20220501__20230430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_zQlP30u4qsNd" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; text-indent: -9pt; padding-left: 20pt"><span style="font-size: 10pt">Vesting of restricted
    stock to employees, net of shares withheld of 273,874 to pay taxes and 9,000 to repay a Note</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">653,308</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_432_c20220501__20230430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_zS3saJZRonp9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Vesting of restricted stock to Board
    of Directors</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">116,507</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_436_c20220501__20230430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_zgHPo5WzBwvi" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Vesting of restricted stock to consultants</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">9,683</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_436_c20220501__20230430_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_zyIxJjsCexVe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-size: 10pt">Shares issued
    for services</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"><span style="font-size: 10pt">39,832</span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43B_c20220501__20230430_eus-gaap--SharesOutstanding_iE_zdcyyyjECh9c" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt"><span style="font-size: 10pt">Shares outstanding as of April 30, 2023</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">54,568,065</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43D_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_zzoEsnKJTOsg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to employees,
    net of shares withheld of 27,189 to pay taxes</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">192,742</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_433_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_zKyaDInkZ1b9" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to Board
    of Directors</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">252,214</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_434_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_zCDWbitN80yc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to consultants</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">1,761</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_432_c20230501__20240430_ecustom--StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_zm142xxnAT7c" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Conversion of preferred stock</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">818,334</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43D_c20230501__20240430_ecustom--IssuanceOfCommonStockThroughATMFacilitiesNetShares_zp6G8urM9Dkl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Issuance of common
    stock through ATM facilities</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">53,235</span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43D_c20230501__20240430_ecustom--StockIssuedDuringPeriodSharesPublicOffering_zHy0mDvCPVK4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Issuance of common
    stock through public offering</span></td><td style="font-size: 9pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; text-align: right">18,400,000</td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left">&#160;</td></tr>
<tr id="xdx_43C_c20230501__20240430_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_zCG8gXSRjP4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Exercise of stock
    options</span></td><td style="font-size: 9pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right">3,000</td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left">&#160;</td></tr>
<tr id="xdx_435_c20230501__20240430_eus-gaap--SharesOutstanding_iE_zAq95RZPCJCh" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Shares outstanding as of April 30, 2024</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"><span style="font-size: 10pt">74,289,351</span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627410256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 18 &#8211; Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote18WarrantsAbstract', window );"><strong>Note 18 Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock', window );">[custom:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfWarrantsIssuedAndFairValueTableTextBlock_zbYUho9Xrdlf" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of warrants issued and fair values (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; text-align: center; width: 16%"></td><td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; width: 3%"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; text-align: center; width: 16%"></td><td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; width: 3%"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%"></td><td style="font-size: 10pt; text-align: right; width: 16%"></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; width: 3%"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; text-align: center; width: 15%"></td><td style="font-size: 10pt; text-align: center; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; width: 3%"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%"></td><td style="font-size: 10pt; text-align: right; width: 15%"></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Upon
    Issuance</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Outstanding at April
    30, 2024</b></span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Date
    of Transaction</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Number
    of Warrants</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Initial
    Fair Value</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Number
    of Warrants</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Fair
    Value</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">October
                                            2020&#160;</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td id="xdx_98B_ecustom--NumberOfWarrantsUponIssuance_c20201001__20201031_zrf8FE8uAXai" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">399,998</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td id="xdx_988_ecustom--InitialFairValueOfWarrantsUponIssuance_c20201001__20201031_zVHJZnweFA2i" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">267,999</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td id="xdx_988_ecustom--NumberOfWarrantsOutstanding_iI_c20240430_zcU3YTNrocc2" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">266,666</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td id="xdx_987_ecustom--FairValueOfWarrantsOutstanding_iI_c20240430_zgGQDHf51rRg" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">209,938</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">January
                                            2021</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td id="xdx_98C_ecustom--NumberOfWarrantsUponIssuance_c20210401__20210430_zqoZk596H3Sa" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">675,000</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td id="xdx_981_ecustom--InitialFairValueOfWarrantsUponIssuance_c20210401__20210430_z0jnE9yWovYf" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">2,870,666</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td id="xdx_98B_ecustom--NumberOfWarrantsOutstanding2_iI_c20240430_z4fwvJPyLxcd" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">540,000</span></td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt; color: Black">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">$</span></td><td id="xdx_985_ecustom--FairValueOfWarrantsOutstanding2_iI_c20240430_z7Ph1C34RfMa" style="font-size: 10pt; text-align: right"><span style="font-size: 10pt; color: Black">443,242</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt; color: Black">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Defined Benefit Plan, Assumptions [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_zJcU7WkxDr3g" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%" summary="xdx: Disclosure - Assumptions used to estimate fair value of stock warrants granted (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Risk-free interest rate</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 15%; font-size: 10pt; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zQFMb5AWOQp9">4.25</span></td><td style="width: 1%; font-size: 10pt; text-align: left">%</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 15%; font-size: 10pt; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zWd6PqRFV4fg"><span style="-sec-ix-hidden: xdx2ixbrl1192">&#8212;</span></span>&#160;&#160;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Expected dividend yield</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zqQqSW2KsB2k"><span style="-sec-ix-hidden: xdx2ixbrl1193">&#8212;</span></span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zFMXQHHtWFij"><span style="-sec-ix-hidden: xdx2ixbrl1194">&#8212;</span></span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Expected term (in years)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zu29Ss1ODlQa">5.00</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Expected volatility</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zMwycctXaBIb">205.50</span></td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_z6hX24aKQBRd"><span style="-sec-ix-hidden: xdx2ixbrl1197">&#8212;</span></span>&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zsdFJDMohnN8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Changes in warrants outstanding (Details)">
<tr style="vertical-align: bottom">
    <td colspan="3"><span style="font-size: 10pt"><b>&#160;</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Shares&#160;</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-average
    Exercise Price per Share</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;Weighted-average
                                            Remaining Contractual Term</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
    years)&#160;</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    Intrinsic Value&#160;</b></span></p></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance as of April 30, 2022</span></td>
    <td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zTW3ZBJWhzde" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,539,999</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td></td>
    <td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zo1SLf91aMLl" style="font-size: 10pt">3.38</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20210501__20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z7rVNAKJOWTi" style="font-size: 10pt">3.89</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zH26NEBRYuvc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">427,533</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-left: 10pt; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; width: 12%"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_znif4T3RcJua" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1204">&#8212;</span></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right; width: 12%"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zxhPX5rdpN7e" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1205">&#8212;</span></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zPHx8GRBEyVg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1206">&#8212;</span></span></td>
    <td style="border-bottom: black 1pt solid"></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zvwPqGg9Id1l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1207">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of April 30, 2023</span></td>
    <td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zjvR3ErN3P7i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,539,999</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td></td>
    <td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zfRHpMCEPmwc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.38</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zhJ9DYhfua59" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.89</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zFf9i1nIvMRc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1211">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted&#160;</span></td>
    <td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zJY4pO2gXjI9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">736,000</span><span style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zdiq75j8N6F7">0.63</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zangf3TGQe9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1214">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z1lfEfCZUQNl"><span style="-sec-ix-hidden: xdx2ixbrl1215">&#8212;</span></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at April 30, 2024</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zxpBA2wbZjV7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,275,999</span></td>
    <td></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$</span></td>
    <td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zLvgU96LzJdk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.49</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z0Ddk3rPDzo6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.77</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zwAMcfA1BcA1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">666,080</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote18WarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote18WarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619385136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 19 &#8211; Share Based Awards (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ScheduleOfAssumptionsUsed1TableTextBlock', window );">[custom:ScheduleOfAssumptionsUsed1TableTextBlock]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfAssumptionsUsed1TableTextBlock_zlJsdOqFLd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Assumptions used to calculate fair value of options granted (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; font-size: 12pt; padding-bottom: 1pt; padding-left: 5.4pt; width: 51%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%">2024</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 3%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%">2025</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Exercise Price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_znr5WCUPbCP">0.72</span>
                                       &#8211; <span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zHbG3tmqs4L">1.12</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zVXfTOgwyk4c">0.89</span> &#8211; <span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zkbYGggAn3ea">2.38</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Stock price on date of grant</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zjBycKek9mpk">0.70</span>
                                            &#8211; <span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z0JKFik2vpkc">1.12</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zGtDkv14j5p4">0.89</span> &#8211; <span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zvfA2hkLNG6l">2.38</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"> <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zmXWPdFCN85i">3.46</span></span>
                                            &#8211; <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zN2NFFOAl9n6">4.41</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zul8iVPo6PW7">3.34</span> &#8211; <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zBNgmE0Chh0c">4.18</span>%</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zjAMVTqHJoDh"><span style="-sec-ix-hidden: xdx2ixbrl1237">&#8212;</span></span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zM3kr2EDyfcb"><span style="-sec-ix-hidden: xdx2ixbrl1238">&#8212;</span></span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zWRksUn4u3Zh">5.28</span>
                                            &#8211; <span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dtY_c20230501__20240430_zNHiDYXCl967">8.25</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pip0_dtY_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zruNJFgz5wdf">6.25</span> &#8211;<span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_pip0_dtY_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zpwSLuFgA2m5"> 8.25</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zuT1upOL7n9l" style="font-size: 10pt">206.99</span>
                                            &#8211; <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zvsJVhzHcbQk">262.07</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zmHcQktbERCa">245.57</span> &#8211; <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zhZz3gVuuXPj">260.06</span>%</span></td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_z5BxiEb8u2p4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of activity under the Plan (Details)">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-Average
    Exercise Price</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-Average
    Remaining Contractual Term</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    Intrinsic Value</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
    as of April 30, 2022</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z9JddxlLgW45" style="text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,694,142</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zDfQygnCPCS3" style="text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.17</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; width: 10%"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20210501__20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zGwlEPulhxN" style="font-size: 10pt">8.56</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zbymHYYhCbFf" style="text-align: right; width: 10%"><span style="font-size: 10pt">1,407,545<span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zHVGkEKKMFai" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,503,500</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zOWUkHLe1st9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.40</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zOyBMZy95HX6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1255">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zsBav4TEliq9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1256">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or expired</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zrW8u4ZZ9JLf" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(412,833</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zhdPZhIPzwUj" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.67</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of April
    30, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zRSYnvSeXz3k" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,784,809</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td></td>
    <td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zgq68MUr38H1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.88</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zB5q62szJRI3" style="font-size: 10pt">8.72</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zvgCYYRYVGSk" style="text-align: right"><span style="font-size: 10pt">74,586<span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zUlbR3r75jh7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,903,542</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zTryk9fE3Q2g" style="text-align: right"><span style="font-size: 10pt">1.02</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zpGkhHfXKiOh" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_ziMGzb74CkBa" style="text-align: right"><span style="font-size: 10pt">0.89</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or expired</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z17Tq6RDB5e7" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(905,417</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zt4VdGNJkAPh" style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">2.27</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of April
    30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zV9ZP6gH2lVf" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,779,934</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"></td>
    <td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zhOok9YBrO74" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.46</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zebS582N3eX5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.02</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zDC90se1bOvk" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,762,242</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable as of April
    30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zgjZ1UjN8Pci" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,578,756</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zyXxS8pebzn5" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.78</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_pip0_dtY_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zgQszYc0IZ06" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.77</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zIFtUMZ7G9P5" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,246,497</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z84tdguiL5Rl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Summary of restricted stock activity under the Plan (Details)">
<tr style="vertical-align: bottom">
    <td style="padding-left: -10pt; text-align: center"></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Weighted Average Grant-Date Fair Value Per Share</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt; width: 52%">Unvested and outstanding as of April 30, 2022</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zV8dAXgikZgj" style="text-align: right; width: 20%">1,083,675</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_98B_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zhXB56LbIqZ3" style="text-align: right; width: 20%">2.59</td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z4jVvh0rQXr3" style="text-align: right">780,884</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zHv6OUJbVmt9" style="text-align: right">2.14</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zQ8MxyxITMWa" style="text-align: right">(1,062,372</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zOb6h99Xb7M9" style="text-align: right">2.42</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zq6ViujPLwkf" style="border-bottom: Black 1pt solid; text-align: right">(21,127</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zMEAvNtQfW98" style="border-bottom: Black 1pt solid; text-align: right">2.13</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Unvested and outstanding as of April 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zf0VHQ1spJak" style="text-align: right">781,060</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zf5lBVZ5H87k" style="text-align: right">2.44</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzWnvNEyDM8h" style="text-align: right">298,643</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zc1G6x12U2B4" style="text-align: right">1.06</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zgBw5Arl4w0c" style="text-align: right">(485,024</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zXvowxgTscu6" style="text-align: right">1.92</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzmxbe74ulea" style="border-bottom: Black 1pt solid; text-align: right">(419,549</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zCcY2OlxCoEi" style="border-bottom: Black 1pt solid; text-align: right">2.09</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Unvested and outstanding as of April 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 3pt double; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zRbhP7FOc4Rf" style="border-bottom: Black 3pt double; text-align: right">175,130</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 3pt double; text-align: left">$</td><td id="xdx_98D_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zCQ8YUGgjMm3" style="border-bottom: Black 3pt double; text-align: right">2.09</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock', window );">Schedule of Deferred Compensation Arrangement with Individual, Share-Based Payments [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_zthfBHLiJRfg" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Stock compensation expense by functional category (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49A_20230501__20240430_zcIPDrqmhWY1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_492_20220501__20230430_zzGJzJJOam09" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2023</td></tr>
  <tr id="xdx_407_ecustom--ResearchAndDevelopmentStockCompensationExpense_zeYrjtkC57Ki" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Research and development</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">395,105</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">692,947</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--SalesAndMarketingStockCompensationExpense_zbYC6Vzdfuc4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Sales and marketing</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">562,110</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">566,153</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--GeneralAndAdministrativeStockCompensationExpense_zXISc5acHtK5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">General and administrative</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,652,052</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,397,624</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--TotalStockCompensationExpense_zGbdAjOOIZx2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,609,267</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,656,724</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock compensation expense pertaining to options totaled
$<span id="xdx_906_ecustom--StockCompensationExpensePertainingToOptions_c20230501__20240430_z8umk4xuPXQ4">2,619,501 </span> and
$<span id="xdx_90F_ecustom--StockCompensationExpensePertainingToOptions_c20220501__20230430_zjbpv0lroDOg">1,617,982 </span> for the year ended April 30, 2024 and 2023, respectively. Stock compensation expense pertaining to restricted
stock totaled $<span id="xdx_90E_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20230501__20240430_zYVyrNIfyO0l">989,766</span> and $<span id="xdx_901_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20220501__20230430_zA1TpSTKGV4j">2,038,742 </span>  for the year ended April 30, 2024 and 2023, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ScheduleOfAssumptionsUsed1TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ScheduleOfAssumptionsUsed1TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an equity-based arrangement (such as stock or unit options and stock or unit awards) with an individual employee, which is generally an employment contract between the entity and a selected officer or key employee containing a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483043/710-10-30-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482943/710-10-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979620695984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impact of restatements of previously issued consolidated financial statements (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 1,480,814<span></span>
</td>
<td class="nump">$ 1,600,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total long-term assets</a></td>
<td class="nump">26,140,063<span></span>
</td>
<td class="nump">28,568,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, long-term</a></td>
<td class="nump">1,321,952<span></span>
</td>
<td class="nump">1,481,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">1,321,952<span></span>
</td>
<td class="nump">1,925,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">124,616,305<span></span>
</td>
<td class="nump">112,642,726<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(81,130,732)<span></span>
</td>
<td class="num">(57,078,103)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">48,537,612<span></span>
</td>
<td class="nump">60,743,328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities', window );">Change in fair value of derivative liability</a></td>
<td class="nump">9,642,427<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (24,052,629)<span></span>
</td>
<td class="num">(28,107,029)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RestatementImpactAxis=RCAT_RestatementImpactOriginallyReportedMember', window );">Restatement Impact Originally Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">620,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,018,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_OperatingLeaseLiabilityCurrentRestatementImpact', window );">Operating lease liabilities, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281,797<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Warrant derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">588,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_LiabilitiesCurrentRestatementImpact', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,760,616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, long-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">822,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,993,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,586,793)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockholdersEquityRestatement', window );">Total shareholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,609,625<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,193,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities', window );">Change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,019,292)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,087,737)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RestatementImpactAxis=RCAT_RestatementImpactAsRestatedMember', window );">Restatement Impact As Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,568,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_OperatingLeaseLiabilityCurrentRestatementImpact', window );">Operating lease liabilities, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Warrant derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_LiabilitiesCurrentRestatementImpact', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,050,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, long-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,481,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,925,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,642,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,078,103)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockholdersEquityRestatement', window );">Total shareholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,767,941<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,743,328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities', window );">Change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,107,029)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RestatementImpactAxis=RCAT_RestatementImpactChangeMember', window );">Restatement Impact Change [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">980,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_OperatingLeaseLiabilityCurrentRestatementImpact', window );">Operating lease liabilities, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(122,374)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Warrant derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(588,205)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_LiabilitiesCurrentRestatementImpact', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(710,579)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, long-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,102,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,102,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,649,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,491,310)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockholdersEquityRestatement', window );">Total shareholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,316<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550,238<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities', window );">Change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,019,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,019,292)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_LiabilitiesCurrentRestatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_LiabilitiesCurrentRestatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_OperatingLeaseLiabilityCurrentRestatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_OperatingLeaseLiabilityCurrentRestatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockholdersEquityRestatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockholdersEquityRestatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the net carrying value of derivative instruments reported as assets and liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RestatementImpactAxis=RCAT_RestatementImpactOriginallyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RestatementImpactAxis=RCAT_RestatementImpactOriginallyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RestatementImpactAxis=RCAT_RestatementImpactAsRestatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RestatementImpactAxis=RCAT_RestatementImpactAsRestatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RestatementImpactAxis=RCAT_RestatementImpactChangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RestatementImpactAxis=RCAT_RestatementImpactChangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979626510608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 &#8211; The Business (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingShares', window );">[custom:FirmCommitmentUnderwrittenPublicOfferingShares]</a></td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds', window );">[custom:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds]</a></td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds', window );">[custom:FirmCommitmentUnderwrittenPublicOfferingNetProceeds]</a></td>
<td class="nump">$ 8,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition1Member', window );">Business Acquisition 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,995,114<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition2Member', window );">Business Acquisition 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,354,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition3Member', window );">Business Acquisition 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,791,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition4Member', window );">Business Acquisition 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,011,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FirmCommitmentUnderwrittenPublicOfferingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979620327888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Customer concentration risk (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk1Member', window );">Customer Concentration Risk 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">53.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk2Member', window );">Customer Concentration Risk 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk3Member', window );">Customer Concentration Risk 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk4Member', window );">Customer Concentration Risk 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk5Member', window );">Customer Concentration Risk 5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619350272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company's revenue disaggregated by revenue type (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Contract related</a></td>
<td class="nump">$ 4,173,005<span></span>
</td>
<td class="nump">$ 1,312,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Product related</a></td>
<td class="nump">13,663,377<span></span>
</td>
<td class="nump">3,308,407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total</a></td>
<td class="nump">$ 17,836,382<span></span>
</td>
<td class="nump">$ 4,620,834<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979620557184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Antidilutive securities excluded from computation of diluted net loss per share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount', window );">Series B Preferred Stock, as converted</a></td>
<td class="nump">3,896<span></span>
</td>
<td class="nump">822,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount', window );">Stock options</a></td>
<td class="nump">6,779,934<span></span>
</td>
<td class="nump">4,784,809<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount', window );">Warrants</a></td>
<td class="nump">2,275,999<span></span>
</td>
<td class="nump">1,539,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount', window );">Restricted stock</a></td>
<td class="nump">175,130<span></span>
</td>
<td class="nump">781,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">9,234,959<span></span>
</td>
<td class="nump">7,928,098<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979620275392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 &#8211; Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 6,067,169<span></span>
</td>
<td class="nump">$ 3,173,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeSecuritiesOther', window );">Interest and Dividend Income, Securities, Operating, Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">151,671<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Equity Method Investment, Other than Temporary Impairment</a></td>
<td class="nump">11,353,875<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract with Customer, Liability, Current</a></td>
<td class="nump">53,939<span></span>
</td>
<td class="nump">155,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Contract with Customer, Asset, before Allowance for Credit Loss, Current</a></td>
<td class="nump">1,477,859<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualCurrent', window );">Standard Product Warranty Accrual, Current</a></td>
<td class="nump">372,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DifferenceBetweenComprehensiveLossAndNetLoss', window );">[custom:DifferenceBetweenComprehensiveLossAndNetLoss]</a></td>
<td class="nump">865,738<span></span>
</td>
<td class="nump">609,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Debt Securities, Available-for-Sale, Unrealized Gain (Loss)</a></td>
<td class="nump">864,165<span></span>
</td>
<td class="nump">610,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</a></td>
<td class="nump">1,573<span></span>
</td>
<td class="nump">974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</a></td>
<td class="num">(21,526,696)<span></span>
</td>
<td class="num">(26,376,643)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</a></td>
<td class="num">(17,687,063)<span></span>
</td>
<td class="num">$ (24,313,674)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Capital', window );">Banking Regulation, Total Capital, Actual</a></td>
<td class="nump">$ 18,746,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DifferenceBetweenComprehensiveLossAndNetLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DifferenceBetweenComprehensiveLossAndNetLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Capital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of total capital as defined by regulatory framework.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480696/942-505-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Capital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-18<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeSecuritiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other operating dividend and interest income, including amortization and accretion of premiums and discounts, on securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeSecuritiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid within one year or the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979620965744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations - results of operations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Revenues</a></td>
<td class="nump">$ 4,213,653<span></span>
</td>
<td class="nump">$ 5,290,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold', window );">Cost of goods sold</a></td>
<td class="nump">4,577,980<span></span>
</td>
<td class="nump">4,793,430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss', window );">Gross (Loss) Profit</a></td>
<td class="num">(364,327)<span></span>
</td>
<td class="nump">497,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">118,093<span></span>
</td>
<td class="nump">346,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">1,157,448<span></span>
</td>
<td class="nump">862,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">863,361<span></span>
</td>
<td class="nump">1,044,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Total operating expenses</a></td>
<td class="nump">2,138,902<span></span>
</td>
<td class="nump">2,252,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(2,503,229)<span></span>
</td>
<td class="num">(1,755,305)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract', window );"><strong>Other expense (income)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense', window );">Interest expense</a></td>
<td class="nump">22,856<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome', window );">Other, net</a></td>
<td class="num">(152)<span></span>
</td>
<td class="num">(24,919)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense', window );">Other expense (income)</a></td>
<td class="nump">22,704<span></span>
</td>
<td class="num">(24,919)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net loss from discontinued operations</a></td>
<td class="num">$ (2,525,933)<span></span>
</td>
<td class="num">$ (1,730,386)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480781/205-20-S99-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-6<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other income attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482551/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979620735680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Assets and liabilities for the Consumer Segment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash', window );">Cash</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 86,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts receivable, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">61,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventory</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,065,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets', window );">Other</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,069,438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total current assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,283,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent', window );">Intangible assets, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets', window );">Other</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent', window );">Operating lease right-of-use assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">84,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent', window );">Total long term assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">108,397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">606,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">109,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Customer deposits</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">244,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent', window );">Operating lease liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">49,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total current liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,010,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent', window );">Long term liabilities - Operating lease liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">41,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisposalGroupIncludingDiscontinuedOperationWorkingCapital', window );">Working capital</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 4,272,654<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisposalGroupIncludingDiscontinuedOperationWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisposalGroupIncludingDiscontinuedOperationWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as capital leased assets attributable to disposal group, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand, demand deposits with banks or financial institutions, and other kinds of accounts that have the general characteristics of demand deposits, held by a disposal group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979625747056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 &#8211; Divestiture of Consumer Segment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Feb. 16, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1', window );">Noncash or Part Noncash Divestiture, Amount of Consideration Received</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1', window );">[custom:NoncashOrPartNoncashDivestitureCashConsiderationReceived1]</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1', window );">[custom:NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1]</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1', window );">[custom:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1]</a></td>
<td class="nump">$ 17,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares', window );">[custom:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares]</a></td>
<td class="nump">4,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_WorkingCapitalAtClosingOfDisposalGroup', window );">[custom:WorkingCapitalAtClosingOfDisposalGroup-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_WorkingCapitalAtClosingOfDisposalGroup">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_WorkingCapitalAtClosingOfDisposalGroup</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619339360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 4 &#8211; Marketable Securities (Details Narrative)<br></strong></div></th>
<th class="th">
<div>Apr. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_CorporateBondsAtCarryingValueFairValue', window );">[custom:CorporateBondsAtCarryingValueFairValue-0]</a></td>
<td class="nump">$ 12,814,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_CorporateBondsAtCarryingValueCostBasis', window );">[custom:CorporateBondsAtCarryingValueCostBasis-0]</a></td>
<td class="nump">13,678,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_CorporateBondsAtCarryingValueUnrealizedLosses', window );">[custom:CorporateBondsAtCarryingValueUnrealizedLosses-0]</a></td>
<td class="nump">$ 864,165<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_CorporateBondsAtCarryingValueCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_CorporateBondsAtCarryingValueCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_CorporateBondsAtCarryingValueFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_CorporateBondsAtCarryingValueFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_CorporateBondsAtCarryingValueUnrealizedLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_CorporateBondsAtCarryingValueUnrealizedLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619747680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 5,750,324<span></span>
</td>
<td class="nump">$ 8,132,196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">1,289,997<span></span>
</td>
<td class="nump">509,381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">966,916<span></span>
</td>
<td class="nump">278,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 8,007,237<span></span>
</td>
<td class="nump">$ 8,920,573<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979624751280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other current assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Contract asset</a></td>
<td class="nump">$ 1,477,859<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">1,206,306<span></span>
</td>
<td class="nump">752,564<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrantsReceivableCurrent', window );">Grant receivable</a></td>
<td class="nump">675,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid inventory</a></td>
<td class="nump">602,888<span></span>
</td>
<td class="nump">359,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss', window );">Accrued interest income</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">151,671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Total</a></td>
<td class="nump">$ 3,962,053<span></span>
</td>
<td class="nump">$ 1,263,735<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accrued interest on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5C<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979625413568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 &#8211; Due From Related Party (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote7DueFromRelatedPartyAbstract', window );"><strong>Note 7 Due From Related Party</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_CashCompensationSubjectToTaxation', window );">[custom:CashCompensationSubjectToTaxation]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IncomeAssociatedWithStockCompensationSubjectToTaxation', window );">[custom:IncomeAssociatedWithStockCompensationSubjectToTaxation]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,413,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation', window );">[custom:NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation]</a></td>
<td class="nump">$ 510,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteShares', window );">[custom:CommonStockWithheldByCompanyAppliedAgainstNoteShares]</a></td>
<td class="nump">104,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteAmount', window );">[custom:CommonStockWithheldByCompanyAppliedAgainstNoteAmount]</a></td>
<td class="nump">$ 280,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharesHeldAtTransferAgentUntilNoteReceivableRepayment', window );">[custom:SharesHeldAtTransferAgentUntilNoteReceivableRepayment]</a></td>
<td class="nump">110,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RestrictedStockScheduledToVestShares', window );">[custom:RestrictedStockScheduledToVestShares]</a></td>
<td class="nump">20,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable', window );">[custom:RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable]</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_PaymentsForTaxLiability', window );">[custom:PaymentsForTaxLiability]</a></td>
<td class="nump">$ 712,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_EstimatedTaxesOwedRelatedToStockCompensation', window );">[custom:EstimatedTaxesOwedRelatedToStockCompensation]</a></td>
<td class="nump">31,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income Tax Examination, Penalties and Interest Expense</a></td>
<td class="nump">$ 170,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_CashCompensationSubjectToTaxation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_CashCompensationSubjectToTaxation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote7DueFromRelatedPartyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote7DueFromRelatedPartyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_EstimatedTaxesOwedRelatedToStockCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_EstimatedTaxesOwedRelatedToStockCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_IncomeAssociatedWithStockCompensationSubjectToTaxation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_IncomeAssociatedWithStockCompensationSubjectToTaxation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_PaymentsForTaxLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_PaymentsForTaxLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RestrictedStockScheduledToVestShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RestrictedStockScheduledToVestShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharesHeldAtTransferAgentUntilNoteReceivableRepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharesHeldAtTransferAgentUntilNoteReceivableRepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979625160320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsGrossCarryingAmountMember', window );">Intangible Assets Gross Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedProprietaryTechnologyGross', window );">Proprietary technology</a></td>
<td class="nump">$ 4,282,001<span></span>
</td>
<td class="nump">$ 4,967,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedNoncompeteAgreementsGross1', window );">Non-compete agreements</a></td>
<td class="nump">65,000<span></span>
</td>
<td class="nump">81,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedCustomerRelationshipsGross1', window );">Customer relationships</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">39,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedIntangibleAssetsGross1', window );">Total finite-lived assets</a></td>
<td class="nump">4,347,001<span></span>
</td>
<td class="nump">5,087,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTradeNames', window );">Brand name</a></td>
<td class="nump">1,430,000<span></span>
</td>
<td class="nump">3,152,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1', window );">Total indefinite-lived assets</a></td>
<td class="nump">1,430,000<span></span>
</td>
<td class="nump">3,152,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IntangibleAssetsNetExcludingGoodwill1', window );">Total intangible assets, net</a></td>
<td class="nump">5,777,001<span></span>
</td>
<td class="nump">8,239,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsAccumulatedAmortizationMember', window );">Intangible Assets Accumulated Amortization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedProprietaryTechnologyGross', window );">Proprietary technology</a></td>
<td class="num">(1,917,612)<span></span>
</td>
<td class="num">(1,271,112)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedNoncompeteAgreementsGross1', window );">Non-compete agreements</a></td>
<td class="num">(65,000)<span></span>
</td>
<td class="num">(56,667)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedCustomerRelationshipsGross1', window );">Customer relationships</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(18,106)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedIntangibleAssetsGross1', window );">Total finite-lived assets</a></td>
<td class="num">(1,982,612)<span></span>
</td>
<td class="num">(1,345,885)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTradeNames', window );">Brand name</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1', window );">Total indefinite-lived assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IntangibleAssetsNetExcludingGoodwill1', window );">Total intangible assets, net</a></td>
<td class="num">(1,982,612)<span></span>
</td>
<td class="num">(1,345,885)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsNetCarryingValueMember', window );">Intangible Assets Net Carrying Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedProprietaryTechnologyGross', window );">Proprietary technology</a></td>
<td class="nump">2,364,389<span></span>
</td>
<td class="nump">3,695,888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedNoncompeteAgreementsGross1', window );">Non-compete agreements</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">24,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedCustomerRelationshipsGross1', window );">Customer relationships</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">20,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedIntangibleAssetsGross1', window );">Total finite-lived assets</a></td>
<td class="nump">2,364,389<span></span>
</td>
<td class="nump">3,741,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTradeNames', window );">Brand name</a></td>
<td class="nump">1,430,000<span></span>
</td>
<td class="nump">3,152,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1', window );">Total indefinite-lived assets</a></td>
<td class="nump">1,430,000<span></span>
</td>
<td class="nump">3,152,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IntangibleAssetsNetExcludingGoodwill1', window );">Total intangible assets, net</a></td>
<td class="nump">$ 3,794,389<span></span>
</td>
<td class="nump">$ 6,893,115<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FiniteLivedCustomerRelationshipsGross1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FiniteLivedCustomerRelationshipsGross1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FiniteLivedIntangibleAssetsGross1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FiniteLivedIntangibleAssetsGross1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FiniteLivedNoncompeteAgreementsGross1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FiniteLivedNoncompeteAgreementsGross1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FiniteLivedProprietaryTechnologyGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FiniteLivedProprietaryTechnologyGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_IntangibleAssetsNetExcludingGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_IntangibleAssetsNetExcludingGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsGrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsGrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsAccumulatedAmortizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsAccumulatedAmortizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsNetCarryingValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsNetCarryingValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979624864336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Expected amortization expense for the unamortized finite-lived intangible assets (Details)<br></strong></div></th>
<th class="th">
<div>Apr. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">&#160;</a></td>
<td class="nump">$ 709,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">&#160;</a></td>
<td class="nump">709,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">&#160;</a></td>
<td class="nump">709,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">&#160;</a></td>
<td class="nump">236,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">&#160;</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">&#160;</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">&#160;</a></td>
<td class="nump">$ 2,364,389<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979621163968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Composition of, and changes in goodwill (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">21 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
<th class="th" colspan="1">30 Months Ended</th>
<th class="th" colspan="1">40 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">&#160;</a></td>
<td class="num">$ (412,999)<span></span>
</td>
<td class="num">$ (2,826,918)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">&#160;</a></td>
<td class="nump">9,088,550<span></span>
</td>
<td class="nump">17,012,832<span></span>
</td>
<td class="nump">$ 9,088,550<span></span>
</td>
<td class="nump">$ 17,012,832<span></span>
</td>
<td class="nump">$ 17,012,832<span></span>
</td>
<td class="nump">$ 17,012,832<span></span>
</td>
<td class="nump">$ 17,012,832<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember', window );">Goodwill [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">&#160;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,995,499<span></span>
</td>
<td class="nump">2,826,918<span></span>
</td>
<td class="nump">6,168,260<span></span>
</td>
<td class="nump">1,849,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">&#160;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,826,918)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">&#160;</a></td>
<td class="nump">$ 9,088,550<span></span>
</td>
<td class="nump">$ 17,012,832<span></span>
</td>
<td class="nump">9,088,550<span></span>
</td>
<td class="nump">$ 17,012,832<span></span>
</td>
<td class="nump">$ 17,012,832<span></span>
</td>
<td class="nump">$ 17,012,832<span></span>
</td>
<td class="nump">$ 17,012,832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">&#160;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,924,282)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619761888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 &#8211; Intangible Assets (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="num">$ (412,999)<span></span>
</td>
<td class="num">$ (2,826,918)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979725912912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial informatino for UMAC derived from their Form 10-Q (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,397,549<span></span>
</td>
<td class="nump">$ 32,175,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,140,063<span></span>
</td>
<td class="nump">28,568,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,651,130<span></span>
</td>
<td class="nump">4,050,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,321,952<span></span>
</td>
<td class="nump">1,925,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,836,382<span></span>
</td>
<td class="nump">4,620,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,680,546<span></span>
</td>
<td class="num">(834,311)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24,052,629)<span></span>
</td>
<td class="num">$ (28,107,029)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember', window );">Equity Method Investment, Nonconsolidated Investee, Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">$ 6,128,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Long-term assets</a></td>
<td class="nump">18,099,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">691,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Long-term liabilities</a></td>
<td class="nump">2,313,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">618,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">204,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,106,001)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979625658208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impacts on investments into UMAC (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Initial investment, February 16, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment</a></td>
<td class="num">(11,353,875)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment balance, April 30, 2024</a></td>
<td class="nump">5,142,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember', window );">Equity Method Investment, Nonconsolidated Investee, Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity method loss</a></td>
<td class="num">(503,625)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment</a></td>
<td class="num">(11,353,875)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment balance, April 30, 2024</a></td>
<td class="nump">$ 5,142,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619187008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Equipment and related</a></td>
<td class="nump">$ 1,540,888<span></span>
</td>
<td class="nump">$ 1,386,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">1,547,976<span></span>
</td>
<td class="nump">1,473,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">163,290<span></span>
</td>
<td class="nump">132,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(911,470)<span></span>
</td>
<td class="num">(342,657)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net carrying value</a></td>
<td class="nump">$ 2,340,684<span></span>
</td>
<td class="nump">$ 2,650,358<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619678480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 &#8211; Property and Equipment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 568,813<span></span>
</td>
<td class="nump">$ 311,545<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619239120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other long term assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote11OtherLongtermAssetsAbstract', window );"><strong>Note 11 Other Long-term Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SAFEAgreementAssets', window );">SAFE agreement</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposits</a></td>
<td class="nump">43,126<span></span>
</td>
<td class="nump">53,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total</a></td>
<td class="nump">$ 293,126<span></span>
</td>
<td class="nump">$ 303,180<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote11OtherLongtermAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote11OtherLongtermAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SAFEAgreementAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SAFEAgreementAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619369536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 11 &#8211; Other Long-Term Assets (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote11OtherLongtermAssetsAbstract', window );"><strong>Note 11 Other Long-term Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_PaymentForSAFEAgreement', window );">[custom:PaymentForSAFEAgreement]</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote11OtherLongtermAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote11OtherLongtermAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_PaymentForSAFEAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_PaymentForSAFEAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619763104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating leases (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation1Member', window );">Operating Lease Location 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="nump">$ 22,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation3Member', window );">Operating Lease Location 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="nump">5,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation4Member', window );">Operating Lease Location 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619397744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental information related to operating leases (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_OperatingCashPaidToSettleLeaseLiabilities', window );">Operating cash paid to settle lease liabilities</a></td>
<td class="nump">$ 350,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">2 years 1 month 28 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">12.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_OperatingCashPaidToSettleLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_OperatingCashPaidToSettleLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619381904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Future lease payment obligations (Details)<br></strong></div></th>
<th class="th">
<div>Apr. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo', window );">&#160;</a></td>
<td class="nump">$ 366,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree', window );">&#160;</a></td>
<td class="nump">372,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour', window );">&#160;</a></td>
<td class="nump">372,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive', window );">&#160;</a></td>
<td class="nump">293,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix', window );">&#160;</a></td>
<td class="nump">280,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_LesseeOperatingLeaseLiabilityPaymentsDueThereafter', window );">&#160;</a></td>
<td class="nump">443,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_LesseeOperatingLeaseLiabilityPaymentsDueSubtotal', window );">&#160;</a></td>
<td class="nump">2,129,056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">&#160;</a></td>
<td class="num">(611,466)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">&#160;</a></td>
<td class="nump">$ 1,517,590<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_LesseeOperatingLeaseLiabilityPaymentsDueSubtotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_LesseeOperatingLeaseLiabilityPaymentsDueSubtotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_LesseeOperatingLeaseLiabilityPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_LesseeOperatingLeaseLiabilityPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979621167056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Outstanding principal payments (Details)<br></strong></div></th>
<th class="th">
<div>Apr. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_OutstandingPrincipalPaymentsDueYearOne', window );">&#160;</a></td>
<td class="nump">$ 751,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_OutstandingPrincipalPaymentsDueLongTerm', window );">&#160;</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_OutstandingPrincipalPaymentsDueTotal', window );">&#160;</a></td>
<td class="nump">$ 751,570<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_OutstandingPrincipalPaymentsDueLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_OutstandingPrincipalPaymentsDueLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_OutstandingPrincipalPaymentsDueTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_OutstandingPrincipalPaymentsDueTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_OutstandingPrincipalPaymentsDueYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_OutstandingPrincipalPaymentsDueYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979624812064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 13 &#8211; Debt Obligations (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-Term Debt, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 895,709<span></span>
</td>
<td class="nump">$ 895,709<span></span>
</td>
<td class="nump">$ 895,709<span></span>
</td>
<td class="nump">$ 370,537<span></span>
</td>
<td class="nump">$ 370,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">409,439<span></span>
</td>
<td class="nump">$ 409,439<span></span>
</td>
<td class="nump">409,439<span></span>
</td>
<td class="nump">1,069,561<span></span>
</td>
<td class="nump">$ 1,069,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation1Member', window );">Debt Obligation 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,670,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation2Member', window );">Debt Obligation 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ConvertibleNoteAgreementAmount', window );">[custom:ConvertibleNoteAgreementAmount]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 878<span></span>
</td>
<td class="nump">$ 878<span></span>
</td>
<td class="nump">878<span></span>
</td>
<td class="nump">1,334<span></span>
</td>
<td class="nump">$ 1,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation3Member', window );">Debt Obligation 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 387,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation6Member', window );">Debt Obligation 6 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-Term Debt, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,586<span></span>
</td>
<td class="nump">66,586<span></span>
</td>
<td class="nump">66,586<span></span>
</td>
<td class="nump">27,495<span></span>
</td>
<td class="nump">27,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_LeaseholdImprovementAgreementFundsReceived', window );">[custom:LeaseholdImprovementAgreementFundsReceived]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation8Member', window );">Debt Obligation 8 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-Term Debt, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,412<span></span>
</td>
<td class="nump">$ 11,412<span></span>
</td>
<td class="nump">$ 11,412<span></span>
</td>
<td class="nump">$ 3,538<span></span>
</td>
<td class="nump">$ 3,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset', window );">[custom:FinancingAgreementFundingOfPurchaseOfFixedAsset]</a></td>
<td class="nump">$ 24,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ConvertibleNoteAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ConvertibleNoteAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_LeaseholdImprovementAgreementFundsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_LeaseholdImprovementAgreementFundsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RCAT_DebtObligation1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RCAT_DebtObligation2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RCAT_DebtObligation3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RCAT_DebtObligation6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation8Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RCAT_DebtObligation8Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619675248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 14 &#8211; Due to Related Party (Details Narrative) - Due To Related Party 2 [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">28 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_LineOfCreditObligationAssumedInConnectionWithAcquisition', window );">[custom:LineOfCreditObligationAssumedInConnectionWithAcquisition]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DebtInstrumentInterestRateDuringPeriod1', window );">[custom:DebtInstrumentInterestRateDuringPeriod1]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.67%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DueToOtherRelatedPartyClassifiedCurrent', window );">[custom:DueToOtherRelatedPartyClassifiedCurrent-0]</a></td>
<td class="nump">$ 37,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DebtInstrumentOutstandingAccruedInterestPayment', window );">[custom:DebtInstrumentOutstandingAccruedInterestPayment]</a></td>
<td class="nump">$ 292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DebtInstrumentInterestRateDuringPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DebtInstrumentInterestRateDuringPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DebtInstrumentOutstandingAccruedInterestPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DebtInstrumentOutstandingAccruedInterestPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DueToOtherRelatedPartyClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DueToOtherRelatedPartyClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_LineOfCreditObligationAssumedInConnectionWithAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_LineOfCreditObligationAssumedInConnectionWithAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RCAT_DueToRelatedParty2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RCAT_DueToRelatedParty2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619239120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 15 &#8211; Income Taxes (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="num">$ (81,130,732)<span></span>
</td>
<td class="num">$ (57,078,103)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Deferred Tax Assets, Operating Loss Carryforwards</a></td>
<td class="nump">$ 15,004,000<span></span>
</td>
<td class="nump">$ 10,101,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979620520736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of shares of common stock issued (Details) - Common Stock [Member] - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding, Beginning Balance</a></td>
<td class="nump">54,568,065<span></span>
</td>
<td class="nump">53,748,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1', window );">Vesting of restricted stock to employees, net of shares withheld of 27,189 to pay taxes</a></td>
<td class="nump">192,742<span></span>
</td>
<td class="nump">653,308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2', window );">Vesting of restricted stock to Board of Directors</a></td>
<td class="nump">252,214<span></span>
</td>
<td class="nump">116,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3', window );">Vesting of restricted stock to consultants</a></td>
<td class="nump">1,761<span></span>
</td>
<td class="nump">9,683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding, Ending Balance</a></td>
<td class="nump">74,289,351<span></span>
</td>
<td class="nump">54,568,065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities', window );">Conversion of preferred stock</a></td>
<td class="nump">818,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares', window );">Issuance of common stock through ATM facilities</a></td>
<td class="nump">53,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockIssuedDuringPeriodSharesPublicOffering', window );">Issuance of common stock through public offering</a></td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockIssuedDuringPeriodSharesPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockIssuedDuringPeriodSharesPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619704240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 17 &#8211; Preferred Stock (Details Narrative) - shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">4,676<span></span>
</td>
<td class="nump">986,676<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=RCAT_SeriesAPreferredStock2Member', window );">Series A Preferred Stock 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock', window );">[custom:StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock]</a></td>
<td class="nump">3,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=RCAT_SeriesAPreferredStock2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=RCAT_SeriesAPreferredStock2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979620532048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of warrants issued and fair values (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote18WarrantsAbstract', window );"><strong>Note 18 Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NumberOfWarrantsUponIssuance', window );">[custom:NumberOfWarrantsUponIssuance]</a></td>
<td class="nump">675,000<span></span>
</td>
<td class="nump">399,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_InitialFairValueOfWarrantsUponIssuance', window );">[custom:InitialFairValueOfWarrantsUponIssuance]</a></td>
<td class="nump">$ 2,870,666<span></span>
</td>
<td class="nump">$ 267,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NumberOfWarrantsOutstanding', window );">[custom:NumberOfWarrantsOutstanding-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FairValueOfWarrantsOutstanding', window );">[custom:FairValueOfWarrantsOutstanding-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 209,938<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NumberOfWarrantsOutstanding2', window );">[custom:NumberOfWarrantsOutstanding2-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">540,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FairValueOfWarrantsOutstanding2', window );">[custom:FairValueOfWarrantsOutstanding2-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 443,242<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote18WarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote18WarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FairValueOfWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FairValueOfWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FairValueOfWarrantsOutstanding2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FairValueOfWarrantsOutstanding2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_InitialFairValueOfWarrantsUponIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_InitialFairValueOfWarrantsUponIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NumberOfWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NumberOfWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NumberOfWarrantsOutstanding2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NumberOfWarrantsOutstanding2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NumberOfWarrantsUponIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NumberOfWarrantsUponIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627410256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assumptions used to estimate fair value of stock warrants granted (Details) - Warrant Assumptions Used [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</a></td>
<td class="nump">205.50%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=RCAT_WarrantAssumptionsUsedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=RCAT_WarrantAssumptionsUsedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979625187312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in warrants outstanding (Details) - Warrants Outstanding 1 [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">2,275,999<span></span>
</td>
<td class="nump">1,539,999<span></span>
</td>
<td class="nump">1,539,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 2.49<span></span>
</td>
<td class="nump">$ 3.38<span></span>
</td>
<td class="nump">$ 3.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">2 years 9 months 7 days<span></span>
</td>
<td class="text">2 years 10 months 20 days<span></span>
</td>
<td class="text">3 years 10 months 20 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 666,080<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 427,533<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="nump">736,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=RCAT_WarrantsOutstanding1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=RCAT_WarrantsOutstanding1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619180624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 18 &#8211; Warrants (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote18WarrantsAbstract', window );"><strong>Note 18 Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_WarrantsIssuedExercisePrice', window );">[custom:WarrantsIssuedExercisePrice]</a></td>
<td class="nump">$ 5.625<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ProceedsReceivedFromExerciseOfWarrants', window );">[custom:ProceedsReceivedFromExerciseOfWarrants]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 301,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ExerciseOfWarrantsShares', window );">[custom:ExerciseOfWarrantsShares]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">268,332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_WarrantsToPurchaseSharesIssued', window );">[custom:WarrantsToPurchaseSharesIssued]</a></td>
<td class="nump">533,333<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote18WarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote18WarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ProceedsReceivedFromExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ProceedsReceivedFromExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_WarrantsIssuedExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_WarrantsIssuedExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_WarrantsToPurchaseSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_WarrantsToPurchaseSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979620558160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assumptions used to calculate fair value of options granted (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2', window );">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2]</a></td>
<td class="text">8 years 3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FairValueOfOptionsAxis=RCAT_OptionsAssumptionsUsedMember', window );">Options Assumptions Used [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</a></td>
<td class="nump">$ 0.72<span></span>
</td>
<td class="nump">$ 0.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1-0]</a></td>
<td class="nump">1.12<span></span>
</td>
<td class="nump">2.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate-0]</a></td>
<td class="nump">0.70<span></span>
</td>
<td class="nump">0.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1-0]</a></td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 2.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</a></td>
<td class="nump">3.46%<span></span>
</td>
<td class="nump">3.34%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</a></td>
<td class="nump">4.41%<span></span>
</td>
<td class="nump">4.18%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">5 years 3 months 10 days<span></span>
</td>
<td class="text">6 years 3 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2', window );">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 3 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</a></td>
<td class="nump">206.99%<span></span>
</td>
<td class="nump">245.57%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</a></td>
<td class="nump">262.07%<span></span>
</td>
<td class="nump">260.06%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FairValueOfOptionsAxis=RCAT_OptionsAssumptionsUsedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FairValueOfOptionsAxis=RCAT_OptionsAssumptionsUsedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979620208464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of activity under the Plan (Details) - Options 1 [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">6,779,934<span></span>
</td>
<td class="nump">4,784,809<span></span>
</td>
<td class="nump">3,694,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 1.46<span></span>
</td>
<td class="nump">$ 1.88<span></span>
</td>
<td class="nump">$ 2.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">8 years 7 days<span></span>
</td>
<td class="text">8 years 8 months 19 days<span></span>
</td>
<td class="text">8 years 6 months 21 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 2,762,242<span></span>
</td>
<td class="nump">$ 74,586<span></span>
</td>
<td class="nump">$ 1,407,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="nump">2,903,542<span></span>
</td>
<td class="nump">1,503,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 1.02<span></span>
</td>
<td class="nump">$ 1.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</a></td>
<td class="num">(3,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 0.89<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</a></td>
<td class="num">(905,417)<span></span>
</td>
<td class="num">(412,833)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 2.27<span></span>
</td>
<td class="nump">$ 2.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</a></td>
<td class="nump">3,578,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 1.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">6 years 9 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 1,246,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=RCAT_Options1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=RCAT_Options1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619973616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of restricted stock activity under the Plan (Details) - Restricted Stock [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber-0]</a></td>
<td class="nump">175,130<span></span>
</td>
<td class="nump">781,060<span></span>
</td>
<td class="nump">1,083,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice', window );">[custom:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice-0]</a></td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="nump">$ 2.44<span></span>
</td>
<td class="nump">$ 2.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross]</a></td>
<td class="nump">298,643<span></span>
</td>
<td class="nump">780,884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue]</a></td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="nump">$ 2.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod', window );">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod]</a></td>
<td class="num">(485,024)<span></span>
</td>
<td class="num">(1,062,372)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue]</a></td>
<td class="nump">$ 1.92<span></span>
</td>
<td class="nump">$ 2.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares', window );">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares]</a></td>
<td class="nump">419,549<span></span>
</td>
<td class="num">(21,127)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice]</a></td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="nump">$ 2.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares', window );">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares]</a></td>
<td class="num">(419,549)<span></span>
</td>
<td class="nump">21,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationSharesRestrictedStockAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationSharesRestrictedStockAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979619401424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock compensation expense by functional category (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ResearchAndDevelopmentStockCompensationExpense', window );">Research and development</a></td>
<td class="nump">$ 395,105<span></span>
</td>
<td class="nump">$ 692,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SalesAndMarketingStockCompensationExpense', window );">Sales and marketing</a></td>
<td class="nump">562,110<span></span>
</td>
<td class="nump">566,153<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_GeneralAndAdministrativeStockCompensationExpense', window );">General and administrative</a></td>
<td class="nump">2,652,052<span></span>
</td>
<td class="nump">2,397,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_TotalStockCompensationExpense', window );">Total</a></td>
<td class="nump">$ 3,609,267<span></span>
</td>
<td class="nump">$ 3,656,724<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_GeneralAndAdministrativeStockCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_GeneralAndAdministrativeStockCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ResearchAndDevelopmentStockCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ResearchAndDevelopmentStockCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SalesAndMarketingStockCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SalesAndMarketingStockCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_TotalStockCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_TotalStockCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979627222144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 19 &#8211; Share Based Awards (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum', window );">[custom:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum]</a></td>
<td class="nump">11,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions', window );">[custom:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions]</a></td>
<td class="nump">$ 943,648<span></span>
</td>
<td class="nump">$ 2,940,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockCompensationExpensePertainingToOptions', window );">[custom:StockCompensationExpensePertainingToOptions]</a></td>
<td class="nump">2,619,501<span></span>
</td>
<td class="nump">1,617,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockCompensationExpensePertainingToRestrictedStockUnits', window );">[custom:StockCompensationExpensePertainingToRestrictedStockUnits]</a></td>
<td class="nump">$ 989,766<span></span>
</td>
<td class="nump">$ 2,038,742<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockCompensationExpensePertainingToOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockCompensationExpensePertainingToOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockCompensationExpensePertainingToRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockCompensationExpensePertainingToRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>102
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MM&I$),LAEVR(IM"4"/W /88<0DIH(/*.@2@.P6M5W1]I42^^#S=Q[\_@#?+
M%*8FY0<$=C!%<9JNB5/V9'JUN,S#W%1KD/?![[-,&3=\Y(%P.SZB X"\N3V]
M!J>3R>7MQ!ND"SR:,I+P'>!M@G0M.4PH(3BP$7&'1@R?U,J4,K^39;",QE'
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MKQ.=:XFFZ./=&W3V\ZOY3,%#]=#9ZO" Z_8!9.0!F*#WHE1;B=Z6*4]/'<Q
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M1-'\W/(DY;4V@/_70JC'"_V [FA_\3]02P,$%     @ %8H(67+!AQ^J"
M2SD  !@   !X;"]W;W)K<VAE971S+W-H965T-2YX;6S%6UUSHS84_2L:M]./
M&6>-Q/<VR4QB ]V'[68VN^U#IP_$5FRZ&%R0DTU_?24@QDBR8J>WTY?$V%?G
M"IU[)=V#.'\LJR_UBE*&OJ[SHKX8K1C;O)U,ZOF*KM/Z3;FA!?_EOJS6*>.7
MU7)2;RJ:+II&ZWQ"+,N;K-.L&%V>-]_=5)?GY9;E64%O*E1OU^NT>KJF>?EX
M,<*CYR\^9LL5$U],+L\WZ9+>4O9Y<U/QJ\D.99&M:5%G98$J>G\QNL)O$Q**
M!HW%KQE]K/<^(W$K=V7Y15R\6UR,+-$CFM,Y$Q I__= IS3/!1+OQU\=Z&CG
M4S3<__R,'C<WSV_F+JWIM,Q_RQ9L=3$*1FA![]-MSCZ6CS_3[H9<@3<O\[KY
MBQX[6VN$YMN:E>NN,>_!.BO:_^G7;B#V&MC>@0:D:T"D!H0<:&!W#>QC/3A=
M T?VX!]HX'8-7-G#H09>U\"3&F#[0 ._:^ W9+6CVU S2UEZ>5Z5CZ@2UAQ-
M?&CX;5IS1K)"A.(MJ_BO&6_'+J=E49=YMD@97:!;QO_Q.&,U*N_Y53G_LBKS
M!:WJ[U'TUS9C3^@,?;Z=H1^^_?%\PKA[ 3*9=ZZN6U?D@*M;6F6T1M?HAD<;
MK:K&(7>!,/K]/5W?T>H/#>C4##HMUVL>T2V0 69FAKE:+#*1&FF.;M)L<985
M:)IN,L:O#:"1&?0C97PNX+<9I561%<O:A!6_T,$/TW?HBK$JN]NR]"ZGB)6\
MJQ4GRX2:F%$_E?P.A\TF/(!V441V440:'.< SG6:I\6<UF-TM:FR'-G6&!&+
MD#%*:SYAU:P)KY2)G]_L?M6%4.O';?R(:?3A,@P\_WSRL!\2JI%K^TXXM)JI
M5M@*'1];V!I:1JKE&0E";ND[0\M88XD=WR(^&1HFJJ$?6J%-@M[W8*3MW4C;
MQI&^77'.^3A_V#(^JL6"A]487=-E5H@(0QT11PUUZ\@;#K7G>])@JV9BL /?
M=J7Q-G9<+*EOZTTZIQ<COF;6M'J@H\OOOL&>]9,NLR#!8DBP! ALP+ZS8]\Q
ML]],<V+I7:!YN>;[D3H5TY:.7B.2OI](-_\"X<P<)8YLS_5\(J58!.0O!L))
M7N[W@$IW1Z5KI/)7/BN*C.4+K9@@JVPNILBZ(7A;9*S6<6J$/(%35YV=?'GZ
M=)7[/G.)[5G2_! !]2D&PDFT_28!\?5\>3N^/"-?'WN2FBP<HW8J1N_J>LN_
M_(67#6+3U'[):P3T*?V*?LO82FRAQ.JO(]3H\\29:>HI=\Y9=<) (A;29P0)
M%D.")4!@@V#Q=\'B'[%*HZP-#1$,PD/&=TBZ(#!BG9#5OI+5CK33F?GJ9!:X
M<H1$0!V*@7 27:\].] G=+#C*#AB+>VR=[:MQ&1\PTN4<O&<VN/G7P6!MP8"
MC8Y.S>) O=DPL*7]Y0S2900)%D.")4!@@P )=P$2&@/D<U'1-,_^Y@&PY'4<
MXF7F.JV^T+;\JNF<QPS+]!%A1#XAI8%P9D X$1!.'"I![O&ZC$A[D.1%LP&Q
MV.I%#\M([71;\<IY_H18E19UGK:JV.+/;<T:^4,K;A@A3^ 4"F@&!11! <4=
MT&#S%<I%=/*2U9#4/24+&TD5.["\K/7D&9N>0AX0T P**.J !J-) FSYEIQ.
M,93/Y"B?0QI[*0F;M:2H$35XD=LH&6/TD.9;1="PM20?)1YIK%S']>1=<F>V
M?XL8$\\A/I$K((WIF>M;/A\06V9 8QIX&&-?SA'5T'5\C^_G\8$![A4D_ H)
MJ1OU _J1?KB/%) T=LV 6YZL()D[?NJN!A0M!D5+H-"&(=#+2!A.1S)#G3)U
M0BE)6"?)6"&14SV"\AA# 25'='U(:2\GX?] 3S)CGL*MJB@YCB^GMT::L6W?
MPC)M4)(2%%"B[SEQ#^U9>E$)_Q^JDMGIJ04I5G4EQ_%\><F:@7J-0-%B4+0$
M"FT8-+VXA,WJTK\I3,W0IV0\$- ,"BB" HJQJC<%GH/E[4KRLMV0X%Z9PF9I
MZE7EZ2ND$CVQ0$ S** ("BC&JK:&7=^6:7W!:DAJKR9ALYQD+$^A]"(HH!D4
M4(15#>>,.)9+/+4\!?*9'.5S>-"AEX[("])163S0JCF)Q1?FS>XH2[/3TIYH
ML-0S V% )&5^JC$+L%R4$E4Y"2U+TH8C\QV<D"]00 D T)"N7A0B9E'H&)5_
M2&E[Q3*QEMX:UU*B44$$LY;"K6K(N;5M1Z;W%?K,X1T4*%H,BI9 H0VC8N^X
MDEEC$O'0Z!R<[WE[@JRME-BJ*K?+%;KZ]![=I_,LS]C3&!64:?DW.CEAUB:Z
M TUR;*B"4(C=4$Y]H"[%4$")KM\$DP/3<"]B$;.(]7M[-O)MD]]M(K=)SI?9
M3RV)G,.XHU!W-.[:[.'4*HGHSDD1Y9 4J-,(%"T&14N@T(8!TDM<Q"QQ15]I
M-<_J)L7;W"XW8A^MG\FA-*X.:#^3E416)2#BN<H:#B5=00$E^GX?J'5(KUL1
MLV[5Y.[9=2-%3O>D2'15\>)GV1Q'1G=/:-_N)GUJOKYZ3"N^CG]HB1VC9\YK
MQ*OB=I77LOT*6<B0^*HV9"M;@!FHSP@4+09%2Z#0AO'4*VK$K*C=;._R;,ZS
MGN_+FR<;12NA?1M8SMBQ+/$Y>U[^YV6MKZ;-3DZ9$#QE0L"!HX:'JK$%MN\3
MV3""ZE@,!91HNQZZGG7@I#/I=2[RPBFJ(_;NO]#'UD)/XRLD(4.FJWI/PZ4F
MVR']1J!H,2A: H4V#)%>*2-FI>RHA\6.-C0"]8F%\IZ!:N,[)%!>-%#-,'$\
M[-F6*Z>O:GH68&Q;OGS"*]9UT"/2LY)$9V6[GN/:A]*O%ZR(6;!ZQ7-B_4BK
M:HRC/B766#5C;;M8'NY7R$2&Y()$BT'1$BBT-@ F>V^)B=<,WZ?5,BMJE--[
M#F^]\7D05>V;>^T%*S?-BV-W)>.E5O-Q1=,%K80!__V^+-GSA7@7;??^Y.4_
M4$L#!!0    ( !6*"%EBO0HL.P(  -<$   8    >&PO=V]R:W-H965T<R]S
M:&5E=#8N>&UL?511;]HP$/XK5C9MK321$%)6L1 ):*?VH1(JZO8P[<$D!['J
M^%+[ N7?SW8@HQ+P$OOL^[[[[G+G=(OZU90 Q-XKJ<PX*(GJ41B:O(2*FQ[6
MH.S-"G7%R9IZ'9I: R\\J))A'$7#L.)"!5GJS^8Z2[$A*13,-3--57&]FX+$
M[3CH!X>#9[$NR1V$65KS-2R 7NJYME;8L12B F4$*J9A-0XF_=$T<?[>X9>
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M,3M^-A6N>_!T@V#K^,A8VX G2_PL8\WF#5C?6 #M!ZQ@?'5>_@M02P,$%
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M^M(A C9+6@@T+VCM"3EIM=^5KY(P!+O"5@/E<5ILLG8S#<Q#H4E @Q &R?<
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MEA2PA88I7: RYL,GXG5_U)IF\L5R'NY+-924FWH9.091?N]BY#.=&'WQB1J
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M(0]?*KWGO_%8ZJK2._Y(![?*T OX?:WA2OX++=#\T<_;_P502P,$%     @
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M N<#30)XOE0X8/0W9&#W!>OB?U!+ P04    "  5B@A9V+:M!KP"   9!@
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MK>^";!99HVA1VN6Q%)I6D153VOTHC0/=KP1]*UO%)&C_3:;_ %!+ P04
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M3M_ 2_9A2!Q>\@K>%5)F-?QUMM!&4:7\_9*3'43Z,H3MGHEN6(XSG]I#HWI
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MC>H9O?CL-!P%5T>T#CNMPV/L__U&1UG?UFQ+G7Q0"I;BY!L3E?&P?0WS)EQ
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MHQ!K.!J,Y\F(:?=IQMU85=/GD)6R5I5TF0L.:. &>+Y6\-;4WJ""_OO8S?\
M4$L#!!0    ( !6*"%D/ORD$Y@(  )@&   9    >&PO=V]R:W-H965T<R]S
M:&5E=#(T+GAM;)U536_;, R]YU<0[E!L0!I_I6G:? !-UV$;T"UHL.TP[*#8
M3"S4ECQ)3MI_/TIVW71+<MC%EBCRO4=:I,=;J1YTAFC@L<B%GGB9,>65[^LD
MPX+IGBQ1T,E*JH(9VJJUKTN%+'5!1>Y'03#P"\:%-QT[VUQ-Q[(R.1<X5Z"K
MHF#J:8:YW$Z\T'LVW/-U9JS!GXY+ML8%FF_E7-'.;U%27J#07 I0N)IXU^'5
MK&_]G<-WCEN]LP:;R5+*![OYE$Z\P K"'!-C$1B]-GB#>6Z!2,;O!M-K*6W@
M[OH9_8/+G7)9,HTW,O_!4Y--O*$'*:Y8E9M[N?V(33[G%B^1N79/V-:^T<"#
MI-)&%DTP*2BXJ-_LL:G#3L P.! 0-0&1TUT3.97OF6'3L9);4-:;T.S"I>JB
M21P7]J,LC*)33G%F^D4:A/ "3D^&41B.8$Y%0:4PA861R</8-T1B7?VD 9S5
M@-$!P#"".RE,IN%6I)B^!O!)72LQ>I8XBXXB7I>J!W'0A2B(^D?PXC;EV.'%
M!_!N?U?</,'/ZZ4VBF[%KWU)UA#]_1"V4ZYTR1*<>-0*&M4&O>GI23@(1D<$
M]EN!_6/H__--C@+NEVM9.H=9X&NE.F5KT\Z6,0T,2J9@P_(*0:[@3= +@A!*
MI$[/F,(>+%!QU##[!_&MI8J"4>O@S,X8CMX!UY!(L4%E^#)'X,)(,A2%%)V:
MG1DB5XRZV1('O6$<]VM2;0VU;Z.4QA4@2[+ZW!Z_9H4,\Q282&%#==!@Y!I-
M1DELN<F 5J_A[/P0':;/^.JL$4EIT3C@N@>7PZ@;!,&.E+^XMJ@07L)<9L-P
MV#VBGPOX7 FT=SZFDC9.E=&&-'.Q[E QJ#%XWG8&I6!83O#][N!B '%W>#F
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MF_EKQ6<H[]$EFB<WGUXV](F3FRV76BU1)^\C9FJ<B'/ZS!OM_=Y; [%4,//
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MR :L5QZWT'8@#O9/V?E74$L#!!0    ( !6*"%DO0OGEOP0  ,@*   9
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ML]:K\ >I=_S"/[]24)3VK?CZ:OV/"ES85^F;V^V_2/ AT3MJ)^1RBT?'HP5
MC;8O^=LOI3KRB_5K59;JP!]I_$UJN@&_;Q4TR7VA!>I_:N'5_P%02P,$%
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MUC.X494LI#!P?,?O*V%.+@86[7#2!L5&Y[C5R7ZC,V#P1=5V;N"Z+D7Y4L
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M2>F:*A;$83@(*D*YEX_=V+W,QZ+1C'*\EZ":JB+R8X9,K"=>Y&T''NARI>U
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MB1:U<]=<:.-5%Z[,XXC2%ICYA3 .VR1V@>ZYS?\!4$L#!!0    ( !6*"%F
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M<%HL]E PQ'J6W^Q3H@?ZK-&4B^)Q+YF#YO:3@7=AO'\8]$8,G2]2*(6^$MZ
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M8,BETBC ^4+ I-0)QD _-H__!5!+ P04    "  5B@A9S0=TS!T#  #V!@
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MXP_@_DIC=]M-O(/NJ9O]!U!+ P04    "  5B@A9 U0U"-<"   2!@  &0
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M&IQ^''J@VGEN#9*UFZ&5)--\MRW,$XC*!ICSM327J#-L@OY13?X!4$L#!!0
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MO]L/_LSW^S]W_VK<,;7FV*8""H2&9Q<C2I2?1&\8V;CN3Z7! KIEB8\7*.N
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M ]S?2+PDAXEU,/PWF/\#4$L#!!0    ( !6*"%E/!75.! 0  )<)   9
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MB:*^TL0S3M-V>^@VDS3IH;,'Q:)M363)2]+Y^/?[2#F*NW74]&"+D@C@ 7@
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M%[Z@S[E[V+I[GC^";88F2N7U7+KUC\F--@K4^6>7]ZUNL5NW+:<CO<JG\F2
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M965T-#0N>&ULM9IK;QHY%(;_BD57W:U4BF]S2Q,D<ED5;=ITDW2KU6H_3,#
MJ'.A8Y.T_WX] \&$\1PPR7Y)&+!?SNLQ/L_Q^/BA*+_)F1 *_<C27)YT9DK-
MCWH].9J)+);OBKG(]2>3HLQBI2_+:4_.2Q&/ZTY9VJ,8^[TL3O)._[A^[W/9
M/RX6*DUR\;E$<I%E<?GS5*3%PTF'=![?N$ZF,U6]T>L?S^.IN!'JR_QSJ:]Z
M:Y5QDHE<)D6.2C$YZ0S(T9G'J@YUB[\2\2 W7J/*REU1?*LNAN.3#JXB$JD8
MJ4HBUO_NQ9E(TTI)Q_%])=I9?V?5<?/UH_KOM7EMYBZ6XJQ(OR9C-3OIA!TT
M%I-XD:KKXN&#6!GR*KU1D<KZ+WI8M<4=-%I(562KSCJ"+,F7_^,?JX'8Z$#\
ME@YTU8%N=^ M'=BJ0SURO65DM:WS6,7]X[)X0&756JM5+^JQJ7MK-TE>W<8;
M5>I/$]U/]8?97(\D*B;ZGD@5*Z%OD9+5M9X5]TFQD.E/E$BY$&,T*G)9I,E8
MMQJC29+'^2B)4[31[;=SH>(DE6]0%WVY.4>__?+FN*=TF-67]4:KD$Z7(=&6
MD A%'XM<S22ZR,=B_%2@I_VM3=)'DZ<45!S,RW>(X;>(8LHM 9WMWYT!X;#U
MF+-:C[?H7<U%&:LDGZ)4Z!F(RFJJ=8M)=Z$O8BF%DK916XIZM6CUZ[SO$Q[B
MD&A']YMF+.U\C#DS[9Y$S==1<S#JVT+IFYT6^;2K1)D!@2YU_(T J$^X7E?8
M5J26AJ'GAXSX]E"]=:B>TP"G27R7I(E*A'QK'-A"]QH1$49)Y-&MR"WM>$@B
M/[ '[J\#]YW&>"-P6[3^GM%:VD748QZV1QNLHPW : ?C<5*MQ3KD>9R,NTF.
M1O$\T19LP0;-("CWB<^PMQ6NI26A/J<!;9D7X3K@$ YX-%IDB[1>O_12GXP2
M98LT;'Q_-R2$X8!M#ZREI1?@("28V2.-UI%&\$2XNAU<HLOAX'1X.;P=7MR@
MP:=S='-[=?;'AZO+\XOKFU_1Q9]?AK=_VPQ$C;!XZ+' )]OQ-QOZ..",T= >
M/L$FK6#0P-DLSJ<"Z2DQB9,2W<?I0E1992S*Y#ZN4O=Z<O^TI@C<""W24T!/
M@BT+<!P5!1U)G>+$24<G-"G*>]'I(V 1)QN9DX 6/VG(2@MI_66NNFXNPEW*
ML4=]&FT;(,U)1/4,"O!&TZ<A4A,B!4.\-CD=K3+]E<XV.G6G.JU?BWE15K^%
M?SZ*[$Z4_UJ=@-]@']_7KW3&>6]+M"^E]G0\3.(E_TOFA56=QX U?W44Z^6E
MY6Z;!$U>*D/#0LZ&;'D<DU OA"V63"(GS\CDHT59ZIEM-0C*.AMLIGO]"PVB
MMCMFTCV!\_W7N"QC_=O<>U4$Y9QM-;G "T.ZD8^?VC)<0& P6$[$U>W9!3&P
MEK.G)CSPP,=^&U(2PPX$AH?#H1(6=G;8A X61-QO,VB0@^Q@#C?XA-6<7351
M)*0TY"TID!H0H3"(N$$J+.9JBC8AAN HBAC!+>A-#7U0F#[V9%E8Q=F0A54\
M[H5^$+4 +S6L0F%664X_.8M+,2M2O2+*UZ]"2H+W2'Q?M*R'L*2S.]I<#[F/
M(Y^VK(C4@ >%P>-Y/ ^+.]NT\ <F$<-1VZ0T!$)A GDN]</RSD:;7-(EVBF-
M:(M1PR44YA*(_>&NSB::[-&E 0Z#@+7@!S7X06'\L)0' XE6[\)E :SL;/*%
MU)Z.@^$5"O/*@64!K.H\!I9M#VC?CAIRH3"Y[%\7P$+.CIJD N_O4<,J%&:5
M0^L"6-;98!-:B!=QVI(+F8$6!D.+:UT R[G:.D0-VE)A!FH8##5.A0.LY6RZ
MB38<>QBWK;+,@ V#P>;PP@$6=G;8Q!MPTYIM/,_803=NE0.LYFRKB3/@[C8S
M-,-@FG$K'6 Q9U=-=MFQ"<X,O# 87O8L'6 59T,6CH'WRIGA&+;/8Q.WT@&6
M='9GV4KA@2Z+.&DQ9^"$[=A,>5;I (L[VVPR"OS @!E(83"D/+=T@.6=C1Z@
M!J9 0S8,)ANHLH"[.GMLTLN.!P_<  R' <926:QN,%14P**N_EY*[>D0&);A
M,,L<6%3 JLYCT*2:*,2$MJ1\;J"&[[-;L]=I@!>%&&[9H_$P92WK#S<,P]T>
M#>U;4<"RSO::,-,EE+*@[?#&QND-&&9<2PI8SMF792L&>M; #<QP&&:<2@98
MR]F4!6D"@KV@;?DT0,-AH#F\9("%G1U:3HX03#W<0C7<4 W?YQ'1WB4#K.9L
MRW;"!+)E*(;O.&'B5#+ 8LZN+-LM/H_\MH*!&R;A,)/L63# *LYV;'C"(\)(
M2V'G&3KQ8#HYI%Z )5W->98G0QYP\,U0A[=C!^59U0(L[FRR"1]0KO8,?'@P
M?#RW5H#EG6U:]E6@IPR>81(/9A*H%H"[.GMH'AIM>532VSAKG(ER6A_!EFA4
M+'*U/)&[?G=]S'M0'V[>>O^4')TM#VL;F>79\8]Q.4URJ7/?1$OB=X$.JUP>
MQUY>J&)>GVB^*Y0JLOKE3,3Z[E<-].>3HE"/%]47K _%]_\#4$L#!!0    (
M !6*"%E,CXBG6P0  %$>   9    >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM
M;+69;6_:.A3'OXJ574V;M#5Q"$\=(!62[4ZZ[5"[WKVH]L($ ]:2F-E.V?WV
MUT[2@-LT NG0%R5V?'[']I^<^'!&.RY^R0VE"OU)DTR.G8U2VTO7E?&&ID1>
M\"W-])T5%RE1NBG6KMP*2I:%49JXON?UW)2PS)F,BKZYF(QXKA*6T;E ,D]3
M(OZ;TH3OQ@YVGCINV7JC3(<[&6W)FMY1=;^="]UR:\J2I323C&=(T-78N<*7
M$1X8@V+$OXSNY,$U,DM9</[+-+XNQXYG9D03&BN#(/KCD<YHDAB2GL?O"NK4
M/HWAX?43_7.Q>+V8!9%TQI,?;*DV8V?@H"5=D3Q1MWSW-ZT6U#6\F">R^(]V
MY=A>QT%Q+A5/*V,]@Y1EY2?Y4VW$@0'NO6+@5P;^<X/@%8-.9= YUB"H#()C
M#;J50;%TMUQ[L7$A460R$GR'A!FM:>:BV/W"6N\7R\P7Y4X)?9=I.S6YX8HB
MC-Z^&?@8?T+?-Q1-<ZD'28G>A501EDAT0X0@1M#WZ".ZOPO1N[_>CUREW1N(
M&U>NIJ4K_Q57V$?7/%,;B:)L29<VP-7SKB?O/TU^ZK<2K[;B G6\#\CW_*!A
M0K/CS?T&\_!X<]Q@'AUO[K5L1J=6LE/P.J_P;JE4(H]5+EBV1C,N%2+9$NEN
M*AXI>OA'CT=?%4WESR;M2GC0##?AZE)N24S'CHY'!=&9O'V#>]ZGIGV'A(60
ML @(9BD4U H%;?3)0_D\7WYF(IWQ-&5*1UQUKQ\&L1-,*9K-\T7"XF^K%34B
MWFV(GD2C6J6C7N'(O L>)W@0>.9OY#X>*M$ZHU.5@(1%0#!+B6ZM1!=4B2^"
M2SD7/*9TV2Q(Z:][(,C0;]*C=5ZGZ@$)BX!@EAZ]6H\>J!XWYLC2HD;OA1K-
M3T?KK$Y5 Q(6 <$L-?JU&OU6->H#P%7\.V>2%2<ZC!ZN:;J@HG'#6X&GOCT@
M82$D+ *"6:H,:E4&YWR_#R 5@H2%D+ ("&8I-*P5&A[WW.@0MF 9,<_-!]W0
M694.9$43?1<DDSJ(B><'X%*E5@>GJ@0)"R%AT?!%?,;#81?CH([/E@#8VV<S
MWNFARV\-7>W$4_<<E!:"TB(HFJW-0::)SQG *CJ43I"T$)060=%LG?R]3OZY
MPUB[AY.U@J2%%<TZ'':Z@=?OV8?#",JM+<,^G<>MN6AS*.NTAS+0)!Z4%H+2
M(BB:K<T^D<?!64,99"(] Z6%H+0(BF;KM$_S<7N>#Q'*()/L&7[Y.X'?'V(/
M^W;P"4'=1E T6X9]=H_;T_O&4!:TAS+(;'H&2@M!:1$4S=9FG^OC_EE#&6CF
M#TH+06D1%,W6:9_]X];4%224@?X&4-&L),[S,-;Q['DL \WPH6BE#NY!Z2RE
M8EW4+"6*>9ZILA!5]]9UT:NB&OBL?VKJI45);H\IBZW71*Q9)E%"5QKI7?3U
MEHFR?EDV%-\6!;H%5XJGQ>6&$JVJ&:#OKSA73PWCH*XB3_X'4$L#!!0    (
M !6*"%D1TT.//P,   T2   9    >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM
M;*U876^;,!3]*Q:3IDVJ H9\=@E2DVY:I56*6FU[J/;@P$V""IC93M/]^]F&
M0,@2=XG\$K#Q/;[G^$"N/=Y2]LS7  *]9FG.)\Y:B.+:=7FTAHSP#BT@ET^6
ME&5$R"9;N;Q@0&(=E*6N[WE]-R-)[H1CW3=GX9AN1)KD,&>(;[*,L#]32.EV
MXF!GU_&0K-9"=;CAN" K> 3QO9@SV7)KE#C)(.<)S1&#Y<2YP=<S/% !>L2/
M!+9\[QXI*@M*GU7C+IXXGLH(4HB$@B#R\@(S2%.%)//X78$Z]9PJ</]^A_Y%
MDY=D%H3#C*8_DUBL)\[003$LR285#W3[%2I"/847T93K7[0MQP8C!T4;+FA6
M!<L,LB0OK^2U$F(O /=/!/A5@'\8T#T1$%0!@29:9J9IW1)!PC&C6\34:(FF
M;K0V.EJR27*UC(^"R:>)C!/A3$\!#$4TCR 7C&AU6<*?T8=;$"1)^<>Q*^14
M*L"-*MAI">N?@,4^NJ>Y6'/T.8\A;@.X,L<Z47^7Z-0W(MX4K(,"[PKYGM\]
MDM#L_\,#0SI!K5N@\;IOZ39KZ?:@=,/HZ1ZR!;!?QX0SXJJW]IH7)(*)(U]+
M#NP%G/#].]SW/ATC;0FL)4&WEJ"KT8,3$LP9C3>10'=Y^351_)^^R4'H3D#&
MCY+OVB1O":Q%OE>3[YG7_Y]EOT)S8*I/?OV.42_Q1AI/?5Q?0J_3DU9\V:=T
M;)!?CVEEVJ\S[5_L5-_H5"/NN8ME":PEP:"68&#=J0.;Y"V!M<@/:_)#RTX=
M'C-A]\"IQDDOI#2J*8TNMG1@M+01]]Q5M036D@![S1^W9]W4%:0E_K;0V@+L
M52[8LK'-@&?3Q^;WI$W+;VCY%YN[:S2W&?AL>I;0VC(T]14.[-O;:FUE"ZTM
M0%-=86/]<HF]K597%5K;WOB4O9NZ";]1.!GLW3/;VPA\-CU+:&T9FJ(,]^W;
MVVI!9@NM+4!3DF%CT7.)O:V69!7:@;T/W.WN;:RE9U?ZO('+O?(F%^76M>ZM
MSS1N]$[^H'^JSCKTAKV!*0]*[@E;)3E'*2PEI-<92%^R\NRA; A:Z.W[@@KY
MXNC;-9 8F!H@GR\I%;N&FJ ^ 0K_ E!+ P04    "  5B@A9"Y[0R*0"  #O
M!@  &0   'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6RM55UOTS 4_2M60+!)
ML'PX3:N11FH[)GB85&T,'A /;G*;6'/L8+OM^N^QG3;T6SSP$G_=<^XYCGV=
MKH1\416 1J\UXVKH55HWM[ZO\@IJHFY$ ]RLS(6LB39#6?JJD4 *!ZJ9'P5!
MXM>$<B]+W=Q49JE8:$8Y3"52B[HF<CT&)E9#+_2V$X^TK+2=\+.T(24\@7YN
MIM*,_(ZEH#5P105'$N9#;Q3>3A(;[P*^4UBIG3ZR3F9"O-C!UV+H!580,,BU
M92"F6<($&+-$1L;O#:?7I;3 W?Z6_=YY-UYF1,%$L!^TT-70&WBH@#E9,/TH
M5E]@XZ=G^7+!E/NB51N;F.!\H;2H-V"CH*:\;<GK9A]V &%R!A!M -$A(#X#
MP!L =D9;9<[6'=$D2Z58(6FC#9OMN+UQ:..&<OL7G[0TJ]3@=#81=4/X^KTR
MOV0)? &HH(J4I822:"C0;-TMZ'4#Z.H.-*%,7:./Z/GI#EV]O4Y];818.C_?
M)!VW2:,S2<,(/0BN*X4^\P**?0+?..AL1%L;X^@BXZB1-P@''U 41/$)09-_
MA^,+<G"WJ]CQX7-\>2X67%->HJE@-*>@T,_13&EICNVO4QO6\L6G^>Q5OE4-
MR6'HF;NJ0"[!R]Z]"9/@TRFS_XELSWK<68\OL9L#Q9U+<VR8/4&GS+8,/<=@
MR\PRB\,^#H)>ZB]W?1S'A3B,XJC?Q>U)['42>Q<E3J4H%I<5M@3)7N8DP;C?
M/Y!X'(AQ,(B#,Q*33F)R4>(WH0D[)2PYWI+^ "=X$!T(.PZ,DR@8X/A F+]3
M.VJ0I2NI"KGSV]Z_;K:KVB-7K [FQZ::M\7W+TW[%#P065*N$(.YH0QN^D:5
M;,MK.]"B<15J)K2I=ZY;F1<)I TPZW,A]'9@$W1O7/8'4$L#!!0    ( !6*
M"%D9_">J#0,  %@(   9    >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;*V6
M38_3,!"&_XH5) 02;-)\9VDCM;L@.*Q4;8$]( YN,FVL=>)@.^WR[[&=-+1-
M6G'@TL3VS.MGQA-/IWO&GT4!(-%+22LQLPHIZUO;%ED!)18WK(9*K6P8+[%4
M0[ZU1<T!Y\:II+;K.*%=8E)9Z=3,+7DZ98VDI((E1Z(I2\Q_+X"R_<R:6(>)
M1[(MI)ZPTVF-M[ "^:U><C6R>Y6<E% )PBK$83.SYI/;NUC;&X/O!/;BZ!WI
M2-:,/>O!EWQF.1H(*&12*V#UV,$=4*J%%,:O3M/JM]2.Q^\']4\F=A7+&@NX
M8_2)Y+*86;&%<MC@ALI'MO\,73R!ULL8%>87[3M;QT)9(R0K.V=%4)*J?>*7
M+@]'#I/P@H/;.;CG#OX%!Z]S\$R@+9D)ZQY+G$XYVR.NK96:?C&Y,=XJ&E+I
M4UQ)KE:)\I/IO)(D)[31R40"LH8324 @>,EHDT..-IR5*&-EW4AL$L\VR#BH
MM4I5&65"H!I48128 WIS#Q(3*MZB]^V,F-I2<>K=[*QC6K1,[@6FB8L>6"4+
M@3Y6"N%4P%8!]E&ZAR@7[E7%><UOD.>\0Z[C^B- =__N[EW!\?JD>T;/NZ27
M9:Q1B:^V:,DHR73"?\S70G)5U3_'$M;J^>-Z^DN_%37.8&:I3UD WX&5OGXU
M"9T/8\'^)[&3T/T^=/^:>KH"KJ-=H*7Z7(%S544KR;+G=P@+56;5#K@\/_(V
M!:UN:'3UW;1+O3@)I_;N.+2A4>RZKN?T9B?000\=7(?6A(C5NOY'ZSD8;!M&
M49)X_AG>T,Z/8C]VDG&^L.<+K_(]8<YQ)4?1PL&6KAL%29*<H0WM)H&7'-N=
MH$4]6G05[1%459-,WQ9"9W$,,1IN'063HT-K"8=F43QQP@MG&_> \57 KTQB
M.D85#[9+7,]/@O/$#>VBQ%5'&I]QV4>7= E\:WJ7KGEU$[0W63_;M\>YZ0IG
M\PO5-MLN]U>F[;D/F&]))1"%C9)T;B)5;[SM8^U LMJT@C63JK&8UT*U?N#:
M0*UO&).'@=Z@_S.1_@%02P,$%     @ %8H(69[N65CY!   &@\  !D   !X
M;"]W;W)K<VAE971S+W-H965T-#DN>&ULK5=M;]LV$/XK!W<H4L"I1;W:J6/
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M X:=IG5KB%F\W&>TW$^3OXJ7G%C?LP?ZU,<RK*KWQBB^*(SU&!@)]_1<Q-;
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MA 14-8A5&R/7Y2RSD 9S=[E,<7AER@K@^Z7$>:;>V _LQN')/U!+ P04
M"  5B@A90S3VU2T$   2#P  &0   'AL+W=O<FMS:&5E=',O<VAE970U,"YX
M;6RM5]ENXS84_15"+8H,,(FX:$UM UFF[0"=3I!TVH>B#XQ%VT(D44/2<?KW
MO91LR9%HM0/DQ9:HNYR[D(=WMI/J26^$,.BE+"H]]S;&U)>^KY<;47)](6M1
MP9>55"4W\*K6OJZ5X%FC5!8^Q3CR2YY7WF+6K-VIQ4QN39%7XDXAO2U+KOZY
M%H7<S3WB'1;N\_7&V 5_,:OY6CP(\Z6^4_#F=U:RO!25SF6%E%C-O2MR>4-B
MJ]!(_)&+G3YZ1C:41RF?[,O';.YABT@48FFL"0Y_S^)&%(6U!#B^[HUZG4^K
M>/Q\L/Y3$SP$\\BUN)'%GWEF-G,O\5 F5GQ;F'NY^T7L PJMO:4L=/.+=JUL
M!,++K3:RW"L#@C*OVG_^LD_$D0*)3BC0O0(=*@0G%-A>@36!MLB:L&ZYX8N9
MDCNDK#18LP]-;AIMB":O;!D?C(*O.>B9Q6VNE[(R>;45&?I<"\5M=C4ZAQII
M2(5&<H5DOWYV*PS/"_T.)+X\W**S[]_-? - K#E_N7=ZW3JE)YP2BCZ!TXU&
M'ZI,9*\-^!!!%P8]A'%-)RU>U>H",?P>44P#!Z";_Z_.)N"P+JNLL<>^,:N\
MRA!\JZ7F!?I9R6VMT5]7C]HH:.>_78EL_01N/W:/7^J:+\7<@TVLA7H6WN*'
M[TB$?W0EX8V,O4I)T*4DF+*^N!?/ M*A74&VFF&C:<^=YT5 "8M"*,7S,?ZQ
M7$A3G 91)_<*6MA!"R>AW4AM;)NOI<PTTK+(7"!;&]$QR#".TP0/0#KDXI0%
M#+M!1AW(:!(D=(N&[?<K_+Y#=TJN<N-"&8V\G[,H8#0>H!S+!6D<DA.9C#N0
M\63?[UN]6J,/+T TVEWN^"U[^HV,O0HWZ<)-_J.GM>!JN6GV=08-7L@:*,Y9
MF&24<$(2G Y;?"S&@@ACZJY+V@%-)X$^\$*TIP]P]9.P%7)A3!T8PS@(D@'(
ML5P2498$;I $]UR$IWM<5- _10.49\!VN3T9+<\[.08[8# 6D0%:AQS!01"P
M\ 3>(^XDDWA_EP;0RJ[IQ433[TT=HX S+DF/2KN'ZQ"D(4TH.0&7]G#I)-Q^
M=Q9PBCA!TO'Q04/,*$V'*!V2) Y#AD]EM>=.,DV>G\U&J$,NT5E>+64IW+>,
M-V7'M[+V.NR>'\DT07ZLC "[YA"Y,^# T1M)& V+,^G)'0F:"J)G4C)-I4WM
MWJ-*.,] ,N;&<Q*.-H!#B@8I24\T5L^@9)I"OZ&QQO1(:8R#(5('VTXA[6F4
M3-+6XC>8W^P>12LE2Y0=WR;[N[@3>#RZ(L$&IF'*AD3CDB0QPRP9W@'\H^FB
M%&K=#%T:+>6V,NT-O5OM!KNK9IP9K%_;@:^96GHS[;3XB:MU#O?C0JS )+Z(
M 99J![#VQ<BZF6$>I8&)J'G<P- JE!6 [RLIS>'%.NC&X,6_4$L#!!0    (
M !6*"%D]5/UU[ ,  ,H1   9    >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM
M;*U8VV[;.!3\%4);%"W01*)NEE/;0.I@T0*[V*#9;I]I^=@F*HDJ2=O)WR\I
M*[)24714* ^Q;C.:X6T.-3LR_D/L "1ZS+-"S)V=E.6-ZXIT!SD1UZR$0MW9
M,)X3J4[YUA4E![*N0'GF^IX7NSFAA;.85=?N^6+&]C*C!=QS)/9Y3OC3)\C8
M<>Y@Y_G"5[K=27W!7<Q*LH4'D-_*>Z[.W(9E37,H!&4%XK"9.[?X9HFG&E ]
M\1^%HV@=(VUEQ=@/??)E/7<\K0@R2*6F(.KG $O(,LVD=/RL29WFG1K8/GYF
M_[,RK\RLB( ER[[3M=S-G<1!:]B0?2:_LN-GJ U%FB]EF:C^H^/IV5@]G.Z%
M9'D-5@IR6IQ^R6/=$"T #GL ?@WP7PL(:D!0&3TIJVS=$4D6,\Z.B.NG%9L^
MJ-JF0BLWM-#=^""YNDL53BYNA0 I$"G6**-D13,J*0BDQ@>2.T!+5J@.!HX>
M8*LZ3Z)W=R )S<1[=(6^/=RA=V_>SURIA&@Z-ZU?^NGT4K_OI26_1H'W ?F>
M'QK@R]?#@Y=P5]EOVL!OVL"O^((>ON6><^V-5&UALG/"AV:\GFDWHB0IS!TU
ME03P SB+MW_@V/MH,C<2V0NK06,UL+$OED3L3 :M*+,F9/)VXHDJ'KV"'!9)
M'$?QS#T81(>-Z- J^C9-V;Y0HY1#"O1 5AE\0 5(DQ$KTP C)YZX923&V)N8
MC42-D<AJY$MQ4..,\2>3<BMT@/*HHSSPXF@:A6;M<:,]MFK_1RT'W*3;"AN@
M.^[H]KUX&@:)6?>DT3VQZOZ729*IE?32%+>R#+ QZ=B(_"3 462VD30VD@M#
M1Y)B2]70KSWTS@ KSP CB:$_U)_9QK2Q,?V]462%#5 ][8[^) K,HK%W#DG/
M+KL$3B0MMB@#53,@KHN#*[:YV@NPC"D[ZP!7-5';5A)&8<^4QJWPQZ^8'!E3
MQB3PW&;%2C3$"NY8P5X23'N65GP.<?RZ%&^5,48CHV;Y6&PO/9_3'-OCO$G&
MDCSI6#0:'BO;:Z(7F>C%R<3OZ;ESO..+^<[WL$;PJ#8GHJ?;Q@IVW$UV[$W#
MI&=AP^=LQ_9P7U;%NBJ5UU R07NFT5@IC[LQ[X=AG/2D)3['/+Z0\[\L=9>F
MTUCQC[OY'T[#&/?X.<<_'I+_E]R,507@;AF />Q%7I^?<QV [87 7\UBW=ZO
M7:&A_396F8"[=4*($]P73>=" =LKA>]J]Z_=I*2DJ@>-'L8J&FJB]K8E]"=^
MW*F9W=9&6W_E^)OP+2V$:O*-0GK7$T7!3Q\.3B>2E=7>>\6D6ARJPQV0-7#]
M@+J_84P^G^CM?//Y9O$_4$L#!!0    ( !6*"%GH1!XV?P,  *(-   9
M>&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;+V7VX[;-A"&7V6@%$$")"M+/JYC
M&_!:3=J+9(TUTEP$O:"EL45$$E626B=OWR$EJW965M>%T+U8BQ3GGYEO*!YF
M!R&_J1A1P_<TR=3<B;7.IZZKPAA3IFY$CAF]V0F9,DU-N7=5+I%%UBA-7+_7
M&[DIXYFSF-F^M5S,1*$3GN%:@BK2E,D?=YB(P]SQG&/' ]_'VG2XBUG.]KA!
M_3E?2VJYM4K$4\P4%QE(W,V=I3<-;LUX.^ /C@=U\@PFDZT0WTSC]VCN]$Q
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M8[I$H30#Z/U.T#);-8R#^EJV^!M02P,$%     @ %8H(64D.B7QN @  FP4
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MNNG:O)Z@;( Y7TK3@NW"=G3W'F?_ %!+ P04    "  5B@A9$=\1?8$"  #
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MS09\OA18WL6-.: <T0?_ E!+ P04    "  5B@A9G"12+F\$  "<%0  &0
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M\B-89_2<"_#71Y)M"?M;)]CXA'*UW? "[\C2DLN)$_9(K-4O/\' ^54G_Y7
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M*<<WG\2$D*"'@HLG.9UG&-TSACE#WS\)#7K@.&=_]SV_=0*C/T$YC]ZQ3;S
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MVV[30!#]E9%!J)6J^)+$E.)82EH02%14#:4/B(>-/;%77>^:W4W2_#U[<4Q
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MU_4KH<T,<<O:#&V4UL#<KX70AXT-T/\-Y+\!4$L#!!0    ( !6*"%F9@E-
M= (  $<(   9    >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;*V676_;(!2&
M_PKRIJF3MACCC]B98ZD?JCIIDZ)6W2ZF79#D)$'%Q@.2M/]^@%W/:IQ=^2;F
M ._+<\#F)#\*^:1V !H]E[Q2<V^G=3WS?;7:04G51-10F9&-D"75)I1;7]42
MZ-J)2NX3C!._I*SRBMSU+621B[WFK(*%1&I?EE2^7 $7Q[D7>*\=]VR[T[;#
M+_*:;N$!]&.]D";R.Y<U*Z%23%1(PF;N70:SJ\ )W(P?#(ZJUT8VE:403S;X
MNIY[V!(!AY6V%M0\#G -G%LGP_&G-?6Z-:VPWWYUOW7)FV265,&UX#_96N_F
M7NJA-6SHGNM[<;R#-J'8^JT$5^X7'9NY4>BAU5YI4;9B0U"RJGG2YW8C>@)"
MS@A(*R".NUG(4=Y038M<BB.2=K9QLPV7JE,;.%;94WG0THPRH]/%[5[O)2 .
M)C-4TQ>SX1J))6=;:G=-H8L;T)1Q]3'WM5G/JOQ5ZWW5>),SWI>UG* 0?T($
MDP@]/MR@B_=O;'R#VS&3CIDXW_",[S<+J]"ORZ72TASK[R&TQB(:MK#O^DS5
M= 5SS[S,"N0!O.+#NR#!7_X#&': X3CN#6IC%CLS^Q4=BC!)TCC,_<, 1-1!
M1&-"-&9)'V)*HB@;AH@[B'A,B'@((DWQ,$32021C0B0G$"0+PS :AIAV$-,Q
M(::G$"G&YW8B[2#2,2'2$X@H"J/D#$36061C0F2G.Q&0#,?),$6 _]U\>$R.
MUJT/\CD)@B@Y!]*[@H-108*3^R*(@VF<O3T7OU<6;(G]3N66F2N=P\8H\61J
M+&13M9I B]I5BJ70INZXYLY4>I!V@AG?"*%? UM\NO\.Q5]02P,$%     @
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ME"8.T:9>0.M7+_">A1G;I/&*;G<\?:AJ!9Z*!IQ]LLH^L26+'MBJ^T(&6CL
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MK*T)11H-I%@3::(UFUG8W%BT=L.XJ>(E2OV4:1Q&9P*!^%VR]64_\/TC,BF
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MRK6K2@ET:96*W T\+W8+RK@S'=NQ!SD=BTKGC,.#)*HJ"BI?9I"+[<3QG?W
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ML<"VS0S?0""- ,ZOA-#[CEF@>55-_P=02P,$%     @ %8H(69/..#CD @
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M"^@< ?@UP#="*\^,K!LL<33@;(VXME9L>F!B8]!*34;U+<XD5[N9PLGHGDE
M;@^=GX6>ZUZCJ8HB< X)FDD6OZ!/-R!QE@MTCSG'.N2?T1<D4LQ!#&RI/- \
M=ER?-JY.\XZ<YGKHCE&9"O25)I#L$MC*]<9_;^/_V&ME'!7\$OG.!?(<KW/
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M#^?P4&S",>J=07V<8#I#^:WO:B)M/NV&>X*C@J!_@F#3AXG(=*S@4Q9A]!3
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M?QY0P]HBV=8Q**\:RCD/:D?"=BYA^W\HX3 ,&89$R$HM!8ODMLF'.Q(O2N=
MED"K,')=U[4ZUMXLJ,RSO'Y"F1:'GVO*PN0XY5.ED_/<>36>_\RV'7*/,D$6
MT4#U4%XVL$:=@ZK8=ES+VN>N,O9G<'<!SLDUK)LSW/T/&3XH.MH$/#6&/Y*(
M'1^^W8/":]5=9T^ RM2>(< %."<%:%A/FV?KU238KHT%%4KWT941G<_<^*6
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M-E#OETPUDGJB S2?(?%?4$L#!!0    ( !:*"%E8M=0D,@,  .X2   -
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M&H[;+_N5<M]Y>Z4DS7)[H^FR;YI3.'8I/DI:;W^*MOT9W;O_ %!+ P04
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M4$L! A0#%     @ %8H(6<5^E\[O    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ %8H(69E<G",0!@  G"<
M !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  5B@A9[?<./:P'   5,P  &               @($."   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ %8H(62H^7YX]!P  @Q\
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M965T-BYX;6Q02P$"% ,4    "  5B@A9I_33I!H*  "X,@  &
M    @(%F*P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
M%8H(67+7\MJ%!@  @0X  !@              ("!MC4  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( !6*"%G@GR(8#!4    T   8
M          " @7$\  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    "  5B@A9O+NQ=(,(  #-$@  &0              @(&S40  >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( !6*"%G8MJT&O (  !D&
M   9              " @6U:  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ %8H(6:ZP+MZ1 @  G04  !D              ("!8%T
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  5B@A9>5C"
M3\X"   H!@  &0              @($H8   >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( !6*"%DYC]F;P@0   <+   9
M  " @2UC  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
M%8H(66;T$9(U!P  51   !D              ("!)F@  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    "  5B@A95V6TU$($   3"0  &0
M            @(&2;P  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( !6*"%G>@/X-.0,   @'   9              " @0MT  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ %8H(62-7XD'+ @
M608  !D              ("!>W<  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    "  5B@A9O&&]?&($  "S"0  &0              @(%]
M>@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( !6*"%D0
M4[_S&P0  *,(   9              " @19_  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ %8H(62RR(<!W @  G 4  !D
M     ("!:(,  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !6*"%E=6\_Q<P8  $,.   9              "
M@<J9  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ %8H(
M68O!S%_^ @  K 8  !D              ("!=*   'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    "  5B@A9YP+-Q,($  #6"@  &0
M        @(&IHP  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( !6*"%DO0OGEOP0  ,@*   9              " @:*H  !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ %8H(62V^;HBP%@  =D$
M !D              ("!F*T  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    "  5B@A9FI:G5[\%  !$#0  &0              @(%_Q
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( !6*"%G)0=5+
MW00  .0*   9              " @77*  !X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ %8H(6<9&?5F: @  >@4  !D
M ("!B<\  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    "  5
MB@A9@&ONW-H"  #^!0  &0              @(%:T@  >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( !6*"%F+RK-OE@0  $(+   9
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M970S.2YX;6Q02P$"% ,4    "  5B@A9>N> !5\"   :!0  &0
M    @($3YP  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M !6*"%GB\1]L?0,  "<(   9              " @:GI  !X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ %8H(64\%=4X$!   EPD  !D
M             ("!7>T  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    "  5B@A9MQ#'?H,%   ]#0  &0              @(&8\0  >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( !6*"%F=GUC@?0<
M " O   9              " @5+W  !X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ %8H(64R/B*=;!   41X  !D              ("!
M!O\  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    "  5B@A9
M$=-#CS\#   -$@  &0              @(&8 P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    ( !6*"%D+GM#(I (  .\&   9
M      " @0X' 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ %8H(61G\)ZH- P  6 @  !D              ("!Z0D! 'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  5B@A9GNY96/D$   :#P
M&0              @($M#0$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    ( !6*"%E#-/;5+00  !(/   9              " @5T2 0!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ %8H(63U4_77L
M P  RA$  !D              ("!P18! 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    "  5B@A9Z$0>-G\#  "B#0  &0
M@('D&@$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( !6*
M"%E)#HE\;@(  )L%   9              " @9H> 0!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ %8H(61'?$7V! @  P 8  !D
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M=#4X+GAM;%!+ 0(4 Q0    ( !6*"%DZ&/DH_@,  -$:   9
M  " @;PR 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
M%8H(6>N(R09Q @  S04  !D              ("!\38! 'AL+W=O<FMS:&5E
M=',O<VAE970V,"YX;6Q02P$"% ,4    "  5B@A9UY\2E)P$   W%P  &0
M            @(&9.0$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4
M Q0    ( !6*"%G0S+UT-0,  $4,   9              " @6P^ 0!X;"]W
M;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ %8H(6=''Z[+$ @
MI <  !D              ("!V$$! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX
M;6Q02P$"% ,4    "  5B@A90%N<VV4"  "X!0  &0              @('3
M1 $ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( !6*"%F3
M(0H24 (  "<&   9              " @6]' 0!X;"]W;W)K<VAE971S+W-H
M965T-C4N>&UL4$L! A0#%     @ %8H(6>7N8LD[ @  PP0  !D
M     ("!]DD! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !6*"%E7FO;,4 @  #1C   9              "
M@;I6 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ %8H(
M65WA+HT? P  "@D  !D              ("!05\! 'AL+W=O<FMS:&5E=',O
M<VAE970W,BYX;6Q02P$"% ,4    "  5B@A9$ @"TW\"  #H!0  &0
M        @(&78@$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0
M   ( !6*"%D6JFJQ^P,  &$-   9              " @4UE 0!X;"]W;W)K
M<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ %8H(69/..#CD @  H@D
M !D              ("!?VD! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q0
M2P$"% ,4    "  5B@A9J_RY1RT#  !Z#   &0              @(&:; $
M>&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( !6*"%D5!FF9
M%0,  !4*   9              " @?YO 0!X;"]W;W)K<VAE971S+W-H965T
M-S<N>&UL4$L! A0#%     @ %8H(61L8@-H2!   5Q$  !D
M ("!2G,! 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4    "  5
MB@A9S-5B52,#   2#   &0              @(&3=P$ >&PO=V]R:W-H965T
M<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( !6*"%E-J'$^)00  #<2   9
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M970X-"YX;6Q02P$"% ,4    "  6B@A96+74)#(#  #N$@  #0
M    @ %"CP$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( !:*"%F7BKL<P
M !,"   +              "  9^2 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M !:*"%G305^^$ <  ,HW   /              "  8B3 0!X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    "  6B@A9DS&\_8 "  "3,0  &@
M@ '%F@$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  6
MB@A9]S F!B<"   R,   $P              @ %]G0$ 6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     7 !< #L9  #5GP$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>126</ContextCount>
  <ElementCount>423</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>38</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/StatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/StatementsOfStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/StatementsOfStockholdersEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Note 1 ??? The Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note1Business</Role>
      <ShortName>Note 1 ??? The Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Note 2 ??? Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Note 2 ??? Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Note 3 ??? Divestiture of Consumer Segment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note3DivestitureOfConsumerSegment</Role>
      <ShortName>Note 3 ??? Divestiture of Consumer Segment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Note 4 ??? Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note4MarketableSecurities</Role>
      <ShortName>Note 4 ??? Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Note 5 ??? Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note5Inventories</Role>
      <ShortName>Note 5 ??? Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Note 6 ??? Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note6OtherCurrentAssets</Role>
      <ShortName>Note 6 ??? Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Note 7 ??? Due From Related Party</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note7DueFromRelatedParty</Role>
      <ShortName>Note 7 ??? Due From Related Party</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Note 8 ??? Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note8IntangibleAssets</Role>
      <ShortName>Note 8 ??? Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Note 9 ??? Equity Method Investment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note9EquityMethodInvestment</Role>
      <ShortName>Note 9 ??? Equity Method Investment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Note 10 ??? Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note10PropertyAndEquipment</Role>
      <ShortName>Note 10 ??? Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Note 11 ??? Other Long-Term Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note11OtherLong-termAssets</Role>
      <ShortName>Note 11 ??? Other Long-Term Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Note 12 ??? Right of Use Assets and Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note12RightOfUseAssetsAndLiabilities</Role>
      <ShortName>Note 12 ??? Right of Use Assets and Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Note 13 ??? Debt Obligations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note13DebtObligations</Role>
      <ShortName>Note 13 ??? Debt Obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Note 14 ??? Due to Related Party</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note14DueToRelatedParty</Role>
      <ShortName>Note 14 ??? Due to Related Party</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Note 15 ??? Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note15IncomeTaxes</Role>
      <ShortName>Note 15 ??? Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Note 16 ??? Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note16CommonStock</Role>
      <ShortName>Note 16 ??? Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Note 17 ??? Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note17PreferredStock</Role>
      <ShortName>Note 17 ??? Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Note 18 ??? Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note18Warrants</Role>
      <ShortName>Note 18 ??? Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Note 19 ??? Share Based Awards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note19ShareBasedAwards</Role>
      <ShortName>Note 19 ??? Share Based Awards</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Note 20 - Related-Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note20-Related-partyTransactions</Role>
      <ShortName>Note 20 - Related-Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Note 21 ??? Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note21CommitmentsAndContingencies</Role>
      <ShortName>Note 21 ??? Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Note 22 ??? Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note22SubsequentEvents</Role>
      <ShortName>Note 22 ??? Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Note 2 ??? Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Note 2 ??? Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Note 2 ??? Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Note 2 ??? Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Note 3 ??? Divestiture of Consumer Segment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note3DivestitureOfConsumerSegmentTables</Role>
      <ShortName>Note 3 ??? Divestiture of Consumer Segment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note3DivestitureOfConsumerSegment</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Note 5 ??? Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note5InventoriesTables</Role>
      <ShortName>Note 5 ??? Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note5Inventories</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Note 6 ??? Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note6OtherCurrentAssetsTables</Role>
      <ShortName>Note 6 ??? Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note6OtherCurrentAssets</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Note 8 ??? Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note8IntangibleAssetsTables</Role>
      <ShortName>Note 8 ??? Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note8IntangibleAssets</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Note 9 ??? Equity Method Investment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note9EquityMethodInvestmentTables</Role>
      <ShortName>Note 9 ??? Equity Method Investment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note9EquityMethodInvestment</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Note 10 ??? Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note10PropertyAndEquipmentTables</Role>
      <ShortName>Note 10 ??? Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note10PropertyAndEquipment</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Note 11 ??? Other Long-Term Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note11OtherLong-termAssetsTables</Role>
      <ShortName>Note 11 ??? Other Long-Term Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note11OtherLong-termAssets</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Note 12 ??? Right of Use Assets and Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note12RightOfUseAssetsAndLiabilitiesTables</Role>
      <ShortName>Note 12 ??? Right of Use Assets and Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note12RightOfUseAssetsAndLiabilities</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Note 13 ??? Debt Obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note13DebtObligationsTables</Role>
      <ShortName>Note 13 ??? Debt Obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note13DebtObligations</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Note 16 ??? Common Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note16CommonStockTables</Role>
      <ShortName>Note 16 ??? Common Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note16CommonStock</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Note 18 ??? Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note18WarrantsTables</Role>
      <ShortName>Note 18 ??? Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note18Warrants</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Note 19 ??? Share Based Awards (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note19ShareBasedAwardsTables</Role>
      <ShortName>Note 19 ??? Share Based Awards (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note19ShareBasedAwards</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails</Role>
      <ShortName>Impact of restatements of previously issued consolidated financial statements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Note 1 ??? The Business (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note1BusinessDetailsNarrative</Role>
      <ShortName>Note 1 ??? The Business (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note1Business</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Customer concentration risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/CustomerConcentrationRiskDetails</Role>
      <ShortName>Customer concentration risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Company's revenue disaggregated by revenue type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails</Role>
      <ShortName>Company's revenue disaggregated by revenue type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails</Role>
      <ShortName>Antidilutive securities excluded from computation of diluted net loss per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Note 2 ??? Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Note 2 ??? Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Discontinued Operations - results of operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails</Role>
      <ShortName>Discontinued Operations - results of operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - Assets and liabilities for the Consumer Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails</Role>
      <ShortName>Assets and liabilities for the Consumer Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - Note 3 ??? Divestiture of Consumer Segment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative</Role>
      <ShortName>Note 3 ??? Divestiture of Consumer Segment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note3DivestitureOfConsumerSegmentTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Note 4 ??? Marketable Securities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note4MarketableSecuritiesDetailsNarrative</Role>
      <ShortName>Note 4 ??? Marketable Securities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note4MarketableSecurities</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Other current assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/OtherCurrentAssetsDetails</Role>
      <ShortName>Other current assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - Note 7 ??? Due From Related Party (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative</Role>
      <ShortName>Note 7 ??? Due From Related Party (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note7DueFromRelatedParty</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - Intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/IntangibleAssetsDetails</Role>
      <ShortName>Intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Expected amortization expense for the unamortized finite-lived intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails</Role>
      <ShortName>Expected amortization expense for the unamortized finite-lived intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Composition of, and changes in goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/CompositionOfAndChangesInGoodwillDetails</Role>
      <ShortName>Composition of, and changes in goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - Note 8 ??? Intangible Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note8IntangibleAssetsDetailsNarrative</Role>
      <ShortName>Note 8 ??? Intangible Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note8IntangibleAssetsTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - Financial informatino for UMAC derived from their Form 10-Q (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails</Role>
      <ShortName>Financial informatino for UMAC derived from their Form 10-Q (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - Impacts on investments into UMAC (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails</Role>
      <ShortName>Impacts on investments into UMAC (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - Property and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/PropertyAndEquipmentDetails</Role>
      <ShortName>Property and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - Note 10 ??? Property and Equipment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note10PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>Note 10 ??? Property and Equipment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note10PropertyAndEquipmentTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - Other long term assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/OtherLongTermAssetsDetails</Role>
      <ShortName>Other long term assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - Note 11 ??? Other Long-Term Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note11OtherLong-termAssetsDetailsNarrative</Role>
      <ShortName>Note 11 ??? Other Long-Term Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note11OtherLong-termAssetsTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - Operating leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/OperatingLeasesDetails</Role>
      <ShortName>Operating leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - Supplemental information related to operating leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails</Role>
      <ShortName>Supplemental information related to operating leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - Future lease payment obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/FutureLeasePaymentObligationsDetails</Role>
      <ShortName>Future lease payment obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - Outstanding principal payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/OutstandingPrincipalPaymentsDetails</Role>
      <ShortName>Outstanding principal payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - Note 13 ??? Debt Obligations (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note13DebtObligationsDetailsNarrative</Role>
      <ShortName>Note 13 ??? Debt Obligations (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note13DebtObligationsTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - Note 14 ??? Due to Related Party (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative</Role>
      <ShortName>Note 14 ??? Due to Related Party (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note14DueToRelatedParty</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - Note 15 ??? Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note15IncomeTaxesDetailsNarrative</Role>
      <ShortName>Note 15 ??? Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note15IncomeTaxes</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - Summary of shares of common stock issued (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails</Role>
      <ShortName>Summary of shares of common stock issued (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - Note 17 ??? Preferred Stock (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note17PreferredStockDetailsNarrative</Role>
      <ShortName>Note 17 ??? Preferred Stock (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note17PreferredStock</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - Summary of warrants issued and fair values (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails</Role>
      <ShortName>Summary of warrants issued and fair values (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - Assumptions used to estimate fair value of stock warrants granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails</Role>
      <ShortName>Assumptions used to estimate fair value of stock warrants granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>00000078 - Disclosure - Changes in warrants outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/ChangesInWarrantsOutstandingDetails</Role>
      <ShortName>Changes in warrants outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>00000079 - Disclosure - Note 18 ??? Warrants (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note18WarrantsDetailsNarrative</Role>
      <ShortName>Note 18 ??? Warrants (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note18WarrantsTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>00000080 - Disclosure - Assumptions used to calculate fair value of options granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails</Role>
      <ShortName>Assumptions used to calculate fair value of options granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>00000081 - Disclosure - Summary of activity under the Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/SummaryOfActivityUnderPlanDetails</Role>
      <ShortName>Summary of activity under the Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>00000082 - Disclosure - Summary of restricted stock activity under the Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails</Role>
      <ShortName>Summary of restricted stock activity under the Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>00000083 - Disclosure - Stock compensation expense by functional category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails</Role>
      <ShortName>Stock compensation expense by functional category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="rcat0808form10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>00000084 - Disclosure - Note 19 ??? Share Based Awards (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note19ShareBasedAwardsDetailsNarrative</Role>
      <ShortName>Note 19 ??? Share Based Awards (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note19ShareBasedAwardsTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>rcat-20240430.xsd</File>
    <File>rcat-20240430_cal.xml</File>
    <File>rcat-20240430_def.xml</File>
    <File>rcat-20240430_lab.xml</File>
    <File>rcat-20240430_pre.xml</File>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="rcat0808form10k.htm">rcat0808form10k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="655">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>109
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "rcat0808form10k.htm": {
   "nsprefix": "RCAT",
   "nsuri": "http://RCAT/20240430",
   "dts": {
    "schema": {
     "local": [
      "rcat-20240430.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "rcat-20240430_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rcat-20240430_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "rcat-20240430_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rcat-20240430_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "rcat0808form10k.htm"
     ]
    }
   },
   "keyStandard": 298,
   "keyCustom": 125,
   "axisStandard": 10,
   "axisCustom": 4,
   "memberStandard": 8,
   "memberCustom": 30,
   "hidden": {
    "total": 148,
    "http://fasb.org/us-gaap/2023": 120,
    "http://RCAT/20240430": 20,
    "http://xbrl.sec.gov/dei/2023": 8
   },
   "contextCount": 126,
   "entityCount": 1,
   "segmentCount": 38,
   "elementCount": 579,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 655,
    "http://xbrl.sec.gov/dei/2023": 40
   },
   "report": {
    "R1": {
     "role": "http://RCAT/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://RCAT/role/BalanceSheets",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-04-30",
      "name": "us-gaap:Investments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://RCAT/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2023-04-30",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-04-30",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://RCAT/role/StatementsOfOperations",
     "longName": "00000004 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://RCAT/role/StatementsOfStockholdersEquity",
     "longName": "00000005 - Statement - Consolidated Statements of Stockholders' Equity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2022-04-30_custom_SeriesBPreferredStock1Member",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-04-30_custom_SeriesBPreferredStock1Member",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://RCAT/role/StatementsOfStockholdersEquityParenthetical",
     "longName": "00000006 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "shortName": "Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://RCAT/role/StatementsOfCashFlows",
     "longName": "00000007 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:IncomeLossFromDiscontinuedOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://RCAT/role/Note1Business",
     "longName": "00000008 - Disclosure - Note 1 \u2013 The Business",
     "shortName": "Note 1 \u2013 The Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies",
     "longName": "00000009 - Disclosure - Note 2 \u2013 Summary of Significant Accounting Policies",
     "shortName": "Note 2 \u2013 Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://RCAT/role/Note3DivestitureOfConsumerSegment",
     "longName": "00000010 - Disclosure - Note 3 \u2013 Divestiture of Consumer Segment",
     "shortName": "Note 3 \u2013 Divestiture of Consumer Segment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://RCAT/role/Note4MarketableSecurities",
     "longName": "00000011 - Disclosure - Note 4 \u2013 Marketable Securities",
     "shortName": "Note 4 \u2013 Marketable Securities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://RCAT/role/Note5Inventories",
     "longName": "00000012 - Disclosure - Note 5 \u2013 Inventories",
     "shortName": "Note 5 \u2013 Inventories",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://RCAT/role/Note6OtherCurrentAssets",
     "longName": "00000013 - Disclosure - Note 6 \u2013 Other Current Assets",
     "shortName": "Note 6 \u2013 Other Current Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://RCAT/role/Note7DueFromRelatedParty",
     "longName": "00000014 - Disclosure - Note 7 \u2013 Due From Related Party",
     "shortName": "Note 7 \u2013 Due From Related Party",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:DueFromRelatedPartyDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:DueFromRelatedPartyDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://RCAT/role/Note8IntangibleAssets",
     "longName": "00000015 - Disclosure - Note 8 \u2013 Intangible Assets",
     "shortName": "Note 8 \u2013 Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://RCAT/role/Note9EquityMethodInvestment",
     "longName": "00000016 - Disclosure - Note 9 \u2013 Equity Method Investment",
     "shortName": "Note 9 \u2013 Equity Method Investment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://RCAT/role/Note10PropertyAndEquipment",
     "longName": "00000017 - Disclosure - Note 10 \u2013 Property and Equipment",
     "shortName": "Note 10 \u2013 Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://RCAT/role/Note11OtherLong-termAssets",
     "longName": "00000018 - Disclosure - Note 11 \u2013 Other Long-Term Assets",
     "shortName": "Note 11 \u2013 Other Long-Term Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:OtherLongTermAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:OtherLongTermAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://RCAT/role/Note12RightOfUseAssetsAndLiabilities",
     "longName": "00000019 - Disclosure - Note 12 \u2013 Right of Use Assets and Liabilities",
     "shortName": "Note 12 \u2013 Right of Use Assets and Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://RCAT/role/Note13DebtObligations",
     "longName": "00000020 - Disclosure - Note 13 \u2013 Debt Obligations",
     "shortName": "Note 13 \u2013 Debt Obligations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://RCAT/role/Note14DueToRelatedParty",
     "longName": "00000021 - Disclosure - Note 14 \u2013 Due to Related Party",
     "shortName": "Note 14 \u2013 Due to Related Party",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:RelatedPartyPayablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:RelatedPartyPayablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://RCAT/role/Note15IncomeTaxes",
     "longName": "00000022 - Disclosure - Note 15 \u2013 Income Taxes",
     "shortName": "Note 15 \u2013 Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://RCAT/role/Note16CommonStock",
     "longName": "00000023 - Disclosure - Note 16 \u2013 Common Stock",
     "shortName": "Note 16 \u2013 Common Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://RCAT/role/Note17PreferredStock",
     "longName": "00000024 - Disclosure - Note 17 \u2013 Preferred Stock",
     "shortName": "Note 17 \u2013 Preferred Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://RCAT/role/Note18Warrants",
     "longName": "00000025 - Disclosure - Note 18 \u2013 Warrants",
     "shortName": "Note 18 \u2013 Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://RCAT/role/Note19ShareBasedAwards",
     "longName": "00000026 - Disclosure - Note 19 \u2013 Share Based Awards",
     "shortName": "Note 19 \u2013 Share Based Awards",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://RCAT/role/Note20-Related-partyTransactions",
     "longName": "00000027 - Disclosure - Note 20 - Related-Party Transactions",
     "shortName": "Note 20 - Related-Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://RCAT/role/Note21CommitmentsAndContingencies",
     "longName": "00000028 - Disclosure - Note 21 \u2013 Commitments and Contingencies",
     "shortName": "Note 21 \u2013 Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://RCAT/role/Note22SubsequentEvents",
     "longName": "00000029 - Disclosure - Note 22 \u2013 Subsequent Events",
     "shortName": "Note 22 \u2013 Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "00000030 - Disclosure - Note 2 \u2013 Summary of Significant Accounting Policies (Policies)",
     "shortName": "Note 2 \u2013 Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables",
     "longName": "00000031 - Disclosure - Note 2 \u2013 Summary of Significant Accounting Policies (Tables)",
     "shortName": "Note 2 \u2013 Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RCAT:RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RCAT:RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://RCAT/role/Note3DivestitureOfConsumerSegmentTables",
     "longName": "00000032 - Disclosure - Note 3 \u2013 Divestiture of Consumer Segment (Tables)",
     "shortName": "Note 3 \u2013 Divestiture of Consumer Segment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://RCAT/role/Note5InventoriesTables",
     "longName": "00000033 - Disclosure - Note 5 \u2013 Inventories (Tables)",
     "shortName": "Note 5 \u2013 Inventories (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://RCAT/role/Note6OtherCurrentAssetsTables",
     "longName": "00000034 - Disclosure - Note 6 \u2013 Other Current Assets (Tables)",
     "shortName": "Note 6 \u2013 Other Current Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://RCAT/role/Note8IntangibleAssetsTables",
     "longName": "00000035 - Disclosure - Note 8 \u2013 Intangible Assets (Tables)",
     "shortName": "Note 8 \u2013 Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://RCAT/role/Note9EquityMethodInvestmentTables",
     "longName": "00000036 - Disclosure - Note 9 \u2013 Equity Method Investment (Tables)",
     "shortName": "Note 9 \u2013 Equity Method Investment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:EquityMethodInvestmentFinancialInformationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:EquityMethodInvestmentFinancialInformationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://RCAT/role/Note10PropertyAndEquipmentTables",
     "longName": "00000037 - Disclosure - Note 10 \u2013 Property and Equipment (Tables)",
     "shortName": "Note 10 \u2013 Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://RCAT/role/Note11OtherLong-termAssetsTables",
     "longName": "00000038 - Disclosure - Note 11 \u2013 Other Long-Term Assets (Tables)",
     "shortName": "Note 11 \u2013 Other Long-Term Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:ScheduleOfOtherLongTermAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RCAT:OtherLongTermAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:ScheduleOfOtherLongTermAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RCAT:OtherLongTermAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://RCAT/role/Note12RightOfUseAssetsAndLiabilitiesTables",
     "longName": "00000039 - Disclosure - Note 12 \u2013 Right of Use Assets and Liabilities (Tables)",
     "shortName": "Note 12 \u2013 Right of Use Assets and Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:ScheduleOfRentExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:ScheduleOfRentExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://RCAT/role/Note13DebtObligationsTables",
     "longName": "00000040 - Disclosure - Note 13 \u2013 Debt Obligations (Tables)",
     "shortName": "Note 13 \u2013 Debt Obligations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:ScheduleOfDebtPaymentsDueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:ScheduleOfDebtPaymentsDueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://RCAT/role/Note16CommonStockTables",
     "longName": "00000041 - Disclosure - Note 16 \u2013 Common Stock (Tables)",
     "shortName": "Note 16 \u2013 Common Stock (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://RCAT/role/Note18WarrantsTables",
     "longName": "00000042 - Disclosure - Note 18 \u2013 Warrants (Tables)",
     "shortName": "Note 18 \u2013 Warrants (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://RCAT/role/Note19ShareBasedAwardsTables",
     "longName": "00000043 - Disclosure - Note 19 \u2013 Share Based Awards (Tables)",
     "shortName": "Note 19 \u2013 Share Based Awards (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:ScheduleOfAssumptionsUsed1TableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:ScheduleOfAssumptionsUsed1TableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails",
     "longName": "00000044 - Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)",
     "shortName": "Impact of restatements of previously issued consolidated financial statements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RCAT:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock",
       "RCAT:RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://RCAT/role/Note1BusinessDetailsNarrative",
     "longName": "00000045 - Disclosure - Note 1 \u2013 The Business (Details Narrative)",
     "shortName": "Note 1 \u2013 The Business (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:FirmCommitmentUnderwrittenPublicOfferingShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:FirmCommitmentUnderwrittenPublicOfferingShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://RCAT/role/CustomerConcentrationRiskDetails",
     "longName": "00000046 - Disclosure - Customer concentration risk (Details)",
     "shortName": "Customer concentration risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2023-05-012024-04-30_custom_CustomerConcentrationRisk1Member",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:ConcentrationRiskCreditRisk",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-012024-04-30_custom_CustomerConcentrationRisk1Member",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:ConcentrationRiskCreditRisk",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails",
     "longName": "00000047 - Disclosure - Company's revenue disaggregated by revenue type (Details)",
     "shortName": "Company's revenue disaggregated by revenue type (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RCAT:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RCAT:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails",
     "longName": "00000048 - Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)",
     "shortName": "Antidilutive securities excluded from computation of diluted net loss per share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "00000049 - Disclosure - Note 2 \u2013 Summary of Significant Accounting Policies (Details Narrative)",
     "shortName": "Note 2 \u2013 Summary of Significant Accounting Policies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:InterestAndDividendIncomeSecuritiesOther",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:MarketableSecuritiesPolicy",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails",
     "longName": "00000050 - Disclosure - Discontinued Operations - results of operations (Details)",
     "shortName": "Discontinued Operations - results of operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails",
     "longName": "00000051 - Disclosure - Assets and liabilities for the Consumer Segment (Details)",
     "shortName": "Assets and liabilities for the Consumer Segment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "AsOf2023-04-30",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-04-30",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative",
     "longName": "00000052 - Disclosure - Note 3 \u2013 Divestiture of Consumer Segment (Details Narrative)",
     "shortName": "Note 3 \u2013 Divestiture of Consumer Segment (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://RCAT/role/Note4MarketableSecuritiesDetailsNarrative",
     "longName": "00000053 - Disclosure - Note 4 \u2013 Marketable Securities (Details Narrative)",
     "shortName": "Note 4 \u2013 Marketable Securities (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "RCAT:CorporateBondsAtCarryingValueFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "RCAT:CorporateBondsAtCarryingValueFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://RCAT/role/InventoriesDetails",
     "longName": "00000054 - Disclosure - Inventories (Details)",
     "shortName": "Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:InventoryRawMaterials",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:InventoryRawMaterials",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://RCAT/role/OtherCurrentAssetsDetails",
     "longName": "00000055 - Disclosure - Other current assets (Details)",
     "shortName": "Other current assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:ContractWithCustomerAssetGrossCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "us-gaap:OtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative",
     "longName": "00000056 - Disclosure - Note 7 \u2013 Due From Related Party (Details Narrative)",
     "shortName": "Note 7 \u2013 Due From Related Party (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-04-30",
      "name": "RCAT:CashCompensationSubjectToTaxation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "RCAT:DueFromRelatedPartyDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-04-30",
      "name": "RCAT:CashCompensationSubjectToTaxation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "RCAT:DueFromRelatedPartyDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://RCAT/role/IntangibleAssetsDetails",
     "longName": "00000057 - Disclosure - Intangible assets (Details)",
     "shortName": "Intangible assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember",
      "name": "RCAT:FiniteLivedProprietaryTechnologyGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember",
      "name": "RCAT:FiniteLivedProprietaryTechnologyGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails",
     "longName": "00000058 - Disclosure - Expected amortization expense for the unamortized finite-lived intangible assets (Details)",
     "shortName": "Expected amortization expense for the unamortized finite-lived intangible assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://RCAT/role/CompositionOfAndChangesInGoodwillDetails",
     "longName": "00000059 - Disclosure - Composition of, and changes in goodwill (Details)",
     "shortName": "Composition of, and changes in goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:Goodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-08-012023-04-30_us-gaap_GoodwillMember",
      "name": "us-gaap:GoodwillPeriodIncreaseDecrease",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://RCAT/role/Note8IntangibleAssetsDetailsNarrative",
     "longName": "00000060 - Disclosure - Note 8 \u2013 Intangible Assets (Details Narrative)",
     "shortName": "Note 8 \u2013 Intangible Assets (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R61": {
     "role": "http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails",
     "longName": "00000061 - Disclosure - Financial informatino for UMAC derived from their Form 10-Q (Details)",
     "shortName": "Financial informatino for UMAC derived from their Form 10-Q (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RCAT:EquityMethodInvestmentFinancialInformationTableTextBlock",
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails",
     "longName": "00000062 - Disclosure - Impacts on investments into UMAC (Details)",
     "shortName": "Impacts on investments into UMAC (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-012024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://RCAT/role/PropertyAndEquipmentDetails",
     "longName": "00000063 - Disclosure - Property and equipment (Details)",
     "shortName": "Property and equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://RCAT/role/Note10PropertyAndEquipmentDetailsNarrative",
     "longName": "00000064 - Disclosure - Note 10 \u2013 Property and Equipment (Details Narrative)",
     "shortName": "Note 10 \u2013 Property and Equipment (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R65": {
     "role": "http://RCAT/role/OtherLongTermAssetsDetails",
     "longName": "00000065 - Disclosure - Other long term assets (Details)",
     "shortName": "Other long term assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "RCAT:SAFEAgreementAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfOtherLongTermAssetsTableTextBlock",
       "RCAT:OtherLongTermAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "RCAT:SAFEAgreementAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfOtherLongTermAssetsTableTextBlock",
       "RCAT:OtherLongTermAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://RCAT/role/Note11OtherLong-termAssetsDetailsNarrative",
     "longName": "00000066 - Disclosure - Note 11 \u2013 Other Long-Term Assets (Details Narrative)",
     "shortName": "Note 11 \u2013 Other Long-Term Assets (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "From2022-11-012022-11-30",
      "name": "RCAT:PaymentForSAFEAgreement",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "RCAT:OtherLongTermAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-11-012022-11-30",
      "name": "RCAT:PaymentForSAFEAgreement",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "RCAT:OtherLongTermAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://RCAT/role/OperatingLeasesDetails",
     "longName": "00000067 - Disclosure - Operating leases (Details)",
     "shortName": "Operating leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "From2023-05-012024-04-30_custom_OperatingLeaseLocation1Member",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRentExpenseTableTextBlock",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-012024-04-30_custom_OperatingLeaseLocation1Member",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRentExpenseTableTextBlock",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails",
     "longName": "00000068 - Disclosure - Supplemental information related to operating leases (Details)",
     "shortName": "Supplemental information related to operating leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:OperatingCashPaidToSettleLeaseLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:OperatingCashPaidToSettleLeaseLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://RCAT/role/FutureLeasePaymentObligationsDetails",
     "longName": "00000069 - Disclosure - Future lease payment obligations (Details)",
     "shortName": "Future lease payment obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://RCAT/role/OutstandingPrincipalPaymentsDetails",
     "longName": "00000070 - Disclosure - Outstanding principal payments (Details)",
     "shortName": "Outstanding principal payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "RCAT:OutstandingPrincipalPaymentsDueYearOne",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfDebtPaymentsDueTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "RCAT:OutstandingPrincipalPaymentsDueYearOne",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfDebtPaymentsDueTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://RCAT/role/Note13DebtObligationsDetailsNarrative",
     "longName": "00000071 - Disclosure - Note 13 \u2013 Debt Obligations (Details Narrative)",
     "shortName": "Note 13 \u2013 Debt Obligations (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "From2021-08-012022-07-31",
      "name": "us-gaap:DebtInstrumentPeriodicPayment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-08-012022-07-31",
      "name": "us-gaap:DebtInstrumentPeriodicPayment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative",
     "longName": "00000072 - Disclosure - Note 14 \u2013 Due to Related Party (Details Narrative)",
     "shortName": "Note 14 \u2013 Due to Related Party (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "From2021-01-012023-04-30_custom_DueToRelatedParty2Member",
      "name": "RCAT:LineOfCreditObligationAssumedInConnectionWithAcquisition",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "RCAT:RelatedPartyPayablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-01-012023-04-30_custom_DueToRelatedParty2Member",
      "name": "RCAT:LineOfCreditObligationAssumedInConnectionWithAcquisition",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "RCAT:RelatedPartyPayablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://RCAT/role/Note15IncomeTaxesDetailsNarrative",
     "longName": "00000073 - Disclosure - Note 15 \u2013 Income Taxes (Details Narrative)",
     "shortName": "Note 15 \u2013 Income Taxes (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails",
     "longName": "00000074 - Disclosure - Summary of shares of common stock issued (Details)",
     "shortName": "Summary of shares of common stock issued (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "AsOf2023-04-30_us-gaap_CommonStockMember",
      "name": "us-gaap:SharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-012024-04-30_us-gaap_CommonStockMember",
      "name": "RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://RCAT/role/Note17PreferredStockDetailsNarrative",
     "longName": "00000075 - Disclosure - Note 17 \u2013 Preferred Stock (Details Narrative)",
     "shortName": "Note 17 \u2013 Preferred Stock (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30_us-gaap_SeriesBPreferredStockMember",
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-012024-04-30_custom_SeriesAPreferredStock2Member",
      "name": "RCAT:StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails",
     "longName": "00000076 - Disclosure - Summary of warrants issued and fair values (Details)",
     "shortName": "Summary of warrants issued and fair values (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "From2021-04-012021-04-30",
      "name": "RCAT:NumberOfWarrantsUponIssuance",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock",
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-04-012021-04-30",
      "name": "RCAT:NumberOfWarrantsUponIssuance",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock",
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails",
     "longName": "00000077 - Disclosure - Assumptions used to estimate fair value of stock warrants granted (Details)",
     "shortName": "Assumptions used to estimate fair value of stock warrants granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "From2023-05-012024-04-30_custom_WarrantAssumptionsUsedMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-012024-04-30_custom_WarrantAssumptionsUsedMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
     "longName": "00000078 - Disclosure - Changes in warrants outstanding (Details)",
     "shortName": "Changes in warrants outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30_custom_WarrantsOutstanding1Member",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-30_custom_WarrantsOutstanding1Member",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://RCAT/role/Note18WarrantsDetailsNarrative",
     "longName": "00000079 - Disclosure - Note 18 \u2013 Warrants (Details Narrative)",
     "shortName": "Note 18 \u2013 Warrants (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "From2023-04-012023-04-30",
      "name": "RCAT:WarrantsIssuedExercisePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-012023-04-30",
      "name": "RCAT:WarrantsIssuedExercisePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails",
     "longName": "00000080 - Disclosure - Assumptions used to calculate fair value of options granted (Details)",
     "shortName": "Assumptions used to calculate fair value of options granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfAssumptionsUsed1TableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfAssumptionsUsed1TableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://RCAT/role/SummaryOfActivityUnderPlanDetails",
     "longName": "00000081 - Disclosure - Summary of activity under the Plan (Details)",
     "shortName": "Summary of activity under the Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30_custom_Options1Member",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-30_custom_Options1Member",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails",
     "longName": "00000082 - Disclosure - Summary of restricted stock activity under the Plan (Details)",
     "shortName": "Summary of restricted stock activity under the Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30_us-gaap_RestrictedStockMember",
      "name": "RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-30_us-gaap_RestrictedStockMember",
      "name": "RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails",
     "longName": "00000083 - Disclosure - Stock compensation expense by functional category (Details)",
     "shortName": "Stock compensation expense by functional category (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:ResearchAndDevelopmentStockCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:ResearchAndDevelopmentStockCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://RCAT/role/Note19ShareBasedAwardsDetailsNarrative",
     "longName": "00000084 - Disclosure - Note 19 \u2013 Share Based Awards (Details Narrative)",
     "shortName": "Note 19 \u2013 Share Based Awards (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2024-04-30",
      "name": "RCAT:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0808form10k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r605"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable, net",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r293",
      "r294"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses",
        "verboseLabel": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r220",
      "r487"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r240",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income (loss)",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r140",
      "r229",
      "r483",
      "r496",
      "r497"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r240",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r17",
      "r40",
      "r438",
      "r441",
      "r463",
      "r492",
      "r493",
      "r653",
      "r654",
      "r655",
      "r666",
      "r667",
      "r668"
     ]
    },
    "us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalCashFlowElementsFinancingActivitiesAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Investing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r605",
      "r713"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r411",
      "r412",
      "r509",
      "r666",
      "r667",
      "r668",
      "r704",
      "r715"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash from operations:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of intangible assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r62",
      "r66"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount",
     "presentation": [
      "http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount",
     "presentation": [
      "http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Preferred Stock, as converted"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount",
     "presentation": [
      "http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount",
     "presentation": [
      "http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r176",
      "r224",
      "r250",
      "r275",
      "r283",
      "r287",
      "r304",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r433",
      "r435",
      "r448",
      "r479",
      "r542",
      "r605",
      "r616",
      "r693",
      "r694",
      "r708"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total current assets",
        "periodEndLabel": "Current assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r234",
      "r250",
      "r304",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r433",
      "r435",
      "r448",
      "r605",
      "r693",
      "r694",
      "r708"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total long-term assets",
        "periodEndLabel": "Long-term assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r304",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r433",
      "r435",
      "r448",
      "r693",
      "r694",
      "r708"
     ]
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term assets of discontinued operations",
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r104",
      "r117",
      "r163",
      "r214",
      "r215"
     ]
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails",
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets of discontinued operations",
        "verboseLabel": "Total current assets",
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r104",
      "r117",
      "r161",
      "r163",
      "r214",
      "r215"
     ]
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract",
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current assets"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r628",
      "r630",
      "r631"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r628",
      "r630",
      "r631"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r628",
      "r630",
      "r631"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Accounting",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 2 \u2013 Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "RCAT_BusinessAcquisition1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "BusinessAcquisition1Member",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_BusinessAcquisition2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "BusinessAcquisition2Member",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_BusinessAcquisition3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "BusinessAcquisition3Member",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition 3 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_BusinessAcquisition4Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "BusinessAcquisition4Member",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition 4 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r601",
      "r602"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r432",
      "r601",
      "r602"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Consideration Transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r15"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://RCAT/role/Note1Business"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 1 \u2013 The Business",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r155",
      "r156"
     ]
    },
    "us-gaap_Capital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Capital",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Banking Regulation, Total Capital, Actual",
        "documentation": "Amount of total capital as defined by regulatory framework."
       }
      }
     },
     "auth_ref": [
      "r477"
     ]
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Cash",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r481",
      "r520",
      "r537",
      "r605",
      "r616",
      "r643"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, beginning of period",
        "periodEndLabel": "Cash, end of period",
        "label": "Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations",
        "documentation": "For the entity and the disposal group, cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Cash of continuing operations, end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r152",
      "r247"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in Cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r152"
     ]
    },
    "RCAT_CashCompensationSubjectToTaxation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "CashCompensationSubjectToTaxation",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:CashCompensationSubjectToTaxation]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing activities",
        "documentation": "Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investing activities",
        "documentation": "Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r152"
     ]
    },
    "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating activities",
        "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r152"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://RCAT/role/BalanceSheetsParenthetical",
      "http://RCAT/role/Note17PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r226",
      "r227",
      "r228",
      "r250",
      "r266",
      "r267",
      "r269",
      "r270",
      "r273",
      "r274",
      "r304",
      "r335",
      "r337",
      "r338",
      "r339",
      "r342",
      "r343",
      "r372",
      "r373",
      "r376",
      "r379",
      "r386",
      "r448",
      "r500",
      "r501",
      "r502",
      "r503",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r521",
      "r529",
      "r551",
      "r572",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r638",
      "r663",
      "r669"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://RCAT/role/Note17PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r227",
      "r228",
      "r273",
      "r372",
      "r373",
      "r374",
      "r376",
      "r379",
      "r384",
      "r386",
      "r500",
      "r501",
      "r502",
      "r503",
      "r600",
      "r638",
      "r663"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails",
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails",
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails",
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails",
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r97",
      "r480",
      "r528"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note21CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 21 \u2013 Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r332",
      "r333",
      "r586",
      "r690"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity",
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r606",
      "r607",
      "r608",
      "r610",
      "r611",
      "r612",
      "r613",
      "r666",
      "r667",
      "r704",
      "r712",
      "r715"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://RCAT/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r529"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://RCAT/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r131",
      "r529",
      "r548",
      "r715",
      "r716"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock - shares authorized 500,000,000; issued and outstanding 74,289,351 and 54,568,065",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r482",
      "r605"
     ]
    },
    "RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "CommonStockWithheldByCompanyAppliedAgainstNoteAmount",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:CommonStockWithheldByCompanyAppliedAgainstNoteAmount]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_CommonStockWithheldByCompanyAppliedAgainstNoteShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "CommonStockWithheldByCompanyAppliedAgainstNoteShares",
     "presentation": [
      "http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:CommonStockWithheldByCompanyAppliedAgainstNoteShares]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-Based Compensation",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Loss",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55",
      "r91",
      "r92",
      "r292",
      "r585",
      "r640"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r204"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55",
      "r91",
      "r92",
      "r292"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55",
      "r91",
      "r92",
      "r292",
      "r585"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principles of Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r590"
     ]
    },
    "us-gaap_ContractWithCustomerAssetGrossCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetGrossCurrent",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://RCAT/role/OtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss, Current",
        "verboseLabel": "Contract asset",
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current."
       }
      }
     },
     "auth_ref": [
      "r696",
      "r697"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer deposits",
        "verboseLabel": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r389",
      "r392"
     ]
    },
    "RCAT_ConversionOfPreferredStockIntoCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ConversionOfPreferredStockIntoCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of preferred stock into common stock"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ConvertibleNoteAgreementAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ConvertibleNoteAgreementAmount",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ConvertibleNoteAgreementAmount]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_CorporateBondsAtCarryingValueCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "CorporateBondsAtCarryingValueCostBasis",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note4MarketableSecuritiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:CorporateBondsAtCarryingValueCostBasis-0]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_CorporateBondsAtCarryingValueFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "CorporateBondsAtCarryingValueFairValue",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note4MarketableSecuritiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:CorporateBondsAtCarryingValueFairValue-0]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_CorporateBondsAtCarryingValueUnrealizedLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "CorporateBondsAtCarryingValueUnrealizedLosses",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note4MarketableSecuritiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "[custom:CorporateBondsAtCarryingValueUnrealizedLosses-0]",
        "label": "CorporateBondsAtCarryingValueUnrealizedLosses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of goods sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r473"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_CustomerConcentrationRisk1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "CustomerConcentrationRisk1Member",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_CustomerConcentrationRisk2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "CustomerConcentrationRisk2Member",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_CustomerConcentrationRisk3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "CustomerConcentrationRisk3Member",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk 3 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_CustomerConcentrationRisk4Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "CustomerConcentrationRisk4Member",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk 4 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_CustomerConcentrationRisk5Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "CustomerConcentrationRisk5Member",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk 5 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note13DebtObligations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 13 \u2013 Debt Obligations",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r248",
      "r344",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r360",
      "r367",
      "r368",
      "r369"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative",
      "http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r127",
      "r128",
      "r177",
      "r178",
      "r253",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r356",
      "r357",
      "r358",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r457",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r664"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r178",
      "r370"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r96",
      "r345",
      "r457",
      "r596",
      "r597"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate During Period",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r94",
      "r363"
     ]
    },
    "RCAT_DebtInstrumentInterestRateDuringPeriod1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DebtInstrumentInterestRateDuringPeriod1",
     "presentation": [
      "http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:DebtInstrumentInterestRateDuringPeriod1]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative",
      "http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r253",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r356",
      "r357",
      "r358",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r457",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r664"
     ]
    },
    "RCAT_DebtInstrumentOutstandingAccruedInterestPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DebtInstrumentOutstandingAccruedInterestPayment",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:DebtInstrumentOutstandingAccruedInterestPayment]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Periodic Payment",
        "documentation": "Amount of the required periodic payments including both interest and principal payments."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r99"
     ]
    },
    "RCAT_DebtObligation1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DebtObligation1Member",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Obligation 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DebtObligation2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DebtObligation2Member",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Obligation 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DebtObligation3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DebtObligation3Member",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Obligation 3 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DebtObligation6Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DebtObligation6Member",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Obligation 6 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DebtObligation8Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DebtObligation8Member",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Obligation 8 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Gain (Loss)",
        "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r674",
      "r675"
     ]
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/OtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest income",
        "documentation": "Amount, after allowance for credit loss, of accrued interest on investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r297",
      "r308",
      "r309"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note15IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r700"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://RCAT/role/Note10PropertyAndEquipmentDetailsNarrative",
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r67"
     ]
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant derivative liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r235"
     ]
    },
    "RCAT_DifferenceBetweenComprehensiveLossAndNetLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DifferenceBetweenComprehensiveLossAndNetLoss",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:DifferenceBetweenComprehensiveLossAndNetLoss]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DisclosureNote11OtherLongtermAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DisclosureNote11OtherLongtermAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 11 Other Long-term Assets",
        "verboseLabel": "Other Long Term Assets"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DisclosureNote14DueToRelatedPartyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DisclosureNote14DueToRelatedPartyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 14 Due To Related Party"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DisclosureNote18WarrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DisclosureNote18WarrantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 18 Warrants",
        "verboseLabel": "Summary Of Warrants Issued And Fair Values"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DisclosureNote7DueFromRelatedPartyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DisclosureNote7DueFromRelatedPartyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 7 Due From Related Party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://RCAT/role/Note19ShareBasedAwards"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 19 \u2013 Share Based Awards",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r394",
      "r395",
      "r407",
      "r408",
      "r409",
      "r603"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "presentation": [
      "http://RCAT/role/Note19ShareBasedAwardsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "documentation": "Tabular disclosure of share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r78"
     ]
    },
    "us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DiscontinuedOperationAdditionalDisclosuresAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Discontinued operations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts receivable, net",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r104",
      "r117",
      "r163"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable, Current",
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r104",
      "r117",
      "r161",
      "r163"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued expenses",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current",
        "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r104",
      "r117",
      "r161",
      "r163"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total long term assets",
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r5",
      "r104",
      "r117",
      "r163",
      "r214",
      "r215"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease right-of-use assets",
        "label": "Disposal Group, Including Discontinued Operation, Capital Leased Assets, Noncurrent",
        "documentation": "Amount classified as capital leased assets attributable to disposal group, expected to be disposed of after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r189",
      "r190"
     ]
    },
    "RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liabilities",
        "label": "DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long term liabilities - Operating lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCash",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails",
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodEndLabel": "Less: Cash of discontinued operations",
        "verboseLabel": "Cash",
        "label": "Disposal Group, Including Discontinued Operation, Cash",
        "documentation": "Amount of currency on hand, demand deposits with banks or financial institutions, and other kinds of accounts that have the general characteristics of demand deposits, held by a disposal group."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cost of goods sold",
        "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold",
        "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r215"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "General and administrative",
        "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense",
        "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross (Loss) Profit",
        "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r215"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible assets, net",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent",
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r5",
      "r104",
      "r117",
      "r163"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest expense",
        "label": "Disposal Group, Including Discontinued Operation, Interest Expense",
        "documentation": "Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r28",
      "r115"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventory",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r104",
      "r117",
      "r161",
      "r163"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total operating expenses",
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating loss",
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Current",
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r104",
      "r117",
      "r161",
      "r163"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncome",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other, net",
        "label": "Disposal Group, Including Discontinued Operation, Other Income",
        "documentation": "Amount of other income attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other expense (income)",
        "label": "DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expense (income)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Customer deposits",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities",
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r104",
      "r117",
      "r163"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent",
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r5",
      "r104",
      "r117",
      "r163"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term liabilities of discontinued operations",
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r5",
      "r104",
      "r117",
      "r163"
     ]
    },
    "RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research and development",
        "label": "DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenues",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r215"
     ]
    },
    "RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Sales and marketing",
        "label": "DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DisposalGroupIncludingDiscontinuedOperationWorkingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DisposalGroupIncludingDiscontinuedOperationWorkingCapital",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working capital"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 3 \u2013 Divestiture of Consumer Segment",
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r160"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r628",
      "r630",
      "r631"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r628",
      "r630",
      "r631",
      "r633"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r617"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r632"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    },
    "RCAT_DueFromRelatedPartyDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DueFromRelatedPartyDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note7DueFromRelatedParty"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 7 \u2013 Due From Related Party"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DueToOtherRelatedPartyClassifiedCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DueToOtherRelatedPartyClassifiedCurrent",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:DueToOtherRelatedPartyClassifiedCurrent-0]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DueToRelatedParty2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "DueToRelatedParty2Member",
     "presentation": [
      "http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due To Related Party 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "EarningsPerShareBasicAndDilutedContinuingOperationsRCAT",
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Continuing operations"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT",
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued operations"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_EarningsPerShareBasicAndDilutedRCAT": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "EarningsPerShareBasicAndDilutedRCAT",
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss per share - basic and diluted",
        "label": "EarningsPerShareBasicAndDilutedRCAT"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_EarningsPerShareBasicAndDilutedRCATAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "EarningsPerShareBasicAndDilutedRCATAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per share - basic and diluted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and Diluted Net Loss per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r623"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r637"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity",
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r213",
      "r239",
      "r240",
      "r241",
      "r254",
      "r255",
      "r256",
      "r258",
      "r263",
      "r265",
      "r272",
      "r306",
      "r307",
      "r387",
      "r410",
      "r411",
      "r412",
      "r424",
      "r425",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r463",
      "r492",
      "r493",
      "r494",
      "r509",
      "r572"
     ]
    },
    "RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "EquityMethodInvestmentFinancialInformationTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note9EquityMethodInvestmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:EquityMethodInvestmentFinancialInformationTableTextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "presentation": [
      "http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r250",
      "r304",
      "r448"
     ]
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "presentation": [
      "http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r250",
      "r304",
      "r448"
     ]
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOtherMember",
     "presentation": [
      "http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Nonconsolidated Investee, Other [Member]",
        "documentation": "Nonconsolidated equity method investee classified as other. Excludes information consolidated by reporting entity."
       }
      }
     },
     "auth_ref": [
      "r642",
      "r665",
      "r678",
      "r705"
     ]
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 2.0
      },
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails",
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://RCAT/role/StatementsOfCashFlows",
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment on equity method investment",
        "verboseLabel": "Equity Method Investment, Other than Temporary Impairment",
        "negatedLabel": "Impairment",
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Equity method loss",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment."
       }
      }
     },
     "auth_ref": [
      "r656",
      "r657",
      "r662"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity method investee",
        "periodStartLabel": "Initial investment, February 16, 2024",
        "periodEndLabel": "Investment balance, April 30, 2024",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r298",
      "r644",
      "r677"
     ]
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note9EquityMethodInvestment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 9 \u2013 Equity Method Investment",
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r302",
      "r305",
      "r639"
     ]
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentsPolicy",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment",
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r93",
      "r301"
     ]
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentsTextBlock",
     "presentation": [
      "http://RCAT/role/Note9EquityMethodInvestmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments [Table Text Block]",
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information."
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "RCAT_EstimatedTaxesOwedRelatedToStockCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "EstimatedTaxesOwedRelatedToStockCompensation",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:EstimatedTaxesOwedRelatedToStockCompensation]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ExerciseOfWarrantsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ExerciseOfWarrantsShares",
     "presentation": [
      "http://RCAT/role/Note18WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ExerciseOfWarrantsShares]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r23"
     ]
    },
    "RCAT_FairValueOfOptionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "FairValueOfOptionsAxis",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Of Options [Axis]",
        "verboseLabel": "FairValueOfOptionsAxis [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FairValueOfOptionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "FairValueOfOptionsDomain",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "auth_ref": []
    },
    "RCAT_FairValueOfSharesWithheldAsPaymentOfNoteReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "FairValueOfSharesWithheldAsPaymentOfNoteReceivable",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares withheld as payment of note receivable"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FairValueOfWarrantsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "FairValueOfWarrantsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:FairValueOfWarrantsOutstanding-0]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FairValueOfWarrantsOutstanding2": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "FairValueOfWarrantsOutstanding2",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:FairValueOfWarrantsOutstanding2-0]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "FinancingAgreementFundingOfPurchaseOfFixedAsset",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:FinancingAgreementFundingOfPurchaseOfFixedAsset]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Axis]",
        "verboseLabel": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "auth_ref": []
    },
    "RCAT_FiniteLivedCustomerRelationshipsGross1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "FiniteLivedCustomerRelationshipsGross1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer relationships"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r323"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/ExpectedAmortizationExpenseForUnamortizedFinite-livedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "RCAT_FiniteLivedIntangibleAssetsGross1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "FiniteLivedIntangibleAssetsGross1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total finite-lived assets"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FiniteLivedNoncompeteAgreementsGross1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "FiniteLivedNoncompeteAgreementsGross1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-compete agreements"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FiniteLivedProprietaryTechnologyGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "FiniteLivedProprietaryTechnologyGross",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proprietary technology"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "FirmCommitmentUnderwrittenPublicOfferingGrossProceeds",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "FirmCommitmentUnderwrittenPublicOfferingNetProceeds",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:FirmCommitmentUnderwrittenPublicOfferingNetProceeds]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FirmCommitmentUnderwrittenPublicOfferingShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "FirmCommitmentUnderwrittenPublicOfferingShares",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:FirmCommitmentUnderwrittenPublicOfferingShares]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r449"
     ]
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesGross",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and fixtures",
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnDispositionOfAssets1",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity method loss",
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee."
       }
      }
     },
     "auth_ref": [
      "r662"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r553"
     ]
    },
    "RCAT_GeneralAndAdministrativeStockCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "GeneralAndAdministrativeStockCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "General and administrative",
        "label": "GeneralAndAdministrativeStockCompensationExpense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/CompositionOfAndChangesInGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "verboseLabel": "",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r316",
      "r474",
      "r594",
      "r605",
      "r680",
      "r687"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Long-lived Assets",
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r320",
      "r594"
     ]
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/CompositionOfAndChangesInGoodwillDetails",
      "http://RCAT/role/Note8IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "",
        "negatedTerseLabel": "Goodwill, Impairment Loss",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r317",
      "r319",
      "r320",
      "r594"
     ]
    },
    "us-gaap_GoodwillMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillMember",
     "presentation": [
      "http://RCAT/role/CompositionOfAndChangesInGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Member]",
        "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillPeriodIncreaseDecrease",
     "presentation": [
      "http://RCAT/role/CompositionOfAndChangesInGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "Goodwill, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r679"
     ]
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/CompositionOfAndChangesInGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r594"
     ]
    },
    "us-gaap_GrantsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrantsReceivableCurrent",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/OtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grant receivable",
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r648"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit (loss)",
        "label": "Gross profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r250",
      "r275",
      "r282",
      "r286",
      "r288",
      "r304",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r448",
      "r593",
      "r693"
     ]
    },
    "us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GuaranteesIndemnificationsAndWarrantiesPolicies",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Warranty",
        "documentation": "Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities."
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r628",
      "r630",
      "r631"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      },
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows",
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment loss",
        "verboseLabel": "Impairment on goodwill and intangible assets",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r21"
     ]
    },
    "RCAT_IncomeAssociatedWithStockCompensationSubjectToTaxation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "IncomeAssociatedWithStockCompensationSubjectToTaxation",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:IncomeAssociatedWithStockCompensationSubjectToTaxation]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperations",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net loss from continuing operations",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r145",
      "r154",
      "r259",
      "r260",
      "r261",
      "r262",
      "r268",
      "r270"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating loss",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r427"
     ]
    },
    "RCAT_IncomeLossFromDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "IncomeLossFromDiscontinuedOperations",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net loss from discontinued operations",
        "label": "IncomeLossFromDiscontinuedOperations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails",
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss from discontinued operations",
        "verboseLabel": "Net loss from discontinued operations",
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r108",
      "r109",
      "r119",
      "r215",
      "r429",
      "r490"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Equity method loss",
        "label": "Income (Loss) from Equity Method Investments",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r141",
      "r180",
      "r279",
      "r298",
      "r489"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note15IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 15 \u2013 Income Taxes",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r415",
      "r418",
      "r419",
      "r422",
      "r426",
      "r428",
      "r430",
      "r431",
      "r505"
     ]
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Examination, Penalties and Interest Expense",
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations."
       }
      }
     },
     "auth_ref": [
      "r699"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r416",
      "r417",
      "r419",
      "r420",
      "r421",
      "r423",
      "r499"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for income taxes",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued expenses",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Customer deposits",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r661"
     ]
    },
    "us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDerivativeAssetsAndLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails",
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on divestiture of consumer segment",
        "label": "Change in fair value of derivative liability",
        "documentation": "The increase (decrease) during the period in the net carrying value of derivative instruments reported as assets and liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer)."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_IncreaseDecreaseInDerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDerivativeLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on divestiture of consumer segment",
        "documentation": "The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer)."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventory",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease right-of-use assets and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Increase (Decrease) in Other Current Assets",
        "documentation": "Amount of increase (decrease) in current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://RCAT/role/CompositionOfAndChangesInGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r322",
      "r324"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "presentation": [
      "http://RCAT/role/CompositionOfAndChangesInGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total indefinite-lived assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://RCAT/role/CompositionOfAndChangesInGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r159"
     ]
    },
    "us-gaap_IndefiniteLivedTradeNames": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedTradeNames",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Brand name",
        "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "RCAT_InitialFairValueOfWarrantsUponIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "InitialFairValueOfWarrantsUponIssuance",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:InitialFairValueOfWarrantsUponIssuance]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_IntangibleAssetsAccumulatedAmortizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "IntangibleAssetsAccumulatedAmortizationMember",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets Accumulated Amortization [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note8IntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 8 \u2013 Intangible Assets",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "RCAT_IntangibleAssetsGrossCarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "IntangibleAssetsGrossCarryingAmountMember",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets Gross Carrying Amount [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_IntangibleAssetsNetCarryingValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "IntangibleAssetsNetCarryingValueMember",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets Net Carrying Value [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets, net",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r64"
     ]
    },
    "RCAT_IntangibleAssetsNetExcludingGoodwill1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "IntangibleAssetsNetExcludingGoodwill1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total intangible assets, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestAndDividendIncomeSecuritiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestAndDividendIncomeSecuritiesOther",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest and Dividend Income, Securities, Operating, Other",
        "documentation": "Amount of other operating dividend and interest income, including amortization and accretion of premiums and discounts, on securities."
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r183",
      "r242",
      "r278",
      "r456",
      "r557",
      "r614",
      "r714"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r245",
      "r246"
     ]
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note5Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 5 \u2013 Inventories",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r310"
     ]
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finished goods",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory",
        "verboseLabel": "Total",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r588",
      "r605"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r218",
      "r230",
      "r310",
      "r311",
      "r312",
      "r472",
      "r591"
     ]
    },
    "us-gaap_InventoryRawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterials",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Raw materials",
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "us-gaap_InventoryWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWorkInProcess",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Work-in-process",
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "us-gaap_InvestmentIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Investment loss (income), net",
        "label": "Investment Income, Net",
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r149"
     ]
    },
    "us-gaap_Investments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Investments",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable securities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments."
       }
      }
     },
     "auth_ref": [
      "r478"
     ]
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note4MarketableSecurities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 4 \u2013 Marketable Securities",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r184",
      "r185",
      "r212",
      "r295",
      "r296",
      "r446",
      "r447"
     ]
    },
    "RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "IssuanceOfCommonStockThroughATMFacilitiesNetShares",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock through ATM facilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock issued for services",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "RCAT_LeaseholdImprovementAgreementFundsReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "LeaseholdImprovementAgreementFundsReceived",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:LeaseholdImprovementAgreementFundsReceived]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsGross",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold improvements",
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesOfLesseeDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesOfLesseeDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note12RightOfUseAssetsAndLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 12 \u2013 Right of Use Assets and Liabilities",
        "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note12RightOfUseAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r707"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/FutureLeasePaymentObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/FutureLeasePaymentObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Rolling Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r707"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/FutureLeasePaymentObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Rolling Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r707"
     ]
    },
    "RCAT_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/FutureLeasePaymentObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/FutureLeasePaymentObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Rolling Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r707"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/FutureLeasePaymentObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Rolling Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r707"
     ]
    },
    "RCAT_LesseeOperatingLeaseLiabilityPaymentsDueSubtotal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueSubtotal",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/FutureLeasePaymentObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "LesseeOperatingLeaseLiabilityPaymentsDueSubtotal"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_LesseeOperatingLeaseLiabilityPaymentsDueThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueThereafter",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/FutureLeasePaymentObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "LesseeOperatingLeaseLiabilityPaymentsDueThereafter"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/FutureLeasePaymentObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r179",
      "r485",
      "r605",
      "r665",
      "r678",
      "r705"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total current liabilities",
        "periodEndLabel": "Current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r217",
      "r250",
      "r304",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r434",
      "r435",
      "r436",
      "r448",
      "r605",
      "r693",
      "r708",
      "r709"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_LiabilitiesCurrentRestatementImpact": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "LiabilitiesCurrentRestatementImpact",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total current liabilities",
        "label": "LiabilitiesCurrentRestatementImpact"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total long-term liabilities",
        "periodEndLabel": "Long-term liabilities",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r123",
      "r124",
      "r125",
      "r129",
      "r250",
      "r304",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r434",
      "r435",
      "r436",
      "r448",
      "r693",
      "r708",
      "r709"
     ]
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails",
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities of discontinued operations",
        "verboseLabel": "Total current liabilities",
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r104",
      "r117",
      "r161",
      "r163",
      "r214",
      "r215"
     ]
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract",
     "presentation": [
      "http://RCAT/role/AssetsAndLiabilitiesForConsumerSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_LineOfCreditObligationAssumedInConnectionWithAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "LineOfCreditObligationAssumedInConnectionWithAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:LineOfCreditObligationAssumedInConnectionWithAcquisition]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermAccountsNotesAndLoansReceivableNetNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note receivable",
        "documentation": "Amount, after allowance for credit loss, of accounts and financing receivables, classified as noncurrent. Includes, but is not limited to, notes and loan receivable."
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt obligations - long term",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "us-gaap_MarketableSecuritiesGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Realized loss from sale of marketable securities",
        "documentation": "Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrealized gain on marketable securities",
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketingAndAdvertisingExpense",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales and marketing",
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in discontinued operations",
        "label": "Net Cash Provided by (Used in) Discontinued Operations",
        "documentation": "Increase (decrease) in cash associated with the entity's discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities of continuing operations",
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations",
        "documentation": "Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r660"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by investing activities of continuing operations",
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations",
        "documentation": "Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r660"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net cash used in operating activities of continuing operations",
        "verboseLabel": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations",
        "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r153",
      "r154"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      },
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails",
      "http://RCAT/role/StatementsOfCashFlows",
      "http://RCAT/role/StatementsOfOperations",
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r154",
      "r181",
      "r215",
      "r236",
      "r237",
      "r241",
      "r250",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r264",
      "r265",
      "r268",
      "r275",
      "r282",
      "r286",
      "r288",
      "r304",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r445",
      "r448",
      "r491",
      "r550",
      "r570",
      "r571",
      "r593",
      "r614",
      "r693"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash transactions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash or Part Noncash Divestiture, Amount of Consideration Received",
        "documentation": "Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r49",
      "r50"
     ]
    },
    "RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "NoncashOrPartNoncashDivestitureCashConsiderationReceived1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NoncashOrPartNoncashDivestitureCashConsiderationReceived1]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_NoncashOrPartNoncashDivestitureNoteReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "NoncashOrPartNoncashDivestitureNoteReceivable",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note receivable from divestiture of consumer segment"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative",
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity method investment from divestiture of consumer segment",
        "verboseLabel": "[custom:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/OtherLongTermAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Long-Lived Assets",
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "RCAT_NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum",
     "presentation": [
      "http://RCAT/role/Note19ShareBasedAwardsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_NumberOfWarrantsOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "NumberOfWarrantsOutstanding",
     "presentation": [
      "http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NumberOfWarrantsOutstanding-0]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_NumberOfWarrantsOutstanding2": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "NumberOfWarrantsOutstanding2",
     "presentation": [
      "http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NumberOfWarrantsOutstanding2-0]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_NumberOfWarrantsUponIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "NumberOfWarrantsUponIssuance",
     "presentation": [
      "http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NumberOfWarrantsUponIssuance]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_OperatingCashPaidToSettleLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "OperatingCashPaidToSettleLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating cash paid to settle lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses [Default Label]",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss from continuing operations",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r282",
      "r286",
      "r288",
      "r593"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r706"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "RCAT_OperatingLeaseLiabilityCurrentRestatementImpact": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "OperatingLeaseLiabilityCurrentRestatementImpact",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities, current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liabilities",
        "label": "Operating lease liabilities, long-term",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "RCAT_OperatingLeaseLocation1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "OperatingLeaseLocation1Member",
     "presentation": [
      "http://RCAT/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Location 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_OperatingLeaseLocation3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "OperatingLeaseLocation3Member",
     "presentation": [
      "http://RCAT/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Location 3 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_OperatingLeaseLocation4Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "OperatingLeaseLocation4Member",
     "presentation": [
      "http://RCAT/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Location 4 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease right-of-use assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted average discount rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r604"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r604"
     ]
    },
    "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasesOfLesseeDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note12RightOfUseAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r193",
      "r194",
      "r196",
      "r197"
     ]
    },
    "RCAT_Options1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "Options1Member",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_OptionsAssumptionsUsedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "OptionsAssumptionsUsedMember",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options Assumptions Used [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/OtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "verboseLabel": "Total",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r605"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unrealized gain on marketable securities",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, before Tax, Portion Attributable to Parent",
        "documentation": "Amount, before tax and after reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r16",
      "r173"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent",
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r16",
      "r173"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency translation adjustments",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r16",
      "r173"
     ]
    },
    "us-gaap_OtherCurrentAssetsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCurrentAssetsTextBlock",
     "presentation": [
      "http://RCAT/role/Note6OtherCurrentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 6 \u2013 Other Current Assets",
        "documentation": "The entire disclosure for other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_OtherLongTermAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "OtherLongTermAssetsDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note11OtherLong-termAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 11 \u2013 Other Long-Term Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Other (income) expense",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other (income) expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonrecurringIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonrecurringIncomeExpense",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other, net",
        "documentation": "Amount of other expense (income) that is infrequent in occurrence or unusual in nature."
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "RCAT_OutstandingPrincipalPaymentsDueLongTerm": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "OutstandingPrincipalPaymentsDueLongTerm",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/OutstandingPrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "OutstandingPrincipalPaymentsDueLongTerm"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_OutstandingPrincipalPaymentsDueTotal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "OutstandingPrincipalPaymentsDueTotal",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/OutstandingPrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "OutstandingPrincipalPaymentsDueTotal"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_OutstandingPrincipalPaymentsDueYearOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "OutstandingPrincipalPaymentsDueYearOne",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/OutstandingPrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "OutstandingPrincipalPaymentsDueYearOne"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_PaymentForSAFEAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "PaymentForSAFEAgreement",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note11OtherLong-termAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:PaymentForSAFEAgreement]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_PaymentsForTaxLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "PaymentsForTaxLiability",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "[custom:PaymentsForTaxLiability]",
        "label": "PaymentsForTaxLiability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "RCAT_PaymentsOfTaxesRelatedToEquityTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "PaymentsOfTaxesRelatedToEquityTransactions",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of taxes related to equity transactions",
        "label": "PaymentsOfTaxesRelatedToEquityTransactions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireAssetsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireAssetsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Investment in SAFE agreement",
        "label": "Payments to Acquire Assets, Investing Activities",
        "documentation": "Aggregate cash payments for a combination of transactions that are classified as investing activities in which assets, which may include securities, other types of investments, or productive assets, are purchased from third-party sellers. This element can be used by entities to aggregate payments for all asset purchases that are classified as investing activities."
       }
      }
     },
     "auth_ref": [
      "r658"
     ]
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireProductiveAssets",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Productive Assets",
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r701",
      "r702",
      "r703"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r624"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://RCAT/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r529"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://RCAT/role/BalanceSheetsParenthetical",
      "http://RCAT/role/Note17PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r529",
      "r548",
      "r715",
      "r716"
     ]
    },
    "us-gaap_PreferredStockTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockTextBlock",
     "presentation": [
      "http://RCAT/role/Note17PreferredStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 17 \u2013 Preferred Stock",
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "RCAT_PreferredStockValueSeriesB": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "PreferredStockValueSeriesB",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B preferred stock - shares authorized 4,300,000; issued and outstanding 4,676 and 986,676"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/OtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid inventory",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/OtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r313",
      "r314",
      "r589"
     ]
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from divestiture of consumer segment",
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "RCAT_ProceedsFromIssuanceOfCommonStockATMFacilityNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ProceedsFromIssuanceOfCommonStockATMFacilityNet",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ATM facility, net"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ProceedsFromIssuanceOfCommonStockPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ProceedsFromIssuanceOfCommonStockPublicOffering",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public offering, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from related party obligations",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of marketable securities",
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercise of stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r19"
     ]
    },
    "RCAT_ProceedsReceivedFromExerciseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ProceedsReceivedFromExerciseOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note18WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ProceedsReceivedFromExerciseOfWarrants]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note10PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 10 \u2013 Property and Equipment",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r205",
      "r208",
      "r209"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment and related",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r219",
      "r488"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "verboseLabel": "Net carrying value",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r476",
      "r488",
      "r605"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r205",
      "r208",
      "r486"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://RCAT/role/Note10PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseAxis",
     "presentation": [
      "http://RCAT/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property Subject to or Available for Operating Lease [Axis]",
        "documentation": "Information by property that could be leased or is available for lease."
       }
      }
     },
     "auth_ref": [
      "r198"
     ]
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseDomain",
     "presentation": [
      "http://RCAT/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A descriptive title of whether the property is subject to or available for operating lease."
       }
      }
     },
     "auth_ref": [
      "r198"
     ]
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, net",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r670",
      "r671",
      "r672",
      "r673"
     ]
    },
    "RCAT_RelatedPartiesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "RelatedPartiesPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_RelatedPartyPayablesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "RelatedPartyPayablesDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note14DueToRelatedParty"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 14 \u2013 Due to Related Party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note20-Related-partyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 20 - Related-Party Transactions",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r506",
      "r507",
      "r508",
      "r554",
      "r555",
      "r556",
      "r576",
      "r578"
     ]
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments under debt obligations",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfRelatedPartyDebt",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments under related party obligations",
        "label": "Repayments of Related Party Debt",
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r414",
      "r710"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "RCAT_ResearchAndDevelopmentStockCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ResearchAndDevelopmentStockCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research and development",
        "label": "ResearchAndDevelopmentStockCompensationExpense"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_RestatementImpactAsRestatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "RestatementImpactAsRestatedMember",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Impact As Restated [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_RestatementImpactAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "RestatementImpactAxis",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Impact [Axis]",
        "verboseLabel": "RestatementImpactAxis [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_RestatementImpactChangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "RestatementImpactChangeMember",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Impact Change [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_RestatementImpactDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "RestatementImpactDomain",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "auth_ref": []
    },
    "RCAT_RestatementImpactOriginallyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "RestatementImpactOriginallyReportedMember",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Impact Originally Reported [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement of Previously Issued Consolidated Financial Statements"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "RCAT_RestrictedStockScheduledToVestShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "RestrictedStockScheduledToVestShares",
     "presentation": [
      "http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:RestrictedStockScheduledToVestShares]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable",
     "presentation": [
      "http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings",
        "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting of restricted stock units",
        "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails",
      "http://RCAT/role/Note15IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "verboseLabel": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r170",
      "r484",
      "r495",
      "r497",
      "r504",
      "r530",
      "r605"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r254",
      "r255",
      "r256",
      "r258",
      "r263",
      "r265",
      "r306",
      "r307",
      "r410",
      "r411",
      "r412",
      "r424",
      "r425",
      "r437",
      "r439",
      "r440",
      "r442",
      "r444",
      "r492",
      "r494",
      "r509",
      "r715"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract related",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r277",
      "r281",
      "r284",
      "r285",
      "r289",
      "r290",
      "r292",
      "r390",
      "r391",
      "r473"
     ]
    },
    "us-gaap_RevenueNotFromContractWithCustomer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueNotFromContractWithCustomer",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product related",
        "documentation": "Amount of revenue that is not accounted for under Topic 606."
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRecognitionLeasesOperating": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionLeasesOperating",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "documentation": "Disclosure of accounting policy for revenue recognition for operating leases."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r587",
      "r592"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails",
      "http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues",
        "verboseLabel": "Total",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r250",
      "r276",
      "r277",
      "r281",
      "r284",
      "r285",
      "r289",
      "r290",
      "r292",
      "r304",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r448",
      "r475",
      "r693"
     ]
    },
    "RCAT_SAFEAgreementAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "SAFEAgreementAssets",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/OtherLongTermAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE agreement"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SalesAndMarketingStockCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "SalesAndMarketingStockCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Sales and marketing",
        "label": "SalesAndMarketingStockCompensationExpense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "RCAT_ScheduleOfAssumptionsUsed1TableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ScheduleOfAssumptionsUsed1TableTextBlock",
     "presentation": [
      "http://RCAT/role/Note19ShareBasedAwardsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ScheduleOfAssumptionsUsed1TableTextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note18WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate."
       }
      }
     },
     "auth_ref": [
      "r393"
     ]
    },
    "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note16CommonStockTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in common stock outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ScheduleOfDebtPaymentsDueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ScheduleOfDebtPaymentsDueTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ScheduleOfDebtPaymentsDueTableTextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock",
     "presentation": [
      "http://RCAT/role/Note19ShareBasedAwardsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Share-Based Payments [Table Text Block]",
        "documentation": "Tabular disclosure of an equity-based arrangement (such as stock or unit options and stock or unit awards) with an individual employee, which is generally an employment contract between the entity and a selected officer or key employee containing a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r76",
      "r78",
      "r171"
     ]
    },
    "RCAT_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r20",
      "r27",
      "r104",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r118",
      "r120",
      "r121",
      "r164"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "presentation": [
      "http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Equity Method Investments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r300",
      "r301",
      "r303",
      "r304",
      "r448"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "presentation": [
      "http://RCAT/role/FinancialInformatinoForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Equity Method Investments [Table]",
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r250",
      "r300",
      "r301",
      "r303",
      "r304",
      "r448"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://RCAT/role/Note8IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r594",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689"
     ]
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://RCAT/role/CompositionOfAndChangesInGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r159"
     ]
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note8IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note5InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r137",
      "r138",
      "r139"
     ]
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note6OtherCurrentAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amounts of other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ScheduleOfOtherLongTermAssetsTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note11OtherLong-termAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ScheduleOfOtherLongTermAssetsTableTextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Product Information [Table]",
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRentExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRentExpenseTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note12RightOfUseAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Rent Expense [Table Text Block]",
        "documentation": "Tabular disclosure of rental expense from operating leases for each period for which an income statement is presented with separate amounts for minimum rentals, contingent rentals, and sublease rentals. Rental payments under leases with terms of a month or less that were not renewed need not be included."
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note19ShareBasedAwardsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]",
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative",
      "http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Short-Term Debt [Table]",
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://RCAT/role/Note17PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock by Class [Table]",
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r70",
      "r71",
      "r72",
      "r73",
      "r74",
      "r75",
      "r168",
      "r169",
      "r170",
      "r226",
      "r227",
      "r228",
      "r273",
      "r372",
      "r373",
      "r374",
      "r376",
      "r379",
      "r384",
      "r386",
      "r500",
      "r501",
      "r502",
      "r503",
      "r600",
      "r638",
      "r663"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://RCAT/role/Note18WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ScheduleOfWarrantsIssuedAndFairValueTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note18WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note8IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r54",
      "r55",
      "r56",
      "r91",
      "r174"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r622"
     ]
    },
    "us-gaap_SecurityDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecurityDeposit",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/OtherLongTermAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security deposits",
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease."
       }
      }
     },
     "auth_ref": [
      "r645"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r621"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r626"
     ]
    },
    "RCAT_SeriesAPreferredStock2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "SeriesAPreferredStock2Member",
     "presentation": [
      "http://RCAT/role/Note17PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Preferred Stock 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SeriesBPreferredStock1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "SeriesBPreferredStock1Member",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Preferred Stock 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesBPreferredStockMember",
     "presentation": [
      "http://RCAT/role/BalanceSheetsParenthetical",
      "http://RCAT/role/Note17PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Preferred Stock [Member]",
        "documentation": "Series B preferred stock."
       }
      }
     },
     "auth_ref": [
      "r646",
      "r647",
      "r695"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price",
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1-0]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails",
      "http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails",
      "http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails",
      "http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate-0]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1-0]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r698"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r399"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r397"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber-0]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationSharesRestrictedStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ShareBasedCompensationSharesRestrictedStockAxis",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Shares Restricted Stock [Axis]",
        "verboseLabel": "ShareBasedCompensationSharesRestrictedStockAxis [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationSharesRestrictedStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "ShareBasedCompensationSharesRestrictedStockDomain",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails",
      "http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
        "documentation": "Number of non-vested options forfeited."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock based compensation - options",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting of restricted stock to employees, net of shares withheld of 27,189 to pay taxes"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting of restricted stock to Board of Directors"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting of restricted stock to consultants"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock based compensation - restricted units"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares]",
        "negatedLabel": "[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod]",
        "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice-0]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SharesHeldAtTransferAgentUntilNoteReceivableRepayment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "SharesHeldAtTransferAgentUntilNoteReceivableRepayment",
     "presentation": [
      "http://RCAT/role/Note7DueFromRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:SharesHeldAtTransferAgentUntilNoteReceivableRepayment]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity",
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Shares, Outstanding, Beginning Balance",
        "periodEndLabel": "Shares, Outstanding, Ending Balance",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt obligations - short term",
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r177",
      "r605",
      "r711"
     ]
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://RCAT/role/Note13DebtObligationsDetailsNarrative",
      "http://RCAT/role/Note14DueToRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r627"
     ]
    },
    "us-gaap_StandardProductWarrantyAccrualCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StandardProductWarrantyAccrualCurrent",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Standard Product Warranty Accrual, Current",
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid within one year or the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability."
       }
      }
     },
     "auth_ref": [
      "r691",
      "r692"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://RCAT/role/BalanceSheetsParenthetical",
      "http://RCAT/role/Note17PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r226",
      "r227",
      "r228",
      "r250",
      "r266",
      "r267",
      "r269",
      "r270",
      "r273",
      "r274",
      "r304",
      "r335",
      "r337",
      "r338",
      "r339",
      "r342",
      "r343",
      "r372",
      "r373",
      "r376",
      "r379",
      "r386",
      "r448",
      "r500",
      "r501",
      "r502",
      "r503",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r521",
      "r529",
      "r551",
      "r572",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r638",
      "r663",
      "r669"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity",
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r38",
      "r213",
      "r239",
      "r240",
      "r241",
      "r254",
      "r255",
      "r256",
      "r258",
      "r263",
      "r265",
      "r272",
      "r306",
      "r307",
      "r387",
      "r410",
      "r411",
      "r412",
      "r424",
      "r425",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r463",
      "r492",
      "r493",
      "r494",
      "r509",
      "r572"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails",
      "http://RCAT/role/BalanceSheetsParenthetical",
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails",
      "http://RCAT/role/IntangibleAssetsDetails",
      "http://RCAT/role/OperatingLeasesDetails",
      "http://RCAT/role/StatementsOfStockholdersEquity",
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r272",
      "r473",
      "r498",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r529",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r538",
      "r539",
      "r540",
      "r541",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r549",
      "r552",
      "r553",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r572",
      "r609"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails",
      "http://RCAT/role/BalanceSheetsParenthetical",
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails",
      "http://RCAT/role/IntangibleAssetsDetails",
      "http://RCAT/role/OperatingLeasesDetails",
      "http://RCAT/role/StatementsOfStockholdersEquity",
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r272",
      "r473",
      "r498",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r529",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r538",
      "r539",
      "r540",
      "r541",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r549",
      "r552",
      "r553",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r572",
      "r609"
     ]
    },
    "RCAT_StockCompensationExpensePertainingToOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "StockCompensationExpensePertainingToOptions",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note19ShareBasedAwardsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:StockCompensationExpensePertainingToOptions]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_StockCompensationExpensePertainingToRestrictedStockUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "StockCompensationExpensePertainingToRestrictedStockUnits",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note19ShareBasedAwardsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:StockCompensationExpensePertainingToRestrictedStockUnits]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Conversion of preferred stock",
        "label": "StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock",
     "presentation": [
      "http://RCAT/role/Note17PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r37",
      "r72",
      "r170",
      "r361"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity",
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "verboseLabel": "Shares issued for services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r130",
      "r131",
      "r170",
      "r500",
      "r572",
      "r580"
     ]
    },
    "RCAT_StockIssuedDuringPeriodSharesPublicOffering": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "StockIssuedDuringPeriodSharesPublicOffering",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock through public offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
      "http://RCAT/role/StatementsOfStockholdersEquity",
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails",
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "verboseLabel": "Exercise of stock options",
        "negatedLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r130",
      "r131",
      "r170",
      "r400"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of preferred stock",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r38",
      "r170"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued for services",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public offering, net of $804,400 of issuance costs",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r130",
      "r131",
      "r170",
      "r509",
      "r572",
      "r580",
      "r615"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock based compensation",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r130",
      "r131",
      "r170"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of stock options",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r38",
      "r170"
     ]
    },
    "RCAT_StockIssuedDuringPeriodValueThroughATMFacility": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "StockIssuedDuringPeriodValueThroughATMFacility",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock through ATM facility, net"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_StockSharesIssuedNetThroughATMFacility": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "StockSharesIssuedNetThroughATMFacility",
     "presentation": [
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:StockSharesIssuedNetThroughATMFacility]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total stockholders' equity",
        "periodStartLabel": "Balances, April 30, 2022, as restated",
        "periodEndLabel": "Ending balance, value",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r134",
      "r135",
      "r157",
      "r531",
      "r548",
      "r573",
      "r574",
      "r605",
      "r616",
      "r665",
      "r678",
      "r705",
      "r715"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note16CommonStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 16 \u2013 Common Stock",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r249",
      "r371",
      "r373",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r387",
      "r443",
      "r575",
      "r577",
      "r584"
     ]
    },
    "RCAT_StockholdersEquityRestatement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "StockholdersEquityRestatement",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total shareholders\u2019 equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://RCAT/role/Note22SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 22 \u2013 Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r469",
      "r470"
     ]
    },
    "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubstantialDoubtAboutGoingConcernTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidity and Going Concern",
        "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "RCAT_TaxesRelatedToNetShareSettlementOfEquityAwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "TaxesRelatedToNetShareSettlementOfEquityAwards",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes related to net share settlement of equity awards"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_TotalStockCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "TotalStockCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "TotalStockCompensationExpense"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note19ShareBasedAwardsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r59",
      "r202",
      "r203",
      "r206",
      "r207"
     ]
    },
    "RCAT_WarrantAssumptionsUsedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "WarrantAssumptionsUsedMember",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToEstimateFairValueOfStockWarrantsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Assumptions Used [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_WarrantsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "WarrantsDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note18Warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 18 \u2013 Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_WarrantsIssuedExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "WarrantsIssuedExercisePrice",
     "presentation": [
      "http://RCAT/role/Note18WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:WarrantsIssuedExercisePrice]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_WarrantsOutstanding1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "WarrantsOutstanding1Member",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Outstanding 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_WarrantsToPurchaseSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "WarrantsToPurchaseSharesIssued",
     "presentation": [
      "http://RCAT/role/Note18WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:WarrantsToPurchaseSharesIssued]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT",
     "presentation": [
      "http://RCAT/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares outstanding - basic and diluted"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_WorkingCapitalAtClosingOfDisposalGroup": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240430",
     "localname": "WorkingCapitalAtClosingOfDisposalGroup",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:WorkingCapitalAtClosingOfDisposalGroup-0]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-11"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21D",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b),(d)",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-6"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-7"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "S99",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480781/205-20-S99-3"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(CFRR 211.02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "710",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482943/710-10-55-8"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b),(f(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-18"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-5"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205-20/tableOfContent"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3A"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3B"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-4"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205-40/tableOfContent"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.13)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483613/220-20-50-1"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-9"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-1"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//940-320/tableOfContent"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//942-320/tableOfContent"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//946-320/tableOfContent"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-11"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//840/tableOfContent"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481440/840-10-50-2"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Subparagraph": "(Note 3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481418/840-10-55-40"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481178/840-20-25-1"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-1"
  },
  "r197": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-2"
  },
  "r198": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-4"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "323",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//323/tableOfContent"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "(b)",
   "Publisher": "SEC"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5C"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-5"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-3A"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-20/tableOfContent"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-30/tableOfContent"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//460/tableOfContent"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482551/740-270-45-3"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480696/942-505-50-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(h))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "323",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481543/323-740-50-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r641": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r642": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r643": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r654": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r667": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r668": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r669": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r670": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2"
  },
  "r671": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-4"
  },
  "r674": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r678": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r679": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A"
  },
  "r689": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r690": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r691": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r692": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r693": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r694": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r695": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r696": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3"
  },
  "r698": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r699": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r700": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r701": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2"
  },
  "r704": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r706": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r707": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r708": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r709": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r710": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r713": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r715": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r716": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>110
<FILENAME>0001554795-24-000195-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001554795-24-000195-xbrl.zip
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M)U@U9(%?^VF^??BT/QKO3T8O'IF?U[1+)?)FZ%:)-%^/2JC<CL4O/S(N/LT
MY1YW*I$A[\6"W/-NA#FC\41?)*LCAS^@^TY,"YV[[$[4.F;["]==FQ2JS7.
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MLF20,+%B+Z "FS5><Q\DT2 T PF:4-X!2VO:Z1Z%,:S;R4)>Z>3#U5TL*%J
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MC,S<QT1_) (;$-JJO^5N8<HG( ^#;Q5<PJ@\3E,K>>_<UAJ5BC=.0)[WJW5
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M]FX[S5YE*#*,G63B,(J_LI]+/=!;B)A W10.$-!T%##$(31*3F5.K0D<X8S
M=V7_3%H.CH'XO%\)DT,V?+;ERU')]X2MI+^5 $C02Q'TB%-"RH.SF&3K\&-Z
MKI6?N%S8P1,_=AD%DZ5MK_>9\([VD1<&Z1<0YQ$79?+A'W&8FB2B4]B>_80\
M/N(_DG9;S?9'P15.D-6C&/]V&[."F&?4L0AEEN+SWC0%8U.G)-SJZ=6DQ7X
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MVVXYMJ5OED<MZN8)8N:Z.#XV<F]C]]:_M-<XM"4U-K4=QC;"RF)I(-DDZ3S
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ML2T$:US8IWQ06LY,U4/3NZ%5<;>C+>T]P1H:'3:<"2=#LL \@Z>8'AI"55J
M-33,[*TJK3EKNJH(%I$A5*4%6$,#V-ZJTIJSIJD*_ ]AVXOM(5[FFAPS=N$7
M,]\M?RBTC(\>5_?7D_KHZS?G&<XT/S"?XWJQ0([$,=LU'F,O<>/PO7H!SA#E
M%D;>*V@R@]ONZACYVI_)#&X;,?5@L+Z<G<D,_C^RP&E:K\;D!<-K"YL9DS"E
M&Z85_ *13$>ZN(?]H;_KA5GB-0[%=Y/F5GH;_A=*HK4<?Z"]7G5: WK7WD6-
MEG3DI@GWLGXG(9JF%8498J7+/<^LB06T>"2(*&(_0!]K:OWU+V>'T^GOUOP9
M63F$P:\AA=$.'T&X='.W>,1+'R^P8_MA4OK-.'U//.P4:V%*^)\+\3_,\$]@
M\^M6<^A6#M[*X6NA[JA4W@EWIT8K1!_1LG0@O4C3]$!(TU%&4P$BOW0U@6EE
M0+40<BRM42L1,!42<)P1D$.R1&5_@Z+]472"L(3MH1#;CQFVPG.7@^)X(CGY
M5D+U2(CJ288JAV,E@*SMNMI!<3Z]BM#VII08Z6,ATJ>Y.D?( DA6 LI*8&E!
M^ZSVKJ82SA^%.)\5="*%HI?+Y^)++L1(GPB1/L^03BZ7CH%916A:<)\>L/"$
M+8WAAJVZ,/:Z'O53\3)TD.&>@K)LW[4*P/1@/N43Z2OQEY,0T95,4VH6T.G6
MG.2PY@R67GV9'BJ>GRS1(%Y$I_DJRH'"6L/ )@1P00B/*0U+T!%LB-X]>7BY
MY7 7*3@4+YG3PIK)H%@E,'K0/6;6;$X:C>*A>(F<'I>L8DAV8A.G'PO/DXC1
M%:^1T^(B"1"L!(0>-$\*185B-,7KXS1?(&,(5@)"#YJG]RR,0VP)=B68BA?%
MZ6G!X"5 ]")[EMY2*493O Y.\X4P[ZX'OW-^Y^H%W+G*+UNMP5.\]$WSM8^#
ML3@<*P6D)YHYF"1S=K*&.2LLN2OA+E[[N$E+(?'9;XEK%X?%?@HS!'.W ):.
M.#V[1'YM!'8H7@ /IZ4YET#DB\863#UTL*#R*4"_(C;J]0NJU>^:\+$8/Z9@
MK!3.F$&P-!@^$J^"78)AZ[?T7SH>'VE!\!RBQ!IRQ6MH-W+C<701*TT"R$@4
MK[O*J0#==!6#:QD9XG59&&+K1ED0:\LP%Z_3\HA;-PF5&%9&0.M(5C?V-2&M
MC(:N@:UN4L01KHR2CG&N=D*$ :^,D(YAKW9"&N)?&4E#1,':Z=L.AR4$';<.
MBK5C7XS@9)C71,?B.$X[UEF,)$.Y)D*N1DK:T:V$3#*T:R)F6>"DDP"XX-,)
MH2(^*#Q0QV+A%TRBP-O  4-XH"-_@2ZI*;&]_"6Z*Q3:V*LAN+*@QT/"M*:%
M0>'G=3:LA?FXEE-\^FZ1CFP5NOV6#*Y-NNEF7#+.=] JN$Q"3&U-_"[<WLMP
MMS*@.JA([^]B0G007.L%P!YP\%,JMHH+D((!F>1P+,H :14"/ YC^YO@ 3&7
M-4(,)WNYI&@)*G&Q2;[.&40I.14_( $;/P,9,%7D<"RW"-YZVF2_ )RUTCEC
M$9*+O0C4(-^DBR_99;../_.U6D<A'^1N<05-D?L=A7 ]\ST+;L!N2'E0<2&*
M0UI!-J:%DD$MV.]G\LZ&A4GJQ@-;/@HM!BFPF/MD!=QHZ9Z+BB&LVDP=;B-[
M1_-87 \S898[\L!HY]]D6O"QXJ04X5HY$/8;&H,&%I#\N]9)(' A;PC="N"E
M]%5<F8+CZ!4<QP6A%G.9!2&\9BV6YB:4=/=C[RS%3A2VMHA!C4BQI]10U+ C
MT@KY$ZDR5IV?8N)%HZ)5DRY2/"MN2QQ-.DF:Q4YB2<TS0U3BH*8KXH1%4\G#
MSI2EG#V22J+BJ!3R13L0P_7;&D&I7O&]+?CF!XC9X1^^'7_G80 .T<1C/'-;
M$5CQ0M(A+;LP)O-!^*"9F8[RH2$0R,:V\$[Y SY8_@J&[U[R\O'@UD\?09#2
M7O$Y"N"8H?X/ODC%%>D!(\Q:)D"US[Q*AE-IVIV($Q[27.=.9EP6H][Z3'^@
MD-4GH+XKV^%/&,7^-(O%,&6?5].#R2^9W$XJ/D4V )-2-@+7U1_?9I>6&P\2
M^\\A#&/!.!8;Z+^TRC*.K8,[/\_),MT,24RYA,**1Y% LIABXAP6S#82TZB3
M#%&65XI^Q5<HI751GM;5G2T0)JC5)E--A4)SJGHG4RK+5\^S=+54(C4>A<<@
M6)#QWI5/(<ZTJTFDILBA.>>^&XF4KO&72Z/B562=+8_WUBJ'QVB]]GB^KF"1
MB9_=E=2&DHK[4 2>6V/(3"6N'C-89)?4WD00=W%2DLNA"AE_*6T5]R &%2-M
M)=>76*2X?Z SA(C"@"W?</CBGF*VVJUM+[WM2D;&:<4K*$"RUBFHE)X=F(#M
M/1REV7]:LR<BV\W965@M*'M4(ZIFUT1>!KE+PHJED6HDU>RHB$LE=T1*GJB$
MQ&A0NIXQWE*1SJ"**U!(1O)4*\_).?&>7,#WY)(-$^US::O84DU$-;LBM<67
MNY92NE48BX:Y;MDS\G)+5W$0"G)Z3;<?$\F T[9@8*T7#E=W&C5:Q;?2P3GE
M.;D.0LR61931E;R:GA+^!?YL4,J*#U$8Q8J">*5%R4 %4KG2<JEF+%G&P^F-
MU-/(/*6QL I)Z:QX&)=Y0)Y10 I+FO8YE^V'J\VVFKH*T<[X3J9911LO$YA%
M=4PN4510Q+.*?R%2Q!3O;4TD2;M=J&!F7Y+K%S8_6"=Z[]F^E+Z*XU&P*G8"
MR8H %,^, ;S=D)&?Y(WO&6Y%5<7S*%!%,\")I1B%3!@9$G+(#XIYSXO-3>3S
M(G#;NV0*M21T(Z6TXI#$:YI3 )VE-Y\VUB*#SI0V!J_?I%1J5I1,RUE-CD)>
MO5)G9)(SV?#'$^O OOP/4$L#!!0    ( !:*"%GA<%3,VB8   1D @ 5
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MP[0RL:2,GJQ<; MD%L&#_Y4;('K_1;Y+5A;5.5:4+I]I\_X>DT[_4YP$>!P
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M'B<,X'W14<PWNO9NK?FBVO$H.S1&V3T@AU_.J^'&K_DTG-NQ\0L]]LYA=67
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M;16LQW_D'(6=X+?I,:"A/*6::UG(0VUZ4LJN7"-AERE2'?4N4^20F2*OB+'
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MSU>;3_)%VO2'B_R;9WJ_\S>2C]7_EA)#%>L+7F!(2UUC)5^O008*1^E0X&!
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MK)!!3,A7-5_@=$5"/D+6^=$0<U[I$I"=NJ_)P*) %YB:"3593X']'C^%:9X
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M.B71,R:/28IOS);'>B,3C!6R?+4C?KK!08KOPZ=M=KOYE(KQI\I+O8Y3^IC
M;]!(IP F)IF@[/"IT$$14T*$:9TFF]-#BJ&L/0Q8A9MN/0_\"NQ$2Z]@6#P<
M>_?UPOCI-*,CPJ-9;NWM>_UVNR8]KM?.MI]7O1VL6'V-6M0!P@^M:SZXH&:
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M @"F[?KPNG- (?\(RBJ[*"@-^V_ZN@'E>1(_8Y)2R+<;\>\L;$3" 8-4 YL
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M(38S:C5$P*PJRG%)";.G(OQEN##7 4 -]@8R/XC;QXZNH/O'WV5 NX^]UZ4
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M)3J^%B*4\%7K#QT%[^2Q02FGT(^H$)^),X5YPU4%K;@SIAB +DFBD87!CWZ
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M_U$Q+9O2L-/<.9,51"-QSFBKT-K&9!YUSFCEKV8'_ .>XIZ-5T&Z'7L0CYJ
M%_V&.M"I4/JC]_AFX<QBM6*)G=*/2<9W(F^2($[O\0J'S^SB"(WGXPO,Y!M
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M8M%$V-+"(EN2($XW=/+Z1'N*3[2SB)H]"NU%@M>=(FO#0$/.:#S*T9+'@ZS
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MK@C&];P3OP0OX>[0?E/#_>?=IB)W6ZC-Y.9NO@VF=3IV6'KX\Y0;1W4 J(:
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M]N"W<OKG&W[PP8I,L I%%]3*8%7%LR)DL=%&?@F*FT<<4BN.%7A0#JBE S3
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M_U6:M],^6XX 0FK 2=V49B$*8Z]YM(K/'^ULVZ!0W>;1$M_V'B<\.0PBCY9
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M==YUE;2VJOOVOG30%"1QFB(U(.FR^J\_@ ^)(@DP00)*R/9&['39!I+(7R:
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MXOSI7SZ=GIS\U9DNB;.E@)-.)L^WQ00TB0+?@^6,D?3!L<%*#"])[%$_>Q+
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M,IJ.&\Z<8$?5F4?485/-*6D[!?'7@(T#OW7-Q,-S$<$OB?.7 ( WL1IH/XN
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MGRG:O;<DLS3@*_\O["_2]176%;M.[ !YJ6"#*)YR<9A&YZ2Y+NQ4:H 8X9_
M+L]J6-RJ6!M2BTF^-O "0,QD*Q]A;P02%K9&RPPY7%@="%A84D[#X<;(L45_
M2L;ATL4XD&BJX\9&?/7DKOPP&]R$A&Z0A:>&,W 14V5"Z)5+>XJZ+[]"@1\N
MR'8_K[8TO.9C,]*V[&U); T/-_OA!T&.]3YG"I$TBF1P9ND]DSSA6\=48!,5
M#>OMNN980R>-W++TDE1MNM4YJZX.R#)A\Y'<L']*+D7;VMHAFW;-$H%?&?[6
M?]A7  *+@T>3)N26O[C,]&5&YKO?U-7G?//5_4=$+P*V)(V>A,]\!M(\!DEI
M8+-R/6"%0"^C%3NDZ!9I2159J!KDI5$!2E!V%WQZ+\?VOYQ'+!;/F7(7X%>R
M>B!4(&N%_JA78)HT??]>3!$Z8_>;^^,8>5ZZ2C-CF8V")OX?&<1*8NR@@7J!
M=0!1@B \D#B_D?WGA4IR%'5&O90Z@ #EH!F27(6O"8W6U&=G,+J9$F\91D&T
MV&0+1/>>*>N+'#XOMJL%6UTW#N9EP;.)</=.0D8+2K+AYVNU*)L/L"]V%+NR
M,+J!,"^,\GE$YLWAJ466_AHL#6EG[+!T97$ H# OCU8C!B *43_L(')E*<@!
ML, 'O+<[3JD[(]_<E2R=OZ0+=N!VMW2Z>3!L?$F-D:NG(IMMZ383S90>=+#C
MK6$SIS= A[.6%80$ZHM=]Q,J& 4@$&\Z^)V+5SM7%?<PUQ']'KKY[\DL7Z/?
M!&UJ)KT>^52_'BD_Z;B5;SHD_Z@SCZB3+(F3[C[MS"O?=OS7VQ6\VQ7)3MVB
M0=^8$DY_D."1?(W"9"G9)(?213Z(Z;BVT0,MNH6DQL9_$9=.?T2Z%&-+#OLP
M>'B%J"%YU,_:>W#.OBRY[.U-$/L4BZ1'531?F"9=1VF;-[<WECD][',XCAY5
ML7QI:E1YXZE%C3)ZV X#)#6JOI=].6J4O6K7K4LUHMA>CL,K5"NJSU:KVB].
M^RF3B!:V0\:T#LDQ/-(\!3S".HI]3F(\9\A=+!G3)+X)2S2E/IW/=9].A9P3
MS?^GXX8SQ\M).G[H+ JBKZZ:P_%:OF\9SSN<Q%V!LHIT[ @!U!)(J\@Y?J"M
M0O!&PWO=>7,%I&:'_/MIO_S:"PC X'#?0ZJ!(!18'0"KXG\/+'P]0<&FQ;X;
M+[^Z%88,P]AO)V:'^ >&!P\!8&!4L#8#1QB56-L>T8.!AX#=*K9V!-"O1<IA
M30CU(\:?1WE]Y4N2_[=;4*)^Z,4#^AL< L')$3KJDWK)XLUJ[?HTBR&0)H@4
MM;=\MO:1>CLDF,^\M4F[6[[X]TP&)/JL9NROU$\2$H[G\]U#=9<;F.=IS/"(
MX^\,NVY! \E@WQ89T 8E (^T-!-_'O])$!LE3_SYX6UKXL]/V\2?E2?EH_V@
M)_3"A2_)IW;@#=QFC[G9C7M**)IK_-H/W=#SW> FG$=TQ6B%$8^%7+G>);--
MV8+(\U],E\2G[->KD[=O_BESEG\XJ<_M[0<<?_>%+/#Q^]?1A3/+/^)PL?%0
M2)\Z_#L.^]!_8CO0\ZI\7TFRY";ZMF8?4Z1_C_PP^87]P'@$E"I5)H3M1!<,
M&.P\E_>WPW'24[I"M[F<9WQW>>=( 4YR%1IV2%E-IU6%:Y4CO'V,V<.[,(X"
M?\;WFOP/A,A=X3U(/0-Q]^ :W0VN-.8N-W@O8G8(OK?R#]$!6QSA2H/.JE!T
MN<S[4\1VUPV8$$-4H055=#<\L !+O]HKQEZ<*9LI-;'I+;"RSAST5R&N=[5X
M5L=4#R;,:DOL":E)H$WFCURF99I7GW1/T;:VV%[TP7(5 _!\) N9LH+FV'YQ
MG?)]=I/WCCR2,)5E0MBUP'[',%B0=6;1#9LL3\:$1G/I-52U$7;H_V 9M+",
M+H9O),FS'<OO!6K-L"/H!XNBE6W,_,VKM>LE\3BL\' 3)E'NPY?XZD\;N9QS
M2DX4.OZ.%D]"$.7>^E>'O%TNVU>'_*M#_M4A_^J0?W7(OSKD7QWRKP[Y5X>\
MU0YYP1*H;*<>OY.^ XF!WJ'[Q*4)JG]H=T#DX5/*<@=VQY[:@]5 "::CCH]O
MYRU;I*9+-YR2U3JB+MWL(@Q55P4YK:._+>@/X#/4&_4MX[?39W"C(.'-T*W"
MH7QX/%<]X<7EPAEG<LWYDOKNSNJ^NY)"EHV"E#2P/7;EJ":!&R95YKI]=("N
M.%-2.#!1C84NANRHKP 656U2PN! M[UO^</*913,V 9!H\=*!0+)S:RD#[;M
MU5=<W3B@B^HZI:'/?;V,K6O_*?/Z=DA*T@7;\NDKJ$X4T.54219U21BLGI^!
MROX=D S=<"^)E! (2323MB]@VSY]M4 WQD=M# NY^T;Z&!)9+^SH#.W;;@6+
M(TW7QI^#GKR5F,0=[TO?M;XO/7F[?6"Z9RM?-6QE]%>FS]%JKJY>XN'OMSI2
MB[B-5<3XD,Q'<AN%BRFAJ^X:%A_>UZ=/1L )& 4G823T5*(0U%39K[]^<K(=
M?+(=O&02-"NX=U#060[F?G1]M2UNEG](,,36EEC*KHS9OLX+^;'$2+TG7DK]
M9,,F)<_9*0FEJ#=$K1D[0"(B?BP1R"X66#A'RD"[1DO4VJ_#12)B_9CMM!T,
M;Y+Z_M)AIWUHM]-.MG9:OO%DM/G>I3L;R//;@B;NAB_!UQ'=6Y(%PQ2V/N*M
MJ ,!3#.,V9(\^<4B\\#)3;"/#1.L[.P$66]LOW[.0_=QI-X.R08HJ]AUQ<O6
MVMD12=6.=7VWKPW=@O!68>E "?"WUH6KMJJ."/Q;F\)/R^/K??KP#^(ETVA,
M1X]LS>",L/5Q?SV2AY_V('5$XNO!'7J8J=*8N\),>Q&S0\"]E7R(#F@*,Q48
M<?O?NN4]&:0GP@A1WJFCCRV7E3VTM6K<@9 Q5.RW_=MG/:1RIB@5XS>31J1R
MABB5=SVD\DY1*L9O"HU(Y9UE$='[HRRJ5HDW*D%S[&AH:&5Y*;>(1]/[=+T.
M,@XJ>2"C<)N\5N7HVJB 726^RP$9A0[-R3M)Y$0O^7C;M;1=N/%RXOH\B3!)
M&-3YA-XE5^A:YKK[(\\?^0%7D1<K%[9?B;]8\IIJC^RW"W)'^*I=_I&[-D^@
M:QZ$$K:U!W)8] 7(;LGRE2]*P^2.K6P30CUI=),Z)6R+<;AD)0 =;?#V=<J#
M\S)N"_?S^"'P%QE-^6;9*"V8D\IW06>=$W.B';47M3%J&&T<$U*SA(O-8E.(
M*KY,R4UX%P7LPXM:7?DVOOI2M'J/'<R=D7O,8U"6:O%X7>J2TSR*77PX:"]/
M9ZJ%XC6I3$[R**R#P9"]0(61ED0?0!+;U65082RI=RXXV_?BZ=Y_$ASU^Y/#
MCG[O/OH/A>J(I3]=$DK<>2+T9/<AA)T)49_$F_ <L:SOTX<D2MRV^GDJF.S(
M8*=9U"?G.C3/UP#X'LX*]PB973UYK.EHQ7_JN?F+R0&5XZ.]&W\75$?]S@TZ
M,X8;A6!5^&2O*K0 <J0!U>,TB1.7:7:XF% _]/RU&VRYD_@1/S8J*E8H,00*
M4J5#$=V+>$D>$I5RB:+V6J_;9-BGA%N5X[!MQF7W4\#.R$Y .>Y[%VY*:%AH
M=W4P4#Z'ZR?/76]L)YTVB=8!.3Z13B7F,ZPKMO],FS"G!LWE@SXN.N.0-"_3
MY.^*/C9JD.;OBLZV[XHX56?<<JN&_O(;=6?4F-'Z?AG1A*\G?(#@+.5MO>P(
M,X9-31!#%KS,J([J%O Z0]#>#M% E*XN( %#^&\V^(!N0J9=:?:46OHHHZWM
MT8JDC1GT1Q;[@_KFKCI?4HA[V"$9L7Y)Y5%EQ,RCA_V-7O[80=#6!EM<IBU5
M T[*KJ%8^?UOGBI ?*H(L3&G<G^(3Q$@EC\.$;0%:[%]&!_FR<?^-S\H8/Q!
M%6.C)[U^&'] P/B3 L:?5#&V<*WX9-DCF7U.KEV/=%T+B7M@/Y61'CVD-DB3
M;\L$<Q,FA*&9A39?II3[9K+ 9*B8Q/VQ+9L!4NL"Q3(9YH/SO<*9!A5=HQNV
M*W& Q 006":H"Y?2#=,FM96PW@L[ &Z F-H!,&0/7$3A(Z&)S\[OW)>ZR_4F
M0I_WZNJ$'7L& Q_"B24S9.1Y-"4SE<+BDB[8@6)*<Z.3=0OOL]HRL6]5ZSH-
M9_$=\8C_2-HLB#R "DX ^^0.GVSJL!A:]*[]T T]OL16O\Y^'L\G*?66;)CC
M^;7_1&996C*!D)2I8,=FP275$R#$A^[9I>*[[(:T>-P^<2E/D0FY5FR42\ZO
M%=_MKA53PA^S%Y2=C/2!DQ4V>5-+52CK_WJG:"[-8;?<7N\8,43U>L?X>L?X
M>L?X7.X8ZVMLQQV8L#FV/T[)M=W!M"'CF:]XX_D%.V7Y%<\ZLP/9D&<W(3M1
MA\3CO_K53Y8C[Y^I'_N"TA#9H: WN:-P> ]CT?A54+<[MRU_37FQ NJ-/:7@
M<E($Q)18^+3.<F-7Y_9%X,:Q/_?)3.SYV2X*D-['X<=68NF LZ42IELXJ$IU
M$=\O-%4,0.4X_-B]6+/#9_ ^KU0]=9\(, BY4: U]Q:\WWH+<HI.1M*> .0M
MGRI1R-)..&;U'<<S)+,KE_(\8O%>';VY[\DJP4#Z(IL5 #'5C&TX($?]OO:R
M&#"#)B\6L7LT&,5Q=FDVC^@/E\ZDIUX%(MB6B[HJ], (-3GI:N72#3_G,SAB
M9B)'JU44WB>1]_L-LXZY_DJ>1C:* 1;TG&CNQ!E%_B\OH^G$G*CC9U2Q'TGF
MQ<Z[%]]Z._1:L)D1QH3$A+\D8<SVLEQ%N7)UN&W5J-CA[FB7D[B,*X Q?/<M
M<+P-4Z^W2&]M<_GV4>A^0K^UR3F\S66=JS4?<A2R'V.YG[BCV[,1:0>?Z-[D
MVK"Z7,F"YG:("Z2*-?D(&!KH3QXLEHK)(G0Y%VU;FF);F%*EJ@E R"EZ=%1A
M/NX\#K++R$93Y/->W_VX<2DIP&!@[F4V56EB($0J&^^#&Y,99YAQ6^!-W7"1
M+0WGFUV3PF4TX@>7\3I[V/T+B1EBWU*NB.4!0N2J-O0M[,D[5',,0F/4$VMB
MS*<'5)U3?.>[K:IS>H2J<W9 U3G#OQ"P577.[#%'*OZKRKUA/LS\][R(+:&/
MOM=:XV5K):O1P8ZZUV7)](+OJ%W;0PS8W^#;B;& ?E,V[&]M^X&>"B):=I-V
M3<W?CN0O2V(F >[7WKXRN2<>:RHI[C24*/9S "W[@Q9@+7P8PGER0X_L775,
MES1*%\O1].NUZQ5O7+Z1))\- BWI0PC[^8$.S>@/H"F+4K9;3=*'P/?&<Z9[
M[8NZ1-G;*6#G=#4XNV60V6W397\L3-.K)T(]/VY]V04Q< 2T@'+_;*O<![!N
M9#$_:(C1QTDYXHQ%6)31^_8HHX_;**,M42>C:D^@T7%=;U=>&W 8S_/ 0O@C
MI&8G.^Y80)?74C[P[ZJST11C:RPM+1<L[<WMD = S^H7+NWL6'237!TA\!:Y
MV>58Q2-A"?VRN#JDKIOBMK:6R*1+SR03QI;[X7MFX)#X?-\"Z+HIEG;"OG82
MZU9]@G2S;NI0EGUYM/]E^9,P>1?L^YINS+MYL.0DM3\Z!<]G9T?DBWRIL5*;
M&D 0,'P6M1A<O@%^7T=AU>NV/_H^;HT>'[%IV>OOWNB-K@UAVK_R@V68%)<P
MHW!V[?KT%S=(MR]GVH^R'R2!VC\*FF5H-IL SIR1=1XSN@-#M6&I-3Z5C*EE
MU&CIIG.6EM>;Y5>XGI3N3\$ Y5VPUD<8=,V)! ' T IY$_J)[P9;_5:2 K0S
MVHK65R!JJ!@235TKY+9#FQ[U,1KT6W:Z9L7AS(86N7>#W]4)+9RE+_XP% ZO
M_*((-GD7M)@1 ^IO.GA,+GD1_IV]T((WS,P F10.9;%FJ37RBZ3O,9E-HZLX
M\5=N0BI#SZSK<OQ?^/]V/#?\6+=B*U]Q4O89GB&.%!^JV+#9<\3LAF9KZR[R
MS[T$XU:7*[,8SIC>^8ME5XXX61_[,L1U3CH 5];<U>R/KG%0!LKJUK;;FVXM
MA CKUJ9;G-81RF]Q)%V>DYCLNL39'QOP-J>]D\5"ZK[6:6?)3#ZYXELU.T)Z
M@2#O8HGW4J9+51,/PC_Z34+F43WO?D5P7G]%L+4"*_S=^?'OUY20:M:OK^Z3
MOTK;*@E7 Y8/,@([[C8Z-O>V<.X#RN=Y*>35TYIX_$SB/_HS=NCA#!]($]L_
M;>42=E =E(G$#N7K\Z9*QBE/_-;VJK:*KJ%O6G+EWD/=C K!#CW3/:-^B0)&
M)O"3S>'WW8XQ8+^WM&?9DPH)T=MWL>1<Q3=ABS=2ZM'[5/?H%90</]SYZJ(=
ML5=_W:N_[M5?]^JOLTA@K_ZZ5W_=J[_NMY:=7UYH7M;!RH-NIZ].POOQGAF*
MUX 5UO+[?P-' _&G7I3OK0MQ.W2I<<3.HVM':;*,J/\'F7UGYP9:>5 Z"=S=
MH]()]3URQY&HL%DP_BOA\)+9Z)%0=T'VNIR3A1_R%-OG;L CW90](UBCM')%
MZ^=+P16TI=JOFCEI%,ZVSJ6(_ZH"3PV7.\+W'?;[BRC,#CNI&YCR"AH8X\OR
M(AH3LAUZ/V _ZX9DM%A0LG 3?L-$_3#VO<P/9L[2&#"DE^63U"7"HU?B+_GK
MFS!_4/2%1K&T[*:!CV&GF$-1/ GLSTRE:MM"]L?+:MCLH=0-,!#LG'<6J")8
M7/AJ>ASIDXPEQ>NG+ =,EO0YOTH+L^US4*Y$\TM:W#%)2CA$\V3OJ#=@1=,\
M#NST?&86-"/"PJX9N+T!A*7R^MR>RNO3-I5724Y;#J^CN&KN\.7G*U_79*UZ
MP%M['-NK9P#[AMZW36CD$3*+[XA'F.;-KADOY?=W3[T$,H!V/KI'SVJH&!)-
M\X/2[+#BYD?WW+F+<T. EQ^;1I.4>DNV>57SCW>L0Z).1_?6&8:"30\]+]S
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MRWH]Q #0PW./R?.@*-;GO;QW3/P"FY3+,3NS^C2C8'JU-SLL]*!BJQ;_0ZB
M'7O! !0*KGA\ANE[Q99/X4<>'Y/&"F5EAQ;JNCBJL FX.#K43:+RJ*"Z_7IU
MJ$L#+)T&< NNPC=^=:E>@X$J_>M=X4!YVZ'K^B^,*I#8<E<(&1)4[U\O"[7(
MWH9767=LQ PQ-OH,4+5'6J>21UIT2]B).>775UM'\6KK-6_R:][D \7$VY8W
M6;;YU)=)<4)E92K'((U>C!E*P:PP#FENYAYT+$C:W%-)>PI2TP.0P2M>;5C"
M%R-%>T%SU"S0O=6VMB)*H; MF69ML-^+JQUF,T->@@Q*(:GT:>R7(6:S:?:0
MPD&S+K5.@O91*EYHB=,.:?LF^M.* ;F7- -O^>H#"VW5.=.&Q+<>:P)H..A'
MI2Y]PD_-X:@O!O58,T3K$99MR05K7.5[<NYG+'E3VN5T?1(])M]L@D$%V#'C
MC0PO>&UL8R][/<>$'H!_T,5OD.!L7P)[1WEJ71$TAWHBYH9&@>4H##[=T90Z
MI_AA0BH1\TE;!-;KNJA[%+\]_QS5_8$Q8E<>+(Z ,UN%BL="A#$YWURGH<=_
MX087;'R+B&ZDH01GC5""+&C JY!V2$[;>=@X\RUUQRO(OP82: PD$*Q>3,L)
MT]$E6U8OR2,)HC7_F$@)!(N/*A%DY[S>H((^ /1=(<[R.<HVN8<H)B9.GFZ0
M;;%?7?H[2?QPH:@)"OVQW>SZM4 9/ L5X L)F045,"Y&LY4?^IS;Q'\DBGJ@
M3@;;B:Y?'?I"::%63*/$#115H*,/MC=;O[Q!(&D6[J&LPF]10DX^[\YJF84<
M%^;9-Y?FFMUN"+ZK&X*<F'/RV?G3OWPZ/3GYJY.1=3*Z3DYX:_DY6]JO-J Q
M&W#_!,-S,O"(L9OP(@I#DAGEO_K),I?,-HQ87"F$TQQ&\MG9ASH0-N2^^!Y2
MXD6+D(?A9XM7PUU3K& %]].H#">H)ND0J($NXL_/5M0+NRG7EF SFQ":Y,^
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M8_\#G/#)M^HWS;X8'/AJBD?4OMUT1"##;[5OQ*SY&2%]-\5C3A"2*_VH^B.
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MGR?8>D&P&TNP9/.Z\$)I"=L&@@T$4ATB+QJ\WM!O0;WVMH?^$':!TN$M@1$
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MI% +]&QP"J@E6I%6LFT7;;?1>ZP%+\Y>V,FIO<\I"M8(S1-0^,'_W_:V=:9
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M<XJ4I1Q2&F -*A)" U/&R#>(,33F@2N%R>]6)GDCU.CNM2A$K?5#I1,^,F1
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M%#K%"C;$&'R<CF!? S1>CUU9^G!$QE(>!-!/.O9B'G@(,EIZ?V,#M1.Q_2_
M_':FBC\LW5![)6T39TM,DTD&GU27DIF26O]_G:>U_CA-1R?CLDO+O*U,30Q(
M^Z%T'-"_8S9P*0,@D+JGE8^N[E(+LWIED,SH8-VDC6I'E'1#H#8.9L0!0 %7
MDV*"6CX;1(EFI(<MF*IAM)I"[O@0W$EM^E-N.YO][#I(!M_M#+0KT]L*>A#F
M9MF#^_N]CRTCJ!LOQ:CMS)C*)']?H"T<)MF8?DS.@OI!IA@Z+0PI35,88IQS
MNG ] QVV9.LGM<39*0%&2<LDQZ5-HYLRPMQJW:H+.VZ5N&9 9RP,5+!HY-.;
MNF.Z1]'O8::)=%.EG8HPF]PHO6RZZ60W^-3SS5B\5VI'[I0M#X.8Z( H99-%
M36FP49I?EY-&#UPZ  ;EMNWC",ODX'*=GD8',(K8Q:J$!:7ZD3UUKDEW#63&
M6JEACR:=E7(,C6-^W/,)G6Y8.H%E_*W830</1+[OFK(?[+NM?14\J;*O"WYT
M)T+?QKD%R)IIR*7;UW$_,L106>/*3. )9K0&12)M+$1CACYPH/ '=6#2+20T
MIS9%9,@SD(ERB0CS%H2$\IGW=G?V+9W(@UEFM4J]4DY=HYGQ(?I!QME#S5\.
M=@[^P?IC3'T5/>QYH%>)(=%$H!TW/EZGR4JYI?S.W>ZURQYX,$]"S2W%>&A+
M@VL"7O9GLBCNIR@R.;WUW9VCP=4QY @0^9VK._O_*/1*;3M.TUS@H$A'6GPZ
MTD&1CK0:5,^T'+A.U&;2P4R\Y\IWE5W(RJ'ZA-DC$T4O-9RN\A3EP11&Z0J-
MTB%G8>7/@EONF5F1C4;2'MS$.'-E-/F:$#2 0BH4-D:E#OS@",FD.#EC=E+[
MWJ0?)%:.@OH#:I !#?4*TR@8 VCG45@RIE]7)V)P\CJ83FAH<8A5SRP:>!K[
MLF!)7-6#O>UT%($FDNLECZQ+,5V*C8J2;9U.V?.A':BF?%S/@HM VS+I?XMM
MP=#0;?H".P5\]ME"[,)7"$G::DJWE?S2^%VKBEV?/'D<WLK N(A^XS.FY2T$
M)>%,N(4BG&E,-3J^EU3/L >0>G[KB"25'2<QONS,;=!:J<5)K5+92[12#$S2
M/'B:'A^PD.QGNG@K3_<+X5[9J3H;9E)ZS'PHTR'"BS%^6TI?CD7L@['=ZA[K
MI6?D\TQ[W?',XJ2^20)>4*\QGW 8-J*V5['0A0 ;"613V=G;LTAIQC1W3*5H
M$AVID)T\"'!)OX= T%UL<0*2>7T@71YO)2CB%.JR19UFI"*@T.JN">8<^PYI
MQ(99I#(OM%Y=88)CM7+PFOO5ZN I7\'N:,!B#($E))^:!4EK/M-(,C]H##M*
M)CM:3OTC_ ZX$#,B>*P6=2UHF;G,>C"N'EW)6%2Z)H*QKF@J=-HFELTT[3'&
M8@>ZE7(WX=W_B@E_3%2>MPZ9FF86O.TIZ@F7W..'!Q5JS&Y QZ9^Y,C*-:HO
MU??X,MW3-M=3,]_2?J^6N3)K)=(!9UK<)CA3K_,=S"?,J&!^$R^>_&@=%98<
M$0GTH/M>&QODQ^VVQ,0:C8_Y[AXN6I<X5(*BF .M0 VG'M;P'2THIA*\*SD@
MS;/HJ$IZWO':.GY^ *T#V44ZDH%GYI80[:FM"_H:K2!V"2U,7A<Q,(TLP(D4
M-MT$]"(KS4@I/>%$W]N4&!?"I!@],#6EW'S;&I6IPR]A8Q_FV@-TGKLL,PR%
M)0E-6=#>4TT,YR=I0T-T["9EG\QWR$UITF( ;45FC"SN11FHX!YNHE03GA-'
M8&GV& [6P"*#T;MB1@!CH^UT- +(I#_AEM!1:<5Q*).D(1QZKWMK> ZKS"TS
M\L',(TZKTK#<%3E-J)MGZTXI=XIZ2KJ*ZZ]9R<(R54P0<('E8^.N,M]F1)23
MZ:V<N.YQNH<)"U!F!+%-+%8%/HCY WB&L'1.T;5]G<$J-$/)-OQ/7&(!J$0(
M6$L]D(M<,Y"DQWE#!30%UKK1(VLR:NE%JGH5KIAT5CVUT]%RJY3J5#A^UE81
M9UP1[]8H%:;UILE1@W03[&I#N@6XJ&1:YU>:C&75-1781@A^8(S[G3'ND\:X
M&\2XTJL/OW^ZO'F=P0(=E,$WZ!?<4YMND\8)4A_;QSA#7I2@#<N-=-P)-<)'
M>4A*1:;?MVD74*+F.;QDP8B9A)-T&UM\<6*7$*,9!2EHD3+/D,B4H17ZID5^
M$CG3*9RN:/K!-F;3<5KG,"77,H%:K<KPZV ? I]'.")]>7Y79YUR#^V$.Q+?
MB83]W=5B.TC,I%!&*9\H444ZL2/>%93/U-'6I?D#."%<*!>]S5PWSVHHL[GL
M34&,[(\];@4I:F'Z2($L975O[ 9,U,%Q-2U=-7;A20K/UX'7Q$[F,0B$"F2"
M,,DF?7WQ:=0JWO25ON"A$AISRY1ZYN&\W\^@UP=)[W<D45W5>L7SGY#MWF/_
M$HY2'&=T9D >*;\3AG7U4Y+Q,Y[$]F9:X37"!(@!@X!A(F-Q/&Z(U&Q\"5QP
M3"HEO(AFRB3*83H0@OKA-T*R,4(@9I,M&R8SVB5Z\'E)S1A0T<N/D"&U(@1S
M"C1H%[/A]*!?W1>"[!-.%!\8[(9[BN%:G-V1[<0')E<,=MS.)!@WC8G\(C#\
MY^;[9.RQ:2K '<EQ LEB77GTS_ZH*6@O8KL&4EF1*=S[I6,PO *D!FI<'U&\
M7=N7CS;72C;7>M6X.6F\-D5,/-HB\"D?F^Y->^ DTBCO("&YE)0KEHSBSC-B
MDA3O1)V-.D@S8:)>)ODCU!Q"A8F![Z)1G,DEH6Z 2:::43,HNT&_VWJE7EO(
M<D"CS+I9^)641SL(3AGN@9M2Z]1HRZAL>RWE4EFE;EC1<CD4DFQGZ-LXCYW%
M*CP(GZ3"[\Q,.K)%7 FV+$RRQI-@+5K+.\PJ6\P"RD\=U=LU%(9I%"T;-1N,
MJDT-:":HMH6!F_%AM"T=VWD4F:K^8\HU1<ZH1]4G>=3NT22/.MK_QTS[?Z7)
M,DQL1"=QE:<=A,A4).K@7B3HM$(XC#@TO9 S'A>_U=H&W-L..])M&?LJL"B5
M',AXY,C/C#ATJ/<0SWOC#+&4*E..0(",Y0JZRD.W_*1Z)+(UR1WO6)BT0..:
M0M,3-IEIM9/=>8HW(M[HD.-\U%(0QDLA#.2@&C<,C;30PYVT6S1MPS0U,&7H
M[#@L8L!Q@VR8V+X6=G>9]F^<74AC(>&2P5[DFNZ:$I5(JOW+#OYZBO (%BU3
M)Z"^<#SY"4V ?2LOD,5(XELS IKS?045KIH*K[E=4:B#/=T>NC]<L.(^4AUZ
MTB0Z[\^/? (CC)M=%9$]UM.%IT:?!2D'I.H:1Y'H(EYGN_J/EV1F0,T3U$10
MZ.Y=U.ML,AD[3,J-E7#+HK(D)6;T0'5]X:C9LO.7YBT$AB<LG]*0*E>T8 ;[
M+_20&^KQT>AG3QNDY7W"IL3MT=S+!;J>\)\9[<TQB3=C\N(.B[RXQ>?%'19Y
M<:M$^\5[?6:'A0LNC_T 9!,.HLE572X03+IVOEU3[T^].P6"C[O9HE<H'7D>
M+KP@<TZ(DR86V7Z8P**[6%AC?"4 !S7W"#'*1X73<(4GVZR;JVX/&UWI#CTR
M77S9R'^Z.:F^SO3I32=3<#'*G>3^ZZH9<P#U,X*1V)G4ND/W&\C'>C+/Y 1P
M:E7,K7PYP&HFW$?:M:V32G12%OO".%$??6@B?-K7\TSE(\O7J-]9(Z4*:-+3
MJMH:*J-Q[.WL(JJ:;UGMT%\.55@T8'L+4-47!$IM :K^@D Y>MKL:$A*R^J*
M7L]XHA#S/>I&![3A804;-4D:5(L3I?B'<746F+])F/]94%B>&K0C$!C:!DOX
MGM (3>)VWS(=W71\(1!A%,3DT2GHH:"'S:*'$Q7R//8 D^G8W5GP_P+?-Q7?
M&^T QZ,B,]<NSA!##MI6*/"]P/?-PO>ORG5<U>*.DC*XT^Z1=4?SY9C6X]J=
M/M=[)_ =G=,\40D:J'!Q>%4/"*^_RO;2RVYB^YP@WG9DR73;X3F<'N91.U1V
MQT.ST]VG5$[<_:0X\/S*)*AS5$-@T"Q4CA)!GPKZKD3$X\N#'N=3I;];'=]U
M0JM6HSHFZ91Z=*V9:YT4?7'V)']]:/5T]Y[Q%_.[SJ]HG&L+%N2G$[QU-B;>
M&$?L(S,/"X371H\ A=%,EQ?LNJ!P8EH<<.+QL*&TU(KB0D^ HQ0U Q]6,G"&
M"';@ILHN/6$8P,-T3>Z(S1%RZNW H<F2#788IPU(A$I*2DEFZ%?2G'.3\3Y!
MS1*B)C<N[^@*$1QI)K&71F@\N-A7J(S=ECAO3MGL*KW&T1$BLIJ -PZCHNNW
M_0GZL;V TUEZ=BV&!;H]U^]+N?@8P#RR>"TVR!1I D?!SC/<B=ED,3"W!G9X
M1%.JMS$ES9)F,XL"A03!3-<<JL&<93K%#[!3NN4WXA:7A=/TAA(/B#"X1\R-
MLQONL2:#1!HU9DOV-U=5@)4&A,$_[97W*I7R49T+''_:+1]5:N5Z?;=,31.X
M2A(3C>6#*83XJ7ZT5ZY6]NC0?MH_JI6/=@^H"BCR[>_;W""3NKQYH>#BX.RC
M)BI7*"INU[!UTE&1(K+X%)&C(D5DT^A-.;]L7:OP^QFWSTR9S5/4>![);JG:
MV+&NSV]^L\X:Q[>7US=K( ?7K)43[JW%FTM3CT31&W*X=@7[%((5A"DH#C8'
MPB:-9PK#BXJ:J6 9(]M%QZ8&>$TTKZ<[PJ]IFO98W^QN[V%AV=OXL-0I:SCT
MX4BG+);$;'<DNW2KE?T%^HF7\/*O>CA3HLEZ$AM&8&(7!T84SPNR98_2KI97
MA_""8B,%PCXKPF*)MB?1>>@D_11TIVP"!(=%8[_9=" GS05,DQAC+P*3[EZ:
MA,# ;\'-IJLUY7NT\&?T67I^9/'X+6#K3:K2"^,D85"_EHQ!73E.+6,< XB+
MG=NI9"C&HB:7@,ITQEBONIXU)9V"2J9]^2=A?T=/03K]S92Z<;I3P+-]J/@&
MIUEF*N32<>F(T-C%G[-J T!U]&W85/.)9(##XPH$+A!X&2^_!#:93)3C1F22
MZB:I\;K)5L6Q-B&W(^6I<T.=<&4];)):0,*!DMU/W<%HO@V\!I"F2X6=#NCP
M?3AW[KA@4\<%)@%L@9 V<[=:P,L+W"]P?QDOOZ46M92#K<>*&\PS2.^[V.\N
MVT8C(!.48KF>KI^F67+4F8,4)I^:B)I:RR8.)0GC@)KBX1 5SY%=#_2? JD+
MI%[&R_5T;V[#&O4YUX$PENL.K X\2P;;V-ET.QE%D;83O1<!UO_W+=L5BIEU
M((%&O%"SZ8[ XJ,,L62;XE O//+"%/A=X/?2%9:\KL'-(TAQIN83P&9QH)6I
M+="FHV;0B:W9:H4RTIU7M=)-?:KU2[ 2FMJ8F?9F1!),1/R*==3/?X#&$07-
M3$4SCQBT]J.P5'!P6 !VQ^9*4E9<:"3O/1:']GR7AU2639M,.]MDO".%"Q23
MUXBH]:]N[96VY Q-UID93(?N'\<)<E,EUX*$"NS?$.QOV&#5FCE[K,,X"O>:
M:JX)_2-J:\L=_7"P,Z?=>1+P'7M4*O1# LUP0SQN#RK+\+T;8Q,D<G\J;IM)
MS=PQT=3X?09)BRYO)3&K0ELJ<'_)G!]=*#3#Q4_;Q+M]+CVC]N)F4MP(_;[
MS0(WEZ[)8P@HC)LX1-"TPW*EUXXZ_7R:7]]>/V6[P,@-P<BO4@_G9$%O X)B
M^4@DJ.<] ?)$ BJW1W&R8RI,,^VT0YOZ&[_#84$I^M.<C.".C%5VBG/T]8XG
M1:/R09[W.XGC4*<G@#>X_G7*%UH-0*.2ABY[4W<#6@' +XBY%%D6B[;,T3K1
MJ0V)S<#6"2EMTB1+N#A. '$XX$D=>M!81P7.-G;WZZ<#>9+ZKV5*S +3"TR?
MX.7G'&%+LQY,T@^65(1)8VQRO=+L[21NK*?7E,%J#KKW-"L-3M!O1?1WW'-X
MB@88\WTB(+OC(XG@L[.MA_VLNIGM]#]HH1,<SQ;<6$#QQYB*AVJE*'E8?,E#
MM5+4/"P$R\<.1=WT$JI"&OXXTA#U/MVC'X2+M\T]T!*IIEORHW0R/3Y!/+$B
M2((LTVP3))>;%VYL;?+@-_:HQ)1+U?-#GAB-P9RV*/+,"TIX?DK /',<O(R3
M>&/L?D_]-9*Y%!AH!]2/ OA"M[%( _Y.6H..,XUYY!I<;?I7A#CNC)-PB5)B
MVY;<]V)%_NV"!@H:F#A*8^N^+J81INFNS?5!>MX)3];SPR1E$<.5:"&Y"HTJ
M9OL8LQ1=T-3TM!/M0,1Q9;K_("6QQ%XOD#@HE[MQWE%N>C8CEYM&>\9"(D"D
M%D)Y&EI-J45!3@4Y3292 M27J)E.ZA9+J*3,%(6=U--I\AA_\EV9:&+)Q=DF
MZ=@$PO>XA@,(:(A+(5O+0<^ ]W;\( )BA$=AF8C^&1&'X&C1G"/S7,ZAUW?:
M'>'1?;H%>Y8V@9*#N,?:8'JY\FC")R6JL;\%PQ+ET9D(B6O#1#?6T;U1D/"/
M1L(W&/A"WU\D>Z$1=>FL+X.O.*N(AR,@_3H2F[71:+P>9FWJ87]VP+EK<+]-
M\W=9B/J^FY=V:9C-D2XF"/4IV2= ,B/O/$VF]P/9QK9KLX?B"EHI:&7!XHXQ
M/Q%X-.5):?F2$5])[IICV2JPT=P"BNC1#'-V=-.,EX1@!L0=.BRT[62DWDO
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M/1'?M/2DQ;/EIR1$'\AET!-M)G2,N0EO**GJ>NS<FDALM#:I"TWVAUNVFX@
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MFPVVV6#?Y0;3=B8ZIP9,68#-\R[TTWB;L=_*WIZ+KQDD%)]OG62C=3OI\Q4
M781+[ZUW;E@1-OOL.]YG>0GT"X)(2LG+AN,(TW_@M,R+"1UNJ8L':\!]??Z
M6L0HTX\DX]"U3%#5@3+Z!!J1I-I0(UN_Y39GV6:/?9][+#C+3B-9>?JQH-)B
M;_1U#5@S=9:C1M#,)XP_X8]*@5%T'*CD"%>1NH?EHM_*V74#\'1W>P,\_?K
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M=Z*?3ARQBLN'<R :/AG]D9TO)K]J8(BJ.5'R-V:8H;N>K(L]Z,;>(0\6\X!
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MJ3L(W93$+SX7-33LGJ2SR&<F%\\U>+>1QSJLI[.5FTUBN/[3SF[3&3%'M':
MY+HFVCL>WJ%[=-O].D<MAL_<+JXA0BXJ! '0U(I>R36(#Y_5HQ'ENX-DX3"?
M<-)=->:2VZKFE%X,W1*&<BSGO=A1QE&NU%QJ18-@0_0.Z!RV#W>Q(-,6A9Q)
M?Q()>37[OY=U !1X7T.?RRABE,*%&27*L&SC0#;(DS%;<PVH^C!TUJ+J?M+O
MI%'FL;6NC8V,X.K(61<=)P;K(EI^<N%1D"6KF[2;EA-!B++X:$H554CZS*2&
M-7'26[.MPJ89\!*'.5_(S?>FY#4)WX.>Q M+[IP57;E -F;[H:BY]C8XD0?
MB>QM<")/OQG>K#3%L(#MW)J@1A )"B=W3)GS 0+:T1RLA:RTH"<%ZR: 9$ P
MB>:3F$\"4((Z9(,]O4?(EX3^",5R 6\ENS!.?5UJUA)E8-*&!HUZE21YN5#
M+,5,Z1Z=+J#@!T-![84OW V2 !K*1Z4C98[N(%2Q1#S" GJ_44!&Q[-X7$VZ
M=+&>L7:OQ =Y0I$=\U%Q:CQ\)N=43^<-M83@C>3E0$H<['WJ(/C.%)VQF\E_
M";M=D#-6UGOBV*H6$>=]$A9@A/V9N$C;F<:<W?>Q6?)/4WI;MXW]BUU]2MJB
M/#V1HYU3=,62D]V]J\B*D, V2"Z8$/-2*)##:ZQ=Y(ZE25:FW5=^V8:W4BQ"
M;,9;=8E]!E *"\38RQM34[S"<A[XVM&C:.@2YE+0:"7".TQF'*AU^D?=[*5[
M90Q%&,4O _+@N/:GR\!Z 6*5.9](AM)4ESFKO4G%T0POR9HBMI?.0LF)V7NT
M=9=Q_+U 69)>"#O-OWTNE+H^&D\$O7P7I23,Q"NAFW4$_[QGXD)]K6&2ZX$!
MU+#>=J%1$F&5V^+>2-0XO5EQ=_<MXR*2=R^[M>4YG]/NQ?>FLK.N3,F*JZ-Q
MQD7(&>J[]C^))RD@B RK>0D:DY=%;V+&DU>(G[QQ7#_3<07\8+GR%:Z$#@QM
M%)#YNZ-M'BC#^80=]2#-9RTJ#>J/A77F9.FPM(]F#\FEN@-EKZ@3%X=9J0JQ
M1:=S.#A7%06<]Y:WW_4:'&1MX/M&E<X;AJ\PE=N9P)YHS6WHP+Z 1N9W20<6
M9(POYG9BA4Y(X]APSZP"\>MIT8_$A+DI$/4UULVA)OUE3'O&'@BCK[HE>68W
M2E425/9[]/K6E*9FLQLWN_%^8R$?*04U'QVX5+O"8+QBCVZV6?Z)\C!V&U(!
M[$)0H?SK?\WK62Y89NE:<;*JFXVSV3C?W<:11:X4+!F?&I-HY0= 75'HRIL&
MWN;F+-ELB>]P2R@S('*) NQSOAVX,6Q$?F7*EB7,1Z7K+_#1GL96UY0UHB*$
M;RBSOP$7!FE^5</-%MILH>]N"[GL1!S&^)#$I"=MD3][:Y?3"&TZA+;/".+%
MW&EEOA 4C!396@?3<A6R(L"N2 ]&PRS]KNRWGB?49I-M-MF7C\4GA.N&1A'G
MA(/3*\Q17I;U!24SJR$ZK2A_*:@P/;5<<W9\< E_U/VWU":GM]E1W\2.4K1]
MW83\P')HN6):7$5>SQ-FLQ,V.^%+QC(LH)\[+UTBC<(:!OE3/7O _9W<8DS+
MBSG^[+YH>O^LHDEH#K"[9A/Z;';.=[ES0JYA&H7*2G3K\M=5%CM83B);A90T
MB-(_K (CT#>T#BM82B_#K:F+_W)!4]#1*/2*@$;!(^0VYR5D@O)Z/O*&_5[X
M?-<-UL"OYS<CTIH79JD)EIMO N+>B*1#*BFG=4.]>&^!="&EL1.T>S2N<PFX
MB6<737%!7 $H<O8W2"4NX+@V&F5L4"KWZN:3J,[NV+D'/CMH!I-EM8[$(^J3
M)U[>L&,N(,]B;$G(/M4%H*4.@!9+K 2\1NC\"KB'<P J=4$Q$8,02SCB_0&O
M+*15[3(," QK>"5$#P< /U N0W/9&'(^LB@%6S2#^43Y)I(E&J1P95*3M_U%
M<%=:K-1S6%>C$OU:]#5^56R7E:E(UCZCKV4: M/LF[" "97"BM!I71'739@M
MQAZX-/5EDT_'..D!<"3#W#J$K)+CVE#_4E]PU#^L00Q1;F@_6=@_R/V6C&L=
MKFR5U$;=B <R1)CU-L[?R'VE]&0$0TMB\JOUWF)]H[NIXVK_3^D_( QB_[GI
MO7J WJO]3>_54Y\X=W %?GIY^O:$Z9%Z78)5AK??2T"N?UQ<%#/R0IX!_S\D
MPYY7RANG&CP0$3'#(B>K2L9VDG\DWW8R!2U7H]$HG2-573VCI_&G2T\+#K,]
M"KT@&M7Y!V?P$FD4#R&11&U(CY(QP_Q@+B0(L)XY:=1TK#<-1!*YP<,UL>J*
M8Q^QMZR;H0JF#.SU[2E;+@@N"GTBZA26[G)Y/<2((>+J7-*DYGD,PMZ!R/H6
M[<Q,N+Q)9WH9DMXK*F K_5 -A4D1$RUC]X.&FH[U+<>F9%GEB"^ UXL. ZAY
M.NOY)1*=(,T&E9 "PD'F%\P\#08QW)M+UG'C\QD5IXH2UHU_^!PM_.!8],U0
M"L$7!L+NLHD(C#V[2!\5'!X_='P#1JXLHD8+F>)4=VR9?<Z4K>'*L; .&?,Q
M%>^AC66)!L5546IT-V@@B .-'Z+Q(?]$._D[X/"(ARBYC<?2DP1DRWCRSV_H
MWD2'=P_55I)Z@\1OB5[98=9X/2F@P7,XD)WECBHEMNJCF.VF$J+, 61MR:-?
ME2S8!'#W/$Y)ZE!BM#XY%&6"K>&X^SF.,5S+;GQ71TQYOQJ*UN7;H)^P 542
M2G9U^*$[:Y"&W 5)=OIB3H48/'UA8)8Q)LEFM>D9?_4D4"JQ@WOG,=!)^#[<
M(F96&<#0=#G']&VH>I9%.^8<!@;Q'J'.W#H</8-X0Z<,GEY]F1/23R-U23KF
M$A[G$LL*TYM>H&=L:-)(_:A+*VX=)6;I1EMRUO?B/ :\9[.JXY.(O,U5T7:)
M&LG'$@$;SP].76W! LKD3 "/:"LZQOR::$CNCEOIV94AY+B0EU!7&UJ&\SG/
MC+V%TD-'[X2<+:%F8^(LIOZD6]$KC.^4Q5]W":GHRP1@=Y=HW!\35=AVO3!#
MTTX+I1L.QANPSOGW%YR%3L(%M%T2341K.<A!L,2C!M]9XH[8%>S;2_0_PAON
M_+FEK:B$Z^0N];P?ET..4R[,[RZ9'=]5?Q/!W3=U1J^W$><1!Y16;*.(U]K1
M@B[[>M);[W) 2#H)FQ7[9,P.U/8Y9:MH(ITSEH3.V.8TON=I'.SY<8ZH=%@P
M:K,@ZF&B4$*$1WSR^!WMVQRB!MT"2K065'N3HPEK>NI9D?O\V+3&E3%[B$>*
M2OUNWTW(5\N1^/2'/!&MD:./LT<(<2-,S]DO9R=]:TZIG31QZ/2PT+&7+).$
M!DWPTD7!4EW4WD2*H>'1M)6^Y<<.\I++6\'%<\'!1>::^1D3O5%>VL<<+G!U
M\H*RD!A?!3<HVUWA9XU\.6L-<PJ>C/>=BX&9:T[*T^+N.J9]>#QV-W+,WA,F
MZ8PL$;"Y\;I+7\QGU+J^ /U<< N_X:L>YJRPY=/+UL6/Z6ZV(B_+7"BN&S2\
ME/:U.\;O_O0^TAW6LZ$DL7\RY6HD7X^6Y#51LORV1'8F1&?A+LB8UYO47H64
MQ.\%,UQ>X\@<R!)G]=A@')+WZ95?LT>_'UT<_P:Z$#VO7DH3/(Z(-YI=M 4Q
MS#&M!'8L2TGPYX/!.3[IP =7%U[\T]NV@M>FFP4ZY?06F/&6"'>)<3NAWW=(
MW8+N8V*N]1([RZW(XHTHG_K==BKE'DB/15ZCW:^?.KX4,;/"*<F$YZ<!5T_;
M"H'NLG?-U#P]E4F=C*&9T&D'ES-V T>!U' 2N<9*^"/*P>"U^^":QN A-G1@
M2!U\E04G3ZMHK:/G!2M$[,@&,NF$P@UG2;&QDM5;W"DFH=8$#1J1ZFF%WUR5
MG(=V)]AC)E9AY,.'=K;]3XJI"_B98]J)H#64W$^B\50JK+%3X,BZNTX[Y>@=
MBT0W+6R7"?)D2KI2V>E50D;[L!1!8<##84.I4<)'L+G!%YG265Z+*E8ZVPA<
MT3,8B\[[ZY/%CH>F7I+7>7'W4DEI^,(-AGR.UZ!C==33%/O,K.<A*3BVW")@
MK=/*P\D"[D7/8LL#_M?<AIX&"5F?*W,N7).$#!VZ)V_X"A%?^41F<+:N7K;1
MQ_I\B.26@^3>_N=Z) /7S<%<$^F8N^4=N0A.P#_HH5'^@N1YA,ESKJ<2)15
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M*L3!WLPO335 _B()CN__;(--Z1,MZ.H'I)L;X?UU&2ON"$]8,]7EN>):L7W
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M]8UM:L.@4;C3*^G>CC7""5JW1N4LSFQRB$EDTCG6</2[G-,/JU>U/5'B6 S
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MOO=\77*[I;MBXMZDZ"$-*N2IE633YIF(-(BR%TKQLDD \1*^YTDX&]:_^26
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M\>_DY\7O_)XN;E\_=81H<\ZQ1^"."NER!FT3.Z <E/2VD!/<0GGMV+$!6[(
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M8Y %"%IG-E]]Y>4]VB_E'#E#4VL8H XD-@7@VAZJ1AN-)Z:E6H]!W(H&KNU
MVZV1;3G:M^.ND]\SXTF4&BL-;7W'C GMC.X3GU^)6JKUZW-RBWHOP*Q6GA4E
M$7L6;R)AEE3[I6UKO[Q2^R\1?N(,:7!,@O?3,KR1X;&G_=79HW9Z,WZXJ/[)
MY6E_$M'S7(<2-M'PQ=QZB?"!P,, (I&5A4++0UJN;%O+N8A-[\D*=?R:R(E5
MY '7&)\,_QS=_M9S?Y+[)!&%]OU EC'0KA[@,6QZ$0W&]J@L\6REE$I?^YQK
M\$I7*AE/LLA("##X06#+E53&%BWKYE&/@(6#H -(I.3-KLVFC^6(U?^G]Z=Z
M6NYUNY5->GQD?^I[=,Q'AG(G@:L$,,*.;9KL)8P#"BMSQ;RR)$S(! $DJ&<3
M6(Y;W:DC#:.A'!,TME!O:EGS0>.%L' M?G-.)L.?[?ML6O]D7<A&R$YB1;RM
MM/Q28=@F*,G[AV6^Q"I24;26:_9G H?E_<.*++%R@FM%VZE16YI8Z^C--G&Q
M'!\>(Y48);-L*#^$YM^-QHED:4$ER;#MV!&^G%4OXF<II#F!Q+$E)?7C_2WP
M)]-R"J&"32\PO%A%R7)">P8F4E%=D7G&_"2N4#DH%\*0'^#\6&TVSF:EKZ7.
M;/*SA2X?OYU-OFVW5CFI1#21&T[K8PTC*D<+GKQ*9=*Z.J?PLB*0$\.EEP!]
M_#126"S(K%Q)LTKK]7(D4Y@7><P/F17+F!_IQ#M3J)HK(#X'$%]?6(=]K-LN
M-"(M* 7U!ZZ&\/Z:_R6*DQ\5P]QN9O19+3'/_ - "Q%*5I'X&'AEWO%:=<++
MQ>-%#AT!;G=)@L16Q-48]\QQFX5,I",3V1Y[T%.5Q=8(*RK9M51=EG)20O"*
M]R%B._OX><1;6NOV>W=P_F)W51+-&!3I+^=N^M$Y;9Y-O5([R"^*T6\K-2LB
M+2\"IR5R4XR3!%86U@]#/VOZVVJ0+<0H+3'*%H'AAJG"\ER9Y5Y(B(J+/;OH
ME\@=U)O:F"T'!R>J9>"=M2^0=354+72DVGH/>K_IHZF#M,M:M1VYW-,3>\+-
MQ>1(_YG[JY_$"9G 50P@C#G Z\&TT>:)E+H<\BM7BWFF\,3==@2!(HG_V9WX
M[;QT)T]^?R_G+)!)L_C!ZK<7NGQRM#W#BX"=_K0AAU(VB1K-^H+S[(*LRHX>
M:_+^(?<AP9B&'$0V<\VP38V/-=E5!G:54JGP6N;M'2?&G7A/.4 >:U __BX\
M"*WN;C;*"M-7Q-/65Z+%\O&RN*> (B4HTRNB:SF3D"T!;87(1^;1UT7W/==P
M&2C.7GT;U=L7O\6+R78MO$3QML7PFMQO* (H&P90DNC@B^-QB2.&S>H>H$5T
M[O4(UW:@O,2#:$FK6R/E+697E!7D( (C!F?Q+6$YTJJ8A>H -:?C+K):?2)R
MK:EC._C4PCL?=T3/S*YT7VK<WEJS08;'\\:',143CT!&I1320]EFS("X5WA"
MKV$4IX*D2X!T<PG+XO#V@34.5.'2*<?RO,+*"?I#I JM"2O<"JE[&:E[UJF^
M5.;$_4/H1P)RMT$/[-1DSCLG/CHJYLCAWMZ_D[ 0TN<R;7V,H;.)[IE+<ZP:
M+/T%RUPA2^]_AJDP QT_G@N>/<G1HZ)[T$-PH1(+4??P"B%&[?7,\40U'N%
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MM&S,DDR !%)3%9G%C]T*D)R$@.0832R\2(*E3RV0XUGUYN:AW+C_4MFB!9(
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MRJE<+6;EP(PJWEF0!W7D3;,Z&=$I3G7=4(W>XDDGLQ\_2_=_Z[]5)6\7!ZF
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MD)B!VP03?-*)(CX&7GF'G@P9DPG$2!CC%9XMI]/U?QG$5!85!X%5ZLY1/WE
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M$ V/5.]4?01RBJ4/9EH'9W=5^SVE]M$1_!$"*1>F1;JA.(ZE=Z=DPG#;Q$J
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M!OG!!)\D)J I1K7VVC'E?I$'':DCHCA70X3]"I5J:[@J5V2C7[@*K[(5&G9
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MF[+YDH3/*8GU^MQEWU1E+B1:-H<OB/-8I8T:O:X^F2$^UI[?AE4W?U8X,#Z
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M3C=(5 ^E! =)TR39T<541J\,<*0*,*Z,%!="$D8<EM;!N%+?KE[5<E(1/).
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M.>#TK_"<T^_U#%)FB36# ^^(3K8$#]1-O4=6R/@/7 #5 RD)EL]H@A-@@94
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M=,3QO3\UZH"Q??+F <O/>?&!,-HV8]ADWQYUPFC6E0>&2D*6_M!>>(&*?=^
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M2'R*(^(31BJ8<]SZT.X;+P_[S[O.2_J W9- @ZZ+CW=B;W#U=J[Y1]@<F]S
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MX76RP!H+K&\"J?V QY#$\">%2OF00[/P)[_XNF)-2W4QTT):1YVW#BQ+=:[
MK-6'C[5>R>PV;J]>A$QL3"(TO.2,C L@[89P!:28;&&'< $G\"/P9EEJS%&R
M+M.2%=&2%<ME7JXL"%N6=(?7E)U V4R,8HE #\L27U@4PW!M'E?)C'S7=:5I
M'@^P4ON"%&J39L?#QQVQH3X<' GY\I*L8U*6)5/E?N T?W)TRMY&3J-G4O+%
M4.M':DIM9)O3MU8(\/1_&YO3U%MY8ULJ%7A)C+O%G[P7=,]^9KS52]WI3*P'
M M?+9;XHS#Y0K<W$*JG3[[JN6#,1RH2:0ZA\6**]=^QUJE4;""[5=.OZ3GWX
MN_;G_,62A[I06C&+X4^;8_.>VAGAZU/\NZXKEI/%A3CY4G,TQ6YVJJ:Z&R"F
M,/:HZWFA/CPZ^5VX.!@>5O;E]##S%V%BD86?Z8QI+]9@SI]BD$E615K;O<PS
M.Q:="0B".SOV/&O3OMF&9^$,R7GP-0LE/I^/RW99T!D*1+^XD.A?*8;FP+Z<
M*O:S%C)F5.IO.S?/9W;M\'611AG9&#$J_V3:1/B[WL2_!"=.VNXE2KV,/2EX
MH5CF"X79X-=?6N[GVNU,1%[<V*Z41%ZJS&[ MH#([RX8WB# ?P;) >KJIDXP
M4?57+2KZ_<NKF_>VV[YI96GP%[P%H%J +82"^$66LHX9SR3S,E6.A&(@\5(I
M#B]B?36P=#)GHNL*:%?RA0)?D(H9WQ1$O)Y%5.#HV9WJO,:AH;R=G;P<R(OH
MO"5>@DIYOY--"/E4FW">_QNE8I3 R]1V1>Q[*  7R D\_;6^RX*RF2BX$NEG
M613YBIB)'4OS"LO?I0!>OCZ4]=??IZJT5SU_^MP@SF@D$J'TO\RU5<S6?L;5
ME8QH_7PQ+_&B.+OSU?(OKY:_X1\0^@3;C:C_?+E8Y*7\;/=FXG9_Y!YKOAYX
MZRNMOV1=L69#6.Q*"\OKJ)3%76K=OM[<%%MEP^JGV#CW _:#% ,RKY?[H9-Y
M__S>Q/ZNZTK3]SEDF$F1LUUOIYE_&ES=7U27E>":-(KE3=?CY*^25#*RS<L\
M86%G>7##BQ_-*LENDQ/V$L("$(+H(/X;:;0T^T/)[<!"QX? $*#XG-55O3X\
M=H=V57%.\^8B=4C+"0F3B?.(0O:%S\HINLX!'9<FG\5\'F%QBJG%/L9,^IJ4
M2PEY "$%4+0%7HYMWO416J9X@SWNLU*#O]_?Z;RU:F_#1C;]QB<KKC%]--%'
M7>G;T_&-7:8*$8F)+^<_>G&Z[/A&1KN<86P#-EM*+.:9!#;22] 5U]&,+[ZN
M6,NP,[%?:CSRR9GFGK>NE??ZL)L_.KX3SE[,915N3.@6'V5=>1+GGD7ZRJIA
M:)4 0B5VAZ,H!;&SF-]'(J^1]GB&QG#&)Z,A3"@7__C R5RI>?AB^?%Z4+(%
M$J\7B[PLS<ZWG,!&B4@0'P);,\A'&21;&UPD]PM2GI<JL\,:*;"'IV@9.'YN
M>G_%ZGY]*-K-8?6Z]F>GJ"Z W;24_HH>_\:$4E84(W$,^RQ1-XK*NAO%Z!,I
M=Z,HK+M1K)RL5!U'<YT<[<E'F_)B'YR)V((Z:Q'\:T5:UJ6';$A.F<N#!:0;
M#W\]";;]6AN'.BR4"@M '8::@*W(DNK#W?MGO?SLYJ_:VE3T0SH,-Y,E61O8
MR>B'"1H]9H-^F.#8EI_@6\P/NC<.-\@P$$W[^/IZI]D_N#,2X_(EF6*<1?#!
M[[B):''9+EP(H2LZW;/WFQNC\>@(RUWX-,2Z<*=GRN$C CD#K80V6HWD#E3*
M;CE_8G1;>T8F)_&Q/5D\KX!-GU/(RC,.(RYRT[=2DYD9L)F'<12G@]'[0SAL
MG!W:TGM1NI-2O&P,(QW&,TR"Z").<H(/*,3YOU-(-?FUN9'XIKX_YZTTWJ\G
MOY6>;Q'3G?@5W[_4X)R A6(!UE.\NBMAS0U?2I CL3@!9QJ/.?:D2E'&'<1S
M)WZ9I9@.;?B!_N29YC+-T'SK:S>O=[TK?74-"=44WI)8GVA<1FQJPCPLO["(
MI:@@*G@[EUQ!I#7E3]R7M 1_-I-GK1;*&]LE@1?RL_&.TM %M44S^+!UGF4/
MF"O&)%]P=FK]L]W&7DE)SR=8V _P)[FZ;)M4G(MK<5XP!3+*IUD+;V5C6^+S
MI2(O%V?G1:0AOPM"EY.D!N\42$Y13((;PK"Q?[WC'!>R2<H96_/'DPEG;FO:
MV6@+L_Z'!IY7953F41FQ5$A/Q+\7!5)-&(P(8=;J"=.R03W)?$&:C2R2!D_,
M]#D6#UXQA;5S]WQ[<Z&89\5VUB['_&DDLTK#F[&!K,1BE%Y.0&JR-,?8<RHT
M0?B(0@O?OV>BTKX'+::JML5E-6.])N1)8XB*Q O%^9$M%F.-;.I$5S>*O%*3
MB34KY86+T12SK8.,4/[&7K<1"U.Y?J_TW;/VI?'\*18F?/,13);9C.\1KA(*
MZ_/MHB5^$Y@W:Y6+A2>3^BRG?\RM?."8&^Q)Y*3[W!2?WH>E%[&?#9;01(]A
MK$)Z==DTJ?B6U^*[^ EPE#^SEEP18U25!.W,TA#<1?L?T=[')Z1']+A=!O&]
MNJF=Z[N6*#\N@M^=WKE/2 ">@ZN@O+-IM3;[CK;H@>]KQTT2:A,QOXY<K7CD
M:JIX9JV_$*NRP!<+LP/LF46P%CQJQ"JRGE"K:,VKGNMD@^&\K%B688&J<S6[
MNXYF)5%R<^%*K*-9Z4>S/B"W66LX. T+^0HOR;-S #X_F#7B2JUNT&BE)C.I
M.8AO5D)9[Q].[<W?[>1;)\+ O<FF/W4&J;VA7/T5I-Y*329-6"$O_>E"&6"Z
MT\A5V[M]W-OM_7E^6>J):^YDOAZ=?,;A@[%DU53=@[D2?%<EHK+8EJ2=NA?E
MW:QM=7%CNY0O\97R;#2E-$X>"W:4@+VQX=\AHQ(5[;NKX?'%E:[=5)84#/V0
MF.-2)H*IKTZ4,*&L2^M<W84%/IZILY;Y$OKG,E](T$@[#9E?L%:'!)=#F\-$
MO=TS#W[;^=+K<8H8L2G*=XU4FFHV$ -6JL\,)'P! 5]G[W[@>B3$P5G+-0*V
M%PI\J3([.2X-N5ZL%V0D]CK1H _+SIZE_WZN#2NK$E6<+[-WY/8DYCSXE\3L
MDRJ9=;[O4F]-YH41G"&V6:LVTN>;+RS:WROM2Y,/1K>8DI-V+EKO#\KY[U;C
MZ^;^?D2S?8\P?4(-5U@G '_RE<D'I39K'2>3_G9"GH>?O\#%R3H+.(O =RU5
MIWKDKO[YZ5807AORTTZ*_;D6-3@;VR?^E7L8VFB32]-Y_AYJ+:F)F2L/>6UB
MTC,Q:;G32[NDQRRU@L!7A/G3D-:FYGN8FM)"IN;.LI_A;XR!B5G1+AYO=J^<
MTX/VY^:R)C['T/@B6PG7I$M9676V,*!Q6E9EKO3X;VM5,B-#*@8E*I99&P\X
MRH(V+HM\*0%.1+KVPX>3GHHFG:\/3YP'ZZ3:?MB[*BT33=J;<V_&%(5J?7A_
M>N)>5Q\N\F^?-\7T,&,#'/17S7$1C=0Y-'>U!D*DGBKVLT8HM_?2U]W!%9@>
MFW@\\,<:V I%-Z]M!?F$9BL&(*C7VC@.;!E+9L.[&:FPRFH"]6'I>=>^OKF[
M[HC"ZB&4_V^#/>COBEBK#_??WEYN[][<_7=Q8QMAH7(%CFASX5\NV!0NV \?
MR[BQ/1/6^+]"OOC/<OATZ5]/MNG7'<W6<F_P/YQIX<>\#77\#>44EXM"PFY]
M_XW=V*Z.K%KBX[<G!SK'T1U74_%60S,&G-4"/63W++!L&CB.IDKQC\DF-PW%
M<?26#D_#MIYHKYK!B9QN$C3D?46W*6X]]UL'PV@W.X,M^MM7_"T/XSHN[ M\
MC\<Q<WW3UF#B0Q@.VZ+ >EV,;L,__Q.5)1EA!SUWN>;-;@<G5W5KBFT/0'.0
M3^/GR _H&S<#!&+][JPOWEKRX9X\U>@G&SS6PJ?7'DL$92&(>#SD\[%8*X1_
M^=S8+NTGW*4:$&('Z3"R2X='MT<G^GDM?]!<?)?\P;/>)0EV2>)+93B6YN,*
M$NDN$>X=VZE*PIVZ\5GTA'!H73\[Q':9H4U[M/9:YN/)U5NYM?BFC7XGG;V;
MW9A$+""0:($72G'8%V0'<Z,:%'2)K3D]#9X"!3#86@E%.LW9VZ\/U:NR>G'P
M4CSZ4X[Q'98XSVP\/@)3-\-K$XLC7EMUQ&N;- AX\UUC(!3.E(OSPI?PO(#@
MA\/!GX>GPE#;:3//J^A[7MYBY_2W/LTC^.0-#FU7R%T /P&M?LLR#.L-U-CW
M:\/A"5C0MF(4$?(:O:E889,*B[7*\ 4RZ4?A6+1STU/5_3MK7Y[:S")$QHP;
M552^4I^*:KA/Q<N9U#O;?<[?%KY_GXIBJ$_%]:6T>_[R>*<=B*O3IZ(<9Y\N
ME;=3\*%L'7P<>JTZ>%<JRO'[K5K()%F1\71Q<E>!2-0,Y@>*C$UPE*J?VDA
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ME@F^1%G@A;7J_C2QSDQUETBB>4DN)L+(2QG/6(X]:IQ9)JFI=K6J5Q!+U9I
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M$*_2GY=2_L^3<_:,^3ZNEI/]V E=/T<W@ MVP.?SQNPL_(Q7WO#YJO%YD_@
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M?9[$U0LO>:@]+6Z?ZY?=Q]O!6RO%9,E2>WSAB.%EU3ZZ#=S:H/_>H5.>U3A
M9S:9*#BY*2@Y625\"Q+#1'^$,)ZV[ >OC851;\(NP76S% +Q"LK(J8C*-B.Z
M:H%J*SQO49(&XF.M57@SE-" B)M8J*C$DL8 KVV#)J;IPRP7C5EN?KBQM$1
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M,QQ_<%R$6;#%Y-##OP?R3FF+,!C6L7RERVN2K,S/7G:E8[<W:D&.VC7C\T_
M-)\9^S@J627-9S =/L_3I3P?83Y\C*C(&6Y*A'EG+P/]5_=7[_S^>0>EC)O4
MWWE1R-S%>&$@E>S3XK75N-+87R_&#S9]!#GWJA.:,N8,D.Q-U[3 E4O<$AI?
MU3/.TO<!3XO.K].WZ['ZWOKE-\<OHQA\Y:=%L5F4?U5_CN12T<+@8VT,/M@M
MU71* C<!W$NGQ-<IKG074RX76VY<ONB!]@RL95PW<6VJ30+G6\% 'DN"Z@3V
MAS_B5AO"S%_Z'%'4\4C+<KH<\+S_D+I7I<.1"4($%!ON?/A_H7=</?(02/#J
M*N5=+(^<VJG4%Z8C!:GBFC"1<33 N^;_+>/U9[#LNJGFJK,A>AC%TKAR'/UW
M%X,T>D#M5:HZ)NW2@$?8)@B.(G6EH;_ ;^PY254OI+US1E5E,A*HQEV>NCIJ
M.;#VIU7.!K0WD:L%[!#X MC7EN1H0S60C,9(Y4)?LOS,ACDEN,S2+F0+[^>]
MT!7P-T=(V5A,94DI3N?LM*H^K[._@E;C:V\QAX7R(5J<B4CA^_8XC#'H[L@7
M2X4\4PG,$%+?X,S-VX#[M*X#I@Q/D+LKJ38,O3:;HHM7"8"E+JN ;*]8]X4^
M^RIK,T.94^*,H'MJ;_#)WIQ0U%3+H=L^HAJF&TV9".2$B/I]I&QQ(X. VX3@
M_J>22GWS&6(0<*?6@Z&;YA1#';8PMN&3.#$IHN*9&_TAVCB9M5Z?7RY/)S?L
M9K01M,J@:=05SS3J.&@F>G\0H!K2@5FCO[\#>&0?0TQ*@ */WGA$M1S"4)V8
M">#N3X0YUK6(S\<:P<V3T;$(BH*]DYP?Q[.!MTU.3>Z;SHW%\_'=\//O:_E7
M0>.DR]YF-[RTLJ"++<=^L:'"H')PS%7R3"EX!#G@_BM(X9">$&!/&RK&5 X<
M0>;M"0J&['7+@]4.)+A^[]C0X+GWE<!KK@FZ/D<O\ IWL_W!:+;%T]O.K:9L
M>$7>IR;L%/.X/JN0YUD_;"UR]G!8&Q"__ZF8<V'[IYU+YIVY9WM*[*<2W_@D
MGCXX+E?X?*D06+B:SV5DT/WF$#[>M>Y]C.SY&">?P<=H20HP+7C5G]&[R#K'
M-M3<M3 /=GL :%UR3='!^@NT7=AHK9HYNPE="MR;,]B7R&H0U+2-?L-L;:<P
MEIUR7U#/6P.5/[\+38&&+\O72*%M##TFS$AA8C-2>(8@EH2,?<J9 \\<<W(V
M01L5)40](C%/8'M4#[ ['/,3F2?8MYQ,%"3[T-=R9Q(2E^C&VW@6 1X> )\0
M+=_#>A!YWQOZQ/*=,UM[(L'XBUO<_\G)?;D@E[O#DY<$/9% /,6/T$)T3X1'
M7E;AB YL=/O;\B:M^Y,-8P9&ZA%5Q:ZEZ*&%M:9J+M!4=<=RS4>[X'UJ9 "E
MUT[]T/4^+^J/Y1_=Z^%M:=WU!BXGS,!-G*<YB$+XU2A3YMWYVKX;'?/VWIY]
MS..B=/,LS1[.)_&><JA[%^,I\\B:+I6WL*0SJ)9WG1G8YP<R;KO7/H/M?B>I
MHJ8[$?'/:, C QG)-%4B<A"']+$9U?\]DPT9_Q+I6FPY0XQ_.9/@GD<C((4\
MQ@D$%T0(>:1 QG BD87VH\Y@$B295#.0]3&VZ7+6M^W0$\0*S<-<TAST!DD"
M>NLD@8T/?Z4AZ[H\/+F;CV)-$M!A28+X8-_Y(C*YRZ4\'V9R(^-7ES F9$#L
MUC=;PVT4NZ7MV"U3**%]+X9R>_C:^\FS"A-__)6VXZ_(M2FA<X[C*$L0YPL]
M23!UK',<S!3 HJ4N9PIV09FCG4%/+==,2.]X&-1QZ"A-=C]*<_D3,8_2K/QQ
MHS0QXUC4]XEM+^;KVEZGD6VOTNYLKYJF3S2<1J[C4>N?T?8ZD=#3\8Q+I"2:
M_:EFSFR@R5!(P2S(  V"C"9!)TK$C&.:4S71QTC0TE=!G[A;@ 1#&FF*V!A/
M=.V51 8MR_4,+<YHD_'EHNEPESX<P"I:%M3OEQ_/Q=:X>]NAUS1Q1%UC4 2K
M%"&"58S/M(+L.1,>S437HEC;@F'GUKX,8ADOTW&>NKJJD2BG F43JU'.Y3NN
M;U\N@>3C1Y/I]AV_%U^:56EJ#%M"@D%*YI N1,BJ;W;%&P0I*P?'Y2,F,,/^
M=PYJ))#-/,<<K".%+J.]V1:U#>?Y<6LZULN[%%X;Y[_O?RCO&]:Z1*N$2.#.
MPMBR".GX/%\)O*;<=(3D\7#DE#]DK_3A0_=Y_7!R0QL_BS>W8E)E$XE?(F!?
ME/*<SRU2;F=KY;A/MZJI^-!Q/Y^]=@N_A-N*''^52EH\@USP8C'/EP.[%?>E
M&G^$R\'LPJ:O1W8YBD'+\YY!)?J*EX>N5-;U4(<[)E4#8@+R;/R9B\8;:JXC
M3::V;@PHGB ^"-:0WJKPE4. 43,#]!X<,)[,]/X($*61%00/>0<OQC"DL/(+
MUO%DSJRW>EP#]._FH&4^N3DX@Z=6X:%+E<'HIRW%?=D.",NUSNVM]'PN2Z'N
MS(8+75,?C'\*4@3E^!0!L@ 9+L^6 S/Q1[GK*.9LL-GC7]C[\=)M^X*4YD.S
MU)'XA\(PD<+>*!7;,=X(AU1S,(I 3M ENU3&,FQ=T83$[-I@?R5NN]:^V.;+
MZ>SB<7C;>.32M6MCO$T>.R?L:B8_*V:M?=JC;N'6^'5S_M#>T"O\J%D;XVE#
MNS*=YWQFH&3,K-W=5))/;A9_X2J(L\]0!=$AXT.H9.U<]'_%P/W$,W&'A.Y<
M?6];#]^)KRD=VY&=_D@29PHR%D%,NM', L?*5,JER*E79ZQ,V3&R([[S:<'.
M6I63_NGUR[P<.DJFZ=M::!]QLH-D>#Q()E3$! UC79V?$(BOY#O9A=ED$(W?
MJ)F04>'^XV.*KO$QS("M=F8M[LQX]L'4( ?B 72WIZ0ZUV7W^[FH %;85 F&
M36]<-V[.WHM:91ODYO48-BX)O#5XC#/ )=)#R!27@-&G'U^&SS.BZJ"/OIKU
MJ9[8%&PQ&FTDW'-71 *NQ--YOK0>AF;[\_-ED[/(;'*EJ4,83TD&)K4O].K-
M\(&_XC\'+-H>M306U%*W#0(C3P_E]\.1+(H2^@PB*$9^[^D*3=,56$69H1DK
M8.V-82>$&;I,W&QDXN[:2*$C^>I5-$[?W\^WH>S=HICM @1T#W"VH4KII@#9
M62Q'5R@QXIJY'*1PE+'3I\545)NOXIV(%I%ME+'@[%L8R!CSM"CT3CB5YZ0B
MS%;(6E;$%X5L9VG01%S-MJ0 [D]+T#&H(-"E$0Z&1A>8XA(8FDN%1'S>T^+L
MI-]O-&ZJKTPEDQ>_#(O&/BVT=_'Z_.:YJ#7+%BP:Y\"BS23(>9G[I_ !9 \:
M+9.91U>Q8R$/U8\1&E3:VE33J;:L30-Z4G ("S[9UR51=@^QM7J!#4E1)#U/
MG;0;75R%E\\%IR-=D9(K].#FH(8?ZX2PJ^3%#;5F+_X>K;WJ+-OLB:"W27N!
M1G2SEMWD./R]Z/%WXL2H!"9(2*7EEHL.:K6@_3-B >N,0UL#VDTI;#*FV=>-
M;!<IM'[2U=@?K3"1MNHGX[Z\JVJG^UR:S.ZZX66R$9>9ZEU%KZ$L%0Z.BT?%
M0*2<ORFKAI(D+G5I+,@JQAESMX8%5SKCG3012^ON[=04) OD@2R)'^G@#KR[
M@O9N_-9^3.598/DKN;MHBXN4H4R.NTHT;G2B*X%99VJBS P3U,W5>1\L,;D@
M-G.9_F;CM471[OH =$O;U*,'WM?Y1>5A^G R.!\'(O_Y\-K:M?KR'+XWW[KT
M!&\09@)5 K.>&.X"^M266@^8K&1 U_@)PK,N_^CWQJ-!JGY"PM###;6OC:6N
M\+[.Y(:!D!Z3VXV9&/849+5JUW>WB]+XK,1\"D,;N;V+[LF4+4^>2_6>96CS
MMJ%-=DNA[4K9P!Y>0MC.J)W=G.DYS0*3IXQ9SY!%&5G=>>2RB%0-V4DM79N\
M";J4AR,^R@,@CXS.VFQ7(3BQ/<$@#4JMF:2#NR/W-<K&[X&N[_%84]\D04%F
MNVEGWR*1A;[4 8!9XXBZEW !DZI-817/R.H$OVDJO!/CO#=?_1(D7MTO'*%_
MRU"%]J;"%W%ETVPZT@#D\(CJR& SP']-X(EYZDU"WWC%OP)E*U*J-*40GQB2
M =)0$M#JYY"!0PLVCTA3T4K1D5%]HIXI:.-!)C%:()+4>(6ZA X&'^8$FU\&
M96*KD@-"'S$DJV!24"B,KTM2GTAR&+(!G\/UD&@'N9ZD2@/DI0A# 9JP+8@B
M$]X(^S.XN?A54&;DG 3(0X-U!*BNQDS!*T'O5;6 -<N$;Z; -P#92D%(BQP0
M6"<2:(@<^K8H#21\2MZO@W-%+M3PV?O.M4C&O=SJ-+>V\,XD5!&,K-EX1N((
MZ#;DODPJ+A$MZ-H[L@6FDC)?-;C<,TG:D%Q7);$NZ&!)&U7GD:?DB6 -B^]7
M;NQ-:3B:W0Y>IHPZ.*"F\A1V].^_#Z</__Y[6*9IME!BF>CI#:3[CLMTGB[@
M=CG*)I"0DC=VZQV8.)F7;[UW[<?)#YZMK.R +Q5*9;K ;K #9!3S7+Y8,!O^
MW!O 7.>4D5&G%M< -^/:9@!8('<(X@T)C &N.J$L5K>9":21(YF)7")21GB'
MTNF)!K^PJC+7$($72YFL":E*7&]L.,-$T$MPS1YZ#1+YHK&$PMJHWHHPI*86
M[)@ZA8"17Y)P/+^$KI;FT55QOOV9%@5& 6;=^-Q,^GO7^#N]TBQH5X&%XG&=
M6WRPK3#;@BX@1J7#^EJ]>%-Y"GG^?5-&S0P+3AS, X^FMLT'3,P6"CA=/N+_
M-K$Q3/\7'HG$WT!#GA( SR B!], /=UD&S 0 .3/5&.@MTUEB-[]-I) AR&C
M ,R0,42 %/D%&&0Z$E1L:Z ?IB;#V1K.Y-,W&6G6'F@U)/47DGA$G6 SQ\2?
M _ :\G7+D$#/RPT1&UMVD8M]T;J!N8T@&V2]/K=M  V9'Z)+K%C+=1>GY0)T
MR<[U<32OCC,T]:=>>OM1&NS,J_,YFTQ,9O%<8!AJ"[=';4D6M84I_'&H+8E$
M.SI3K?\"L B2;A#P _#MUX4^2LNA#S>.9.1'/BU^L[_>7RJ+*_EB!^.LM@V&
MG#TM:/&T,[B4YB=#V@J&%.U@2 W[VQ0^ADP$0S+NAT$4A,0HT$?1F>%0@H!8
M2\>JF*0:"D>% HT'8!@C09<@9$%!R,*,,2R(20]PM!+%$^< NSCXT]A3<[_B
MB*I#@ '_T?E;CKP>62O0-SE5R#,U5:)>T16;ME'5JJ^&[_D_G2Q#M,(F5AJ4
MV!\>FX#!$9J@"O9=8I/%+6;L2G;"'9@Y7('\-CJ ,V):!];3([%3V:*>W@W-
MLO4RGA:_WNJS[J_;,^5-#BVQ[T2ECF2+[4'7'Y )J1O6VF]<;HE_\6;VI?20
MW ^NY\,=X2;AX0<?')\BLM%E;)'CE:#3ZN!SBSK >N7U :6K&ZPI9#RW;[7_
M2?W)I?W,F")1?<#\2(*H4P,GQ>R/N>C/RH:U^^6KAY-Q;?JSO&S4?> R_(VN
M#0Z#W 8^@ :FW#4SK%G&["7F/7EY%Q/B![JX[DGN/"VJ"OOSV7B0S^1>TN6K
M>),FGY0*:_JNK /P]NQBKO:*\O7TZGXOO?Z]&PV)7\%:(,TM=M']YB^+^!YL
M13LO*J]]4W@(9H4X@D:[X12N^:VG%6[:I&#"#L*0=WOC,/S!,<_F2UPY7V(#
MH8PV.:^/WXL/RU7\6<[N(X.-X301B"-)-4BAD:X+ZA#+JI.Y\Q$SB5X%)=C$
M<MFXDR S@NP!=++- 3DF^FGQ4VFQA1GWV[A)9L1\P-FM((4L-YDRA77H(0?'
ML"7@9,3&4#F [!RT0[P6HJ21X2>-)XHVET#MXG"PK="A_FV$?#/X%5-B\^42
M!Y^?"'.2R<&QGPHV/]&O =)WCNQ9,ETF KTD+Q>2%0;;"0#29)D$H08!2/#>
M$JSD94D1("38/%L('""PJ2")1WH$*.PDI0?SM.BPAG#YJZVIDTHJ"G]5D'BE
M!KVMU' DQHF&=FU9L:>R+O6GFA[!D-TS?>STE1FFA^FP=#'/%P)K+7?#],7T
MF9Y]6@PO6AI_OSAY>Y73-!EBYW0H%YDIR$2=[ME[!^S-9H:]RP?'E7PQ&*<K
M4\SM#=$3;]Y=K4XV2'Y_IND=27^5^Y+QM)@WWB^?C9KT?B?M6%=[6FTW9VO3
MER<A.+P**.HPS(U&O+.-PDM1^7N#2$_\_/^1EW] /GB24)'),3.\7SDX9BOY
M,AM8X+UIOWB"$N%D\Z!<_6DA]N?S^7.]-JKTDU+7\43?V+T6CBFTEAK[E NX
MDH\OEO.%8FRAM7BXY=1W?FC2\;2%5C?4'Y?=IC',A$<<@6/6F,E." VO)2R,
MEJ?+%4\4;<_168F5K0ZE35XXT,AMKC#Y$A=9N:8C&=CT)0/SM/@Q%TX;ZLLO
MNK=-K"PFM_GCXF ?'\L*H_O'QW;!Z- BR3-YAEZ=7+Q31N?29W3V:5$[O>_)
MTYMR8;Z-P9U%$V ?*<M@I&P7C Z=(/E2D<X6FS-KV-P_,D$PM6N:BG@3NO&@
MGDS%?-I3I [ZMHXGEC\MQC3'O+^KU6XI,0<Z%B9VM@)\/-&M%@?#4\2ZYUM_
MOOT0D62&03GH#2SG639CFGB-,PX'#STZGIK.+AG!4.U>GPE]6<$'?2--R;:?
M%I/B>7FF7U=.7Y3LQK,C,)6U=U<-LZN$Q1Q#@0X!^J7,4]AEC/O3<OCF-)89
MKB8%;$STXK4=!JG7A=W"T@2M64^1^\T!4EP0O5Y<S OCT]=:Z^X'MPO-FP)?
M3_".T4?(EC_"V"%HINMO?BV0:B [;JQ2_:XZ,YP&4T[*>:X0-(HV%C9;@2[U
M<E#-GX.B)7Y)-P3Q)>KODMZ7D9^!?-+S\O"ATWYN;<-(V=&5UHYP!!IV2@)1
M9+L),<_'D[H?AL3>C/DB961]Z20S;%B"T4Z[XT!^'0?Z)EJKORM\^U>K=ED;
M):>M J"LX\B_<ELR4*0E;%D\$8B-G5+]1/3WIY;<38\+ <<;2?UR)<_RD4,^
MZQ&]XS4^HV%^EYX6K3K;:E[>W,VNQ?0Q$6)LWUT'9)W4T]W7$]9J#:ZJZ4S-
MU_=,0Z-D59<%)4]=2,JK!-(2K4M0C</(B[.[W?X/@_^3=+=T= AFJCH;HN\0
M&*K<F[0\]]40%&@UL6>^?H/^<Z;P'[0<XYF1[L/$?Z/_^TZPF[LC67TA_8F
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MF]-^AC(V7'3)Q!06 ';1,BWMIT@ZVJ=E:^6F%A*S9QX*O 1+2FQAFO:8^PG
M.P(UD/4Q41]3O"3[$U-)78[^>^PHBU@L"RJWK%WIH@] DFN)&,JJ])\1P=XU
M093<KW<#8+F,N&E.6%FU;0BC!_(%-[Y3U[T:(#E!,32DKP4,YKQR8 +%\8<B
MF.\X+HDKB6<ZTD2&9&H4P4%7%I0<8P7J70?@7C<I77H%38W^ZQ"0(/$E&)'D
MUZ<*"B3!@NCV;)%% 3@2@>ZTV9*F+7QE#U#VU.W/8%#2===DW@-A,@?_TVO7
M8?.ODF?(HXZH:'NX<=M[)I-:+#S0M3'^A;7)5;O/0Z+P"_"/H2(DGUNF7I/=
MB"D'-J)M%,(__/@2:N[&>*?-94,R;\[%]AH#]D%FA'XC8)&>/2U$Y>7'I/%:
M[]S+6<(BW;U5L&H&A*&1\GLTTN5/Q(Q&2N_12.. "6Q9A8>DP,8/!) I+4\Z
M= /\!3S@:?'0&1;;5_+YFZN3,5,,C3_H@(QR3XO)78F[;AC5BFJ/-BS9(*/V
M1O<XHYO@C"Y5MD:#&H7EH76?+!^Z'3>W/^ Q>0';L^]4?!*'PX,T"I$J"H\V
M@1<7CLHLRP6%O"!:)7E 2[UOI7 K'=@+ %8*!LN0X*_;H7#/XP#=7,T)QJ$\
M.#07*>%1,K)Q1%7*S)+-M?0N;&$X7\,[,VM' U$O5>IRII*8PA&UFE7.N2'4
MR3@.:[S"\EP .I#A?9+K_O/E;)1&//2M.<#?)F/+G,_@/9]XW^",FNNU).UD
M9G3D=:G9-4N,E*@-64ML*5L8YI@OEE:GS=E3&HB5+3AW[]#U\AW5(I;MN3+0
MN.@-/?!VHJGNJFGOIGW+*R)=K+T>?)95[V/MF70_W@9O(^%WB>7[VU>H;;RK
MB-4SYLBZL!W$10Z5 M31E'V&#UKDD//G]*S$:]>Y%N]E^6;X?%\0_*#'/QO.
M,B;)>P%:A:;K9D4S4)SAL:!<8R%#GO&T.&]71^?OW,/+C/\41A3SM/C5^WU6
M6##SN[%H&5%EVXBR-KNWGJ)%=.P,%$&PYDEB[\T\10S C@2< 4V]OB.CWS2/
MXE#1=5C3V-2A06)^]M/(:!:5DJRZ32>3Y\F1^XZ?M6Z6"&BK2+$%3S"!4*Q)
MI@R9$E23G@<C[;'>G(2/C@UY<! NC3EVE-EH.)!7/M]V3EM^,AJZY(_XP/E
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M*0#YDO9#_0R9H1?\M>CS\IQ6T#4/\20^'#OS;'F V\GZ*>TGRU/:[32(2\C
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M15'&@MJXIC0D#APB7RZY?.0F36;X\-R(5]$EY%?ZG,]6D$5)^IC%@V-[P$*
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MRPM\GR%6,$Z$5ZY;5^3?:9FZ45FAN&>%O5&Q?\D?<%O)A71#YK?%;16>:?I
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MI3N2<H(EYRG9$O34*[ "A&4U5S&:1J0ZI4L3I(&A3Y2:CB0*;5 R< P7_F6
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MAI9^H;VA]>K$.])FT[XVQN=FS/HC<[WF-L%AD578ESI58$K@!+FZ<I\8/B!
MC%GO&9:*O"> +Y:1FR.HT]P,Z7H<=)PBN8+/"F\5G1:><*N+N'-W3BEHW4,2
MVT9+E_17J Z$Y1/J\T;]8C31-Z=)GQ:J!,*,T2B_J4H6>>7<UX7=2Y4R(\,#
M&7( PA#=@H$6)IFU4VZ/&#& 0-T>=8Z@<P/'A=&?D+\+?ZBAM2$C2I6%([+K
M+OHB9",4N%9T2^BZ$*7UT3_'1@Y"MF!ZP6#Q ;8)(*R;M]\X4Q7A;3!3X$]
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MM4KW[R_]V_YX5 W4$AZ-L;W!:A"/.E^Z=T^#[JAVVC3B--;V61R9J..R4_R
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M*79]WUJDM618H3K:N04V2>X#O $7&Q9ET)0DQBF'5W ;5GYU-)WI&LDE(/.
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MJYL;R;B\P"JW!+$V*'<C[*XJ_M4H'<^DUWF*_G,:((+TD[#?EV4VCL;E+'C
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MK. 26K@'2VK3Z]^@SD'8?3E\Z3_*TZBD% ]6'=]_!&QG)03I@Q>B8AQLCUH
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MVB' OQ*@'A7W^^3J%8),71/U%9NG':?4^P8;AUX_[JC?_>1XG )Y@9W:;E"
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M$'FYH.C8[MAP)U*X(7N\D1(Z8,#%\.ASP(]SW+*+\ /QCO\J+C#<XDQ.9&(
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M!ZZ/Y-*3+U/IIZKDB]9O4$L#!!0    ( !:*"%E[DTO#5@<   @D   :
M<F-A=# X,#AF;W)M,3!K97AH,S%?,2YH=&WM6FM3XS84_;XS^Q\TF=D.S(1'
M>'1:2#-C$E/<4F""Z>Q^5&PY4;&MK&0GI+^^YTK.@TU8 @L[[7;Y +$E75WI
MGGOND4CS+/SCO/7V3?/,]SKXR^BG&0;AN=]J[KB_:-VIFILGEYT/[#K\<.[_
M4DM47ARQQNZP8*',A&$78LRZ*N-YW;VHLVNA95+#0 R]>NJX8Y9QW9?Y$=L]
M9H6X*[9X*OMXU+(_*&JMYDG+?W\6G 0AVV]L-YH[)W#YZJ4G^ZLTA4PFM=8/
M><\,CU]AADCDA=!V/6V_&P:G0=L+@\L+=GG*VF>!?\K\]W[[)@S^]/$*K7[W
ME=:ZX,G53??ZQKL(67C)KOVV]6=_=X]\"L]\=NUU3[P+_WKK\OVY_X%Y[?#M
M&^^BP[HWYSYK['M;C8,-;_/UW;SLLL9AQ\W&;BXZ?M>YA_WJ!F'@7V/OVF?>
MQ:\^^0COW[YI_+Q_\)_%RFR&H,Y^$TFBQ82% Y4-C8*)2&AJ9<6 %T=?<7VA
M=X*PM_WS\^LKKQU<_/I+;;=FGZ^\3F?Z?-^+O<>]&,NX&)##N^]JEIN:87=J
M941+C7@Z=:U0PUK%7\VP,^U563CX:7CWP$J:IY< ^8)K6T;^+=PNU5J-;=;<
MH1Y$AIUE^\\P&; !'PFFQ4B*L8@1*VF8E^<E3UE7#)4NF,K9J=(9!FS]SE2"
MUS%K\X*=J326>1\;%.31=IUQ;-V(QYQ%2F,@+R2!(%$:1@6;"*Z9R&,,]H9:
MIDC?.MO;W3LX7EP2?G6?MK>SX"]NR.++IYO\@NW<>_D(G7"#/4,0L@F[S=4X
M%7%?U%V@M(M0K(#;7!78^;S@,F<\G[ R+W0IF"EX(3)0%(6.(Y7 51+!37B$
M5YJI3!98O^NWU"$7D3"&ZPEUR?BML+&<V31X%\,93)E2%:0YJ$,D=51FZ)9C
M.#R)A6;C@8P&S)3T:SY^++2HC- ",FE2P0E62+=B@ 6:H8BL@V1W"-=4C&4B
M@-B4WF1Q&[XI(.U_12 )EL@<H:*HST.#A,[1'<UZH5WF2.C,YC8^1VE)"8WP
M+\0!.<^E3B=LB.@1\ B0:3I'5A54\\G4 &\L'6F@1YFB ^"D$',[G;'^1-P,
M6)*JL9EB38N^-(7FF(C32^<WO*PO0,9,G5GR]IM"S<'+HR:\M\4_:/.Q5,>F
MPD55X2E=59)(/&Z83;O_ >-:V$@C<K*7"EL(!.#52Z49T CJEH&MB+'H.98F
M2I4I,8YX3*O4A7RH521BO#9L Q&.!2#CPNC?10.>]P7S0!'=,D6/QC[?:AQN
M".=%XS!V3^Y1DE#+'=3(/B,>64"@0P3YLO9$R;V)$DPT+7B+N$0/*K-'J[&V
M8P5+ZUO31LOP6X'[V5 21;65V;3NZ&=)J@V^^>(ITQ$&W8$<6^P>AW6=ZG#$
M2[/^$"J(/0&(5C.Y$JM*#0-@O)$TED?12^36#FGP.0,OLK@6*;>8KVKL'+?U
MBN&I48*-X8M1J8QY81WM&1E+KB4M0#HE8.M*3I9*0]79LH2QI=RRKC("#A5@
M>1HTY!30,N54++ LZ\2\RF.$TPR+4@>?>H(Z@L\Q7L2OS=^/DOI:0'T&LI\#
MYMYK@WEM!EW"]/K<NS:TD0XC&1-B.<Z;G(H,-T [J4Z",=?Q%%( N>0]F<IB
M0KIAU;248!9]%E@N-^YU75"MMI;=50L:ECCN&.0DZ9P(AY_8.F#U:U_DD"\I
M\(T6,:3$H2[0Y@[#2# Y1#GYCN(%%$<OCV)_Q-/2\A:%6"0)]*<<(3AFA8Z<
MB9PU>-@]KI:6%K08" XU3L#V5%D\[,$ZE8+/>@M2Y\GCQR+6F^I^FX?"[03\
M.2;CWW$WQUW\"NSI0KH,#3JA5YK2MJS$WQ,XD\J[BJ)2$P 6:ND*JYDR!=[3
MM25L&>P<^UBB%,/TQ@-#$B 9;/9)[\IQ',F$O5R@>P=[<>3\VG1>#;B9"0_B
M08M\$=L"8?>C(N\)2^6M2*N;AD_ZU[]XBSZ#]F]4?W_=N\G#?]'1TUYIQM/4
MJ\\9D AY$?YS,B0 /T'<+&GEF7<<>KE0VLSTA'T!DUDFBT*(SY2;GH)BH?98
MPC]K9 -) G8W5#WPEU3[-+/%QU+"?9O%91[9*Y+-[R?,_\4)TTLA1S%  OAT
MP4!7%9$4@&DE268GO;'@MZ0QG#RU*L,*:WOU.[U:>Q+XJT.9N]Y9P=T\QD C
M9M3]8*)4<AQ#@':HYKH3.@8Q-V4&U&'!=C%5R5QY"?E=Q+S^$="#5DDT>*R.
MV O+OD"/O:ZO8%9WI5[F(Y6.!-7[G/>K_SKHBK!%-DS51*!U/%".HOD]$ -T
M+R*&MO_G'%CU.MQ_]Z@Z1?B.F%?VL0SVD_MWW&?!,W7@4<LGDZ-U#!W\^.X8
M94_CA+_54T6ALB/62WETRQK;A]@/>]WTV%S-H+5C=I;^_]S<"5H/$<.SDO_S
M7BQ/_X)35Y^^!+BU5GL@1<+\.Q&5=/)DETXV.="^@/V-*W>=@5Q<FF239GDH
M(>D;/?1-'O?5'OH&T#]02P,$%     @ %HH(68QYUW_1!@  L2(  !H   !R
M8V%T,#@P.&9O<FTQ,&ME>&@S,5\R+FAT;>U:74\C-Q1]K]3_8$7:"J1 ^*Q6
MD(T4()2H*2#(0_?1F?$D+IYQUO8DI+^^Y]J39%@""2R@BH4'8,;7]K7ON><>
M.ZF?=?_J-'[]I7[6:I[@+Z.?>K?=[;0:]5KXB]9:T5P_NCCYRJZ[7SNM+Y5$
M9^Z ;6\-'>O*5%AV+L;L2J<\JX87578MC$PJZ(BNET_M=\A2;OHR.V!;A\R)
M6[?!E>SCT<C^P%4:]:-&Z^^S]E&[RW:W-W?JM2.X?/G2DT4B<\)4&K]E/3L\
M?,4)L)SCUE6W?=H^;G;;%^?7K[2@?W+K9#)YQ17-9FA764?P >OD65^8*I9J
MJ(&Y 7<';[BT;O.HTV+'K4[G^K)YW#[_XTMEJ^*?+YLG)]/GNU[L+/=B+&,W
M((>W/E5\[M2[5]-11K34B*NI:TX/*T5^U;LG4ZMBA+W/P]L'5E(_O3COEEW;
ML/)?$7:ITMC>9/4:65"RGMP?_QE#MMF CP0S8B3%6,2(E;2LF64Y5^Q*#+5Q
M3&?L5)L4'3;^9#K!ZY@=<\?.M(IEUL<&M;-HL\HXMF[$8\XB;="1.ZFQAXDV
M&%2PB>"&B2Q&Y^;02,5VMZIL9VMG[["\)/RZ>MK>SH)?WI#RRZ</^0/;N?/R
M$3KB%GN&(*03=I/IL1)Q7U1#H$R(4*R!VTP[['SFN,P8SR8LSYS)!;...Y&"
M="AT'*D$]I$(;L(CO#),I])A_<'NGD$F(F$M-Q,R2?F-\+&<C6GQ+H8SF%(1
M2],<9!!)$^4IS#)TAR>Q,&P\D-& V9Q^S?N/A1'%(+2 5%HE.,$*Z>8&6* =
MBL@[2.,.X9J.L4P$$)O2FY2WX5T!:?<-@218(C.$BJ(^#PT2.H,YFDVI769(
MZ-3G-OZ/5$X)C?"7XH"<Y]*H"1LB>@0\ J12<V050;7?30WPQC*0!BQR!0/
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M9M)73^@K)^$[*/15E?\ 4$L#!!0    ( !:*"%E3B+6_R0,  &D.   :
M<F-A=# X,#AF;W)M,3!K97AH,S)?,2YH=&W55VUOVD@0_AZ)_S!":@22>0]W
M*;B6##C%=QP@[$C-Q\5>P][9:W>]).%^_<W:YN6:-+3HJ*X(@=:S\\PSK^O5
MQ^X?$Z-TI8\M<X3_H#ZZ:[L3R] ;^3]*&X58'\Q&#^"X#Q/K0SF(N>Q!JYE(
M<%E$4YC2)UC$$>%:_D #APH6E%$15>??J]>'B(@5XSUH]D'29UDC(5OA4K#5
M6I8-?6!8G\;VP':ATZZW],8 *<__:V-_;E+)@FW9N.;+-.E?P()'N:0B\V=H
M+5S[SAZ:KCV;POQ^X=R;4Q?<V86<.S+=NH7[NE,?UL&QAIGY5J?;U"YOV'3
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M6)HJJ_A5.WTB*6RHH,CZF$CAV(&'K<&4D@U,,\01&@PWC 8P9IQPCY$0YD'
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M_.U",+2=H/$##3573,^+,R[Q/6_'JGIBBJ@+H[HH%C='=<'\%U!+ P04
M"  6B@A9<LKNC&\G   .KP  &0   ')C870P.# X9F]R;3$P:V5X:#1?,BYH
M=&WM/6EO&\F5WPGP/U2\FX$$M&1[QA/'1P10$B4SD24M2=EK+!9!L;M(]KC9
MS>E#,O?7[SOJZH,^)HJIV>P$B*56=]6K5Z_>_5Z]?C-]>W'4[[U^,QR<PK\"
M_WL]'4TOAD>O'_._\-?'^L^OCZ]./XC)],/%\"^/YEE:OA1/GZQ+,8U7JA"7
MZDZ,LY5, WX0B(G*X_DC^! ^O3;?E>I3>2"3>)&^%'F\6):OQ$KFBQA^??+H
MZ/7QT?#3,I[%I7AV^./KQ\< QW5C!)YYEB61>/KCEZ;W1H?_X?NOA ]"J-)2
MY8^.QL-3<3*8BC=7%Z>CR_-)($:7)X>OC\<P^61Z=?(W<74]'5U=BO/QX'(J
M+J^FHY.A&%R>FN>#\_%P^'9X.>5O]GY\\O2%&/Y:Q>5&C%*<)KY5XCJ1Z?ZV
M)?WCJ_FE*LIXOM$/XS12..Z3PY_C]-'1H!!2?%0;D2@9J5S$J<BJO-^;546<
MJ@+FV&25D+G"OTBQSHJXC+-4E)E82H"]@"GB>1S*M(0WYDFE8%D"7U@JL5;Y
M/,L!8'@DTT@451C"F"*;B[&*Q(DLQ1O8L3A=P#R CT.QAY_]D$2_5MDKV/:3
M;+66Z0:W_(><'NX?]GLC(5=B#0 7, @  O/"+ 1HN91E@*#F*LP ,H(5IL-A
M\RQ1]-(ZD1N]4!%F2:)"V@8-':^8%C=3*A6+'-8&$TGX8&W6OJ[R< GS]WO%
M$I!3F#DTP#_D!0);X.\K^&)29N''0S%=QH#N.YE' GXHJMDO,#4.AY\"Q:T*
M0E.8I1%!;H?=@BV/G  K-7H*X#N8XQR!%Y=9&8<JH,%QN#DL.KN#@1@P<<7K
M&BQRI58P"$*J1*1*&2<:!@LXDT($.XY(F2D8Z-#2[G1P?#$4)\.+B\GUX 2.
MS%\>/7E$OU\/3D_-[YJ^[^*H7"*W>/+'5W!R<R"_ ]P.N2[42V%^>D0LZ/5T
M;#Z[53FL1B:&O,ML_4BSJ=?3T\;@/^/8:QDAU@Z(L\"SPV=X1,S31,W=PZ\]
M<X^.&&=*O02>>/KY^?7:9EE99BM@4HD$G#^%*8HLB:-O@._1T0_IK%B_HBGA
M_\:_#3?_%'R< CT@J1#%;4'*OP0B+JO5#!@IH&+"K*%QSIEP_I4Q-/RD\C N
M@%'EP);$-6"+4/4;<?+U<O(;L/?O?W?_/40<3C=K.F[?BYKTV!W*R>.G3W_^
M(TBG))[E<2#>J.16(58 5)D6!TT5!=2YLRM0EKQQ#N9R%2>;E^+M1)QG(&O"
M+<, 4?_;B^?/G@%5XQB?&>D+V!M-KLP0)+JVK>VK%:_[7-5EEOY: 3KGL8H8
M-%]*(\ /D2"'G]9Q+DF/0%'PD,[RE+2KM%R*O:=/7D]NKH_*Y>O'^.\^J$0I
MJ$QY(?.-4;9JDNPAHOJ= H4^7>Q(A#PF)>_H'[14W.#W8/;<\V#MHWPK\QC5
M&E&L9)(<A*"8@G78J93K0PS*=K]WJ6YE)$&5S=<9GXV'N-Q['>SO6_Z[I^&/
M-R_O::116=BA8+ _'!R(LU@ET4MQ+1?J%7SQ*]FR,+ X.##'['3TSLS*8]ES
M]B<\,)X!Y!L\38.H;0#AI^,C[Q2WW1&O1.W]YMDTY_+U8X"Q ]Q9KN3'@YD"
M4QG6M*8UZB4 ZWJ@\'N[\ABWA7?B/OP^W^#PN3]G4_>D;,7_Q\UH^@&G&UY.
M1^^&XOIB</F=W%PU5Y9S6>W&(35],YJ(;HCZO;TR6RB0T3G0$HASE-9REMTJ
M=M*(E/P<32>2[P/Q/4F!J+]GW1_^2^BH6<F(_5>$+U3*XA2,.6G=,Q%J#(4J
M08;G );V?OGSBMF&1IBI\@Z=2MVR X2&:,N,KW"*!?V>\>V@;^8VCD"!;'YG
M/!:UY7T6ZL-=.24/02-^=5WE187 :,-YC)CWD=9R@C5\JDT$X+,V 0RB59S&
M10G(SG*QA%V-%/KBXA2]BTN8+RZ1"C04,KH%F( 7,<IGH(L!SI$NX(>Z%Q _
M8<*LF?Y*=?L2Z96TZ3UHK(&?^JOH]SZ[AT!3)3U4QNI>D]6]-E;WYTF G8;H
M^TT2 3.O55AVNRZ!!B,UCU/MN<3/UGEV&Q>^(Y-=DW=@#"T1IW%JZ!QP#<=:
MP41P4G(UAY]3Y[*$5^WI[";KFHMX1V1[3&1[DR;DXT8V=1>CBYC08A<8"% ?
MXQ(&_!\D,/+Z5NC)CM/F2HLE8IU<T;CFE9(IT;W;L3BU:#T49T"_0$SKK%#.
M:VM'@_VI^W[]W>*9Y'J=W)."]0W8>XJXVXOWQ0^P>R5NZ6E<R%F<P(GVMI5<
M[0 D8D%S.OV2(2Y[O/!0<>@!4)7? AG;XVN.9E0I#AW\4J'EEXLX23#>\=UI
M1Z\>EV])>DKL1S;HNH6 TKUF4*!6ZR3;$/' FO3B6_BQPM-@ T\9#CV8SP&C
M<!H+_'.NX,,].*-)A?P6>%TH*R3HQG@VVL&S V,)E2SP"\#PC+B=- ,W6.3^
M%ZE6>,@ P %(D/(B"T.,4MTM09;:92TR' '#5"ND"S3I$P6'!\5J$8,5K'^#
M"65*YQ,TJ52*>0SRG?Z&\\M903$L8OUW( [@5  ?PV#'IH8T.'MW>8R6.!RM
MUZ,CXG:1%AJO'X^.1,6L )=BMZ5::RZKG,,$9BTJX(@, RQ_44F*.O&D(1!@
M+D/:TD3>!8V7Y[@>)/@XBVAO$$$K4/,1D%3\!#^GY;)X1;O<"2=.$*<5/#(4
M$X*:0TL#FM[@'A85L/X4OXJJ')\[& *S3LOR8,4@CTE3 O 'P%7B4,X2)2[D
M77$(\OM.W:J\8VMI6P7MJL4ZKS-219C',X]-%ABV@P\!JL*"<,YH$_%J!0L
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MO*HMU(TF8S7;0JZ4N 7BCU"=(U-[/D<# \6O-Q*J$9]8*()HBW;%>G[\_9Q
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M%#4P[VPO=Q?9KFG*W&<>\7V..=FYV50R0]AEW6A87]C(!RS+[TT0V YN*UD
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M[A;/5CN99G&.<041,6@65!6M7>48I#0>I,*ZD/QMS;./.AS3>!EM*ZU]ZQ<
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MELP>'U^=?CC"']Y,WUX<_2]02P,$%     @ %HH(6<B;L,#L(   HX<  !D
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M+Y.IB6AQ7&X&Q\Z7L)#Z#.BJ=UT8,X<U$7"C8E/J)!60_#F8-V)@ 5@#&,?
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M!.>PI;V+HKP>Y[3M>@RB,01<H3\W!@:0;%DED@L\L0\UMC7&@W@>8DOSMOO
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M4$L! A0#%     @ %HH(65JHE!+(&@  !T8! !$              ( !
M ')C870M,C R-# T,S N>'-D4$L! A0#%     @ %HH(674ZY^+M&   QR@!
M !4              ( !]QH  ')C870M,C R-# T,S!?8V%L+GAM;%!+ 0(4
M Q0    ( !:*"%GA<%3,VB8   1D @ 5              "  1<T  !R8V%T
M+3(P,C0P-#,P7V1E9BYX;6Q02P$"% ,4    "  6B@A9)@>]?U!Q  #^U@8
M%0              @ $D6P  <F-A="TR,#(T,#0S,%]L86(N>&UL4$L! A0#
M%     @ %HH(6?\^1.\@5   &8$% !4              ( !I\P  ')C870M
M,C R-# T,S!?<')E+GAM;%!+ 0(4 Q0    ( !:*"%ET.6_JL"D" !HB%  3
M              "  ?H@ 0!R8V%T,#@P.&9O<FTQ,&LN:'1M4$L! A0#%
M  @ %HH(6?-GY7 '>   ,5," !H              ( !VTH# ')C870P.# X
M9F]R;3$P:V5X:#$P7S$N:'1M4$L! A0#%     @ %HH(68M;M4![ @  V!(
M !H              ( !&L,# ')C870P.# X9F]R;3$P:V5X:#(Q7S$N:'1M
M4$L! A0#%     @ %HH(67N32\-6!P  ""0  !H              ( !S<4#
M ')C870P.# X9F]R;3$P:V5X:#,Q7S$N:'1M4$L! A0#%     @ %HH(68QY
MUW_1!@  L2(  !H              ( !6\T# ')C870P.# X9F]R;3$P:V5X
M:#,Q7S(N:'1M4$L! A0#%     @ %HH(65.(M;_) P  :0X  !H
M     ( !9-0# ')C870P.# X9F]R;3$P:V5X:#,R7S$N:'1M4$L! A0#%
M  @ %HH(66?UG$C& P  9PX  !H              ( !9=@# ')C870P.# X
M9F]R;3$P:V5X:#,R7S(N:'1M4$L! A0#%     @ %HH(67+*[HQO)P  #J\
M !D              ( !8]P# ')C870P.# X9F]R;3$P:V5X:#1?,BYH=&U0
M2P$"% ,4    "  6B@A9R)NPP.P@  "CAP  &0              @ $)! 0
M<F-A=# X,#AF;W)M,3!K97AH-%\S+FAT;5!+ 0(4 Q0    ( !:*"%GU5Z-7
M,R$  ,J]   :              "  2PE! !R8V%T,#@P.&9O<FTQ,&ME>&@Y
=-U\Q+FAT;5!+!08     #P / !($  "71@0    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>rcat0808form10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:RCAT="http://RCAT/20240430"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="rcat-20240430.xsd" xlink:type="simple"/>
    <context id="From2023-05-01to2024-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="AsOf2024-08-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <instant>2024-08-05</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-30_custom_SeriesBPreferredStock1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_SeriesBPreferredStock1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_SeriesBPreferredStock1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_custom_SeriesBPreferredStock1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="From2019-05-012020-04-30_custom_BusinessAcquisition1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="From2020-05-012021-04-30_custom_BusinessAcquisition2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_BusinessAcquisition3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_BusinessAcquisition4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactOriginallyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactAsRestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_RestatementImpactChangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactChangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_RestatementImpactOriginallyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactOriginallyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_RestatementImpactAsRestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactAsRestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_RestatementImpactChangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactChangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_custom_CustomerConcentrationRisk1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_CustomerConcentrationRisk1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_custom_CustomerConcentrationRisk2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_CustomerConcentrationRisk3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_CustomerConcentrationRisk4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_CustomerConcentrationRisk5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <instant>2024-02-16</instant>
        </period>
    </context>
    <context id="From2023-01-012023-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2023-03-012023-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsGrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsAccumulatedAmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsNetCarryingValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsGrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsAccumulatedAmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsNetCarryingValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2020-01-012023-04-30_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2020-11-012023-04-30_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012023-04-30_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2021-08-012023-04-30_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-04-30_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2024-02-012024-04-30_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-30_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="From2023-04-012023-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="From2022-11-012022-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_custom_OperatingLeaseLocation1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">RCAT:OperatingLeaseLocation1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_custom_OperatingLeaseLocation3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">RCAT:OperatingLeaseLocation3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_custom_OperatingLeaseLocation4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">RCAT:OperatingLeaseLocation4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-08-31_custom_DebtObligation1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="From2022-09-012023-04-30_custom_DebtObligation1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-08-012023-04-30_custom_DebtObligation1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_DebtObligation2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_custom_DebtObligation2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-30_custom_DebtObligation2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_DebtObligation2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2021-08-31_custom_DebtObligation3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="From2021-08-012022-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-04-30_custom_DebtObligation6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-04-30_custom_DebtObligation6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-30_custom_DebtObligation6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_DebtObligation6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2022-09-012022-09-30_custom_DebtObligation8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-09-012023-04-30_custom_DebtObligation8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-30_custom_DebtObligation8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_DebtObligation8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2021-01-012023-04-30_custom_DueToRelatedParty2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DueToRelatedParty2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-30_custom_DueToRelatedParty2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DueToRelatedParty2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="From2024-04-012024-04-30_custom_DueToRelatedParty2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DueToRelatedParty2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_custom_SeriesAPreferredStock2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RCAT:SeriesAPreferredStock2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2022-03-012022-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012022-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="From2020-10-012020-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_custom_WarrantAssumptionsUsedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantAssumptionsUsedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_WarrantAssumptionsUsedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantAssumptionsUsedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-30_custom_WarrantsOutstanding1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_WarrantsOutstanding1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_WarrantsOutstanding1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_WarrantsOutstanding1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_custom_WarrantsOutstanding1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-30_custom_WarrantsOutstanding1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_custom_OptionsAssumptionsUsedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_OptionsAssumptionsUsedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_custom_OptionsAssumptionsUsedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-30_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-30_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2021-04-30_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-30_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-05-01to2024-04-30" id="ixv-13524">0000748268</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-05-01to2024-04-30" id="ixv-13525">false</dei:AmendmentFlag>
    <dei:DocumentAnnualReport contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0011">true</dei:DocumentAnnualReport>
    <dei:DocumentFiscalPeriodFocus contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0012">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0013">2024</dei:DocumentFiscalYearFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0014">--04-30</dei:CurrentFiscalYearEndDate>
    <dei:EntitySmallBusiness contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0038">true</dei:EntitySmallBusiness>
    <dei:IcfrAuditorAttestationFlag contextRef="From2023-05-01to2024-04-30" id="xdx2ixbrl0040">true</dei:IcfrAuditorAttestationFlag>
    <us-gaap:Investments
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0058"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0070"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EquityMethodInvestments
      contextRef="AsOf2023-04-30"
      id="xdx2ixbrl0083"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent
      contextRef="AsOf2023-04-30"
      id="xdx2ixbrl0086"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0097"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0127"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0136"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0139"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0212"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0215"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0218"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012023-04-30_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0265"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0266"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0268"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0269"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2022-05-012023-04-30_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0272"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0275"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0276"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012023-04-30_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0280"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0283"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0284"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-05-012023-04-30_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0288"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0289"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0290"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0291"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-05-012023-04-30_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0295"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0296"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0297"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0298"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0302"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0303"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0304"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0306"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0318"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0319"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0321"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0322"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0325"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0328"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0329"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0336"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0337"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-05-01to2024-04-30"
      id="xdx2ixbrl0338"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:StockIssuedDuringPeriodValueThroughATMFacility
      contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0342"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:StockIssuedDuringPeriodValueThroughATMFacility
      contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0345"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:StockIssuedDuringPeriodValueThroughATMFacility
      contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0346"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0350"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0353"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0354"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0358"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0361"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0362"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0367"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0368"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0369"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0370"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0374"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0375"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0376"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0377"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0381"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0382"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0383"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2023-05-01to2024-04-30"
      id="xdx2ixbrl0418"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDerivativeLiabilities
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0431"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0434"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0437"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireAssetsInvestingActivities
      contextRef="From2023-05-01to2024-04-30"
      id="xdx2ixbrl0481"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:ProceedsFromIssuanceOfCommonStockPublicOffering
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0491"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:ProceedsFromIssuanceOfCommonStockATMFacilityNet
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-05-01to2024-04-30"
      id="xdx2ixbrl0505"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2023-05-01to2024-04-30"
      id="xdx2ixbrl0508"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="From2023-05-01to2024-04-30"
      id="xdx2ixbrl0520"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0521"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
      contextRef="From2023-05-01to2024-04-30"
      id="xdx2ixbrl0523"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0524"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCash
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0538"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2023-05-01to2024-04-30"
      id="xdx2ixbrl0547"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0548"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0554"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:NoncashOrPartNoncashDivestitureNoteReceivable
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0557"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:ConversionOfPreferredStockIntoCommonStock
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0563"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:FairValueOfSharesWithheldAsPaymentOfNoteReceivable
      contextRef="From2023-05-01to2024-04-30"
      id="xdx2ixbrl0565"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:TaxesRelatedToNetShareSettlementOfEquityAwards
      contextRef="From2023-05-01to2024-04-30"
      id="xdx2ixbrl0568"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember"
      id="xdx2ixbrl0601"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities
      contextRef="From2022-05-012023-04-30_custom_RestatementImpactAsRestatedMember"
      id="xdx2ixbrl0633"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="xdx2ixbrl0737"
      unitRef="USD">-21526696</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="xdx2ixbrl0738"
      unitRef="USD">-17687063</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl0783"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCash
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0799"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0802"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0805"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0808"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0811"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0814"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0817"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0820"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0823"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0829"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0832"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0835"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0838"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0841"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0844"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationWorkingCapital
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0847"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GrantsReceivableCurrent
      contextRef="AsOf2023-04-30"
      id="xdx2ixbrl0882"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0887"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:FiniteLivedNoncompeteAgreementsGross1
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember"
      id="xdx2ixbrl0920"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:FiniteLivedCustomerRelationshipsGross1
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember"
      id="xdx2ixbrl0925"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:FiniteLivedCustomerRelationshipsGross1
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember"
      id="xdx2ixbrl0926"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:FiniteLivedCustomerRelationshipsGross1
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember"
      id="xdx2ixbrl0927"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember"
      id="xdx2ixbrl0940"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember"
      id="xdx2ixbrl0943"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember"
      id="xdx2ixbrl0947"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember"
      id="xdx2ixbrl0950"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0970"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl0972"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2023-04-012023-04-30"
      decimals="0"
      id="xdx2ixbrl0993"
      unitRef="USD">2826918</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2024-04-012024-04-30"
      decimals="0"
      id="xdx2ixbrl0994"
      unitRef="USD">412999</us-gaap:GoodwillImpairmentLoss>
    <RCAT:OutstandingPrincipalPaymentsDueLongTerm
      contextRef="AsOf2024-04-30"
      id="xdx2ixbrl1119"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="xdx2ixbrl1130"
      unitRef="USD">-81130732</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="xdx2ixbrl1131"
      unitRef="USD">-57078103</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2022-05-012023-04-30_custom_WarrantAssumptionsUsedMember"
      id="xdx2ixbrl1192"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-05-012024-04-30_custom_WarrantAssumptionsUsedMember"
      id="xdx2ixbrl1193"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-05-012023-04-30_custom_WarrantAssumptionsUsedMember"
      id="xdx2ixbrl1194"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2022-05-012023-04-30_custom_WarrantAssumptionsUsedMember"
      id="xdx2ixbrl1197"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-05-012023-04-30_custom_WarrantsOutstanding1Member"
      id="xdx2ixbrl1204"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2022-05-012023-04-30_custom_WarrantsOutstanding1Member"
      id="xdx2ixbrl1205"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-05-012023-04-30_custom_WarrantsOutstanding1Member"
      id="xdx2ixbrl1206"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2022-05-012023-04-30_custom_WarrantsOutstanding1Member"
      id="xdx2ixbrl1207"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2023-04-30_custom_WarrantsOutstanding1Member"
      id="xdx2ixbrl1211"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-05-012024-04-30_custom_WarrantsOutstanding1Member"
      id="xdx2ixbrl1214"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2023-05-012024-04-30_custom_WarrantsOutstanding1Member"
      id="xdx2ixbrl1215"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-05-012024-04-30_custom_OptionsAssumptionsUsedMember"
      id="xdx2ixbrl1237"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember"
      id="xdx2ixbrl1238"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-05-012023-04-30_custom_Options1Member"
      id="xdx2ixbrl1255"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2022-05-012023-04-30_custom_Options1Member"
      id="xdx2ixbrl1256"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2023-05-01to2024-04-30" id="ixv-14601">10-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-05-01to2024-04-30" id="ixv-14602">2024-04-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2023-05-01to2024-04-30" id="ixv-14603">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2023-05-01to2024-04-30" id="ixv-14604">001-40202</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2023-05-01to2024-04-30" id="ixv-14605">Red Cat Holdings, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-05-01to2024-04-30" id="ixv-14606">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-05-01to2024-04-30" id="ixv-14607">88-0490034</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-05-01to2024-04-30" id="ixv-14608">15 Ave. Munoz Rivera</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-05-01to2024-04-30" id="ixv-14609">Ste 2200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-05-01to2024-04-30" id="ixv-14610">San Juan</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2023-05-01to2024-04-30" id="ixv-14611">PR</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="From2023-05-01to2024-04-30" id="ixv-14612">00901</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-05-01to2024-04-30" id="ixv-14613">(833)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-05-01to2024-04-30" id="ixv-14614">373-3228</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2023-05-01to2024-04-30" id="ixv-14615">Common     stock, par value $0.001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-05-01to2024-04-30" id="ixv-14616">RCAT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-05-01to2024-04-30" id="ixv-14617">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2023-05-01to2024-04-30" id="ixv-14618">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2023-05-01to2024-04-30" id="ixv-14619">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2023-05-01to2024-04-30" id="ixv-14620">No</dei:EntityVoluntaryFilers>
    <dei:EntityVoluntaryFilers contextRef="From2023-05-01to2024-04-30" id="ixv-14621">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2023-05-01to2024-04-30" id="ixv-14622">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2023-05-01to2024-04-30" id="ixv-14623">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2023-05-01to2024-04-30" id="ixv-14624">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-05-01to2024-04-30" id="ixv-14625">false</dei:EntityEmergingGrowthCompany>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2023-05-01to2024-04-30" id="ixv-14626">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="From2023-05-01to2024-04-30" id="ixv-14627">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="AsOf2023-10-31"
      decimals="0"
      id="ixv-14628"
      unitRef="USD">50844411</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2024-08-05"
      decimals="INF"
      id="ixv-14629"
      unitRef="Shares">74600737</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorFirmId contextRef="From2023-05-01to2024-04-30" id="ixv-14630">3501</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2023-05-01to2024-04-30" id="ixv-14631">dbbmckennon</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2023-05-01to2024-04-30" id="ixv-14632">Newport Beach, California</dei:AuditorLocation>
    <us-gaap:Cash
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14633"
      unitRef="USD">6067169</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14634"
      unitRef="USD">3173649</us-gaap:Cash>
    <us-gaap:Investments
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14635"
      unitRef="USD">12814038</us-gaap:Investments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14636"
      unitRef="USD">4361090</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14637"
      unitRef="USD">719862</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14638"
      unitRef="USD">8007237</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14639"
      unitRef="USD">8920573</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14640"
      unitRef="USD">3962053</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14641"
      unitRef="USD">1263735</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14642"
      unitRef="USD">5283155</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14643"
      unitRef="USD">22397549</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14644"
      unitRef="USD">32175012</us-gaap:AssetsCurrent>
    <us-gaap:Goodwill
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14645"
      unitRef="USD">9088550</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14646"
      unitRef="USD">17012832</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14647"
      unitRef="USD">3794389</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14648"
      unitRef="USD">6893115</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14649"
      unitRef="USD">5142500</us-gaap:EquityMethodInvestments>
    <us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14650"
      unitRef="USD">4000000</us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14651"
      unitRef="USD">2340684</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14652"
      unitRef="USD">2650358</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14653"
      unitRef="USD">293126</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14654"
      unitRef="USD">303180</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14655"
      unitRef="USD">1480814</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14656"
      unitRef="USD">1600434</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14657"
      unitRef="USD">108397</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14658"
      unitRef="USD">26140063</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14659"
      unitRef="USD">28568316</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14660"
      unitRef="USD">48537612</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14661"
      unitRef="USD">60743328</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14662"
      unitRef="USD">1580422</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14663"
      unitRef="USD">1392550</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14664"
      unitRef="USD">1069561</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14665"
      unitRef="USD">409439</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ShortTermBorrowings
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14666"
      unitRef="USD">751570</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14667"
      unitRef="USD">922138</us-gaap:ShortTermBorrowings>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14668"
      unitRef="USD">53939</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14669"
      unitRef="USD">155986</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14670"
      unitRef="USD">195638</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14671"
      unitRef="USD">159423</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14672"
      unitRef="USD">1010501</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14673"
      unitRef="USD">3651130</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14674"
      unitRef="USD">4050037</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14675"
      unitRef="USD">1321952</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14676"
      unitRef="USD">1481967</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14677"
      unitRef="USD">401569</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14678"
      unitRef="USD">41814</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14679"
      unitRef="USD">1321952</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14680"
      unitRef="USD">1925350</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-04-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="ixv-14681"
      unitRef="Shares">4300000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-04-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="ixv-14682"
      unitRef="Shares">4676</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-04-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="ixv-14683"
      unitRef="Shares">986676</us-gaap:PreferredStockSharesOutstanding>
    <RCAT:PreferredStockValueSeriesB
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14684"
      unitRef="USD">47</RCAT:PreferredStockValueSeriesB>
    <RCAT:PreferredStockValueSeriesB
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14685"
      unitRef="USD">9867</RCAT:PreferredStockValueSeriesB>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-04-30"
      decimals="INF"
      id="ixv-14686"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-04-30"
      decimals="INF"
      id="ixv-14687"
      unitRef="Shares">74289351</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-04-30"
      decimals="INF"
      id="ixv-14688"
      unitRef="Shares">54568065</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14689"
      unitRef="USD">74289</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14690"
      unitRef="USD">54568</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14691"
      unitRef="USD">124616305</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14692"
      unitRef="USD">112642726</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14693"
      unitRef="USD">-81130732</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14694"
      unitRef="USD">-57078103</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14695"
      unitRef="USD">4621</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14696"
      unitRef="USD">-861117</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14697"
      unitRef="USD">43564530</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14698"
      unitRef="USD">54767941</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14699"
      unitRef="USD">48537612</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14700"
      unitRef="USD">60743328</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14701"
      unitRef="USD">17836382</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14702"
      unitRef="USD">4620834</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14703"
      unitRef="USD">14155836</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14704"
      unitRef="USD">5455145</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14705"
      unitRef="USD">3680546</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14706"
      unitRef="USD">-834311</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14707"
      unitRef="USD">5896037</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14708"
      unitRef="USD">5595281</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14709"
      unitRef="USD">4568617</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14710"
      unitRef="USD">3731776</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14711"
      unitRef="USD">10679105</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14712"
      unitRef="USD">12383470</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14713"
      unitRef="USD">412999</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14714"
      unitRef="USD">2826918</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:OperatingExpenses
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14715"
      unitRef="USD">21556758</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14716"
      unitRef="USD">24537445</us-gaap:OperatingExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14717"
      unitRef="USD">-17876212</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14718"
      unitRef="USD">-25371756</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14719"
      unitRef="USD">9642427</us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14720"
      unitRef="USD">11353875</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14721"
      unitRef="USD">-503625</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14722"
      unitRef="USD">-651943</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14723"
      unitRef="USD">82798</us-gaap:InvestmentIncomeNet>
    <us-gaap:InterestExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14724"
      unitRef="USD">68609</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14725"
      unitRef="USD">122004</us-gaap:InterestExpense>
    <us-gaap:OtherNonrecurringIncomeExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14726"
      unitRef="USD">714859</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14727"
      unitRef="USD">965681</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14728"
      unitRef="USD">-3650484</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14729"
      unitRef="USD">-1004887</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14730"
      unitRef="USD">-21526696</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14731"
      unitRef="USD">-26376643</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14732"
      unitRef="USD">-2525933</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14733"
      unitRef="USD">-1730386</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14734"
      unitRef="USD">-24052629</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14735"
      unitRef="USD">-28107029</us-gaap:NetIncomeLoss>
    <RCAT:EarningsPerShareBasicAndDilutedContinuingOperationsRCAT
      contextRef="From2023-05-01to2024-04-30"
      decimals="INF"
      id="ixv-14736"
      unitRef="USDPShares">-0.36</RCAT:EarningsPerShareBasicAndDilutedContinuingOperationsRCAT>
    <RCAT:EarningsPerShareBasicAndDilutedContinuingOperationsRCAT
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      id="ixv-14737"
      unitRef="USDPShares">-0.49</RCAT:EarningsPerShareBasicAndDilutedContinuingOperationsRCAT>
    <RCAT:EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT
      contextRef="From2023-05-01to2024-04-30"
      decimals="INF"
      id="ixv-14738"
      unitRef="USDPShares">-0.04</RCAT:EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT>
    <RCAT:EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      id="ixv-14739"
      unitRef="USDPShares">-0.03</RCAT:EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT>
    <RCAT:EarningsPerShareBasicAndDilutedRCAT
      contextRef="From2023-05-01to2024-04-30"
      decimals="INF"
      id="ixv-14740"
      unitRef="USDPShares">-0.40</RCAT:EarningsPerShareBasicAndDilutedRCAT>
    <RCAT:EarningsPerShareBasicAndDilutedRCAT
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      id="ixv-14741"
      unitRef="USDPShares">-0.52</RCAT:EarningsPerShareBasicAndDilutedRCAT>
    <RCAT:WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT
      contextRef="From2023-05-01to2024-04-30"
      decimals="INF"
      id="ixv-14742"
      unitRef="Shares">60118675</RCAT:WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT>
    <RCAT:WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      id="ixv-14743"
      unitRef="Shares">53860199</RCAT:WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-04-30_custom_SeriesBPreferredStock1Member"
      decimals="INF"
      id="ixv-14744"
      unitRef="Shares">986676</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_custom_SeriesBPreferredStock1Member"
      decimals="0"
      id="ixv-14745"
      unitRef="USD">9867</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-14746"
      unitRef="Shares">53748735</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-14747"
      unitRef="USD">53749</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-14748"
      unitRef="USD">109471010</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-14749"
      unitRef="USD">-28971074</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ixv-14750"
      unitRef="USD">-1470272</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30"
      decimals="0"
      id="ixv-14751"
      unitRef="USD">79093280</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-14752"
      unitRef="USD">3656724</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14753"
      unitRef="USD">3656724</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-14754"
      unitRef="Shares">779498</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-14755"
      unitRef="USD">779</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-14756"
      unitRef="USD">-523606</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14757"
      unitRef="USD">-522827</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-14758"
      unitRef="Shares">39832</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-14759"
      unitRef="USD">40</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-14760"
      unitRef="USD">38598</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14761"
      unitRef="USD">38638</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ixv-14762"
      unitRef="USD">610129</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14763"
      unitRef="USD">610129</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ixv-14764"
      unitRef="USD">-974</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14765"
      unitRef="USD">-974</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-14766"
      unitRef="USD">-28107029</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14767"
      unitRef="USD">-28107029</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-04-30_custom_SeriesBPreferredStock1Member"
      decimals="INF"
      id="ixv-14768"
      unitRef="Shares">986676</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_custom_SeriesBPreferredStock1Member"
      decimals="0"
      id="ixv-14769"
      unitRef="USD">9867</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-14770"
      unitRef="Shares">54568065</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-14771"
      unitRef="USD">54568</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-14772"
      unitRef="USD">112642726</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-14773"
      unitRef="USD">-57078103</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ixv-14774"
      unitRef="USD">-861117</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14775"
      unitRef="USD">54767941</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-14776"
      unitRef="USD">3609267</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14777"
      unitRef="USD">3609267</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-14778"
      unitRef="Shares">446717</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-14779"
      unitRef="USD">447</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-14780"
      unitRef="USD">-33701</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14781"
      unitRef="USD">-33254</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member"
      decimals="INF"
      id="ixv-14782"
      unitRef="Shares">982000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-05-012024-04-30_custom_SeriesBPreferredStock1Member"
      decimals="0"
      id="ixv-14783"
      unitRef="USD">-9820</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-14784"
      unitRef="Shares">-818334</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-14785"
      unitRef="USD">818</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-14786"
      unitRef="USD">9002</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <RCAT:StockSharesIssuedNetThroughATMFacility
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-14787"
      unitRef="Shares">53235</RCAT:StockSharesIssuedNetThroughATMFacility>
    <RCAT:StockIssuedDuringPeriodValueThroughATMFacility
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-14788"
      unitRef="USD">53</RCAT:StockIssuedDuringPeriodValueThroughATMFacility>
    <RCAT:StockIssuedDuringPeriodValueThroughATMFacility
      contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-14789"
      unitRef="USD">9159</RCAT:StockIssuedDuringPeriodValueThroughATMFacility>
    <RCAT:StockIssuedDuringPeriodValueThroughATMFacility
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14790"
      unitRef="USD">9212</RCAT:StockIssuedDuringPeriodValueThroughATMFacility>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-14791"
      unitRef="Shares">3000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-14792"
      unitRef="USD">3</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-14793"
      unitRef="USD">2652</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14794"
      unitRef="USD">2655</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14795"
      unitRef="USD">804400</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-14796"
      unitRef="Shares">18400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-14797"
      unitRef="USD">18400</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-05-012024-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-14798"
      unitRef="USD">8377200</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14799"
      unitRef="USD">8395600</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ixv-14800"
      unitRef="USD">864165</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14801"
      unitRef="USD">864165</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-05-012024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ixv-14802"
      unitRef="USD">1573</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14803"
      unitRef="USD">1573</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012024-04-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-14804"
      unitRef="USD">-24052629</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14805"
      unitRef="USD">-24052629</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-04-30_custom_SeriesBPreferredStock1Member"
      decimals="INF"
      id="ixv-14806"
      unitRef="Shares">4676</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-04-30_custom_SeriesBPreferredStock1Member"
      decimals="0"
      id="ixv-14807"
      unitRef="USD">47</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-14808"
      unitRef="Shares">74289351</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-04-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-14809"
      unitRef="USD">74289</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-14810"
      unitRef="USD">124616305</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-04-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-14811"
      unitRef="USD">-81130732</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ixv-14812"
      unitRef="USD">4621</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14813"
      unitRef="USD">43564530</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14814"
      unitRef="USD">-24052629</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14815"
      unitRef="USD">-28107029</us-gaap:NetIncomeLoss>
    <RCAT:IncomeLossFromDiscontinuedOperations
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14816"
      unitRef="USD">2525933</RCAT:IncomeLossFromDiscontinuedOperations>
    <RCAT:IncomeLossFromDiscontinuedOperations
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14817"
      unitRef="USD">1730386</RCAT:IncomeLossFromDiscontinuedOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14818"
      unitRef="USD">-21526696</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14819"
      unitRef="USD">-26376643</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14820"
      unitRef="USD">2619501</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14821"
      unitRef="USD">1617982</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14822"
      unitRef="USD">989766</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14823"
      unitRef="USD">2038742</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14824"
      unitRef="USD">38638</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14825"
      unitRef="USD">854311</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14826"
      unitRef="USD">654527</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:MarketableSecuritiesGainLoss
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14827"
      unitRef="USD">851986</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:MarketableSecuritiesGainLoss
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14828"
      unitRef="USD">296012</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:Depreciation
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14829"
      unitRef="USD">568813</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14830"
      unitRef="USD">311545</us-gaap:Depreciation>
    <us-gaap:IncreaseDecreaseInDerivativeLiabilities
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14831"
      unitRef="USD">-9642427</us-gaap:IncreaseDecreaseInDerivativeLiabilities>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14832"
      unitRef="USD">11353875</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14833"
      unitRef="USD">503625</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14834"
      unitRef="USD">412999</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14835"
      unitRef="USD">2826918</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14836"
      unitRef="USD">-3641228</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14837"
      unitRef="USD">-288986</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14838"
      unitRef="USD">913336</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14839"
      unitRef="USD">-5707525</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14840"
      unitRef="USD">-2688264</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14841"
      unitRef="USD">559660</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <RCAT:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14842"
      unitRef="USD">-4180</RCAT:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities>
    <RCAT:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14843"
      unitRef="USD">25733</RCAT:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14844"
      unitRef="USD">-102047</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14845"
      unitRef="USD">-136628</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14846"
      unitRef="USD">187872</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14847"
      unitRef="USD">434803</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14848"
      unitRef="USD">661695</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14849"
      unitRef="USD">-608452</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14850"
      unitRef="USD">-17687063</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14851"
      unitRef="USD">-24313674</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14852"
      unitRef="USD">1000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14853"
      unitRef="USD">259139</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14854"
      unitRef="USD">2450213</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14855"
      unitRef="USD">12826217</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14856"
      unitRef="USD">32290448</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquireAssetsInvestingActivities
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14857"
      unitRef="USD">250000</us-gaap:PaymentsToAcquireAssetsInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14858"
      unitRef="USD">13567078</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14859"
      unitRef="USD">29590235</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <RCAT:ProceedsFromIssuanceOfCommonStockPublicOffering
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14860"
      unitRef="USD">8395600</RCAT:ProceedsFromIssuanceOfCommonStockPublicOffering>
    <RCAT:ProceedsFromIssuanceOfCommonStockATMFacilityNet
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14861"
      unitRef="USD">9212</RCAT:ProceedsFromIssuanceOfCommonStockATMFacilityNet>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14862"
      unitRef="USD">572137</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14863"
      unitRef="USD">606897</us-gaap:RepaymentsOfDebt>
    <RCAT:PaymentsOfTaxesRelatedToEquityTransactions
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14864"
      unitRef="USD">33254</RCAT:PaymentsOfTaxesRelatedToEquityTransactions>
    <RCAT:PaymentsOfTaxesRelatedToEquityTransactions
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14865"
      unitRef="USD">581775</RCAT:PaymentsOfTaxesRelatedToEquityTransactions>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14866"
      unitRef="USD">2655</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14867"
      unitRef="USD">13404</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14868"
      unitRef="USD">40057</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14869"
      unitRef="USD">7802076</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14870"
      unitRef="USD">-1215325</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14871"
      unitRef="USD">-875227</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14872"
      unitRef="USD">-4885746</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14873"
      unitRef="USD">-875227</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14874"
      unitRef="USD">-4885746</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14875"
      unitRef="USD">2806864</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14876"
      unitRef="USD">-824510</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14877"
      unitRef="USD">3260305</us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
      contextRef="AsOf2022-04-30"
      decimals="0"
      id="ixv-14878"
      unitRef="USD">4084815</us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14879"
      unitRef="USD">6067169</us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14880"
      unitRef="USD">3260305</us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCash
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14881"
      unitRef="USD">86656</us-gaap:DisposalGroupIncludingDiscontinuedOperationCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14882"
      unitRef="USD">6067169</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14883"
      unitRef="USD">3173649</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14884"
      unitRef="USD">70177</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14885"
      unitRef="USD">122103</us-gaap:InterestPaidNet>
    <RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14886"
      unitRef="USD">17000000</RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1>
    <RCAT:NoncashOrPartNoncashDivestitureNoteReceivable
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14887"
      unitRef="USD">4000000</RCAT:NoncashOrPartNoncashDivestitureNoteReceivable>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14888"
      unitRef="USD">864165</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14889"
      unitRef="USD">610129</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent>
    <RCAT:ConversionOfPreferredStockIntoCommonStock
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14890"
      unitRef="USD">9820</RCAT:ConversionOfPreferredStockIntoCommonStock>
    <RCAT:FairValueOfSharesWithheldAsPaymentOfNoteReceivable
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14891"
      unitRef="USD">18449</RCAT:FairValueOfSharesWithheldAsPaymentOfNoteReceivable>
    <RCAT:TaxesRelatedToNetShareSettlementOfEquityAwards
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14892"
      unitRef="USD">32468</RCAT:TaxesRelatedToNetShareSettlementOfEquityAwards>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-8401">&lt;p id="xdx_806_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zltuPOrpHefe" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_820_zyNUDVPUESx7"&gt;Note 1 &#x2013; The Business&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company was originally incorporated in February
1984. Since April 2016, the Company&#x2019;s primary business has been to provide products, services, and solutions to the drone industry
which it presently does through its wholly owned operating subsidiaries. Beginning in January 2020, the Company expanded the scope
of its drone products and services through four acquisitions, including:&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;A.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;In January 2020, the Company acquired Rotor Riot, a provider of First Person View (&#x201c;FPV&#x201d;) drones and equipment, primarily to consumers. The purchase price was $&lt;span id="xdx_905_eus-gaap--BusinessCombinationConsiderationTransferred1_c20190501__20200430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition1Member_zpwsbSsI3RSb"&gt;1,995,114&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;B.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;In November 2020, the Company acquired Fat Shark Holdings (&#x201c;Fat Shark&#x201d;), a provider of FPV video goggles to the&#160;drone industry. The purchase price was $&lt;span id="xdx_902_eus-gaap--BusinessCombinationConsiderationTransferred1_c20200501__20210430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition2Member_zAFKmFlHEGj6"&gt;8,354,076&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&#160;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;C.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;In May 2021, the Company acquired Skypersonic which provided hardware and software solutions that enable drones to complete inspection services in locations where GPS is either denied or not available, yet still record and transmit data even while being operated from thousands of miles away. The purchase price was $&lt;span id="xdx_90B_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition3Member_zOaBBegpRDD"&gt;2,791,012&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;D.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;In August 2021, the Company acquired Teal Drones (&#x201c;Teal&#x201d;), a leader in commercial and government Unmanned Aerial Vehicles (&#x201c;UAV&#x201d;) technology.&#160;The purchase price was $&lt;span id="xdx_90C_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition4Member_z4CsCK87WY23"&gt;10,011,279&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;Following the Teal acquisition
in August 2021, we concentrated on integrating and organizing these businesses. Effective May 1, 2022, we established the Enterprise segment
(&#x201c;Enterprise&#x201d;) and the Consumer segment (&#x201c;Consumer&#x201d;) to focus on the unique opportunities in each sector. Enterprise's
initial strategy was to provide UAVs to commercial enterprises, and the military, to navigate dangerous military environments and confined
industrial and commercial interior spaces. Subsequently, Enterprise narrowed its near-term attention on the military and other government
agencies. Skypersonic's technology has been redirected to military applications and its operations consolidated into Teal.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;On December 11, 2023,
the Company completed a firm commitment underwritten public offering with ThinkEquity of &lt;span id="xdx_909_ecustom--FirmCommitmentUnderwrittenPublicOfferingShares_c20230501__20240430_zSG6z2QSN606"&gt;18,400,000&lt;/span&gt; shares of common stock which generated
gross proceeds of $&lt;span id="xdx_909_ecustom--FirmCommitmentUnderwrittenPublicOfferingGrossProceeds_c20230501__20240430_z4eh6TKg5mMe"&gt;9,200,000&lt;/span&gt; and net proceeds of approximately $&lt;span id="xdx_901_ecustom--FirmCommitmentUnderwrittenPublicOfferingNetProceeds_c20230501__20240430_zU9OJaE6rpsd"&gt;8,400,000&lt;/span&gt;.&lt;/span&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;On February 16, 2024&lt;/span&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;span style="font-size: 10pt"&gt;,
we closed the sale of our Consumer segment, consisting of Rotor Riot and Fat Shark, to Unusual Machines. The sale reflects the Company's
decision to focus its efforts and capital on defense where it believes that there are more opportunities to create long term shareholder
value. See Note 3 and Note 9.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&#160;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2019-05-012020-04-30_custom_BusinessAcquisition1Member"
      decimals="0"
      id="ixv-14893"
      unitRef="USD">1995114</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2020-05-012021-04-30_custom_BusinessAcquisition2Member"
      decimals="0"
      id="ixv-14894"
      unitRef="USD">8354076</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2021-05-012022-04-30_custom_BusinessAcquisition3Member"
      decimals="0"
      id="ixv-14895"
      unitRef="USD">2791012</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2021-05-012022-04-30_custom_BusinessAcquisition4Member"
      decimals="0"
      id="ixv-14896"
      unitRef="USD">10011279</us-gaap:BusinessCombinationConsiderationTransferred1>
    <RCAT:FirmCommitmentUnderwrittenPublicOfferingShares
      contextRef="From2023-05-01to2024-04-30"
      decimals="INF"
      id="ixv-14897"
      unitRef="Shares">18400000</RCAT:FirmCommitmentUnderwrittenPublicOfferingShares>
    <RCAT:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14898"
      unitRef="USD">9200000</RCAT:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds>
    <RCAT:FirmCommitmentUnderwrittenPublicOfferingNetProceeds
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14899"
      unitRef="USD">8400000</RCAT:FirmCommitmentUnderwrittenPublicOfferingNetProceeds>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-8461">&lt;p id="xdx_803_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zwwPn4Q2x3yc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_828_zMckm5OJyIie"&gt;Note 2 &#x2013; Summary of Significant Accounting
Policies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zcACN2x0a8Jg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86F_zWm6aVzxMiw7"&gt;Basis of Accounting&lt;/span&gt; &lt;/b&gt;&#x2013; The financial statements
and accompanying notes are prepared in accordance with generally accepted accounting principles in the United States (&#x201c;GAAP&#x201d;).
Certain prior period amounts have been restated to conform to the current year presentation.&lt;/p&gt;

&lt;p id="xdx_856_zjhcB2lVPwf6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock_zdZxPdSJcoK8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_869_zUpKgUyCkTh4"&gt;Restatement of Previously Issued Consolidated Financial Statements&lt;/span&gt; &lt;/b&gt;&#x2013;
The Company&#x2019;s Consolidated Balance Sheet as of April 30, 2023, Consolidated Statement of Operations, Stockholders&#x2019; Equity
and Cash Flows for the year then ended, and its Notes to the Consolidated Financial Statements for the year ended April 30, 2023, which
were originally filed with the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on July 27, 2023 (the &#x201c;Original Form
10-K&#x201d;), have been restated. The Company revised its accounting estimate of the life of an operating lease that was previously reported
in its Original Form 10-K. Upon further evaluation, the Company determined that prior year adjustments were necessary. These Consolidated
Financial Statements were restated to reflect a change in accounting estimate of the life of the operating lease under FASB ASC Topic
842 from three to nine years. Additionally, the Company revised its financial statements to&#160;remove derivative liabilities due to
erroneously reporting warrants from our convertible note financings, as described in Note 18, as having a derivative component.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The impacts of these restatements are detailed
in the tables below:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_z37Q9DXaN6uh" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49B_20230430__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zSBEY5ZMCnF2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20230430__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zJcotfhJMGR4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_494_20230430__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zE2BMOTeUBXc"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Consolidated Balance Sheet&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;As of April 30, 2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Originally&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;As&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Restated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Change&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zEXj3ClQpUhe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Operating lease right-of-use assets&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;620,307&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;1,600,434&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;980,127&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AssetsNoncurrent_iI_zYu0GCBj0U15" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total long-term assets&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;28,018,078&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;28,568,316&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;550,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--OperatingLeaseLiabilityCurrentRestatementImpact_iI_zV5Lsmzs6zX9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Operating lease liabilities, current&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;281,797&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;159,423&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(122,374&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DerivativeLiabilitiesCurrent_iI_zxK5uK4Xu5t7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Warrant derivative liability&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;588,205&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0601"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(588,205&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--LiabilitiesCurrentRestatementImpact_iI_zcX5gpj013m1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total current liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,760,616&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,050,037&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(710,579&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zAZyNo5AY9uj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Operating lease liabilities, long-term&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;379,466&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,481,967&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,102,501&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LiabilitiesNoncurrent_iI_zeRaeufH1G8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total long-term liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;822,849&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,925,350&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,102,501&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AdditionalPaidInCapital_iI_zmMRlkMLIJZj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Additional paid-in capital&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;109,993,100&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;112,642,726&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,649,626&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zz9tAYWDUSnc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Accumulated deficit&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(54,586,793&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(57,078,103&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(2,491,310&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--StockholdersEquityRestatement_iI_z1d3aGID1Wt2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total shareholders&#x2019; equity&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;54,609,625&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;54,767,941&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;158,316&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_z7xYP0md9CXe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total liabilities and stockholders&#x2019; equity&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;60,193,090&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;60,743,328&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;550,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zCkwzAt0N4Gl"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49B_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zXWdYMkcEnHd"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zmsSZnt9OMe3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Consolidated Statement of Operations&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;For the year ended April 30, 2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Originally&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;As&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Restated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Change&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncreaseDecreaseInDerivativeAssetsAndLiabilities_zPjADrAsg60l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Change in fair value of derivative liability&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;(1,019,292&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0633"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;1,019,292&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NetIncomeLoss_zNvjvy3NUWNc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Net loss&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(27,087,737&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(28,107,029&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(1,019,292&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zjYLGJLijuGc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Amounts
presented as originally reported as of April 30, 2023 are exclusive of Discontinued Operations with the exception of (i) change in fair
value of derivative liability, (ii) net loss, and (iii) Consolidated Balance Sheet totals. The Consolidated Statement of Cash Flows is
not presented above as there was no change in net cash used in operating activities of continuing operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_857_z2bELDmieZlc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zkZvGA0mBHSh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_863_zyRmJgruZNZd"&gt;Principles of Consolidation&lt;/span&gt;&lt;/b&gt;
&#x2013; &lt;span style="background-color: white"&gt;Our consolidated financial statements include the accounts of our wholly owned subsidiaries
which include Teal and Skypersonic as well as Rotor Riot and Fat Shark which were sold on February 16, 2024. Non-majority owned investments,
including the formerly wholly owned subsidiaries Rotor Riot and Fat Shark, are accounted for using the equity method when the Company
is able to significantly influence the operating policies of the investee. Intercompany transactions and balances have been eliminated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;The
Consumer segment businesses are characterized as discontinued operations in these financial statements.&#160; The operating results and
cash flows of discontinued operations are separately stated in those respective financial statements. See Note 3. &lt;/span&gt;&lt;/p&gt;
&lt;p id="xdx_851_zCQiBK40AJg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--UseOfEstimates_zqrdyK4RO69i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86A_zBAJUmoHd7A7"&gt;Use of Estimates&lt;/span&gt;&lt;/b&gt; &#x2013;&lt;span style="background-color: white"&gt;&#160;The
preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the
reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates
reflected in these financial statements include those used to (i) complete purchase price accounting for acquisitions,  (ii) the evaluation of long-term assets, including goodwill, for impairment,
and (iii) the evaluation of other-than-temporary-impairment of equity method investments.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85B_z3oVXhzOnpVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zSCZZ1XMQgNj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86F_zWXrT1PWaWk1"&gt;Cash and Cash Equivalents&lt;/span&gt; &lt;/b&gt;&#x2013; At April
30, 2024, we had cash of $&lt;span id="xdx_90D_eus-gaap--Cash_iI_c20240430_zDhCfMNsSqrd"&gt;6,067,169&lt;/span&gt; in multiple commercial banks and financial services companies. We have not experienced any loss on
these cash balances and believe they are not exposed to any significant credit risk.&lt;/p&gt;

&lt;p id="xdx_859_zI5S9I5ZzCok" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p id="xdx_843_eus-gaap--MarketableSecuritiesPolicy_zPBL5OWH1NVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span&gt;&lt;span id="xdx_862_zEb69Umoc0T3"&gt;Marketable Securities&lt;/span&gt;&lt;/span&gt; &lt;/b&gt;&#x2013; Our marketable
securities were classified and accounted for as available-for-sale securities. These securities were primarily invested in corporate bonds
and were readily saleable, and therefore, we have classified them as short term. Our available-for-sale securities were carried at fair
value with any unrealized gains and losses reported as a component of comprehensive income (loss). Once realized, any gains or losses
were recognized in the statement of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;We have elected to present accrued interest income
separately from marketable securities on our consolidated balance sheets. Accrued interest income was $&lt;span id="xdx_90D_eus-gaap--InterestAndDividendIncomeSecuritiesOther_c20230501__20240430_z3s3egVeqBJl"&gt;0&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--InterestAndDividendIncomeSecuritiesOther_c20220501__20230430_zmYMfQrnKUk7"&gt;151,671&lt;/span&gt; as of April 30,
2024 and April 30, 2023, respectively, and was included in other current assets. We did not write off any accrued interest income during
the years ended April 30, 2024 and April 30, 2023.&lt;/p&gt;

&lt;p id="xdx_85B_znwQguNJh3Ze" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--ReceivablesPolicyTextBlock_zzUwQf7dHQS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_864_zoZnjrvVWqQ9"&gt;Accounts Receivable, net&lt;/span&gt;&lt;/b&gt; &#x2013; &lt;span style="background-color: white"&gt;Accounts
receivable are recorded at the invoiced amount less allowances for doubtful accounts. The Company's estimate of the allowance for doubtful
accounts is based on a multitude of factors, including historical bad debt levels for its customer base, experience with a specific customer,
the economic environment, and other factors. Accounts receivable balances are written off against the allowance when it is probable that
the receivable will not be collected.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_851_zqj2otVRpYqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zoW6JvszIsA6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_zie9xKVIAR93"&gt;Concentration
of Credit Risk&lt;/span&gt; &lt;/b&gt;&#x2013; Financial instruments, which potentially subject the Company to concentrations of credit risk, include
trade receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company
performs ongoing credit evaluations of its customers, generally does not require collateral and considers the credit risk profile of
the customer from which the receivable is due in further evaluating collection risk. Customers that accounted for 10% or greater of
accounts receivable, net as of April&#160;30, 2024 and 2023 were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQaKUgLgYhkf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Customer concentration risk (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;April 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-align: left"&gt;Customer A&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zCN9cNhwol9i" style="width: 12%; text-align: right"&gt;53&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zElcIGrV5OD2" style="width: 12%; text-align: right"&gt;20&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zT9MUrfmoD3g" style="text-align: right"&gt;24&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;*&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer C&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;*&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk3Member_zfSzRhphaKsh" style="text-align: right"&gt;24&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer D&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;*&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk4Member_zLX4OaDIWoh6" style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer E&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;*&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk5Member_zCjPkuR5tOIc" style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A9_zdZqixz5godd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;* Accounts Receivable was less than 10%&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;As of April 30, 2024, three customers accounted for equal to or greater
than 10% of total revenue, totaling 28%, 23% and 10%, respectively. As of April 30, 2023, two customers accounted for equal to or greater
than 10% of total revenue, totaling 22% and 20%, respectively.&lt;/p&gt;

&lt;p id="xdx_857_z9LQfsPL8mb7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zxgsdOPYKXS2" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86A_zzZlSG6nNFdj" style="font-size: 10pt"&gt;&lt;b&gt;Inventories&lt;/b&gt;&lt;/span&gt;&lt;span style="font-size: 10pt"&gt;&#160;&#x2013;&#160;&lt;span style="background-color: white"&gt;Inventories,
which consist of raw materials, work-in-process, and finished goods, are stated at the lower of cost or net realizable value, and
are measured using the first-in, first-out method. Cost components include direct materials, direct labor, indirect overhead, as
well as in-bound freight. At each balance sheet date, the Company evaluates the net realizable value of its inventory using various
reference measures including current product selling prices and recent customer demand, as well as evaluating for excess quantities
and obsolescence.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85C_zT5l4QmkQWUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zkY1ypyaw2r9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_866_zZii5SDJXWqk"&gt;Goodwill and Long-lived
Assets&lt;/span&gt;&lt;/b&gt; &#x2013; Goodwill represents the future economic benefit arising from other assets acquired in an acquisition&#160;that are
not individually identified and separately recognized. We test goodwill for impairment in accordance with the provisions of&#160;&lt;i&gt;ASC
350, Intangibles &#x2013; Goodwill and Other,&#160;&lt;/i&gt;(&#x201c;ASC 350&#x201d;). Goodwill is tested for impairment at least annually at
the reporting unit level or whenever events or changes in circumstances indicate that goodwill might be impaired. ASC 350 provides that
an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a
determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing
the totality of events or circumstances, an entity determines it is not more likely than not that the fair value of a reporting unit
is less than its carrying amount, then additional impairment testing is not required. However, if an entity concludes otherwise, then
it is required to perform an impairment test. The impairment test involves comparing the estimated fair value of a reporting unit with
its book value, including goodwill. If the estimated fair value exceeds book value, goodwill is considered not to be impaired. If, however,
the fair value of the reporting unit is less than book value, then an impairment loss is recognized in an amount equal to the amount
that the book value of the reporting unit exceeds its fair value, not to exceed the total amount of goodwill allocated to the reporting
unit.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;The estimate of fair value
of a reporting unit is computed using either an income approach, a market approach, or a combination of both. Under the income approach,
we utilize the discounted cash flow method to estimate the fair value of a reporting unit. Significant assumptions inherent in estimating
the fair values include the estimated future cash flows, growth assumptions for future revenues (including gross profit, operating expenses,
and capital expenditures), and a rate used to discount estimated future cash flow projections to their present value based on estimated
weighted average cost of capital (i.e., the selected discount rate). Our assumptions are based on historical data, supplemented by current
and anticipated market conditions, estimated growth rates, and management&#x2019;s plans. Under the market approach, fair value is derived
from metrics of publicly traded companies or historically completed transactions of comparable businesses. The selection of comparable
businesses is based on the markets in which the reporting units operate and consider risk profiles, size, geography, and diversity of
products and services.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;Goodwill for Teal is ascribed
to its existing relationship with several U.S. government agencies including its classification as an approved vendor. The Company expects
that the Goodwill recognized in each transaction will be deductible for tax purposes.&#160; The Company has reported net losses since
its inception and is presently unable to determine when and if the tax benefit of this deduction will be realized.&lt;/p&gt;

&lt;p id="xdx_85F_zg8gIXVmqzQb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zlK9paOcqBP1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_zCZchCcWsyZd"&gt;Property and equipment&lt;/span&gt; &#x2013; &lt;/b&gt;&lt;span style="background-color: white"&gt;Property
and equipment is stated at cost less accumulated depreciation which is calculated using the straight-line method over the estimated useful
life of the asset. The estimated useful lives of our property and equipment are generally: (i) furniture and fixtures - seven years,
(ii) equipment and related - two to five years, and (iii) leasehold improvements &#x2013; nine to fifteen years.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_857_z8gVcBYGcbW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--EquityMethodInvestmentsPolicy_zRNYqmezB3t2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86C_z3SozqVYzUWe"&gt;Equity Method Investment&lt;/span&gt; &#x2013; &lt;/b&gt;&lt;span style="background-color: white"&gt;The
equity method of accounting is applied to investments in which the Company has an ownership interest of between 20% and 50%. The Company
evaluates its equity method investments each reporting period for evidence of a loss in value that is other than a temporary decline.
Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount
of the investment or the inability of the investee to sustain an earnings capacity that would justify the carrying amount of the investment.
The Company performed this analysis and concluded that its investment in UMAC was other-than-temporarily impaired and recognized an impairment
charge of $&lt;span id="xdx_906_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_c20230501__20240430_zLjRlyQIuHVk"&gt;11,353,875&lt;/span&gt; for the year ended April&#160;30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_857_zy7AdKmGwC28" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--RevenueRecognitionLeasesOperating_zwjyPe10sMh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86C_zahzqreQGjDg"&gt;Leases&lt;/span&gt; &#x2013; &lt;/b&gt;Accounting Standards Codification
(ASC) 842 requires the recognition of assets and liabilities associated with lease agreements. &lt;span style="background-color: white"&gt;The
Company determines if a contract is a lease or contains a lease at inception. Operating lease liabilities are measured, on each reporting
date, based on the present value of the future minimum lease payments over the remaining lease term. The Company's leases do not provide
an implicit rate.&#160;Therefore, the Company uses an effective discount rate of 12% based on its last debt financing.&#160;Operating
lease assets are measured by adjusting the lease liability for lease incentives, initial direct costs incurred and asset impairments.
Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term with the operating lease asset reduced
by the amount of the expense. Lease terms may include options to extend or terminate a lease when they are reasonably certain to occur.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_856_z8yK5E1mh1Ec" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zEG4RIQjII5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_860_zhrT8UDCrKS"&gt;Fair Values, Inputs and Valuation Techniques for
Financial Assets and Liabilities, and Related Disclosures&lt;/span&gt;&lt;/b&gt; &#x2013; The fair value measurements and disclosure guidance defines fair
value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset
or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. In accordance
with this guidance, the Company has categorized its recurring basis financial assets and liabilities into a three-level fair value hierarchy
based on the priority of the inputs to the valuation technique.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value hierarchy gives the highest priority
to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level
3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the
fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input
that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input
to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;The guidance establishes
three levels of the fair value hierarchy as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"&gt;&lt;i&gt;Level 1&lt;/i&gt;:
Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"&gt;&lt;i&gt;Level 2&lt;/i&gt;:
Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical
or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable
market data for substantially the full term of the related assets or liabilities; and&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"&gt;&lt;i&gt;Level 3&lt;/i&gt;:
Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little
or no market data.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Disclosures for Non-Financial Assets Measured at
Fair Value on a Non-Recurring Basis&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company's financial instruments mainly consist
of cash, receivables, current assets, accounts payable, accrued expenses and debt. The carrying amounts of these instruments approximates
fair value due to their short-term nature.&lt;/p&gt;

&lt;p id="xdx_85E_zCKWxkzpA9Ml" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--RevenueRecognitionPolicyTextBlock_zU59Ys8Odozl" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86C_zxp8L7adoPgg"&gt;Revenue Recognition&lt;/span&gt; &lt;/b&gt;&#x2013; The Company
recognizes revenue in accordance with ASC Topic 606 - Revenue from Contracts with Customers, issued by the Financial Accounting Standards
Board (&#x201c;FASB&#x201d;). This standard includes a comprehensive evaluation of factors to be considered regarding revenue recognition
including (i) identifying the promised goods, (ii) evaluating performance obligations, (iii) measuring the transaction price, (iv) allocating
the transaction price to the performance obligations if there are multiple components, and (v) recognizing revenue as each obligation
is satisfied.&#160;The Company&#x2019;s revenue transactions include the shipment of goods to customers as orders are fulfilled, completion
of non-recurring engineering, completion of training, and customer support services. The Company recognizes revenue upon shipment of product
or prototypes unless otherwise specified in the purchase order or contract. Customer deposits totaled $&lt;span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240430_zTRmOLvQ36X4"&gt;53,939&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20230430_zUyPr8922sC6"&gt;155,986&lt;/span&gt; at April 30,
2024 and April 30, 2023, respectively. From time to time, non-recurring engineering contracts may involve the capitalization of engineering
prototypes, classified as contract assets. Contract assets totaled $&lt;span id="xdx_907_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20240430_zhdr7vv0kb34"&gt;1,477,859&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20230430_zIBr7xEVQFj3"&gt;0&lt;/span&gt; at April 30, 2024 and April 30, 2023, respectively.&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table presents the Company&#x2019;s
revenue disaggregated by revenue type:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_zet5crVfizG" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Company's revenue disaggregated by revenue type (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20230501__20240430_zMjAJJjOleO3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_499_20220501__20230430_zmPFbgIgRww1" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Year Ended&#160;April 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zdwJLPvW4QR9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-size: 10pt; text-align: left"&gt;Contract related&lt;/td&gt;&lt;td style="width: 8%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;4,173,005&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;1,312,427&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomer_zm0HlgsW7Fbk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Product related&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;13,663,377&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;3,308,407&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Revenues_zPnw8zXZaaAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;17,836,382&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;4,620,834&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A9_zKDDmRXWSIx6" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_854_zGLhvXkLfpFa" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_z92tZr6bcLMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_862_zlvGi8T6cAC7"&gt;Research and Development&lt;/span&gt; &lt;/b&gt;&#x2013; Research and
development expenses include payroll, employee benefits, and other headcount-related expenses associated with product development. Research
and development expenses also include third-party development and programming costs, materials, and a proportionate share of overhead
costs such as rent.&lt;/p&gt;

&lt;p id="xdx_854_zO2c0Kh2SYg6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zrulqYFkDsq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_zT5ZW2pySwOe"&gt;Product
Warranty&lt;/span&gt; - &lt;/b&gt;The Company accrues an estimate of its exposure to warranty claims based upon both current and historical
product sales data and warranty costs incurred. Product warranty reserves are recorded in current liabilities under accrued
expenses.&#160;Warranty liability was $&lt;span id="xdx_90D_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240430_zkpemxJKlCd5"&gt;372,000&lt;/span&gt;
and $&lt;span id="xdx_90A_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20230430_zNpyM4tHDtmk"&gt;90,000&lt;/span&gt; as of April 30, 2024
and April 30, 2023 respectively.&lt;/p&gt;

&lt;p id="xdx_858_zaPoXhhgw6Ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zRkFoxX8Urv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_zhFDWVR5zHo1"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt; &#x2013; Deferred taxes are provided
on the liability method whereby deferred tax assets are recognized for deductible temporary differences and deferred tax liabilities are
recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities
and their tax bases. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of
enactment.&#160;&lt;/p&gt;

&lt;p id="xdx_853_zBAPanN5HK0j" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zvxhnOmm86Mb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86A_zg7JfXrxaVQj"&gt;Recent Accounting Pronouncements&lt;/span&gt; &lt;/b&gt;&#x2013; &lt;span style="background-color: white"&gt;Management
does not believe that recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the
accompanying consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85A_zfRIZnPqn77l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zKHsbsxKpxej" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_z4k4QCX9HQR"&gt;Foreign Currency&lt;/span&gt; &#x2013; &lt;/b&gt;The functional currency
of our former international subsidiary, Skyset, was the local Italian currency. For that subsidiary, we translated assets and liabilities
to U.S. dollars using period-end exchange rates, and average monthly exchange rates for revenues, costs, and expenses. We recorded translation
gains and losses in accumulated other comprehensive income.&lt;/p&gt;

&lt;p id="xdx_857_zTFTHwMuepS6" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&#160;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zeZrDIVXtY43" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86C_zWiNRp5rUhJ3"&gt;Comprehensive Loss&lt;/span&gt; &lt;/b&gt;&#x2013; Comprehensive loss
consists of net loss and other comprehensive loss. Other comprehensive loss refers to gains and losses that are recorded as an element
of stockholders' equity but are excluded from net loss. Our other comprehensive loss is comprised of foreign currency translation adjustments
and unrealized gains or losses on available-for-sale securities. During the year ended April 30, 2024, comprehensive loss was $&lt;span id="xdx_906_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20230501__20240430_z20MHAd0Bx09"&gt;865,738&lt;/span&gt;
lower than net loss, related to unrealized gains on available-for-sale securities totaling $&lt;span id="xdx_902_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20230501__20240430_zu9aCfjA5Wh3"&gt;864,165&lt;/span&gt; and foreign currency translation adjustments
of $&lt;span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20230501__20240430_zA7NB9TbVz76"&gt;1,573&lt;/span&gt;. During the year ended April 30, 2023, comprehensive loss was $&lt;span id="xdx_901_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20220501__20230430_zCjsInfVH5i4"&gt;609,155&lt;/span&gt; lower than net loss, related to unrealized gains on available-for-sale
securities totaling $&lt;span id="xdx_901_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20220501__20230430_zUYz8lZOzpvd"&gt;610,129&lt;/span&gt;, partially offset by foreign currency translation adjustments of $&lt;span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20220501__20230430_zmMIZSeEG8Ma"&gt;974&lt;/span&gt;.&#160;&lt;/p&gt;

&lt;p id="xdx_85E_zQ3z2lCecTVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zIYMkuiE3t7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_862_ziZAPTrXDv1a"&gt;Stock-Based Compensation&lt;/span&gt; &lt;/b&gt;&#x2013; S&lt;span style="background-color: white"&gt;tock
options are valued using the estimated grant-date fair value method of accounting in accordance with ASC Topic 718, Compensation &#x2013;
Stock Compensation. Fair value is determined based on the Black-Scholes Model using inputs reflecting our estimates of expected volatility,
term and future dividends. We recognize forfeitures as they occur. The fair value of restricted stock is based on our stock price on the
date of grant. Compensation cost is recognized on a straight-line basis over the service period which is the vesting term.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85D_z8yricEN9N3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zxizuRADbMh3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86E_zNqdQaJZswfb"&gt;Basic and Diluted Net Loss per Share&lt;/span&gt;&lt;/b&gt; &#x2013;
Basic and diluted net loss per share has been calculated by dividing net loss by the weighted average number of shares of common stock
outstanding during the period. Common stock equivalents were excluded from the computation of diluted net loss per share of common stock
because they were anti-dilutive. The conversion or exercise of these common stock equivalents would dilute earnings per share if we become
profitable in the future. Outstanding securities not included in the computation of diluted net loss per share because their effect would
have been anti-dilutive include:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z9tJBwS9KIPf" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_494_20230501__20240430_zqag83BE45nl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20220501__20230430_zgFS9fM9BDJi" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_zgjK8cfnMyAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Series B Preferred Stock, as converted&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;3,896&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;822,230&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_zhEgkUq1hHz2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Stock options&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;6,779,934&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,784,809&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_zOCXNCCHhdL2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt"&gt;Warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,275,999&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,539,999&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_zfeTr9nC4ms5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Restricted stock&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;175,130&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;781,060&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zGwJOfxndp3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;9,234,959&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;7,928,098&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zQiqjBwavoJ5" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_85C_zOiYa4Rs803g" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zCXtklxqrUV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_866_zNIcK9TfCCch"&gt;Related Parties&lt;/span&gt;&lt;/b&gt; &#x2013; Parties are considered
to be related to us if they have control or significant influence, directly or indirectly, over us, including key management personnel
and members of the Board of Directors or are direct relatives of key management personnel of members of the Board of Directors. Related
Party transactions are disclosed in Note 20.&lt;/p&gt;

&lt;p id="xdx_85E_zYopETudmrMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zTlQsOqnNxS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_86B_zY3r2rak3238"&gt;Liquidity
and Going Concern&lt;/span&gt; &lt;/b&gt;&#x2013; The Company has never been profitable and has incurred net losses related to acquisitions, as well as costs
incurred to pursue its long-term growth strategy. During the year ended April 30, 2024, the Company incurred a net loss from continuing
&lt;/span&gt;operations of $&lt;span id="xdx_909_eus-gaap--IncomeLossFromContinuingOperations_dxL_c20230501__20240430_zSzkm1Ldsnmh" title="::XDX::-21526696"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0737"&gt;21,526,696&lt;/span&gt;&lt;/span&gt;&#160;and used cash in operating activities of continuing operations of $&lt;span id="xdx_903_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_dxL_c20230501__20240430_zaIhyh0n4g01" title="::XDX::-17687063"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0738"&gt;17,687,063&lt;/span&gt;&lt;/span&gt;. As of April 30,
2024, working capital for continuing operations totaled $&lt;span id="xdx_907_eus-gaap--Capital_iI_c20240430_zQPgJOzWJ7ca"&gt;18,746,419&lt;/span&gt;. These financial results and our financial position &lt;span style="background-color: white"&gt;at&#160;April
30, 2024&#160;raise substantial doubt about our ability to continue as a going concern. However, the Company has recently taken actions
to strengthen its liquidity.&#160;On&#160;December 11, 2023, we completed a public offering of 18,400,000 shares of common stock which
generated net proceeds of approximately $8,400,000 as further described in Note 1 and Note 16. In addition, the Company&#x2019;s operating
plan for the next twelve months has been updated to reflect recent operating improvements.&#160; Revenues have accelerated and are expected
to continue growing. The Company&#x2019;s manufacturing facility is scaling production and gross profits are projected to increase.&#160;&lt;span style="background-color: white"&gt;If necessary, the Company will seek
to obtain additional debt financing for which there can be no guarantee.&lt;/span&gt; Subsequent
to year end, as further described in Note 22, the Company sold its equity method investment for $4,400,000. Management has concluded
that these recent positive developments alleviate any substantial doubt about the Company&#x2019;s ability to&#160;continue its operations,
and meet its financial obligations, for twelve months from the date these consolidated financial statements&#160;are&#160;issued.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85D_ziynwxu1WGN5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-8466">&lt;p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zcACN2x0a8Jg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86F_zWm6aVzxMiw7"&gt;Basis of Accounting&lt;/span&gt; &lt;/b&gt;&#x2013; The financial statements
and accompanying notes are prepared in accordance with generally accepted accounting principles in the United States (&#x201c;GAAP&#x201d;).
Certain prior period amounts have been restated to conform to the current year presentation.&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <RCAT:RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-8471">&lt;p id="xdx_84D_ecustom--RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock_zdZxPdSJcoK8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_869_zUpKgUyCkTh4"&gt;Restatement of Previously Issued Consolidated Financial Statements&lt;/span&gt; &lt;/b&gt;&#x2013;
The Company&#x2019;s Consolidated Balance Sheet as of April 30, 2023, Consolidated Statement of Operations, Stockholders&#x2019; Equity
and Cash Flows for the year then ended, and its Notes to the Consolidated Financial Statements for the year ended April 30, 2023, which
were originally filed with the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on July 27, 2023 (the &#x201c;Original Form
10-K&#x201d;), have been restated. The Company revised its accounting estimate of the life of an operating lease that was previously reported
in its Original Form 10-K. Upon further evaluation, the Company determined that prior year adjustments were necessary. These Consolidated
Financial Statements were restated to reflect a change in accounting estimate of the life of the operating lease under FASB ASC Topic
842 from three to nine years. Additionally, the Company revised its financial statements to&#160;remove derivative liabilities due to
erroneously reporting warrants from our convertible note financings, as described in Note 18, as having a derivative component.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The impacts of these restatements are detailed
in the tables below:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_z37Q9DXaN6uh" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49B_20230430__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zSBEY5ZMCnF2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20230430__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zJcotfhJMGR4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_494_20230430__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zE2BMOTeUBXc"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Consolidated Balance Sheet&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;As of April 30, 2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Originally&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;As&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Restated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Change&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zEXj3ClQpUhe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Operating lease right-of-use assets&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;620,307&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;1,600,434&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;980,127&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AssetsNoncurrent_iI_zYu0GCBj0U15" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total long-term assets&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;28,018,078&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;28,568,316&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;550,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--OperatingLeaseLiabilityCurrentRestatementImpact_iI_zV5Lsmzs6zX9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Operating lease liabilities, current&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;281,797&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;159,423&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(122,374&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DerivativeLiabilitiesCurrent_iI_zxK5uK4Xu5t7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Warrant derivative liability&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;588,205&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0601"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(588,205&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--LiabilitiesCurrentRestatementImpact_iI_zcX5gpj013m1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total current liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,760,616&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,050,037&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(710,579&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zAZyNo5AY9uj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Operating lease liabilities, long-term&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;379,466&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,481,967&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,102,501&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LiabilitiesNoncurrent_iI_zeRaeufH1G8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total long-term liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;822,849&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,925,350&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,102,501&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AdditionalPaidInCapital_iI_zmMRlkMLIJZj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Additional paid-in capital&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;109,993,100&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;112,642,726&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,649,626&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zz9tAYWDUSnc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Accumulated deficit&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(54,586,793&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(57,078,103&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(2,491,310&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--StockholdersEquityRestatement_iI_z1d3aGID1Wt2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total shareholders&#x2019; equity&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;54,609,625&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;54,767,941&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;158,316&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_z7xYP0md9CXe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total liabilities and stockholders&#x2019; equity&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;60,193,090&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;60,743,328&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;550,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zCkwzAt0N4Gl"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49B_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zXWdYMkcEnHd"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zmsSZnt9OMe3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Consolidated Statement of Operations&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;For the year ended April 30, 2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Originally&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;As&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Restated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Change&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncreaseDecreaseInDerivativeAssetsAndLiabilities_zPjADrAsg60l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Change in fair value of derivative liability&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;(1,019,292&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0633"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;1,019,292&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NetIncomeLoss_zNvjvy3NUWNc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Net loss&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(27,087,737&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(28,107,029&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(1,019,292&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zjYLGJLijuGc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Amounts
presented as originally reported as of April 30, 2023 are exclusive of Discontinued Operations with the exception of (i) change in fair
value of derivative liability, (ii) net loss, and (iii) Consolidated Balance Sheet totals. The Consolidated Statement of Cash Flows is
not presented above as there was no change in net cash used in operating activities of continuing operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

</RCAT:RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock>
    <RCAT:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-8486">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_z37Q9DXaN6uh" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49B_20230430__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zSBEY5ZMCnF2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20230430__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zJcotfhJMGR4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_494_20230430__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zE2BMOTeUBXc"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Consolidated Balance Sheet&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;As of April 30, 2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Originally&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;As&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Restated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Change&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zEXj3ClQpUhe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Operating lease right-of-use assets&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;620,307&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;1,600,434&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;980,127&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AssetsNoncurrent_iI_zYu0GCBj0U15" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total long-term assets&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;28,018,078&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;28,568,316&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;550,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--OperatingLeaseLiabilityCurrentRestatementImpact_iI_zV5Lsmzs6zX9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Operating lease liabilities, current&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;281,797&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;159,423&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(122,374&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DerivativeLiabilitiesCurrent_iI_zxK5uK4Xu5t7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Warrant derivative liability&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;588,205&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0601"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(588,205&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--LiabilitiesCurrentRestatementImpact_iI_zcX5gpj013m1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total current liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,760,616&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,050,037&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(710,579&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zAZyNo5AY9uj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Operating lease liabilities, long-term&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;379,466&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,481,967&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,102,501&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LiabilitiesNoncurrent_iI_zeRaeufH1G8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total long-term liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;822,849&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,925,350&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,102,501&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AdditionalPaidInCapital_iI_zmMRlkMLIJZj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Additional paid-in capital&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;109,993,100&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;112,642,726&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,649,626&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zz9tAYWDUSnc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Accumulated deficit&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(54,586,793&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(57,078,103&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(2,491,310&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--StockholdersEquityRestatement_iI_z1d3aGID1Wt2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total shareholders&#x2019; equity&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;54,609,625&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;54,767,941&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;158,316&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_z7xYP0md9CXe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total liabilities and stockholders&#x2019; equity&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;60,193,090&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;60,743,328&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;550,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zCkwzAt0N4Gl"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49B_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zXWdYMkcEnHd"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20220501__20230430__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zmsSZnt9OMe3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Consolidated Statement of Operations&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;For the year ended April 30, 2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Originally&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;As&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Restated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Change&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncreaseDecreaseInDerivativeAssetsAndLiabilities_zPjADrAsg60l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Change in fair value of derivative liability&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;(1,019,292&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0633"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;1,019,292&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NetIncomeLoss_zNvjvy3NUWNc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Net loss&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(27,087,737&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(28,107,029&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(1,019,292&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RCAT:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-14900"
      unitRef="USD">620307</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember"
      decimals="0"
      id="ixv-14901"
      unitRef="USD">1600434</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-14902"
      unitRef="USD">980127</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-14903"
      unitRef="USD">28018078</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember"
      decimals="0"
      id="ixv-14904"
      unitRef="USD">28568316</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-14905"
      unitRef="USD">550238</us-gaap:AssetsNoncurrent>
    <RCAT:OperatingLeaseLiabilityCurrentRestatementImpact
      contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-14906"
      unitRef="USD">281797</RCAT:OperatingLeaseLiabilityCurrentRestatementImpact>
    <RCAT:OperatingLeaseLiabilityCurrentRestatementImpact
      contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember"
      decimals="0"
      id="ixv-14907"
      unitRef="USD">159423</RCAT:OperatingLeaseLiabilityCurrentRestatementImpact>
    <RCAT:OperatingLeaseLiabilityCurrentRestatementImpact
      contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-14908"
      unitRef="USD">-122374</RCAT:OperatingLeaseLiabilityCurrentRestatementImpact>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-14909"
      unitRef="USD">588205</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-14910"
      unitRef="USD">-588205</us-gaap:DerivativeLiabilitiesCurrent>
    <RCAT:LiabilitiesCurrentRestatementImpact
      contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-14911"
      unitRef="USD">4760616</RCAT:LiabilitiesCurrentRestatementImpact>
    <RCAT:LiabilitiesCurrentRestatementImpact
      contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember"
      decimals="0"
      id="ixv-14912"
      unitRef="USD">4050037</RCAT:LiabilitiesCurrentRestatementImpact>
    <RCAT:LiabilitiesCurrentRestatementImpact
      contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-14913"
      unitRef="USD">-710579</RCAT:LiabilitiesCurrentRestatementImpact>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-14914"
      unitRef="USD">379466</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember"
      decimals="0"
      id="ixv-14915"
      unitRef="USD">1481967</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-14916"
      unitRef="USD">1102501</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-14917"
      unitRef="USD">822849</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember"
      decimals="0"
      id="ixv-14918"
      unitRef="USD">1925350</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-14919"
      unitRef="USD">1102501</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-14920"
      unitRef="USD">109993100</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember"
      decimals="0"
      id="ixv-14921"
      unitRef="USD">112642726</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-14922"
      unitRef="USD">2649626</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-14923"
      unitRef="USD">-54586793</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember"
      decimals="0"
      id="ixv-14924"
      unitRef="USD">-57078103</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-14925"
      unitRef="USD">-2491310</us-gaap:RetainedEarningsAccumulatedDeficit>
    <RCAT:StockholdersEquityRestatement
      contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-14926"
      unitRef="USD">54609625</RCAT:StockholdersEquityRestatement>
    <RCAT:StockholdersEquityRestatement
      contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember"
      decimals="0"
      id="ixv-14927"
      unitRef="USD">54767941</RCAT:StockholdersEquityRestatement>
    <RCAT:StockholdersEquityRestatement
      contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-14928"
      unitRef="USD">158316</RCAT:StockholdersEquityRestatement>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-04-30_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-14929"
      unitRef="USD">60193090</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-04-30_custom_RestatementImpactAsRestatedMember"
      decimals="0"
      id="ixv-14930"
      unitRef="USD">60743328</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-04-30_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-14931"
      unitRef="USD">550238</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities
      contextRef="From2022-05-012023-04-30_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-14932"
      unitRef="USD">-1019292</us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities>
    <us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities
      contextRef="From2022-05-012023-04-30_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-14933"
      unitRef="USD">1019292</us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-14934"
      unitRef="USD">-27087737</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30_custom_RestatementImpactAsRestatedMember"
      decimals="0"
      id="ixv-14935"
      unitRef="USD">-28107029</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-14936"
      unitRef="USD">-1019292</us-gaap:NetIncomeLoss>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-8766">&lt;p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zkZvGA0mBHSh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_863_zyRmJgruZNZd"&gt;Principles of Consolidation&lt;/span&gt;&lt;/b&gt;
&#x2013; &lt;span style="background-color: white"&gt;Our consolidated financial statements include the accounts of our wholly owned subsidiaries
which include Teal and Skypersonic as well as Rotor Riot and Fat Shark which were sold on February 16, 2024. Non-majority owned investments,
including the formerly wholly owned subsidiaries Rotor Riot and Fat Shark, are accounted for using the equity method when the Company
is able to significantly influence the operating policies of the investee. Intercompany transactions and balances have been eliminated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;The
Consumer segment businesses are characterized as discontinued operations in these financial statements.&#160; The operating results and
cash flows of discontinued operations are separately stated in those respective financial statements. See Note 3. &lt;/span&gt;&lt;/p&gt;
</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2023-05-01to2024-04-30" id="ixv-8779">&lt;p id="xdx_842_eus-gaap--UseOfEstimates_zqrdyK4RO69i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86A_zBAJUmoHd7A7"&gt;Use of Estimates&lt;/span&gt;&lt;/b&gt; &#x2013;&lt;span style="background-color: white"&gt;&#160;The
preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the
reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates
reflected in these financial statements include those used to (i) complete purchase price accounting for acquisitions,  (ii) the evaluation of long-term assets, including goodwill, for impairment,
and (iii) the evaluation of other-than-temporary-impairment of equity method investments.&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-8785">&lt;p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zSCZZ1XMQgNj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86F_zWXrT1PWaWk1"&gt;Cash and Cash Equivalents&lt;/span&gt; &lt;/b&gt;&#x2013; At April
30, 2024, we had cash of $&lt;span id="xdx_90D_eus-gaap--Cash_iI_c20240430_zDhCfMNsSqrd"&gt;6,067,169&lt;/span&gt; in multiple commercial banks and financial services companies. We have not experienced any loss on
these cash balances and believe they are not exposed to any significant credit risk.&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:Cash
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14937"
      unitRef="USD">6067169</us-gaap:Cash>
    <us-gaap:MarketableSecuritiesPolicy contextRef="From2023-05-01to2024-04-30" id="ixv-8801">&lt;p id="xdx_843_eus-gaap--MarketableSecuritiesPolicy_zPBL5OWH1NVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span&gt;&lt;span id="xdx_862_zEb69Umoc0T3"&gt;Marketable Securities&lt;/span&gt;&lt;/span&gt; &lt;/b&gt;&#x2013; Our marketable
securities were classified and accounted for as available-for-sale securities. These securities were primarily invested in corporate bonds
and were readily saleable, and therefore, we have classified them as short term. Our available-for-sale securities were carried at fair
value with any unrealized gains and losses reported as a component of comprehensive income (loss). Once realized, any gains or losses
were recognized in the statement of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;We have elected to present accrued interest income
separately from marketable securities on our consolidated balance sheets. Accrued interest income was $&lt;span id="xdx_90D_eus-gaap--InterestAndDividendIncomeSecuritiesOther_c20230501__20240430_z3s3egVeqBJl"&gt;0&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--InterestAndDividendIncomeSecuritiesOther_c20220501__20230430_zmYMfQrnKUk7"&gt;151,671&lt;/span&gt; as of April 30,
2024 and April 30, 2023, respectively, and was included in other current assets. We did not write off any accrued interest income during
the years ended April 30, 2024 and April 30, 2023.&lt;/p&gt;

</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:InterestAndDividendIncomeSecuritiesOther
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14938"
      unitRef="USD">0</us-gaap:InterestAndDividendIncomeSecuritiesOther>
    <us-gaap:InterestAndDividendIncomeSecuritiesOther
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14939"
      unitRef="USD">151671</us-gaap:InterestAndDividendIncomeSecuritiesOther>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-8811">&lt;p id="xdx_84C_eus-gaap--ReceivablesPolicyTextBlock_zzUwQf7dHQS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_864_zoZnjrvVWqQ9"&gt;Accounts Receivable, net&lt;/span&gt;&lt;/b&gt; &#x2013; &lt;span style="background-color: white"&gt;Accounts
receivable are recorded at the invoiced amount less allowances for doubtful accounts. The Company's estimate of the allowance for doubtful
accounts is based on a multitude of factors, including historical bad debt levels for its customer base, experience with a specific customer,
the economic environment, and other factors. Accounts receivable balances are written off against the allowance when it is probable that
the receivable will not be collected.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2023-05-01to2024-04-30" id="ixv-8817">&lt;p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zoW6JvszIsA6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_zie9xKVIAR93"&gt;Concentration
of Credit Risk&lt;/span&gt; &lt;/b&gt;&#x2013; Financial instruments, which potentially subject the Company to concentrations of credit risk, include
trade receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company
performs ongoing credit evaluations of its customers, generally does not require collateral and considers the credit risk profile of
the customer from which the receivable is due in further evaluating collection risk. Customers that accounted for 10% or greater of
accounts receivable, net as of April&#160;30, 2024 and 2023 were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQaKUgLgYhkf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Customer concentration risk (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;April 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-align: left"&gt;Customer A&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zCN9cNhwol9i" style="width: 12%; text-align: right"&gt;53&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zElcIGrV5OD2" style="width: 12%; text-align: right"&gt;20&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zT9MUrfmoD3g" style="text-align: right"&gt;24&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;*&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer C&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;*&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk3Member_zfSzRhphaKsh" style="text-align: right"&gt;24&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer D&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;*&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk4Member_zLX4OaDIWoh6" style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer E&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;*&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk5Member_zCjPkuR5tOIc" style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A9_zdZqixz5godd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;* Accounts Receivable was less than 10%&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;As of April 30, 2024, three customers accounted for equal to or greater
than 10% of total revenue, totaling 28%, 23% and 10%, respectively. As of April 30, 2023, two customers accounted for equal to or greater
than 10% of total revenue, totaling 22% and 20%, respectively.&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-8822">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQaKUgLgYhkf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Customer concentration risk (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;April 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-align: left"&gt;Customer A&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zCN9cNhwol9i" style="width: 12%; text-align: right"&gt;53&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zElcIGrV5OD2" style="width: 12%; text-align: right"&gt;20&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zT9MUrfmoD3g" style="text-align: right"&gt;24&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;*&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer C&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;*&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk3Member_zfSzRhphaKsh" style="text-align: right"&gt;24&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer D&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;*&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk4Member_zLX4OaDIWoh6" style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer E&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;*&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk5Member_zCjPkuR5tOIc" style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-05-012024-04-30_custom_CustomerConcentrationRisk1Member"
      decimals="INF"
      id="ixv-14940"
      unitRef="Pure">0.53</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-05-012023-04-30_custom_CustomerConcentrationRisk1Member"
      decimals="INF"
      id="ixv-14941"
      unitRef="Pure">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-05-012024-04-30_custom_CustomerConcentrationRisk2Member"
      decimals="INF"
      id="ixv-14942"
      unitRef="Pure">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-05-012023-04-30_custom_CustomerConcentrationRisk3Member"
      decimals="INF"
      id="ixv-14943"
      unitRef="Pure">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-05-012023-04-30_custom_CustomerConcentrationRisk4Member"
      decimals="INF"
      id="ixv-14944"
      unitRef="Pure">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-05-012023-04-30_custom_CustomerConcentrationRisk5Member"
      decimals="INF"
      id="ixv-14945"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-8889">&lt;p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zxgsdOPYKXS2" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86A_zzZlSG6nNFdj" style="font-size: 10pt"&gt;&lt;b&gt;Inventories&lt;/b&gt;&lt;/span&gt;&lt;span style="font-size: 10pt"&gt;&#160;&#x2013;&#160;&lt;span style="background-color: white"&gt;Inventories,
which consist of raw materials, work-in-process, and finished goods, are stated at the lower of cost or net realizable value, and
are measured using the first-in, first-out method. Cost components include direct materials, direct labor, indirect overhead, as
well as in-bound freight. At each balance sheet date, the Company evaluates the net realizable value of its inventory using various
reference measures including current product selling prices and recent customer demand, as well as evaluating for excess quantities
and obsolescence.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="From2023-05-01to2024-04-30" id="ixv-8898">&lt;p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zkY1ypyaw2r9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_866_zZii5SDJXWqk"&gt;Goodwill and Long-lived
Assets&lt;/span&gt;&lt;/b&gt; &#x2013; Goodwill represents the future economic benefit arising from other assets acquired in an acquisition&#160;that are
not individually identified and separately recognized. We test goodwill for impairment in accordance with the provisions of&#160;&lt;i&gt;ASC
350, Intangibles &#x2013; Goodwill and Other,&#160;&lt;/i&gt;(&#x201c;ASC 350&#x201d;). Goodwill is tested for impairment at least annually at
the reporting unit level or whenever events or changes in circumstances indicate that goodwill might be impaired. ASC 350 provides that
an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a
determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing
the totality of events or circumstances, an entity determines it is not more likely than not that the fair value of a reporting unit
is less than its carrying amount, then additional impairment testing is not required. However, if an entity concludes otherwise, then
it is required to perform an impairment test. The impairment test involves comparing the estimated fair value of a reporting unit with
its book value, including goodwill. If the estimated fair value exceeds book value, goodwill is considered not to be impaired. If, however,
the fair value of the reporting unit is less than book value, then an impairment loss is recognized in an amount equal to the amount
that the book value of the reporting unit exceeds its fair value, not to exceed the total amount of goodwill allocated to the reporting
unit.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;The estimate of fair value
of a reporting unit is computed using either an income approach, a market approach, or a combination of both. Under the income approach,
we utilize the discounted cash flow method to estimate the fair value of a reporting unit. Significant assumptions inherent in estimating
the fair values include the estimated future cash flows, growth assumptions for future revenues (including gross profit, operating expenses,
and capital expenditures), and a rate used to discount estimated future cash flow projections to their present value based on estimated
weighted average cost of capital (i.e., the selected discount rate). Our assumptions are based on historical data, supplemented by current
and anticipated market conditions, estimated growth rates, and management&#x2019;s plans. Under the market approach, fair value is derived
from metrics of publicly traded companies or historically completed transactions of comparable businesses. The selection of comparable
businesses is based on the markets in which the reporting units operate and consider risk profiles, size, geography, and diversity of
products and services.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;Goodwill for Teal is ascribed
to its existing relationship with several U.S. government agencies including its classification as an approved vendor. The Company expects
that the Goodwill recognized in each transaction will be deductible for tax purposes.&#160; The Company has reported net losses since
its inception and is presently unable to determine when and if the tax benefit of this deduction will be realized.&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-8918">&lt;p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zlK9paOcqBP1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_zCZchCcWsyZd"&gt;Property and equipment&lt;/span&gt; &#x2013; &lt;/b&gt;&lt;span style="background-color: white"&gt;Property
and equipment is stated at cost less accumulated depreciation which is calculated using the straight-line method over the estimated useful
life of the asset. The estimated useful lives of our property and equipment are generally: (i) furniture and fixtures - seven years,
(ii) equipment and related - two to five years, and (iii) leasehold improvements &#x2013; nine to fifteen years.&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:EquityMethodInvestmentsPolicy contextRef="From2023-05-01to2024-04-30" id="ixv-8924">&lt;p id="xdx_843_eus-gaap--EquityMethodInvestmentsPolicy_zRNYqmezB3t2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86C_z3SozqVYzUWe"&gt;Equity Method Investment&lt;/span&gt; &#x2013; &lt;/b&gt;&lt;span style="background-color: white"&gt;The
equity method of accounting is applied to investments in which the Company has an ownership interest of between 20% and 50%. The Company
evaluates its equity method investments each reporting period for evidence of a loss in value that is other than a temporary decline.
Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount
of the investment or the inability of the investee to sustain an earnings capacity that would justify the carrying amount of the investment.
The Company performed this analysis and concluded that its investment in UMAC was other-than-temporarily impaired and recognized an impairment
charge of $&lt;span id="xdx_906_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_c20230501__20240430_zLjRlyQIuHVk"&gt;11,353,875&lt;/span&gt; for the year ended April&#160;30, 2024.&lt;/span&gt;&lt;/p&gt;

</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14946"
      unitRef="USD">11353875</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:RevenueRecognitionLeasesOperating contextRef="From2023-05-01to2024-04-30" id="ixv-8931">&lt;p id="xdx_84D_eus-gaap--RevenueRecognitionLeasesOperating_zwjyPe10sMh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86C_zahzqreQGjDg"&gt;Leases&lt;/span&gt; &#x2013; &lt;/b&gt;Accounting Standards Codification
(ASC) 842 requires the recognition of assets and liabilities associated with lease agreements. &lt;span style="background-color: white"&gt;The
Company determines if a contract is a lease or contains a lease at inception. Operating lease liabilities are measured, on each reporting
date, based on the present value of the future minimum lease payments over the remaining lease term. The Company's leases do not provide
an implicit rate.&#160;Therefore, the Company uses an effective discount rate of 12% based on its last debt financing.&#160;Operating
lease assets are measured by adjusting the lease liability for lease incentives, initial direct costs incurred and asset impairments.
Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term with the operating lease asset reduced
by the amount of the expense. Lease terms may include options to extend or terminate a lease when they are reasonably certain to occur.&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionLeasesOperating>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-05-01to2024-04-30" id="ixv-8937">&lt;p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zEG4RIQjII5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_860_zhrT8UDCrKS"&gt;Fair Values, Inputs and Valuation Techniques for
Financial Assets and Liabilities, and Related Disclosures&lt;/span&gt;&lt;/b&gt; &#x2013; The fair value measurements and disclosure guidance defines fair
value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset
or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. In accordance
with this guidance, the Company has categorized its recurring basis financial assets and liabilities into a three-level fair value hierarchy
based on the priority of the inputs to the valuation technique.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value hierarchy gives the highest priority
to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level
3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the
fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input
that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input
to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;The guidance establishes
three levels of the fair value hierarchy as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"&gt;&lt;i&gt;Level 1&lt;/i&gt;:
Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"&gt;&lt;i&gt;Level 2&lt;/i&gt;:
Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical
or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable
market data for substantially the full term of the related assets or liabilities; and&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"&gt;&lt;i&gt;Level 3&lt;/i&gt;:
Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little
or no market data.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Disclosures for Non-Financial Assets Measured at
Fair Value on a Non-Recurring Basis&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company's financial instruments mainly consist
of cash, receivables, current assets, accounts payable, accrued expenses and debt. The carrying amounts of these instruments approximates
fair value due to their short-term nature.&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-8968">&lt;p id="xdx_843_eus-gaap--RevenueRecognitionPolicyTextBlock_zU59Ys8Odozl" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86C_zxp8L7adoPgg"&gt;Revenue Recognition&lt;/span&gt; &lt;/b&gt;&#x2013; The Company
recognizes revenue in accordance with ASC Topic 606 - Revenue from Contracts with Customers, issued by the Financial Accounting Standards
Board (&#x201c;FASB&#x201d;). This standard includes a comprehensive evaluation of factors to be considered regarding revenue recognition
including (i) identifying the promised goods, (ii) evaluating performance obligations, (iii) measuring the transaction price, (iv) allocating
the transaction price to the performance obligations if there are multiple components, and (v) recognizing revenue as each obligation
is satisfied.&#160;The Company&#x2019;s revenue transactions include the shipment of goods to customers as orders are fulfilled, completion
of non-recurring engineering, completion of training, and customer support services. The Company recognizes revenue upon shipment of product
or prototypes unless otherwise specified in the purchase order or contract. Customer deposits totaled $&lt;span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240430_zTRmOLvQ36X4"&gt;53,939&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20230430_zUyPr8922sC6"&gt;155,986&lt;/span&gt; at April 30,
2024 and April 30, 2023, respectively. From time to time, non-recurring engineering contracts may involve the capitalization of engineering
prototypes, classified as contract assets. Contract assets totaled $&lt;span id="xdx_907_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20240430_zhdr7vv0kb34"&gt;1,477,859&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20230430_zIBr7xEVQFj3"&gt;0&lt;/span&gt; at April 30, 2024 and April 30, 2023, respectively.&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table presents the Company&#x2019;s
revenue disaggregated by revenue type:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_zet5crVfizG" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Company's revenue disaggregated by revenue type (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20230501__20240430_zMjAJJjOleO3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_499_20220501__20230430_zmPFbgIgRww1" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Year Ended&#160;April 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zdwJLPvW4QR9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-size: 10pt; text-align: left"&gt;Contract related&lt;/td&gt;&lt;td style="width: 8%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;4,173,005&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;1,312,427&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomer_zm0HlgsW7Fbk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Product related&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;13,663,377&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;3,308,407&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Revenues_zPnw8zXZaaAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;17,836,382&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;4,620,834&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A9_zKDDmRXWSIx6" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14947"
      unitRef="USD">53939</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14948"
      unitRef="USD">155986</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14949"
      unitRef="USD">1477859</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14950"
      unitRef="USD">0</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <RCAT:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-8978">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_zet5crVfizG" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Company's revenue disaggregated by revenue type (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20230501__20240430_zMjAJJjOleO3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_499_20220501__20230430_zmPFbgIgRww1" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Year Ended&#160;April 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zdwJLPvW4QR9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-size: 10pt; text-align: left"&gt;Contract related&lt;/td&gt;&lt;td style="width: 8%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;4,173,005&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;1,312,427&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomer_zm0HlgsW7Fbk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Product related&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;13,663,377&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;3,308,407&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Revenues_zPnw8zXZaaAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;17,836,382&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;4,620,834&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</RCAT:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14951"
      unitRef="USD">4173005</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14952"
      unitRef="USD">1312427</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14953"
      unitRef="USD">13663377</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14954"
      unitRef="USD">3308407</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:Revenues
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14955"
      unitRef="USD">17836382</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14956"
      unitRef="USD">4620834</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2023-05-01to2024-04-30" id="ixv-9030">&lt;p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_z92tZr6bcLMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_862_zlvGi8T6cAC7"&gt;Research and Development&lt;/span&gt; &lt;/b&gt;&#x2013; Research and
development expenses include payroll, employee benefits, and other headcount-related expenses associated with product development. Research
and development expenses also include third-party development and programming costs, materials, and a proportionate share of overhead
costs such as rent.&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies contextRef="From2023-05-01to2024-04-30" id="ixv-9035">&lt;p id="xdx_846_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zrulqYFkDsq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_zT5ZW2pySwOe"&gt;Product
Warranty&lt;/span&gt; - &lt;/b&gt;The Company accrues an estimate of its exposure to warranty claims based upon both current and historical
product sales data and warranty costs incurred. Product warranty reserves are recorded in current liabilities under accrued
expenses.&#160;Warranty liability was $&lt;span id="xdx_90D_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240430_zkpemxJKlCd5"&gt;372,000&lt;/span&gt;
and $&lt;span id="xdx_90A_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20230430_zNpyM4tHDtmk"&gt;90,000&lt;/span&gt; as of April 30, 2024
and April 30, 2023 respectively.&lt;/p&gt;

</us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies>
    <us-gaap:StandardProductWarrantyAccrualCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14957"
      unitRef="USD">372000</us-gaap:StandardProductWarrantyAccrualCurrent>
    <us-gaap:StandardProductWarrantyAccrualCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-14958"
      unitRef="USD">90000</us-gaap:StandardProductWarrantyAccrualCurrent>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9042">&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zRkFoxX8Urv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_zhFDWVR5zHo1"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt; &#x2013; Deferred taxes are provided
on the liability method whereby deferred tax assets are recognized for deductible temporary differences and deferred tax liabilities are
recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities
and their tax bases. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of
enactment.&#160;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9047">&lt;p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zvxhnOmm86Mb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86A_zg7JfXrxaVQj"&gt;Recent Accounting Pronouncements&lt;/span&gt; &lt;/b&gt;&#x2013; &lt;span style="background-color: white"&gt;Management
does not believe that recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the
accompanying consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9053">&lt;p id="xdx_841_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zKHsbsxKpxej" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_z4k4QCX9HQR"&gt;Foreign Currency&lt;/span&gt; &#x2013; &lt;/b&gt;The functional currency
of our former international subsidiary, Skyset, was the local Italian currency. For that subsidiary, we translated assets and liabilities
to U.S. dollars using period-end exchange rates, and average monthly exchange rates for revenues, costs, and expenses. We recorded translation
gains and losses in accumulated other comprehensive income.&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9058">&lt;p id="xdx_84F_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zeZrDIVXtY43" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86C_zWiNRp5rUhJ3"&gt;Comprehensive Loss&lt;/span&gt; &lt;/b&gt;&#x2013; Comprehensive loss
consists of net loss and other comprehensive loss. Other comprehensive loss refers to gains and losses that are recorded as an element
of stockholders' equity but are excluded from net loss. Our other comprehensive loss is comprised of foreign currency translation adjustments
and unrealized gains or losses on available-for-sale securities. During the year ended April 30, 2024, comprehensive loss was $&lt;span id="xdx_906_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20230501__20240430_z20MHAd0Bx09"&gt;865,738&lt;/span&gt;
lower than net loss, related to unrealized gains on available-for-sale securities totaling $&lt;span id="xdx_902_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20230501__20240430_zu9aCfjA5Wh3"&gt;864,165&lt;/span&gt; and foreign currency translation adjustments
of $&lt;span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20230501__20240430_zA7NB9TbVz76"&gt;1,573&lt;/span&gt;. During the year ended April 30, 2023, comprehensive loss was $&lt;span id="xdx_901_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20220501__20230430_zCjsInfVH5i4"&gt;609,155&lt;/span&gt; lower than net loss, related to unrealized gains on available-for-sale
securities totaling $&lt;span id="xdx_901_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20220501__20230430_zUYz8lZOzpvd"&gt;610,129&lt;/span&gt;, partially offset by foreign currency translation adjustments of $&lt;span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20220501__20230430_zmMIZSeEG8Ma"&gt;974&lt;/span&gt;.&#160;&lt;/p&gt;

</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <RCAT:DifferenceBetweenComprehensiveLossAndNetLoss
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14959"
      unitRef="USD">865738</RCAT:DifferenceBetweenComprehensiveLossAndNetLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14960"
      unitRef="USD">864165</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14961"
      unitRef="USD">1573</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <RCAT:DifferenceBetweenComprehensiveLossAndNetLoss
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14962"
      unitRef="USD">609155</RCAT:DifferenceBetweenComprehensiveLossAndNetLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14963"
      unitRef="USD">610129</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14964"
      unitRef="USD">974</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9080">&lt;p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zIYMkuiE3t7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_862_ziZAPTrXDv1a"&gt;Stock-Based Compensation&lt;/span&gt; &lt;/b&gt;&#x2013; S&lt;span style="background-color: white"&gt;tock
options are valued using the estimated grant-date fair value method of accounting in accordance with ASC Topic 718, Compensation &#x2013;
Stock Compensation. Fair value is determined based on the Black-Scholes Model using inputs reflecting our estimates of expected volatility,
term and future dividends. We recognize forfeitures as they occur. The fair value of restricted stock is based on our stock price on the
date of grant. Compensation cost is recognized on a straight-line basis over the service period which is the vesting term.&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9087">&lt;p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zxizuRADbMh3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86E_zNqdQaJZswfb"&gt;Basic and Diluted Net Loss per Share&lt;/span&gt;&lt;/b&gt; &#x2013;
Basic and diluted net loss per share has been calculated by dividing net loss by the weighted average number of shares of common stock
outstanding during the period. Common stock equivalents were excluded from the computation of diluted net loss per share of common stock
because they were anti-dilutive. The conversion or exercise of these common stock equivalents would dilute earnings per share if we become
profitable in the future. Outstanding securities not included in the computation of diluted net loss per share because their effect would
have been anti-dilutive include:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z9tJBwS9KIPf" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_494_20230501__20240430_zqag83BE45nl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20220501__20230430_zgFS9fM9BDJi" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_zgjK8cfnMyAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Series B Preferred Stock, as converted&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;3,896&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;822,230&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_zhEgkUq1hHz2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Stock options&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;6,779,934&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,784,809&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_zOCXNCCHhdL2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt"&gt;Warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,275,999&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,539,999&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_zfeTr9nC4ms5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Restricted stock&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;175,130&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;781,060&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zGwJOfxndp3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;9,234,959&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;7,928,098&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zQiqjBwavoJ5" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9092">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z9tJBwS9KIPf" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_494_20230501__20240430_zqag83BE45nl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20220501__20230430_zgFS9fM9BDJi" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_zgjK8cfnMyAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Series B Preferred Stock, as converted&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;3,896&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;822,230&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_zhEgkUq1hHz2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Stock options&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;6,779,934&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,784,809&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_zOCXNCCHhdL2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt"&gt;Warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,275,999&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,539,999&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_zfeTr9nC4ms5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Restricted stock&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;175,130&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;781,060&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zGwJOfxndp3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;9,234,959&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;7,928,098&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount
      contextRef="From2023-05-01to2024-04-30"
      decimals="INF"
      id="ixv-14965"
      unitRef="Shares">3896</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      id="ixv-14966"
      unitRef="Shares">822230</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount
      contextRef="From2023-05-01to2024-04-30"
      decimals="INF"
      id="ixv-14967"
      unitRef="Shares">6779934</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      id="ixv-14968"
      unitRef="Shares">4784809</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount
      contextRef="From2023-05-01to2024-04-30"
      decimals="INF"
      id="ixv-14969"
      unitRef="Shares">2275999</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      id="ixv-14970"
      unitRef="Shares">1539999</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount
      contextRef="From2023-05-01to2024-04-30"
      decimals="INF"
      id="ixv-14971"
      unitRef="Shares">175130</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      id="ixv-14972"
      unitRef="Shares">781060</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-05-01to2024-04-30"
      decimals="INF"
      id="ixv-14973"
      unitRef="Shares">9234959</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      id="ixv-14974"
      unitRef="Shares">7928098</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <RCAT:RelatedPartiesPolicyTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9158">&lt;p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zCXtklxqrUV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_866_zNIcK9TfCCch"&gt;Related Parties&lt;/span&gt;&lt;/b&gt; &#x2013; Parties are considered
to be related to us if they have control or significant influence, directly or indirectly, over us, including key management personnel
and members of the Board of Directors or are direct relatives of key management personnel of members of the Board of Directors. Related
Party transactions are disclosed in Note 20.&lt;/p&gt;

</RCAT:RelatedPartiesPolicyTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9163">&lt;p id="xdx_84E_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zTlQsOqnNxS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_86B_zY3r2rak3238"&gt;Liquidity
and Going Concern&lt;/span&gt; &lt;/b&gt;&#x2013; The Company has never been profitable and has incurred net losses related to acquisitions, as well as costs
incurred to pursue its long-term growth strategy. During the year ended April 30, 2024, the Company incurred a net loss from continuing
&lt;/span&gt;operations of $&lt;span id="xdx_909_eus-gaap--IncomeLossFromContinuingOperations_dxL_c20230501__20240430_zSzkm1Ldsnmh" title="::XDX::-21526696"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0737"&gt;21,526,696&lt;/span&gt;&lt;/span&gt;&#160;and used cash in operating activities of continuing operations of $&lt;span id="xdx_903_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_dxL_c20230501__20240430_zaIhyh0n4g01" title="::XDX::-17687063"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0738"&gt;17,687,063&lt;/span&gt;&lt;/span&gt;. As of April 30,
2024, working capital for continuing operations totaled $&lt;span id="xdx_907_eus-gaap--Capital_iI_c20240430_zQPgJOzWJ7ca"&gt;18,746,419&lt;/span&gt;. These financial results and our financial position &lt;span style="background-color: white"&gt;at&#160;April
30, 2024&#160;raise substantial doubt about our ability to continue as a going concern. However, the Company has recently taken actions
to strengthen its liquidity.&#160;On&#160;December 11, 2023, we completed a public offering of 18,400,000 shares of common stock which
generated net proceeds of approximately $8,400,000 as further described in Note 1 and Note 16. In addition, the Company&#x2019;s operating
plan for the next twelve months has been updated to reflect recent operating improvements.&#160; Revenues have accelerated and are expected
to continue growing. The Company&#x2019;s manufacturing facility is scaling production and gross profits are projected to increase.&#160;&lt;span style="background-color: white"&gt;If necessary, the Company will seek
to obtain additional debt financing for which there can be no guarantee.&lt;/span&gt; Subsequent
to year end, as further described in Note 22, the Company sold its equity method investment for $4,400,000. Management has concluded
that these recent positive developments alleviate any substantial doubt about the Company&#x2019;s ability to&#160;continue its operations,
and meet its financial obligations, for twelve months from the date these consolidated financial statements&#160;are&#160;issued.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:Capital
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-14975"
      unitRef="USD">18746419</us-gaap:Capital>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9179">&lt;p id="xdx_800_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_znkVdmID5oz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_821_zmTl67wUUEn5"&gt;Note
3 &#x2013; Divestiture of Consumer Segment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-size: 10pt; background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-size: 10pt; background-color: white"&gt;On
February 16, 2024,&lt;/span&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size: 10pt; background-color: white"&gt;the Company
closed the sale of Rotor Riot and Fat Shark to Unusual Machines. The sale was conducted pursuant to a Share Purchase Agreement dated November
21, 2022, as amended on April 13, 2023, July 10, 2023, and December 11, 2023 (the &#x201c;SPA&#x201d;). The transaction closed concurrently
with UMAC&#x2019;s initial public offering and listing on the NYSE American exchange (&#x201c;IPO&#x201d;) under the symbol &#x201c;UMAC.&#x201d;
&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-size: 10pt; background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;The total consideration received
by the Company was valued at $&lt;span id="xdx_901_eus-gaap--NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_pn6n6_c20230501__20240430_zIXV4zI4A94i"&gt;20&lt;/span&gt; million and consisted of i) $&lt;span id="xdx_90D_ecustom--NoncashOrPartNoncashDivestitureCashConsiderationReceived1_pn6n6_c20230501__20240430_z1osYl9p5B02"&gt;1&lt;/span&gt; million in cash, ii) $&lt;span id="xdx_907_ecustom--NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1_pn6n6_c20230501__20240430_zCK7vEmGVK8e"&gt;2&lt;/span&gt; million in a secured promissory note (&#x201c;Promissory
Note&#x201d;), iii) $&lt;span id="xdx_906_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_pn6n6_c20230501__20240430_zUNYrjV0pWxc"&gt;17&lt;/span&gt; million in securities of Unusual Machines, and iv) a post-closing adjustment for excess working capital.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Secured Promissory Note&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;The Promissory Note from
Unusual Machines bears interest at a rate of 8% per year, is due 18 months from the date of issue, and requires monthly payments of interest
due in arrears on the 15th&#160;day of each month. In the event of a Qualified Financing (defined as one or more related debt or equity
financings by UMAC resulting in net proceeds of at least $5 million, other than UMAC&#x2019;s completed IPO), the Company may require payment
of this Promissory Note in whole or in part upon written notice given within 10 days of the Qualified Financing. During the occurrence
and continuance of any event of default under the Note, The Company may, at its option, convert the amounts due under the Note to common
stock of UMAC in whole or in part from time to time. The conversion price will be a 10% discount to the average daily volume weighted
average price for UMAC&#x2019;s common stock over the 10 days preceding the conversion price. Conversions under the Note will be limited
such that no conversion may be made to the extent that, after giving effect to the conversion, the Company, together with its affiliates,
would beneficially own in excess of 4.99% of UMAC&#x2019;s common stock. This limit may be increased by the Company upon 61 days written
notice.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Unusual Machines Securities
&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt/11.75pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;br/&gt;
The $&lt;span id="xdx_90C_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_pn6n6_c20230501__20240430_zkbm6zDCF2jj"&gt;17&lt;/span&gt; million worth of UMAC common stock was valued at the IPO price for UMAC&#x2019;s common stock of $4.00 per share, resulting in
&lt;span id="xdx_90E_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares_c20230501__20240430_zDwBwuAsBU63"&gt;4,250,000&lt;/span&gt; shares of UMAC common stock being issued to the Company (representing approximately 49% of UMAC&#x2019;s issued and outstanding
common stock after giving effect to the IPO and to the issuance of common stock to the Company upon closing of the IPO).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Working Capital&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;The
purchase price was adjusted for working capital as of the closing date. &lt;/span&gt;Actual working capital excess amounts increased the
principal amount of the Promissory Note dollar for dollar. &lt;span style="background-color: white"&gt;Working capital as of closing was
finalized at $&lt;span id="xdx_90B_ecustom--WorkingCapitalAtClosingOfDisposalGroup_iI_pn6n6_c20240216_zbXgynZ6d6f9"&gt;2&lt;/span&gt; million,
as further described in Note 22.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;The Consumer
segment has been classified as Discontinued Operations and reported in accordance with the applicable accounting standards. Set forth
below are the results of operations for the Consumer segment for:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zSkyfwXJYvJf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Discontinued Operations - results of operations (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_493_20230501__20240430_zshf715XYCU1" style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_490_20220501__20230430_zEvfNYksleKf" style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;April 30,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_zet66lxCG3cd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-indent: -10pt; padding-left: 10pt"&gt;Revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;4,213,653&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;5,290,946&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_zZCp6nmbVSq1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt"&gt;Cost of goods sold&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,577,980&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,793,430&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_zZB2bdYGJ107" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Gross (Loss) Profit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(364,327&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;497,516&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract_iB_zHCQOqo9zi16" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Operating Expenses&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_i01_zJLH4PGzI8F9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Research and development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118,093&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;346,002&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_i01_zVhUkNrCIv5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Sales and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,157,448&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;862,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_i01_zVuRSUxgtgUf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;General and administrative&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;863,361&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,044,435&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_i01_zbIlawNLqG9f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt"&gt;Total operating expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,138,902&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,252,821&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_z9ivHMd3EAOj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Operating loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,503,229&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,755,305&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_iB_zVvUU5f7lou5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Other expense (income)&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInterestExpense_i01_zpBc0jySXPA1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,856&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0783"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherIncome_i01N_di_zKtzrAasM0nd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Other, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(152&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(24,919&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_i01_zFuBhwfCwzb3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 20pt"&gt;Other expense (income)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,704&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(24,919&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 12pt; text-indent: -10pt; padding-left: 20pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_zm0JKW1Nqn7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 20pt"&gt;Net loss from discontinued operations&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(2,525,933&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(1,730,386&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AF_z2rczATCQB5d" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&#160;&#160;&lt;/span&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Assets
and liabilities for the Consumer segment included:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock_zDXki7kt0Sge" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Assets and liabilities for the Consumer Segment (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_490_20240430_znrKTTBcuGWl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_491_20230430_zsmNxUUlbZs1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_iB_z87t70LlmfEl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCash_i01I_z2NIr3x53W3d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 62%; font-size: 10pt; text-indent: -10pt; padding-left: 20pt"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0799"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;86,656&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_i01I_zcwueUvWpSi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Accounts receivable, net&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0802"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;61,107&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_i01I_z1sBCuNDbE6a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt"&gt;Inventory&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0805"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;3,065,954&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_i01I_zb1zbFTBsK43" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Other&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0808"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;2,069,438&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_i01I_zBWkVUPanN5g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt"&gt;Total current assets&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0811"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;5,283,155&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_i01I_z8Tx8utNgRlk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Intangible assets, net&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0814"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;20,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_i01I_zkc2jxz6q2uf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-left: 10pt"&gt;Other&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0817"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;3,853&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent_iI_zSUCOiDo29Z6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Operating lease right-of-use assets&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0820"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;84,544&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_iI_zp1C8ecSpts5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt"&gt;Total long term assets&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0823"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;108,397&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_iB_z0WB0fL1ytUd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_i01I_zBxrKpDpQkq" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Accounts payable&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0829"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;606,872&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_i01I_zWSzKPSieU8f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Accrued expenses&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0832"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;109,480&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_i01I_zgpnGHr06vK5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Customer deposits&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0835"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;244,688&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent_i01I_zz7sEoiHkCz8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Operating lease liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0838"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;49,461&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_i01I_z3BPfxYaOHfb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt"&gt;Total current liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0841"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;1,010,501&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent_iI_zkjV11vb9jBj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Long term liabilities - Operating lease liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0844"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;41,814&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DisposalGroupIncludingDiscontinuedOperationWorkingCapital_iI_zePZUDSsMGg6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt"&gt;Working capital&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0847"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;4,272,654&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zLsYoLAgYES6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
      contextRef="From2023-05-01to2024-04-30"
      decimals="-6"
      id="ixv-14976"
      unitRef="USD">20000000</us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1>
    <RCAT:NoncashOrPartNoncashDivestitureCashConsiderationReceived1
      contextRef="From2023-05-01to2024-04-30"
      decimals="-6"
      id="ixv-14977"
      unitRef="USD">1000000</RCAT:NoncashOrPartNoncashDivestitureCashConsiderationReceived1>
    <RCAT:NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1
      contextRef="From2023-05-01to2024-04-30"
      decimals="-6"
      id="ixv-14978"
      unitRef="USD">2000000</RCAT:NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1>
    <RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1
      contextRef="From2023-05-01to2024-04-30"
      decimals="-6"
      id="ixv-14979"
      unitRef="USD">17000000</RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1>
    <RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1
      contextRef="From2023-05-01to2024-04-30"
      decimals="-6"
      id="ixv-14980"
      unitRef="USD">17000000</RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1>
    <RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares
      contextRef="From2023-05-01to2024-04-30"
      decimals="INF"
      id="ixv-14981"
      unitRef="Shares">4250000</RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares>
    <RCAT:WorkingCapitalAtClosingOfDisposalGroup
      contextRef="AsOf2024-02-16"
      decimals="-6"
      id="ixv-14982"
      unitRef="USD">2000000</RCAT:WorkingCapitalAtClosingOfDisposalGroup>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9235">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zSkyfwXJYvJf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Discontinued Operations - results of operations (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_493_20230501__20240430_zshf715XYCU1" style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_490_20220501__20230430_zEvfNYksleKf" style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;April 30,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_zet66lxCG3cd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; text-indent: -10pt; padding-left: 10pt"&gt;Revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;4,213,653&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;5,290,946&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_zZCp6nmbVSq1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt"&gt;Cost of goods sold&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,577,980&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,793,430&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_zZB2bdYGJ107" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Gross (Loss) Profit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(364,327&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;497,516&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract_iB_zHCQOqo9zi16" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Operating Expenses&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_i01_zJLH4PGzI8F9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Research and development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118,093&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;346,002&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_i01_zVhUkNrCIv5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Sales and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,157,448&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;862,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_i01_zVuRSUxgtgUf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;General and administrative&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;863,361&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,044,435&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_i01_zbIlawNLqG9f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt"&gt;Total operating expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,138,902&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,252,821&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_z9ivHMd3EAOj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Operating loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,503,229&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,755,305&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 12pt; text-indent: -10pt; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_iB_zVvUU5f7lou5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Other expense (income)&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInterestExpense_i01_zpBc0jySXPA1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,856&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0783"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherIncome_i01N_di_zKtzrAasM0nd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Other, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(152&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(24,919&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_i01_zFuBhwfCwzb3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 20pt"&gt;Other expense (income)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,704&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(24,919&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 12pt; text-indent: -10pt; padding-left: 20pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_zm0JKW1Nqn7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 20pt"&gt;Net loss from discontinued operations&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(2,525,933&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(1,730,386&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14983"
      unitRef="USD">4213653</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14984"
      unitRef="USD">5290946</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14985"
      unitRef="USD">4577980</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14986"
      unitRef="USD">4793430</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14987"
      unitRef="USD">-364327</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14988"
      unitRef="USD">497516</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14989"
      unitRef="USD">118093</RCAT:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14990"
      unitRef="USD">346002</RCAT:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14991"
      unitRef="USD">1157448</RCAT:DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14992"
      unitRef="USD">862384</RCAT:DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14993"
      unitRef="USD">863361</us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14994"
      unitRef="USD">1044435</us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14995"
      unitRef="USD">2138902</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14996"
      unitRef="USD">2252821</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14997"
      unitRef="USD">-2503229</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-14998"
      unitRef="USD">-1755305</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-14999"
      unitRef="USD">22856</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-15000"
      unitRef="USD">152</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-15001"
      unitRef="USD">24919</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-15002"
      unitRef="USD">22704</RCAT:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-15003"
      unitRef="USD">-24919</RCAT:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-15004"
      unitRef="USD">-2525933</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-15005"
      unitRef="USD">-1730386</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <RCAT:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9464">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock_zDXki7kt0Sge" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Assets and liabilities for the Consumer Segment (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_490_20240430_znrKTTBcuGWl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_491_20230430_zsmNxUUlbZs1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_iB_z87t70LlmfEl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCash_i01I_z2NIr3x53W3d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 62%; font-size: 10pt; text-indent: -10pt; padding-left: 20pt"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0799"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;86,656&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_i01I_zcwueUvWpSi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Accounts receivable, net&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0802"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;61,107&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_i01I_z1sBCuNDbE6a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt"&gt;Inventory&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0805"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;3,065,954&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_i01I_zb1zbFTBsK43" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Other&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0808"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;2,069,438&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_i01I_zBWkVUPanN5g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt"&gt;Total current assets&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0811"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;5,283,155&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_i01I_z8Tx8utNgRlk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Intangible assets, net&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0814"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;20,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_i01I_zkc2jxz6q2uf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-left: 10pt"&gt;Other&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0817"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;3,853&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent_iI_zSUCOiDo29Z6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Operating lease right-of-use assets&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0820"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;84,544&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_iI_zp1C8ecSpts5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt"&gt;Total long term assets&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0823"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;108,397&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract_iB_z0WB0fL1ytUd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_i01I_zBxrKpDpQkq" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Accounts payable&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0829"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;606,872&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_i01I_zWSzKPSieU8f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Accrued expenses&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0832"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;109,480&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_i01I_zgpnGHr06vK5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Customer deposits&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0835"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;244,688&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent_i01I_zz7sEoiHkCz8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Operating lease liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0838"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;49,461&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_i01I_z3BPfxYaOHfb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt"&gt;Total current liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0841"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;1,010,501&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent_iI_zkjV11vb9jBj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Long term liabilities - Operating lease liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0844"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;41,814&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DisposalGroupIncludingDiscontinuedOperationWorkingCapital_iI_zePZUDSsMGg6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt"&gt;Working capital&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0847"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;4,272,654&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RCAT:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresAssetsAndLiabilitiesTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCash
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15006"
      unitRef="USD">86656</us-gaap:DisposalGroupIncludingDiscontinuedOperationCash>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15007"
      unitRef="USD">61107</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15008"
      unitRef="USD">3065954</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15009"
      unitRef="USD">2069438</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15010"
      unitRef="USD">5283155</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15011"
      unitRef="USD">20000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15012"
      unitRef="USD">3853</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15013"
      unitRef="USD">84544</us-gaap:DisposalGroupIncludingDiscontinuedOperationCapitalLeasedAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15014"
      unitRef="USD">108397</us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15015"
      unitRef="USD">606872</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15016"
      unitRef="USD">109480</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15017"
      unitRef="USD">244688</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15018"
      unitRef="USD">49461</RCAT:DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15019"
      unitRef="USD">1010501</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15020"
      unitRef="USD">41814</RCAT:DisposalGroupIncludingDiscontinuedOperationCapitalLeasedLiabilitiesNoncurrent>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationWorkingCapital
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15021"
      unitRef="USD">4272654</RCAT:DisposalGroupIncludingDiscontinuedOperationWorkingCapital>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9710">&lt;p id="xdx_808_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_z6kDrTUWTh21" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82C_zFwwqVWwtFx2"&gt;Note
4 &#x2013; Marketable Securities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;There
were no marketable securities at April 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At April 30, 2023, marketable securities
consisted solely of corporate bonds and were classified at Level 2 in the Fair Value Hierarchy. Fair value, cost basis, and
unrealized losses totaled $&lt;span id="xdx_900_ecustom--CorporateBondsAtCarryingValueFairValue_iI_c20240430_ziWNu2Vo9IE9"&gt;12,814,038&lt;/span&gt;,
$&lt;span id="xdx_90F_ecustom--CorporateBondsAtCarryingValueCostBasis_iI_c20240430_zIJVJLiOC0Gc"&gt;13,678,203&lt;/span&gt;, and $&lt;span id="xdx_908_ecustom--CorporateBondsAtCarryingValueUnrealizedLosses_iNI_di_c20240430_zZoEfnZLSw7f"&gt;864,165&lt;/span&gt;
at April 30, 2023, respectively.&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <RCAT:CorporateBondsAtCarryingValueFairValue
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15022"
      unitRef="USD">12814038</RCAT:CorporateBondsAtCarryingValueFairValue>
    <RCAT:CorporateBondsAtCarryingValueCostBasis
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15023"
      unitRef="USD">13678203</RCAT:CorporateBondsAtCarryingValueCostBasis>
    <RCAT:CorporateBondsAtCarryingValueUnrealizedLosses
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15024"
      unitRef="USD">-864165</RCAT:CorporateBondsAtCarryingValueUnrealizedLosses>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9725">&lt;p id="xdx_80A_eus-gaap--InventoryDisclosureTextBlock_zLmly14NaPO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82F_zIzyQYj4zeBg"&gt;Note
5 &#x2013; Inventories&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Inventories
consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z6BUpddFWoF9" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20240430_znqN3pNDk0V4" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_495_20230430_zTR3DOqZWeG2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_zkyxa8aKxVd4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Raw materials&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;5,750,324&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;8,132,196&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--InventoryWorkInProcess_iI_z8Vu5WAs9G9f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt"&gt;Work-in-process&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,289,997&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;509,381&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--InventoryFinishedGoods_iI_zCIqhYR0CO7j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Finished goods&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;966,916&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;278,996&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InventoryNet_iI_zaJzXLheb7x5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;8,007,237&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;8,920,573&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zklwzZoeO8Ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9734">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z6BUpddFWoF9" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20240430_znqN3pNDk0V4" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_495_20230430_zTR3DOqZWeG2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_zkyxa8aKxVd4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Raw materials&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;5,750,324&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;8,132,196&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--InventoryWorkInProcess_iI_z8Vu5WAs9G9f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt"&gt;Work-in-process&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,289,997&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;509,381&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--InventoryFinishedGoods_iI_zCIqhYR0CO7j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Finished goods&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;966,916&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;278,996&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InventoryNet_iI_zaJzXLheb7x5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;8,007,237&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;8,920,573&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15025"
      unitRef="USD">5750324</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15026"
      unitRef="USD">8132196</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15027"
      unitRef="USD">1289997</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15028"
      unitRef="USD">509381</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15029"
      unitRef="USD">966916</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15030"
      unitRef="USD">278996</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15031"
      unitRef="USD">8007237</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15032"
      unitRef="USD">8920573</us-gaap:InventoryNet>
    <us-gaap:OtherCurrentAssetsTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9793">&lt;p id="xdx_808_eus-gaap--OtherCurrentAssetsTextBlock_zrXyK6Rmvhra" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_825_z1VWG65ssHXc"&gt;Note
6 &#x2013; Other Current Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Other
current assets included:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zve7ktwRkWRi" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Other current assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_495_20240430_zngNaW3Pybsj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49F_20230430_zCwwNg2UMCl9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_d0_zw8bDNFFohF2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Contract asset&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;1,477,859&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&#x2014;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PrepaidExpenseCurrent_iI_z9jCggJwMmil" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,206,306&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;752,564&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--GrantsReceivableCurrent_iI_zqOJt7hTi7s1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Grant receivable&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;675,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0882"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_zD0u2si96To6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Prepaid inventory&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;602,888&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;359,500&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss_iI_zlv58nsr7y2a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Accrued interest income&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0887"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;151,671&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OtherAssetsCurrent_iI_zwrVf7JHUR99" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;3,962,053&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;1,263,735&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zpLfa8wx07L" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9802">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zve7ktwRkWRi" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Other current assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_495_20240430_zngNaW3Pybsj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49F_20230430_zCwwNg2UMCl9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_d0_zw8bDNFFohF2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Contract asset&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;1,477,859&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&#x2014;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PrepaidExpenseCurrent_iI_z9jCggJwMmil" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,206,306&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;752,564&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--GrantsReceivableCurrent_iI_zqOJt7hTi7s1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Grant receivable&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;675,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0882"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_zD0u2si96To6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Prepaid inventory&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;602,888&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;359,500&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss_iI_zlv58nsr7y2a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Accrued interest income&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0887"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;151,671&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OtherAssetsCurrent_iI_zwrVf7JHUR99" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;3,962,053&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;1,263,735&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15033"
      unitRef="USD">1477859</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15034"
      unitRef="USD">0</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15035"
      unitRef="USD">1206306</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15036"
      unitRef="USD">752564</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:GrantsReceivableCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15037"
      unitRef="USD">675000</us-gaap:GrantsReceivableCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15038"
      unitRef="USD">602888</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15039"
      unitRef="USD">359500</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15040"
      unitRef="USD">151671</us-gaap:DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:OtherAssetsCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15041"
      unitRef="USD">3962053</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15042"
      unitRef="USD">1263735</us-gaap:OtherAssetsCurrent>
    <RCAT:DueFromRelatedPartyDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9875">&lt;p id="xdx_80F_ecustom--DueFromRelatedPartyDisclosureTextBlock_z6iSk9tDE2Aj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_829_zkUwNtFzveF8"&gt;Note
7 &#x2013; Due From Related Party&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;In
January 2022, the Company determined that a senior executive had relocated in 2021 but their compensation had not been subject to the
income tax withholding required by the new jurisdiction.&#160;The amount subject to taxation included $&lt;span id="xdx_905_ecustom--CashCompensationSubjectToTaxation_c20230101__20230430_zQxsx4gKigi8"&gt;155,624&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;of
cash compensation and $&lt;span id="xdx_90F_ecustom--IncomeAssociatedWithStockCompensationSubjectToTaxation_c20230101__20230430_zTRvDHCqurNe"&gt;1,413,332&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;of
income associated with the vesting of restricted stock ("Stock Compensation").&#160;In March 2022, the Company entered into a
note agreement (the "Note") with the employee in the amount of $&lt;span id="xdx_905_ecustom--NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation_c20230301__20230430_zusjUOFElLFb"&gt;510,323&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;,
representing the estimated taxes owed by the employee related to the Stock Compensation. Under the terms of the Note, &lt;span id="xdx_904_ecustom--CommonStockWithheldByCompanyAppliedAgainstNoteShares_c20230301__20230430_zgQ8PC66lk46"&gt;104,166
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;shares of common stock with a fair value
of $&lt;span id="xdx_906_ecustom--CommonStockWithheldByCompanyAppliedAgainstNoteAmount_c20230301__20230430_zCQrzJCwEZp5"&gt;280,832&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;,
which had vested during calendar 2021, were withheld by the Company and applied against the Note.&#160;The employee agreed not to sell
or transfer &lt;span id="xdx_90C_ecustom--SharesHeldAtTransferAgentUntilNoteReceivableRepayment_c20230301__20230430_zxjOO0m6PW6b"&gt;110,983&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;shares
of common stock held at the Company's transfer agent until the Note was repaid.&#160;In addition, the employee has &lt;span id="xdx_90D_ecustom--RestrictedStockScheduledToVestShares_c20230301__20230430_zvevZOtcsT5j"&gt;20,833&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;shares
of restricted stock vesting monthly in calendar 2022, of which &lt;span id="xdx_901_ecustom--RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable_c20230301__20230430_zs9qgjRKJ70l"&gt;3,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;shares were withheld with&#160;the fair
value of those shares&#160;applied against the Note. Shares issued to the employee in 2022 were held at the transfer agent until the
Note was repaid.&#160;The Note matured on December 31, 2022.&#160;The Company filed amended payroll tax returns on March 16, 2022. In
March and April 2022, the Company made payments to the relevant tax authorities totaling $&lt;span id="xdx_909_ecustom--PaymentsForTaxLiability_iN_di_c20230301__20230430_zkZI4pv5OqYk"&gt;712,646&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;representing
$&lt;span id="xdx_908_ecustom--NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation_c20230301__20230430_zAMluM6eRz9k"&gt;510,323
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;owed by the employee, $&lt;span id="xdx_904_ecustom--EstimatedTaxesOwedRelatedToStockCompensation_c20230301__20230430_zeXZhTxDKhRk"&gt;31,604
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;owed by the Company, and $&lt;span id="xdx_902_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20230301__20230430_zdi5GWabzaJe"&gt;170,719
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;of penalties and interest. The Note was
repaid in full in August 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

</RCAT:DueFromRelatedPartyDisclosureTextBlock>
    <RCAT:CashCompensationSubjectToTaxation
      contextRef="From2023-01-012023-04-30"
      decimals="0"
      id="ixv-15043"
      unitRef="USD">155624</RCAT:CashCompensationSubjectToTaxation>
    <RCAT:IncomeAssociatedWithStockCompensationSubjectToTaxation
      contextRef="From2023-01-012023-04-30"
      decimals="0"
      id="ixv-15044"
      unitRef="USD">1413332</RCAT:IncomeAssociatedWithStockCompensationSubjectToTaxation>
    <RCAT:NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation
      contextRef="From2023-03-012023-04-30"
      decimals="0"
      id="ixv-15045"
      unitRef="USD">510323</RCAT:NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation>
    <RCAT:CommonStockWithheldByCompanyAppliedAgainstNoteShares
      contextRef="From2023-03-012023-04-30"
      decimals="INF"
      id="ixv-15046"
      unitRef="Shares">104166</RCAT:CommonStockWithheldByCompanyAppliedAgainstNoteShares>
    <RCAT:CommonStockWithheldByCompanyAppliedAgainstNoteAmount
      contextRef="From2023-03-012023-04-30"
      decimals="0"
      id="ixv-15047"
      unitRef="USD">280832</RCAT:CommonStockWithheldByCompanyAppliedAgainstNoteAmount>
    <RCAT:SharesHeldAtTransferAgentUntilNoteReceivableRepayment
      contextRef="From2023-03-012023-04-30"
      decimals="INF"
      id="ixv-15048"
      unitRef="Shares">110983</RCAT:SharesHeldAtTransferAgentUntilNoteReceivableRepayment>
    <RCAT:RestrictedStockScheduledToVestShares
      contextRef="From2023-03-012023-04-30"
      decimals="INF"
      id="ixv-15049"
      unitRef="Shares">20833</RCAT:RestrictedStockScheduledToVestShares>
    <RCAT:RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable
      contextRef="From2023-03-012023-04-30"
      decimals="INF"
      id="ixv-15050"
      unitRef="Shares">3000</RCAT:RestrictedStockScheduledToVestSharesWithheldToBeAppliedAgainstNoteReceivable>
    <RCAT:PaymentsForTaxLiability
      contextRef="From2023-03-012023-04-30"
      decimals="0"
      id="ixv-15051"
      unitRef="USD">-712646</RCAT:PaymentsForTaxLiability>
    <RCAT:NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation
      contextRef="From2023-03-012023-04-30"
      decimals="0"
      id="ixv-15052"
      unitRef="USD">510323</RCAT:NoteReceivableWithEmployeeRepresentingEstimatedTaxesOwedRelatedToStockCompensation>
    <RCAT:EstimatedTaxesOwedRelatedToStockCompensation
      contextRef="From2023-03-012023-04-30"
      decimals="0"
      id="ixv-15053"
      unitRef="USD">31604</RCAT:EstimatedTaxesOwedRelatedToStockCompensation>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="From2023-03-012023-04-30"
      decimals="0"
      id="ixv-15054"
      unitRef="USD">170719</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9909">&lt;p id="xdx_809_eus-gaap--IntangibleAssetsDisclosureTextBlock_znmNgMdHyJ7g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_828_zUz3OvP4qMSl"&gt;Note
8 &#x2013; Intangible Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Intangible
assets relate to acquisitions completed by the Company, including those described in Note 1, and were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zX2LoD05fw32" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20240430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_z2lGxlgYlT0j" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49E_20240430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_zQpL6rgyu3u3" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_499_20240430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zdHSJKKxRag8" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_492_20230430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_zj7diAdCNLV3" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_493_20230430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_z87k05xiuure" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49C_20230430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zv7ORBT9jZo3" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Gross Value&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Net Value&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.85pt 0 0; text-align: center"&gt;&lt;b&gt;Gross&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Net Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--FiniteLivedProprietaryTechnologyGross_iI_z9OH8LlngRLe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-size: 10pt; text-align: left"&gt;Proprietary technology&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;4,282,001&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;(1,917,612&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;2,364,389&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;4,967,000&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;(1,271,112&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;3,695,888&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--FiniteLivedNoncompeteAgreementsGross1_iI_zZTkVcNMkU6i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Non-compete agreements&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;65,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(65,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0920"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;81,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(56,667&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;24,333&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--FiniteLivedCustomerRelationshipsGross1_iI_zUBASyRu0cX4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Customer relationships&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0925"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0926"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0927"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;39,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(18,106&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;20,894&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FiniteLivedIntangibleAssetsGross1_iI_zO3OZ9bu8atf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: 10pt"&gt;Total finite-lived assets&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,347,001&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(1,982,612&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,364,389&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;5,087,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(1,345,885&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;3,741,115&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IndefiniteLivedTradeNames_iI_ztjiNZM883Fg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Brand name&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;1,430,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0940"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;1,430,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;3,152,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0943"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;3,152,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IndefiniteLivedIntangibleAssetsExcludingGoodwill1_iI_zgHiUt7bR99j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt"&gt;Total indefinite-lived assets&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;1,430,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0947"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;1,430,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;3,152,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0950"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;3,152,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--IntangibleAssetsNetExcludingGoodwill1_iI_z7Gl2PfL7N0h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: 10pt"&gt;Total intangible assets, net&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;5,777,001&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;(1,982,612&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;3,794,389&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;8,239,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;(1,345,885&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;6,893,115&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zkZhxjEOzKul" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Proprietary
technology and non-compete agreements are being amortized over six years and three years, respectively. Customer relationships are being
amortized over seven years. Goodwill and Brand name are not amortized but evaluated for impairment on a quarterly basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;As
of April 30, 2024, expected amortization expense for finite-lived intangible assets for the next five years is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zjneipPSX354" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Expected amortization expense for the unamortized finite-lived intangible assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left; font-size: 10pt"&gt;Fiscal Year Ended:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49E_20240430_zXaRMnPYpHdb"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_zexbQb0J4IVj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 65%; font-size: 10pt; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 30%; font-size: 10pt; text-align: right"&gt;709,316&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_zuPC7NIpEPni" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;709,316&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_z8fubbCcSvLk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;2027&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;709,316&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_zwTo7HbdELuk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;2028&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;236,441&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_zxuDNQg8YLt5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;2029&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0970"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_zMpmporglwSl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0972"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_zpbixktmPMy8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;2,364,389&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zuSgWyOZlpOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.25in"&gt;&#160;&lt;span style="background-color: white"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Goodwill
represents the future economic benefit arising from other assets acquired in an acquisition&#160;that are not individually identified
and separately recognized. The composition of, and changes in goodwill, consist of:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfGoodwillTextBlock_zIm5jaFCEO12" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Composition of, and changes in goodwill (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt"&gt;Date&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;Entity&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_4BC_us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap--GoodwillMember_zTxPMT2MHiE9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;Goodwill&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20200101__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_zVBMNDR9lQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 36%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;January 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 30%; font-size: 10pt; text-align: center; padding-left: 5.75pt"&gt;Rotor Riot&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;1,849,073&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20201101__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_z2jBZyYLS7Ti" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;November 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-left: 5.75pt"&gt;Fat Shark&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;6,168,260&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20210501__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_zyUCw4f48f31" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;May 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-left: 5.75pt"&gt;Skypersonic&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,826,918&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20210801__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_zJ8BOuIQznS4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;August 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-left: 5.75pt"&gt;Teal Drones&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;8,995,499&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20230401__20230430_eus-gaap--GoodwillImpairmentLoss_iN_di_zarFtKrXSuf2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;April 2023 - Impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-bottom: 1pt; padding-left: 5.75pt"&gt;Skypersonic&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(2,826,918&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20230430_eus-gaap--Goodwill_iI_z6nMnHPAnlYh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Balance at April 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-left: 5.75pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;17,012,832&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20240201__20240430_eus-gaap--GoodwillWrittenOffRelatedToSaleOfBusinessUnit_iN_di_zSBGoPCLIeJd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;February 2024 &#x2013; Divestiture&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt; padding-left: 5.75pt"&gt;Rotor Riot, Fat Shark&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;(7,924,282&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20240430_eus-gaap--Goodwill_iI_zba2WDzOY1E8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Balance at April 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt; padding-left: 5.75pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;9,088,550&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zfMXaQMEccCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;span style="background-color: white"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Included
in the amounts presented above is goodwill related to other insignificant transactions. Following the establishment of the Enterprise
and Consumer segments, management evaluated the long-term business strategy of each segment. This resulted in the Enterprise segment narrowing
its focus on the military and other government agencies. It was determined that Skypersonic's technology would be re-focused for the near
term on military applications and consolidated into the operations of Teal. The Company completes a formal evaluation of the carrying
value of its intangible assets, including goodwill, at the end of each fiscal year. Based on (i) the operating results for Skypersonic
since its acquisition in May 2021, (ii) its consolidation into Teal, (iii) our current expectations of its future business conditions
and trends, including its projected revenues, expenses, and cash flows, the Company recognized an impairment charge of $&lt;span id="xdx_90F_eus-gaap--GoodwillImpairmentLoss_iN_dixL_c20230401__20230430_zupUsiY7K2kd" title="::XDX::-2826918"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0993"&gt;2,826,918&lt;/span&gt;&lt;/span&gt; in April
2023. During FY2024, an impairment change of $&lt;span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_iN_dixL_c20240401__20240430_zWxtw0o07ZAb" title="::XDX::-412999"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0994"&gt;412,999&lt;/span&gt;&lt;/span&gt; was recognized related to Skypersonic&#x2019;s proprietary technology.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-9918">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zX2LoD05fw32" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20240430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_z2lGxlgYlT0j" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49E_20240430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_zQpL6rgyu3u3" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_499_20240430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zdHSJKKxRag8" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_492_20230430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_zj7diAdCNLV3" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_493_20230430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_z87k05xiuure" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49C_20230430__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zv7ORBT9jZo3" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Gross Value&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Net Value&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.85pt 0 0; text-align: center"&gt;&lt;b&gt;Gross&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Net Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--FiniteLivedProprietaryTechnologyGross_iI_z9OH8LlngRLe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-size: 10pt; text-align: left"&gt;Proprietary technology&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;4,282,001&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;(1,917,612&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;2,364,389&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;4,967,000&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;(1,271,112&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;3,695,888&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--FiniteLivedNoncompeteAgreementsGross1_iI_zZTkVcNMkU6i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Non-compete agreements&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;65,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(65,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0920"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;81,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(56,667&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;24,333&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--FiniteLivedCustomerRelationshipsGross1_iI_zUBASyRu0cX4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Customer relationships&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0925"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0926"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0927"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;39,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(18,106&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;20,894&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FiniteLivedIntangibleAssetsGross1_iI_zO3OZ9bu8atf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: 10pt"&gt;Total finite-lived assets&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,347,001&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(1,982,612&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,364,389&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;5,087,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(1,345,885&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;3,741,115&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IndefiniteLivedTradeNames_iI_ztjiNZM883Fg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Brand name&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;1,430,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0940"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;1,430,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;3,152,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0943"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;3,152,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IndefiniteLivedIntangibleAssetsExcludingGoodwill1_iI_zgHiUt7bR99j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt"&gt;Total indefinite-lived assets&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;1,430,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0947"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;1,430,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;3,152,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0950"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;3,152,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--IntangibleAssetsNetExcludingGoodwill1_iI_z7Gl2PfL7N0h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: 10pt"&gt;Total intangible assets, net&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;5,777,001&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;(1,982,612&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;3,794,389&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;8,239,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;(1,345,885&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;6,893,115&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <RCAT:FiniteLivedProprietaryTechnologyGross
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-15055"
      unitRef="USD">4282001</RCAT:FiniteLivedProprietaryTechnologyGross>
    <RCAT:FiniteLivedProprietaryTechnologyGross
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-15056"
      unitRef="USD">-1917612</RCAT:FiniteLivedProprietaryTechnologyGross>
    <RCAT:FiniteLivedProprietaryTechnologyGross
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-15057"
      unitRef="USD">2364389</RCAT:FiniteLivedProprietaryTechnologyGross>
    <RCAT:FiniteLivedProprietaryTechnologyGross
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-15058"
      unitRef="USD">4967000</RCAT:FiniteLivedProprietaryTechnologyGross>
    <RCAT:FiniteLivedProprietaryTechnologyGross
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-15059"
      unitRef="USD">-1271112</RCAT:FiniteLivedProprietaryTechnologyGross>
    <RCAT:FiniteLivedProprietaryTechnologyGross
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-15060"
      unitRef="USD">3695888</RCAT:FiniteLivedProprietaryTechnologyGross>
    <RCAT:FiniteLivedNoncompeteAgreementsGross1
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-15061"
      unitRef="USD">65000</RCAT:FiniteLivedNoncompeteAgreementsGross1>
    <RCAT:FiniteLivedNoncompeteAgreementsGross1
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-15062"
      unitRef="USD">-65000</RCAT:FiniteLivedNoncompeteAgreementsGross1>
    <RCAT:FiniteLivedNoncompeteAgreementsGross1
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-15063"
      unitRef="USD">81000</RCAT:FiniteLivedNoncompeteAgreementsGross1>
    <RCAT:FiniteLivedNoncompeteAgreementsGross1
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-15064"
      unitRef="USD">-56667</RCAT:FiniteLivedNoncompeteAgreementsGross1>
    <RCAT:FiniteLivedNoncompeteAgreementsGross1
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-15065"
      unitRef="USD">24333</RCAT:FiniteLivedNoncompeteAgreementsGross1>
    <RCAT:FiniteLivedCustomerRelationshipsGross1
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-15066"
      unitRef="USD">39000</RCAT:FiniteLivedCustomerRelationshipsGross1>
    <RCAT:FiniteLivedCustomerRelationshipsGross1
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-15067"
      unitRef="USD">-18106</RCAT:FiniteLivedCustomerRelationshipsGross1>
    <RCAT:FiniteLivedCustomerRelationshipsGross1
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-15068"
      unitRef="USD">20894</RCAT:FiniteLivedCustomerRelationshipsGross1>
    <RCAT:FiniteLivedIntangibleAssetsGross1
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-15069"
      unitRef="USD">4347001</RCAT:FiniteLivedIntangibleAssetsGross1>
    <RCAT:FiniteLivedIntangibleAssetsGross1
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-15070"
      unitRef="USD">-1982612</RCAT:FiniteLivedIntangibleAssetsGross1>
    <RCAT:FiniteLivedIntangibleAssetsGross1
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-15071"
      unitRef="USD">2364389</RCAT:FiniteLivedIntangibleAssetsGross1>
    <RCAT:FiniteLivedIntangibleAssetsGross1
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-15072"
      unitRef="USD">5087000</RCAT:FiniteLivedIntangibleAssetsGross1>
    <RCAT:FiniteLivedIntangibleAssetsGross1
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-15073"
      unitRef="USD">-1345885</RCAT:FiniteLivedIntangibleAssetsGross1>
    <RCAT:FiniteLivedIntangibleAssetsGross1
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-15074"
      unitRef="USD">3741115</RCAT:FiniteLivedIntangibleAssetsGross1>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-15075"
      unitRef="USD">1430000</us-gaap:IndefiniteLivedTradeNames>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-15076"
      unitRef="USD">1430000</us-gaap:IndefiniteLivedTradeNames>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-15077"
      unitRef="USD">3152000</us-gaap:IndefiniteLivedTradeNames>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-15078"
      unitRef="USD">3152000</us-gaap:IndefiniteLivedTradeNames>
    <RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-15079"
      unitRef="USD">1430000</RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1>
    <RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-15080"
      unitRef="USD">1430000</RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1>
    <RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-15081"
      unitRef="USD">3152000</RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1>
    <RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-15082"
      unitRef="USD">3152000</RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1>
    <RCAT:IntangibleAssetsNetExcludingGoodwill1
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-15083"
      unitRef="USD">5777001</RCAT:IntangibleAssetsNetExcludingGoodwill1>
    <RCAT:IntangibleAssetsNetExcludingGoodwill1
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-15084"
      unitRef="USD">-1982612</RCAT:IntangibleAssetsNetExcludingGoodwill1>
    <RCAT:IntangibleAssetsNetExcludingGoodwill1
      contextRef="AsOf2024-04-30_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-15085"
      unitRef="USD">3794389</RCAT:IntangibleAssetsNetExcludingGoodwill1>
    <RCAT:IntangibleAssetsNetExcludingGoodwill1
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-15086"
      unitRef="USD">8239000</RCAT:IntangibleAssetsNetExcludingGoodwill1>
    <RCAT:IntangibleAssetsNetExcludingGoodwill1
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-15087"
      unitRef="USD">-1345885</RCAT:IntangibleAssetsNetExcludingGoodwill1>
    <RCAT:IntangibleAssetsNetExcludingGoodwill1
      contextRef="AsOf2023-04-30_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-15088"
      unitRef="USD">6893115</RCAT:IntangibleAssetsNetExcludingGoodwill1>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-10201">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zjneipPSX354" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Expected amortization expense for the unamortized finite-lived intangible assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left; font-size: 10pt"&gt;Fiscal Year Ended:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49E_20240430_zXaRMnPYpHdb"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_zexbQb0J4IVj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 65%; font-size: 10pt; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 30%; font-size: 10pt; text-align: right"&gt;709,316&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_zuPC7NIpEPni" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;709,316&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_z8fubbCcSvLk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;2027&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;709,316&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_zwTo7HbdELuk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;2028&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;236,441&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_zxuDNQg8YLt5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;2029&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0970"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_zMpmporglwSl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0972"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_zpbixktmPMy8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;2,364,389&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15089"
      unitRef="USD">709316</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15090"
      unitRef="USD">709316</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15091"
      unitRef="USD">709316</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15092"
      unitRef="USD">236441</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15093"
      unitRef="USD">2364389</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-10275">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfGoodwillTextBlock_zIm5jaFCEO12" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Composition of, and changes in goodwill (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt"&gt;Date&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;Entity&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_4BC_us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap--GoodwillMember_zTxPMT2MHiE9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;Goodwill&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20200101__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_zVBMNDR9lQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 36%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;January 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 30%; font-size: 10pt; text-align: center; padding-left: 5.75pt"&gt;Rotor Riot&lt;/td&gt;&lt;td style="width: 5%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;1,849,073&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20201101__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_z2jBZyYLS7Ti" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;November 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-left: 5.75pt"&gt;Fat Shark&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;6,168,260&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20210501__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_zyUCw4f48f31" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;May 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-left: 5.75pt"&gt;Skypersonic&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,826,918&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20210801__20230430_eus-gaap--GoodwillPeriodIncreaseDecrease_zJ8BOuIQznS4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;August 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-left: 5.75pt"&gt;Teal Drones&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;8,995,499&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20230401__20230430_eus-gaap--GoodwillImpairmentLoss_iN_di_zarFtKrXSuf2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;April 2023 - Impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-bottom: 1pt; padding-left: 5.75pt"&gt;Skypersonic&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(2,826,918&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20230430_eus-gaap--Goodwill_iI_z6nMnHPAnlYh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Balance at April 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-left: 5.75pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;17,012,832&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20240201__20240430_eus-gaap--GoodwillWrittenOffRelatedToSaleOfBusinessUnit_iN_di_zSBGoPCLIeJd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;February 2024 &#x2013; Divestiture&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt; padding-left: 5.75pt"&gt;Rotor Riot, Fat Shark&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;(7,924,282&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20240430_eus-gaap--Goodwill_iI_zba2WDzOY1E8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Balance at April 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt; padding-left: 5.75pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;9,088,550&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="From2020-01-012023-04-30_us-gaap_GoodwillMember"
      decimals="0"
      id="ixv-15094"
      unitRef="USD">1849073</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="From2020-11-012023-04-30_us-gaap_GoodwillMember"
      decimals="0"
      id="ixv-15095"
      unitRef="USD">6168260</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="From2021-05-012023-04-30_us-gaap_GoodwillMember"
      decimals="0"
      id="ixv-15096"
      unitRef="USD">2826918</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="From2021-08-012023-04-30_us-gaap_GoodwillMember"
      decimals="0"
      id="ixv-15097"
      unitRef="USD">8995499</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2023-04-012023-04-30_us-gaap_GoodwillMember"
      decimals="0"
      id="ixv-15098"
      unitRef="USD">2826918</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="AsOf2023-04-30_us-gaap_GoodwillMember"
      decimals="0"
      id="ixv-15099"
      unitRef="USD">17012832</us-gaap:Goodwill>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="From2024-02-012024-04-30_us-gaap_GoodwillMember"
      decimals="0"
      id="ixv-15100"
      unitRef="USD">7924282</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:Goodwill
      contextRef="AsOf2024-04-30_us-gaap_GoodwillMember"
      decimals="0"
      id="ixv-15101"
      unitRef="USD">9088550</us-gaap:Goodwill>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-10382">&lt;p id="xdx_80E_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_ze3r0cHA8g83" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_826_zW6Qq60QjsNk"&gt;Note
9 &#x2013; Equity Method Investment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;As
of April 30, 2024, the Company owned a 46% interest in Unusual Machines. The primary business operations include selling first-person-view
video goggles for drone pilots, drones, parts and related equipment to the consumer marketplace. UMAC&#x2019;s financial statements are prepared
in accordance with GAAP.&lt;/span&gt; See Note 3 and Note 22 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Financial
information for UMAC is derived from UMAC&#x2019;s  Form 10-Q for the quarter ending March 31, 2024 and was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--EquityMethodInvestmentFinancialInformationTableTextBlock_zKROqMKzMPrg" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Financial informatino for UMAC derived from their Form 10-Q (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_498_20240101__20240331__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zYeBfmK7l2wj"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AssetsCurrent_iE_zNk2JRkdgya5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 67%; font-size: 10pt; text-align: left"&gt;Current assets&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 30%; font-size: 10pt; text-align: right"&gt;6,128,890&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AssetsNoncurrent_iE_zfYhJXWFPV3k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Long-term assets&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;18,099,802&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LiabilitiesCurrent_iE_zIfxmBi54kE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Current liabilities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;691,978&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LiabilitiesNoncurrent_iE_zkpKr46q3Q9g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Long-term liabilities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,313,896&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Revenues_zEoIDgypOTUc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt"&gt;Revenues&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;618,915&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--GrossProfit_zaEArg6XVZr4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Gross profit&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;204,167&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NetIncomeLoss_zqWGToyTOZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(1,106,001&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zNWE9zsBjaA5" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;



&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;The
Company&#x2019;s investments in UMAC have been impacted by the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--EquityMethodInvestmentsTextBlock_zLOji0k794G2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Impacts on investments into UMAC (Details)"&gt;
  &lt;tr id="xdx_402_eus-gaap--EquityMethodInvestments_iS_zlF5Ab6Egy26" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 67%"&gt;Initial investment, February 16, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_494_20230501__20240430__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zVEBHNE7SSel" style="width: 30%; text-align: right"&gt;17,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeLossFromEquityMethodInvestments_iN_di_zBxykRuVOIT" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Equity method loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(503,625&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_iN_di_z2OIJekif81" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Impairment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(11,353,875&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--EquityMethodInvestments_iE_zV98VQyDhPIb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Investment balance, April 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,142,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_z7x9uz0RfKge" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;The
computation of both the initial investment as of February 16, 2024 and investment balance as of April 30, 2024, is based on the fair market
value of UMAC&#x2019;s common stock. &lt;/span&gt;&lt;/p&gt;

</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <RCAT:EquityMethodInvestmentFinancialInformationTableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-10394">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--EquityMethodInvestmentFinancialInformationTableTextBlock_zKROqMKzMPrg" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Financial informatino for UMAC derived from their Form 10-Q (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_498_20240101__20240331__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zYeBfmK7l2wj"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AssetsCurrent_iE_zNk2JRkdgya5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 67%; font-size: 10pt; text-align: left"&gt;Current assets&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 30%; font-size: 10pt; text-align: right"&gt;6,128,890&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AssetsNoncurrent_iE_zfYhJXWFPV3k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Long-term assets&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;18,099,802&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LiabilitiesCurrent_iE_zIfxmBi54kE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Current liabilities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;691,978&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LiabilitiesNoncurrent_iE_zkpKr46q3Q9g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Long-term liabilities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,313,896&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Revenues_zEoIDgypOTUc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt"&gt;Revenues&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;618,915&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--GrossProfit_zaEArg6XVZr4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Gross profit&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;204,167&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NetIncomeLoss_zqWGToyTOZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(1,106,001&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RCAT:EquityMethodInvestmentFinancialInformationTableTextBlock>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-15102"
      unitRef="USD">6128890</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-15103"
      unitRef="USD">18099802</us-gaap:AssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-15104"
      unitRef="USD">691978</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-15105"
      unitRef="USD">2313896</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-15106"
      unitRef="USD">618915</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-15107"
      unitRef="USD">204167</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-15108"
      unitRef="USD">-1106001</us-gaap:NetIncomeLoss>
    <us-gaap:EquityMethodInvestmentsTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-10456">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--EquityMethodInvestmentsTextBlock_zLOji0k794G2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Impacts on investments into UMAC (Details)"&gt;
  &lt;tr id="xdx_402_eus-gaap--EquityMethodInvestments_iS_zlF5Ab6Egy26" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 67%"&gt;Initial investment, February 16, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_494_20230501__20240430__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zVEBHNE7SSel" style="width: 30%; text-align: right"&gt;17,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeLossFromEquityMethodInvestments_iN_di_zBxykRuVOIT" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Equity method loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(503,625&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_iN_di_z2OIJekif81" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Impairment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(11,353,875&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--EquityMethodInvestments_iE_zV98VQyDhPIb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Investment balance, April 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,142,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2023-05-012024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-15109"
      unitRef="USD">503625</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="From2023-05-012024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-15110"
      unitRef="USD">11353875</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestments
      contextRef="AsOf2024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-15111"
      unitRef="USD">5142500</us-gaap:EquityMethodInvestments>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-10492">&lt;p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zNngJgqAgHHb" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82E_z9dMcRlJbVge"&gt;Note
10 &#x2013; Property and Equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Property
and equipment consist of assets with an estimated useful life greater than one year and are reported net of accumulated depreciation.
The reported values are periodically assessed for impairment, and were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--PropertyPlantAndEquipmentTextBlock_z5oH0fjSeHPe" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Property and equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_496_20240430_zaTMthThlrWb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_494_20230430_z1qnxPEDFgu5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentGross_iI_z2KRiK3mgwlj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Equipment and related&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;1,540,888&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;1,386,373&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LeaseholdImprovementsGross_iI_zoau8fUQKb9l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,547,976&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,473,890&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FurnitureAndFixturesGross_iI_zg3QM2Hv2a7f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Furniture and fixtures&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;163,290&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;132,752&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_zYuCwcne8EL1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(911,470&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(342,657&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iI_zNnVB50SjlS7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt"&gt;Net carrying value&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;2,340,684&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;2,650,358&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Depreciation
expense totaled $&lt;span id="xdx_906_eus-gaap--Depreciation_c20230501__20240430_zJK5OyBrgMO"&gt;568,813&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--Depreciation_c20220501__20230430_zYaiW4pDORZ7"&gt;311,545&lt;/span&gt; for the years ended April 30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-10501">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--PropertyPlantAndEquipmentTextBlock_z5oH0fjSeHPe" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Property and equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_496_20240430_zaTMthThlrWb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_494_20230430_z1qnxPEDFgu5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentGross_iI_z2KRiK3mgwlj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Equipment and related&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;1,540,888&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;1,386,373&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LeaseholdImprovementsGross_iI_zoau8fUQKb9l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,547,976&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,473,890&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FurnitureAndFixturesGross_iI_zg3QM2Hv2a7f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Furniture and fixtures&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;163,290&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;132,752&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_zYuCwcne8EL1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(911,470&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(342,657&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iI_zNnVB50SjlS7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt"&gt;Net carrying value&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;2,340,684&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;2,650,358&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Depreciation
expense totaled $&lt;span id="xdx_906_eus-gaap--Depreciation_c20230501__20240430_zJK5OyBrgMO"&gt;568,813&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--Depreciation_c20220501__20230430_zYaiW4pDORZ7"&gt;311,545&lt;/span&gt; for the years ended April 30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15112"
      unitRef="USD">1540888</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15113"
      unitRef="USD">1386373</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15114"
      unitRef="USD">1547976</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15115"
      unitRef="USD">1473890</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15116"
      unitRef="USD">163290</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15117"
      unitRef="USD">132752</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15118"
      unitRef="USD">911470</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15119"
      unitRef="USD">342657</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15120"
      unitRef="USD">2340684</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15121"
      unitRef="USD">2650358</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-15122"
      unitRef="USD">568813</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-15123"
      unitRef="USD">311545</us-gaap:Depreciation>
    <RCAT:OtherLongTermAssetsDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-10566">&lt;p id="xdx_809_ecustom--OtherLongTermAssetsDisclosureTextBlock_zXQLH0kdO6ak" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82B_zCTGEJagbx4f"&gt;Note
11 &#x2013; Other Long-Term Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Other
long-term assets included:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfOtherLongTermAssetsTableTextBlock_zTbXFIaRadZd" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Other long term assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20240430_zB94gUgtyTR3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20230430_zGS0C8OOI27k" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--SAFEAgreementAssets_iI_zXHoQtbOXWhi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;SAFE agreement&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;250,000&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;250,000&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--SecurityDeposit_iI_zUHiVGMrR6jb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Security deposits&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;43,126&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;53,180&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NoncurrentAssets_iI_zVI3O7DTXcjg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;293,126&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;303,180&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_ziapqAxsjAYa" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;In
November 2022, the Company entered into a SAFE (Simple Agreement for Future Equity) agreement with Firestorm Labs, Inc. (&#x201c;Firestorm&#x201d;)
under which it made a payment of $&lt;span id="xdx_900_ecustom--PaymentForSAFEAgreement_c20221101__20221130_zSNCj7gfXCKd"&gt;250,000&lt;/span&gt; to Firestorm in exchange for the right to certain shares of Firestorm stock. The SAFE permits
the Company to participate in a future equity financing of Firestorm by converting the $&lt;span id="xdx_90C_ecustom--PaymentForSAFEAgreement_c20221101__20221130_z1gsZASEQBQ9"&gt;250,000&lt;/span&gt; into shares of Preferred Stock of Firestorm.
If there is a change in control of Firestorm or a public offering of shares of its stock, then the Company shall have the right to receive
cash payments, or shares of stock, whichever has greater value. The Company&#x2019;s investment in the SAFE agreement has been recorded
on the cost method of accounting. The Company evaluates the investment for any indications of impairment in value on a quarterly
basis. No&#160;factors indicative of impairment were identified&#160;during&#160;the&#160;year ended&#160;April&#160;30,&#160;2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

</RCAT:OtherLongTermAssetsDisclosureTextBlock>
    <RCAT:ScheduleOfOtherLongTermAssetsTableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-10575">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfOtherLongTermAssetsTableTextBlock_zTbXFIaRadZd" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Other long term assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20240430_zB94gUgtyTR3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20230430_zGS0C8OOI27k" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--SAFEAgreementAssets_iI_zXHoQtbOXWhi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;SAFE agreement&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;250,000&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;250,000&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--SecurityDeposit_iI_zUHiVGMrR6jb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Security deposits&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;43,126&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;53,180&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NoncurrentAssets_iI_zVI3O7DTXcjg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;293,126&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;303,180&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RCAT:ScheduleOfOtherLongTermAssetsTableTextBlock>
    <RCAT:SAFEAgreementAssets
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15124"
      unitRef="USD">250000</RCAT:SAFEAgreementAssets>
    <RCAT:SAFEAgreementAssets
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15125"
      unitRef="USD">250000</RCAT:SAFEAgreementAssets>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15126"
      unitRef="USD">43126</us-gaap:SecurityDeposit>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15127"
      unitRef="USD">53180</us-gaap:SecurityDeposit>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15128"
      unitRef="USD">293126</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15129"
      unitRef="USD">303180</us-gaap:NoncurrentAssets>
    <RCAT:PaymentForSAFEAgreement
      contextRef="From2022-11-012022-11-30"
      decimals="0"
      id="ixv-15130"
      unitRef="USD">250000</RCAT:PaymentForSAFEAgreement>
    <RCAT:PaymentForSAFEAgreement
      contextRef="From2022-11-012022-11-30"
      decimals="0"
      id="ixv-15131"
      unitRef="USD">250000</RCAT:PaymentForSAFEAgreement>
    <us-gaap:LeasesOfLesseeDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-10632">&lt;p id="xdx_80F_eus-gaap--LeasesOfLesseeDisclosureTextBlock_zw3b8dL1jBt1" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_821_zE9onxcMSbR7"&gt;Note
12 &#x2013; Right of Use Assets and Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;As
of April 30, 2024, the Company had operating type leases for real estate and no finance type leases. The Company&#x2019;s leases have remaining
lease terms of up to 6.67 years, including options to extend certain leases for up to six years. Operating lease expense totaled $351,369
for the year ended April 30, 2024, including period cost for short-term, cancellable, and variable leases, not included in lease liabilities,
of $4,950 for the year ended April 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Leases
on which the Company made rent payments during the reporting period included:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfRentExpenseTableTextBlock_zQ1JIeepMl5k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Operating leases (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Location&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Monthly Rent&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Expiration&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 42%"&gt;South Salt Lake, Utah&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingLeaseExpense_c20230501__20240430__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation1Member_zj3FQbQY4iSa" style="text-align: right; width: 25%"&gt;22,667&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 25%"&gt;&lt;span style="font-size: 10pt"&gt;December 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;San Juan, Puerto Rico&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLeaseExpense_c20230501__20240430__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation3Member_z08KIHOS9lxh" style="text-align: right"&gt;5,647&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;June 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Grantsville, Utah&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLeaseExpense_c20230501__20240430__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation4Member_zJALeoBESDX7" style="text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;December 2026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;


&lt;p id="xdx_8AC_zUjEJTYUfwP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.25in"&gt;&#160;&lt;span style="background-color: white"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Supplemental
information related to operating leases for the year ended April 30, 2024 was:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_z7efdYCP0wsl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Supplemental information related to operating leases (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20230501__20240430_zFXEY9gfNDOl" style="font-size: 12pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--OperatingCashPaidToSettleLeaseLiabilities_zOf4I3cCkeX9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt; width: 77%"&gt;&lt;span style="font-size: 10pt"&gt;Operating cash
    paid to settle lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; width: 20%"&gt;$&lt;span style="font-size: 10pt"&gt;$350,162&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_pip0_dtY_c20240430_zbG3UQ5mByma"&gt;2.16&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iE_zY85bVC2Kdmg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A1_znwjP9FnHAk2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Future
lease payments at April 30, 2024 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zuRpKwgz6M9" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 40%" summary="xdx: Disclosure - Future lease payment obligations (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="text-align: left; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Fiscal Year Ended:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_491_20240430_zvEq4KDDN9o7"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_zaYkZNg8TXwc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 65%"&gt;&lt;span style="font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;$&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; width: 30%"&gt;&lt;span style="font-size: 10pt"&gt;366,853&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_zImF4TEPWzRl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;372,449&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_iI_zNHSwZ8slT03" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;372,880&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_iI_zklrfpA29ay7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;293,334&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix_iI_zYRWSdd79em4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;280,080&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueThereafter_iI_zQQDjEuYhUv8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;443,460&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueSubtotal_iI_zbyHydiK5Osi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,129,056&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_z1mCQdrdNofd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;Imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(611,466&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_z59T5oeilyFk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;Total liability&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;1,517,590&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;


&lt;p id="xdx_8AB_zCkfrZTZbGWj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;span style="background-color: white"&gt;&#160;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LeasesOfLesseeDisclosureTextBlock>
    <us-gaap:ScheduleOfRentExpenseTableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-10648">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfRentExpenseTableTextBlock_zQ1JIeepMl5k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Operating leases (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Location&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Monthly Rent&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Expiration&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 42%"&gt;South Salt Lake, Utah&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingLeaseExpense_c20230501__20240430__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation1Member_zj3FQbQY4iSa" style="text-align: right; width: 25%"&gt;22,667&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 25%"&gt;&lt;span style="font-size: 10pt"&gt;December 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;San Juan, Puerto Rico&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLeaseExpense_c20230501__20240430__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation3Member_z08KIHOS9lxh" style="text-align: right"&gt;5,647&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;June 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Grantsville, Utah&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLeaseExpense_c20230501__20240430__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation4Member_zJALeoBESDX7" style="text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;December 2026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;


</us-gaap:ScheduleOfRentExpenseTableTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2023-05-012024-04-30_custom_OperatingLeaseLocation1Member"
      decimals="0"
      id="ixv-15132"
      unitRef="USD">22667</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2023-05-012024-04-30_custom_OperatingLeaseLocation3Member"
      decimals="0"
      id="ixv-15133"
      unitRef="USD">5647</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2023-05-012024-04-30_custom_OperatingLeaseLocation4Member"
      decimals="0"
      id="ixv-15134"
      unitRef="USD">1000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-10696">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_z7efdYCP0wsl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Supplemental information related to operating leases (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20230501__20240430_zFXEY9gfNDOl" style="font-size: 12pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--OperatingCashPaidToSettleLeaseLiabilities_zOf4I3cCkeX9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt; width: 77%"&gt;&lt;span style="font-size: 10pt"&gt;Operating cash
    paid to settle lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; width: 20%"&gt;$&lt;span style="font-size: 10pt"&gt;$350,162&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_pip0_dtY_c20240430_zbG3UQ5mByma"&gt;2.16&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iE_zY85bVC2Kdmg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
    <RCAT:OperatingCashPaidToSettleLeaseLiabilities
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-15135"
      unitRef="USD">350162</RCAT:OperatingCashPaidToSettleLeaseLiabilities>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2024-04-30" id="ixv-15136">P2Y1M28D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2024-04-30"
      decimals="INF"
      id="ixv-15137"
      unitRef="Pure">0.12</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-10745">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zuRpKwgz6M9" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 40%" summary="xdx: Disclosure - Future lease payment obligations (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="text-align: left; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Fiscal Year Ended:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_491_20240430_zvEq4KDDN9o7"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_zaYkZNg8TXwc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 65%"&gt;&lt;span style="font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;$&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; width: 30%"&gt;&lt;span style="font-size: 10pt"&gt;366,853&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_zImF4TEPWzRl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;372,449&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_iI_zNHSwZ8slT03" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;372,880&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_iI_zklrfpA29ay7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;293,334&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix_iI_zYRWSdd79em4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;280,080&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueThereafter_iI_zQQDjEuYhUv8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;443,460&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueSubtotal_iI_zbyHydiK5Osi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,129,056&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_z1mCQdrdNofd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;Imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(611,466&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_z59T5oeilyFk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;Total liability&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;1,517,590&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;


</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15138"
      unitRef="USD">366853</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15139"
      unitRef="USD">372449</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15140"
      unitRef="USD">372880</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15141"
      unitRef="USD">293334</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive>
    <RCAT:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15142"
      unitRef="USD">280080</RCAT:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearSix>
    <RCAT:LesseeOperatingLeaseLiabilityPaymentsDueThereafter
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15143"
      unitRef="USD">443460</RCAT:LesseeOperatingLeaseLiabilityPaymentsDueThereafter>
    <RCAT:LesseeOperatingLeaseLiabilityPaymentsDueSubtotal
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15144"
      unitRef="USD">2129056</RCAT:LesseeOperatingLeaseLiabilityPaymentsDueSubtotal>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15145"
      unitRef="USD">611466</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15146"
      unitRef="USD">1517590</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-10874">&lt;p id="xdx_80A_eus-gaap--DebtDisclosureTextBlock_zSZDwMmnxPZk" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_828_z6O6iZAQhi76"&gt;Note
13 &#x2013; Debt Obligations&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;&#160;Decathlon Capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;On
August 31, 2021, Teal entered into an Amended and Restated Loan and Security Agreement with Decathlon Alpha IV, L.P. (&#x201c;DA4&#x201d;)
in the amount of $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20220831__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_z8el6ty3tAnj"&gt;1,670,294&lt;/span&gt; (the &#x201c;Loan&#x201d;), representing the outstanding principal amount previously due and owing by Teal to
DA4. Interest on the Loan accrues at a rate of ten (&lt;span id="xdx_900_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220901__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_zBuPvjkJDpN3"&gt;10&lt;/span&gt;%) percent per annum. Principal and interest is payable in monthly installments
of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20220801__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_zjqMiZ0o4eJb"&gt;49,275&lt;/span&gt; until maturity on December 31, 2024. The balance outstanding at April 30, 2024 and April 30, 2023 totaled $&lt;span id="xdx_909_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430_zsORdDUSUolb"&gt;370,537&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--DebtInstrumentCarryingAmount_iI_c20230430_zcDSJ2x2W3bl"&gt;895,709&lt;/span&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;&#160;Pelion Note&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;In
May 2021, Teal entered into a note agreement totaling $&lt;span id="xdx_900_ecustom--ConvertibleNoteAgreementAmount_c20210501__20220430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zW0nGPfn5GV"&gt;350,000&lt;/span&gt;
which is payable upon demand. The Note bears interest at the applicable
Federal Rate as of the date of the Note which was &lt;span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230501__20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zBBW80i8TgBk"&gt;0.13&lt;/span&gt;% on the date of issuance. Accrued interest at April 30, 2024 and April 30, 2023
totaled $&lt;span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrent_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zjzEY8KTMgU7"&gt;1,334 &lt;/span&gt;and $&lt;span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrent_iI_c20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zm6eNjeuXGp"&gt;878&lt;/span&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;&#160;Vendor Agreement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;In
connection with the acquisition of Teal on August 31, 2021, the Company assumed an obligation with a contract manufacturing firm. The
assumed balance of $&lt;/span&gt;&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20210831__us-gaap--DebtInstrumentAxis__custom--DebtObligation3Member_zLoCAT8gBVyh"&gt;387,500&lt;/span&gt;
was repaid in monthly installments of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPayment_c20210801__20220731_zgiRgvbQ53l2"&gt;37,500&lt;/span&gt;
and paid in full in July 2022.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 97%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;&#160;Corporate Equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Beginning
in October 2021, and amended in January 2022, Teal financed a total of $&lt;span id="xdx_90B_ecustom--LeaseholdImprovementAgreementFundsReceived_c20230701__20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zqkKj6PmTUS1"&gt;120,000&lt;/span&gt;
of leasehold improvements with Corporate Equity, LLC. The loan bears interest at &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20221001__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zx6kOAetsgPa"&gt;8.25&lt;/span&gt;%
annually and requires monthly payments of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPayment_c20221001__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zJavIGqWKlx3"&gt;3,595&lt;/span&gt;
through December 2024. The balance outstanding at April 30, 2024 and April 30, 2023 totaled $&lt;span id="xdx_909_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zMXBN1sQ6NUd"&gt;27,495 &lt;/span&gt;
and $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zjFvT0ZaU9ib"&gt;66,586&lt;/span&gt;
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 96%; padding-bottom: 8pt; padding-left: 9pt; text-align: justify; line-height: 105%; text-indent: -9pt"&gt;&lt;span style="font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;&#160;Ascentium Capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;In
September 2021, Teal entered into a financing agreement with Ascentium Capital to fund the purchase of a fixed asset totaling $&lt;span id="xdx_903_ecustom--FinancingAgreementFundingOfPurchaseOfFixedAsset_c20220901__20220930__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zLiCSUUejGie"&gt;24,383&lt;/span&gt;.
Monthly payments of $&lt;span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPayment_c20220901__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zlOXO7Se5X0g"&gt;656&lt;/span&gt;
are payable through October 2024. The balance outstanding at April 30, 2024 and April 30, 2023 totaled $&lt;span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zOkDuHYgUIY4"&gt;3,538 &lt;/span&gt;
and $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zhT0UsZNGXR3"&gt;11,412&lt;/span&gt;
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;&#160;Summary &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Future
annual principal payments at April 30, 2024 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfDebtPaymentsDueTableTextBlock_z3uP9BcDMky8" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Outstanding principal payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left; font-size: 10pt"&gt;Fiscal Year Ended:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_496_20240430_z2f3ASuP4Fsj"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--OutstandingPrincipalPaymentsDueYearOne_iI_zbmEsNFx6o97" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 65%; font-size: 10pt; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 30%; font-size: 10pt; text-align: right"&gt;751,570&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--OutstandingPrincipalPaymentsDueLongTerm_iI_zaRHrANgX5L5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1119"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--OutstandingPrincipalPaymentsDueTotal_iI_zhiLvdsDxxG5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;751,570&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_ztdnOvdVdtyl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;span style="background-color: white"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-08-31_custom_DebtObligation1Member"
      decimals="0"
      id="ixv-15147"
      unitRef="USD">1670294</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-09-012023-04-30_custom_DebtObligation1Member"
      decimals="INF"
      id="ixv-15148"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-08-012023-04-30_custom_DebtObligation1Member"
      decimals="0"
      id="ixv-15149"
      unitRef="USD">49275</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15150"
      unitRef="USD">370537</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15151"
      unitRef="USD">895709</us-gaap:DebtInstrumentCarryingAmount>
    <RCAT:ConvertibleNoteAgreementAmount
      contextRef="From2021-05-012022-04-30_custom_DebtObligation2Member"
      decimals="0"
      id="ixv-15152"
      unitRef="USD">350000</RCAT:ConvertibleNoteAgreementAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2023-05-012024-04-30_custom_DebtObligation2Member"
      decimals="INF"
      id="ixv-15153"
      unitRef="Pure">0.0013</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-04-30_custom_DebtObligation2Member"
      decimals="0"
      id="ixv-15154"
      unitRef="USD">1334</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-04-30_custom_DebtObligation2Member"
      decimals="0"
      id="ixv-15155"
      unitRef="USD">878</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-08-31_custom_DebtObligation3Member"
      decimals="0"
      id="ixv-15156"
      unitRef="USD">387500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2021-08-012022-07-31"
      decimals="0"
      id="ixv-15157"
      unitRef="USD">37500</us-gaap:DebtInstrumentPeriodicPayment>
    <RCAT:LeaseholdImprovementAgreementFundsReceived
      contextRef="From2023-07-012024-04-30_custom_DebtObligation6Member"
      decimals="0"
      id="ixv-15158"
      unitRef="USD">120000</RCAT:LeaseholdImprovementAgreementFundsReceived>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-10-012023-04-30_custom_DebtObligation6Member"
      decimals="INF"
      id="ixv-15159"
      unitRef="Pure">0.0825</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-10-012023-04-30_custom_DebtObligation6Member"
      decimals="0"
      id="ixv-15160"
      unitRef="USD">3595</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2024-04-30_custom_DebtObligation6Member"
      decimals="0"
      id="ixv-15161"
      unitRef="USD">27495</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-04-30_custom_DebtObligation6Member"
      decimals="0"
      id="ixv-15162"
      unitRef="USD">66586</us-gaap:DebtInstrumentCarryingAmount>
    <RCAT:FinancingAgreementFundingOfPurchaseOfFixedAsset
      contextRef="From2022-09-012022-09-30_custom_DebtObligation8Member"
      decimals="0"
      id="ixv-15163"
      unitRef="USD">24383</RCAT:FinancingAgreementFundingOfPurchaseOfFixedAsset>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-09-012023-04-30_custom_DebtObligation8Member"
      decimals="0"
      id="ixv-15164"
      unitRef="USD">656</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2024-04-30_custom_DebtObligation8Member"
      decimals="0"
      id="ixv-15165"
      unitRef="USD">3538</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-04-30_custom_DebtObligation8Member"
      decimals="0"
      id="ixv-15166"
      unitRef="USD">11412</us-gaap:DebtInstrumentCarryingAmount>
    <RCAT:ScheduleOfDebtPaymentsDueTableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-10987">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfDebtPaymentsDueTableTextBlock_z3uP9BcDMky8" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Outstanding principal payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left; font-size: 10pt"&gt;Fiscal Year Ended:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_496_20240430_z2f3ASuP4Fsj"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--OutstandingPrincipalPaymentsDueYearOne_iI_zbmEsNFx6o97" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 65%; font-size: 10pt; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 30%; font-size: 10pt; text-align: right"&gt;751,570&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--OutstandingPrincipalPaymentsDueLongTerm_iI_zaRHrANgX5L5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1119"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--OutstandingPrincipalPaymentsDueTotal_iI_zhiLvdsDxxG5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;751,570&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RCAT:ScheduleOfDebtPaymentsDueTableTextBlock>
    <RCAT:OutstandingPrincipalPaymentsDueYearOne
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15167"
      unitRef="USD">751570</RCAT:OutstandingPrincipalPaymentsDueYearOne>
    <RCAT:OutstandingPrincipalPaymentsDueTotal
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15168"
      unitRef="USD">751570</RCAT:OutstandingPrincipalPaymentsDueTotal>
    <RCAT:RelatedPartyPayablesDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-11026">&lt;p id="xdx_803_ecustom--RelatedPartyPayablesDisclosureTextBlock_zFBccIINAv29" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_823_zoxdMGNj6oO8"&gt;Note
14 &#x2013; Due to Related Party&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;In
January 2020, in connection with the acquisition of Rotor Riot, the Company assumed a line of credit obligation of the seller, BRIT, LLC,
totaling $&lt;span id="xdx_908_ecustom--LineOfCreditObligationAssumedInConnectionWithAcquisition_c20210101__20230430__us-gaap--DebtInstrumentAxis__custom--DueToRelatedParty2Member_zgqzb5Vdps94"&gt;47,853&lt;/span&gt; which bore interest at &lt;span id="xdx_900_ecustom--DebtInstrumentInterestRateDuringPeriod1_dp_c20210101__20230430__us-gaap--DebtInstrumentAxis__custom--DueToRelatedParty2Member_zLASTj7puVT1"&gt;6.67&lt;/span&gt;% annually. The remaining balance of $&lt;span id="xdx_90B_ecustom--DueToOtherRelatedPartyClassifiedCurrent_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DueToRelatedParty2Member_z0oxsqoKtiua"&gt;37,196&lt;/span&gt; plus accrued interest totaling $&lt;span id="xdx_904_ecustom--DebtInstrumentOutstandingAccruedInterestPayment_c20240401__20240430__us-gaap--DebtInstrumentAxis__custom--DueToRelatedParty2Member_zGH9XtXBfGmj"&gt;292&lt;/span&gt; was paid
in October 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

</RCAT:RelatedPartyPayablesDisclosureTextBlock>
    <RCAT:LineOfCreditObligationAssumedInConnectionWithAcquisition
      contextRef="From2021-01-012023-04-30_custom_DueToRelatedParty2Member"
      decimals="0"
      id="ixv-15169"
      unitRef="USD">47853</RCAT:LineOfCreditObligationAssumedInConnectionWithAcquisition>
    <RCAT:DebtInstrumentInterestRateDuringPeriod1
      contextRef="From2021-01-012023-04-30_custom_DueToRelatedParty2Member"
      decimals="INF"
      id="ixv-15170"
      unitRef="Pure">0.0667</RCAT:DebtInstrumentInterestRateDuringPeriod1>
    <RCAT:DueToOtherRelatedPartyClassifiedCurrent
      contextRef="AsOf2024-04-30_custom_DueToRelatedParty2Member"
      decimals="0"
      id="ixv-15171"
      unitRef="USD">37196</RCAT:DueToOtherRelatedPartyClassifiedCurrent>
    <RCAT:DebtInstrumentOutstandingAccruedInterestPayment
      contextRef="From2024-04-012024-04-30_custom_DueToRelatedParty2Member"
      decimals="0"
      id="ixv-15172"
      unitRef="USD">292</RCAT:DebtInstrumentOutstandingAccruedInterestPayment>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-11040">&lt;p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_zooMVUz7mF72" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82D_zzTBt38pj7Eb"&gt;Note
15 &#x2013; Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Our
operating subsidiary, Red Cat Propware, Inc., is incorporated and based in Puerto Rico which is a commonwealth of the United States. We
are not subject to taxation by the United States as Puerto Rico has its own taxing authority. Since inception, we have incurred net losses
in each year of operations. Our current provision for the reporting periods presented in these financial statements consisted of a tax
benefit against which we applied a full valuation allowance, resulting in no current provision for income taxes. In addition, there was
no deferred provision for any of these reporting periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;At
April 30, 2024 and April 30, 2023, we had accumulated deficits of approximately $&lt;span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_dxL_c20240430_zeghuUfkt2nf" title="::XDX::-81130732"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1130"&gt;81,100,000 &lt;/span&gt;&lt;/span&gt;
and $&lt;span id="xdx_903_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_dxL_c20230430_zJwbxoKBK539" title="::XDX::-57078103"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1131"&gt;54,600,000&lt;/span&gt;&lt;/span&gt;, respectively. Deferred tax
assets related to the future benefit of these net operating losses for tax purposes totaled approximately $&lt;span id="xdx_900_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_c20240430_zIAUdeilyCT1"&gt;15,004,000 &lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_c20230430_zxo5Vr9O0oLe"&gt;10,101,000&lt;/span&gt;,
respectively, calculated using the base Puerto Rico corporate tax rate of 18.5%.&#160;Currently, we focus on projected future taxable
income in evaluating whether it is more likely than not that these deferred assets will be realized. Based on the fact that we have not
generated an operating profit since inception, we have applied a full valuation allowance against our deferred tax assets at April 30,
2024 and April 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15173"
      unitRef="USD">15004000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-15174"
      unitRef="USD">10101000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-11070">&lt;p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zq3Zxk9zLiH3" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82F_z1dDSfJeyBg1"&gt;Note
16 &#x2013; Common Stock&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Our
common stock has a par value of $0.001 per share. We are authorized to issue 500,000,000 shares of common stock. Each share of common
stock is entitled to one vote.&#160;A summary of shares of common stock issued by the Company since April 30, 2022 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zZwEuTZUFlwi" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of shares of common stock issued (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt; color: Black"&gt;Description
    of Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zRc8LXBmCtQ8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt; color: Black"&gt;Shares
    Issued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_432_c20220501__20230430_eus-gaap--SharesOutstanding_iS_zAl3QjsXiFib" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; width: 70%"&gt;&lt;span style="font-size: 10pt"&gt;Shares outstanding as of April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; width: 10%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right; width: 18%"&gt;&lt;span style="font-size: 10pt"&gt;53,748,735&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_439_c20220501__20230430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_zQlP30u4qsNd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; text-indent: -9pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted
    stock to employees, net of shares withheld of 273,874 to pay taxes and 9,000 to repay a Note&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;653,308&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_432_c20220501__20230430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_zS3saJZRonp9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to Board
    of Directors&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;116,507&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_436_c20220501__20230430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_zgHPo5WzBwvi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to consultants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;9,683&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_436_c20220501__20230430_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_zyIxJjsCexVe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Shares issued
    for services&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;39,832&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43B_c20220501__20230430_eus-gaap--SharesOutstanding_iE_zdcyyyjECh9c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Shares outstanding as of April 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;54,568,065&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43D_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_zzoEsnKJTOsg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to employees,
    net of shares withheld of 27,189 to pay taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;192,742&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_433_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_zKyaDInkZ1b9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to Board
    of Directors&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;252,214&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_434_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_zCDWbitN80yc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to consultants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,761&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_432_c20230501__20240430_ecustom--StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_zm142xxnAT7c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Conversion of preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;818,334&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43D_c20230501__20240430_ecustom--IssuanceOfCommonStockThroughATMFacilitiesNetShares_zp6G8urM9Dkl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Issuance of common
    stock through ATM facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;53,235&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43D_c20230501__20240430_ecustom--StockIssuedDuringPeriodSharesPublicOffering_zHy0mDvCPVK4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Issuance of common
    stock through public offering&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;18,400,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43C_c20230501__20240430_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_zCG8gXSRjP4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Exercise of stock
    options&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"&gt;3,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_435_c20230501__20240430_eus-gaap--SharesOutstanding_iE_zAq95RZPCJCh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Shares outstanding as of April 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;74,289,351&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zPE3POJNVuMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;ATM Facility&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #222222"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;In August 2023,
we entered into a sales agreement (&#x201c;the 2023 ATM Facility&#x201d;) with ThinkEquity LLC (&#x201c;ThinkEquity&#x201d;), which provides
for the sale, in our sole discretion, of shares of our common stock through ThinkEquity, as our sales agent. &lt;/span&gt;&lt;span style="letter-spacing: 0.2pt"&gt;In
accordance with the terms of the ATM Sales Agreement, the Company may offer and sell shares of our common stock, par value $0.001 per
share, having an aggregate offering price of up to $4,375,000. &lt;/span&gt;&lt;span style="background-color: white"&gt;The issuance and sale of these
shares by us pursuant to the 2023 ATM Facility are deemed &#x201c;at the market&#x201d; offerings as defined in Rule 415 under the Securities
Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), and are registered under the Securities Act. We pay a commission of up to
2.5% of gross sales proceeds of any common stock sold under the 2023 ATM Facility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;During
the year ended April 30, 2024, we sold an aggregate of 53,235 shares of common stock under the 2023 ATM Facility, at an average price
of $1.07 per share, for gross proceeds of approximately $57,000 and net proceeds of approximately $55,700, after deducting commissions
and other offering expenses payable by us. Additionally, the Company incurred legal fees of approximately $46,000 establishing the 2023
ATM Facility. In December 2023, the Prospectus Supplement dated August 8, 2023 was amended to change the aggregate offering price under
the ATM facility to up to $4,375,000.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-size: 10pt; background-color: white"&gt;As
of April 30, 2024, approximately $4,318,000 of common stock remained available to be sold under the 2023 ATM Facility, subject to certain
conditions as specified in the sales agreement.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;Public
Offering&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;In
December 2023, the Company entered into an underwriting agreement with ThinkEquity LLC, as representative of the underwriters, pursuant
to which the Company agreed to sell to the underwriters in a firm commitment underwritten public offering (the &#x201c;Offering&#x201d;)
an aggregate of 16,000,000 shares of the Company&#x2019;s common stock, par value $0.001 per share (the &#x201c;Common Stock&#x201d;), at
a public offering price of $0.50 per share. The Company&#160;also granted the underwriters a 45-day option to purchase up to an additional
2,400,000 shares of Common Stock to cover over-allotments.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;The
Offering closed on December 11, 2023, resulting in the issuance of 18,400,000 shares of Common Stock &lt;/span&gt;which generated gross proceeds
of $9,200,000. &lt;span style="background-color: white"&gt;Net proceeds to the Company from the Offering, after deducting the underwriting discount,
the underwriters&#x2019; fees and expenses and the Company&#x2019;s estimated Offering expenses, were approximately $8,400,000.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-11079">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zZwEuTZUFlwi" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of shares of common stock issued (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt; color: Black"&gt;Description
    of Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zRc8LXBmCtQ8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt; color: Black"&gt;Shares
    Issued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_432_c20220501__20230430_eus-gaap--SharesOutstanding_iS_zAl3QjsXiFib" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; width: 70%"&gt;&lt;span style="font-size: 10pt"&gt;Shares outstanding as of April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; width: 10%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right; width: 18%"&gt;&lt;span style="font-size: 10pt"&gt;53,748,735&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_439_c20220501__20230430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_zQlP30u4qsNd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; text-indent: -9pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted
    stock to employees, net of shares withheld of 273,874 to pay taxes and 9,000 to repay a Note&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;653,308&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_432_c20220501__20230430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_zS3saJZRonp9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to Board
    of Directors&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;116,507&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_436_c20220501__20230430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_zgHPo5WzBwvi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to consultants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;9,683&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_436_c20220501__20230430_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_zyIxJjsCexVe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Shares issued
    for services&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;39,832&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43B_c20220501__20230430_eus-gaap--SharesOutstanding_iE_zdcyyyjECh9c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Shares outstanding as of April 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;54,568,065&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43D_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_zzoEsnKJTOsg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to employees,
    net of shares withheld of 27,189 to pay taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;192,742&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_433_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_zKyaDInkZ1b9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to Board
    of Directors&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;252,214&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_434_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_zCDWbitN80yc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to consultants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,761&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_432_c20230501__20240430_ecustom--StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_zm142xxnAT7c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Conversion of preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;818,334&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43D_c20230501__20240430_ecustom--IssuanceOfCommonStockThroughATMFacilitiesNetShares_zp6G8urM9Dkl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Issuance of common
    stock through ATM facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;53,235&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43D_c20230501__20240430_ecustom--StockIssuedDuringPeriodSharesPublicOffering_zHy0mDvCPVK4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Issuance of common
    stock through public offering&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;18,400,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43C_c20230501__20240430_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_zCG8gXSRjP4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Exercise of stock
    options&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"&gt;3,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_435_c20230501__20240430_eus-gaap--SharesOutstanding_iE_zAq95RZPCJCh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Shares outstanding as of April 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;74,289,351&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-15175"
      unitRef="Shares">53748735</us-gaap:SharesOutstanding>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-15176"
      unitRef="Shares">653308</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-15177"
      unitRef="Shares">116507</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-15178"
      unitRef="Shares">9683</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-15179"
      unitRef="Shares">39832</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-15180"
      unitRef="Shares">54568065</us-gaap:SharesOutstanding>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-15181"
      unitRef="Shares">192742</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-15182"
      unitRef="Shares">252214</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-15183"
      unitRef="Shares">1761</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3>
    <RCAT:StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-15184"
      unitRef="Shares">818334</RCAT:StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities>
    <RCAT:IssuanceOfCommonStockThroughATMFacilitiesNetShares
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-15185"
      unitRef="Shares">53235</RCAT:IssuanceOfCommonStockThroughATMFacilitiesNetShares>
    <RCAT:StockIssuedDuringPeriodSharesPublicOffering
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-15186"
      unitRef="Shares">18400000</RCAT:StockIssuedDuringPeriodSharesPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-15187"
      unitRef="Shares">3000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-15188"
      unitRef="Shares">74289351</us-gaap:SharesOutstanding>
    <us-gaap:PreferredStockTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-11276">&lt;p id="xdx_80E_eus-gaap--PreferredStockTextBlock_zXSg6RLiGw9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_824_zpV74MIsA9n8"&gt;Note
17 &#x2013; Preferred Stock&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Our
preferred stock has a par value of $0.001 per share. Series B Preferred Stock (&#x201c;Series B Stock&#x201d;) is convertible into common
stock at a ratio of 0.8334 shares of common stock for each share of Series B Stock held and votes together with the common stock on an
as-if-converted basis. 982,000 shares of Series B Stock were converted into 818,334 shares of common stock in June 2023. Shares outstanding
at April 30, 2024 totaled &lt;span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_c20240430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z0obPeoBusSi"&gt;4,676 &lt;/span&gt; which are convertible into &lt;span id="xdx_90C_ecustom--StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock_c20230501__20240430__us-gaap--StatementClassOfStockAxis__custom--SeriesAPreferredStock2Member_zKwfwhaq735c"&gt;3,896 &lt;/span&gt;
shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

</us-gaap:PreferredStockTextBlock>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-04-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="ixv-15189"
      unitRef="Shares">4676</us-gaap:PreferredStockSharesOutstanding>
    <RCAT:StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock
      contextRef="From2023-05-012024-04-30_custom_SeriesAPreferredStock2Member"
      decimals="INF"
      id="ixv-15190"
      unitRef="Shares">3896</RCAT:StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock>
    <RCAT:WarrantsDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-11288">&lt;p id="xdx_804_ecustom--WarrantsDisclosureTextBlock_zGRAhGx4Xku5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_822_zZbqF0z2yVmd"&gt;Note
18 &#x2013; Warrants&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;The
Company issued 5 year warrants to investors in connection with two convertible note financings. The warrants have an exercise price
of $&lt;/span&gt;&lt;span id="xdx_90B_ecustom--WarrantsIssuedExercisePrice_c20220401__20220430_zCejfhoYEOpa"&gt;1.50&lt;/span&gt;. The warrants were
valued using the multinominal lattice The value of the warrants was included in the determination of the initial accounting for each
financing.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;A
summary of the warrants issued and their fair values were:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfWarrantsIssuedAndFairValueTableTextBlock_zbYUho9Xrdlf" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of warrants issued and fair values (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; width: 16%"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; width: 3%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; width: 16%"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; width: 3%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; width: 16%"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; width: 3%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; width: 15%"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; width: 3%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; width: 15%"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Upon
    Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Outstanding at April
    30, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Date
    of Transaction&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Number
    of Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Initial
    Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Number
    of Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Fair
    Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;October
                                            2020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NumberOfWarrantsUponIssuance_c20201001__20201031_zrf8FE8uAXai" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;399,998&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--InitialFairValueOfWarrantsUponIssuance_c20201001__20201031_zVHJZnweFA2i" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;267,999&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NumberOfWarrantsOutstanding_iI_c20240430_zcU3YTNrocc2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;266,666&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--FairValueOfWarrantsOutstanding_iI_c20240430_zgGQDHf51rRg" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;209,938&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;January
                                            2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NumberOfWarrantsUponIssuance_c20210401__20210430_zqoZk596H3Sa" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;675,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--InitialFairValueOfWarrantsUponIssuance_c20210401__20210430_z0jnE9yWovYf" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;2,870,666&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NumberOfWarrantsOutstanding2_iI_c20240430_z4fwvJPyLxcd" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;540,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--FairValueOfWarrantsOutstanding2_iI_c20240430_z7Ph1C34RfMa" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;443,242&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;


&lt;p id="xdx_8AA_zeoq8hguxcca" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&lt;span style="background-color: white"&gt;To date,
we have received $&lt;/span&gt;&lt;span id="xdx_905_ecustom--ProceedsReceivedFromExerciseOfWarrants_c20220301__20220430_zgA8xhD9MCKb"&gt;301,248
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;related to the exercise of &lt;span id="xdx_900_ecustom--ExerciseOfWarrantsShares_c20220301__20220430_ztGoxU2DKPN8"&gt;268,332
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;In
May 2021, the Company issued warrants to purchase&lt;/span&gt;
&lt;span id="xdx_90A_ecustom--WarrantsToPurchaseSharesIssued_c20220501__20220531_zbkVYr0YrHaa"&gt;200,000&lt;/span&gt; shares of common stock to the placement agent of its common stock offering.
The warrants have a five-year term and an exercise price of $&lt;span id="xdx_900_ecustom--WarrantsIssuedExercisePrice_c20220501__20220531_zwWNi4oqeZb6"&gt;5.00&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;In
July 2021, the Company issued warrants to purchase &lt;/span&gt;&lt;span id="xdx_90E_ecustom--WarrantsToPurchaseSharesIssued_c20230401__20230430_zmb56uvxdgwh"&gt;533,333
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;shares of common stock to the placement agent of its common stock offering.
The warrants have a five-year term and an exercise price of $&lt;span id="xdx_905_ecustom--WarrantsIssuedExercisePrice_c20230401__20230430_zACHn60xjbR9"&gt;5.625&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;In
December 2023, the Company issued warrants to purchase 736,000&lt;/span&gt; shares of common stock to the placement agent of its common stock
offering. The warrants have a five-year term and an exercise price of $0.625.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table presents the range of assumptions
used to estimate the fair values of the stock warrants granted during the fiscal years ended April 30:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_zJcU7WkxDr3g" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%" summary="xdx: Disclosure - Assumptions used to estimate fair value of stock warrants granted (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zQFMb5AWOQp9"&gt;4.25&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zWd6PqRFV4fg"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1192"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zqQqSW2KsB2k"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1193"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zFMXQHHtWFij"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1194"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Expected term (in years)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zu29Ss1ODlQa"&gt;5.00&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2014;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Expected volatility&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zMwycctXaBIb"&gt;205.50&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_z6hX24aKQBRd"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1197"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zwktyI1mTKO1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes the changes in warrants
outstanding since April 30, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zsdFJDMohnN8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Changes in warrants outstanding (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
    of Shares&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-average
    Exercise Price per Share&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;Weighted-average
                                            Remaining Contractual Term&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(in
    years)&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate
    Intrinsic Value&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance as of April 30, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zTW3ZBJWhzde" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,539,999&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zo1SLf91aMLl" style="font-size: 10pt"&gt;3.38&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20210501__20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z7rVNAKJOWTi" style="font-size: 10pt"&gt;3.89&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zH26NEBRYuvc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;427,533&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 10pt; width: 35%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; width: 12%"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_znif4T3RcJua" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1204"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; width: 12%"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zxhPX5rdpN7e" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1205"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zPHx8GRBEyVg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1206"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zvwPqGg9Id1l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1207"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of April 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zjvR3ErN3P7i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,539,999&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zfRHpMCEPmwc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.38&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zhJ9DYhfua59" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.89&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zFf9i1nIvMRc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1211"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zJY4pO2gXjI9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;736,000&lt;/span&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zdiq75j8N6F7"&gt;0.63&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zangf3TGQe9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1214"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z1lfEfCZUQNl"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1215"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at April 30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zxpBA2wbZjV7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,275,999&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zLvgU96LzJdk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.49&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z0Ddk3rPDzo6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.77&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zwAMcfA1BcA1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;666,080&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zVB84czH59te" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;

</RCAT:WarrantsDisclosureTextBlock>
    <RCAT:WarrantsIssuedExercisePrice
      contextRef="From2022-04-012022-04-30"
      decimals="INF"
      id="ixv-15191"
      unitRef="USDPShares">1.50</RCAT:WarrantsIssuedExercisePrice>
    <RCAT:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-11301">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfWarrantsIssuedAndFairValueTableTextBlock_zbYUho9Xrdlf" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of warrants issued and fair values (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; width: 16%"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; width: 3%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; width: 16%"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; width: 3%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; width: 16%"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; width: 3%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; width: 15%"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; width: 3%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; width: 15%"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Upon
    Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Outstanding at April
    30, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Date
    of Transaction&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Number
    of Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Initial
    Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Number
    of Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Fair
    Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;October
                                            2020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NumberOfWarrantsUponIssuance_c20201001__20201031_zrf8FE8uAXai" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;399,998&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--InitialFairValueOfWarrantsUponIssuance_c20201001__20201031_zVHJZnweFA2i" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;267,999&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NumberOfWarrantsOutstanding_iI_c20240430_zcU3YTNrocc2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;266,666&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--FairValueOfWarrantsOutstanding_iI_c20240430_zgGQDHf51rRg" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;209,938&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;January
                                            2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NumberOfWarrantsUponIssuance_c20210401__20210430_zqoZk596H3Sa" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;675,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--InitialFairValueOfWarrantsUponIssuance_c20210401__20210430_z0jnE9yWovYf" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;2,870,666&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NumberOfWarrantsOutstanding2_iI_c20240430_z4fwvJPyLxcd" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;540,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--FairValueOfWarrantsOutstanding2_iI_c20240430_z7Ph1C34RfMa" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;443,242&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;


</RCAT:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock>
    <RCAT:NumberOfWarrantsUponIssuance
      contextRef="From2020-10-012020-10-31"
      decimals="INF"
      id="ixv-15192"
      unitRef="Shares">399998</RCAT:NumberOfWarrantsUponIssuance>
    <RCAT:InitialFairValueOfWarrantsUponIssuance
      contextRef="From2020-10-012020-10-31"
      decimals="0"
      id="ixv-15193"
      unitRef="USD">267999</RCAT:InitialFairValueOfWarrantsUponIssuance>
    <RCAT:NumberOfWarrantsOutstanding
      contextRef="AsOf2024-04-30"
      decimals="INF"
      id="ixv-15194"
      unitRef="Shares">266666</RCAT:NumberOfWarrantsOutstanding>
    <RCAT:FairValueOfWarrantsOutstanding
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15195"
      unitRef="USD">209938</RCAT:FairValueOfWarrantsOutstanding>
    <RCAT:NumberOfWarrantsUponIssuance
      contextRef="From2021-04-012021-04-30"
      decimals="INF"
      id="ixv-15196"
      unitRef="Shares">675000</RCAT:NumberOfWarrantsUponIssuance>
    <RCAT:InitialFairValueOfWarrantsUponIssuance
      contextRef="From2021-04-012021-04-30"
      decimals="0"
      id="ixv-15197"
      unitRef="USD">2870666</RCAT:InitialFairValueOfWarrantsUponIssuance>
    <RCAT:NumberOfWarrantsOutstanding2
      contextRef="AsOf2024-04-30"
      decimals="INF"
      id="ixv-15198"
      unitRef="Shares">540000</RCAT:NumberOfWarrantsOutstanding2>
    <RCAT:FairValueOfWarrantsOutstanding2
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-15199"
      unitRef="USD">443242</RCAT:FairValueOfWarrantsOutstanding2>
    <RCAT:ProceedsReceivedFromExerciseOfWarrants
      contextRef="From2022-03-012022-04-30"
      decimals="0"
      id="ixv-15200"
      unitRef="USD">301248</RCAT:ProceedsReceivedFromExerciseOfWarrants>
    <RCAT:ExerciseOfWarrantsShares
      contextRef="From2022-03-012022-04-30"
      decimals="INF"
      id="ixv-15201"
      unitRef="Shares">268332</RCAT:ExerciseOfWarrantsShares>
    <RCAT:WarrantsToPurchaseSharesIssued
      contextRef="From2022-05-012022-05-31"
      decimals="INF"
      id="ixv-15202"
      unitRef="Shares">200000</RCAT:WarrantsToPurchaseSharesIssued>
    <RCAT:WarrantsIssuedExercisePrice
      contextRef="From2022-05-012022-05-31"
      decimals="INF"
      id="ixv-15203"
      unitRef="USDPShares">5.00</RCAT:WarrantsIssuedExercisePrice>
    <RCAT:WarrantsToPurchaseSharesIssued
      contextRef="From2023-04-012023-04-30"
      decimals="INF"
      id="ixv-15204"
      unitRef="Shares">533333</RCAT:WarrantsToPurchaseSharesIssued>
    <RCAT:WarrantsIssuedExercisePrice
      contextRef="From2023-04-012023-04-30"
      decimals="INF"
      id="ixv-15205"
      unitRef="USDPShares">5.625</RCAT:WarrantsIssuedExercisePrice>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-11473">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_zJcU7WkxDr3g" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%" summary="xdx: Disclosure - Assumptions used to estimate fair value of stock warrants granted (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zQFMb5AWOQp9"&gt;4.25&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zWd6PqRFV4fg"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1192"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zqQqSW2KsB2k"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1193"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zFMXQHHtWFij"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1194"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Expected term (in years)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zu29Ss1ODlQa"&gt;5.00&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2014;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;Expected volatility&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_zMwycctXaBIb"&gt;205.50&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantAssumptionsUsedMember_z6hX24aKQBRd"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1197"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2023-05-012024-04-30_custom_WarrantAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15206"
      unitRef="Pure">0.0425</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-05-012024-04-30_custom_WarrantAssumptionsUsedMember"
      id="ixv-15207">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2023-05-012024-04-30_custom_WarrantAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15208"
      unitRef="Pure">2.0550</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-11545">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zsdFJDMohnN8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Changes in warrants outstanding (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
    of Shares&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-average
    Exercise Price per Share&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;Weighted-average
                                            Remaining Contractual Term&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(in
    years)&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate
    Intrinsic Value&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance as of April 30, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zTW3ZBJWhzde" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,539,999&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zo1SLf91aMLl" style="font-size: 10pt"&gt;3.38&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20210501__20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z7rVNAKJOWTi" style="font-size: 10pt"&gt;3.89&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zH26NEBRYuvc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;427,533&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 10pt; width: 35%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; width: 12%"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_znif4T3RcJua" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1204"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; width: 12%"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zxhPX5rdpN7e" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1205"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zPHx8GRBEyVg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1206"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zvwPqGg9Id1l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1207"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of April 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zjvR3ErN3P7i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,539,999&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zfRHpMCEPmwc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.38&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20220501__20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zhJ9DYhfua59" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.89&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zFf9i1nIvMRc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1211"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zJY4pO2gXjI9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;736,000&lt;/span&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zdiq75j8N6F7"&gt;0.63&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zangf3TGQe9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1214"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z1lfEfCZUQNl"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1215"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at April 30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zxpBA2wbZjV7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,275,999&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zLvgU96LzJdk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.49&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20230501__20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z0Ddk3rPDzo6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.77&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zwAMcfA1BcA1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;666,080&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-04-30_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-15209"
      unitRef="Shares">1539999</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="AsOf2022-04-30_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-15210"
      unitRef="USDPShares">3.38</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="From2021-05-012022-04-30_custom_WarrantsOutstanding1Member"
      id="ixv-15211">P3Y10M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2022-04-30_custom_WarrantsOutstanding1Member"
      decimals="0"
      id="ixv-15212"
      unitRef="USD">427533</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-04-30_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-15213"
      unitRef="Shares">1539999</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="AsOf2023-04-30_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-15214"
      unitRef="USDPShares">3.38</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="From2022-05-012023-04-30_custom_WarrantsOutstanding1Member"
      id="ixv-15215">P2Y10M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-05-012024-04-30_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-15216"
      unitRef="Shares">736000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-05-012024-04-30_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-15217"
      unitRef="USDPShares">0.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-04-30_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-15218"
      unitRef="Shares">2275999</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="AsOf2024-04-30_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-15219"
      unitRef="USDPShares">2.49</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="From2023-05-012024-04-30_custom_WarrantsOutstanding1Member"
      id="ixv-15220">P2Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2024-04-30_custom_WarrantsOutstanding1Member"
      decimals="0"
      id="ixv-15221"
      unitRef="USD">666080</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-11846">&lt;p id="xdx_80A_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_z10bcvI9UIt" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_828_zhfV6RI7SuAf"&gt;Note
19 &#x2013; Share Based Awards&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;The
2019 Equity Incentive Plan (the "Plan") allows us to incentivize key employees, consultants, and directors with long term compensation
awards such as stock options, restricted stock, and restricted stock units (collectively, the "Awards"). The number of shares
issuable in connection with Awards under the Plan may not exceed &lt;span id="xdx_90E_ecustom--NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum_c20230501__20240430_zpckOMdwMUD8"&gt;11,750,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;A.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Options&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;The
range of assumptions used to calculate the fair value of options granted during the year ended April 30 was:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfAssumptionsUsed1TableTextBlock_zlJsdOqFLd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Assumptions used to calculate fair value of options granted (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; font-size: 12pt; padding-bottom: 1pt; padding-left: 5.4pt; width: 51%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Exercise Price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_znr5WCUPbCP"&gt;0.72&lt;/span&gt;
                                       &#x2013; &lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zHbG3tmqs4L"&gt;1.12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zVXfTOgwyk4c"&gt;0.89&lt;/span&gt; &#x2013; &lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zkbYGggAn3ea"&gt;2.38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Stock price on date of grant&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zjBycKek9mpk"&gt;0.70&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z0JKFik2vpkc"&gt;1.12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zGtDkv14j5p4"&gt;0.89&lt;/span&gt; &#x2013; &lt;span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zvfA2hkLNG6l"&gt;2.38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt; &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zmXWPdFCN85i"&gt;3.46&lt;/span&gt;&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zN2NFFOAl9n6"&gt;4.41&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zul8iVPo6PW7"&gt;3.34&lt;/span&gt; &#x2013; &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zBNgmE0Chh0c"&gt;4.18&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zjAMVTqHJoDh"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1237"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zM3kr2EDyfcb"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1238"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Expected term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zWRksUn4u3Zh"&gt;5.28&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dtY_c20230501__20240430_zNHiDYXCl967"&gt;8.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pip0_dtY_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zruNJFgz5wdf"&gt;6.25&lt;/span&gt; &#x2013;&lt;span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_pip0_dtY_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zpwSLuFgA2m5"&gt; 8.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zuT1upOL7n9l" style="font-size: 10pt"&gt;206.99&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zvsJVhzHcbQk"&gt;262.07&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zmHcQktbERCa"&gt;245.57&lt;/span&gt; &#x2013; &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zhZz3gVuuXPj"&gt;260.06&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_z3DArA8jR2xd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&#160;&#160;&lt;span style="background-color: white"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;A
summary of options activity under the Plan since April 30, 2022 was:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_z5BxiEb8u2p4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of activity under the Plan (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-Average
    Exercise Price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-Average
    Remaining Contractual Term&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate
    Intrinsic Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 5.4pt; width: 45%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding
    as of April 30, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z9JddxlLgW45" style="text-align: right; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,694,142&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zDfQygnCPCS3" style="text-align: right; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.17&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; width: 10%"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20210501__20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zGwlEPulhxN" style="font-size: 10pt"&gt;8.56&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zbymHYYhCbFf" style="text-align: right; width: 10%"&gt;&lt;span style="font-size: 10pt"&gt;1,407,545&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zHVGkEKKMFai" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,503,500&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zOWUkHLe1st9" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.40&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zOyBMZy95HX6" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1255"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zsBav4TEliq9" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1256"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited
    or expired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zrW8u4ZZ9JLf" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(412,833&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zhdPZhIPzwUj" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.67&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of April
    30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zRSYnvSeXz3k" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,784,809&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zgq68MUr38H1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.88&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zB5q62szJRI3" style="font-size: 10pt"&gt;8.72&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zvgCYYRYVGSk" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;74,586&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zUlbR3r75jh7" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,903,542&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zTryk9fE3Q2g" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1.02&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zpGkhHfXKiOh" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_ziMGzb74CkBa" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0.89&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited
    or expired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z17Tq6RDB5e7" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(905,417&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zt4VdGNJkAPh" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2.27&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of April
    30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zV9ZP6gH2lVf" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,779,934&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zhOok9YBrO74" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.46&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zebS582N3eX5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8.02&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zDC90se1bOvk" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,762,242&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercisable as of April
    30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zgjZ1UjN8Pci" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,578,756&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zyXxS8pebzn5" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.78&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_pip0_dtY_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zgQszYc0IZ06" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.77&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zIFtUMZ7G9P5" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,246,497&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A8_zGRmYjvNuSY8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&#160;&lt;span style="background-color: white"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;The
aggregate intrinsic value of outstanding options represents the excess of the stock price at the indicated date over the exercise price
of each option. As of April 30, 2024 and April 30, 2023, there was $&lt;span id="xdx_902_ecustom--UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions_c20230501__20240430_zZoeAsxhxJOd"&gt;943,648 &lt;/span&gt; and $&lt;span id="xdx_903_ecustom--UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions_c20220501__20230430_zcRltzszwp71"&gt;2,940,239 &lt;/span&gt; of unrecognized stock-based compensation expense
related to unvested stock options which is expected to be recognized over the weighted average periods of 1.95 and 1.94 years, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;B.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Restricted Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;A
summary of restricted stock activity under the Plan since April 30, 2022 was:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z84tdguiL5Rl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Summary of restricted stock activity under the Plan (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: -10pt; text-align: center"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Weighted Average Grant-Date Fair Value Per Share&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt; width: 52%"&gt;Unvested and outstanding as of April 30, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zV8dAXgikZgj" style="text-align: right; width: 20%"&gt;1,083,675&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zhXB56LbIqZ3" style="text-align: right; width: 20%"&gt;2.59&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z4jVvh0rQXr3" style="text-align: right"&gt;780,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zHv6OUJbVmt9" style="text-align: right"&gt;2.14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zQ8MxyxITMWa" style="text-align: right"&gt;(1,062,372&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zOb6h99Xb7M9" style="text-align: right"&gt;2.42&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zq6ViujPLwkf" style="border-bottom: Black 1pt solid; text-align: right"&gt;(21,127&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zMEAvNtQfW98" style="border-bottom: Black 1pt solid; text-align: right"&gt;2.13&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Unvested and outstanding as of April 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zf0VHQ1spJak" style="text-align: right"&gt;781,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zf5lBVZ5H87k" style="text-align: right"&gt;2.44&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzWnvNEyDM8h" style="text-align: right"&gt;298,643&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zc1G6x12U2B4" style="text-align: right"&gt;1.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zgBw5Arl4w0c" style="text-align: right"&gt;(485,024&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zXvowxgTscu6" style="text-align: right"&gt;1.92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzmxbe74ulea" style="border-bottom: Black 1pt solid; text-align: right"&gt;(419,549&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zCcY2OlxCoEi" style="border-bottom: Black 1pt solid; text-align: right"&gt;2.09&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Unvested and outstanding as of April 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zRbhP7FOc4Rf" style="border-bottom: Black 3pt double; text-align: right"&gt;175,130&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zCQ8YUGgjMm3" style="border-bottom: Black 3pt double; text-align: right"&gt;2.09&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_z49cwLUvr352" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&#160;&lt;span style="background-color: white"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&#160;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;C.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Stock Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Stock
compensation expense by functional operating expense was:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_zthfBHLiJRfg" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Stock compensation expense by functional category (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20230501__20240430_zcIPDrqmhWY1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_492_20220501__20230430_zzGJzJJOam09" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ResearchAndDevelopmentStockCompensationExpense_zeYrjtkC57Ki" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Research and development&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;395,105&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;692,947&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SalesAndMarketingStockCompensationExpense_zbYC6Vzdfuc4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Sales and marketing&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;562,110&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;566,153&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--GeneralAndAdministrativeStockCompensationExpense_zXISc5acHtK5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;General and administrative&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;2,652,052&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;2,397,624&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--TotalStockCompensationExpense_zGbdAjOOIZx2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;3,609,267&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;3,656,724&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Stock compensation expense pertaining to options totaled
$&lt;span id="xdx_906_ecustom--StockCompensationExpensePertainingToOptions_c20230501__20240430_z8umk4xuPXQ4"&gt;2,619,501 &lt;/span&gt; and
$&lt;span id="xdx_90F_ecustom--StockCompensationExpensePertainingToOptions_c20220501__20230430_zjbpv0lroDOg"&gt;1,617,982 &lt;/span&gt; for the year ended April 30, 2024 and 2023, respectively. Stock compensation expense pertaining to restricted
stock totaled $&lt;span id="xdx_90E_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20230501__20240430_zYVyrNIfyO0l"&gt;989,766&lt;/span&gt; and $&lt;span id="xdx_901_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20220501__20230430_zA1TpSTKGV4j"&gt;2,038,742 &lt;/span&gt;  for the year ended April 30, 2024 and 2023, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <RCAT:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum
      contextRef="From2023-05-01to2024-04-30"
      decimals="INF"
      id="ixv-15222"
      unitRef="Shares">11750000</RCAT:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum>
    <RCAT:ScheduleOfAssumptionsUsed1TableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-11872">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfAssumptionsUsed1TableTextBlock_zlJsdOqFLd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Assumptions used to calculate fair value of options granted (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; font-size: 12pt; padding-bottom: 1pt; padding-left: 5.4pt; width: 51%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Exercise Price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_znr5WCUPbCP"&gt;0.72&lt;/span&gt;
                                       &#x2013; &lt;span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zHbG3tmqs4L"&gt;1.12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zVXfTOgwyk4c"&gt;0.89&lt;/span&gt; &#x2013; &lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zkbYGggAn3ea"&gt;2.38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Stock price on date of grant&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zjBycKek9mpk"&gt;0.70&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z0JKFik2vpkc"&gt;1.12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zGtDkv14j5p4"&gt;0.89&lt;/span&gt; &#x2013; &lt;span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zvfA2hkLNG6l"&gt;2.38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt; &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zmXWPdFCN85i"&gt;3.46&lt;/span&gt;&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zN2NFFOAl9n6"&gt;4.41&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zul8iVPo6PW7"&gt;3.34&lt;/span&gt; &#x2013; &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zBNgmE0Chh0c"&gt;4.18&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zjAMVTqHJoDh"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1237"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zM3kr2EDyfcb"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1238"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Expected term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zWRksUn4u3Zh"&gt;5.28&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dtY_c20230501__20240430_zNHiDYXCl967"&gt;8.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pip0_dtY_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zruNJFgz5wdf"&gt;6.25&lt;/span&gt; &#x2013;&lt;span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_pip0_dtY_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zpwSLuFgA2m5"&gt; 8.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zuT1upOL7n9l" style="font-size: 10pt"&gt;206.99&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20230501__20240430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zvsJVhzHcbQk"&gt;262.07&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zmHcQktbERCa"&gt;245.57&lt;/span&gt; &#x2013; &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pip0_dp_c20220501__20230430__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zhZz3gVuuXPj"&gt;260.06&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</RCAT:ScheduleOfAssumptionsUsed1TableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2024-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15223"
      unitRef="USDPShares">0.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1
      contextRef="AsOf2024-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15224"
      unitRef="USDPShares">1.12</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2023-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15225"
      unitRef="USDPShares">0.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1
      contextRef="AsOf2023-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15226"
      unitRef="USDPShares">2.38</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate
      contextRef="AsOf2024-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15227"
      unitRef="USDPShares">0.70</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1
      contextRef="AsOf2024-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15228"
      unitRef="USDPShares">1.12</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate
      contextRef="AsOf2023-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15229"
      unitRef="USDPShares">0.89</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1
      contextRef="AsOf2023-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15230"
      unitRef="USDPShares">2.38</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2023-05-012024-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15231"
      unitRef="Pure">0.0346</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2023-05-012024-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15232"
      unitRef="Pure">0.0441</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15233"
      unitRef="Pure">0.0334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15234"
      unitRef="Pure">0.0418</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-05-012024-04-30_custom_OptionsAssumptionsUsedMember"
      id="ixv-15235">P5Y3M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2 contextRef="From2023-05-01to2024-04-30" id="ixv-15236">P8Y3M</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember"
      id="ixv-15237">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
      contextRef="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember"
      id="ixv-15238">P8Y3M</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2023-05-012024-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15239"
      unitRef="Pure">2.0699</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2023-05-012024-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15240"
      unitRef="Pure">2.6207</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15241"
      unitRef="Pure">2.4557</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2022-05-012023-04-30_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-15242"
      unitRef="Pure">2.6006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-11982">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_z5BxiEb8u2p4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of activity under the Plan (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-Average
    Exercise Price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-Average
    Remaining Contractual Term&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate
    Intrinsic Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 5.4pt; width: 45%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding
    as of April 30, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z9JddxlLgW45" style="text-align: right; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,694,142&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zDfQygnCPCS3" style="text-align: right; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.17&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; width: 10%"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20210501__20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zGwlEPulhxN" style="font-size: 10pt"&gt;8.56&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zbymHYYhCbFf" style="text-align: right; width: 10%"&gt;&lt;span style="font-size: 10pt"&gt;1,407,545&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zHVGkEKKMFai" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,503,500&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zOWUkHLe1st9" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.40&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zOyBMZy95HX6" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1255"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zsBav4TEliq9" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1256"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited
    or expired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zrW8u4ZZ9JLf" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(412,833&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zhdPZhIPzwUj" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.67&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of April
    30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zRSYnvSeXz3k" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,784,809&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zgq68MUr38H1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.88&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20220501__20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zB5q62szJRI3" style="font-size: 10pt"&gt;8.72&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zvgCYYRYVGSk" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;74,586&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zUlbR3r75jh7" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,903,542&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zTryk9fE3Q2g" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1.02&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zpGkhHfXKiOh" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_ziMGzb74CkBa" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0.89&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited
    or expired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z17Tq6RDB5e7" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(905,417&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zt4VdGNJkAPh" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2.27&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of April
    30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zV9ZP6gH2lVf" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,779,934&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zhOok9YBrO74" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.46&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zebS582N3eX5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8.02&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zDC90se1bOvk" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,762,242&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercisable as of April
    30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zgjZ1UjN8Pci" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,578,756&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zyXxS8pebzn5" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.78&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_pip0_dtY_c20230501__20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zgQszYc0IZ06" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.77&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_c20240430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zIFtUMZ7G9P5" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,246,497&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15243"
      unitRef="Shares">3694142</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="AsOf2022-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15244"
      unitRef="USDPShares">2.17</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2021-05-012022-04-30_custom_Options1Member"
      id="ixv-15245">P8Y6M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2022-04-30_custom_Options1Member"
      decimals="0"
      id="ixv-15246"
      unitRef="USD">1407545</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-05-012023-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15247"
      unitRef="Shares">1503500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2022-05-012023-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15248"
      unitRef="USDPShares">1.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2022-05-012023-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15249"
      unitRef="Shares">412833</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-05-012023-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15250"
      unitRef="USDPShares">2.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15251"
      unitRef="Shares">4784809</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="AsOf2023-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15252"
      unitRef="USDPShares">1.88</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2022-05-012023-04-30_custom_Options1Member"
      id="ixv-15253">P8Y8M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2023-04-30_custom_Options1Member"
      decimals="0"
      id="ixv-15254"
      unitRef="USD">74586</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-05-012024-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15255"
      unitRef="Shares">2903542</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-05-012024-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15256"
      unitRef="USDPShares">1.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-05-012024-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15257"
      unitRef="Shares">3000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2023-05-012024-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15258"
      unitRef="USDPShares">0.89</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2023-05-012024-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15259"
      unitRef="Shares">905417</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-05-012024-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15260"
      unitRef="USDPShares">2.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15261"
      unitRef="Shares">6779934</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="AsOf2024-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15262"
      unitRef="USDPShares">1.46</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2023-05-012024-04-30_custom_Options1Member"
      id="ixv-15263">P8Y7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2024-04-30_custom_Options1Member"
      decimals="0"
      id="ixv-15264"
      unitRef="USD">2762242</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15265"
      unitRef="Shares">3578756</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2024-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-15266"
      unitRef="USDPShares">1.78</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2023-05-012024-04-30_custom_Options1Member"
      id="ixv-15267">P6Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="AsOf2024-04-30_custom_Options1Member"
      decimals="0"
      id="ixv-15268"
      unitRef="USD">1246497</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <RCAT:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-15269"
      unitRef="USD">943648</RCAT:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions>
    <RCAT:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-15270"
      unitRef="USD">2940239</RCAT:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-12398">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z84tdguiL5Rl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Summary of restricted stock activity under the Plan (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: -10pt; text-align: center"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Weighted Average Grant-Date Fair Value Per Share&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt; width: 52%"&gt;Unvested and outstanding as of April 30, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zV8dAXgikZgj" style="text-align: right; width: 20%"&gt;1,083,675&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zhXB56LbIqZ3" style="text-align: right; width: 20%"&gt;2.59&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z4jVvh0rQXr3" style="text-align: right"&gt;780,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zHv6OUJbVmt9" style="text-align: right"&gt;2.14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zQ8MxyxITMWa" style="text-align: right"&gt;(1,062,372&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zOb6h99Xb7M9" style="text-align: right"&gt;2.42&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zq6ViujPLwkf" style="border-bottom: Black 1pt solid; text-align: right"&gt;(21,127&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220501__20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zMEAvNtQfW98" style="border-bottom: Black 1pt solid; text-align: right"&gt;2.13&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Unvested and outstanding as of April 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zf0VHQ1spJak" style="text-align: right"&gt;781,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20230430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zf5lBVZ5H87k" style="text-align: right"&gt;2.44&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzWnvNEyDM8h" style="text-align: right"&gt;298,643&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zc1G6x12U2B4" style="text-align: right"&gt;1.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zgBw5Arl4w0c" style="text-align: right"&gt;(485,024&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zXvowxgTscu6" style="text-align: right"&gt;1.92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzmxbe74ulea" style="border-bottom: Black 1pt solid; text-align: right"&gt;(419,549&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zCcY2OlxCoEi" style="border-bottom: Black 1pt solid; text-align: right"&gt;2.09&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Unvested and outstanding as of April 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zRbhP7FOc4Rf" style="border-bottom: Black 3pt double; text-align: right"&gt;175,130&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20240430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zCQ8YUGgjMm3" style="border-bottom: Black 3pt double; text-align: right"&gt;2.09&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber
      contextRef="AsOf2021-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15271"
      unitRef="Shares">1083675</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber>
    <RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15272"
      unitRef="USDPShares">2.59</RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross
      contextRef="From2022-05-012023-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15273"
      unitRef="Shares">780884</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2022-05-012023-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15274"
      unitRef="USDPShares">2.14</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod
      contextRef="From2022-05-012023-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15275"
      unitRef="Shares">1062372</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2022-05-012023-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15276"
      unitRef="USDPShares">2.42</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2022-05-012023-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15277"
      unitRef="Shares">-21127</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-05-012023-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15278"
      unitRef="USDPShares">2.13</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber
      contextRef="AsOf2023-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15279"
      unitRef="Shares">781060</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber>
    <RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15280"
      unitRef="USDPShares">2.44</RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross
      contextRef="From2023-05-012024-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15281"
      unitRef="Shares">298643</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-05-012024-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15282"
      unitRef="USDPShares">1.06</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod
      contextRef="From2023-05-012024-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15283"
      unitRef="Shares">485024</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-05-012024-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15284"
      unitRef="USDPShares">1.92</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2023-05-012024-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15285"
      unitRef="Shares">419549</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-05-012024-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15286"
      unitRef="USDPShares">2.09</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber
      contextRef="AsOf2024-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15287"
      unitRef="Shares">175130</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber>
    <RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-15288"
      unitRef="USDPShares">2.09</RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-12516">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_zthfBHLiJRfg" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Stock compensation expense by functional category (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20230501__20240430_zcIPDrqmhWY1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_492_20220501__20230430_zzGJzJJOam09" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ResearchAndDevelopmentStockCompensationExpense_zeYrjtkC57Ki" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Research and development&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;395,105&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;692,947&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SalesAndMarketingStockCompensationExpense_zbYC6Vzdfuc4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Sales and marketing&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;562,110&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;566,153&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--GeneralAndAdministrativeStockCompensationExpense_zXISc5acHtK5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;General and administrative&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;2,652,052&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;2,397,624&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--TotalStockCompensationExpense_zGbdAjOOIZx2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;3,609,267&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;3,656,724&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Stock compensation expense pertaining to options totaled
$&lt;span id="xdx_906_ecustom--StockCompensationExpensePertainingToOptions_c20230501__20240430_z8umk4xuPXQ4"&gt;2,619,501 &lt;/span&gt; and
$&lt;span id="xdx_90F_ecustom--StockCompensationExpensePertainingToOptions_c20220501__20230430_zjbpv0lroDOg"&gt;1,617,982 &lt;/span&gt; for the year ended April 30, 2024 and 2023, respectively. Stock compensation expense pertaining to restricted
stock totaled $&lt;span id="xdx_90E_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20230501__20240430_zYVyrNIfyO0l"&gt;989,766&lt;/span&gt; and $&lt;span id="xdx_901_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20220501__20230430_zA1TpSTKGV4j"&gt;2,038,742 &lt;/span&gt;  for the year ended April 30, 2024 and 2023, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock>
    <RCAT:ResearchAndDevelopmentStockCompensationExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-15289"
      unitRef="USD">395105</RCAT:ResearchAndDevelopmentStockCompensationExpense>
    <RCAT:ResearchAndDevelopmentStockCompensationExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-15290"
      unitRef="USD">692947</RCAT:ResearchAndDevelopmentStockCompensationExpense>
    <RCAT:SalesAndMarketingStockCompensationExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-15291"
      unitRef="USD">562110</RCAT:SalesAndMarketingStockCompensationExpense>
    <RCAT:SalesAndMarketingStockCompensationExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-15292"
      unitRef="USD">566153</RCAT:SalesAndMarketingStockCompensationExpense>
    <RCAT:GeneralAndAdministrativeStockCompensationExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-15293"
      unitRef="USD">2652052</RCAT:GeneralAndAdministrativeStockCompensationExpense>
    <RCAT:GeneralAndAdministrativeStockCompensationExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-15294"
      unitRef="USD">2397624</RCAT:GeneralAndAdministrativeStockCompensationExpense>
    <RCAT:TotalStockCompensationExpense
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-15295"
      unitRef="USD">3609267</RCAT:TotalStockCompensationExpense>
    <RCAT:TotalStockCompensationExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-15296"
      unitRef="USD">3656724</RCAT:TotalStockCompensationExpense>
    <RCAT:StockCompensationExpensePertainingToOptions
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-15297"
      unitRef="USD">2619501</RCAT:StockCompensationExpensePertainingToOptions>
    <RCAT:StockCompensationExpensePertainingToOptions
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-15298"
      unitRef="USD">1617982</RCAT:StockCompensationExpensePertainingToOptions>
    <RCAT:StockCompensationExpensePertainingToRestrictedStockUnits
      contextRef="From2023-05-01to2024-04-30"
      decimals="0"
      id="ixv-15299"
      unitRef="USD">989766</RCAT:StockCompensationExpensePertainingToRestrictedStockUnits>
    <RCAT:StockCompensationExpensePertainingToRestrictedStockUnits
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      id="ixv-15300"
      unitRef="USD">2038742</RCAT:StockCompensationExpensePertainingToRestrictedStockUnits>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-12573">&lt;p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zCeuTJOA1JFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_822_zmrto8EkK6Q7"&gt;Note
20 - Related-Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;In
January 2022, the Company entered into a note agreement with an employee in the principal amount of $510,323, as further described in
Note 7.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;In
February 2024, the Company sold Rotor Riot and Fat Shark to Unusual Machines, as further described in Note 3 and Note 9. UMAC&#x2019;s
Chief Executive Officer is a direct relative of a member of the Company&#x2019;s management.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;Additional
related party transactions are disclosed in Note 14.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-12603">&lt;p id="xdx_80B_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zjcUp5DmeAv3" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82D_zb3uvmSSls8d"&gt;Note
21 &#x2013; Commitments and Contingencies&lt;/span&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-size: 8pt; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt/11.75pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;Legal
Proceedings&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;In
the ordinary course of business, we may be involved, at times, in various legal proceedings involving a variety of matters. We do not
believe there are any pending legal proceedings that will have a material adverse effect on our business, consolidated financial position,
results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant
uncertainties. We have not recorded any litigation reserves as of&#160;April 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;One pending
legal matter is an action filed against Teal and the Company in a U.S. District Court in California.&#160;The complaint asserts claims
for breach of contract, and the unlawful conversion and sale of shares of common stock that plaintiff alleges to have purchased in Teal
prior to its acquisition by the Company. The complaint also alleges breach of fiduciary duty and seeks in excess of $1 million in damages.
The Company plans to vigorously assert defenses to the complaint.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Another pending legal matter is an action filed against
Teal in a U.S. District Court in Delaware. The complaint asserts claims for breach of contract which management denies. We are asserting
vigorous defenses to the complaint. Additionally, the Company has filed a lawsuit against the complainant for Tortious Interference with
Contractual Relations and Prospective Contractual Relations. No discovery or other significant developments in the Lawsuit have occurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="background-color: yellow"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2023-05-01to2024-04-30" id="ixv-12626">&lt;p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zYDkfI5lm2B4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82A_zTmqKKtFM0dg"&gt;Note
22 &#x2013; Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;Subsequent events have been evaluated
through the date of this filing and there are no subsequent events which require disclosure, except as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;As described in Note 3, the SPA pertaining
to the divestiture of the Consumer segment provided that the purchase price was to be increased on a dollar-for-dollar basis by the amount
by which the working capital exceeded the agreed working capital (the &#x201c;Working Capital Adjustment&#x201d;). After negotiations between
the parties, it was determined in July 2024 that UMAC owed the Company $2,000,000 as a Working Capital Adjustment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;As a result, UMAC issued the Company
$4,000,000 of its 8% Promissory Notes due November 30, 2025 (the &#x201c;New Notes&#x201d;) reflecting (i) satisfaction and settlement of
working capital adjustments and (ii) a maturity date extension to November 30, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;On July 22, 2024, the Company sold
all of its securities in UMAC to two unaffiliated third-party purchasers (the &#x201c;Purchasers&#x201d;). As part of the transaction,
on July 22, 2024, the Company entered into an Exchange Agreement (the &#x201c;Exchange Agreement&#x201d;) with UMAC pursuant to which the
Company exchanged 4,250,000 shares of UMAC&#x2019;s common stock, par value $0.001 per share, for 4,250 shares of UMAC&#x2019;s newly designated
Series A Convertible Preferred Stock (the &#x201c;Series A&#x201d;). The Company sold the Series A and the New Notes to the Purchasers
for $4.4 million in cash pursuant to a Purchase Agreement in a transaction that closed on July 22, 2024.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
